primaryid,caseid,age,sex,event_dt,fda_dt,serious,drugname,pt,outc_cod,ae_text,week
100289774,10028977,53,M,,20250806,,DICLOFENAC POTASSIUM,Fixed eruption,HO,DICLOFENAC POTASSIUM | Fixed eruption | HO,NaT
1078729226,10787292,51,F,2015-01-16,20250926,,XOLAIR,Middle insomnia,OT,XOLAIR | Middle insomnia | OT,2015-01-12/2015-01-18
111462422,11146242,68,F,2012-10-13,20250805,,HYDROCHLOROTHIAZIDE\VALSARTAN,Infarction,DS,HYDROCHLOROTHIAZIDE\VALSARTAN | Infarction | DS,2012-10-08/2012-10-14
120429906,12042990,54,F,2016-01-07,20250709,,ALLEGRA,Asthma,HO,ALLEGRA | Asthma | HO,2016-01-04/2016-01-10
120984983,12098498,75,F,,20250810,,SYMBICORT,Sensation of foreign body,,SYMBICORT | Sensation of foreign body,NaT
128724082,12872408,,M,2014-06-01,20250916,,OXYCONTIN,Overdose,DE,OXYCONTIN | Overdose | DE,2014-05-26/2014-06-01
130932869,13093286,18,F,,20250716,,FENTANYL CITRATE,Adrenal insufficiency,OT,FENTANYL CITRATE | Adrenal insufficiency | OT,NaT
132340786,13234078,59,F,2017-02-02,20250715,,COSENTYX,Dysphagia,HO,COSENTYX | Dysphagia | HO,2017-01-30/2017-02-05
137398815,13739881,,M,,20250903,,AMITRIPTYLINE HYDROCHLORIDE,Drug interaction,OT,AMITRIPTYLINE HYDROCHLORIDE | Drug interaction | OT,NaT
138806013,13880601,14,,,20250808,,LACOSAMIDE,Drug interaction,OT,LACOSAMIDE | Drug interaction | OT,NaT
139282123,13928212,76,M,,20250915,,MYCOPHENOLATE MOFETIL,Aplasia pure red cell,LT,MYCOPHENOLATE MOFETIL | Aplasia pure red cell | LT,NaT
139400183,13940018,60,F,,20250901,,PREDNISONE,Posterior reversible encephalopathy syndrome,LT,PREDNISONE | Posterior reversible encephalopathy syndrome | LT,NaT
144261993,14426199,64,F,2016-01-01,20250829,,CLOPIDOGREL BISULFATE,Pain,HO,CLOPIDOGREL BISULFATE | Pain | HO,2015-12-28/2016-01-03
146792669,14679266,48,M,2018-03-01,20250828,,BOSULIF,Memory impairment,,BOSULIF | Memory impairment,2018-02-26/2018-03-04
148544778,14854477,13,M,,20250804,,PREDNISONE,Mouth ulceration,OT,PREDNISONE | Mouth ulceration | OT,NaT
149515208,14951520,70,F,2017-04-01,20250918,,TAFINLAR,Pleural effusion,DE,TAFINLAR | Pleural effusion | DE,2017-03-27/2017-04-02
150131879,15013187,8,,,20250803,,BUSULFAN,Thrombocytopenia,OT,BUSULFAN | Thrombocytopenia | OT,NaT
151350882,15135088,49,F,2018-05-01,20250812,,KALYDECO,Infective pulmonary exacerbation of cystic fibrosis,HO,KALYDECO | Infective pulmonary exacerbation of cystic fibrosis | HO,2018-04-30/2018-05-06
151706353,15170635,,M,,20250708,,RAMIPRIL,Premature baby,CA,RAMIPRIL | Premature baby | CA,NaT
152537184,15253718,53,M,,20250709,,TACROLIMUS,Dysgraphia,HO,TACROLIMUS | Dysgraphia | HO,NaT
1529742241,15297422,36,F,,20250912,,ACTEMRA,Hepatic enzyme increased,OT,ACTEMRA | Hepatic enzyme increased | OT,NaT
153050754,15305075,67,F,,20250709,,RACECADOTRIL,Colitis microscopic,OT,RACECADOTRIL | Colitis microscopic | OT,NaT
153196952,15319695,,,,20250717,,RIBAVIRIN,Drug ineffective,OT,RIBAVIRIN | Drug ineffective | OT,NaT
153503392,15350339,37,F,,20250717,,OXALIPLATIN,Hemianaesthesia,OT,OXALIPLATIN | Hemianaesthesia | OT,NaT
154724003,15472400,78,F,2015-01-01,20250715,,CIPROFLOXACIN,Cerebral amyloid angiopathy,HO,CIPROFLOXACIN | Cerebral amyloid angiopathy | HO,2014-12-29/2015-01-04
155158142,15515814,82,M,,20250814,,METFORMIN,Sweat gland tumour,HO,METFORMIN | Sweat gland tumour | HO,NaT
155346622,15534662,55,M,,20250721,,OXYCODONE,Drug dependence,HO,OXYCODONE | Drug dependence | HO,NaT
155467542,15546754,58,M,,20250718,,DAPSONE,Treatment failure,OT,DAPSONE | Treatment failure | OT,NaT
155600852,15560085,4,M,,20250718,,AZITHROMYCIN,Acoustic neuroma,DS,AZITHROMYCIN | Acoustic neuroma | DS,NaT
155784503,15578450,53,M,,20250701,,FLUCONAZOLE,Mucormycosis,OT,FLUCONAZOLE | Mucormycosis | OT,NaT
156885832,15688583,41,M,,20250722,,ACETAMINOPHEN,Acute hepatic failure,LT,ACETAMINOPHEN | Acute hepatic failure | LT,NaT
157546482,15754648,,,,20250901,,MYCOPHENOLATE MOFETIL,Off label use,OT,MYCOPHENOLATE MOFETIL | Off label use | OT,NaT
157741902,15774190,73,F,,20250709,,IBUPROFEN,Drug dependence,OT,IBUPROFEN | Drug dependence | OT,NaT
157786842,15778684,31,F,,20250710,,PREDNISONE,Lymphadenopathy mediastinal,OT,PREDNISONE | Lymphadenopathy mediastinal | OT,NaT
157875062,15787506,36,M,,20250725,,BUPROPION HYDROCHLORIDE,Toxicity to various agents,DE,BUPROPION HYDROCHLORIDE | Toxicity to various agents | DE,NaT
157957362,15795736,30,M,,20250724,,BUPROPION HYDROCHLORIDE,Intentional overdose,DE,BUPROPION HYDROCHLORIDE | Intentional overdose | DE,NaT
158520222,15852022,37,M,,20250924,,PREGABALIN,Toxicity to various agents,OT,PREGABALIN | Toxicity to various agents | OT,NaT
159225323,15922532,42,F,,20250728,,ACETAMINOPHEN,Biliary colic,HO,ACETAMINOPHEN | Biliary colic | HO,NaT
159605732,15960573,10,F,,20250911,,BOSENTAN,Condition aggravated,DE,BOSENTAN | Condition aggravated | DE,NaT
159891082,15989108,68,F,,20250723,,LOSARTAN,Acquired digital fibrokeratoma,OT,LOSARTAN | Acquired digital fibrokeratoma | OT,NaT
1601105712,16011057,46,M,2018-02-08,20250923,,LEVOTHYROXINE SODIUM,Insomnia,OT,LEVOTHYROXINE SODIUM | Insomnia | OT,2018-02-05/2018-02-11
160435815,16043581,,M,,20250822,,VEDOLIZUMAB,Hypoacusis,HO,VEDOLIZUMAB | Hypoacusis | HO,NaT
161158602,16115860,92,F,,20250703,,PIPERACILLIN AND TAZOBACTAM,Drug ineffective,OT,PIPERACILLIN AND TAZOBACTAM | Drug ineffective | OT,NaT
1615636313,16156363,40,F,2017-04-20,20250806,,ALEMTUZUMAB,Thrombocytopenia,HO,ALEMTUZUMAB | Thrombocytopenia | HO,2017-04-17/2017-04-23
161624012,16162401,67,M,,20250723,,EVEROLIMUS,Renal tubular disorder,OT,EVEROLIMUS | Renal tubular disorder | OT,NaT
161624492,16162449,73,M,2016-01-01,20250804,,GLICLAZIDE,Weight decreased,OT,GLICLAZIDE | Weight decreased | OT,2015-12-28/2016-01-03
162345872,16234587,36,M,,20250723,,FLUOROURACIL,Arteriospasm coronary,OT,FLUOROURACIL | Arteriospasm coronary | OT,NaT
162588512,16258851,51,F,,20250723,,OLANZAPINE,Psychotic disorder,HO,OLANZAPINE | Psychotic disorder | HO,NaT
162631022,16263102,75,,,20250722,,RIBAVIRIN,Drug ineffective,OT,RIBAVIRIN | Drug ineffective | OT,NaT
162742752,16274275,,,,20250721,,BISOPROLOL,Toxicity to various agents,DE,BISOPROLOL | Toxicity to various agents | DE,NaT
163086223,16308622,59,F,,20250723,,IBUPROFEN,Anastomotic ulcer,HO,IBUPROFEN | Anastomotic ulcer | HO,NaT
163420182,16342018,38,F,,20250728,,KEPPRA,Multiple-drug resistance,OT,KEPPRA | Multiple-drug resistance | OT,NaT
1636023511,16360235,,M,2016-01-01,20250807,,TYSABRI,Off label use,OT,TYSABRI | Off label use | OT,2015-12-28/2016-01-03
163709012,16370901,,M,,20250912,,GEMCITABINE,Neurotoxicity,OT,GEMCITABINE | Neurotoxicity | OT,NaT
163762482,16376248,19,F,,20250723,,PREDNISONE,Herpes zoster,OT,PREDNISONE | Herpes zoster | OT,NaT
164129592,16412959,,,,20250715,,RIBAVIRIN,Treatment failure,OT,RIBAVIRIN | Treatment failure | OT,NaT
164304207,16430420,23,F,,20250721,,OLANZAPINE,Speech disorder,HO,OLANZAPINE | Speech disorder | HO,NaT
164374553,16437455,59,M,,20250720,,CARBOPLATIN,Central nervous system lymphoma,DE,CARBOPLATIN | Central nervous system lymphoma | DE,NaT
164442603,16444260,44,F,2018-05-01,20250715,,OXALIPLATIN,Panniculitis,OT,OXALIPLATIN | Panniculitis | OT,2018-04-30/2018-05-06
164721374,16472137,79,M,2012-10-21,20250722,,REPAGLINIDE,Drug interaction,OT,REPAGLINIDE | Drug interaction | OT,2012-10-15/2012-10-21
165273795,16527379,15,M,2018-03-01,20250923,,ICLUSIG,Congenital megacolon,CA,ICLUSIG | Congenital megacolon | CA,2018-02-26/2018-03-04
165301632,16530163,,F,,20250718,,LETROZOLE,Disease progression,OT,LETROZOLE | Disease progression | OT,NaT
166501092,16650109,,,,20250825,,HERCEPTIN,Incorrect dose administered,OT,HERCEPTIN | Incorrect dose administered | OT,NaT
166598093,16659809,,F,2019-01-01,20250909,,VEDOLIZUMAB,Crohn's disease,HO,VEDOLIZUMAB | Crohn's disease | HO,2018-12-31/2019-01-06
168207155,16820715,,M,,20250918,,VEDOLIZUMAB,Pancreatitis,HO,VEDOLIZUMAB | Pancreatitis | HO,NaT
168837084,16883708,42,M,,20250701,,TOBRAMYCIN,Condition aggravated,OT,TOBRAMYCIN | Condition aggravated | OT,NaT
168959145,16895914,,,,20250813,,AMPICILLIN,Drug ineffective,DE,AMPICILLIN | Drug ineffective | DE,NaT
169128414,16912841,51,F,2016-01-01,20250822,,PACLITAXEL,Drug interaction,LT,PACLITAXEL | Drug interaction | LT,2015-12-28/2016-01-03
169504602,16950460,69,F,2018-01-01,20250926,,LATUDA,Tremor,OT,LATUDA | Tremor | OT,2018-01-01/2018-01-07
169822782,16982278,83,F,,20250821,,AMLODIPINE,Plasma cell myeloma,HO,AMLODIPINE | Plasma cell myeloma | HO,NaT
170290892,17029089,71,M,,20250822,,ASPIRIN,Tumour lysis syndrome,HO,ASPIRIN | Tumour lysis syndrome | HO,NaT
170292193,17029219,89,M,,20250705,,LERCANIDIPINE,Pericardial effusion,DE,LERCANIDIPINE | Pericardial effusion | DE,NaT
1705309618,17053096,73,F,,20250908,,XELJANZ XR,Abdominal discomfort,,XELJANZ XR | Abdominal discomfort,NaT
170735072,17073507,76,F,,20250825,,FUROSEMIDE,Renal artery stenosis,HO,FUROSEMIDE | Renal artery stenosis | HO,NaT
171305703,17130570,75,F,,20250818,,COSENTYX,Nasopharyngitis,OT,COSENTYX | Nasopharyngitis | OT,NaT
171328582,17132858,22,M,,20250718,,CLOZAPINE,Psychotic symptom,OT,CLOZAPINE | Psychotic symptom | OT,NaT
171671172,17167117,56,M,,20250710,,DEXAMETHASONE,Venoocclusive liver disease,LT,DEXAMETHASONE | Venoocclusive liver disease | LT,NaT
1719240638,17192406,,,2019-10-28,20250715,,INFLECTRA,Off label use,HO,INFLECTRA | Off label use | HO,2019-10-28/2019-11-03
171932574,17193257,16,M,2019-11-12,20250904,,ADVATE,Nasopharyngitis,OT,ADVATE | Nasopharyngitis | OT,2019-11-11/2019-11-17
172024082,17202408,83,F,,20250729,,BISOPROLOL,Bronchial secretion retention,OT,BISOPROLOL | Bronchial secretion retention | OT,NaT
1721976915,17219769,,F,,20250929,,HUMAN IMMUNOGLOBULIN G,Hypersensitivity,HO,HUMAN IMMUNOGLOBULIN G | Hypersensitivity | HO,NaT
172398962,17239896,62,F,,20250709,,CIPROFLOXACIN,Secondary adrenocortical insufficiency,OT,CIPROFLOXACIN | Secondary adrenocortical insufficiency | OT,NaT
172630256,17263025,65,M,,20250729,,XELJANZ XR,Memory impairment,,XELJANZ XR | Memory impairment,NaT
1732409719,17324097,,F,2021-01-01,20250711,,BELIMUMAB,Headache,,BELIMUMAB | Headache,2020-12-28/2021-01-03
173753017,17375301,59,M,,20250707,,METHOTREXATE,Cachexia,OT,METHOTREXATE | Cachexia | OT,NaT
174116512,17411651,53,F,,20250711,,TRANEXAMIC ACID,Back pain,OT,TRANEXAMIC ACID | Back pain | OT,NaT
174182982,17418298,,F,,20250821,,REMODULIN,Aversion,,REMODULIN | Aversion,NaT
174384415,17438441,73,M,2012-01-01,20250826,,RIBAVIRIN,Hepatitis E,OT,RIBAVIRIN | Hepatitis E | OT,2011-12-26/2012-01-01
174391662,17439166,,M,,20250701,,BENDAMUSTINE HYDROCHLORIDE,Pneumonia,HO,BENDAMUSTINE HYDROCHLORIDE | Pneumonia | HO,NaT
174664552,17466455,60,M,2018-01-01,20250806,,FUROSEMIDE,Dyspnoea,OT,FUROSEMIDE | Dyspnoea | OT,2018-01-01/2018-01-07
174742523,17474252,48,M,,20250704,,FLUOROURACIL,Agitation,HO,FLUOROURACIL | Agitation | HO,NaT
174864152,17486415,64,F,,20250801,,ONDANSETRON,Seizure,HO,ONDANSETRON | Seizure | HO,NaT
175317526,17531752,,F,,20250707,,GILENYA,Lymphocyte count decreased,OT,GILENYA | Lymphocyte count decreased | OT,NaT
1754971922,17549719,71,F,2024-01-02,20250708,,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Product dose omission issue,HO,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN | Product dose omission issue | HO,2024-01-01/2024-01-07
1755998736,17559987,76,F,2022-09-19,20250928,,.ALPHA.1-PROTEINASE INHIBITOR HUMAN,Fungal foot infection,OT,.ALPHA.1-PROTEINASE INHIBITOR HUMAN | Fungal foot infection | OT,2022-09-19/2022-09-25
175645973,17564597,,F,,20250711,,ILUMYA,Product dose omission issue,HO,ILUMYA | Product dose omission issue | HO,NaT
175966192,17596619,53,F,,20250703,,METHOTREXATE,Thrombocytopenia,HO,METHOTREXATE | Thrombocytopenia | HO,NaT
176886622,17688662,30,M,2019-09-01,20250711,,PALIPERIDONE PALMITATE,Increased appetite,CA,PALIPERIDONE PALMITATE | Increased appetite | CA,2019-08-26/2019-09-01
177093552,17709355,67,M,2012-01-01,20250704,,OLANZAPINE,Parkinsonism,HO,OLANZAPINE | Parkinsonism | HO,2011-12-26/2012-01-01
177351392,17735139,71,F,2020-04-02,20250703,,TYMLOS,Heart rate increased,,TYMLOS | Heart rate increased,2020-03-30/2020-04-05
177575167,17757516,,M,2016-01-01,20250808,,VIREAD,Quality of life decreased,OT,VIREAD | Quality of life decreased | OT,2015-12-28/2016-01-03
177685192,17768519,63,M,,20250703,,CLOPIDOGREL,Abdominal mass,HO,CLOPIDOGREL | Abdominal mass | HO,NaT
177688313,17768831,19,F,,20250922,,VENLAFAXINE,Intentional self-injury,OT,VENLAFAXINE | Intentional self-injury | OT,NaT
177775844,17777584,,,,20250819,,LEFLUNOMIDE,Renal aplasia,CA,LEFLUNOMIDE | Renal aplasia | CA,NaT
177961414,17796141,64,F,2013-12-12,20250804,,XOLAIR,Dyspnoea,HO,XOLAIR | Dyspnoea | HO,2013-12-09/2013-12-15
178116512,17811651,54,F,2018-03-06,20250709,,SANDOSTATIN LAR DEPOT,Diarrhoea,HO,SANDOSTATIN LAR DEPOT | Diarrhoea | HO,2018-03-05/2018-03-11
178840503,17884050,17,M,,20250715,,CYTARABINE,Drug ineffective,HO,CYTARABINE | Drug ineffective | HO,NaT
179139702,17913970,53,F,,20250708,,COMBIVENT,Dyspnoea,OT,COMBIVENT | Dyspnoea | OT,NaT
1792605155,17926051,31,F,2020-10-24,20250917,,HUMAN IMMUNOGLOBULIN G,Pneumonia,HO,HUMAN IMMUNOGLOBULIN G | Pneumonia | HO,2020-10-19/2020-10-25
179330162,17933016,78,M,,20250826,,FUROSEMIDE,Iron deficiency anaemia,OT,FUROSEMIDE | Iron deficiency anaemia | OT,NaT
179808455,17980845,78,M,,20250701,,LOPINAVIR\RITONAVIR,Hyperreflexia,HO,LOPINAVIR\RITONAVIR | Hyperreflexia | HO,NaT
1799247215,17992472,74,F,2023-05-19,20250917,,HUMAN IMMUNOGLOBULIN G,Pyrexia,OT,HUMAN IMMUNOGLOBULIN G | Pyrexia | OT,2023-05-15/2023-05-21
180390832,18039083,82,F,,20250703,,METFORMIN,Metabolic acidosis,HO,METFORMIN | Metabolic acidosis | HO,NaT
180764244,18076424,64,F,2025-01-01,20250826,,MEPOLIZUMAB,Pneumonia bacterial,HO,MEPOLIZUMAB | Pneumonia bacterial | HO,2024-12-30/2025-01-05
1811472514,18114725,52,F,2018-10-02,20250814,,OCREVUS,Headache,HO,OCREVUS | Headache | HO,2018-10-01/2018-10-07
181601544,18160154,38,M,,20250706,,AZITHROMYCIN,Off label use,HO,AZITHROMYCIN | Off label use | HO,NaT
1818939135,18189391,36,F,2019-09-05,20250701,,HUMAN IMMUNOGLOBULIN G,Off label use,OT,HUMAN IMMUNOGLOBULIN G | Off label use | OT,2019-09-02/2019-09-08
1821009410,18210094,54,M,2019-11-18,20250822,,VENETOCLAX,Tumour lysis syndrome,LT,VENETOCLAX | Tumour lysis syndrome | LT,2019-11-18/2019-11-24
1822122839,18221228,80,F,2024-01-01,20250924,,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Allergy to plants,HO,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN | Allergy to plants | HO,2024-01-01/2024-01-07
182428633,18242863,,,2020-01-01,20250721,,DESMOPRESSIN ACETATE,Gastric fistula,OT,DESMOPRESSIN ACETATE | Gastric fistula | OT,2019-12-30/2020-01-05
1825455419,18254554,,F,,20250801,,HUMAN IMMUNOGLOBULIN G,Cystitis,OT,HUMAN IMMUNOGLOBULIN G | Cystitis | OT,NaT
182545725,18254572,,F,,20250909,,HUMAN IMMUNOGLOBULIN G,Muscular weakness,OT,HUMAN IMMUNOGLOBULIN G | Muscular weakness | OT,NaT
182768917,18276891,81,M,2020-01-05,20250822,,VENETOCLAX,Syncope,HO,VENETOCLAX | Syncope | HO,2019-12-30/2020-01-05
182826055,18282605,60,F,,20250803,,PACLITAXEL,Autoimmune nephritis,OT,PACLITAXEL | Autoimmune nephritis | OT,NaT
184030314,18403031,54,F,,20250819,,ALPRAZOLAM,Serotonin syndrome,HO,ALPRAZOLAM | Serotonin syndrome | HO,NaT
184197345,18419734,64,F,,20250929,,ALBUTEROL SULFATE,Fatigue,HO,ALBUTEROL SULFATE | Fatigue | HO,NaT
184554389,18455438,45,F,2020-10-26,20250826,,VEDOLIZUMAB,Vomiting,OT,VEDOLIZUMAB | Vomiting | OT,2020-10-26/2020-11-01
184768352,18476835,65,F,,20250821,,CARBOPLATIN,Injection site oedema,HO,CARBOPLATIN | Injection site oedema | HO,NaT
184873243,18487324,,,,20250912,,RITUXIMAB,Blood pressure increased,OT,RITUXIMAB | Blood pressure increased | OT,NaT
184891202,18489120,51,F,,20250912,,RIVASTIGMINE,Nystagmus,HO,RIVASTIGMINE | Nystagmus | HO,NaT
184953622,18495362,40,F,2017-01-01,20250702,,FLUDARABINE PHOSPHATE,Pneumonia,OT,FLUDARABINE PHOSPHATE | Pneumonia | OT,2016-12-26/2017-01-01
1851709218,18517092,66,F,2022-11-26,20250808,,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Chills,OT,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN | Chills | OT,2022-11-21/2022-11-27
186042475,18604247,64,M,2020-08-03,20250721,,RITUXIMAB,Ill-defined disorder,OT,RITUXIMAB | Ill-defined disorder | OT,2020-08-03/2020-08-09
186245212,18624521,,M,2013-05-15,20250725,,OXYCONTIN,Drug dependence,DE,OXYCONTIN | Drug dependence | DE,2013-05-13/2013-05-19
1868282813,18682828,57,M,2020-03-01,20250707,,ENTRESTO,Brain fog,HO,ENTRESTO | Brain fog | HO,2020-02-24/2020-03-01
186927623,18692762,76,M,,20250912,,DIPHENHYDRAMINE,Intentional overdose,HO,DIPHENHYDRAMINE | Intentional overdose | HO,NaT
187219612,18721961,71,F,2018-04-13,20250731,,VALSARTAN,Atrial fibrillation,OT,VALSARTAN | Atrial fibrillation | OT,2018-04-09/2018-04-15
1876011820,18760118,,,2020-11-24,20250822,,GLOFITAMAB,Neutropenia,DE,GLOFITAMAB | Neutropenia | DE,2020-11-23/2020-11-29
1878670357,18786703,49,F,2020-12-21,20250929,,TEDUGLUTIDE,Gastrointestinal disorder,HO,TEDUGLUTIDE | Gastrointestinal disorder | HO,2020-12-21/2020-12-27
188068784,18806878,59,F,2019-01-01,20250730,,HUMIRA,Dizziness,OT,HUMIRA | Dizziness | OT,2018-12-31/2019-01-06
1888054511,18880545,44,F,2021-02-01,20250805,,HUMAN IMMUNOGLOBULIN G,Renal disorder,OT,HUMAN IMMUNOGLOBULIN G | Renal disorder | OT,2021-02-01/2021-02-07
188819072,18881907,84,M,2021-01-09,20250711,,VEKLURY,Chronic kidney disease,OT,VEKLURY | Chronic kidney disease | OT,2021-01-04/2021-01-10
1890303114,18903031,75,M,2021-02-18,20250901,,VEDOLIZUMAB,Faeces soft,OT,VEDOLIZUMAB | Faeces soft | OT,2021-02-15/2021-02-21
189245593,18924559,,F,,20250810,,SYMBICORT,Throat irritation,,SYMBICORT | Throat irritation,NaT
189783174,18978317,,,2021-02-01,20250704,,ESTRADIOL,Injury associated with device,OT,ESTRADIOL | Injury associated with device | OT,2021-02-01/2021-02-07
190159937,19015993,53,M,,20250711,,BOTOX,Sedation,OT,BOTOX | Sedation | OT,NaT
190416652,19041665,50,F,,20250924,,ACETAMINOPHEN,Depression,HO,ACETAMINOPHEN | Depression | HO,NaT
190614642,19061464,28,F,,20250701,,AMOXICILLIN,Exposure during pregnancy,DE,AMOXICILLIN | Exposure during pregnancy | DE,NaT
190890162,19089016,63,F,,20250808,,METFORMIN,Intentional product use issue,OT,METFORMIN | Intentional product use issue | OT,NaT
191323904,19132390,2,F,,20250717,,MYCOPHENOLIC ACID,Epstein-Barr virus infection reactivation,OT,MYCOPHENOLIC ACID | Epstein-Barr virus infection reactivation | OT,NaT
191367622,19136762,,,,20250731,,APTIOM,Blood pressure increased,OT,APTIOM | Blood pressure increased | OT,NaT
1919730841,19197308,49,M,2021-03-02,20250703,,TAKHZYRO,Asthma,HO,TAKHZYRO | Asthma | HO,2021-03-01/2021-03-07
1921764716,19217647,,M,,20250728,,IDURSULFASE,Product use issue,HO,IDURSULFASE | Product use issue | HO,NaT
192336492,19233649,36,M,2021-01-14,20250709,,ENTYVIO,Tubulointerstitial nephritis,HO,ENTYVIO | Tubulointerstitial nephritis | HO,2021-01-11/2021-01-17
192381889,19238188,,F,,20250717,,VEDOLIZUMAB,Therapeutic reaction time decreased,OT,VEDOLIZUMAB | Therapeutic reaction time decreased | OT,NaT
1924006012,19240060,,,,20250702,,ACTEMRA,Heart rate irregular,HO,ACTEMRA | Heart rate irregular | HO,NaT
193017702,19301770,,F,2016-10-18,20250728,,OXYCONTIN,Drug abuse,DE,OXYCONTIN | Drug abuse | DE,2016-10-17/2016-10-23
193524902,19352490,,F,,20250831,,DUPIXENT,Skin haemorrhage,,DUPIXENT | Skin haemorrhage,NaT
1937675713,19376757,21,F,2020-11-06,20250927,,ICATIBANT,Respiratory tract infection viral,HO,ICATIBANT | Respiratory tract infection viral | HO,2020-11-02/2020-11-08
194334622,19433462,46,F,,20250926,,TRANEXAMIC ACID,Pulmonary embolism,HO,TRANEXAMIC ACID | Pulmonary embolism | HO,NaT
194446262,19444626,20,F,,20250707,,BUPROPION HYDROCHLORIDE,Toxicity to various agents,HO,BUPROPION HYDROCHLORIDE | Toxicity to various agents | HO,NaT
1947723925,19477239,,M,2018-01-01,20250725,,ABILIFY MAINTENA,Gastrooesophageal reflux disease,OT,ABILIFY MAINTENA | Gastrooesophageal reflux disease | OT,2018-01-01/2018-01-07
195608194,19560819,29,M,2021-01-01,20250710,,GILENYA,Alanine aminotransferase increased,OT,GILENYA | Alanine aminotransferase increased | OT,2020-12-28/2021-01-03
1958178216,19581782,67,F,2018-03-02,20250910,,VEDOLIZUMAB,Disturbance in attention,OT,VEDOLIZUMAB | Disturbance in attention | OT,2018-02-26/2018-03-04
195900482,19590048,49,F,,20250916,,DUPIXENT,Product dose omission issue,,DUPIXENT | Product dose omission issue,NaT
196537743,19653774,64,F,2021-01-01,20250722,,OTEZLA,Product dose omission issue,,OTEZLA | Product dose omission issue,2020-12-28/2021-01-03
196547952,19654795,32,M,,20250709,,BROMAZEPAM,Toxicity to various agents,OT,BROMAZEPAM | Toxicity to various agents | OT,NaT
196548407,19654840,41,M,2018-04-05,20250913,,LEUPROLIDE ACETATE,Injection site reaction,OT,LEUPROLIDE ACETATE | Injection site reaction | OT,2018-04-02/2018-04-08
196730414,19673041,,M,2021-07-01,20250722,,COSENTYX,Diarrhoea,HO,COSENTYX | Diarrhoea | HO,2021-06-28/2021-07-04
196772816,19677281,18,M,2020-11-16,20250707,,FLUDARABINE,Malaise,OT,FLUDARABINE | Malaise | OT,2020-11-16/2020-11-22
196862685,19686268,34,M,2017-01-01,20250709,,LEVETIRACETAM,Insomnia,OT,LEVETIRACETAM | Insomnia | OT,2016-12-26/2017-01-01
197099543,19709954,,F,,20250909,,PLEGRIDY,Lethargy,,PLEGRIDY | Lethargy,NaT
197112424,19711242,68,F,2021-08-11,20250828,,IXAZOMIB,Off label use,,IXAZOMIB | Off label use,2021-08-09/2021-08-15
197331182,19733118,,,,20250818,,CYCLOPHOSPHAMIDE,Infection,HO,CYCLOPHOSPHAMIDE | Infection | HO,NaT
197464198,19746419,,M,,20250715,,IDURSULFASE,Malaise,DS,IDURSULFASE | Malaise | DS,NaT
197493412,19749341,,,,20250923,,LEVOFLOXACIN,Nikolsky's sign positive,OT,LEVOFLOXACIN | Nikolsky's sign positive | OT,NaT
197634275,19763427,70,F,2021-08-03,20250903,,VEDOLIZUMAB,Urinary tract infection,HO,VEDOLIZUMAB | Urinary tract infection | HO,2021-08-02/2021-08-08
197696383,19769638,39,M,,20250903,,DIAZEPAM,Agitation,OT,DIAZEPAM | Agitation | OT,NaT
1984642713,19846427,31,F,2025-03-14,20250909,,LANADELUMAB,Lip swelling,HO,LANADELUMAB | Lip swelling | HO,2025-03-10/2025-03-16
198535082,19853508,52,F,,20250806,,PREDNISOLONE,Diarrhoea,OT,PREDNISOLONE | Diarrhoea | OT,NaT
1985591212,19855912,75,F,2021-08-13,20250722,,EDOXABAN,Cardiac failure acute,HO,EDOXABAN | Cardiac failure acute | HO,2021-08-09/2021-08-15
198790615,19879061,59,F,2021-01-25,20250903,,QUTENZA,Walking disability,OT,QUTENZA | Walking disability | OT,2021-01-25/2021-01-31
198987619,19898761,59,M,2021-08-25,20250811,,VENETOCLAX,Neutropenia,HO,VENETOCLAX | Neutropenia | HO,2021-08-23/2021-08-29
199112952,19911295,,,2020-04-01,20250818,,RITUXIMAB,Off label use,OT,RITUXIMAB | Off label use | OT,2020-03-30/2020-04-05
199207682,19920768,42,M,2000-01-01,20250709,,CLOZAPINE,Cardiomyopathy,OT,CLOZAPINE | Cardiomyopathy | OT,1999-12-27/2000-01-02
199802525,19980252,,F,2018-08-28,20250828,,KISQALI,Osteonecrosis of jaw,OT,KISQALI | Osteonecrosis of jaw | OT,2018-08-27/2018-09-02
200065024,20006502,,M,,20250702,,MEPOLIZUMAB,Pneumonia,HO,MEPOLIZUMAB | Pneumonia | HO,NaT
2003489822,20034898,60,F,2021-08-05,20250819,,HUMAN IMMUNOGLOBULIN G,Infection,OT,HUMAN IMMUNOGLOBULIN G | Infection | OT,2021-08-02/2021-08-08
2005801112,20058011,72,F,,20250903,,XELJANZ XR,Swelling,DS,XELJANZ XR | Swelling | DS,NaT
2007027411,20070274,51,M,,20250911,,RITUXIMAB,Pruritus,OT,RITUXIMAB | Pruritus | OT,NaT
200907925,20090792,,F,,20250728,,PONATINIB,Neuropathy peripheral,OT,PONATINIB | Neuropathy peripheral | OT,NaT
201207663,20120766,,,,20250717,,PREDNISONE,Skin fissures,OT,PREDNISONE | Skin fissures | OT,NaT
201377775,20137777,,,,20250912,,RITUXIMAB,Inappropriate schedule of product administration,OT,RITUXIMAB | Inappropriate schedule of product administration | OT,NaT
202351475,20235147,,,,20250716,,RITUXIMAB,Stent placement,OT,RITUXIMAB | Stent placement | OT,NaT
203533926,20353392,14,F,2025-07-09,20250915,,ALDURAZYME,Intentional dose omission,,ALDURAZYME | Intentional dose omission,2025-07-07/2025-07-13
2041087332,20410873,65,F,,20250919,,OMALIZUMAB,Nasal oedema,OT,OMALIZUMAB | Nasal oedema | OT,NaT
2045172911,20451729,,F,,20250922,,VEDOLIZUMAB,Frequent bowel movements,OT,VEDOLIZUMAB | Frequent bowel movements | OT,NaT
204720324,20472032,63,M,,20250710,,EPIDIOLEX,Unresponsive to stimuli,OT,EPIDIOLEX | Unresponsive to stimuli | OT,NaT
204822194,20482219,53,F,,20250701,,CETIRIZINE HYDROCHLORIDE,Blood pressure increased,OT,CETIRIZINE HYDROCHLORIDE | Blood pressure increased | OT,NaT
204858786,20485878,,F,2020-01-01,20250819,,ICATIBANT,Pregnancy,,ICATIBANT | Pregnancy,2019-12-30/2020-01-05
2048597410,20485974,31,F,,20250702,,RITUXIMAB,Disorientation,OT,RITUXIMAB | Disorientation | OT,NaT
2048691023,20486910,60,M,2022-02-09,20250908,,RECOMBINATE,Haemorrhage,HO,RECOMBINATE | Haemorrhage | HO,2022-02-07/2022-02-13
204935862,20493586,50,F,,20250911,,OMALIZUMAB,Blood pressure diastolic increased,OT,OMALIZUMAB | Blood pressure diastolic increased | OT,NaT
205049292,20504929,,F,,20250902,,METHYLPREDNISOLONE,Coma,DE,METHYLPREDNISOLONE | Coma | DE,NaT
205274448,20527444,12,M,2022-01-27,20250927,,DEFITELIO,Blood bilirubin increased,OT,DEFITELIO | Blood bilirubin increased | OT,2022-01-24/2022-01-30
2053903627,20539036,43,F,,20250830,,DESOXIMETASONE,Nail disorder,CA,DESOXIMETASONE | Nail disorder | CA,NaT
205552052,20555205,,F,,20250930,,OXYCODONE HYDROCHLORIDE,Depression,OT,OXYCODONE HYDROCHLORIDE | Depression | OT,NaT
2056643218,20566432,71,F,2024-06-24,20250818,,.ALPHA.1-PROTEINASE INHIBITOR HUMAN,Sinusitis,OT,.ALPHA.1-PROTEINASE INHIBITOR HUMAN | Sinusitis | OT,2024-06-24/2024-06-30
205911713,20591171,1,M,2022-03-06,20250729,,ADVATE,Tongue biting,OT,ADVATE | Tongue biting | OT,2022-02-28/2022-03-06
205950023,20595002,69,F,2021-12-01,20250818,,VIMPAT,Headache,OT,VIMPAT | Headache | OT,2021-11-29/2021-12-05
206093916,20609391,,,,20250819,,RITUXIMAB,Pneumonia viral,OT,RITUXIMAB | Pneumonia viral | OT,NaT
206520524,20652052,9,M,2020-07-27,20250724,,REMICADE,Drug level decreased,OT,REMICADE | Drug level decreased | OT,2020-07-27/2020-08-02
206630145,20663014,10,M,2022-01-01,20250710,,EPIDIOLEX,Product use in unapproved indication,HO,EPIDIOLEX | Product use in unapproved indication | HO,2021-12-27/2022-01-02
206665037,20666503,44,M,2018-10-01,20250811,,DUPIXENT,Hyperhidrosis,,DUPIXENT | Hyperhidrosis,2018-10-01/2018-10-07
206901128,20690112,67,F,2022-11-02,20250825,,TEDUGLUTIDE,Sepsis,OT,TEDUGLUTIDE | Sepsis | OT,2022-10-31/2022-11-06
207064062,20706406,71,,,20250905,,JAKAFI,General physical condition abnormal,,JAKAFI | General physical condition abnormal,NaT
2072374522,20723745,,,2021-01-01,20250724,,INFLECTRA,Off label use,OT,INFLECTRA | Off label use | OT,2020-12-28/2021-01-03
2072635618,20726356,79,F,2023-04-07,20250930,,XYREM,Product administration interrupted,HO,XYREM | Product administration interrupted | HO,2023-04-03/2023-04-09
207749855,20774985,30,M,2021-03-31,20250829,,PONATINIB,Rash,HO,PONATINIB | Rash | HO,2021-03-29/2021-04-04
207772023,20777202,82,M,,20250703,,DUPIXENT,Therapeutic response unexpected,,DUPIXENT | Therapeutic response unexpected,NaT
207778143,20777814,,M,,20250804,,VEDOLIZUMAB,Colitis ulcerative,OT,VEDOLIZUMAB | Colitis ulcerative | OT,NaT
2078349319,20783493,57,M,2022-04-25,20250822,,RUXIENCE,Influenza like illness,OT,RUXIENCE | Influenza like illness | OT,2022-04-25/2022-05-01
207941523,20794152,72,M,,20250922,,SIMVASTATIN,Immune-mediated myositis,OT,SIMVASTATIN | Immune-mediated myositis | OT,NaT
2080189716,20801897,,F,,20250912,,HUMAN IMMUNOGLOBULIN G,Fall,HO,HUMAN IMMUNOGLOBULIN G | Fall | HO,NaT
208028648,20802864,73,F,2025-01-02,20250729,,VYNDAMAX,Rash,HO,VYNDAMAX | Rash | HO,2024-12-30/2025-01-05
208158214,20815821,22,F,2022-03-22,20250923,,MITAPIVAT,Post procedural discomfort,,MITAPIVAT | Post procedural discomfort,2022-03-21/2022-03-27
208351862,20835186,42,F,2022-05-01,20250813,,DUPIXENT,Dry eye,,DUPIXENT | Dry eye,2022-04-25/2022-05-01
208451134,20845113,,M,2023-01-01,20250916,,VEDOLIZUMAB,Crohn's disease,OT,VEDOLIZUMAB | Crohn's disease | OT,2022-12-26/2023-01-01
208547852,20854785,56,M,,20250724,,XELJANZ XR,Drug ineffective,,XELJANZ XR | Drug ineffective,NaT
208625555,20862555,60,F,2020-08-24,20250905,,TEDUGLUTIDE,Device related bacteraemia,HO,TEDUGLUTIDE | Device related bacteraemia | HO,2020-08-24/2020-08-30
208726114,20872611,,F,,20250710,,EPIDIOLEX,Cardiac failure,OT,EPIDIOLEX | Cardiac failure | OT,NaT
2092464911,20924649,66,F,,20250903,,PREMPRO,Back disorder,,PREMPRO | Back disorder,NaT
209888014,20988801,,F,,20250826,,VEDOLIZUMAB,Colitis ulcerative,OT,VEDOLIZUMAB | Colitis ulcerative | OT,NaT
210004156,21000415,76,M,2021-08-30,20250818,,TEDUGLUTIDE,Dysphagia,OT,TEDUGLUTIDE | Dysphagia | OT,2021-08-30/2021-09-05
210339083,21033908,,M,,20250710,,EPIDIOLEX,Death,OT,EPIDIOLEX | Death | OT,NaT
210421675,21042167,66,F,2021-09-13,20250926,,RIBOCICLIB,Positron emission tomogram abnormal,OT,RIBOCICLIB | Positron emission tomogram abnormal | OT,2021-09-13/2021-09-19
210522808,21052280,30,F,,20250813,,RITUXIMAB,COVID-19,HO,RITUXIMAB | COVID-19 | HO,NaT
210563056,21056305,51,M,,20250721,,ZOLPIDEM,Off label use,HO,ZOLPIDEM | Off label use | HO,NaT
210591307,21059130,,M,,20250710,,EPIDIOLEX,Off label use,OT,EPIDIOLEX | Off label use | OT,NaT
210823163,21082316,56,M,2021-01-01,20250703,,URSODIOL,Condition aggravated,HO,URSODIOL | Condition aggravated | HO,2020-12-28/2021-01-03
210824113,21082411,,F,,20250710,,EPIDIOLEX,Hysterectomy,OT,EPIDIOLEX | Hysterectomy | OT,NaT
2109943515,21099435,74,M,2022-01-01,20250806,,LETROZOLE,White blood cell count decreased,OT,LETROZOLE | White blood cell count decreased | OT,2021-12-27/2022-01-02
211079132,21107913,50,M,,20250717,,DUPIXENT,Visual impairment,,DUPIXENT | Visual impairment,NaT
2111990814,21119908,81,M,2021-07-01,20250724,,ENCORAFENIB,Nausea,HO,ENCORAFENIB | Nausea | HO,2021-06-28/2021-07-04
2112959125,21129591,,F,,20250812,,GLASSIA,Cough,HO,GLASSIA | Cough | HO,NaT
211338033,21133803,,F,,20250801,,VEDOLIZUMAB,Ectopic pregnancy,OT,VEDOLIZUMAB | Ectopic pregnancy | OT,NaT
211512963,21151296,24,F,,20250805,,DROSPIRENONE\ETHINYL ESTRADIOL,Migraine,OT,DROSPIRENONE\ETHINYL ESTRADIOL | Migraine | OT,NaT
2118298922,21182989,,,2022-01-01,20250721,,INFLECTRA,Labyrinthitis,DS,INFLECTRA | Labyrinthitis | DS,2021-12-27/2022-01-02
211919495,21191949,79,M,2022-03-15,20250821,,NINTEDANIB,Pyrexia,OT,NINTEDANIB | Pyrexia | OT,2022-03-14/2022-03-20
212114243,21211424,49,F,,20250709,,AMBISOME,Fusarium infection,OT,AMBISOME | Fusarium infection | OT,NaT
212131853,21213185,57,F,2022-01-01,20250827,,HUMIRA,Glaucoma,OT,HUMIRA | Glaucoma | OT,2021-12-27/2022-01-02
212180004,21218000,19,M,2022-11-01,20250721,,LARONIDASE,Mobility decreased,HO,LARONIDASE | Mobility decreased | HO,2022-10-31/2022-11-06
212415022,21241502,72,F,,20250723,,FLUTICASONE,Intestinal obstruction,OT,FLUTICASONE | Intestinal obstruction | OT,NaT
2124330812,21243308,35,M,2022-02-02,20250822,,VEDOLIZUMAB,Abdominal pain,OT,VEDOLIZUMAB | Abdominal pain | OT,2022-01-31/2022-02-06
2125772111,21257721,67,F,2021-12-17,20250925,,VEDOLIZUMAB,Product dose omission issue,HO,VEDOLIZUMAB | Product dose omission issue | HO,2021-12-13/2021-12-19
2126756923,21267569,38,M,2022-08-22,20250821,,CLOZARIL,Differential white blood cell count abnormal,OT,CLOZARIL | Differential white blood cell count abnormal | OT,2022-08-22/2022-08-28
212754993,21275499,,M,,20250710,,EPIDIOLEX,Emergency care,HO,EPIDIOLEX | Emergency care | HO,NaT
2127850011,21278500,,,2020-03-23,20250819,,INFLECTRA,Illness,OT,INFLECTRA | Illness | OT,2020-03-23/2020-03-29
212895703,21289570,23,F,2021-12-10,20250710,,EPIDIOLEX,Hospitalisation,HO,EPIDIOLEX | Hospitalisation | HO,2021-12-06/2021-12-12
212940963,21294096,12,F,2022-08-23,20250710,,VALPROATE SODIUM,Pancytopenia,HO,VALPROATE SODIUM | Pancytopenia | HO,2022-08-22/2022-08-28
2134632320,21346323,,,2022-01-01,20250718,,INFLECTRA,Herpes zoster,HO,INFLECTRA | Herpes zoster | HO,2021-12-27/2022-01-02
213468324,21346832,81,F,2020-03-09,20250708,,KISQALI,Acute kidney injury,HO,KISQALI | Acute kidney injury | HO,2020-03-09/2020-03-15
213924962,21392496,50,F,2022-01-01,20250701,,SKYRIZI,Headache,OT,SKYRIZI | Headache | OT,2021-12-27/2022-01-02
213967214,21396721,59,F,2020-05-13,20250825,,ENCORAFENIB,Ventriculo-peritoneal shunt,DE,ENCORAFENIB | Ventriculo-peritoneal shunt | DE,2020-05-11/2020-05-17
214060703,21406070,,M,2022-08-01,20250701,,TILDRAKIZUMAB,Bursitis,HO,TILDRAKIZUMAB | Bursitis | HO,2022-08-01/2022-08-07
214081793,21408179,,F,,20250710,,EPIDIOLEX,Fatigue,OT,EPIDIOLEX | Fatigue | OT,NaT
214088114,21408811,,M,,20250710,,EPIDIOLEX,Hospitalisation,HO,EPIDIOLEX | Hospitalisation | HO,NaT
214356439,21435643,63,F,,20250911,,IBRANCE,Panic reaction,OT,IBRANCE | Panic reaction | OT,NaT
214417335,21441733,41,F,2025-03-01,20250719,,DUPIXENT,Erythema,,DUPIXENT | Erythema,2025-02-24/2025-03-02
2146716912,21467169,71,F,2025-04-30,20250812,,VEDOLIZUMAB,Bowel movement irregularity,OT,VEDOLIZUMAB | Bowel movement irregularity | OT,2025-04-28/2025-05-04
214933083,21493308,,M,,20250710,,EPIDIOLEX,Hospitalisation,HO,EPIDIOLEX | Hospitalisation | HO,NaT
215357232,21535723,,M,,20250806,,SKYRIZI,Arthritis,,SKYRIZI | Arthritis,NaT
215538763,21553876,81,F,2021-06-01,20250812,,TEDUGLUTIDE,Urinary tract infection,HO,TEDUGLUTIDE | Urinary tract infection | HO,2021-05-31/2021-06-06
215570633,21557063,,F,,20250710,,EPIDIOLEX,Tongue disorder,OT,EPIDIOLEX | Tongue disorder | OT,NaT
215572822,21557282,72,F,,20250817,,IMATINIB,Pneumatosis intestinalis,OT,IMATINIB | Pneumatosis intestinalis | OT,NaT
215587494,21558749,74,M,,20250920,,MELPHALAN,Acute myocardial infarction,OT,MELPHALAN | Acute myocardial infarction | OT,NaT
2157969814,21579698,68,F,2025-07-30,20250811,,BRIGATINIB,Nasopharyngitis,OT,BRIGATINIB | Nasopharyngitis | OT,2025-07-28/2025-08-03
215860133,21586013,,M,,20250710,,EPIDIOLEX,Drug ineffective,OT,EPIDIOLEX | Drug ineffective | OT,NaT
215881323,21588132,,,,20250816,,ACETAMINOPHEN,Cardiotoxicity,HO,ACETAMINOPHEN | Cardiotoxicity | HO,NaT
216320653,21632065,62,F,,20250812,,CARBIDOPA AND LEVODOPA,Aggression,OT,CARBIDOPA AND LEVODOPA | Aggression | OT,NaT
216415424,21641542,3,M,,20250812,,DOXAZOSIN,Blood pressure abnormal,OT,DOXAZOSIN | Blood pressure abnormal | OT,NaT
216444563,21644456,1,F,2022-11-21,20250710,,EPIDIOLEX,Death,DE,EPIDIOLEX | Death | DE,2022-11-21/2022-11-27
216513822,21651382,57,M,2020-10-30,20250905,,ATORVASTATIN,Hepatitis E,HO,ATORVASTATIN | Hepatitis E | HO,2020-10-26/2020-11-01
2168412921,21684129,8,M,2022-02-07,20250825,,IDURSULFASE,Productive cough,OT,IDURSULFASE | Productive cough | OT,2022-02-07/2022-02-13
2168799621,21687996,38,F,2022-01-25,20250730,,ARIPIPRAZOLE,Anxiety,HO,ARIPIPRAZOLE | Anxiety | HO,2022-01-24/2022-01-30
217043692,21704369,2,M,,20250703,,ONDANSETRON,Accidental exposure to product,HO,ONDANSETRON | Accidental exposure to product | HO,NaT
217317515,21731751,77,M,2024-04-01,20250929,,DUPIXENT,Prostatic operation,HO,DUPIXENT | Prostatic operation | HO,2024-04-01/2024-04-07
217320742,21732074,74,F,,20250703,,METOPROLOL,Drug ineffective,HO,METOPROLOL | Drug ineffective | HO,NaT
217352633,21735263,,F,,20250710,,EPIDIOLEX,Blood pressure increased,OT,EPIDIOLEX | Blood pressure increased | OT,NaT
217377374,21737737,72,F,,20250817,,BORTEZOMIB,Disease progression,OT,BORTEZOMIB | Disease progression | OT,NaT
217440692,21744069,59,M,,20250805,,APIXABAN,Condition aggravated,OT,APIXABAN | Condition aggravated | OT,NaT
217524162,21752416,17,F,,20250722,,OLANZAPINE,Digestive enzyme increased,OT,OLANZAPINE | Digestive enzyme increased | OT,NaT
2177080514,21770805,71,M,2022-09-01,20250918,,CARBIDOPA\LEVODOPA,Device dislocation,HO,CARBIDOPA\LEVODOPA | Device dislocation | HO,2022-08-29/2022-09-04
217773087,21777308,6,F,2022-11-18,20250718,,FINTEPLA,Mitral valve thickening,OT,FINTEPLA | Mitral valve thickening | OT,2022-11-14/2022-11-20
217795564,21779556,49,F,2022-12-16,20250710,,EPIDIOLEX,Diarrhoea,HO,EPIDIOLEX | Diarrhoea | HO,2022-12-12/2022-12-18
217844402,21784440,42,F,2018-10-18,20250904,,VEDOLIZUMAB,Off label use,OT,VEDOLIZUMAB | Off label use | OT,2018-10-15/2018-10-21
217977642,21797764,19,,,20250703,,ONDANSETRON,Drug interaction,OT,ONDANSETRON | Drug interaction | OT,NaT
218002713,21800271,74,F,2022-12-25,20250820,,PAXLOVID,Disease recurrence,,PAXLOVID | Disease recurrence,2022-12-19/2022-12-25
2183019316,21830193,21,F,2023-09-11,20250929,,VEDOLIZUMAB,Faeces discoloured,OT,VEDOLIZUMAB | Faeces discoloured | OT,2023-09-11/2023-09-17
218313056,21831305,,M,,20250730,,FUROSEMIDE,Low birth weight baby,OT,FUROSEMIDE | Low birth weight baby | OT,NaT
218314636,21831463,73,F,,20250827,,XELJANZ,Joint injury,OT,XELJANZ | Joint injury | OT,NaT
218346494,21834649,56,M,2020-04-14,20250827,,HUMIRA,Foot fracture,OT,HUMIRA | Foot fracture | OT,2020-04-13/2020-04-19
218374577,21837457,54,F,2021-01-01,20250925,,XELJANZ XR,Intentional product misuse,OT,XELJANZ XR | Intentional product misuse | OT,2020-12-28/2021-01-03
218473694,21847369,64,M,,20250915,,MYCOPHENOLATE MOFETIL,Varicella zoster virus infection,HO,MYCOPHENOLATE MOFETIL | Varicella zoster virus infection | HO,NaT
218564942,21856494,86,F,2022-12-16,20250830,,REPATHA,Accidental exposure to product,,REPATHA | Accidental exposure to product,2022-12-12/2022-12-18
218764678,21876467,,,,20250822,,RITUXIMAB,Drug ineffective,DE,RITUXIMAB | Drug ineffective | DE,NaT
2188620210,21886202,41,F,,20250903,,INDOMETHACIN,Dysphonia,OT,INDOMETHACIN | Dysphonia | OT,NaT
218906123,21890612,,M,,20250710,,EPIDIOLEX,Urinary tract infection,OT,EPIDIOLEX | Urinary tract infection | OT,NaT
218977882,21897788,10,F,2022-01-31,20250813,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,2022-01-31/2022-02-06
219086428,21908642,,M,2021-01-08,20250718,,RITUXIMAB,Malignant neoplasm progression,OT,RITUXIMAB | Malignant neoplasm progression | OT,2021-01-04/2021-01-10
219212873,21921287,31,M,2023-01-12,20250710,,EPIDIOLEX,Death,OT,EPIDIOLEX | Death | OT,2023-01-09/2023-01-15
219352606,21935260,,F,,20250925,,VEDOLIZUMAB,Victim of crime,HO,VEDOLIZUMAB | Victim of crime | HO,NaT
219625569,21962556,61,F,2023-01-07,20250919,,VEDOLIZUMAB,Vomiting,HO,VEDOLIZUMAB | Vomiting | HO,2023-01-02/2023-01-08
219792723,21979272,75,M,2023-01-01,20250715,,SCEMBLIX,Brain neoplasm,HO,SCEMBLIX | Brain neoplasm | HO,2022-12-26/2023-01-01
219919823,21991982,,F,,20250710,,EPIDIOLEX,Anxiety,OT,EPIDIOLEX | Anxiety | OT,NaT
220094584,22009458,,,,20250930,,CARFILZOMIB,Cardiac failure,HO,CARFILZOMIB | Cardiac failure | HO,NaT
220416236,22041623,15,M,2023-02-16,20250819,,ADVATE,Haemarthrosis,OT,ADVATE | Haemarthrosis | OT,2023-02-13/2023-02-19
220453823,22045382,,M,2023-02-04,20250722,,LAMPRENE,Wound,HO,LAMPRENE | Wound | HO,2023-01-30/2023-02-05
220566282,22056628,,,,20250801,,VICTOZA,Spina bifida,CA,VICTOZA | Spina bifida | CA,NaT
220630178,22063017,75,M,2022-03-17,20250902,,TECENTRIQ,Hypertension,OT,TECENTRIQ | Hypertension | OT,2022-03-14/2022-03-20
220715413,22071541,,M,,20250710,,EPIDIOLEX,Fall,OT,EPIDIOLEX | Fall | OT,NaT
220833802,22083380,75,M,,20250728,,AMIODARONE,Drug ineffective,OT,AMIODARONE | Drug ineffective | OT,NaT
220963373,22096337,60,M,2021-01-01,20250812,,BLINATUMOMAB,Adenoviral haemorrhagic cystitis,OT,BLINATUMOMAB | Adenoviral haemorrhagic cystitis | OT,2020-12-28/2021-01-03
221068442,22106844,68,F,2023-01-01,20250716,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2022-12-26/2023-01-01
221079613,22107961,,F,2023-01-01,20250811,,PLEGRIDY,Neoplasm malignant,OT,PLEGRIDY | Neoplasm malignant | OT,2022-12-26/2023-01-01
221447983,22144798,,,,20250904,,ACETAMINOPHEN,Hot flush,OT,ACETAMINOPHEN | Hot flush | OT,NaT
221571154,22157115,6,F,2023-03-01,20250710,,EPIDIOLEX,Injury,HO,EPIDIOLEX | Injury | HO,2023-02-27/2023-03-05
2216336010,22163360,18,F,2021-05-22,20250728,,TAKHZYRO,Hereditary angioedema,OT,TAKHZYRO | Hereditary angioedema | OT,2021-05-17/2021-05-23
221785656,22178565,57,F,2023-03-01,20250730,,KEVZARA,Condition aggravated,,KEVZARA | Condition aggravated,2023-02-27/2023-03-05
221811283,22181128,65,M,,20250801,,PADCEV,Alopecia,OT,PADCEV | Alopecia | OT,NaT
221823687,22182368,64,F,2024-11-01,20250908,,VEDOLIZUMAB,Haematochezia,OT,VEDOLIZUMAB | Haematochezia | OT,2024-10-28/2024-11-03
222034832,22203483,49,F,,20250917,,GLATIRAMER ACETATE,Multiple sclerosis,OT,GLATIRAMER ACETATE | Multiple sclerosis | OT,NaT
222259643,22225964,5,M,,20250708,,OMEPRAZOLE,Drug level increased,HO,OMEPRAZOLE | Drug level increased | HO,NaT
222339853,22233985,,M,,20250820,,ESBRIET,Ageusia,,ESBRIET | Ageusia,NaT
222441015,22244101,68,F,,20250911,,DUPIXENT,Skin exfoliation,OT,DUPIXENT | Skin exfoliation | OT,NaT
2224517310,22245173,63,M,,20250918,,SIMULECT,Neutropenia,DE,SIMULECT | Neutropenia | DE,NaT
222510262,22251026,,F,,20250814,,VEDOLIZUMAB,Mobility decreased,OT,VEDOLIZUMAB | Mobility decreased | OT,NaT
222549723,22254972,,,,20250828,,RITUXIMAB,Multiple sclerosis relapse,OT,RITUXIMAB | Multiple sclerosis relapse | OT,NaT
222617189,22261718,50,F,,20250805,,METHOTREXATE,Pain,DE,METHOTREXATE | Pain | DE,NaT
222666423,22266642,10,M,2023-04-16,20250710,,EPIDIOLEX,Death,DE,EPIDIOLEX | Death | DE,2023-04-10/2023-04-16
222703547,22270354,34,F,,20250805,,IBRANCE,Malignant neoplasm progression,OT,IBRANCE | Malignant neoplasm progression | OT,NaT
222836758,22283675,43,F,,20250724,,METHOTREXATE,Headache,HO,METHOTREXATE | Headache | HO,NaT
2229305017,22293050,,,2023-01-01,20250721,,INFLECTRA,Condition aggravated,HO,INFLECTRA | Condition aggravated | HO,2022-12-26/2023-01-01
223015504,22301550,30,M,,20250912,,BUPRENORPHINE,Drug dependence,LT,BUPRENORPHINE | Drug dependence | LT,NaT
223126542,22312654,37,F,2023-04-18,20250702,,ALPRAZOLAM,Agitation,,ALPRAZOLAM | Agitation,2023-04-17/2023-04-23
223148803,22314880,18,F,2023-04-27,20250710,,EPIDIOLEX,Death,DE,EPIDIOLEX | Death | DE,2023-04-24/2023-04-30
223176443,22317644,,F,,20250710,,EPIDIOLEX,Intellectual disability,OT,EPIDIOLEX | Intellectual disability | OT,NaT
2231789219,22317892,,,2023-01-01,20250922,,INFLECTRA,Off label use,OT,INFLECTRA | Off label use | OT,2022-12-26/2023-01-01
223180843,22318084,65,F,2021-01-01,20250801,,OZEMPIC,Diabetes mellitus inadequate control,OT,OZEMPIC | Diabetes mellitus inadequate control | OT,2020-12-28/2021-01-03
223209399,22320939,73,F,2023-01-01,20250804,,DUPIXENT,Exposure via skin contact,HO,DUPIXENT | Exposure via skin contact | HO,2022-12-26/2023-01-01
223252963,22325296,84,M,,20250822,,ELIQUIS,Abdominal discomfort,,ELIQUIS | Abdominal discomfort,NaT
223260313,22326031,18,F,2023-05-05,20250710,,EPIDIOLEX,Death,OT,EPIDIOLEX | Death | OT,2023-05-01/2023-05-07
223374893,22337489,34,M,2023-05-12,20250710,,EPIDIOLEX,Nausea,HO,EPIDIOLEX | Nausea | HO,2023-05-08/2023-05-14
223405235,22340523,,M,,20250710,,EPIDIOLEX,Product administration interrupted,HO,EPIDIOLEX | Product administration interrupted | HO,NaT
2235029712,22350297,64,M,2019-07-18,20250722,,VEDOLIZUMAB,Dust allergy,OT,VEDOLIZUMAB | Dust allergy | OT,2019-07-15/2019-07-21
223555678,22355567,62,M,2022-01-01,20250917,,IXAZOMIB,Skin exfoliation,OT,IXAZOMIB | Skin exfoliation | OT,2021-12-27/2022-01-02
223559542,22355954,,,,20250709,,RYALTRIS,Oropharyngeal blistering,OT,RYALTRIS | Oropharyngeal blistering | OT,NaT
223705323,22370532,,M,,20250710,,EPIDIOLEX,Hospitalisation,HO,EPIDIOLEX | Hospitalisation | HO,NaT
223870393,22387039,17,M,2023-04-25,20250710,,EPIDIOLEX,Hospitalisation,HO,EPIDIOLEX | Hospitalisation | HO,2023-04-24/2023-04-30
223872552,22387255,51,M,,20250709,,MIDODRINE HYDROCHLORIDE,Drug ineffective,OT,MIDODRINE HYDROCHLORIDE | Drug ineffective | OT,NaT
2239242714,22392427,52,F,2023-07-12,20250922,,VEDOLIZUMAB,Haemoglobin decreased,OT,VEDOLIZUMAB | Haemoglobin decreased | OT,2023-07-10/2023-07-16
225286363,22528636,31,M,2023-05-31,20250710,,EPIDIOLEX,Product administration interrupted,HO,EPIDIOLEX | Product administration interrupted | HO,2023-05-29/2023-06-04
225876932,22587693,53,F,,20250728,,HYDROCORTISONE,Hypertriglyceridaemia,HO,HYDROCORTISONE | Hypertriglyceridaemia | HO,NaT
225877773,22587777,,M,,20250710,,EPIDIOLEX,Death,DE,EPIDIOLEX | Death | DE,NaT
226237753,22623775,37,M,,20250805,,PAROXETINE,Rash,OT,PAROXETINE | Rash | OT,NaT
2262568919,22625689,,F,,20250916,,ALBUTEROL SULFATE,Infusion site bruising,HO,ALBUTEROL SULFATE | Infusion site bruising | HO,NaT
2262841711,22628417,,F,,20250814,,VEDOLIZUMAB,Hypertension,OT,VEDOLIZUMAB | Hypertension | OT,NaT
226289074,22628907,45,M,2022-03-26,20250822,,BELATACEPT,Renal ischaemia,HO,BELATACEPT | Renal ischaemia | HO,2022-03-21/2022-03-27
226319035,22631903,,M,,20250903,,COSENTYX,Psoriasis,,COSENTYX | Psoriasis,NaT
226416233,22641623,45,M,2022-03-26,20250822,,BELATACEPT,Plasmodium falciparum infection,OT,BELATACEPT | Plasmodium falciparum infection | OT,2022-03-21/2022-03-27
226488397,22648839,,F,,20250930,,IXAZOMIB,Pain,OT,IXAZOMIB | Pain | OT,NaT
2266994410,22669944,62,F,2024-06-13,20250925,,HUMAN IMMUNOGLOBULIN G,Pseudomonas infection,HO,HUMAN IMMUNOGLOBULIN G | Pseudomonas infection | HO,2024-06-10/2024-06-16
226804126,22680412,37,M,2023-06-02,20250827,,VEDOLIZUMAB,Haemorrhoids,HO,VEDOLIZUMAB | Haemorrhoids | HO,2023-05-29/2023-06-04
226842317,22684231,,,2023-01-01,20250721,,TRIKAFTA,Restlessness,,TRIKAFTA | Restlessness,2022-12-26/2023-01-01
226996462,22699646,70,F,,20250930,,SULFAMETHOXAZOLE\TRIMETHOPRIM,Gastroenteritis,HO,SULFAMETHOXAZOLE\TRIMETHOPRIM | Gastroenteritis | HO,NaT
227095274,22709527,47,F,,20250822,,METHYLPREDNISOLONE,Dyspnoea exertional,OT,METHYLPREDNISOLONE | Dyspnoea exertional | OT,NaT
227137142,22713714,37,F,2023-06-01,20250711,,SERTRALINE,Intentional self-injury,HO,SERTRALINE | Intentional self-injury | HO,2023-05-29/2023-06-04
227146148,22714614,75,F,,20250818,,BRINZOLAMIDE\TIMOLOL MALEATE,Rash erythematous,OT,BRINZOLAMIDE\TIMOLOL MALEATE | Rash erythematous | OT,NaT
2271623614,22716236,72,F,2023-05-01,20250904,,VEDOLIZUMAB,Cataract,OT,VEDOLIZUMAB | Cataract | OT,2023-05-01/2023-05-07
227170595,22717059,75,F,,20250820,,IBRANCE,Neutropenia,OT,IBRANCE | Neutropenia | OT,NaT
2272316414,22723164,,F,2023-01-01,20250822,,MEPOLIZUMAB,Skeletal injury,OT,MEPOLIZUMAB | Skeletal injury | OT,2022-12-26/2023-01-01
227326862,22732686,,F,2023-02-17,20250715,,OZEMPIC,Unevaluable event,,OZEMPIC | Unevaluable event,2023-02-13/2023-02-19
227343842,22734384,11,M,2023-06-15,20250703,,LUMIZYME,Drug specific antibody present,,LUMIZYME | Drug specific antibody present,2023-06-12/2023-06-18
227434992,22743499,69,,,20250815,,DEXAMETHASONE,Plasma cell myeloma recurrent,OT,DEXAMETHASONE | Plasma cell myeloma recurrent | OT,NaT
227461904,22746190,62,M,2021-07-02,20250701,,TEDUGLUTIDE,Decreased appetite,HO,TEDUGLUTIDE | Decreased appetite | HO,2021-06-28/2021-07-04
227476257,22747625,77,F,2023-11-20,20250901,,IXAZOMIB,Fall,HO,IXAZOMIB | Fall | HO,2023-11-20/2023-11-26
227570773,22757077,70,F,2023-01-01,20250829,,CLOFAZIMINE,Weight decreased,,CLOFAZIMINE | Weight decreased,2022-12-26/2023-01-01
227573904,22757390,16,F,2023-07-01,20250730,,FINTEPLA,Decreased appetite,OT,FINTEPLA | Decreased appetite | OT,2023-06-26/2023-07-02
2276142418,22761424,65,F,,20250929,,BOSULIF,Eye haemorrhage,OT,BOSULIF | Eye haemorrhage | OT,NaT
227702385,22770238,57,M,,20250903,,XOLAIR,Osteoarthritis,HO,XOLAIR | Osteoarthritis | HO,NaT
228111972,22811197,60,F,,20250725,,ENHERTU,Death,DE,ENHERTU | Death | DE,NaT
228121674,22812167,49,F,2023-01-01,20250916,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2022-12-26/2023-01-01
228128104,22812810,73,F,2023-01-01,20250813,,KEYTRUDA,Sepsis,HO,KEYTRUDA | Sepsis | HO,2022-12-26/2023-01-01
228176894,22817689,64,M,2023-07-30,20250718,,IDELVION,Fall,HO,IDELVION | Fall | HO,2023-07-24/2023-07-30
228228003,22822800,72,M,2023-08-09,20250923,,XTANDI,Dizziness,OT,XTANDI | Dizziness | OT,2023-08-07/2023-08-13
228234313,22823431,,F,,20250729,,VEDOLIZUMAB,Intrapartum haemorrhage,OT,VEDOLIZUMAB | Intrapartum haemorrhage | OT,NaT
228289853,22828985,,M,,20250901,,ENTRESTO,Weight increased,HO,ENTRESTO | Weight increased | HO,NaT
228349747,22834974,54,M,2023-01-01,20250825,,CELEBREX,Pneumonia,HO,CELEBREX | Pneumonia | HO,2022-12-26/2023-01-01
228430412,22843041,22,F,2023-07-28,20250805,,QUETIAPINE FUMARATE,Seizure,OT,QUETIAPINE FUMARATE | Seizure | OT,2023-07-24/2023-07-30
228461395,22846139,,,,20250929,,RITUXIMAB,Intentional product use issue,OT,RITUXIMAB | Intentional product use issue | OT,NaT
228494012,22849401,,M,,20250903,,TRIAMCINOLONE,Product use in unapproved indication,,TRIAMCINOLONE | Product use in unapproved indication,NaT
228588159,22858815,65,F,2023-08-01,20250811,,VERZENIO,Diarrhoea,OT,VERZENIO | Diarrhoea | OT,2023-07-31/2023-08-06
228703663,22870366,66,M,2023-07-24,20250822,,VENCLEXTA,Death,DE,VENCLEXTA | Death | DE,2023-07-24/2023-07-30
228717642,22871764,,,,20250909,,XYZAL,Product administered to patient of inappropriate age,,XYZAL | Product administered to patient of inappropriate age,NaT
2291040012,22910400,76,F,2024-04-01,20250807,,TREPROSTINIL,Pain in jaw,HO,TREPROSTINIL | Pain in jaw | HO,2024-04-01/2024-04-07
229226232,22922623,,F,,20250905,,OXERVATE,Foreign body sensation in eyes,,OXERVATE | Foreign body sensation in eyes,NaT
2292481915,22924819,63,M,2022-12-14,20250812,,TREPROSTINIL,Complication associated with device,HO,TREPROSTINIL | Complication associated with device | HO,2022-12-12/2022-12-18
229322362,22932236,58,M,,20250929,,NITRIC OXIDE,Ventricular tachycardia,OT,NITRIC OXIDE | Ventricular tachycardia | OT,NaT
229366822,22936682,46,,,20250801,,JAKAFI,White blood cell count decreased,,JAKAFI | White blood cell count decreased,NaT
2294558312,22945583,3,M,2020-12-23,20250912,,IDURSULFASE,Incorrect dose administered,OT,IDURSULFASE | Incorrect dose administered | OT,2020-12-21/2020-12-27
229583775,22958377,,,,20250930,,COPIKTRA,Abdominal pain,HO,COPIKTRA | Abdominal pain | HO,NaT
229668365,22966836,54,F,2023-01-01,20250716,,XELJANZ XR,Somnolence,,XELJANZ XR | Somnolence,2022-12-26/2023-01-01
229871766,22987176,36,F,2023-09-25,20250919,,BRIGATINIB,Muscle spasms,OT,BRIGATINIB | Muscle spasms | OT,2023-09-25/2023-10-01
2299318612,22993186,39,F,,20250708,,QUETIAPINE FUMARATE,Memory impairment,OT,QUETIAPINE FUMARATE | Memory impairment | OT,NaT
229939204,22993920,45,M,,20250722,,ENTYVIO,Product dose omission issue,OT,ENTYVIO | Product dose omission issue | OT,NaT
229954554,22995455,75,F,,20250803,,BUDESONIDE\FORMOTEROL,Asthma,OT,BUDESONIDE\FORMOTEROL | Asthma | OT,NaT
230110424,23011042,42,F,,20250918,,VORICONAZOLE,Drug interaction,OT,VORICONAZOLE | Drug interaction | OT,NaT
2301425511,23014255,,M,2021-01-01,20250723,,FIRDAPSE,Asthenia,OT,FIRDAPSE | Asthenia | OT,2020-12-28/2021-01-03
230265782,23026578,37,M,,20250919,,ENTYVIO,Inappropriate schedule of product administration,OT,ENTYVIO | Inappropriate schedule of product administration | OT,NaT
230367362,23036736,,F,,20250729,,DUPIXENT,Secretion discharge,OT,DUPIXENT | Secretion discharge | OT,NaT
230424413,23042441,,,,20250709,,RITUXIMAB,Product dispensing error,OT,RITUXIMAB | Product dispensing error | OT,NaT
230442284,23044228,,F,,20250718,,VEDOLIZUMAB,Disability,OT,VEDOLIZUMAB | Disability | OT,NaT
230509665,23050966,53,M,2023-09-01,20250822,,DUPIXENT,Skin burning sensation,,DUPIXENT | Skin burning sensation,2023-08-28/2023-09-03
230535614,23053561,55,F,2023-10-25,20250914,,SKYRIZI,Squamous cell carcinoma,OT,SKYRIZI | Squamous cell carcinoma | OT,2023-10-23/2023-10-29
230567572,23056757,53,F,2020-12-01,20250829,,MYCOPHENOLATE MOFETIL,Pain,OT,MYCOPHENOLATE MOFETIL | Pain | OT,2020-11-30/2020-12-06
230630493,23063049,56,M,2020-01-01,20250703,,CYTARABINE,Disease progression,OT,CYTARABINE | Disease progression | OT,2019-12-30/2020-01-05
230678747,23067874,18,M,2018-10-23,20250908,,VEDOLIZUMAB,Product dose omission issue,OT,VEDOLIZUMAB | Product dose omission issue | OT,2018-10-22/2018-10-28
230761937,23076193,,F,,20250904,,VEDOLIZUMAB,Maternal exposure during breast feeding,OT,VEDOLIZUMAB | Maternal exposure during breast feeding | OT,NaT
230770973,23077097,63,F,2021-06-20,20250721,,ELIQUIS,Subdural haematoma,OT,ELIQUIS | Subdural haematoma | OT,2021-06-14/2021-06-20
230876722,23087672,,F,,20250813,,SPRAVATO,Adverse drug reaction,,SPRAVATO | Adverse drug reaction,NaT
230883473,23088347,55,F,2017-10-20,20250729,,VEDOLIZUMAB,Constipation,OT,VEDOLIZUMAB | Constipation | OT,2017-10-16/2017-10-22
231074772,23107477,,F,,20250816,,FLECAINIDE,Treatment failure,OT,FLECAINIDE | Treatment failure | OT,NaT
231257153,23125715,17,F,2023-01-01,20250826,,DUPIXENT,Product dose omission in error,,DUPIXENT | Product dose omission in error,2022-12-26/2023-01-01
231358334,23135833,,,,20250818,,RITUXIMAB,Haematological malignancy,HO,RITUXIMAB | Haematological malignancy | HO,NaT
231359913,23135991,65,M,,20250912,,METFORMIN HYDROCHLORIDE,Therapeutic product effect incomplete,HO,METFORMIN HYDROCHLORIDE | Therapeutic product effect incomplete | HO,NaT
231691373,23169137,66,F,2023-10-20,20250724,,CAPECITABINE,Radius fracture,OT,CAPECITABINE | Radius fracture | OT,2023-10-16/2023-10-22
231750483,23175048,48,F,2023-01-01,20250730,,RINVOQ,Constipation,OT,RINVOQ | Constipation | OT,2022-12-26/2023-01-01
231760312,23176031,,F,,20250909,,CHILDRENS XYZAL ALLERGY 24HR,Product administered to patient of inappropriate age,,CHILDRENS XYZAL ALLERGY 24HR | Product administered to patient of inappropriate age,NaT
231784749,23178474,82,F,,20250723,,OPDIVO,Pemphigoid,OT,OPDIVO | Pemphigoid | OT,NaT
231799082,23179908,76,F,,20250724,,ESBRIET,Urinary tract infection,HO,ESBRIET | Urinary tract infection | HO,NaT
231801872,23180187,71,M,2024-01-01,20250910,,SKYRIZI,Gait disturbance,HO,SKYRIZI | Gait disturbance | HO,2024-01-01/2024-01-07
2318422012,23184220,,,2021-11-04,20250917,,INFLECTRA,Sciatica,OT,INFLECTRA | Sciatica | OT,2021-11-01/2021-11-07
231969923,23196992,11,F,,20250820,,TACROLIMUS,Off label use,OT,TACROLIMUS | Off label use | OT,NaT
232101624,23210162,,F,2023-01-01,20250810,,STRENSIQ,Avulsion fracture,OT,STRENSIQ | Avulsion fracture | OT,2022-12-26/2023-01-01
2321851710,23218517,61,M,2023-01-01,20250910,,LENVATINIB,Myocardial infarction,HO,LENVATINIB | Myocardial infarction | HO,2022-12-26/2023-01-01
232203374,23220337,87,F,,20250816,,ULTOMIRIS,Eyelid ptosis,,ULTOMIRIS | Eyelid ptosis,NaT
232368784,23236878,,M,,20250805,,VEDOLIZUMAB,Headache,OT,VEDOLIZUMAB | Headache | OT,NaT
232452753,23245275,60,M,,20250923,,ALBUTEROL,Dyspnoea,OT,ALBUTEROL | Dyspnoea | OT,NaT
232495664,23249566,,F,2025-01-01,20250820,,OMNITROPE,Urinary tract infection,OT,OMNITROPE | Urinary tract infection | OT,2024-12-30/2025-01-05
232568793,23256879,4,F,2023-11-24,20250717,,SPINRAZA,Glomerulonephritis,HO,SPINRAZA | Glomerulonephritis | HO,2023-11-20/2023-11-26
232624573,23262457,,F,,20250810,,STRENSIQ,Hypoaesthesia,,STRENSIQ | Hypoaesthesia,NaT
232938542,23293854,,,2022-01-01,20250911,,NOURIANZ,Therapy interrupted,OT,NOURIANZ | Therapy interrupted | OT,2021-12-27/2022-01-02
233174975,23317497,17,M,2024-03-21,20250905,,HEMLIBRA,Haemorrhage,,HEMLIBRA | Haemorrhage,2024-03-18/2024-03-24
233246114,23324611,54,F,2025-04-30,20250908,,VEDOLIZUMAB,Rectal discharge,HO,VEDOLIZUMAB | Rectal discharge | HO,2025-04-28/2025-05-04
233342247,23334224,77,F,2023-01-01,20250828,,DUPIXENT,Arthralgia,,DUPIXENT | Arthralgia,2022-12-26/2023-01-01
233355015,23335501,26,M,2023-09-25,20250702,,VEDOLIZUMAB,Colitis ulcerative,OT,VEDOLIZUMAB | Colitis ulcerative | OT,2023-09-25/2023-10-01
233355703,23335570,18,F,2023-12-18,20250714,,FINTEPLA,Product dose omission issue,OT,FINTEPLA | Product dose omission issue | OT,2023-12-18/2023-12-24
233376922,23337692,,,,20250901,,FLUDARABINE,Epstein-Barr virus infection reactivation,OT,FLUDARABINE | Epstein-Barr virus infection reactivation | OT,NaT
2334538413,23345384,38,M,2024-09-11,20250919,,XYWAV,Gastrooesophageal reflux disease,OT,XYWAV | Gastrooesophageal reflux disease | OT,2024-09-09/2024-09-15
2335020710,23350207,,F,2023-01-01,20250917,,FINTEPLA,Seizure,HO,FINTEPLA | Seizure | HO,2022-12-26/2023-01-01
233516303,23351630,,F,,20250922,,TYSABRI,Upper respiratory tract infection,,TYSABRI | Upper respiratory tract infection,NaT
233663007,23366300,62,F,2018-03-20,20250910,,DEXAMETHASONE,Thrombocytopenia,DE,DEXAMETHASONE | Thrombocytopenia | DE,2018-03-19/2018-03-25
233765556,23376555,52,F,,20250911,,DIAZEPAM,Off label use,HO,DIAZEPAM | Off label use | HO,NaT
233875246,23387524,42,F,2023-03-24,20250804,,NURTEC ODT,Nephrolithiasis,OT,NURTEC ODT | Nephrolithiasis | OT,2023-03-20/2023-03-26
233960765,23396076,30,M,,20250909,,BREXUCABTAGENE AUTOLEUCEL,Acute myeloid leukaemia,DE,BREXUCABTAGENE AUTOLEUCEL | Acute myeloid leukaemia | DE,NaT
233966003,23396600,65,F,,20250929,,VEDOLIZUMAB,Product availability issue,HO,VEDOLIZUMAB | Product availability issue | HO,NaT
234094575,23409457,33,M,2023-11-20,20250723,,TOLVAPTAN,Thirst,OT,TOLVAPTAN | Thirst | OT,2023-11-20/2023-11-26
234174704,23417470,40,F,,20250927,,FOLIC ACID,Therapeutic product effect decreased,CA,FOLIC ACID | Therapeutic product effect decreased | CA,NaT
234294284,23429428,,F,2011-01-01,20250821,,OXYCONTIN,Product use in unapproved indication,DS,OXYCONTIN | Product use in unapproved indication | DS,2010-12-27/2011-01-02
234368903,23436890,45,M,,20250930,,TACROLIMUS,Drug level above therapeutic,OT,TACROLIMUS | Drug level above therapeutic | OT,NaT
234411452,23441145,84,M,2024-01-23,20250825,,HUMAN IMMUNOGLOBULIN G,Peripheral swelling,OT,HUMAN IMMUNOGLOBULIN G | Peripheral swelling | OT,2024-01-22/2024-01-28
234428094,23442809,67,M,2023-03-01,20250826,,ATACAND,Osteoporosis,DE,ATACAND | Osteoporosis | DE,2023-02-27/2023-03-05
2344592211,23445922,65,F,2024-09-13,20250729,,HUMAN IMMUNOGLOBULIN G,Weight decreased,OT,HUMAN IMMUNOGLOBULIN G | Weight decreased | OT,2024-09-09/2024-09-15
234554086,23455408,44,F,2023-11-06,20250804,,VEDOLIZUMAB,Fear of injection,OT,VEDOLIZUMAB | Fear of injection | OT,2023-11-06/2023-11-12
234566045,23456604,71,F,,20250901,,OPDIVO,Immune-mediated hepatic disorder,DE,OPDIVO | Immune-mediated hepatic disorder | DE,NaT
234603252,23460325,60,F,,20250911,,ACETAMINOPHEN,Product use in unapproved indication,HO,ACETAMINOPHEN | Product use in unapproved indication | HO,NaT
234708112,23470811,67,M,2023-12-20,20250718,,CYCLOSPORINE,Renal failure,HO,CYCLOSPORINE | Renal failure | HO,2023-12-18/2023-12-24
234817113,23481711,79,F,2023-12-01,20250813,,VEDOLIZUMAB,Colitis ulcerative,OT,VEDOLIZUMAB | Colitis ulcerative | OT,2023-11-27/2023-12-03
234828852,23482885,,F,,20250728,,ENHERTU,Metastases to central nervous system,OT,ENHERTU | Metastases to central nervous system | OT,NaT
234991544,23499154,,,2021-02-09,20250917,,ASTRAZENECA COVID-19 VACCINE,Memory impairment,OT,ASTRAZENECA COVID-19 VACCINE | Memory impairment | OT,2021-02-08/2021-02-14
235035829,23503582,85,F,2024-02-02,20250810,,ULTOMIRIS,Blood phosphorus increased,OT,ULTOMIRIS | Blood phosphorus increased | OT,2024-01-29/2024-02-04
235069642,23506964,11,,2024-01-04,20250807,,ZOLGENSMA,Measles,HO,ZOLGENSMA | Measles | HO,2024-01-01/2024-01-07
235151403,23515140,87,M,2023-01-26,20250710,,DAPAGLIFLOZIN PROPANEDIOL,Gastrointestinal haemorrhage,HO,DAPAGLIFLOZIN PROPANEDIOL | Gastrointestinal haemorrhage | HO,2023-01-23/2023-01-29
235194263,23519426,80,M,2023-08-01,20250805,,DUPIXENT,Uveitis,OT,DUPIXENT | Uveitis | OT,2023-07-31/2023-08-06
235203465,23520346,,F,,20250702,,MEPOLIZUMAB,Asthma,HO,MEPOLIZUMAB | Asthma | HO,NaT
235236073,23523607,49,M,2024-03-01,20250916,,PALBOCICLIB,Neutrophil count decreased,OT,PALBOCICLIB | Neutrophil count decreased | OT,2024-02-26/2024-03-03
235257553,23525755,,,2024-02-09,20250812,,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Inappropriate schedule of product administration,HO,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN | Inappropriate schedule of product administration | HO,2024-02-05/2024-02-11
235261772,23526177,26,F,,20250829,,DUPIXENT,Skin haemorrhage,OT,DUPIXENT | Skin haemorrhage | OT,NaT
235368402,23536840,,F,,20250804,,LUPKYNIS,Product dose omission issue,,LUPKYNIS | Product dose omission issue,NaT
235463092,23546309,61,F,2024-01-01,20250701,,DUPIXENT,Pruritus,DS,DUPIXENT | Pruritus | DS,2024-01-01/2024-01-07
235552772,23555277,,M,,20250710,,CYCLOPHOSPHAMIDE,Premature baby,OT,CYCLOPHOSPHAMIDE | Premature baby | OT,NaT
2356536013,23565360,34,M,2024-01-01,20250908,,ALPROLIX,Haemorrhage,OT,ALPROLIX | Haemorrhage | OT,2024-01-01/2024-01-07
235731072,23573107,,,2023-12-07,20250701,,ADALIMUMAB,Basal cell carcinoma,OT,ADALIMUMAB | Basal cell carcinoma | OT,2023-12-04/2023-12-10
235748465,23574846,72,M,2024-02-18,20250814,,LUMAKRAS,Headache,HO,LUMAKRAS | Headache | HO,2024-02-12/2024-02-18
235759723,23575972,53,F,2023-05-19,20250721,,DEXAMETHASONE SODIUM PHOSPHATE,Peripheral sensorimotor neuropathy,OT,DEXAMETHASONE SODIUM PHOSPHATE | Peripheral sensorimotor neuropathy | OT,2023-05-15/2023-05-21
235884297,23588429,41,M,,20250829,,SERTRALINE,Product prescribing error,HO,SERTRALINE | Product prescribing error | HO,NaT
235938597,23593859,69,F,2023-08-18,20250818,,DENOSUMAB,Pelvic mass,HO,DENOSUMAB | Pelvic mass | HO,2023-08-14/2023-08-20
235966154,23596615,57,F,2024-01-01,20250924,,DUPIXENT,Injection site pruritus,HO,DUPIXENT | Injection site pruritus | HO,2024-01-01/2024-01-07
236012972,23601297,,M,,20250703,,DOXORUBICIN,Deep vein thrombosis,OT,DOXORUBICIN | Deep vein thrombosis | OT,NaT
236017184,23601718,63,F,2024-03-05,20250728,,HUMAN IMMUNOGLOBULIN G,Pneumonia,OT,HUMAN IMMUNOGLOBULIN G | Pneumonia | OT,2024-03-04/2024-03-10
236119393,23611939,25,F,2013-01-01,20250707,,BETAMETHASONE DIPROPIONATE,Haemoperitoneum,HO,BETAMETHASONE DIPROPIONATE | Haemoperitoneum | HO,2012-12-31/2013-01-06
236147854,23614785,69,F,2023-01-01,20250923,,SKYRIZI,Arthralgia,OT,SKYRIZI | Arthralgia | OT,2022-12-26/2023-01-01
236225173,23622517,61,M,2024-01-01,20250922,,DUPIXENT,Skin fissures,,DUPIXENT | Skin fissures,2024-01-01/2024-01-07
236279113,23627911,68,F,,20250723,,LENVIMA,Small intestinal perforation,HO,LENVIMA | Small intestinal perforation | HO,NaT
236336043,23633604,44,F,2021-01-01,20250726,,DUPIXENT,Menstruation delayed,,DUPIXENT | Menstruation delayed,2020-12-28/2021-01-03
236361772,23636177,67,F,2023-12-01,20250715,,EXFORGE,Peripheral swelling,LT,EXFORGE | Peripheral swelling | LT,2023-11-27/2023-12-03
236495176,23649517,,F,2024-02-06,20250709,,KISQALI,Arthralgia,OT,KISQALI | Arthralgia | OT,2024-02-05/2024-02-11
236545445,23654544,,F,,20250930,,CIMZIA,Exposure during pregnancy,DS,CIMZIA | Exposure during pregnancy | DS,NaT
236561569,23656156,70,F,2024-05-28,20250927,,REMICADE,Product dose omission issue,HO,REMICADE | Product dose omission issue | HO,2024-05-27/2024-06-02
236569362,23656936,,M,,20250806,,METHOTREXATE,Polyneuropathy chronic,OT,METHOTREXATE | Polyneuropathy chronic | OT,NaT
236616222,23661622,,M,,20250829,,VEDOLIZUMAB,Anal haemorrhage,OT,VEDOLIZUMAB | Anal haemorrhage | OT,NaT
236628852,23662885,,F,,20250701,,PALIPERIDONE,Sedation,HO,PALIPERIDONE | Sedation | HO,NaT
236679902,23667990,,F,,20250904,,ERELZI,Death,DE,ERELZI | Death | DE,NaT
236685225,23668522,,F,,20250810,,TEZSPIRE,Adrenal insufficiency,OT,TEZSPIRE | Adrenal insufficiency | OT,NaT
236697114,23669711,52,F,,20250929,,PALBOCICLIB,Heart rate increased,OT,PALBOCICLIB | Heart rate increased | OT,NaT
236705953,23670595,,,2023-02-01,20250913,,INFLIXIMAB,Faecal calprotectin increased,OT,INFLIXIMAB | Faecal calprotectin increased | OT,2023-01-30/2023-02-05
236712653,23671265,,F,2023-01-01,20250916,,AVONEX,Visual impairment,,AVONEX | Visual impairment,2022-12-26/2023-01-01
236838563,23683856,13,,2023-12-01,20250708,,FINTEPLA,Weight decreased,OT,FINTEPLA | Weight decreased | OT,2023-11-27/2023-12-03
236966843,23696684,33,F,,20250704,,ACTEMRA,Oral candidiasis,OT,ACTEMRA | Oral candidiasis | OT,NaT
237039285,23703928,17,M,2020-01-03,20250703,,IDURSULFASE,Product dose omission issue,OT,IDURSULFASE | Product dose omission issue | OT,2019-12-30/2020-01-05
237224306,23722430,79,M,2024-03-08,20250926,,IMFINZI,Gastrointestinal perforation,HO,IMFINZI | Gastrointestinal perforation | HO,2024-03-04/2024-03-10
237440443,23744044,53,F,2025-07-01,20250818,,DUPIXENT,Pneumonia,OT,DUPIXENT | Pneumonia | OT,2025-06-30/2025-07-06
237441333,23744133,54,F,,20250807,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,NaT
237454642,23745464,68,F,2022-04-01,20250717,,DUPIXENT,Rash erythematous,,DUPIXENT | Rash erythematous,2022-03-28/2022-04-03
237661763,23766176,51,F,2021-07-01,20250826,,TASIGNA,Platelet count decreased,OT,TASIGNA | Platelet count decreased | OT,2021-06-28/2021-07-04
237693614,23769361,,F,2020-01-01,20250716,,TYSABRI,Tachycardia,HO,TYSABRI | Tachycardia | HO,2019-12-30/2020-01-05
237768172,23776817,3,F,,20250930,,METHOTREXATE,Obstructive sleep apnoea syndrome,HO,METHOTREXATE | Obstructive sleep apnoea syndrome | HO,NaT
237788654,23778865,60,F,,20250920,,SKYRIZI,Memory impairment,,SKYRIZI | Memory impairment,NaT
237820632,23782063,70,M,,20250919,,OMALIZUMAB,Measles,OT,OMALIZUMAB | Measles | OT,NaT
237901944,23790194,80,M,,20250825,,BREXUCABTAGENE AUTOLEUCEL,Myelodysplastic syndrome,OT,BREXUCABTAGENE AUTOLEUCEL | Myelodysplastic syndrome | OT,NaT
237926442,23792644,61,M,2023-07-01,20250929,,DUPIXENT,Knee arthroplasty,OT,DUPIXENT | Knee arthroplasty | OT,2023-06-26/2023-07-02
237946664,23794666,,,,20250731,,BREYANZI,Death,DE,BREYANZI | Death | DE,NaT
238050082,23805008,68,M,2024-04-27,20250707,,SKYRIZI,Crohn's disease,HO,SKYRIZI | Crohn's disease | HO,2024-04-22/2024-04-28
238079884,23807988,6,M,2024-04-04,20250902,,TECENTRIQ,Metastases to lymph nodes,HO,TECENTRIQ | Metastases to lymph nodes | HO,2024-04-01/2024-04-07
238102496,23810249,63,F,2019-10-30,20250904,,PALBOCICLIB,Dysphagia,DE,PALBOCICLIB | Dysphagia | DE,2019-10-28/2019-11-03
238112795,23811279,64,F,2024-01-01,20250904,,RUXIENCE,Off label use,HO,RUXIENCE | Off label use | HO,2024-01-01/2024-01-07
238158613,23815861,,M,,20250701,,PIRFENIDONE,Idiopathic pulmonary fibrosis,HO,PIRFENIDONE | Idiopathic pulmonary fibrosis | HO,NaT
238175577,23817557,48,F,2025-06-09,20250704,,OTEZLA,Loss of personal independence in daily activities,OT,OTEZLA | Loss of personal independence in daily activities | OT,2025-06-09/2025-06-15
238191952,23819195,,F,,20250910,,NASACORT ALLERGY 24HR,Cataract,OT,NASACORT ALLERGY 24HR | Cataract | OT,NaT
238225096,23822509,49,M,,20250922,,RITUXIMAB,Heart rate decreased,OT,RITUXIMAB | Heart rate decreased | OT,NaT
238314342,23831434,59,M,,20250805,,FENOFIBRATE,Hip surgery,HO,FENOFIBRATE | Hip surgery | HO,NaT
238318103,23831810,42,M,2024-03-01,20250803,,QUETIAPINE,Cholestasis,HO,QUETIAPINE | Cholestasis | HO,2024-02-26/2024-03-03
238328932,23832893,74,M,,20250910,,DUPIXENT,Off label use,,DUPIXENT | Off label use,NaT
238582433,23858243,,M,,20250810,,ULTOMIRIS,Neck pain,,ULTOMIRIS | Neck pain,NaT
238584703,23858470,70,M,,20250924,,REMICADE,Infusion related reaction,OT,REMICADE | Infusion related reaction | OT,NaT
238600132,23860013,46,F,2025-01-01,20250807,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2024-12-30/2025-01-05
238633237,23863323,10,F,2024-05-15,20250819,,FINTEPLA,Autism spectrum disorder,OT,FINTEPLA | Autism spectrum disorder | OT,2024-05-13/2024-05-19
238646563,23864656,68,F,2023-01-01,20250711,,KEVZARA,Product use in unapproved indication,OT,KEVZARA | Product use in unapproved indication | OT,2022-12-26/2023-01-01
238754367,23875436,53,M,2025-04-22,20250715,,LENALIDOMIDE,Platelet count decreased,OT,LENALIDOMIDE | Platelet count decreased | OT,2025-04-21/2025-04-27
238854812,23885481,3,M,,20250908,,CHILDRENS XYZAL ALLERGY 24HR,Wrong dose,,CHILDRENS XYZAL ALLERGY 24HR | Wrong dose,NaT
238869164,23886916,60,F,2023-06-01,20250925,,SKYRIZI,Nail pitting,OT,SKYRIZI | Nail pitting | OT,2023-05-29/2023-06-04
2388962514,23889625,72,F,2024-09-13,20250911,,TRESIBA,Rheumatoid arthritis,OT,TRESIBA | Rheumatoid arthritis | OT,2024-09-09/2024-09-15
238979802,23897980,29,M,2024-01-01,20250917,,DUPIXENT,Rebound effect,,DUPIXENT | Rebound effect,2024-01-01/2024-01-07
238979993,23897999,39,M,2024-04-01,20250701,,DUPIXENT,Sleep disorder due to a general medical condition,,DUPIXENT | Sleep disorder due to a general medical condition,2024-04-01/2024-04-07
238980773,23898077,18,F,,20250723,,DUPIXENT,Ocular hyperaemia,,DUPIXENT | Ocular hyperaemia,NaT
239061152,23906115,60,M,2014-01-01,20250909,,HUMIRA,Intestinal resection,OT,HUMIRA | Intestinal resection | OT,2013-12-30/2014-01-05
239076175,23907617,,M,,20250717,,PONATINIB,Feeling cold,HO,PONATINIB | Feeling cold | HO,NaT
239096582,23909658,68,F,2024-03-01,20250930,,REPATHA,Device difficult to use,HO,REPATHA | Device difficult to use | HO,2024-02-26/2024-03-03
239114712,23911471,,M,,20250724,,SODIUM CHLORIDE,Carpal tunnel syndrome,,SODIUM CHLORIDE | Carpal tunnel syndrome,NaT
239129755,23912975,44,F,,20250701,,METHOTREXATE,Weight increased,LT,METHOTREXATE | Weight increased | LT,NaT
239150402,23915040,54,F,2020-01-01,20250728,,XELJANZ,Fall,HO,XELJANZ | Fall | HO,2019-12-30/2020-01-05
239183907,23918390,35,F,2024-05-13,20250821,,TEDUGLUTIDE,Underweight,OT,TEDUGLUTIDE | Underweight | OT,2024-05-13/2024-05-19
2392712514,23927125,,F,2024-01-01,20250807,,TYVASO,Nausea,HO,TYVASO | Nausea | HO,2024-01-01/2024-01-07
239283682,23928368,80,F,2024-02-01,20250703,,TYMLOS,Asthenia,,TYMLOS | Asthenia,2024-01-29/2024-02-04
239293862,23929386,,F,,20250703,,TYMLOS,Heart rate increased,,TYMLOS | Heart rate increased,NaT
239296852,23929685,,F,,20250703,,TYMLOS,Nausea,,TYMLOS | Nausea,NaT
239296862,23929686,66,M,2024-04-19,20250703,,TYMLOS,Psychomotor hyperactivity,,TYMLOS | Psychomotor hyperactivity,2024-04-15/2024-04-21
239391175,23939117,42,F,2022-01-01,20250703,,RINVOQ,COVID-19,OT,RINVOQ | COVID-19 | OT,2021-12-27/2022-01-02
239401002,23940100,,F,,20250904,,LENALIDOMIDE,Product dose omission issue,,LENALIDOMIDE | Product dose omission issue,NaT
239410294,23941029,,F,,20250810,,ULTOMIRIS,Cough,,ULTOMIRIS | Cough,NaT
239422365,23942236,44,M,2024-05-01,20250919,,TARPEYO,Heart rate increased,,TARPEYO | Heart rate increased,2024-04-29/2024-05-05
2394898515,23948985,12,M,2024-05-13,20250903,,TEDUGLUTIDE,Injection site pain,HO,TEDUGLUTIDE | Injection site pain | HO,2024-05-13/2024-05-19
239500503,23950050,,M,,20250709,,DOCETAXEL,Performance status decreased,OT,DOCETAXEL | Performance status decreased | OT,NaT
239530135,23953013,54,M,2024-04-23,20250914,,ESKETAMINE,Depression,HO,ESKETAMINE | Depression | HO,2024-04-22/2024-04-28
239541284,23954128,69,M,,20250915,,DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION,Vision blurred,,DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION | Vision blurred,NaT
239553227,23955322,40,F,2012-01-01,20250916,,TRUVADA,Bone density decreased,OT,TRUVADA | Bone density decreased | OT,2011-12-26/2012-01-01
239595304,23959530,,F,,20250730,,OTEZLA,Therapy interrupted,OT,OTEZLA | Therapy interrupted | OT,NaT
239644112,23964411,63,M,,20250916,,RETEVMO,Nephrolithiasis,HO,RETEVMO | Nephrolithiasis | HO,NaT
239666358,23966635,68,M,2023-10-02,20250807,,TEDUGLUTIDE,Blood urine present,HO,TEDUGLUTIDE | Blood urine present | HO,2023-10-02/2023-10-08
239710582,23971058,73,F,,20250703,,PREDNISONE,Henoch-Schonlein purpura,OT,PREDNISONE | Henoch-Schonlein purpura | OT,NaT
239713386,23971338,21,M,2022-12-01,20250723,,RUXIENCE,Urticaria,OT,RUXIENCE | Urticaria | OT,2022-11-28/2022-12-04
2397434014,23974340,,,2023-06-14,20250703,,INFLECTRA,Immunodeficiency,HO,INFLECTRA | Immunodeficiency | HO,2023-06-12/2023-06-18
239748364,23974836,40,F,2024-02-17,20250803,,SOLIRIS,Pulmonary alveolar haemorrhage,DE,SOLIRIS | Pulmonary alveolar haemorrhage | DE,2024-02-12/2024-02-18
239841086,23984108,16,M,2024-06-03,20250715,,FINTEPLA,Fatigue,HO,FINTEPLA | Fatigue | HO,2024-06-03/2024-06-09
239846893,23984689,,,,20250709,,LUTATHERA,Death,DE,LUTATHERA | Death | DE,NaT
239861744,23986174,76,M,2024-03-01,20250808,,ORGOVYX,Stent placement,HO,ORGOVYX | Stent placement | HO,2024-02-26/2024-03-03
239874183,23987418,,F,,20250810,,SOLIRIS,Rash,,SOLIRIS | Rash,NaT
239897593,23989759,87,M,2023-08-18,20250801,,ABILIFY,Delirium,HO,ABILIFY | Delirium | HO,2023-08-14/2023-08-20
239915883,23991588,,F,,20250816,,SOLIRIS,Fatigue,,SOLIRIS | Fatigue,NaT
239916622,23991662,,,,20250813,,ANDROGEL,Therapeutic response decreased,,ANDROGEL | Therapeutic response decreased,NaT
239965513,23996551,,F,,20250816,,STRENSIQ,Fracture,,STRENSIQ | Fracture,NaT
240026303,24002630,,F,,20250810,,SOLIRIS,Feeling abnormal,,SOLIRIS | Feeling abnormal,NaT
240075418,24007541,,,2024-01-01,20250719,,INFLECTRA,Muscle spasms,OT,INFLECTRA | Muscle spasms | OT,2024-01-01/2024-01-07
240081962,24008196,,,,20250825,,AMLODIPINE,Serotonin syndrome,OT,AMLODIPINE | Serotonin syndrome | OT,NaT
240193685,24019368,46,F,2024-05-01,20250715,,ORENCIA,Rheumatoid arthritis,OT,ORENCIA | Rheumatoid arthritis | OT,2024-04-29/2024-05-05
240268195,24026819,20,M,2024-05-27,20250918,,EXONDYS 51,Acute respiratory distress syndrome,HO,EXONDYS 51 | Acute respiratory distress syndrome | HO,2024-05-27/2024-06-02
240285745,24028574,45,M,2024-06-21,20250929,,HEMLIBRA,Haemorrhage,,HEMLIBRA | Haemorrhage,2024-06-17/2024-06-23
240304679,24030467,73,F,2023-12-09,20250808,,ENTYVIO,Oral blood blister,OT,ENTYVIO | Oral blood blister | OT,2023-12-04/2023-12-10
240323073,24032307,75,M,2022-12-23,20250718,,PREDNISOLONE,Intentional product misuse,DE,PREDNISOLONE | Intentional product misuse | DE,2022-12-19/2022-12-25
240386673,24038667,59,F,2024-06-05,20250810,,BYDUREON BCISE,Wrong technique in device usage process,,BYDUREON BCISE | Wrong technique in device usage process,2024-06-03/2024-06-09
240511452,24051145,76,M,,20250906,,DUPIXENT,Eye pruritus,,DUPIXENT | Eye pruritus,NaT
240579853,24057985,28,F,,20250804,,LUSPATERCEPT,Maternal exposure during pregnancy,OT,LUSPATERCEPT | Maternal exposure during pregnancy | OT,NaT
240609466,24060946,74,F,2025-01-31,20250926,,HIZENTRA,Patient dissatisfaction with treatment,HO,HIZENTRA | Patient dissatisfaction with treatment | HO,2025-01-27/2025-02-02
240675732,24067573,,,2017-01-01,20250915,,INFLECTRA,Cholangitis,OT,INFLECTRA | Cholangitis | OT,2016-12-26/2017-01-01
240758405,24075840,60,F,,20250903,,BUDESONIDE\FORMOTEROL FUMARATE,Platelet count increased,HO,BUDESONIDE\FORMOTEROL FUMARATE | Platelet count increased | HO,NaT
240759507,24075950,41,M,2020-04-01,20250826,,PREDNISOLONE,Hepatitis E,OT,PREDNISOLONE | Hepatitis E | OT,2020-03-30/2020-04-05
240807243,24080724,,F,,20250802,,LYNPARZA,Chills,OT,LYNPARZA | Chills | OT,NaT
240828243,24082824,14,M,2024-07-03,20250806,,SOMATROPIN,Drug dose omission by device,,SOMATROPIN | Drug dose omission by device,2024-07-01/2024-07-07
240837776,24083777,,F,,20250911,,VEDOLIZUMAB,Pneumonia,HO,VEDOLIZUMAB | Pneumonia | HO,NaT
240882715,24088271,,M,,20250825,,TEDUGLUTIDE,Decreased appetite,HO,TEDUGLUTIDE | Decreased appetite | HO,NaT
240974792,24097479,,,2024-04-07,20250820,,XCOPRI,Coma,LT,XCOPRI | Coma | LT,2024-04-01/2024-04-07
240986612,24098661,,M,,20250715,,OZEMPIC,Weight increased,,OZEMPIC | Weight increased,NaT
240997002,24099700,44,F,2024-03-01,20250715,,OZEMPIC,Nausea,,OZEMPIC | Nausea,2024-02-26/2024-03-03
241016762,24101676,54,F,2024-05-15,20250715,,OZEMPIC,Increased appetite,,OZEMPIC | Increased appetite,2024-05-13/2024-05-19
241017232,24101723,,F,2024-01-01,20250715,,OZEMPIC,Contusion,,OZEMPIC | Contusion,2024-01-01/2024-01-07
241021352,24102135,,M,,20250715,,OZEMPIC,Product label confusion,,OZEMPIC | Product label confusion,NaT
241023892,24102389,63,F,2024-04-01,20250715,,OZEMPIC,Dry mouth,,OZEMPIC | Dry mouth,2024-04-01/2024-04-07
241153402,24115340,,F,,20250718,,WEGOVY,Oropharyngeal discomfort,,WEGOVY | Oropharyngeal discomfort,NaT
241154102,24115410,33,F,2024-04-13,20250718,,WEGOVY,Decreased appetite,,WEGOVY | Decreased appetite,2024-04-08/2024-04-14
241159165,24115916,70,F,,20250916,,REVLIMID,Neuropathy peripheral,OT,REVLIMID | Neuropathy peripheral | OT,NaT
241212549,24121254,12,M,,20250924,,GENOTROPIN,Device breakage,,GENOTROPIN | Device breakage,NaT
241226538,24122653,70,F,,20250919,,ACETAMINOPHEN,Altered state of consciousness,HO,ACETAMINOPHEN | Altered state of consciousness | HO,NaT
241260808,24126080,23,F,2024-01-01,20250804,,REMICADE,Cough,OT,REMICADE | Cough | OT,2024-01-01/2024-01-07
241315933,24131593,20,M,,20250901,,ALLOPURINOL,Toxic epidermal necrolysis,OT,ALLOPURINOL | Toxic epidermal necrolysis | OT,NaT
241365732,24136573,,M,,20250912,,ATORVASTATIN,Gastrointestinal stromal tumour,OT,ATORVASTATIN | Gastrointestinal stromal tumour | OT,NaT
241373782,24137378,53,F,2024-06-05,20250830,,MIRTAZAPINE,Anticonvulsant drug level increased,LT,MIRTAZAPINE | Anticonvulsant drug level increased | LT,2024-06-03/2024-06-09
241413392,24141339,83,M,,20250930,,AMLODIPINE,Gingivitis,OT,AMLODIPINE | Gingivitis | OT,NaT
241478055,24147805,66,M,2024-01-01,20250917,,OFEV,Dyspepsia,HO,OFEV | Dyspepsia | HO,2024-01-01/2024-01-07
241519302,24151930,9,M,2024-03-21,20250728,,AMONDYS 45,Poor venous access,,AMONDYS 45 | Poor venous access,2024-03-18/2024-03-24
241559104,24155910,10,F,,20250801,,CYCLOSPORINE,Off label use,HO,CYCLOSPORINE | Off label use | HO,NaT
241641062,24164106,60,M,,20250820,,CISPLATIN,Acute kidney injury,OT,CISPLATIN | Acute kidney injury | OT,NaT
241686004,24168600,78,F,,20250802,,IMFINZI,Liver abscess,OT,IMFINZI | Liver abscess | OT,NaT
241703894,24170389,65,F,,20250704,,MOXIFLOXACIN HYDROCHLORIDE,Oedema,OT,MOXIFLOXACIN HYDROCHLORIDE | Oedema | OT,NaT
241744453,24174445,74,M,2024-01-01,20250821,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,2024-01-01/2024-01-07
241749765,24174976,61,F,2019-02-01,20250829,,TEDUGLUTIDE,Viral infection,HO,TEDUGLUTIDE | Viral infection | HO,2019-01-28/2019-02-03
241750712,24175071,18,F,,20250807,,ACETAMINOPHEN,Pyroglutamic acidosis,HO,ACETAMINOPHEN | Pyroglutamic acidosis | HO,NaT
241763802,24176380,48,M,,20250926,,HYDROXYUREA,Febrile neutropenia,OT,HYDROXYUREA | Febrile neutropenia | OT,NaT
2417819210,24178192,14,M,2024-07-02,20250818,,GENOTROPIN,Device use error,,GENOTROPIN | Device use error,2024-07-01/2024-07-07
241828323,24182832,85,M,2024-07-09,20250809,,PRIVIGEN,Balanoposthitis,HO,PRIVIGEN | Balanoposthitis | HO,2024-07-08/2024-07-14
241849422,24184942,71,F,2024-07-18,20250701,,LENVIMA,Aspartate aminotransferase increased,HO,LENVIMA | Aspartate aminotransferase increased | HO,2024-07-15/2024-07-21
241896004,24189600,,M,,20250816,,ULTOMIRIS,Therapeutic response shortened,,ULTOMIRIS | Therapeutic response shortened,NaT
241896672,24189667,,,,20250807,,VELSIPITY,Heart rate decreased,OT,VELSIPITY | Heart rate decreased | OT,NaT
241976882,24197688,,F,,20250726,,DUPIXENT,Cough,,DUPIXENT | Cough,NaT
242054243,24205424,,F,,20250810,,WAINUA,Peripheral swelling,OT,WAINUA | Peripheral swelling | OT,NaT
242097412,24209741,54,F,2024-02-15,20250708,,RITUXIMAB,Condition aggravated,HO,RITUXIMAB | Condition aggravated | HO,2024-02-12/2024-02-18
242099172,24209917,,F,,20250812,,JUXTAPID,Product dose omission issue,,JUXTAPID | Product dose omission issue,NaT
242100143,24210014,33,M,,20250822,,PREDNISOLONE,Aortic aneurysm rupture,DE,PREDNISOLONE | Aortic aneurysm rupture | DE,NaT
242122595,24212259,,,2024-06-01,20250730,,INFLIXIMAB,Diarrhoea,OT,INFLIXIMAB | Diarrhoea | OT,2024-05-27/2024-06-02
242137694,24213769,45,F,,20250809,,SOLIRIS,Off label use,DE,SOLIRIS | Off label use | DE,NaT
242195723,24219572,29,F,2023-08-01,20250804,,MOUNJARO,Off label use,OT,MOUNJARO | Off label use | OT,2023-07-31/2023-08-06
242226573,24222657,61,F,2024-01-01,20250822,,DUPIXENT,Impaired quality of life,,DUPIXENT | Impaired quality of life,2024-01-01/2024-01-07
242229504,24222950,39,F,2018-10-10,20250909,,VEDOLIZUMAB,Colitis ulcerative,OT,VEDOLIZUMAB | Colitis ulcerative | OT,2018-10-08/2018-10-14
242229797,24222979,,F,2024-01-01,20250807,,ARIKAYCE,Cough,OT,ARIKAYCE | Cough | OT,2024-01-01/2024-01-07
242266873,24226687,,F,,20250810,,ULTOMIRIS,Headache,,ULTOMIRIS | Headache,NaT
2422977410,24229774,49,F,2023-10-28,20250714,,KISQALI,Dysphonia,OT,KISQALI | Dysphonia | OT,2023-10-23/2023-10-29
242308995,24230899,70,F,2025-06-01,20250729,,VEDOLIZUMAB,Nervousness,OT,VEDOLIZUMAB | Nervousness | OT,2025-05-26/2025-06-01
242332566,24233256,,F,,20250717,,LITHIUM,Delusion,HO,LITHIUM | Delusion | HO,NaT
242405377,24240537,48,F,,20250909,,AYVAKIT,Vomiting,OT,AYVAKIT | Vomiting | OT,NaT
242407653,24240765,39,F,,20250717,,SEMAGLUTIDE,Abdominal pain,OT,SEMAGLUTIDE | Abdominal pain | OT,NaT
242436454,24243645,56,M,,20250707,,RITUXIMAB,Pneumonia,HO,RITUXIMAB | Pneumonia | HO,NaT
242495863,24249586,,F,,20250811,,DUPIXENT,Inappropriate schedule of product administration,,DUPIXENT | Inappropriate schedule of product administration,NaT
242496974,24249697,66,M,2025-01-01,20250915,,DUPIXENT,Dyspnoea,HO,DUPIXENT | Dyspnoea | HO,2024-12-30/2025-01-05
242503472,24250347,68,F,,20250827,,DICLOFENAC SODIUM,Spinal stenosis,OT,DICLOFENAC SODIUM | Spinal stenosis | OT,NaT
242504784,24250478,,M,,20250816,,ULTOMIRIS,Arthralgia,,ULTOMIRIS | Arthralgia,NaT
242524352,24252435,79,M,2023-12-17,20250820,,RELUGOLIX,Therapy interrupted,,RELUGOLIX | Therapy interrupted,2023-12-11/2023-12-17
242524598,24252459,,,2023-02-17,20250912,,INFLECTRA,Erythema nodosum,OT,INFLECTRA | Erythema nodosum | OT,2023-02-13/2023-02-19
242545803,24254580,,F,,20250810,,ULTOMIRIS,Diplopia,,ULTOMIRIS | Diplopia,NaT
242547033,24254703,,F,2024-01-01,20250717,,TYSABRI,Vomiting,,TYSABRI | Vomiting,2024-01-01/2024-01-07
242548033,24254803,,F,,20250810,,BREZTRI,Wrong technique in device usage process,,BREZTRI | Wrong technique in device usage process,NaT
242555213,24255521,27,F,2024-08-01,20250820,,PREDNISONE,Sleep disorder,,PREDNISONE | Sleep disorder,2024-07-29/2024-08-04
242567633,24256763,,F,,20250810,,SAPHNELO,Palpitations,,SAPHNELO | Palpitations,NaT
242589573,24258957,72,F,2024-08-05,20250816,,BUDESONIDE,Incorrect dose administered by device,,BUDESONIDE | Incorrect dose administered by device,2024-08-05/2024-08-11
242589998,24258999,84,F,,20250923,,IBRANCE,Skin exfoliation,,IBRANCE | Skin exfoliation,NaT
242599692,24259969,34,F,,20250730,,DUPIXENT,Product storage error,,DUPIXENT | Product storage error,NaT
2426067910,24260679,66,M,,20250903,,CODEINE,Febrile neutropenia,OT,CODEINE | Febrile neutropenia | OT,NaT
242611312,24261131,42,F,,20250723,,RITUXIMAB,Off label use,OT,RITUXIMAB | Off label use | OT,NaT
242637513,24263751,75,M,2024-08-01,20250903,,XELJANZ,Renal impairment,OT,XELJANZ | Renal impairment | OT,2024-07-29/2024-08-04
242641514,24264151,80,M,,20250929,,RITUXIMAB,Pancytopenia,OT,RITUXIMAB | Pancytopenia | OT,NaT
242696532,24269653,,,2024-01-01,20250923,,KORLYM,Hypoglycaemia,OT,KORLYM | Hypoglycaemia | OT,2024-01-01/2024-01-07
242709479,24270947,67,M,2024-08-01,20250729,,EPCORITAMAB,Oesophagitis,OT,EPCORITAMAB | Oesophagitis | OT,2024-07-29/2024-08-04
242721393,24272139,87,M,2024-08-29,20250723,,PROCRIT,Wrong technique in product usage process,,PROCRIT | Wrong technique in product usage process,2024-08-26/2024-09-01
242732892,24273289,,,,20250901,,TRIKAFTA,Glucose tolerance decreased,,TRIKAFTA | Glucose tolerance decreased,NaT
242757233,24275723,,M,,20250810,,ULTOMIRIS,Musculoskeletal stiffness,,ULTOMIRIS | Musculoskeletal stiffness,NaT
242798802,24279880,,F,,20250908,,NASACORT ALLERGY 24HR,No adverse event,,NASACORT ALLERGY 24HR | No adverse event,NaT
242802158,24280215,36,F,,20250729,,FENTANYL,Decreased activity,OT,FENTANYL | Decreased activity | OT,NaT
242835423,24283542,,,,20250801,,ORGOVYX,Diarrhoea,,ORGOVYX | Diarrhoea,NaT
2428509112,24285091,,,2024-01-01,20250712,,INFLECTRA,Off label use,OT,INFLECTRA | Off label use | OT,2024-01-01/2024-01-07
242872623,24287262,7,M,,20250803,,PEMETREXED,Rash,DS,PEMETREXED | Rash | DS,NaT
242880426,24288042,,,,20250718,,ORGOVYX,Vomiting,,ORGOVYX | Vomiting,NaT
242886503,24288650,31,F,,20250820,,ACETAMINOPHEN,Abdominal pain,HO,ACETAMINOPHEN | Abdominal pain | HO,NaT
242904642,24290464,67,F,,20250708,,HYDRALAZINE,Glomerulonephritis,OT,HYDRALAZINE | Glomerulonephritis | OT,NaT
242918703,24291870,,F,,20250809,,STRENSIQ,Injection site swelling,OT,STRENSIQ | Injection site swelling | OT,NaT
242942352,24294235,55,M,2024-05-01,20250905,,OXERVATE,Eye pain,,OXERVATE | Eye pain,2024-04-29/2024-05-05
242942612,24294261,76,F,2024-06-16,20250905,,OXERVATE,Photophobia,,OXERVATE | Photophobia,2024-06-10/2024-06-16
242979453,24297945,76,F,,20250814,,ACTEMRA,Drug hypersensitivity,HO,ACTEMRA | Drug hypersensitivity | HO,NaT
243004913,24300491,,F,,20250810,,SOLIRIS,Vaccination site mass,,SOLIRIS | Vaccination site mass,NaT
243005283,24300528,,F,,20250816,,BREZTRI,Device delivery system issue,,BREZTRI | Device delivery system issue,NaT
243020133,24302013,11,F,,20250817,,FLUDARABINE,Cytomegalovirus infection,OT,FLUDARABINE | Cytomegalovirus infection | OT,NaT
243036758,24303675,43,M,2014-01-01,20250714,,ATRIPLA,Renal failure,OT,ATRIPLA | Renal failure | OT,2013-12-30/2014-01-05
243041435,24304143,74,F,2024-08-16,20250809,,ULTOMIRIS,Epilepsy,HO,ULTOMIRIS | Epilepsy | HO,2024-08-12/2024-08-18
243046582,24304658,,,,20250710,,ORGOVYX,Diabetes mellitus,HO,ORGOVYX | Diabetes mellitus | HO,NaT
243088403,24308840,80,F,,20250827,,XELJANZ XR,Pain,,XELJANZ XR | Pain,NaT
243111093,24311109,70,M,2022-08-01,20250920,,DUPIXENT,Condition aggravated,,DUPIXENT | Condition aggravated,2022-08-01/2022-08-07
243144903,24314490,,F,,20250816,,ULTOMIRIS,Musculoskeletal stiffness,,ULTOMIRIS | Musculoskeletal stiffness,NaT
243154932,24315493,,,,20250904,,TECVAYLI,Immune effector cell-associated HLH-like syndrome,DE,TECVAYLI | Immune effector cell-associated HLH-like syndrome | DE,NaT
243175212,24317521,80,M,,20250729,,REVLIMID,Hypertension,OT,REVLIMID | Hypertension | OT,NaT
243177745,24317774,49,M,2020-12-01,20250904,,BUSULFAN,Device related infection,OT,BUSULFAN | Device related infection | OT,2020-11-30/2020-12-06
243212433,24321243,,F,,20250816,,FASENRA,Product dose omission issue,,FASENRA | Product dose omission issue,NaT
243219497,24321949,,F,,20250812,,ROSUVASTATIN,Lip swelling,OT,ROSUVASTATIN | Lip swelling | OT,NaT
243229412,24322941,41,F,,20250805,,PHENOBARBITAL,Cross sensitivity reaction,HO,PHENOBARBITAL | Cross sensitivity reaction | HO,NaT
243239132,24323913,,M,,20250916,,HYRIMOZ,Crohn's disease,OT,HYRIMOZ | Crohn's disease | OT,NaT
243256033,24325603,56,F,,20250810,,BUDESONIDE\FORMOTEROL,Pneumonia,OT,BUDESONIDE\FORMOTEROL | Pneumonia | OT,NaT
243262963,24326296,81,F,,20250809,,DAPAGLIFLOZIN,Cardiac disorder,HO,DAPAGLIFLOZIN | Cardiac disorder | HO,NaT
243264087,24326408,,F,2024-01-01,20250922,,ARIKAYCE,Pyrexia,HO,ARIKAYCE | Pyrexia | HO,2024-01-01/2024-01-07
243269833,24326983,65,M,,20250810,,CALQUENCE,Leukocytosis,HO,CALQUENCE | Leukocytosis | HO,NaT
243280293,24328029,,M,,20250810,,ULTOMIRIS,Back pain,,ULTOMIRIS | Back pain,NaT
243295252,24329525,77,F,2024-08-07,20250818,,LEQEMBI,Haemorrhage,DE,LEQEMBI | Haemorrhage | DE,2024-08-05/2024-08-11
243297505,24329750,37,M,2024-11-01,20250730,,DUPIXENT,Dysphagia,OT,DUPIXENT | Dysphagia | OT,2024-10-28/2024-11-03
243300523,24330052,,F,,20250809,,FASENRA,Pulmonary oedema,HO,FASENRA | Pulmonary oedema | HO,NaT
243303823,24330382,,F,,20250803,,FARXIGA,Musculoskeletal disorder,OT,FARXIGA | Musculoskeletal disorder | OT,NaT
243308483,24330848,72,M,2023-07-03,20250804,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Nasal congestion,OT,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Nasal congestion | OT,2023-07-03/2023-07-09
243313623,24331362,68,M,2024-07-25,20250803,,TICAGRELOR,Enteritis,HO,TICAGRELOR | Enteritis | HO,2024-07-22/2024-07-28
243314103,24331410,,M,,20250809,,TAGRISSO,Nausea,OT,TAGRISSO | Nausea | OT,NaT
243333012,24333301,24,,2024-09-12,20250814,,VELSIPITY,Malaise,,VELSIPITY | Malaise,2024-09-09/2024-09-15
243334834,24333483,53,M,2014-09-04,20250913,,HUMIRA,Calculus urinary,HO,HUMIRA | Calculus urinary | HO,2014-09-01/2014-09-07
243342703,24334270,48,F,2023-05-17,20250803,,SOLIRIS,Spinal pain,OT,SOLIRIS | Spinal pain | OT,2023-05-15/2023-05-21
243346095,24334609,69,M,,20250925,,ORGOVYX,Somnolence,OT,ORGOVYX | Somnolence | OT,NaT
243397243,24339724,54,F,2024-06-01,20250930,,TARPEYO,Cataract,OT,TARPEYO | Cataract | OT,2024-05-27/2024-06-02
243422192,24342219,,F,,20250821,,EPIDIOLEX,Enterovirus infection,HO,EPIDIOLEX | Enterovirus infection | HO,NaT
243433425,24343342,,,2024-08-16,20250725,,ORSERDU,Malaise,HO,ORSERDU | Malaise | HO,2024-08-12/2024-08-18
243466125,24346612,59,M,2023-01-01,20250827,,SKYRIZI,Hepatic failure,OT,SKYRIZI | Hepatic failure | OT,2022-12-26/2023-01-01
243535254,24353525,43,F,,20250911,,XELJANZ XR,Herpes zoster,OT,XELJANZ XR | Herpes zoster | OT,NaT
243566958,24356695,30,F,,20250925,,REPLAGAL,Brain fog,HO,REPLAGAL | Brain fog | HO,NaT
243604283,24360428,54,F,,20250704,,ORENCIA,Joint swelling,,ORENCIA | Joint swelling,NaT
243616812,24361681,52,F,,20250821,,CARBOPLATIN,Condition aggravated,OT,CARBOPLATIN | Condition aggravated | OT,NaT
243620754,24362075,,F,,20250801,,CYCLOSPORINE,Gestational diabetes,OT,CYCLOSPORINE | Gestational diabetes | OT,NaT
243630583,24363058,,,,20250717,,ORGOVYX,Decreased appetite,,ORGOVYX | Decreased appetite,NaT
2436499510,24364995,77,F,2024-12-12,20250903,,POMALYST,Urinary tract infection,OT,POMALYST | Urinary tract infection | OT,2024-12-09/2024-12-15
243671925,24367192,92,F,2024-01-01,20250821,,TREPROSTINIL,Flank pain,HO,TREPROSTINIL | Flank pain | HO,2024-01-01/2024-01-07
2436867010,24368670,50,M,2023-03-13,20250723,,SKYRIZI,Rectal cancer,HO,SKYRIZI | Rectal cancer | HO,2023-03-13/2023-03-19
243735282,24373528,,,,20250919,,QSYMIA,Headache,,QSYMIA | Headache,NaT
243743634,24374363,,M,,20250904,,LUPKYNIS,Dementia,OT,LUPKYNIS | Dementia | OT,NaT
243785962,24378596,94,F,2024-06-01,20250915,,CHOLESTYRAMINE,Intestinal obstruction,,CHOLESTYRAMINE | Intestinal obstruction,2024-05-27/2024-06-02
243798972,24379897,70,M,,20250816,,BREZTRI,Chronic obstructive pulmonary disease,,BREZTRI | Chronic obstructive pulmonary disease,NaT
243813492,24381349,,F,,20250809,,TAGRISSO,Metastases to meninges,OT,TAGRISSO | Metastases to meninges | OT,NaT
243828884,24382888,69,F,,20250929,,ENTYVIO,Constipation,OT,ENTYVIO | Constipation | OT,NaT
243829553,24382955,,F,,20250809,,SOLIRIS,Arthralgia,HO,SOLIRIS | Arthralgia | HO,NaT
243844342,24384434,,,,20250810,,FASENRA,Asthma prophylaxis,,FASENRA | Asthma prophylaxis,NaT
243857372,24385737,,F,,20250816,,LYNPARZA,Death,DE,LYNPARZA | Death | DE,NaT
243873542,24387354,,,,20250810,,SAPHNELO,Neuromyelitis optica spectrum disorder,LT,SAPHNELO | Neuromyelitis optica spectrum disorder | LT,NaT
243878972,24387897,79,M,,20250803,,DAPAGLIFLOZIN,Euglycaemic diabetic ketoacidosis,HO,DAPAGLIFLOZIN | Euglycaemic diabetic ketoacidosis | HO,NaT
243880982,24388098,69,M,2024-07-10,20250802,,BREZTRI,Death,OT,BREZTRI | Death | OT,2024-07-08/2024-07-14
243881242,24388124,,,,20250810,,BREZTRI,Neoplasm malignant,OT,BREZTRI | Neoplasm malignant | OT,NaT
243889303,24388930,63,M,2024-01-01,20250803,,CALQUENCE,Pericarditis,OT,CALQUENCE | Pericarditis | OT,2024-01-01/2024-01-07
243890402,24389040,67,F,2024-09-20,20250803,,BUDESONIDE,Tachycardia,OT,BUDESONIDE | Tachycardia | OT,2024-09-16/2024-09-22
243904783,24390478,11,M,2023-01-01,20250901,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2022-12-26/2023-01-01
243905312,24390531,61,F,2024-02-26,20250807,,KISQALI,Therapeutic product effect incomplete,OT,KISQALI | Therapeutic product effect incomplete | OT,2024-02-26/2024-03-03
243918975,24391897,59,F,,20250910,,LETROZOLE,Productive cough,,LETROZOLE | Productive cough,NaT
243924792,24392479,70,F,2024-09-05,20250809,,DURVALUMAB,Febrile neutropenia,HO,DURVALUMAB | Febrile neutropenia | HO,2024-09-02/2024-09-08
243931842,24393184,,F,,20250810,,OSIMERTINIB,Carcinoembryonic antigen increased,OT,OSIMERTINIB | Carcinoembryonic antigen increased | OT,NaT
243936662,24393666,,F,,20250803,,FARXIGA,Myocardial infarction,OT,FARXIGA | Myocardial infarction | OT,NaT
243942943,24394294,40,M,2024-09-01,20250818,,RINVOQ,Face oedema,OT,RINVOQ | Face oedema | OT,2024-08-26/2024-09-01
243951862,24395186,,M,,20250816,,IMFINZI,Death,DE,IMFINZI | Death | DE,NaT
243952582,24395258,,,2024-07-17,20250809,,SOLIRIS,Myocardial infarction,DE,SOLIRIS | Myocardial infarction | DE,2024-07-15/2024-07-21
243965402,24396540,50,F,2024-09-01,20250703,,OTEZLA,Discomfort,,OTEZLA | Discomfort,2024-08-26/2024-09-01
243982792,24398279,,M,,20250810,,FARXIGA,Death,DE,FARXIGA | Death | DE,NaT
243990552,24399055,,F,2024-01-01,20250918,,TYVASO,Therapy non-responder,,TYVASO | Therapy non-responder,2024-01-01/2024-01-07
243992502,24399250,,,,20250816,,FARXIGA,Death,DE,FARXIGA | Death | DE,NaT
243992972,24399297,77,F,2024-09-02,20250809,,FARXIGA,Death,DE,FARXIGA | Death | DE,2024-09-02/2024-09-08
243997322,24399732,,M,,20250810,,SYMBICORT,Choking,OT,SYMBICORT | Choking | OT,NaT
243999662,24399966,,F,,20250809,,TEZEPELUMAB,Lung disorder,HO,TEZEPELUMAB | Lung disorder | HO,NaT
244015692,24401569,,F,2024-01-01,20250806,,BIMEKIZUMAB,Asthenia,HO,BIMEKIZUMAB | Asthenia | HO,2024-01-01/2024-01-07
244028252,24402825,,,2024-09-06,20250923,,CETIRIZINE,Tremor,OT,CETIRIZINE | Tremor | OT,2024-09-02/2024-09-08
244039643,24403964,,,,20250802,,DURVALUMAB,Death,DE,DURVALUMAB | Death | DE,NaT
244054632,24405463,,F,,20250816,,NEXIUM,Gastrooesophageal reflux disease,,NEXIUM | Gastrooesophageal reflux disease,NaT
244054712,24405471,,F,,20250803,,TAGRISSO,Death,DE,TAGRISSO | Death | DE,NaT
244069472,24406947,54,F,2024-08-01,20250918,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,2024-07-29/2024-08-04
244069714,24406971,60,F,2023-05-02,20250911,,VEDOLIZUMAB,Inappropriate schedule of product administration,OT,VEDOLIZUMAB | Inappropriate schedule of product administration | OT,2023-05-01/2023-05-07
244092512,24409251,,M,,20250803,,DURVALUMAB,Death,OT,DURVALUMAB | Death | OT,NaT
244113183,24411318,67,M,,20250809,,DURVALUMAB,Hepatic failure,OT,DURVALUMAB | Hepatic failure | OT,NaT
244127356,24412735,35,M,2004-06-01,20250714,,TRUVADA,Chronic kidney disease,OT,TRUVADA | Chronic kidney disease | OT,2004-05-31/2004-06-06
244156992,24415699,85,F,,20250726,,EVENITY,Adverse event,HO,EVENITY | Adverse event | HO,NaT
244157247,24415724,,M,,20250930,,HUMAN IMMUNOGLOBULIN G,Arthropod bite,OT,HUMAN IMMUNOGLOBULIN G | Arthropod bite | OT,NaT
244191812,24419181,84,M,2024-08-25,20250810,,CALQUENCE,Death,DE,CALQUENCE | Death | DE,2024-08-19/2024-08-25
244219083,24421908,,F,2024-08-01,20250802,,TICAGRELOR,Contusion,OT,TICAGRELOR | Contusion | OT,2024-07-29/2024-08-04
244224182,24422418,37,M,2019-01-01,20250723,,BORTEZOMIB,Staphylococcal infection,DE,BORTEZOMIB | Staphylococcal infection | DE,2018-12-31/2019-01-06
244237767,24423776,,M,2024-10-07,20250708,,PANTOPRAZOLE SODIUM,Device dislocation,HO,PANTOPRAZOLE SODIUM | Device dislocation | HO,2024-10-07/2024-10-13
244257594,24425759,25,F,2023-09-14,20250801,,TILDRAKIZUMAB,Diarrhoea,OT,TILDRAKIZUMAB | Diarrhoea | OT,2023-09-11/2023-09-17
244279262,24427926,31,M,,20250802,,EVUSHELD,Pain,OT,EVUSHELD | Pain | OT,NaT
244295262,24429526,,M,2024-08-28,20250803,,FARXIGA,Death,DE,FARXIGA | Death | DE,2024-08-26/2024-09-01
244295442,24429544,58,F,,20250810,,CAPIVASERTIB,Stevens-Johnson syndrome,OT,CAPIVASERTIB | Stevens-Johnson syndrome | OT,NaT
244298212,24429821,,F,,20250810,,TEZSPIRE,Headache,,TEZSPIRE | Headache,NaT
244321663,24432166,65,M,,20250919,,VELCADE,Streptococcal bacteraemia,OT,VELCADE | Streptococcal bacteraemia | OT,NaT
244328382,24432838,,M,,20250803,,FASENRA,Pancreatic carcinoma,OT,FASENRA | Pancreatic carcinoma | OT,NaT
244334727,24433472,5,F,2024-10-03,20250919,,FINTEPLA,Tricuspid valve incompetence,OT,FINTEPLA | Tricuspid valve incompetence | OT,2024-09-30/2024-10-06
244357934,24435793,,M,,20250905,,FINTEPLA,Tricuspid valve incompetence,OT,FINTEPLA | Tricuspid valve incompetence | OT,NaT
244361362,24436136,,F,,20250803,,BREZTRI,Death,DE,BREZTRI | Death | DE,NaT
244398323,24439832,70,M,2024-10-01,20250702,,APALUTAMIDE,Dermatitis exfoliative generalised,OT,APALUTAMIDE | Dermatitis exfoliative generalised | OT,2024-09-30/2024-10-06
244398583,24439858,,F,,20250812,,TEZEPELUMAB,Asthma,OT,TEZEPELUMAB | Asthma | OT,NaT
244401772,24440177,,F,2024-10-07,20250809,,ACALABRUTINIB,Melaena,OT,ACALABRUTINIB | Melaena | OT,2024-10-07/2024-10-13
244411023,24441102,47,M,2023-11-23,20250725,,HEMLIBRA,Abdominal discomfort,,HEMLIBRA | Abdominal discomfort,2023-11-20/2023-11-26
244431892,24443189,63,M,,20250806,,CAPECITABINE,Myocardial ischaemia,OT,CAPECITABINE | Myocardial ischaemia | OT,NaT
244437072,24443707,,M,,20250809,,CALQUENCE,Product dose omission issue,OT,CALQUENCE | Product dose omission issue | OT,NaT
244444752,24444475,21,F,,20250709,,PROPYLTHIOURACIL,Drug-induced liver injury,OT,PROPYLTHIOURACIL | Drug-induced liver injury | OT,NaT
244451832,24445183,70,M,,20250809,,DAPAGLIFLOZIN,Food craving,OT,DAPAGLIFLOZIN | Food craving | OT,NaT
244452672,24445267,,M,,20250803,,CALQUENCE,General physical condition abnormal,HO,CALQUENCE | General physical condition abnormal | HO,NaT
244452933,24445293,,F,,20250816,,TEZSPIRE,Incorrect dose administered by device,,TEZSPIRE | Incorrect dose administered by device,NaT
244500153,24450015,66,F,2024-01-01,20250918,,DUPIXENT,Injection site rash,OT,DUPIXENT | Injection site rash | OT,2024-01-01/2024-01-07
244501862,24450186,,,,20250803,,TICAGRELOR,Haemorrhage,OT,TICAGRELOR | Haemorrhage | OT,NaT
244502933,24450293,,F,,20250803,,DAPAGLIFLOZIN,Off label use,,DAPAGLIFLOZIN | Off label use,NaT
244606213,24460621,64,M,,20250802,,SOLIRIS,Neuromyelitis optica spectrum disorder,DE,SOLIRIS | Neuromyelitis optica spectrum disorder | DE,NaT
244632074,24463207,59,M,2024-07-01,20250816,,KORLYM,Atrial fibrillation,HO,KORLYM | Atrial fibrillation | HO,2024-07-01/2024-07-07
244661233,24466123,44,F,2025-04-27,20250807,,VEDOLIZUMAB,Abdominal pain,OT,VEDOLIZUMAB | Abdominal pain | OT,2025-04-21/2025-04-27
244681674,24468167,57,F,2023-01-01,20250924,,XELJANZ,Intentional dose omission,OT,XELJANZ | Intentional dose omission | OT,2022-12-26/2023-01-01
244685012,24468501,24,M,,20250803,,OMEPRAZOLE,Wheezing,OT,OMEPRAZOLE | Wheezing | OT,NaT
245247334,24524733,,M,,20250810,,BREZTRI,Overdose,,BREZTRI | Overdose,NaT
245267112,24526711,,F,,20250810,,SYMBICORT,Chronic obstructive pulmonary disease,,SYMBICORT | Chronic obstructive pulmonary disease,NaT
245275193,24527519,,,,20250810,,TEZSPIRE,Accidental exposure to product,OT,TEZSPIRE | Accidental exposure to product | OT,NaT
245282344,24528234,66,M,2023-11-11,20250809,,DURVALUMAB,Death,DE,DURVALUMAB | Death | DE,2023-11-06/2023-11-12
245292822,24529282,,,,20250810,,ULTOMIRIS,Haemoglobin decreased,OT,ULTOMIRIS | Haemoglobin decreased | OT,NaT
245295883,24529588,57,F,2024-05-30,20250812,,ACETAMINOPHEN,Pyrexia,LT,ACETAMINOPHEN | Pyrexia | LT,2024-05-27/2024-06-02
245305852,24530585,,M,,20250803,,DAPAGLIFLOZIN,Death,OT,DAPAGLIFLOZIN | Death | OT,NaT
245318603,24531860,,M,2024-09-15,20250803,,ULTOMIRIS,Impaired driving ability,OT,ULTOMIRIS | Impaired driving ability | OT,2024-09-09/2024-09-15
245324962,24532496,,,,20250802,,OSIMERTINIB,Interstitial lung disease,OT,OSIMERTINIB | Interstitial lung disease | OT,NaT
245341862,24534186,44,F,,20250730,,METHOTREXATE,Paraesthesia,DS,METHOTREXATE | Paraesthesia | DS,NaT
245347503,24534750,63,F,2024-04-01,20250809,,BENRALIZUMAB,Death,DE,BENRALIZUMAB | Death | DE,2024-04-01/2024-04-07
245371703,24537170,10,F,2024-01-01,20250903,,DUPIXENT,Rebound eczema,,DUPIXENT | Rebound eczema,2024-01-01/2024-01-07
245394414,24539441,,,2024-01-01,20250726,,INFLECTRA,Blood pressure increased,HO,INFLECTRA | Blood pressure increased | HO,2024-01-01/2024-01-07
245399442,24539944,,F,,20250809,,BYDUREON BCISE,Weight decreased,DS,BYDUREON BCISE | Weight decreased | DS,NaT
245399532,24539953,,M,,20250809,,ULTOMIRIS,Myasthenia gravis crisis,HO,ULTOMIRIS | Myasthenia gravis crisis | HO,NaT
245404232,24540423,80,M,,20250803,,TREMELIMUMAB,Death,DE,TREMELIMUMAB | Death | DE,NaT
245404753,24540475,44,F,,20250809,,SAPHNELO,Pleurisy,OT,SAPHNELO | Pleurisy | OT,NaT
245404927,24540492,69,M,2018-08-01,20250809,,XARELTO,Gastrooesophageal reflux disease,HO,XARELTO | Gastrooesophageal reflux disease | HO,2018-07-30/2018-08-05
245411362,24541136,,F,,20250802,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,NaT
245432622,24543262,52,M,,20250802,,DAPAGLIFLOZIN,Malaise,HO,DAPAGLIFLOZIN | Malaise | HO,NaT
245433013,24543301,45,M,2020-10-05,20250703,,VEDOLIZUMAB,Crohn's disease,OT,VEDOLIZUMAB | Crohn's disease | OT,2020-10-05/2020-10-11
245450863,24545086,,,,20250810,,NEXIUM,Gastric cancer,OT,NEXIUM | Gastric cancer | OT,NaT
245451763,24545176,69,F,,20250926,,AUSTEDO XR,Tardive dyskinesia,OT,AUSTEDO XR | Tardive dyskinesia | OT,NaT
245460174,24546017,44,F,,20250715,,METHOTREXATE,Drug ineffective,HO,METHOTREXATE | Drug ineffective | HO,NaT
245471772,24547177,,M,,20250809,,FARXIGA,Nephrolithiasis,HO,FARXIGA | Nephrolithiasis | HO,NaT
245475742,24547574,,,,20250808,,MESALAMINE,Therapy partial responder,OT,MESALAMINE | Therapy partial responder | OT,NaT
245479243,24547924,,,,20250801,,ORGOVYX,Diabetes mellitus,HO,ORGOVYX | Diabetes mellitus | HO,NaT
245484255,24548425,,,2023-11-01,20250719,,INFLECTRA,Influenza,HO,INFLECTRA | Influenza | HO,2023-10-30/2023-11-05
245492623,24549262,,,,20250803,,SOLIRIS,Death,OT,SOLIRIS | Death | OT,NaT
245494932,24549493,,,2024-10-01,20250810,,AIRSUPRA,Device delivery system issue,,AIRSUPRA | Device delivery system issue,2024-09-30/2024-10-06
245500954,24550095,64,F,,20250902,,CYCLOPHOSPHAMIDE,Systemic candida,DE,CYCLOPHOSPHAMIDE | Systemic candida | DE,NaT
245501884,24550188,51,F,2024-07-01,20250923,,XELJANZ XR,Condition aggravated,,XELJANZ XR | Condition aggravated,2024-07-01/2024-07-07
245503862,24550386,,M,,20250803,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,NaT
245510692,24551069,,,,20250802,,OSIMERTINIB,Drug resistance,OT,OSIMERTINIB | Drug resistance | OT,NaT
245513112,24551311,,F,,20250809,,TEZSPIRE,Aortic stenosis,OT,TEZSPIRE | Aortic stenosis | OT,NaT
245514162,24551416,,F,,20250809,,OSIMERTINIB,Blindness,OT,OSIMERTINIB | Blindness | OT,NaT
245514972,24551497,,,,20250816,,BREZTRI,Dysphonia,,BREZTRI | Dysphonia,NaT
245518652,24551865,82,M,,20250816,,FARXIGA,Cardiac disorder,,FARXIGA | Cardiac disorder,NaT
245519912,24551991,,F,,20250802,,FARXIGA,Neoplasm malignant,OT,FARXIGA | Neoplasm malignant | OT,NaT
245521122,24552112,,F,,20250802,,IMFINZI,Colorectal cancer metastatic,OT,IMFINZI | Colorectal cancer metastatic | OT,NaT
245521662,24552166,72,M,,20250816,,FARXIGA,Glycosylated haemoglobin increased,,FARXIGA | Glycosylated haemoglobin increased,NaT
245526072,24552607,,M,2024-09-17,20250809,,DAPAGLIFLOZIN,Death,OT,DAPAGLIFLOZIN | Death | OT,2024-09-16/2024-09-22
245527432,24552743,,M,,20250809,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Blindness,OT,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Blindness | OT,NaT
245527912,24552791,,M,,20250803,,CALQUENCE,Hypotension,HO,CALQUENCE | Hypotension | HO,NaT
245548404,24554840,,F,,20250826,,VEDOLIZUMAB,Anal skin tags,OT,VEDOLIZUMAB | Anal skin tags | OT,NaT
245548912,24554891,,F,,20250809,,BENRALIZUMAB,Sinus congestion,OT,BENRALIZUMAB | Sinus congestion | OT,NaT
245549022,24554902,41,M,,20250810,,DAPAGLIFLOZIN,Glucose urine absent,HO,DAPAGLIFLOZIN | Glucose urine absent | HO,NaT
245573414,24557341,,M,2024-05-07,20250915,,COSENTYX,Diverticulitis,HO,COSENTYX | Diverticulitis | HO,2024-05-06/2024-05-12
245577562,24557756,76,M,,20250908,,ORGOVYX,Anorectal discomfort,,ORGOVYX | Anorectal discomfort,NaT
245606432,24560643,90,F,2023-10-10,20250803,,BENRALIZUMAB,Death,OT,BENRALIZUMAB | Death | OT,2023-10-09/2023-10-15
245616172,24561617,,,,20250809,,OSIMERTINIB,Drug resistance,OT,OSIMERTINIB | Drug resistance | OT,NaT
245639383,24563938,57,F,2024-08-01,20250701,,SKYRIZI,Decreased appetite,OT,SKYRIZI | Decreased appetite | OT,2024-07-29/2024-08-04
245654312,24565431,50,M,2019-04-02,20250708,,MORPHINE,Drug dependence,OT,MORPHINE | Drug dependence | OT,2019-04-01/2019-04-07
245660582,24566058,,F,,20250809,,TAGRISSO,Amnesia,OT,TAGRISSO | Amnesia | OT,NaT
245661382,24566138,,,,20250810,,BREZTRI,Device issue,,BREZTRI | Device issue,NaT
245665832,24566583,,F,,20250803,,OSIMERTINIB,Arthritis,OT,OSIMERTINIB | Arthritis | OT,NaT
245670782,24567078,,M,,20250809,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Death,DE,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Death | DE,NaT
245672732,24567273,,F,,20250802,,DURVALUMAB,Malaise,HO,DURVALUMAB | Malaise | HO,NaT
245672792,24567279,76,M,2024-10-01,20250810,,BREZTRI,Incorrect dose administered by device,,BREZTRI | Incorrect dose administered by device,2024-09-30/2024-10-06
245673852,24567385,,M,,20250802,,DAPAGLIFLOZIN,Cerebrovascular accident,OT,DAPAGLIFLOZIN | Cerebrovascular accident | OT,NaT
245674032,24567403,,F,,20250816,,BREZTRI,Hypoacusis,,BREZTRI | Hypoacusis,NaT
245681166,24568116,,,2023-04-12,20250918,,ADALIMUMAB-AATY,Malaise,OT,ADALIMUMAB-AATY | Malaise | OT,2023-04-10/2023-04-16
245682042,24568204,,F,,20250810,,TEZSPIRE,Alopecia,,TEZSPIRE | Alopecia,NaT
245684073,24568407,70,M,2024-01-01,20250916,,RINVOQ,Ear pruritus,HO,RINVOQ | Ear pruritus | HO,2024-01-01/2024-01-07
245704662,24570466,76,F,2024-01-01,20250703,,OPCON-A,Eye irritation,,OPCON-A | Eye irritation,2024-01-01/2024-01-07
245706712,24570671,48,M,2024-09-12,20250810,,KOMBIGLYZE XR,Dizziness,HO,KOMBIGLYZE XR | Dizziness | HO,2024-09-09/2024-09-15
245720733,24572073,,M,,20250810,,BREZTRI,Device delivery system issue,,BREZTRI | Device delivery system issue,NaT
245725803,24572580,,,,20250816,,SOLIRIS,Drug ineffective,,SOLIRIS | Drug ineffective,NaT
245729543,24572954,,,,20250810,,DURVALUMAB,Interstitial lung disease,OT,DURVALUMAB | Interstitial lung disease | OT,NaT
245749563,24574956,,,,20250810,,DURVALUMAB,Renal failure,OT,DURVALUMAB | Renal failure | OT,NaT
245755042,24575504,,M,,20250803,,ACALABRUTINIB,Diabetes mellitus,OT,ACALABRUTINIB | Diabetes mellitus | OT,NaT
245758032,24575803,,,,20250730,,ALBUTEROL SULFATE,Drug dose omission by device,,ALBUTEROL SULFATE | Drug dose omission by device,NaT
245760282,24576028,,M,,20250919,,FILSPARI,Photosensitivity reaction,,FILSPARI | Photosensitivity reaction,NaT
245777802,24577780,,M,,20250809,,BENRALIZUMAB,Death,OT,BENRALIZUMAB | Death | OT,NaT
245781003,24578100,,F,,20250816,,BREZTRI,Muscle spasms,,BREZTRI | Muscle spasms,NaT
245785455,24578545,21,F,2023-05-18,20250930,,ICATIBANT,Weight increased,OT,ICATIBANT | Weight increased | OT,2023-05-15/2023-05-21
245786852,24578685,,F,,20250816,,CRESTOR,Eczema,,CRESTOR | Eczema,NaT
245797193,24579719,,M,,20250809,,FARXIGA,Cataract,OT,FARXIGA | Cataract | OT,NaT
245805302,24580530,,F,2024-06-29,20250803,,OSIMERTINIB,Death,DE,OSIMERTINIB | Death | DE,2024-06-24/2024-06-30
245828422,24582842,73,F,2023-01-01,20250802,,CRESTOR,Tendon injury,HO,CRESTOR | Tendon injury | HO,2022-12-26/2023-01-01
245833832,24583383,68,M,2024-03-19,20250917,,Solondo,Crohn's disease,OT,Solondo | Crohn's disease | OT,2024-03-18/2024-03-24
245840882,24584088,,F,,20250803,,ONDEXXYA,Death,DE,ONDEXXYA | Death | DE,NaT
245840902,24584090,,F,,20250803,,IMFINZI,Myocardial necrosis marker increased,OT,IMFINZI | Myocardial necrosis marker increased | OT,NaT
245844092,24584409,,M,,20250803,,SOLIRIS,Neuromyelitis optica spectrum disorder,OT,SOLIRIS | Neuromyelitis optica spectrum disorder | OT,NaT
245851356,24585135,46,F,2024-10-23,20250805,,VEDOLIZUMAB,Product distribution issue,OT,VEDOLIZUMAB | Product distribution issue | OT,2024-10-21/2024-10-27
245853213,24585321,75,F,2024-09-23,20250930,,APIXABAN,Ascites,DE,APIXABAN | Ascites | DE,2024-09-23/2024-09-29
245855307,24585530,76,M,,20250925,,ORGOVYX,Intraocular pressure increased,OT,ORGOVYX | Intraocular pressure increased | OT,NaT
245858522,24585852,,F,,20250810,,OSIMERTINIB,Death,DE,OSIMERTINIB | Death | DE,NaT
245871952,24587195,92,M,,20250809,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,NaT
245898232,24589823,62,M,,20250803,,DAPAGLIFLOZIN,Arrhythmia,HO,DAPAGLIFLOZIN | Arrhythmia | HO,NaT
245898352,24589835,,M,,20250809,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,NaT
245898392,24589839,,F,,20250816,,TEZSPIRE,Dermatitis,,TEZSPIRE | Dermatitis,NaT
245903323,24590332,,,,20250810,,DURVALUMAB,Neuropathy peripheral,OT,DURVALUMAB | Neuropathy peripheral | OT,NaT
245911722,24591172,,F,,20250803,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Death,OT,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Death | OT,NaT
245916098,24591609,20,M,2024-10-30,20250903,,OMAVELOXOLONE,Ischaemic stroke,LT,OMAVELOXOLONE | Ischaemic stroke | LT,2024-10-28/2024-11-03
245918692,24591869,35,M,2024-10-30,20250809,,SOLIRIS,Malaise,HO,SOLIRIS | Malaise | HO,2024-10-28/2024-11-03
245918832,24591883,78,M,,20250803,,DAPAGLIFLOZIN,Arrhythmia,HO,DAPAGLIFLOZIN | Arrhythmia | HO,NaT
245929382,24592938,54,F,,20250810,,DAPAGLIFLOZIN,Vomiting,OT,DAPAGLIFLOZIN | Vomiting | OT,NaT
245931513,24593151,,F,,20250701,,VEDOLIZUMAB,Atrial fibrillation,OT,VEDOLIZUMAB | Atrial fibrillation | OT,NaT
245936154,24593615,83,F,2023-12-01,20250917,,OSIMERTINIB,Nausea,OT,OSIMERTINIB | Nausea | OT,2023-11-27/2023-12-03
245946012,24594601,57,F,2024-10-30,20250920,,RINVOQ,Pain management,HO,RINVOQ | Pain management | HO,2024-10-28/2024-11-03
245954982,24595498,68,F,2024-09-30,20250803,,TAGRISSO,Myocardial necrosis marker increased,OT,TAGRISSO | Myocardial necrosis marker increased | OT,2024-09-30/2024-10-06
245956452,24595645,,M,,20250809,,OSIMERTINIB,Myelosuppression,OT,OSIMERTINIB | Myelosuppression | OT,NaT
245959652,24595965,,F,,20250809,,OSIMERTINIB,Disease progression,DE,OSIMERTINIB | Disease progression | DE,NaT
245959672,24595967,62,M,,20250809,,DAPAGLIFLOZIN,Monoplegia,HO,DAPAGLIFLOZIN | Monoplegia | HO,NaT
245962062,24596206,,,2024-10-13,20250809,,DAPAGLIFLOZIN,Neoplasm malignant,OT,DAPAGLIFLOZIN | Neoplasm malignant | OT,2024-10-07/2024-10-13
245988843,24598884,68,M,,20250814,,IMFINZI,Pyrexia,OT,IMFINZI | Pyrexia | OT,NaT
245995933,24599593,56,M,2024-01-01,20250813,,ATOMOXETINE,Drug ineffective,,ATOMOXETINE | Drug ineffective,2024-01-01/2024-01-07
246006234,24600623,37,F,2024-01-01,20250910,,DUPIXENT,Accidental exposure to product,,DUPIXENT | Accidental exposure to product,2024-01-01/2024-01-07
246010402,24601040,,F,,20250810,,DURVALUMAB,Platelet count decreased,OT,DURVALUMAB | Platelet count decreased | OT,NaT
246019132,24601913,39,M,2024-10-28,20250905,,JARDIANCE,Nausea,,JARDIANCE | Nausea,2024-10-28/2024-11-03
246024182,24602418,51,M,,20250803,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Product prescribing error,OT,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Product prescribing error | OT,NaT
246024292,24602429,,F,,20250809,,OLAPARIB,Embolism,LT,OLAPARIB | Embolism | LT,NaT
246028393,24602839,76,M,,20250723,,GAZYVA,Neuropathy peripheral,OT,GAZYVA | Neuropathy peripheral | OT,NaT
246045532,24604553,,M,,20250810,,DAPAGLIFLOZIN,Hypoacusis,OT,DAPAGLIFLOZIN | Hypoacusis | OT,NaT
246050372,24605037,,M,,20250810,,SOLIRIS,Breakthrough haemolysis,OT,SOLIRIS | Breakthrough haemolysis | OT,NaT
246057373,24605737,48,F,2024-11-08,20250816,,TEZSPIRE,Device leakage,,TEZSPIRE | Device leakage,2024-11-04/2024-11-10
246062072,24606207,91,F,,20250803,,BUDESONIDE\FORMOTEROL,Pneumonia,HO,BUDESONIDE\FORMOTEROL | Pneumonia | HO,NaT
246065962,24606596,,M,,20250810,,FASENRA,Feeling abnormal,OT,FASENRA | Feeling abnormal | OT,NaT
246069652,24606965,,,,20250803,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Death,DE,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Death | DE,NaT
246069912,24606991,68,F,2024-05-22,20250809,,OSIMERTINIB,Necrotising oesophagitis,DE,OSIMERTINIB | Necrotising oesophagitis | DE,2024-05-20/2024-05-26
246073202,24607320,32,F,2022-03-31,20250711,,PARAGARD T 380A,Foreign body in reproductive tract,DS,PARAGARD T 380A | Foreign body in reproductive tract | DS,2022-03-28/2022-04-03
246081222,24608122,,,,20250809,,DAPAGLIFLOZIN,End stage renal disease,OT,DAPAGLIFLOZIN | End stage renal disease | OT,NaT
246094222,24609422,,F,,20250809,,TAGRISSO,Pulmonary embolism,OT,TAGRISSO | Pulmonary embolism | OT,NaT
246094442,24609444,,,,20250816,,BREZTRI,Ocular discomfort,OT,BREZTRI | Ocular discomfort | OT,NaT
246102862,24610286,80,M,,20250802,,BUDESONIDE,Obstructive airways disorder,HO,BUDESONIDE | Obstructive airways disorder | HO,NaT
246104743,24610474,,,,20250723,,JANUVIA,Dyspepsia,,JANUVIA | Dyspepsia,NaT
246107602,24610760,,M,,20250814,,OMNITROPE,Product dose omission issue,HO,OMNITROPE | Product dose omission issue | HO,NaT
246112232,24611223,,F,,20250803,,OSIMERTINIB,Bone disorder,OT,OSIMERTINIB | Bone disorder | OT,NaT
246112422,24611242,83,F,2024-03-21,20250803,,DAPAGLIFLOZIN,Pemphigoid,OT,DAPAGLIFLOZIN | Pemphigoid | OT,2024-03-18/2024-03-24
246129682,24612968,,,,20250803,,IMFINZI,Adverse drug reaction,DE,IMFINZI | Adverse drug reaction | DE,NaT
246129712,24612971,66,M,2024-11-03,20250805,,CRESTOR,Diarrhoea,OT,CRESTOR | Diarrhoea | OT,2024-10-28/2024-11-03
246129912,24612991,70,M,,20250810,,ACALABRUTINIB,Chronic kidney disease,OT,ACALABRUTINIB | Chronic kidney disease | OT,NaT
246136782,24613678,89,M,,20250802,,BYDUREON,Diabetic ketoacidosis,OT,BYDUREON | Diabetic ketoacidosis | OT,NaT
246136882,24613688,,F,,20250809,,ACALABRUTINIB,Cataract,OT,ACALABRUTINIB | Cataract | OT,NaT
246149063,24614906,,F,,20250809,,FARXIGA,Drug hypersensitivity,OT,FARXIGA | Drug hypersensitivity | OT,NaT
246149103,24614910,60,M,2024-10-30,20250809,,ACALABRUTINIB,Adenocarcinoma,HO,ACALABRUTINIB | Adenocarcinoma | HO,2024-10-28/2024-11-03
246149182,24614918,,F,2024-10-07,20250809,,IMFINZI,Death,OT,IMFINZI | Death | OT,2024-10-07/2024-10-13
246157664,24615766,84,F,2024-01-01,20250828,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2024-01-01/2024-01-07
246162054,24616205,,F,,20250907,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
246172732,24617273,,,2024-06-01,20250809,,OSIMERTINIB,Death,OT,OSIMERTINIB | Death | OT,2024-05-27/2024-06-02
246176022,24617602,20,F,,20250709,,MORPHINE,Death,DE,MORPHINE | Death | DE,NaT
246179212,24617921,,,,20250816,,TEZSPIRE,Headache,,TEZSPIRE | Headache,NaT
246192652,24619265,,M,,20250908,,VEDOLIZUMAB,Stress,OT,VEDOLIZUMAB | Stress | OT,NaT
246210112,24621011,,F,,20250816,,BYDUREON BCISE,Incorrect dose administered,,BYDUREON BCISE | Incorrect dose administered,NaT
246211304,24621130,78,M,2025-08-01,20250829,,OFEV,Constipation,HO,OFEV | Constipation | HO,2025-07-28/2025-08-03
246220572,24622057,,M,,20250809,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,NaT
246227953,24622795,64,M,2024-09-01,20250816,,BREZTRI,Wrong technique in product usage process,,BREZTRI | Wrong technique in product usage process,2024-08-26/2024-09-01
246228592,24622859,,F,,20250803,,ALBUTEROL\BUDESONIDE,Pulmonary fibrosis,OT,ALBUTEROL\BUDESONIDE | Pulmonary fibrosis | OT,NaT
246231892,24623189,72,M,2024-10-20,20250803,,TICAGRELOR,Breath holding,HO,TICAGRELOR | Breath holding | HO,2024-10-14/2024-10-20
246232642,24623264,,M,,20250810,,BYDUREON BCISE,Visual impairment,,BYDUREON BCISE | Visual impairment,NaT
246249365,24624936,48,F,2017-01-01,20250723,,METHYLPHENIDATE HYDROCHLORIDE,Product use issue,OT,METHYLPHENIDATE HYDROCHLORIDE | Product use issue | OT,2016-12-26/2017-01-01
246258682,24625868,,F,,20250825,,CORTICOTROPIN,Drug ineffective,OT,CORTICOTROPIN | Drug ineffective | OT,NaT
246259672,24625967,63,F,2024-06-06,20250808,,CORTICOTROPIN,Fluid retention,OT,CORTICOTROPIN | Fluid retention | OT,2024-06-03/2024-06-09
246261202,24626120,21,F,2019-01-28,20250803,,QUETIAPINE FUMARATE,Tension,HO,QUETIAPINE FUMARATE | Tension | HO,2019-01-28/2019-02-03
246261953,24626195,18,M,2024-01-01,20250912,,LUMIZYME,Inappropriate schedule of product administration,,LUMIZYME | Inappropriate schedule of product administration,2024-01-01/2024-01-07
246265952,24626595,25,F,2023-07-01,20250701,,DUPIXENT,Hypersensitivity,HO,DUPIXENT | Hypersensitivity | HO,2023-06-26/2023-07-02
246267723,24626772,80,F,2024-03-19,20250716,,OZEMPIC,Osteoporosis,,OZEMPIC | Osteoporosis,2024-03-18/2024-03-24
246274722,24627472,,M,,20250803,,OSIMERTINIB,Blindness,OT,OSIMERTINIB | Blindness | OT,NaT
246276482,24627648,60,F,2024-11-11,20250810,,FASENRA,Injection,,FASENRA | Injection,2024-11-11/2024-11-17
246277172,24627717,47,F,,20250809,,QUETIAPINE FUMARATE,Weight increased,OT,QUETIAPINE FUMARATE | Weight increased | OT,NaT
246290033,24629003,,F,,20250809,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,NaT
246292033,24629203,86,F,2024-09-09,20250816,,SYMBICORT,Device use issue,,SYMBICORT | Device use issue,2024-09-09/2024-09-15
246294755,24629475,75,M,2023-01-01,20250919,,THYMOCYTE IMMUNE GLOBULIN NOS,Phaeohyphomycosis,HO,THYMOCYTE IMMUNE GLOBULIN NOS | Phaeohyphomycosis | HO,2022-12-26/2023-01-01
246295702,24629570,77,M,,20250803,,DAPAGLIFLOZIN,Anxiety,HO,DAPAGLIFLOZIN | Anxiety | HO,NaT
246309253,24630925,75,F,2024-10-31,20250810,,DURVALUMAB,Acquired amegakaryocytic thrombocytopenia,OT,DURVALUMAB | Acquired amegakaryocytic thrombocytopenia | OT,2024-10-28/2024-11-03
246321432,24632143,49,F,2024-10-17,20250810,,BENRALIZUMAB,COVID-19,OT,BENRALIZUMAB | COVID-19 | OT,2024-10-14/2024-10-20
246323765,24632376,71,M,,20250821,,ENTYVIO,Acute kidney injury,OT,ENTYVIO | Acute kidney injury | OT,NaT
246334412,24633441,44,F,,20250929,,DUPIXENT,Urticaria,,DUPIXENT | Urticaria,NaT
246341023,24634102,67,M,2024-10-01,20250810,,IMFINZI,Myocarditis,OT,IMFINZI | Myocarditis | OT,2024-09-30/2024-10-06
246342353,24634235,,F,,20250803,,STRENSIQ,Dizziness,OT,STRENSIQ | Dizziness | OT,NaT
246344882,24634488,17,F,2025-06-25,20250702,,FINTEPLA,Seizure,OT,FINTEPLA | Seizure | OT,2025-06-23/2025-06-29
246350502,24635050,,,,20250816,,BREZTRI,Oral pain,,BREZTRI | Oral pain,NaT
246372172,24637217,31,F,,20250703,,METOPROLOL,Drug ineffective for unapproved indication,LT,METOPROLOL | Drug ineffective for unapproved indication | LT,NaT
246374523,24637452,60,F,2022-02-21,20250810,,LIVALO,Rectal cancer,HO,LIVALO | Rectal cancer | HO,2022-02-21/2022-02-27
246401612,24640161,65,F,,20250803,,CRESTOR,Chest pain,OT,CRESTOR | Chest pain | OT,NaT
246402053,24640205,78,F,,20250923,,POMALYST,Sensitive skin,,POMALYST | Sensitive skin,NaT
246403302,24640330,,F,,20250809,,BENRALIZUMAB,Kidney infection,OT,BENRALIZUMAB | Kidney infection | OT,NaT
246420122,24642012,19,F,2024-01-01,20250911,,BIMZELX,Skin burning sensation,,BIMZELX | Skin burning sensation,2024-01-01/2024-01-07
246443382,24644338,85,F,2024-10-01,20250925,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2024-09-30/2024-10-06
246446564,24644656,73,M,2024-10-07,20250906,,TREPROSTINIL,Overdose,DE,TREPROSTINIL | Overdose | DE,2024-10-07/2024-10-13
246446617,24644661,,F,,20250806,,NUPLAZID,Condition aggravated,OT,NUPLAZID | Condition aggravated | OT,NaT
246465573,24646557,71,M,,20250810,,DURVALUMAB,Febrile neutropenia,LT,DURVALUMAB | Febrile neutropenia | LT,NaT
246466533,24646653,73,F,2024-09-05,20250810,,DAPAGLIFLOZIN,Urinary tract infection,HO,DAPAGLIFLOZIN | Urinary tract infection | HO,2024-09-02/2024-09-08
246478593,24647859,,M,,20250909,,OXERVATE,Eye irritation,OT,OXERVATE | Eye irritation | OT,NaT
246490922,24649092,11,M,2024-01-01,20250801,,DUPIXENT,Off label use,,DUPIXENT | Off label use,2024-01-01/2024-01-07
246491602,24649160,33,F,2025-01-01,20250702,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2024-12-30/2025-01-05
246495833,24649583,61,F,2024-11-29,20250810,,SAPHNELO,Lung neoplasm malignant,OT,SAPHNELO | Lung neoplasm malignant | OT,2024-11-25/2024-12-01
246505222,24650522,,F,,20250803,,BUDESONIDE\FORMOTEROL,Dyspnoea,OT,BUDESONIDE\FORMOTEROL | Dyspnoea | OT,NaT
246511232,24651123,,F,,20250802,,DAPAGLIFLOZIN,Dementia,OT,DAPAGLIFLOZIN | Dementia | OT,NaT
246522192,24652219,,,,20250810,,TEZSPIRE,Body temperature decreased,,TEZSPIRE | Body temperature decreased,NaT
2465316911,24653169,67,F,2021-06-01,20250916,,TUKYSA,Off label use,OT,TUKYSA | Off label use | OT,2021-05-31/2021-06-06
246535694,24653569,35,F,,20250922,,FILSPARI,Vomiting,,FILSPARI | Vomiting,NaT
246543893,24654389,,F,2024-10-22,20250803,,ULTOMIRIS,Monocyte count decreased,HO,ULTOMIRIS | Monocyte count decreased | HO,2024-10-21/2024-10-27
246551682,24655168,,F,,20250809,,DAPAGLIFLOZIN,Wrist fracture,OT,DAPAGLIFLOZIN | Wrist fracture | OT,NaT
246560385,24656038,67,F,2024-01-01,20250708,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2024-01-01/2024-01-07
246574363,24657436,54,F,2025-04-18,20250722,,HIZENTRA,Pain in extremity,OT,HIZENTRA | Pain in extremity | OT,2025-04-14/2025-04-20
246596423,24659642,71,M,,20250819,,MEROPENEM,Tubulointerstitial nephritis,OT,MEROPENEM | Tubulointerstitial nephritis | OT,NaT
246602692,24660269,,F,,20250809,,OSIMERTINIB,Death,DE,OSIMERTINIB | Death | DE,NaT
246636433,24663643,49,F,2025-05-01,20250724,,ORENCIA,Nasopharyngitis,,ORENCIA | Nasopharyngitis,2025-04-28/2025-05-04
246639602,24663960,39,F,2024-08-02,20250710,,MORPHINE,Dizziness,OT,MORPHINE | Dizziness | OT,2024-07-29/2024-08-04
246640213,24664021,78,F,,20250725,,KISQALI,Illness,OT,KISQALI | Illness | OT,NaT
246684964,24668496,,F,2024-01-01,20250719,,REMODULIN,Cerebrovascular accident,OT,REMODULIN | Cerebrovascular accident | OT,2024-01-01/2024-01-07
246703004,24670300,59,F,,20250916,,METHADONE,Disease progression,OT,METHADONE | Disease progression | OT,NaT
246705232,24670523,63,,,20250821,,JAKAFI,Haemoglobin decreased,,JAKAFI | Haemoglobin decreased,NaT
246749043,24674904,55,F,2023-12-01,20250914,,ENTRESTO,Off label use,OT,ENTRESTO | Off label use | OT,2023-11-27/2023-12-03
246772582,24677258,55,F,2024-09-30,20250802,,LYNPARZA,Underdose,OT,LYNPARZA | Underdose | OT,2024-09-30/2024-10-06
246774422,24677442,,M,,20250810,,LYNPARZA,Mean cell volume increased,OT,LYNPARZA | Mean cell volume increased | OT,NaT
246788033,24678803,84,M,,20250919,,REBLOZYL,Death,OT,REBLOZYL | Death | OT,NaT
246791532,24679153,,,,20250810,,SAPHNELO,Lupus nephritis,OT,SAPHNELO | Lupus nephritis | OT,NaT
246798192,24679819,,F,2024-10-28,20250802,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2024-10-28/2024-11-03
246802552,24680255,30,F,2024-10-10,20250810,,SODIUM ZIRCONIUM CYCLOSILICATE,Death,DE,SODIUM ZIRCONIUM CYCLOSILICATE | Death | DE,2024-10-07/2024-10-13
246802732,24680273,,F,2024-10-27,20250809,,OSIMERTINIB,Death,DE,OSIMERTINIB | Death | DE,2024-10-21/2024-10-27
246804122,24680412,64,F,,20250810,,LYNPARZA,Anaemia,OT,LYNPARZA | Anaemia | OT,NaT
246804382,24680438,,F,,20250803,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Blindness,OT,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Blindness | OT,NaT
246804602,24680460,52,F,,20250803,,NIFEDIPINE,Peripheral swelling,HO,NIFEDIPINE | Peripheral swelling | HO,NaT
246807902,24680790,7,F,2024-10-07,20250803,,KOSELUGO,Blood creatine phosphokinase MB increased,OT,KOSELUGO | Blood creatine phosphokinase MB increased | OT,2024-10-07/2024-10-13
246812473,24681247,43,F,,20250807,,VELSIPITY,Condition aggravated,,VELSIPITY | Condition aggravated,NaT
246821032,24682103,32,F,2024-07-24,20250803,,BENRALIZUMAB,Asthma,HO,BENRALIZUMAB | Asthma | HO,2024-07-22/2024-07-28
246829783,24682978,73,M,2024-11-14,20250810,,BYDUREON BCISE,Injection site injury,,BYDUREON BCISE | Injection site injury,2024-11-11/2024-11-17
246832982,24683298,,M,,20250802,,FASLODEX,Neoplasm malignant,HO,FASLODEX | Neoplasm malignant | HO,NaT
246848273,24684827,,F,,20250802,,TEZEPELUMAB,Feeling abnormal,OT,TEZEPELUMAB | Feeling abnormal | OT,NaT
246859697,24685969,79,F,,20250808,,IBRANCE,Chronic obstructive pulmonary disease,,IBRANCE | Chronic obstructive pulmonary disease,NaT
246867502,24686750,67,F,,20250809,,DAPAGLIFLOZIN,Hypertrophic cardiomyopathy,HO,DAPAGLIFLOZIN | Hypertrophic cardiomyopathy | HO,NaT
246879852,24687985,48,M,,20250816,,DUPIXENT,Product dose omission in error,,DUPIXENT | Product dose omission in error,NaT
246884543,24688454,50,,,20250804,,BRUKINSA,Depressed mood,HO,BRUKINSA | Depressed mood | HO,NaT
246887892,24688789,,F,,20250802,,ALBUTEROL\BUDESONIDE,Cough,OT,ALBUTEROL\BUDESONIDE | Cough | OT,NaT
246892582,24689258,85,M,,20250803,,CRESTOR,Drug interaction,OT,CRESTOR | Drug interaction | OT,NaT
246903423,24690342,6,F,2024-11-20,20250707,,LUMIZYME,Weight decreased,,LUMIZYME | Weight decreased,2024-11-18/2024-11-24
246910492,24691049,25,F,2024-10-31,20250803,,QUETIAPINE FUMARATE,Toxicity to various agents,LT,QUETIAPINE FUMARATE | Toxicity to various agents | LT,2024-10-28/2024-11-03
246920832,24692083,,M,,20250809,,ULTOMIRIS,Prostate cancer,OT,ULTOMIRIS | Prostate cancer | OT,NaT
246933163,24693316,62,M,2024-10-12,20250802,,BUDESONIDE\FORMOTEROL,Chronic obstructive pulmonary disease,HO,BUDESONIDE\FORMOTEROL | Chronic obstructive pulmonary disease | HO,2024-10-07/2024-10-13
246933172,24693317,,M,,20250810,,TAGRISSO,Rash morbilliform,,TAGRISSO | Rash morbilliform,NaT
246937583,24693758,33,,2024-10-18,20250729,,PHOTREXA,Impaired healing,,PHOTREXA | Impaired healing,2024-10-14/2024-10-20
246940393,24694039,75,M,2024-12-02,20250710,,NUPLAZID,Hallucination,OT,NUPLAZID | Hallucination | OT,2024-12-02/2024-12-08
246943322,24694332,49,M,,20250701,,MELPHALAN,Multiple organ dysfunction syndrome,DE,MELPHALAN | Multiple organ dysfunction syndrome | DE,NaT
246946176,24694617,59,F,2018-10-10,20250710,,REMICADE,Diarrhoea,OT,REMICADE | Diarrhoea | OT,2018-10-08/2018-10-14
246966364,24696636,53,F,2024-11-13,20250810,,SAPHNELO,Herpes zoster meningoencephalitis,DS,SAPHNELO | Herpes zoster meningoencephalitis | DS,2024-11-11/2024-11-17
246977743,24697774,4,M,2024-11-01,20250819,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,2024-10-28/2024-11-03
246978662,24697866,7,F,2024-01-01,20250811,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2024-01-01/2024-01-07
246984602,24698460,,M,,20250803,,TAGRISSO,Erectile dysfunction,OT,TAGRISSO | Erectile dysfunction | OT,NaT
246989045,24698904,,,2024-09-03,20250729,,CLOZAPINE,Faecaloma,HO,CLOZAPINE | Faecaloma | HO,2024-09-02/2024-09-08
246989142,24698914,,F,,20250810,,TEZSPIRE,Pneumonia,HO,TEZSPIRE | Pneumonia | HO,NaT
246989552,24698955,,F,,20250809,,FULVESTRANT,Breast pain,OT,FULVESTRANT | Breast pain | OT,NaT
246989822,24698982,,F,,20250802,,STRENSIQ,Precancerous cells present,OT,STRENSIQ | Precancerous cells present | OT,NaT
246990103,24699010,77,M,2024-11-22,20250809,,ACALABRUTINIB,Heart rate decreased,HO,ACALABRUTINIB | Heart rate decreased | HO,2024-11-18/2024-11-24
247010339,24701033,,F,,20250818,,VEDOLIZUMAB,Gastroenteritis viral,OT,VEDOLIZUMAB | Gastroenteritis viral | OT,NaT
247018913,24701891,8,F,2025-02-01,20250709,,DUPIXENT,Skin swelling,,DUPIXENT | Skin swelling,2025-01-27/2025-02-02
247025053,24702505,29,M,2024-11-07,20250702,,CYCLOPHOSPHAMIDE,Cytokine release syndrome,OT,CYCLOPHOSPHAMIDE | Cytokine release syndrome | OT,2024-11-04/2024-11-10
247028472,24702847,49,F,2024-08-16,20250910,,HYRIMOZ,General physical health deterioration,HO,HYRIMOZ | General physical health deterioration | HO,2024-08-12/2024-08-18
247045062,24704506,77,M,2024-10-09,20250804,,DEXAMETHASONE,Glucocorticoid deficiency,OT,DEXAMETHASONE | Glucocorticoid deficiency | OT,2024-10-07/2024-10-13
247057612,24705761,66,F,2024-11-26,20250803,,OLAPARIB,Haemoglobin decreased,HO,OLAPARIB | Haemoglobin decreased | HO,2024-11-25/2024-12-01
247058192,24705819,,M,,20250809,,DAPAGLIFLOZIN,Product dose omission issue,OT,DAPAGLIFLOZIN | Product dose omission issue | OT,NaT
247062607,24706260,,M,2024-12-19,20250722,,NOVOEIGHT,Haemarthrosis,HO,NOVOEIGHT | Haemarthrosis | HO,2024-12-16/2024-12-22
247086133,24708613,66,F,,20250809,,OSIMERTINIB,Acquired gene mutation,OT,OSIMERTINIB | Acquired gene mutation | OT,NaT
247094642,24709464,,F,,20250803,,OSIMERTINIB,Malignant neoplasm progression,OT,OSIMERTINIB | Malignant neoplasm progression | OT,NaT
247094932,24709493,,F,,20250809,,LYNPARZA,Metastases to lymph nodes,OT,LYNPARZA | Metastases to lymph nodes | OT,NaT
247097202,24709720,59,F,,20250808,,DOCETAXEL,Microvascular coronary artery disease,OT,DOCETAXEL | Microvascular coronary artery disease | OT,NaT
247097234,24709723,,M,,20250810,,ULTOMIRIS,Weight decreased,,ULTOMIRIS | Weight decreased,NaT
247110622,24711062,44,F,,20250721,,PREDNISONE,Discomfort,DE,PREDNISONE | Discomfort | DE,NaT
247118702,24711870,,F,,20250810,,TRUQAP,Rash,,TRUQAP | Rash,NaT
247130022,24713002,,F,,20250810,,OLAPARIB,Drug ineffective,OT,OLAPARIB | Drug ineffective | OT,NaT
247140045,24714004,47,F,2020-04-20,20250708,,TYSABRI,Prescribed underdose,HO,TYSABRI | Prescribed underdose | HO,2020-04-20/2020-04-26
247143982,24714398,,M,,20250810,,OSIMERTINIB,Thrombosis,OT,OSIMERTINIB | Thrombosis | OT,NaT
247171242,24717124,16,M,,20250803,,TEZSPIRE,Pneumonia,OT,TEZSPIRE | Pneumonia | OT,NaT
247174663,24717466,77,F,2024-11-30,20250910,,SKYRIZI,Rib fracture,HO,SKYRIZI | Rib fracture | HO,2024-11-25/2024-12-01
247185912,24718591,47,M,2024-01-01,20250811,,DUPIXENT,Dyspnoea,,DUPIXENT | Dyspnoea,2024-01-01/2024-01-07
247189922,24718992,48,M,2024-02-10,20250809,,FASENRA,Lower respiratory tract infection,OT,FASENRA | Lower respiratory tract infection | OT,2024-02-05/2024-02-11
247198722,24719872,,F,,20250803,,OSIMERTINIB,Muscle spasms,OT,OSIMERTINIB | Muscle spasms | OT,NaT
247218473,24721847,83,F,,20250809,,CARVEDILOL,BRASH syndrome,OT,CARVEDILOL | BRASH syndrome | OT,NaT
247223952,24722395,,,,20250803,,FULVESTRANT,Death,DE,FULVESTRANT | Death | DE,NaT
247243062,24724306,39,F,2024-10-01,20250721,,DUPIXENT,Weight increased,,DUPIXENT | Weight increased,2024-09-30/2024-10-06
2472670811,24726708,61,F,2024-11-24,20250930,,ORENITRAM,Nasal congestion,,ORENITRAM | Nasal congestion,2024-11-18/2024-11-24
247276222,24727622,86,M,2024-07-16,20250721,,VEDOLIZUMAB,Rectal tenesmus,OT,VEDOLIZUMAB | Rectal tenesmus | OT,2024-07-15/2024-07-21
247286552,24728655,74,M,2024-10-04,20250809,,DAPAGLIFLOZIN,Myocardial infarction,OT,DAPAGLIFLOZIN | Myocardial infarction | OT,2024-09-30/2024-10-06
247288652,24728865,72,M,2024-10-03,20250816,,TEZSPIRE,Arthralgia,,TEZSPIRE | Arthralgia,2024-09-30/2024-10-06
247290902,24729090,,F,,20250816,,FASENRA,Arthralgia,,FASENRA | Arthralgia,NaT
247296902,24729690,32,F,2024-09-27,20250902,,ULTOMIRIS,Death,DE,ULTOMIRIS | Death | DE,2024-09-23/2024-09-29
247299172,24729917,44,F,,20250807,,ACTEMRA,Nasopharyngitis,CA,ACTEMRA | Nasopharyngitis | CA,NaT
247319314,24731931,,F,,20250715,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,NaT
247325962,24732596,,,,20250809,,OSIMERTINIB,Death,DE,OSIMERTINIB | Death | DE,NaT
247347642,24734764,,,,20250701,,YUFLYMA,Juvenile idiopathic arthritis,OT,YUFLYMA | Juvenile idiopathic arthritis | OT,NaT
247350952,24735095,72,M,,20250803,,LYNPARZA,Death,DE,LYNPARZA | Death | DE,NaT
247366523,24736652,,M,2024-12-07,20250809,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Death,DE,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Death | DE,2024-12-02/2024-12-08
247371872,24737187,63,F,2024-12-03,20250918,,ICATIBANT,Periorbital swelling,HO,ICATIBANT | Periorbital swelling | HO,2024-12-02/2024-12-08
247372164,24737216,64,M,2024-11-04,20250722,,NIVOLUMAB,Renal failure,HO,NIVOLUMAB | Renal failure | HO,2024-11-04/2024-11-10
247374512,24737451,,M,,20250803,,ACALABRUTINIB,Malaise,OT,ACALABRUTINIB | Malaise | OT,NaT
247378324,24737832,77,F,,20250829,,LENALIDOMIDE,Diarrhoea,,LENALIDOMIDE | Diarrhoea,NaT
247384284,24738428,44,F,2024-04-01,20250730,,ABRILADA,Off label use,OT,ABRILADA | Off label use | OT,2024-04-01/2024-04-07
247398343,24739834,30,M,2024-10-01,20250802,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,2024-09-30/2024-10-06
247404082,24740408,,,,20250816,,FASENRA,Asthma,,FASENRA | Asthma,NaT
247411813,24741181,,F,,20250816,,BYDUREON BCISE,Therapy cessation,,BYDUREON BCISE | Therapy cessation,NaT
247416252,24741625,,M,,20250816,,ULTOMIRIS,Fatigue,,ULTOMIRIS | Fatigue,NaT
247419332,24741933,,F,,20250809,,FULVESTRANT,Disease progression,OT,FULVESTRANT | Disease progression | OT,NaT
247420122,24742012,,F,,20250809,,BENRALIZUMAB,Macular degeneration,OT,BENRALIZUMAB | Macular degeneration | OT,NaT
247421542,24742154,,F,,20250802,,FULVESTRANT,Disease progression,OT,FULVESTRANT | Disease progression | OT,NaT
247435982,24743598,59,F,,20250809,,TAGRISSO,Ulcer,OT,TAGRISSO | Ulcer | OT,NaT
247443152,24744315,,F,,20250809,,FULVESTRANT,Disease progression,OT,FULVESTRANT | Disease progression | OT,NaT
247445993,24744599,55,M,,20250809,,ANDEXXA,Hydrocephalus,OT,ANDEXXA | Hydrocephalus | OT,NaT
247464532,24746453,61,M,,20250802,,OSIMERTINIB,Malignant neoplasm progression,OT,OSIMERTINIB | Malignant neoplasm progression | OT,NaT
247476882,24747688,51,F,,20250922,,TRASTUZUMAB,Anaemia,OT,TRASTUZUMAB | Anaemia | OT,NaT
247482102,24748210,35,F,2024-01-01,20250714,,XELJANZ XR,Pyrexia,,XELJANZ XR | Pyrexia,2024-01-01/2024-01-07
247485122,24748512,40,F,,20250915,,ACTEMRA,Onychomadesis,HO,ACTEMRA | Onychomadesis | HO,NaT
247489623,24748962,69,M,2024-10-01,20250802,,DURVALUMAB,Intestinal metastasis,OT,DURVALUMAB | Intestinal metastasis | OT,2024-09-30/2024-10-06
247492413,24749241,92,M,2024-10-25,20250810,,OSIMERTINIB,Neoplasm progression,OT,OSIMERTINIB | Neoplasm progression | OT,2024-10-21/2024-10-27
247492662,24749266,51,F,,20250816,,TRUQAP,Diarrhoea,,TRUQAP | Diarrhoea,NaT
247511632,24751163,13,F,,20250709,,NORDITROPIN,Blood iron decreased,OT,NORDITROPIN | Blood iron decreased | OT,NaT
247517722,24751772,,F,,20250810,,SAPHNELO,Pain,,SAPHNELO | Pain,NaT
247522823,24752282,,,2024-12-01,20250807,,YUFLYMA,Diarrhoea,OT,YUFLYMA | Diarrhoea | OT,2024-11-25/2024-12-01
247529392,24752939,,M,,20250809,,DURVALUMAB,General physical condition abnormal,OT,DURVALUMAB | General physical condition abnormal | OT,NaT
247539802,24753980,,,,20250717,,ORGOVYX,Blood glucose increased,,ORGOVYX | Blood glucose increased,NaT
247546842,24754684,,F,,20250809,,OSIMERTINIB,Breast cancer,OT,OSIMERTINIB | Breast cancer | OT,NaT
247548562,24754856,41,F,,20250902,,ZEPBOUND,Injection site pain,,ZEPBOUND | Injection site pain,NaT
247563932,24756393,,,,20250803,,TAGRISSO,Death,DE,TAGRISSO | Death | DE,NaT
247570672,24757067,,,,20250816,,FASENRA,Asthma,,FASENRA | Asthma,NaT
247605973,24760597,80,M,2024-08-06,20250803,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2024-08-05/2024-08-11
247608747,24760874,34,M,2024-01-01,20250804,,DUPIXENT,Erythema,OT,DUPIXENT | Erythema | OT,2024-01-01/2024-01-07
247614053,24761405,49,F,,20250803,,TUCATINIB,Diarrhoea,HO,TUCATINIB | Diarrhoea | HO,NaT
247618222,24761822,33,M,,20250803,,SEROQUEL,Toxicity to various agents,DE,SEROQUEL | Toxicity to various agents | DE,NaT
247626262,24762626,,M,,20250809,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,NaT
247642004,24764200,,,,20250924,,INFLECTRA,Carpal tunnel syndrome,OT,INFLECTRA | Carpal tunnel syndrome | OT,NaT
247654952,24765495,,F,,20250810,,OLAPARIB,Second primary malignancy,OT,OLAPARIB | Second primary malignancy | OT,NaT
247657632,24765763,,F,2024-11-28,20250803,,OLAPARIB,Death,DE,OLAPARIB | Death | DE,2024-11-25/2024-12-01
247660775,24766077,,,,20250707,,ORGOVYX,Abdominal discomfort,,ORGOVYX | Abdominal discomfort,NaT
247673264,24767326,,M,2024-12-12,20250807,,CLOZARIL,Leukocytosis,OT,CLOZARIL | Leukocytosis | OT,2024-12-09/2024-12-15
247673842,24767384,76,F,,20250810,,LYNPARZA,Chest pain,OT,LYNPARZA | Chest pain | OT,NaT
247698032,24769803,67,F,,20250810,,DAPAGLIFLOZIN,Depression,HO,DAPAGLIFLOZIN | Depression | HO,NaT
247715714,24771571,58,F,2024-12-01,20250714,,BENLYSTA,Arthralgia,,BENLYSTA | Arthralgia,2024-11-25/2024-12-01
247730524,24773052,,M,2024-07-12,20250806,,BOTOX,Factor V Leiden mutation,CA,BOTOX | Factor V Leiden mutation | CA,2024-07-08/2024-07-14
247738852,24773885,72,M,2024-08-01,20250809,,TAGRISSO,Diarrhoea haemorrhagic,HO,TAGRISSO | Diarrhoea haemorrhagic | HO,2024-07-29/2024-08-04
247739573,24773957,,F,,20250809,,LYNPARZA,Haemoglobin abnormal,OT,LYNPARZA | Haemoglobin abnormal | OT,NaT
247741373,24774137,47,F,2024-11-01,20250930,,DUPIXENT,Asthma,HO,DUPIXENT | Asthma | HO,2024-10-28/2024-11-03
247742993,24774299,48,M,2023-01-01,20250819,,DUPIXENT,Rheumatoid arthritis,OT,DUPIXENT | Rheumatoid arthritis | OT,2022-12-26/2023-01-01
247753963,24775396,39,F,2024-12-12,20250811,,DOXORUBICIN,Diarrhoea,HO,DOXORUBICIN | Diarrhoea | HO,2024-12-09/2024-12-15
247760662,24776066,,F,2024-07-26,20250710,,ZEJULA,Ovarian cancer recurrent,OT,ZEJULA | Ovarian cancer recurrent | OT,2024-07-22/2024-07-28
247781452,24778145,,F,,20250809,,DAPAGLIFLOZIN,Chest pain,OT,DAPAGLIFLOZIN | Chest pain | OT,NaT
247790002,24779000,,M,,20250802,,DAPAGLIFLOZIN,Cerebrovascular accident,OT,DAPAGLIFLOZIN | Cerebrovascular accident | OT,NaT
247840122,24784012,65,M,2024-06-08,20250809,,PULMICORT RESPULES,Cough,OT,PULMICORT RESPULES | Cough | OT,2024-06-03/2024-06-09
247857842,24785784,55,F,2024-12-01,20250902,,DUPIXENT,Erythema,,DUPIXENT | Erythema,2024-11-25/2024-12-01
247858452,24785845,,M,2024-10-02,20250810,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Death,OT,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Death | OT,2024-09-30/2024-10-06
247858662,24785866,74,M,2024-12-08,20250803,,LYNPARZA,Contusion,HO,LYNPARZA | Contusion | HO,2024-12-02/2024-12-08
247862053,24786205,15,M,2024-11-27,20250730,,FINTEPLA,Neuroprosthesis implantation,HO,FINTEPLA | Neuroprosthesis implantation | HO,2024-11-25/2024-12-01
247867395,24786739,,F,,20250918,,ARIKAYCE,Hospitalisation,HO,ARIKAYCE | Hospitalisation | HO,NaT
247878152,24787815,,,,20250809,,SEROQUEL,Hospitalisation,HO,SEROQUEL | Hospitalisation | HO,NaT
247892082,24789208,72,F,2024-12-10,20250810,,CRESTOR,Liver injury,OT,CRESTOR | Liver injury | OT,2024-12-09/2024-12-15
247915405,24791540,72,M,2024-12-10,20250710,,HEMGENIX,Aspartate aminotransferase increased,,HEMGENIX | Aspartate aminotransferase increased,2024-12-09/2024-12-15
247921738,24792173,,F,,20250906,,VEDOLIZUMAB,Haemoglobin decreased,LT,VEDOLIZUMAB | Haemoglobin decreased | LT,NaT
247922613,24792261,33,F,,20250710,,BUPIVACAINE,Loss of consciousness,OT,BUPIVACAINE | Loss of consciousness | OT,NaT
247923382,24792338,94,,2024-12-08,20250809,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2024-12-02/2024-12-08
247945073,24794507,,F,,20250803,,SYMBICORT,Dyspnoea,OT,SYMBICORT | Dyspnoea | OT,NaT
247955532,24795553,5,F,2024-10-30,20250810,,BEYFORTUS,Incorrect dose administered,,BEYFORTUS | Incorrect dose administered,2024-10-28/2024-11-03
247971852,24797185,85,M,,20250702,,DUPIXENT,Intentional product misuse,,DUPIXENT | Intentional product misuse,NaT
247990304,24799030,60,M,2024-01-01,20250828,,KEVZARA,Mental disorder,,KEVZARA | Mental disorder,2024-01-01/2024-01-07
247991122,24799112,65,M,,20250721,,POMALYST,Product dose omission issue,,POMALYST | Product dose omission issue,NaT
247992942,24799294,73,F,,20250929,,NURTEC ODT,Dementia Alzheimer's type,OT,NURTEC ODT | Dementia Alzheimer's type | OT,NaT
248011412,24801141,71,M,2024-01-01,20250916,,LENVATINIB,Asthenia,HO,LENVATINIB | Asthenia | HO,2024-01-01/2024-01-07
248035862,24803586,67,F,,20250722,,ZEPBOUND,Abdominal pain upper,,ZEPBOUND | Abdominal pain upper,NaT
248044983,24804498,54,M,2024-05-01,20250909,,BIMEKIZUMAB,Renal cell carcinoma,OT,BIMEKIZUMAB | Renal cell carcinoma | OT,2024-04-29/2024-05-05
248048142,24804814,,M,,20250822,,DUPIXENT,Eczema,,DUPIXENT | Eczema,NaT
248049852,24804985,,F,,20250721,,KEVZARA,Full blood count decreased,,KEVZARA | Full blood count decreased,NaT
248096892,24809689,67,M,2024-12-01,20250815,,CARBIDOPA\LEVODOPA,Stoma site erythema,HO,CARBIDOPA\LEVODOPA | Stoma site erythema | HO,2024-11-25/2024-12-01
248117028,24811702,78,F,2024-01-01,20250903,,INOTUZUMAB OZOGAMICIN,Death,HO,INOTUZUMAB OZOGAMICIN | Death | HO,2024-01-01/2024-01-07
248131933,24813193,57,M,,20250806,,TECVAYLI,Adverse reaction,DE,TECVAYLI | Adverse reaction | DE,NaT
248135432,24813543,,M,,20250803,,DAPAGLIFLOZIN,Urinary tract infection,OT,DAPAGLIFLOZIN | Urinary tract infection | OT,NaT
248142762,24814276,,F,,20250803,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Neoplasm malignant,OT,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Neoplasm malignant | OT,NaT
248144588,24814458,56,M,2024-11-01,20250708,,KESIMPTA,Fatigue,OT,KESIMPTA | Fatigue | OT,2024-10-28/2024-11-03
248167832,24816783,,F,,20250809,,DAPAGLIFLOZIN,Death,OT,DAPAGLIFLOZIN | Death | OT,NaT
248186934,24818693,45,F,2024-09-01,20250805,,VIJOICE,Rash,OT,VIJOICE | Rash | OT,2024-08-26/2024-09-01
248204477,24820447,44,F,2025-08-22,20250917,,ROZANOLIXIZUMAB,Off label use,OT,ROZANOLIXIZUMAB | Off label use | OT,2025-08-18/2025-08-24
248205526,24820552,68,F,2024-08-24,20250703,,XOSPATA,Hepatic enzyme increased,DE,XOSPATA | Hepatic enzyme increased | DE,2024-08-19/2024-08-25
248210433,24821043,29,F,2024-01-01,20250814,,DUPIXENT,Skin irritation,,DUPIXENT | Skin irritation,2024-01-01/2024-01-07
248213192,24821319,44,M,2025-05-01,20250702,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2025-04-28/2025-05-04
248217704,24821770,38,F,2024-01-01,20250710,,DUPIXENT,Rebound atopic dermatitis,,DUPIXENT | Rebound atopic dermatitis,2024-01-01/2024-01-07
248218903,24821890,4,F,2024-01-01,20250819,,DUPIXENT,Product dose omission in error,,DUPIXENT | Product dose omission in error,2024-01-01/2024-01-07
248223242,24822324,,M,,20250816,,BREZTRI,Incorrect dose administered,,BREZTRI | Incorrect dose administered,NaT
248224069,24822406,51,F,2024-09-27,20250917,,GLASSIA,Drug effect less than expected,OT,GLASSIA | Drug effect less than expected | OT,2024-09-23/2024-09-29
248226302,24822630,,F,,20250918,,HUMIRA,Therapeutic product effect incomplete,,HUMIRA | Therapeutic product effect incomplete,NaT
248242943,24824294,74,M,,20250916,,ORGOVYX,Micturition urgency,,ORGOVYX | Micturition urgency,NaT
248243322,24824332,62,F,2024-03-01,20250810,,BENRALIZUMAB,Laryngitis,OT,BENRALIZUMAB | Laryngitis | OT,2024-02-26/2024-03-03
248246662,24824666,64,F,,20250904,,LOPERAMIDE,Drug ineffective,OT,LOPERAMIDE | Drug ineffective | OT,NaT
248256666,24825666,58,F,2024-01-01,20250717,,IBRANCE,Full blood count decreased,,IBRANCE | Full blood count decreased,2024-01-01/2024-01-07
248267982,24826798,,,,20250803,,TICAGRELOR,Myocardial infarction,OT,TICAGRELOR | Myocardial infarction | OT,NaT
248268393,24826839,,,,20250810,,BEYFORTUS,Death,DE,BEYFORTUS | Death | DE,NaT
248283214,24828321,64,F,2024-12-01,20250820,,DUPIXENT,Blood test abnormal,HO,DUPIXENT | Blood test abnormal | HO,2024-11-25/2024-12-01
248285123,24828512,34,F,2025-01-01,20250916,,BENLYSTA,Product dose omission issue,,BENLYSTA | Product dose omission issue,2024-12-30/2025-01-05
248288852,24828885,93,M,2024-12-27,20250810,,PRILOSEC OTC,Renal pain,,PRILOSEC OTC | Renal pain,2024-12-23/2024-12-29
248289622,24828962,71,,2024-04-01,20250803,,OSIMERTINIB,Death,DE,OSIMERTINIB | Death | DE,2024-04-01/2024-04-07
248289852,24828985,64,F,2024-12-26,20250802,,OLAPARIB,Blood sodium decreased,HO,OLAPARIB | Blood sodium decreased | HO,2024-12-23/2024-12-29
248302892,24830289,52,M,2024-12-01,20250803,,ROSUVASTATIN CALCIUM,Retinal vein occlusion,HO,ROSUVASTATIN CALCIUM | Retinal vein occlusion | HO,2024-11-25/2024-12-01
248305063,24830506,62,M,2024-12-25,20250809,,ULTOMIRIS,Fall,HO,ULTOMIRIS | Fall | HO,2024-12-23/2024-12-29
248307732,24830773,70,F,2024-04-01,20250819,,BACTRIM,Condition aggravated,OT,BACTRIM | Condition aggravated | OT,2024-04-01/2024-04-07
248311862,24831186,,M,,20250809,,ACALABRUTINIB,Death,DE,ACALABRUTINIB | Death | DE,NaT
248322032,24832203,,F,,20250809,,DAPAGLIFLOZIN,Cerebrovascular accident,OT,DAPAGLIFLOZIN | Cerebrovascular accident | OT,NaT
248335783,24833578,94,F,2024-06-01,20250803,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Lung disorder,OT,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Lung disorder | OT,2024-05-27/2024-06-02
248345073,24834507,,,,20250803,,ACALABRUTINIB,Death,OT,ACALABRUTINIB | Death | OT,NaT
248352032,24835203,75,F,2025-01-02,20250803,,TEZEPELUMAB,Pulmonary oedema,HO,TEZEPELUMAB | Pulmonary oedema | HO,2024-12-30/2025-01-05
2483641210,24836412,70,F,2025-02-01,20250929,,REVLIMID,Frequent bowel movements,,REVLIMID | Frequent bowel movements,2025-01-27/2025-02-02
248366542,24836654,55,F,,20250716,,PREDNISONE,Hodgkin's disease,DE,PREDNISONE | Hodgkin's disease | DE,NaT
248367632,24836763,,F,,20250810,,ULTOMIRIS,Drug ineffective,,ULTOMIRIS | Drug ineffective,NaT
248377382,24837738,,F,,20250802,,STRENSIQ,Transient ischaemic attack,OT,STRENSIQ | Transient ischaemic attack | OT,NaT
248379732,24837973,,M,,20250810,,EPLONTERSEN SODIUM,Carpal tunnel syndrome,OT,EPLONTERSEN SODIUM | Carpal tunnel syndrome | OT,NaT
248388582,24838858,,M,,20250802,,BENRALIZUMAB,Death,DE,BENRALIZUMAB | Death | DE,NaT
248391332,24839133,77,M,,20250802,,DAPAGLIFLOZIN,Cardiac disorder,HO,DAPAGLIFLOZIN | Cardiac disorder | HO,NaT
248399812,24839981,,,,20250816,,BEVESPI AEROSPHERE,Drug dose omission by device,,BEVESPI AEROSPHERE | Drug dose omission by device,NaT
248402192,24840219,50,M,,20250810,,ESOMEPRAZOLE,Gastrointestinal neuroendocrine tumour,OT,ESOMEPRAZOLE | Gastrointestinal neuroendocrine tumour | OT,NaT
248405607,24840560,34,M,,20250811,,ABRILADA,Drug specific antibody present,OT,ABRILADA | Drug specific antibody present | OT,NaT
248436633,24843663,71,M,,20250809,,TEZSPIRE,Product dose omission issue,HO,TEZSPIRE | Product dose omission issue | HO,NaT
248437132,24843713,,,2021-05-28,20250803,,ACALABRUTINIB,Septic shock,DE,ACALABRUTINIB | Septic shock | DE,2021-05-24/2021-05-30
248441922,24844192,74,M,,20250717,,OFEV,Diarrhoea,HO,OFEV | Diarrhoea | HO,NaT
248441942,24844194,,F,,20250809,,CAPIVASERTIB,Pruritus,OT,CAPIVASERTIB | Pruritus | OT,NaT
248446923,24844692,,M,,20250829,,NASACORT ALLERGY 24HR,Drug ineffective,,NASACORT ALLERGY 24HR | Drug ineffective,NaT
248460012,24846001,55,F,2024-11-01,20250803,,OMEPRAZOLE,Alopecia,LT,OMEPRAZOLE | Alopecia | LT,2024-10-28/2024-11-03
248460352,24846035,60,,,20250809,,TAGRISSO,Respiratory failure,DE,TAGRISSO | Respiratory failure | DE,NaT
248477982,24847798,,M,,20250707,,REMICADE,Streptococcal infection,OT,REMICADE | Streptococcal infection | OT,NaT
248479713,24847971,74,F,2025-01-10,20250722,,IXAZOMIB,Fall,HO,IXAZOMIB | Fall | HO,2025-01-06/2025-01-12
248495032,24849503,73,F,,20250820,,ZOLEDRONIC ACID,Osteonecrosis of jaw,OT,ZOLEDRONIC ACID | Osteonecrosis of jaw | OT,NaT
248501812,24850181,41,F,2024-12-14,20250803,,QUETIAPINE FUMARATE,Intentional overdose,HO,QUETIAPINE FUMARATE | Intentional overdose | HO,2024-12-09/2024-12-15
248524632,24852463,,M,,20250810,,TEZSPIRE,Enlarged uvula,,TEZSPIRE | Enlarged uvula,NaT
248529192,24852919,,F,,20250816,,FASENRA,Malaise,,FASENRA | Malaise,NaT
248538494,24853849,,F,,20250828,,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,Dependence,OT,HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Dependence | OT,NaT
248540973,24854097,62,F,,20250809,,BRILINTA,Haemoglobin decreased,OT,BRILINTA | Haemoglobin decreased | OT,NaT
248541552,24854155,,F,,20250810,,BREZTRI,Walking disability,,BREZTRI | Walking disability,NaT
248543102,24854310,52,M,,20250803,,OSIMERTINIB,Acquired gene mutation,OT,OSIMERTINIB | Acquired gene mutation | OT,NaT
248552862,24855286,23,M,2024-12-26,20250809,,SEROQUEL,Rash,OT,SEROQUEL | Rash | OT,2024-12-23/2024-12-29
248555983,24855598,,F,2024-01-01,20250704,,ZILUCOPLAN,Fatigue,OT,ZILUCOPLAN | Fatigue | OT,2024-01-01/2024-01-07
248579132,24857913,89,M,2024-12-10,20250804,,QUETIAPINE,Depressed level of consciousness,OT,QUETIAPINE | Depressed level of consciousness | OT,2024-12-09/2024-12-15
248598553,24859855,1,M,2024-06-24,20250903,,DUPIXENT,Product dose omission issue,,DUPIXENT | Product dose omission issue,2024-06-24/2024-06-30
248604582,24860458,,,,20250816,,TEZSPIRE,Pain,,TEZSPIRE | Pain,NaT
248608893,24860889,6,F,,20250816,,STRENSIQ,Depression,,STRENSIQ | Depression,NaT
248636922,24863692,64,M,,20250810,,DURVALUMAB,Pneumonitis,OT,DURVALUMAB | Pneumonitis | OT,NaT
248646612,24864661,21,F,,20250821,,DUPIXENT,Injection site infection,,DUPIXENT | Injection site infection,NaT
248651252,24865125,,,,20250810,,NEXIUM,Neoplasm malignant,OT,NEXIUM | Neoplasm malignant | OT,NaT
248688802,24868880,72,M,2025-01-07,20250809,,DAPAGLIFLOZIN,Haematochezia,HO,DAPAGLIFLOZIN | Haematochezia | HO,2025-01-06/2025-01-12
248703564,24870356,63,F,2025-02-01,20250716,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2025-01-27/2025-02-02
248707312,24870731,,M,,20250810,,CRESTOR,Malaise,,CRESTOR | Malaise,NaT
248713802,24871380,,,,20250816,,TEZSPIRE,Fatigue,,TEZSPIRE | Fatigue,NaT
248734873,24873487,33,F,2024-12-01,20250825,,CIMZIA,Drug hypersensitivity,OT,CIMZIA | Drug hypersensitivity | OT,2024-11-25/2024-12-01
248758422,24875842,54,F,2024-10-21,20250809,,DAPAGLIFLOZIN,Eosinophilia,HO,DAPAGLIFLOZIN | Eosinophilia | HO,2024-10-21/2024-10-27
248760419,24876041,84,M,2025-01-01,20250716,,TYVASO DPI,Dizziness,HO,TYVASO DPI | Dizziness | HO,2024-12-30/2025-01-05
248769535,24876953,23,F,2024-12-26,20250821,,CERTOLIZUMAB PEGOL,Thrombosis,OT,CERTOLIZUMAB PEGOL | Thrombosis | OT,2024-12-23/2024-12-29
248770683,24877068,63,F,2025-01-01,20250818,,SIMPONI,Blood glucose increased,HO,SIMPONI | Blood glucose increased | HO,2024-12-30/2025-01-05
248798833,24879883,37,F,2025-01-18,20250801,,VEDOLIZUMAB,Abdominal pain,OT,VEDOLIZUMAB | Abdominal pain | OT,2025-01-13/2025-01-19
248801075,24880107,,M,,20250815,,VEDOLIZUMAB,General physical health deterioration,OT,VEDOLIZUMAB | General physical health deterioration | OT,NaT
248803912,24880391,,,,20250816,,TEZSPIRE,Diarrhoea,,TEZSPIRE | Diarrhoea,NaT
248807622,24880762,79,F,,20250803,,DAPAGLIFLOZIN,Deafness,OT,DAPAGLIFLOZIN | Deafness | OT,NaT
2488091112,24880911,41,F,2024-12-18,20250919,,ABEMACICLIB,Migraine,HO,ABEMACICLIB | Migraine | HO,2024-12-16/2024-12-22
248826903,24882690,3,F,,20250718,,IBUPROFEN,Angioedema,OT,IBUPROFEN | Angioedema | OT,NaT
248830882,24883088,,,,20250810,,DURVALUMAB,Myelosuppression,OT,DURVALUMAB | Myelosuppression | OT,NaT
248833104,24883310,75,M,,20250725,,ACYCLOVIR,Condition aggravated,OT,ACYCLOVIR | Condition aggravated | OT,NaT
248842194,24884219,,M,,20250803,,ULTOMIRIS,Influenza,HO,ULTOMIRIS | Influenza | HO,NaT
248859922,24885992,34,M,2024-09-09,20250714,,SERTRALINE,Loss of consciousness,HO,SERTRALINE | Loss of consciousness | HO,2024-09-09/2024-09-15
248868932,24886893,6,,,20250704,,XOSPATA,Neutrophil count decreased,OT,XOSPATA | Neutrophil count decreased | OT,NaT
248881844,24888184,52,F,2025-01-18,20250803,,STRENSIQ,Tremor,OT,STRENSIQ | Tremor | OT,2025-01-13/2025-01-19
248883742,24888374,86,F,2025-01-12,20250802,,PERINDOPRIL,Drug interaction,HO,PERINDOPRIL | Drug interaction | HO,2025-01-06/2025-01-12
248895543,24889554,,F,,20250913,,LEVETIRACETAM,Stillbirth,OT,LEVETIRACETAM | Stillbirth | OT,NaT
248900192,24890019,,F,,20250809,,OSIMERTINIB,Dementia,OT,OSIMERTINIB | Dementia | OT,NaT
248900988,24890098,13,F,2025-01-19,20250815,,GENOTROPIN,Device defective,,GENOTROPIN | Device defective,2025-01-13/2025-01-19
248905773,24890577,31,M,2024-11-05,20250803,,SOLIRIS,Kidney transplant rejection,OT,SOLIRIS | Kidney transplant rejection | OT,2024-11-04/2024-11-10
248939443,24893944,,,,20250710,,ORGOVYX,Urinary tract infection,HO,ORGOVYX | Urinary tract infection | HO,NaT
248945542,24894554,,,,20250724,,GEMTESA,Dry mouth,,GEMTESA | Dry mouth,NaT
248950573,24895057,,F,2024-11-19,20250717,,CLOZARIL,Treatment noncompliance,HO,CLOZARIL | Treatment noncompliance | HO,2024-11-18/2024-11-24
248981755,24898175,77,F,2024-01-01,20250916,,HIZENTRA,Peripheral swelling,OT,HIZENTRA | Peripheral swelling | OT,2024-01-01/2024-01-07
248986943,24898694,49,F,2025-01-06,20250809,,SAPHNELO,Anaemia macrocytic,HO,SAPHNELO | Anaemia macrocytic | HO,2025-01-06/2025-01-12
248989092,24898909,,F,,20250809,,OLAPARIB,Toxicity to various agents,OT,OLAPARIB | Toxicity to various agents | OT,NaT
248995142,24899514,,F,,20250809,,OLAPARIB,Somnolence,OT,OLAPARIB | Somnolence | OT,NaT
249004422,24900442,61,F,2025-01-26,20250809,,LYNPARZA,Platelet count decreased,HO,LYNPARZA | Platelet count decreased | HO,2025-01-20/2025-01-26
249006652,24900665,73,F,2025-01-13,20250809,,VANCOMYCIN,Photophobia,OT,VANCOMYCIN | Photophobia | OT,2025-01-13/2025-01-19
249035234,24903523,46,F,2024-02-21,20250916,,VEDOLIZUMAB,Pruritus,OT,VEDOLIZUMAB | Pruritus | OT,2024-02-19/2024-02-25
249036882,24903688,52,F,2024-12-01,20250809,,BENRALIZUMAB,Wheezing,OT,BENRALIZUMAB | Wheezing | OT,2024-11-25/2024-12-01
249064092,24906409,,F,,20250807,,ELAHERE,Death,DE,ELAHERE | Death | DE,NaT
249083382,24908338,,M,2024-11-17,20250802,,OSIMERTINIB,Death,DE,OSIMERTINIB | Death | DE,2024-11-11/2024-11-17
249084422,24908442,,F,,20250810,,OSIMERTINIB,Death,DE,OSIMERTINIB | Death | DE,NaT
249084462,24908446,,M,,20250803,,SOLIRIS,Decreased activity,HO,SOLIRIS | Decreased activity | HO,NaT
249087582,24908758,42,M,2024-06-01,20250725,,TRABECTEDIN,Implant site dermatitis,HO,TRABECTEDIN | Implant site dermatitis | HO,2024-05-27/2024-06-02
249089042,24908904,,F,,20250803,,DAPAGLIFLOZIN,Chronic kidney disease,OT,DAPAGLIFLOZIN | Chronic kidney disease | OT,NaT
249100912,24910091,,,2025-01-01,20250810,,OSIMERTINIB,Myelosuppression,OT,OSIMERTINIB | Myelosuppression | OT,2024-12-30/2025-01-05
249104824,24910482,86,M,,20250803,,CANDESARTAN CILEXETIL,Tremor,HO,CANDESARTAN CILEXETIL | Tremor | HO,NaT
249107582,24910758,,M,2024-05-09,20250803,,BEYFORTUS,Seizure,OT,BEYFORTUS | Seizure | OT,2024-05-06/2024-05-12
249111743,24911174,,,,20250704,,ORGOVYX,Cough,,ORGOVYX | Cough,NaT
249125965,24912596,23,F,2025-01-02,20250807,,CEFIDEROCOL,Atypical mycobacterial infection,DE,CEFIDEROCOL | Atypical mycobacterial infection | DE,2024-12-30/2025-01-05
249126422,24912642,62,M,,20250715,,MELPHALAN HYDROCHLORIDE,Drug-induced liver injury,HO,MELPHALAN HYDROCHLORIDE | Drug-induced liver injury | HO,NaT
249126942,24912694,,F,,20250816,,IMJUDO,Psoriasis,,IMJUDO | Psoriasis,NaT
249130672,24913067,,F,,20250809,,DAPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,Dementia,OT,DAPAGLIFLOZIN\METFORMIN HYDROCHLORIDE | Dementia | OT,NaT
249145522,24914552,21,M,,20250921,,DUPIXENT,Inappropriate schedule of product administration,,DUPIXENT | Inappropriate schedule of product administration,NaT
249152252,24915225,34,M,,20250722,,CHOLESTYRAMINE,Therapeutic product effect incomplete,OT,CHOLESTYRAMINE | Therapeutic product effect incomplete | OT,NaT
249153523,24915352,,,,20250803,,ULTOMIRIS,Death,OT,ULTOMIRIS | Death | OT,NaT
249167882,24916788,71,F,2024-12-17,20250809,,BENRALIZUMAB,Sinusitis,OT,BENRALIZUMAB | Sinusitis | OT,2024-12-16/2024-12-22
249174977,24917497,73,M,2023-12-25,20250908,,GLASSIA,Headache,OT,GLASSIA | Headache | OT,2023-12-25/2023-12-31
249185522,24918552,,M,,20250810,,BREZTRI,Therapeutic product effect decreased,,BREZTRI | Therapeutic product effect decreased,NaT
249185822,24918582,,F,,20250816,,SAPHNELO,Weight increased,,SAPHNELO | Weight increased,NaT
249189577,24918957,11,F,2022-10-05,20250707,,FINTEPLA,Hyperphagia,OT,FINTEPLA | Hyperphagia | OT,2022-10-03/2022-10-09
249191623,24919162,,M,,20250810,,BREZTRI,Device deployment issue,,BREZTRI | Device deployment issue,NaT
249223714,24922371,,F,,20250810,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Device breakage,OT,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Device breakage | OT,NaT
249233542,24923354,,M,,20250809,,OSIMERTINIB,Neoplasm malignant,OT,OSIMERTINIB | Neoplasm malignant | OT,NaT
249237912,24923791,,F,,20250803,,OSIMERTINIB,Neuropathy peripheral,OT,OSIMERTINIB | Neuropathy peripheral | OT,NaT
249266194,24926619,,,,20250911,,YUFLYMA,Intentional dose omission,OT,YUFLYMA | Intentional dose omission | OT,NaT
249275452,24927545,,F,,20250810,,FARXIGA,Headache,,FARXIGA | Headache,NaT
249282742,24928274,,F,,20250816,,TEZSPIRE,Urticaria,,TEZSPIRE | Urticaria,NaT
249290702,24929070,,M,,20250803,,IMFINZI,Disease progression,OT,IMFINZI | Disease progression | OT,NaT
249300353,24930035,61,F,,20250825,,RITUXIMAB,Angina pectoris,HO,RITUXIMAB | Angina pectoris | HO,NaT
249306022,24930602,,F,,20250804,,LUPKYNIS,Adverse event,,LUPKYNIS | Adverse event,NaT
249314202,24931420,41,M,2024-12-01,20250804,,LUPKYNIS,Headache,,LUPKYNIS | Headache,2024-11-25/2024-12-01
249331272,24933127,,M,,20250810,,TEZSPIRE,Palpitations,,TEZSPIRE | Palpitations,NaT
249337373,24933737,57,M,,20250723,,CABOMETYX,Malignant neoplasm progression,OT,CABOMETYX | Malignant neoplasm progression | OT,NaT
249339242,24933924,,F,,20250731,,KESIMPTA,Multiple sclerosis,OT,KESIMPTA | Multiple sclerosis | OT,NaT
249353802,24935380,89,M,,20250809,,DAPAGLIFLOZIN,Cerebrovascular accident,HO,DAPAGLIFLOZIN | Cerebrovascular accident | HO,NaT
249354983,24935498,44,M,2024-01-01,20250825,,IMBRUVICA,Depression,HO,IMBRUVICA | Depression | HO,2024-01-01/2024-01-07
249385343,24938534,44,F,,20250812,,DUPIXENT,Ageusia,,DUPIXENT | Ageusia,NaT
249386312,24938631,42,M,,20250819,,DUPIXENT,Infection,,DUPIXENT | Infection,NaT
249394302,24939430,,M,,20250809,,DAPAGLIFLOZIN,Death,OT,DAPAGLIFLOZIN | Death | OT,NaT
249395682,24939568,,F,,20250809,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,NaT
249396258,24939625,45,M,2021-01-01,20250725,,TRUVADA,Bone density decreased,OT,TRUVADA | Bone density decreased | OT,2020-12-28/2021-01-03
249419433,24941943,16,M,2025-01-27,20250716,,PREDNISONE,Hepatotoxicity,HO,PREDNISONE | Hepatotoxicity | HO,2025-01-27/2025-02-02
249422445,24942244,71,F,2024-08-01,20250827,,LENVIMA,Diarrhoea,OT,LENVIMA | Diarrhoea | OT,2024-07-29/2024-08-04
249426112,24942611,16,M,2025-01-01,20250828,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2024-12-30/2025-01-05
249435464,24943546,,F,,20250810,,CALQUENCE,Fatigue,,CALQUENCE | Fatigue,NaT
249443724,24944372,,,2023-10-01,20250923,,ADALIMUMAB-AATY,Loss of therapeutic response,OT,ADALIMUMAB-AATY | Loss of therapeutic response | OT,2023-09-25/2023-10-01
249447583,24944758,,,2025-02-02,20250710,,INFLIXIMAB,Haematochezia,OT,INFLIXIMAB | Haematochezia | OT,2025-01-27/2025-02-02
249448323,24944832,,M,,20250802,,TEZEPELUMAB,Cholelithiasis,HO,TEZEPELUMAB | Cholelithiasis | HO,NaT
2494483310,24944833,,,2025-01-01,20250922,,INFLECTRA,Fatigue,OT,INFLECTRA | Fatigue | OT,2024-12-30/2025-01-05
249451142,24945114,,F,,20250802,,DAPAGLIFLOZIN,Bone marrow transplant,OT,DAPAGLIFLOZIN | Bone marrow transplant | OT,NaT
249451713,24945171,46,M,2025-01-01,20250724,,DUPIXENT,Nephrolithiasis,OT,DUPIXENT | Nephrolithiasis | OT,2024-12-30/2025-01-05
249453242,24945324,,F,,20250803,,BENRALIZUMAB,Death,DE,BENRALIZUMAB | Death | DE,NaT
249473242,24947324,,F,,20250803,,DAPAGLIFLOZIN,Vomiting,OT,DAPAGLIFLOZIN | Vomiting | OT,NaT
249479352,24947935,,,,20250709,,TERBINAFINE,Knee operation,OT,TERBINAFINE | Knee operation | OT,NaT
249518104,24951810,,F,,20250901,,LEFLUNOMIDE,Maternal exposure during pregnancy,OT,LEFLUNOMIDE | Maternal exposure during pregnancy | OT,NaT
249520794,24952079,85,F,2025-01-17,20250801,,LEQEMBI,Cerebral haemorrhage,OT,LEQEMBI | Cerebral haemorrhage | OT,2025-01-13/2025-01-19
249522694,24952269,85,M,2024-11-08,20250904,,KISUNLA,Weight decreased,OT,KISUNLA | Weight decreased | OT,2024-11-04/2024-11-10
249528582,24952858,21,F,2024-10-01,20250907,,DUPIXENT,Lip swelling,,DUPIXENT | Lip swelling,2024-09-30/2024-10-06
249538372,24953837,79,F,,20250905,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,NaT
249539103,24953910,30,F,2024-12-27,20250803,,ULTOMIRIS,Hyperhidrosis,OT,ULTOMIRIS | Hyperhidrosis | OT,2024-12-23/2024-12-29
249540602,24954060,,F,,20250803,,ACALABRUTINIB,Cardiac failure congestive,HO,ACALABRUTINIB | Cardiac failure congestive | HO,NaT
249552322,24955232,78,M,2025-01-10,20250802,,OMEPRAZOLE,Confusional state,HO,OMEPRAZOLE | Confusional state | HO,2025-01-06/2025-01-12
249553292,24955329,,F,,20250809,,SOLIRIS,Fluid retention,OT,SOLIRIS | Fluid retention | OT,NaT
249563974,24956397,43,F,,20250901,,METHOTREXATE,Fibromyalgia,CA,METHOTREXATE | Fibromyalgia | CA,NaT
249572023,24957202,,F,,20250809,,BUDESONIDE\FORMOTEROL,Death,OT,BUDESONIDE\FORMOTEROL | Death | OT,NaT
249574172,24957417,,F,,20250803,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,NaT
249575052,24957505,,F,,20250810,,ULTOMIRIS,COVID-19,,ULTOMIRIS | COVID-19,NaT
249583395,24958339,50,F,,20250829,,POMALYST,Palpitations,,POMALYST | Palpitations,NaT
249592252,24959225,60,,,20250814,,ATORVASTATIN,Heart rate increased,OT,ATORVASTATIN | Heart rate increased | OT,NaT
249596215,24959621,71,F,2024-12-28,20250826,,PALBOCICLIB,Death,HO,PALBOCICLIB | Death | HO,2024-12-23/2024-12-29
249613812,24961381,,,2025-02-01,20250809,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2025-01-27/2025-02-02
249615952,24961595,,M,,20250809,,DURVALUMAB,Death,DE,DURVALUMAB | Death | DE,NaT
249623583,24962358,58,F,,20250716,,ORENITRAM,Weight decreased,,ORENITRAM | Weight decreased,NaT
249629882,24962988,82,M,,20250709,,DUPIXENT,Off label use,,DUPIXENT | Off label use,NaT
249631622,24963162,8,M,,20250926,,POMALYST,Humerus fracture,OT,POMALYST | Humerus fracture | OT,NaT
249635152,24963515,,,,20250803,,DAPAGLIFLOZIN,Deafness,OT,DAPAGLIFLOZIN | Deafness | OT,NaT
249646589,24964658,,F,2025-01-01,20250723,,ORENITRAM,Wrong dose,,ORENITRAM | Wrong dose,2024-12-30/2025-01-05
249650943,24965094,25,F,,20250827,,VELSIPITY,Migraine,,VELSIPITY | Migraine,NaT
249656014,24965601,,M,,20250715,,BLINCYTO,Therapy partial responder,OT,BLINCYTO | Therapy partial responder | OT,NaT
249667955,24966795,59,F,2024-11-22,20250923,,IBUPROFEN SODIUM,Granulomatosis with polyangiitis,LT,IBUPROFEN SODIUM | Granulomatosis with polyangiitis | LT,2024-11-18/2024-11-24
249672063,24967206,,M,2024-01-01,20250810,,BREZTRI,Device use issue,,BREZTRI | Device use issue,2024-01-01/2024-01-07
249681402,24968140,,,2021-11-23,20250909,,PREDNISONE,Fall,HO,PREDNISONE | Fall | HO,2021-11-22/2021-11-28
249683713,24968371,10,F,2025-02-12,20250810,,SYMBICORT,Wrong technique in product usage process,,SYMBICORT | Wrong technique in product usage process,2025-02-10/2025-02-16
249687192,24968719,,F,,20250809,,TAGRISSO,Death,DE,TAGRISSO | Death | DE,NaT
249704963,24970496,,F,,20250810,,BREZTRI,Dysphonia,,BREZTRI | Dysphonia,NaT
249705742,24970574,64,M,,20250810,,NEXIUM,Hypoacusis,,NEXIUM | Hypoacusis,NaT
249709942,24970994,,M,,20250809,,TICAGRELOR,Death,DE,TICAGRELOR | Death | DE,NaT
249716533,24971653,87,F,2022-12-06,20250810,,ANIFROLUMAB,Off label use,OT,ANIFROLUMAB | Off label use | OT,2022-12-05/2022-12-11
249717362,24971736,,,,20250810,,FARXIGA,Fall,,FARXIGA | Fall,NaT
249718862,24971886,,F,2009-09-25,20250816,,NEXIUM,Tinnitus,,NEXIUM | Tinnitus,2009-09-21/2009-09-27
249719033,24971903,19,F,,20250803,,DUPIXENT,Air embolism,OT,DUPIXENT | Air embolism | OT,NaT
249719202,24971920,93,F,2012-01-01,20250810,,NEXIUM,Hypoacusis,,NEXIUM | Hypoacusis,2011-12-26/2012-01-01
249721982,24972198,52,F,,20250810,,NEXIUM,Tinnitus,,NEXIUM | Tinnitus,NaT
249723539,24972353,86,M,2025-01-01,20250813,,TYVASO DPI,Chronic sinusitis,,TYVASO DPI | Chronic sinusitis,2024-12-30/2025-01-05
249723822,24972382,61,F,2021-02-08,20250810,,NEXIUM,Ear pain,,NEXIUM | Ear pain,2021-02-08/2021-02-14
249724532,24972453,62,F,2014-01-01,20250816,,SYMBICORT,Pneumonia,OT,SYMBICORT | Pneumonia | OT,2013-12-30/2014-01-05
249724572,24972457,,F,,20250810,,NEXIUM,Dyspepsia,,NEXIUM | Dyspepsia,NaT
249724662,24972466,89,F,,20250816,,NEXIUM,Unevaluable event,OT,NEXIUM | Unevaluable event | OT,NaT
249761412,24976141,,,,20250803,,SEROQUEL XR,Hypoaesthesia,OT,SEROQUEL XR | Hypoaesthesia | OT,NaT
249761982,24976198,76,F,2015-04-01,20250810,,NEXIUM,Weight decreased,,NEXIUM | Weight decreased,2015-03-30/2015-04-05
249788127,24978812,80,M,,20250916,,POMALYST,Influenza,,POMALYST | Influenza,NaT
249790002,24979000,64,F,2016-10-01,20250810,,LYNPARZA,Diarrhoea,,LYNPARZA | Diarrhoea,2016-09-26/2016-10-02
249791444,24979144,40,M,2025-01-01,20250714,,VENCLEXTA,Oropharyngeal pain,HO,VENCLEXTA | Oropharyngeal pain | HO,2024-12-30/2025-01-05
249795477,24979547,71,M,2024-12-01,20250929,,HADLIMA,Dementia,HO,HADLIMA | Dementia | HO,2024-11-25/2024-12-01
249798592,24979859,,F,2022-11-28,20250810,,ESOMEPRAZOLE,Tinnitus,,ESOMEPRAZOLE | Tinnitus,2022-11-28/2022-12-04
249812144,24981214,7,F,2024-02-20,20250803,,SOLIRIS,Multiple organ dysfunction syndrome,OT,SOLIRIS | Multiple organ dysfunction syndrome | OT,2024-02-19/2024-02-25
249812152,24981215,73,M,2025-01-01,20250810,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2024-12-30/2025-01-05
249828483,24982848,72,F,2025-01-17,20250802,,DAPAGLIFLOZIN,Escherichia urinary tract infection,,DAPAGLIFLOZIN | Escherichia urinary tract infection,2025-01-13/2025-01-19
249830034,24983003,,M,,20250809,,TEZEPELUMAB,Dyspnoea,OT,TEZEPELUMAB | Dyspnoea | OT,NaT
249830112,24983011,,F,,20250810,,OSIMERTINIB,Arthralgia,OT,OSIMERTINIB | Arthralgia | OT,NaT
249836574,24983657,59,F,2023-04-24,20250919,,VUMERITY,Central nervous system lesion,,VUMERITY | Central nervous system lesion,2023-04-24/2023-04-30
249841023,24984102,68,F,2025-01-17,20250829,,GOLIMUMAB,Dengue fever,HO,GOLIMUMAB | Dengue fever | HO,2025-01-13/2025-01-19
249846012,24984601,42,F,2024-12-04,20250820,,MYFEMBREE,Vaginal haemorrhage,,MYFEMBREE | Vaginal haemorrhage,2024-12-02/2024-12-08
2498471417,24984714,71,F,2025-01-01,20250910,,PADCEV,Neuropathy peripheral,OT,PADCEV | Neuropathy peripheral | OT,2024-12-30/2025-01-05
249848582,24984858,,,,20250809,,BREZTRI,Mental impairment,OT,BREZTRI | Mental impairment | OT,NaT
249849485,24984948,78,F,2025-01-23,20250813,,TALIMOGENE LAHERPAREPVEC,Rash maculo-papular,OT,TALIMOGENE LAHERPAREPVEC | Rash maculo-papular | OT,2025-01-20/2025-01-26
249864452,24986445,,M,,20250803,,ACALABRUTINIB,Spinal disorder,OT,ACALABRUTINIB | Spinal disorder | OT,NaT
249869495,24986949,79,F,,20250709,,POMALYST,Muscular weakness,,POMALYST | Muscular weakness,NaT
249877452,24987745,,M,,20250816,,CALQUENCE,Haemoglobin abnormal,,CALQUENCE | Haemoglobin abnormal,NaT
249880712,24988071,68,M,2019-01-01,20250916,,SERTRALINE,Nausea,HO,SERTRALINE | Nausea | HO,2018-12-31/2019-01-06
249882914,24988291,73,M,2025-01-04,20250802,,PROPRANOLOL HYDROCHLORIDE,Hypersensitivity,OT,PROPRANOLOL HYDROCHLORIDE | Hypersensitivity | OT,2024-12-30/2025-01-05
249899762,24989976,42,M,,20250816,,NEXIUM,Tinnitus,,NEXIUM | Tinnitus,NaT
249903892,24990389,,F,,20250802,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Death,DE,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Death | DE,NaT
249907962,24990796,,M,,20250810,,BENRALIZUMAB,Death,DE,BENRALIZUMAB | Death | DE,NaT
249911623,24991162,74,M,2024-01-01,20250818,,XELJANZ XR,Hypertension,OT,XELJANZ XR | Hypertension | OT,2024-01-01/2024-01-07
249913012,24991301,,M,2020-10-01,20250803,,ROSUVASTATIN,Disease recurrence,OT,ROSUVASTATIN | Disease recurrence | OT,2020-09-28/2020-10-04
249913072,24991307,,F,,20250901,,TECFIDERA,Drug ineffective,,TECFIDERA | Drug ineffective,NaT
249924703,24992470,10,M,,20250809,,DAPAGLIFLOZIN,Localised oedema,HO,DAPAGLIFLOZIN | Localised oedema | HO,NaT
249926512,24992651,84,F,2024-11-19,20250728,,PREDONINE,Drug eruption,HO,PREDONINE | Drug eruption | HO,2024-11-18/2024-11-24
249926922,24992692,,,,20250816,,FASENRA,Nasal congestion,,FASENRA | Nasal congestion,NaT
249927752,24992775,80,F,2024-12-25,20250802,,TEZEPELUMAB,Arthralgia,HO,TEZEPELUMAB | Arthralgia | HO,2024-12-23/2024-12-29
249932772,24993277,70,M,,20250911,,ORGOVYX,Sinusitis,HO,ORGOVYX | Sinusitis | HO,NaT
249941622,24994162,,F,,20250816,,TRUQAP,Hyperglycaemia,,TRUQAP | Hyperglycaemia,NaT
249943942,24994394,,F,,20250809,,DURVALUMAB,Tumour marker increased,OT,DURVALUMAB | Tumour marker increased | OT,NaT
249952955,24995295,,,2023-12-15,20250728,,XEOMIN,Dysphagia,HO,XEOMIN | Dysphagia | HO,2023-12-11/2023-12-17
249974642,24997464,,F,,20250810,,FASENRA,Asthma,,FASENRA | Asthma,NaT
249978542,24997854,57,F,,20250902,,DUPIXENT,Eye operation,,DUPIXENT | Eye operation,NaT
249986414,24998641,10,F,,20250811,,DUPIXENT,Eczema,OT,DUPIXENT | Eczema | OT,NaT
250000272,25000027,60,F,2025-02-01,20250704,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,2025-01-27/2025-02-02
250003583,25000358,25,F,2025-01-01,20250724,,DUPIXENT,Rebound atopic dermatitis,,DUPIXENT | Rebound atopic dermatitis,2024-12-30/2025-01-05
250004073,25000407,61,F,2025-02-18,20250820,,REZUROCK,White blood cell count decreased,,REZUROCK | White blood cell count decreased,2025-02-17/2025-02-23
250008642,25000864,18,F,2025-01-01,20250813,,DUPIXENT,Injection site reaction,,DUPIXENT | Injection site reaction,2024-12-30/2025-01-05
250040892,25004089,40,F,2024-07-18,20250721,,ISTURISA,Thrombocytopenia,OT,ISTURISA | Thrombocytopenia | OT,2024-07-15/2024-07-21
250063292,25006329,,F,,20250803,,OLAPARIB,Hypersensitivity,OT,OLAPARIB | Hypersensitivity | OT,NaT
250072199,25007219,73,F,2025-02-10,20250925,,SIGNIFOR LAR,Peripheral swelling,DE,SIGNIFOR LAR | Peripheral swelling | DE,2025-02-10/2025-02-16
250072672,25007267,76,M,,20250709,,QUETIAPINE,Off label use,HO,QUETIAPINE | Off label use | HO,NaT
250077004,25007700,77,F,2025-01-01,20250723,,DEMSER,Insomnia,HO,DEMSER | Insomnia | HO,2024-12-30/2025-01-05
250087723,25008772,59,F,,20250807,,ORENCIA,Nausea,,ORENCIA | Nausea,NaT
250098772,25009877,,F,,20250803,,OSIMERTINIB,Hyperkalaemia,OT,OSIMERTINIB | Hyperkalaemia | OT,NaT
250099932,25009993,,F,,20250803,,OLAPARIB,Product dose omission issue,OT,OLAPARIB | Product dose omission issue | OT,NaT
250099992,25009999,82,F,,20250809,,BUDESONIDE\FORMOTEROL,Deafness,OT,BUDESONIDE\FORMOTEROL | Deafness | OT,NaT
250111184,25011118,12,F,2025-02-01,20250903,,SAIZEN,Type 1 diabetes mellitus,HO,SAIZEN | Type 1 diabetes mellitus | HO,2025-01-27/2025-02-02
250122712,25012271,,F,,20250803,,AIRSUPRA,Pneumonia,OT,AIRSUPRA | Pneumonia | OT,NaT
250133803,25013380,,M,,20250815,,NUCALA,Headache,,NUCALA | Headache,NaT
250148302,25014830,48,F,2025-01-01,20250706,,DUPIXENT,Injection site mass,OT,DUPIXENT | Injection site mass | OT,2024-12-30/2025-01-05
250148763,25014876,65,F,2023-04-20,20250715,,LENVATINIB MESYLATE,Urticaria,OT,LENVATINIB MESYLATE | Urticaria | OT,2023-04-17/2023-04-23
250151303,25015130,94,M,,20250910,,ORGOVYX,Fatigue,,ORGOVYX | Fatigue,NaT
250170713,25017071,68,F,2024-11-13,20250930,,PACLITAXEL,Inappropriate schedule of product administration,HO,PACLITAXEL | Inappropriate schedule of product administration | HO,2024-11-11/2024-11-17
250177152,25017715,22,M,2025-02-07,20250723,,QUVIVIQ,Intentional overdose,LT,QUVIVIQ | Intentional overdose | LT,2025-02-03/2025-02-09
250179322,25017932,,F,,20250802,,TAGRISSO,Uterine leiomyoma,HO,TAGRISSO | Uterine leiomyoma | HO,NaT
250193682,25019368,57,F,2023-03-01,20250717,,MOUNJARO,Nausea,HO,MOUNJARO | Nausea | HO,2023-02-27/2023-03-05
250194802,25019480,53,F,,20250802,,DAPAGLIFLOZIN,Ankle fracture,OT,DAPAGLIFLOZIN | Ankle fracture | OT,NaT
250196062,25019606,39,F,2025-02-01,20250815,,PALYNZIQ,Abortion spontaneous,OT,PALYNZIQ | Abortion spontaneous | OT,2025-01-27/2025-02-02
250200103,25020010,89,F,2025-02-05,20250812,,EXELON,Depressed mood,HO,EXELON | Depressed mood | HO,2025-02-03/2025-02-09
250208663,25020866,13,F,,20250909,,REMICADE,Therapeutic response decreased,OT,REMICADE | Therapeutic response decreased | OT,NaT
250209083,25020908,6,F,,20250717,,ESTRADIOL\NORETHINDRONE ACETATE,Cerebral infarction,OT,ESTRADIOL\NORETHINDRONE ACETATE | Cerebral infarction | OT,NaT
250217524,25021752,,F,,20250728,,VEDOLIZUMAB,Nasopharyngitis,OT,VEDOLIZUMAB | Nasopharyngitis | OT,NaT
250219214,25021921,64,M,2025-01-01,20250921,,ORENCIA,Rash macular,,ORENCIA | Rash macular,2024-12-30/2025-01-05
250221132,25022113,53,F,2025-02-07,20250810,,DAPAGLIFLOZIN,Ketosis,HO,DAPAGLIFLOZIN | Ketosis | HO,2025-02-03/2025-02-09
250221252,25022125,,M,,20250809,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Death,OT,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Death | OT,NaT
250232052,25023205,,F,,20250803,,OLAPARIB,Carbohydrate antigen 125 increased,OT,OLAPARIB | Carbohydrate antigen 125 increased | OT,NaT
250239975,25023997,9,M,2019-01-01,20250821,,TRIHEPTANOIN,Headache,OT,TRIHEPTANOIN | Headache | OT,2018-12-31/2019-01-06
250243522,25024352,16,F,2025-01-22,20250802,,ULTOMIRIS,Anaphylactoid reaction,OT,ULTOMIRIS | Anaphylactoid reaction | OT,2025-01-20/2025-01-26
250248613,25024861,,,,20250804,,STELARA,Device issue,,STELARA | Device issue,NaT
250255432,25025543,43,F,,20250801,,SULFASALAZINE,Drug intolerance,OT,SULFASALAZINE | Drug intolerance | OT,NaT
250266383,25026638,63,F,2024-11-01,20250804,,HUMIRA,Hypertension,OT,HUMIRA | Hypertension | OT,2024-10-28/2024-11-03
250284347,25028434,,F,,20250816,,XYWAV,Tonsillar hypertrophy,OT,XYWAV | Tonsillar hypertrophy | OT,NaT
250290342,25029034,,,,20250816,,BREZTRI,Ageusia,,BREZTRI | Ageusia,NaT
250295922,25029592,34,M,2024-01-01,20250701,,DUPIXENT,Arthralgia,,DUPIXENT | Arthralgia,2024-01-01/2024-01-07
250298796,25029879,60,F,2020-01-01,20250802,,LYNPARZA,Platelet count decreased,LT,LYNPARZA | Platelet count decreased | LT,2019-12-30/2020-01-05
250300242,25030024,,M,,20250803,,TEZSPIRE,Headache,OT,TEZSPIRE | Headache | OT,NaT
250305782,25030578,8,M,2024-12-01,20250803,,IMFINZI,Hepatic function abnormal,DE,IMFINZI | Hepatic function abnormal | DE,2024-11-25/2024-12-01
250321144,25032114,,,,20250801,,ORGOVYX,Spinal fracture,OT,ORGOVYX | Spinal fracture | OT,NaT
250325273,25032527,,F,2024-01-01,20250827,,RYSTIGGO,Influenza,OT,RYSTIGGO | Influenza | OT,2024-01-01/2024-01-07
250326123,25032612,10,M,,20250703,,GENOTROPIN,Insulin-like growth factor decreased,,GENOTROPIN | Insulin-like growth factor decreased,NaT
250326622,25032662,57,M,,20250809,,DURVALUMAB,Pericardial effusion,OT,DURVALUMAB | Pericardial effusion | OT,NaT
250330947,25033094,9,F,2025-02-01,20250801,,ABRILADA,Tooth extraction,OT,ABRILADA | Tooth extraction | OT,2025-01-27/2025-02-02
250332502,25033250,39,F,2025-01-24,20250917,,SODIUM CHLORIDE,Product use issue,OT,SODIUM CHLORIDE | Product use issue | OT,2025-01-20/2025-01-26
250338492,25033849,,,,20250810,,ESOMEPRAZOLE,Weight decreased,,ESOMEPRAZOLE | Weight decreased,NaT
250347413,25034741,,M,,20250825,,NASACORT ALLERGY 24HR,Contusion,,NASACORT ALLERGY 24HR | Contusion,NaT
250356612,25035661,53,F,2025-03-01,20250810,,BYETTA,Product dose omission issue,,BYETTA | Product dose omission issue,2025-02-24/2025-03-02
250365125,25036512,75,M,2022-07-06,20250905,,POMALIDOMIDE,COVID-19,HO,POMALIDOMIDE | COVID-19 | HO,2022-07-04/2022-07-10
250385772,25038577,57,F,2025-02-10,20250802,,TAGRISSO,Liver injury,OT,TAGRISSO | Liver injury | OT,2025-02-10/2025-02-16
250409463,25040946,71,F,,20250806,,REVLIMID,Constipation,,REVLIMID | Constipation,NaT
250418332,25041833,76,F,,20250810,,DURVALUMAB,Neuromyelitis optica spectrum disorder,OT,DURVALUMAB | Neuromyelitis optica spectrum disorder | OT,NaT
250432944,25043294,,F,,20250915,,TEDUGLUTIDE,Fistula,HO,TEDUGLUTIDE | Fistula | HO,NaT
250441312,25044131,,,,20250930,,METFORMIN,Toxicity to various agents,HO,METFORMIN | Toxicity to various agents | HO,NaT
250443313,25044331,62,M,2025-01-20,20250812,,CABOTEGRAVIR,Injection site pain,OT,CABOTEGRAVIR | Injection site pain | OT,2025-01-20/2025-01-26
250443562,25044356,,M,,20250803,,OSIMERTINIB,Death,DE,OSIMERTINIB | Death | DE,NaT
250452553,25045255,,M,,20250803,,BENRALIZUMAB,Myocardial infarction,OT,BENRALIZUMAB | Myocardial infarction | OT,NaT
250454742,25045474,80,F,2025-02-27,20250810,,DAPAGLIFLOZIN,Malaise,HO,DAPAGLIFLOZIN | Malaise | HO,2025-02-24/2025-03-02
250459322,25045932,60,F,2024-04-03,20250711,,VASCEPA,Off label use,OT,VASCEPA | Off label use | OT,2024-04-01/2024-04-07
250463166,25046316,90,,,20250929,,ONPATTRO,Urinary tract infection,HO,ONPATTRO | Urinary tract infection | HO,NaT
250464805,25046480,,M,2025-02-10,20250810,,SOLIRIS,Hepatic failure,DE,SOLIRIS | Hepatic failure | DE,2025-02-10/2025-02-16
250464883,25046488,64,F,2024-01-01,20250702,,LENVATINIB MESYLATE,Dysphonia,HO,LENVATINIB MESYLATE | Dysphonia | HO,2024-01-01/2024-01-07
250474362,25047436,39,M,2025-02-01,20250904,,RITUXIMAB,Off label use,HO,RITUXIMAB | Off label use | HO,2025-01-27/2025-02-02
250480423,25048042,,M,,20250809,,BUDESONIDE\FORMOTEROL,Heart rate irregular,OT,BUDESONIDE\FORMOTEROL | Heart rate irregular | OT,NaT
250480786,25048078,8,F,2025-02-01,20250701,,DAYBUE,Diarrhoea,,DAYBUE | Diarrhoea,2025-01-27/2025-02-02
250483923,25048392,,F,,20250803,,OLAPARIB,BRCA1 gene mutation,OT,OLAPARIB | BRCA1 gene mutation | OT,NaT
250486992,25048699,27,F,2022-02-07,20250716,,TRULICITY,Nausea,HO,TRULICITY | Nausea | HO,2022-02-07/2022-02-13
250490213,25049021,,,2024-02-01,20250717,,VYVGART,Device related infection,LT,VYVGART | Device related infection | LT,2024-01-29/2024-02-04
250491613,25049161,,,2025-01-01,20250826,,NEMOLIZUMAB,Erythema,HO,NEMOLIZUMAB | Erythema | HO,2024-12-30/2025-01-05
250502832,25050283,64,F,,20250704,,LEFLUNOMIDE,Seizure,HO,LEFLUNOMIDE | Seizure | HO,NaT
250505032,25050503,,F,2025-02-08,20250803,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2025-02-03/2025-02-09
250505875,25050587,,,2025-02-01,20250904,,INFLECTRA,Hip fracture,DE,INFLECTRA | Hip fracture | DE,2025-01-27/2025-02-02
250514612,25051461,90,M,,20250810,,BUDESONIDE\FORMOTEROL,Infection,OT,BUDESONIDE\FORMOTEROL | Infection | OT,NaT
250516076,25051607,15,M,,20250718,,GENOTROPIN,Drug dose omission by device,,GENOTROPIN | Drug dose omission by device,NaT
250529255,25052925,92,F,,20250927,,DUPIXENT,Vertebroplasty,HO,DUPIXENT | Vertebroplasty | HO,NaT
250529693,25052969,27,F,,20250826,,DUPIXENT,COVID-19,,DUPIXENT | COVID-19,NaT
250542892,25054289,2,M,,20250806,,DUPIXENT,Therapeutic response shortened,,DUPIXENT | Therapeutic response shortened,NaT
250548432,25054843,,M,,20250803,,DURVALUMAB,Ascites,OT,DURVALUMAB | Ascites | OT,NaT
250563863,25056386,,F,,20250802,,RILAST,Choking,OT,RILAST | Choking | OT,NaT
250565762,25056576,,F,,20250803,,DAPAGLIFLOZIN,Blindness,DS,DAPAGLIFLOZIN | Blindness | DS,NaT
250571472,25057147,45,M,,20250810,,BENRALIZUMAB,Myocardial infarction,OT,BENRALIZUMAB | Myocardial infarction | OT,NaT
250587816,25058781,87,M,2024-12-02,20250822,,FOSCARBIDOPA\FOSLEVODOPA,Movement disorder,HO,FOSCARBIDOPA\FOSLEVODOPA | Movement disorder | HO,2024-12-02/2024-12-08
250595343,25059534,,F,,20250814,,VEDOLIZUMAB,Frequent bowel movements,OT,VEDOLIZUMAB | Frequent bowel movements | OT,NaT
250598832,25059883,73,M,,20250809,,LYNPARZA,Disease progression,OT,LYNPARZA | Disease progression | OT,NaT
250611032,25061103,,M,,20250803,,DAPAGLIFLOZIN,Nephropathy,OT,DAPAGLIFLOZIN | Nephropathy | OT,NaT
250619012,25061901,46,F,2025-02-19,20250815,,AMOXICILLIN\CLAVULANIC ACID,Psoriasis,OT,AMOXICILLIN\CLAVULANIC ACID | Psoriasis | OT,2025-02-17/2025-02-23
250625412,25062541,4,M,2025-02-01,20250809,,ULTOMIRIS,Pyrexia,HO,ULTOMIRIS | Pyrexia | HO,2025-01-27/2025-02-02
250633163,25063316,72,F,2025-03-08,20250828,,JARDIANCE,Asthenia,,JARDIANCE | Asthenia,2025-03-03/2025-03-09
250637263,25063726,,M,,20250707,,HIZENTRA,Myocardial infarction,HO,HIZENTRA | Myocardial infarction | HO,NaT
250637362,25063736,,F,,20250802,,BENRALIZUMAB,Drug ineffective,OT,BENRALIZUMAB | Drug ineffective | OT,NaT
250650132,25065013,,M,,20250803,,TICAGRELOR,C-reactive protein increased,DE,TICAGRELOR | C-reactive protein increased | DE,NaT
250655065,25065506,,,2025-03-19,20250722,,ORGOVYX,Fatigue,,ORGOVYX | Fatigue,2025-03-17/2025-03-23
250661003,25066100,69,F,,20250813,,.ALPHA.1-PROTEINASE INHIBITOR HUMAN,Bronchiectasis,OT,.ALPHA.1-PROTEINASE INHIBITOR HUMAN | Bronchiectasis | OT,NaT
250666694,25066669,41,F,2021-06-14,20250905,,GOLD BOND ORIGINAL STRENGTH,Mesothelioma,DS,GOLD BOND ORIGINAL STRENGTH | Mesothelioma | DS,2021-06-14/2021-06-20
250670492,25067049,,F,,20250803,,SYMBICORT,Throat cancer,OT,SYMBICORT | Throat cancer | OT,NaT
250681793,25068179,75,F,,20250702,,VYNDAMAX,Gait disturbance,,VYNDAMAX | Gait disturbance,NaT
250689652,25068965,,F,,20250709,,KEVZARA,Cellulitis,,KEVZARA | Cellulitis,NaT
250691655,25069165,18,F,2025-01-01,20250807,,DUPIXENT,Injection site induration,,DUPIXENT | Injection site induration,2024-12-30/2025-01-05
250702747,25070274,,M,2024-09-06,20250916,,ADYNOVATE,Reactive gastropathy,OT,ADYNOVATE | Reactive gastropathy | OT,2024-09-02/2024-09-08
250704163,25070416,,,2024-08-01,20250801,,OXLUMO,Malaise,OT,OXLUMO | Malaise | OT,2024-07-29/2024-08-04
250704862,25070486,48,F,2025-01-01,20250829,,DUPIXENT,Asthma,,DUPIXENT | Asthma,2024-12-30/2025-01-05
250712353,25071235,44,F,2025-02-01,20250827,,ORENCIA,Systemic lupus erythematosus,,ORENCIA | Systemic lupus erythematosus,2025-01-27/2025-02-02
250716212,25071621,81,F,,20250810,,TAGRISSO,Gastrointestinal haemorrhage,HO,TAGRISSO | Gastrointestinal haemorrhage | HO,NaT
250716462,25071646,47,M,2025-07-08,20250718,,REVLIMID,Arterial occlusive disease,HO,REVLIMID | Arterial occlusive disease | HO,2025-07-07/2025-07-13
250717022,25071702,38,F,2025-02-02,20250821,,ELTROMBOPAG OLAMINE,Headache,HO,ELTROMBOPAG OLAMINE | Headache | HO,2025-01-27/2025-02-02
250722353,25072235,,,,20250720,,ALBUTEROL SULFATE,Drug dose omission by device,,ALBUTEROL SULFATE | Drug dose omission by device,NaT
250726942,25072694,,F,,20250802,,TEZEPELUMAB,Death,DE,TEZEPELUMAB | Death | DE,NaT
250729943,25072994,52,M,2025-01-01,20250814,,DUPIXENT,Ear pain,OT,DUPIXENT | Ear pain | OT,2024-12-30/2025-01-05
250731332,25073133,58,F,2023-11-25,20250802,,ESOMEPRAZOLE,Hypokalaemia,HO,ESOMEPRAZOLE | Hypokalaemia | HO,2023-11-20/2023-11-26
250735832,25073583,69,F,2023-09-30,20250809,,ULTOMIRIS,Encephalitis,HO,ULTOMIRIS | Encephalitis | HO,2023-09-25/2023-10-01
250745702,25074570,,F,,20250803,,OSIMERTINIB,Headache,OT,OSIMERTINIB | Headache | OT,NaT
250746933,25074693,74,F,,20250816,,ULTOMIRIS,Eyelid ptosis,,ULTOMIRIS | Eyelid ptosis,NaT
250747752,25074775,42,F,2025-03-10,20250810,,OLAPARIB,Death,DE,OLAPARIB | Death | DE,2025-03-10/2025-03-16
250747822,25074782,84,F,2025-01-01,20250925,,DUPIXENT,Ocular discomfort,,DUPIXENT | Ocular discomfort,2024-12-30/2025-01-05
250752732,25075273,19,M,2025-02-28,20250718,,YESCARTA,Brain oedema,DE,YESCARTA | Brain oedema | DE,2025-02-24/2025-03-02
250754042,25075404,48,F,,20250902,,XELJANZ,Drug ineffective,,XELJANZ | Drug ineffective,NaT
250759933,25075993,77,F,2024-11-01,20250803,,BENRALIZUMAB,Death,DE,BENRALIZUMAB | Death | DE,2024-10-28/2024-11-03
250767012,25076701,,F,,20250708,,TYMLOS,Dizziness,OT,TYMLOS | Dizziness | OT,NaT
250793892,25079389,,M,,20250802,,IMFINZI,Shock haemorrhagic,LT,IMFINZI | Shock haemorrhagic | LT,NaT
250795862,25079586,67,F,2024-03-22,20250911,,AXICABTAGENE CILOLEUCEL,Disturbance in attention,OT,AXICABTAGENE CILOLEUCEL | Disturbance in attention | OT,2024-03-18/2024-03-24
250797554,25079755,52,M,2025-02-11,20250803,,SOLIRIS,Haemoglobin decreased,HO,SOLIRIS | Haemoglobin decreased | HO,2025-02-10/2025-02-16
250802992,25080299,25,M,2024-01-01,20250715,,SKYRIZI,Pericarditis,HO,SKYRIZI | Pericarditis | HO,2024-01-01/2024-01-07
250807943,25080794,70,F,2024-03-01,20250829,,WEGOVY,Haemoglobin decreased,OT,WEGOVY | Haemoglobin decreased | OT,2024-02-26/2024-03-03
250827872,25082787,46,F,2023-12-08,20250714,,VEDOLIZUMAB,Nausea,OT,VEDOLIZUMAB | Nausea | OT,2023-12-04/2023-12-10
250843255,25084325,12,F,2022-05-10,20250721,,FABRAZYME,Pain,,FABRAZYME | Pain,2022-05-09/2022-05-15
250848193,25084819,69,F,2025-01-01,20250831,,REMICADE,Breast cancer,OT,REMICADE | Breast cancer | OT,2024-12-30/2025-01-05
250848823,25084882,,M,,20250803,,ULTOMIRIS,Lung neoplasm malignant,DE,ULTOMIRIS | Lung neoplasm malignant | DE,NaT
250852618,25085261,68,F,2025-06-05,20250919,,ADEMPAS,Blood pressure systolic decreased,OT,ADEMPAS | Blood pressure systolic decreased | OT,2025-06-02/2025-06-08
250868862,25086886,67,M,,20250722,,METHOTREXATE,Lymphoproliferative disorder,OT,METHOTREXATE | Lymphoproliferative disorder | OT,NaT
250869972,25086997,,M,,20250701,,OMNITROPE,Incorrect dose administered by device,,OMNITROPE | Incorrect dose administered by device,NaT
250871102,25087110,,,,20250809,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Death,DE,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Death | DE,NaT
250871432,25087143,,F,,20250809,,DURVALUMAB,Death,DE,DURVALUMAB | Death | DE,NaT
250872592,25087259,,,2024-09-05,20250709,,VABYSMO,Intraocular pressure increased,OT,VABYSMO | Intraocular pressure increased | OT,2024-09-02/2024-09-08
250879522,25087952,54,F,2025-03-02,20250703,,QINLOCK,Intentional product use issue,,QINLOCK | Intentional product use issue,2025-02-24/2025-03-02
250883433,25088343,16,F,2025-03-14,20250919,,ZENATANE,Adverse drug reaction,,ZENATANE | Adverse drug reaction,2025-03-10/2025-03-16
250889352,25088935,,F,,20250810,,BYDUREON BCISE,Incorrect dose administered by device,,BYDUREON BCISE | Incorrect dose administered by device,NaT
250891074,25089107,,F,2025-01-01,20250716,,LUMRYZ,Drug ineffective,OT,LUMRYZ | Drug ineffective | OT,2024-12-30/2025-01-05
250892222,25089222,74,M,2024-01-01,20250809,,CALQUENCE,Arrhythmia,HO,CALQUENCE | Arrhythmia | HO,2024-01-01/2024-01-07
250892294,25089229,,,,20250703,,JAKAFI,Fatigue,OT,JAKAFI | Fatigue | OT,NaT
250901763,25090176,65,F,,20250731,,OMALIZUMAB,Nasal oedema,OT,OMALIZUMAB | Nasal oedema | OT,NaT
250905893,25090589,69,F,,20250816,,FULVESTRANT,Malignant neoplasm progression,OT,FULVESTRANT | Malignant neoplasm progression | OT,NaT
250914573,25091457,61,F,2025-01-01,20250930,,SODIUM CHLORIDE,Hospitalisation,HO,SODIUM CHLORIDE | Hospitalisation | HO,2024-12-30/2025-01-05
250916824,25091682,69,F,2025-01-01,20250920,,DUPIXENT,Dyspnoea,,DUPIXENT | Dyspnoea,2024-12-30/2025-01-05
250922232,25092223,74,M,2025-03-06,20250803,,ULTOMIRIS,Lower respiratory tract infection,OT,ULTOMIRIS | Lower respiratory tract infection | OT,2025-03-03/2025-03-09
250922783,25092278,8,M,2023-11-09,20250803,,SUBUTEX,Drug withdrawal syndrome neonatal,HO,SUBUTEX | Drug withdrawal syndrome neonatal | HO,2023-11-06/2023-11-12
250924052,25092405,,F,,20250803,,IMJUDO,Diarrhoea,OT,IMJUDO | Diarrhoea | OT,NaT
250925622,25092562,65,F,2022-01-01,20250710,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,2021-12-27/2022-01-02
250933593,25093359,8,M,2025-02-03,20250827,,XTANDI,Rhabdomyolysis,HO,XTANDI | Rhabdomyolysis | HO,2025-02-03/2025-02-09
250935542,25093554,,M,,20250803,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,NaT
250937462,25093746,39,M,,20250821,,DUPIXENT,Dry mouth,,DUPIXENT | Dry mouth,NaT
250939252,25093925,,M,,20250910,,GLASSIA,Vein disorder,HO,GLASSIA | Vein disorder | HO,NaT
250943932,25094393,40,F,2025-01-01,20250707,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2024-12-30/2025-01-05
250993062,25099306,,M,,20250803,,DAPAGLIFLOZIN,Constipation,OT,DAPAGLIFLOZIN | Constipation | OT,NaT
250993172,25099317,70,F,2025-02-04,20250810,,TEZSPIRE,Pulmonary hypertension,HO,TEZSPIRE | Pulmonary hypertension | HO,2025-02-03/2025-02-09
251011522,25101152,67,F,2024-11-01,20250711,,RINVOQ,Polyarthritis,HO,RINVOQ | Polyarthritis | HO,2024-10-28/2024-11-03
251012112,25101211,,,,20250812,,JOENJA,Product dose omission issue,,JOENJA | Product dose omission issue,NaT
251014843,25101484,60,M,2025-01-01,20250804,,KEVZARA,Therapeutic response decreased,,KEVZARA | Therapeutic response decreased,2024-12-30/2025-01-05
251017532,25101753,66,F,,20250820,,XELJANZ XR,Knee operation,OT,XELJANZ XR | Knee operation | OT,NaT
251035842,25103584,45,F,,20250728,,ADBRY,Rash,,ADBRY | Rash,NaT
251039253,25103925,,F,,20250715,,SKYRIZI,Fistula,OT,SKYRIZI | Fistula | OT,NaT
251041232,25104123,,F,,20250716,,WINREVAIR,Rash,,WINREVAIR | Rash,NaT
251052772,25105277,,F,,20250810,,OSIMERTINIB,Death,DE,OSIMERTINIB | Death | DE,NaT
251065782,25106578,63,F,2025-03-18,20250802,,ULTOMIRIS,Abdominal distension,OT,ULTOMIRIS | Abdominal distension | OT,2025-03-17/2025-03-23
251066732,25106673,77,F,,20250803,,OSIMERTINIB,Aortic stenosis,OT,OSIMERTINIB | Aortic stenosis | OT,NaT
251069823,25106982,,,,20250802,,ULTOMIRIS,Cardiac arrest,DE,ULTOMIRIS | Cardiac arrest | DE,NaT
251072403,25107240,,F,,20250809,,ULTOMIRIS,Eye disorder,OT,ULTOMIRIS | Eye disorder | OT,NaT
251078852,25107885,56,M,2025-02-01,20250723,,DUPIXENT,Inappropriate schedule of product administration,,DUPIXENT | Inappropriate schedule of product administration,2025-01-27/2025-02-02
251086132,25108613,33,F,2025-03-15,20250902,,LILETTA,Device breakage,,LILETTA | Device breakage,2025-03-10/2025-03-16
251087622,25108762,56,M,2025-01-01,20250922,,FOSCARBIDOPA\FOSLEVODOPA,Malaise,HO,FOSCARBIDOPA\FOSLEVODOPA | Malaise | HO,2024-12-30/2025-01-05
251092112,25109211,53,M,2025-01-01,20250722,,DUPIXENT,Hospitalisation,HO,DUPIXENT | Hospitalisation | HO,2024-12-30/2025-01-05
251102192,25110219,79,F,2025-03-07,20250803,,TAGRISSO,Pleural effusion,HO,TAGRISSO | Pleural effusion | HO,2025-03-03/2025-03-09
251131572,25113157,,F,,20250809,,PULMICORT TURBUHALER,Drug ineffective,OT,PULMICORT TURBUHALER | Drug ineffective | OT,NaT
251135362,25113536,,M,2024-09-01,20250805,,ALPHAGAN P,Eye opacity,OT,ALPHAGAN P | Eye opacity | OT,2024-08-26/2024-09-01
251138473,25113847,66,F,2025-03-19,20250810,,SOLIRIS,Off label use,DE,SOLIRIS | Off label use | DE,2025-03-17/2025-03-23
251138532,25113853,60,F,,20250810,,PULMICORT TURBUHALER,Pulmonary function test abnormal,HO,PULMICORT TURBUHALER | Pulmonary function test abnormal | HO,NaT
251139872,25113987,,F,,20250810,,OLAPARIB,Death,DE,OLAPARIB | Death | DE,NaT
251142873,25114287,33,M,2025-01-01,20250909,,DUPIXENT,Rebound effect,,DUPIXENT | Rebound effect,2024-12-30/2025-01-05
251153522,25115352,39,F,2024-12-01,20250905,,TREMFYA,Atelectasis,OT,TREMFYA | Atelectasis | OT,2024-11-25/2024-12-01
251163662,25116366,91,F,2025-03-04,20250809,,SODIUM ZIRCONIUM CYCLOSILICATE,Pain,HO,SODIUM ZIRCONIUM CYCLOSILICATE | Pain | HO,2025-03-03/2025-03-09
251171693,25117169,80,M,,20250926,,ORGOVYX,Pain in extremity,,ORGOVYX | Pain in extremity,NaT
251172912,25117291,51,F,2025-09-04,20250930,,IQIRVO,Abdominal pain,,IQIRVO | Abdominal pain,2025-09-01/2025-09-07
251181362,25118136,,,,20250721,,ALBUTEROL SULFATE,No adverse event,,ALBUTEROL SULFATE | No adverse event,NaT
251182922,25118292,74,M,2024-03-01,20250810,,TICAGRELOR,Condition aggravated,OT,TICAGRELOR | Condition aggravated | OT,2024-02-26/2024-03-03
251183985,25118398,72,F,2025-06-08,20250708,,HUMAN IMMUNOGLOBULIN G,Headache,OT,HUMAN IMMUNOGLOBULIN G | Headache | OT,2025-06-02/2025-06-08
251189492,25118949,78,F,2025-01-01,20250825,,DUPIXENT,Pyrexia,,DUPIXENT | Pyrexia,2024-12-30/2025-01-05
251196874,25119687,85,F,,20250802,,OSIMERTINIB,Myocardial infarction,OT,OSIMERTINIB | Myocardial infarction | OT,NaT
251197192,25119719,,,,20250809,,DAPAGLIFLOZIN,Cerebral infarction,OT,DAPAGLIFLOZIN | Cerebral infarction | OT,NaT
251207633,25120763,42,M,2025-01-01,20250916,,SKYRIZI,Drug ineffective,OT,SKYRIZI | Drug ineffective | OT,2024-12-30/2025-01-05
251217322,25121732,71,F,,20250802,,SYMBICORT,Hospitalisation,HO,SYMBICORT | Hospitalisation | HO,NaT
251228044,25122804,,F,,20250905,,QUTENZA,Application site hypoaesthesia,,QUTENZA | Application site hypoaesthesia,NaT
251236922,25123692,,F,2025-01-01,20250809,,DAPAGLIFLOZIN,Fatigue,HO,DAPAGLIFLOZIN | Fatigue | HO,2024-12-30/2025-01-05
251241172,25124117,,F,,20250802,,DAPAGLIFLOZIN,Back pain,OT,DAPAGLIFLOZIN | Back pain | OT,NaT
251241852,25124185,,,,20250723,,ORGOVYX,Pollakiuria,,ORGOVYX | Pollakiuria,NaT
251244182,25124418,,F,,20250802,,BENRALIZUMAB,Illness,OT,BENRALIZUMAB | Illness | OT,NaT
251245685,25124568,79,F,,20250724,,XOLAIR PFS,Off label use,HO,XOLAIR PFS | Off label use | HO,NaT
251251362,25125136,,M,,20250803,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,NaT
251273563,25127356,58,M,2024-08-01,20250821,,SKYRIZI,Crohn's disease,HO,SKYRIZI | Crohn's disease | HO,2024-07-29/2024-08-04
251277752,25127775,,F,,20250803,,DAPAGLIFLOZIN,Illness,OT,DAPAGLIFLOZIN | Illness | OT,NaT
251280362,25128036,72,M,,20250722,,REVLIMID,Diarrhoea,,REVLIMID | Diarrhoea,NaT
251288984,25128898,73,M,,20250822,,DUPIXENT,Initial insomnia,OT,DUPIXENT | Initial insomnia | OT,NaT
251294823,25129482,57,F,2025-01-01,20250915,,XELJANZ XR,Product dose omission in error,OT,XELJANZ XR | Product dose omission in error | OT,2024-12-30/2025-01-05
251295072,25129507,52,F,,20250810,,STRENSIQ,Gastrointestinal haemorrhage,HO,STRENSIQ | Gastrointestinal haemorrhage | HO,NaT
251299083,25129908,69,F,2025-01-01,20250716,,DUPIXENT,Pain in extremity,,DUPIXENT | Pain in extremity,2024-12-30/2025-01-05
251300762,25130076,,F,,20250802,,CRESTOR,Hypokinesia,HO,CRESTOR | Hypokinesia | HO,NaT
251302082,25130208,,M,2024-01-01,20250807,,TYVASO DPI,Glycosylated haemoglobin increased,HO,TYVASO DPI | Glycosylated haemoglobin increased | HO,2024-01-01/2024-01-07
251334733,25133473,57,F,2025-03-25,20250810,,BREZTRI,Wrong technique in product usage process,,BREZTRI | Wrong technique in product usage process,2025-03-24/2025-03-30
251335267,25133526,53,F,2024-12-29,20250729,,REMICADE,Breast cancer recurrent,HO,REMICADE | Breast cancer recurrent | HO,2024-12-23/2024-12-29
251346512,25134651,84,F,2025-01-28,20250711,,MIRTAZAPINE,Posterior reversible encephalopathy syndrome,HO,MIRTAZAPINE | Posterior reversible encephalopathy syndrome | HO,2025-01-27/2025-02-02
251351996,25135199,,,2024-10-07,20250902,,LIVMARLI,Transaminases increased,HO,LIVMARLI | Transaminases increased | HO,2024-10-07/2024-10-13
251355033,25135503,,F,2024-01-01,20250916,,CERTOLIZUMAB PEGOL,Drug ineffective,OT,CERTOLIZUMAB PEGOL | Drug ineffective | OT,2024-01-01/2024-01-07
251356092,25135609,74,M,,20250809,,DURVALUMAB,Immune-mediated adrenal insufficiency,OT,DURVALUMAB | Immune-mediated adrenal insufficiency | OT,NaT
251361312,25136131,,M,,20250809,,DURVALUMAB,Death,DE,DURVALUMAB | Death | DE,NaT
251365862,25136586,58,F,2025-03-20,20250809,,SOLIRIS,Autoimmune thyroiditis,OT,SOLIRIS | Autoimmune thyroiditis | OT,2025-03-17/2025-03-23
251377203,25137720,,,,20250711,,TRIPTORELIN,Hypocalcaemia,OT,TRIPTORELIN | Hypocalcaemia | OT,NaT
251388372,25138837,44,M,2002-12-30,20250810,,CRESTOR,Renal impairment,OT,CRESTOR | Renal impairment | OT,2002-12-30/2003-01-05
251391662,25139166,,M,,20250803,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,NaT
251395725,25139572,,F,,20250704,,DAYBUE,Regurgitation,,DAYBUE | Regurgitation,NaT
251411883,25141188,39,F,2025-03-01,20250718,,SODIUM CHLORIDE,Bacterial infection,HO,SODIUM CHLORIDE | Bacterial infection | HO,2025-02-24/2025-03-02
251414034,25141403,2,M,2024-01-01,20250922,,DUPIXENT,Therapeutic response shortened,,DUPIXENT | Therapeutic response shortened,2024-01-01/2024-01-07
251419772,25141977,23,F,2022-09-01,20250813,,VEDOLIZUMAB,Gastrooesophageal reflux disease,OT,VEDOLIZUMAB | Gastrooesophageal reflux disease | OT,2022-08-29/2022-09-04
251431392,25143139,,F,,20250801,,NEXVIAZYME,Ligament sprain,,NEXVIAZYME | Ligament sprain,NaT
251441682,25144168,77,F,2025-02-01,20250816,,BREZTRI,Product use issue,,BREZTRI | Product use issue,2025-01-27/2025-02-02
251455714,25145571,47,F,2024-01-01,20250725,,ABRILADA,Off label use,OT,ABRILADA | Off label use | OT,2024-01-01/2024-01-07
251459563,25145956,59,F,2024-08-19,20250803,,DAPAGLIFLOZIN,Treatment noncompliance,OT,DAPAGLIFLOZIN | Treatment noncompliance | OT,2024-08-19/2024-08-25
251464942,25146494,,M,,20250704,,STELARA,Prostatic specific antigen increased,OT,STELARA | Prostatic specific antigen increased | OT,NaT
251468093,25146809,,F,,20250810,,SOLIRIS,Meningitis,HO,SOLIRIS | Meningitis | HO,NaT
251477822,25147782,72,F,2024-01-05,20250810,,TEZEPELUMAB,Headache,OT,TEZEPELUMAB | Headache | OT,2024-01-01/2024-01-07
251478013,25147801,39,F,2025-03-28,20250816,,TEZSPIRE,Headache,,TEZSPIRE | Headache,2025-03-24/2025-03-30
251481712,25148171,,M,,20250816,,FASENRA,Palpitations,,FASENRA | Palpitations,NaT
251487722,25148772,,,,20250812,,ALBUTEROL SULFATE,Drug dose omission by device,,ALBUTEROL SULFATE | Drug dose omission by device,NaT
251496372,25149637,27,M,2025-03-23,20250803,,AIRSUPRA,Photophobia,DS,AIRSUPRA | Photophobia | DS,2025-03-17/2025-03-23
251496442,25149644,,M,,20250803,,DAPAGLIFLOZIN,Critical illness,HO,DAPAGLIFLOZIN | Critical illness | HO,NaT
251507064,25150706,49,F,2025-01-01,20250909,,DUPIXENT,Asthma,,DUPIXENT | Asthma,2024-12-30/2025-01-05
251518742,25151874,67,F,,20250803,,OLAPARIB,Diarrhoea,OT,OLAPARIB | Diarrhoea | OT,NaT
251518822,25151882,,,,20250730,,ORGOVYX,Bronchitis,OT,ORGOVYX | Bronchitis | OT,NaT
251520522,25152052,54,F,2023-10-01,20250710,,PREDNISONE,Peripheral swelling,OT,PREDNISONE | Peripheral swelling | OT,2023-09-25/2023-10-01
251532762,25153276,63,F,,20250821,,AMBRISENTAN,Abdominal discomfort,HO,AMBRISENTAN | Abdominal discomfort | HO,NaT
251533402,25153340,,,,20250820,,PEGFILGRASTIM,Febrile neutropenia,HO,PEGFILGRASTIM | Febrile neutropenia | HO,NaT
251547292,25154729,65,M,,20250728,,PREDNISONE,Bradyphrenia,HO,PREDNISONE | Bradyphrenia | HO,NaT
251549492,25154949,,F,,20250707,,VENCLEXTA,Diverticulitis intestinal perforated,HO,VENCLEXTA | Diverticulitis intestinal perforated | HO,NaT
251549962,25154996,61,F,2025-03-26,20250802,,DAPAGLIFLOZIN,Oedema peripheral,OT,DAPAGLIFLOZIN | Oedema peripheral | OT,2025-03-24/2025-03-30
251557923,25155792,,M,,20250710,,GENOTROPIN,Device information output issue,,GENOTROPIN | Device information output issue,NaT
251559724,25155972,,F,2023-01-01,20250721,,TYSABRI,Prescribed underdose,HO,TYSABRI | Prescribed underdose | HO,2022-12-26/2023-01-01
251563692,25156369,,F,,20250803,,PULMICORT TURBUHALER,Pneumonia,OT,PULMICORT TURBUHALER | Pneumonia | OT,NaT
251563765,25156376,,M,2018-01-01,20250822,,TYSABRI,Balance disorder,,TYSABRI | Balance disorder,2018-01-01/2018-01-07
251564332,25156433,,F,,20250704,,DUPIXENT,Asthma,,DUPIXENT | Asthma,NaT
251567092,25156709,28,F,,20250709,,ADALIMUMAB,Back pain,OT,ADALIMUMAB | Back pain | OT,NaT
251577932,25157793,74,M,2025-01-01,20250720,,SKYRIZI,Cerebrovascular accident,OT,SKYRIZI | Cerebrovascular accident | OT,2024-12-30/2025-01-05
251578683,25157868,73,M,2025-01-01,20250912,,DUOPA,Hospice care,OT,DUOPA | Hospice care | OT,2024-12-30/2025-01-05
251583223,25158322,77,F,2025-01-01,20250905,,DUPIXENT,Loss of personal independence in daily activities,HO,DUPIXENT | Loss of personal independence in daily activities | HO,2024-12-30/2025-01-05
251587232,25158723,,,,20250803,,QUETIAPINE FUMARATE,Insomnia,OT,QUETIAPINE FUMARATE | Insomnia | OT,NaT
251590892,25159089,55,M,,20250809,,QUETIAPINE FUMARATE,Schizophrenia,OT,QUETIAPINE FUMARATE | Schizophrenia | OT,NaT
251601152,25160115,,M,2025-02-06,20250803,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2025-02-03/2025-02-09
251606493,25160649,,,,20250816,,FASENRA,No adverse event,,FASENRA | No adverse event,NaT
251610272,25161027,,M,,20250803,,OSIMERTINIB,Cardiac fibrillation,DE,OSIMERTINIB | Cardiac fibrillation | DE,NaT
251613134,25161313,,M,,20250714,,ELEXACAFTOR\IVACAFTOR\TEZACAFTOR,Congenital vas deferens absence,CA,ELEXACAFTOR\IVACAFTOR\TEZACAFTOR | Congenital vas deferens absence | CA,NaT
251625703,25162570,,M,,20250711,,FLAREX,Product delivery mechanism issue,OT,FLAREX | Product delivery mechanism issue | OT,NaT
251628665,25162866,53,F,2025-03-28,20250828,,AYVAKIT,Eyelash discolouration,OT,AYVAKIT | Eyelash discolouration | OT,2025-03-24/2025-03-30
251633942,25163394,,M,,20250809,,OSIMERTINIB,Lung carcinoma cell type unspecified stage IV,DE,OSIMERTINIB | Lung carcinoma cell type unspecified stage IV | DE,NaT
251637922,25163792,56,F,2025-01-01,20250731,,DUPIXENT,Headache,,DUPIXENT | Headache,2024-12-30/2025-01-05
251642082,25164208,,,,20250810,,FASENRA,Asthma,,FASENRA | Asthma,NaT
251652122,25165212,,M,,20250809,,TEZEPELUMAB,Lower respiratory tract infection,OT,TEZEPELUMAB | Lower respiratory tract infection | OT,NaT
251663592,25166359,,M,2025-02-26,20250718,,TREMFYA,Hyperhidrosis,OT,TREMFYA | Hyperhidrosis | OT,2025-02-24/2025-03-02
251664592,25166459,,F,,20250810,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Death,DE,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Death | DE,NaT
251665102,25166510,55,F,2024-04-12,20250813,,YERVOY,Immune-mediated uveitis,OT,YERVOY | Immune-mediated uveitis | OT,2024-04-08/2024-04-14
251670372,25167037,13,M,2025-03-28,20250921,,FINTEPLA,Tricuspid valve incompetence,OT,FINTEPLA | Tricuspid valve incompetence | OT,2025-03-24/2025-03-30
251676703,25167670,,F,,20250809,,SOLIRIS,Asthenia,OT,SOLIRIS | Asthenia | OT,NaT
251682882,25168288,61,,,20250812,,ALBUTEROL SULFATE,Device deposit issue,,ALBUTEROL SULFATE | Device deposit issue,NaT
251692033,25169203,82,M,2024-02-01,20250803,,DURVALUMAB,Cholangitis,OT,DURVALUMAB | Cholangitis | OT,2024-01-29/2024-02-04
251697095,25169709,56,F,2025-01-01,20250803,,VENCLEXTA,Diarrhoea,HO,VENCLEXTA | Diarrhoea | HO,2024-12-30/2025-01-05
251701035,25170103,25,F,2025-01-01,20250701,,RINVOQ,Rash pruritic,OT,RINVOQ | Rash pruritic | OT,2024-12-30/2025-01-05
251706622,25170662,57,,,20250812,,ALBUTEROL SULFATE,No adverse event,,ALBUTEROL SULFATE | No adverse event,NaT
251709942,25170994,,,,20250716,,ORGOVYX,Incorrect dose administered,,ORGOVYX | Incorrect dose administered,NaT
251713473,25171347,,M,,20250919,,NASACORT ALLERGY 24HR,No adverse event,,NASACORT ALLERGY 24HR | No adverse event,NaT
251725462,25172546,72,M,,20250809,,DURVALUMAB,Cholangitis,OT,DURVALUMAB | Cholangitis | OT,NaT
251727792,25172779,,M,,20250809,,DURVALUMAB,Death,DE,DURVALUMAB | Death | DE,NaT
251738994,25173899,22,M,2008-07-29,20250722,,AGALSIDASE BETA,Chest pain,HO,AGALSIDASE BETA | Chest pain | HO,2008-07-28/2008-08-03
251743532,25174353,16,F,,20250822,,REMICADE,Lupus-like syndrome,LT,REMICADE | Lupus-like syndrome | LT,NaT
251743792,25174379,,,2025-03-05,20250709,,REZDIFFRA,Abdominal pain,,REZDIFFRA | Abdominal pain,2025-03-03/2025-03-09
251744042,25174404,,F,,20250826,,XYWAV,Bipolar disorder,OT,XYWAV | Bipolar disorder | OT,NaT
251747782,25174778,,F,,20250803,,ULTOMIRIS,Lymphoma,OT,ULTOMIRIS | Lymphoma | OT,NaT
251748164,25174816,69,F,,20250821,,XELJANZ,Arthralgia,,XELJANZ | Arthralgia,NaT
251751542,25175154,,,,20250709,,UBLITUXIMAB,Drug ineffective,,UBLITUXIMAB | Drug ineffective,NaT
251759562,25175956,,M,2025-01-01,20250809,,DAPAGLIFLOZIN,Acidosis,HO,DAPAGLIFLOZIN | Acidosis | HO,2024-12-30/2025-01-05
251759813,25175981,33,M,2025-04-05,20250721,,COSENTYX,Drug dose omission by device,,COSENTYX | Drug dose omission by device,2025-03-31/2025-04-06
251763125,25176312,75,F,2025-03-31,20250816,,BYDUREON BCISE,Drug dose omission by device,OT,BYDUREON BCISE | Drug dose omission by device | OT,2025-03-31/2025-04-06
251767162,25176716,41,M,2025-03-04,20250718,,TREMFYA,Infusion related reaction,OT,TREMFYA | Infusion related reaction | OT,2025-03-03/2025-03-09
251771283,25177128,85,M,2025-01-01,20250803,,DAPAGLIFLOZIN,Urinary tract infection,DS,DAPAGLIFLOZIN | Urinary tract infection | DS,2024-12-30/2025-01-05
251779052,25177905,43,F,2025-02-16,20250802,,MORPHINE,Hypoaesthesia,HO,MORPHINE | Hypoaesthesia | HO,2025-02-10/2025-02-16
251781915,25178191,57,F,2025-02-25,20250802,,SOLIRIS,Light chain analysis increased,,SOLIRIS | Light chain analysis increased,2025-02-24/2025-03-02
251813212,25181321,89,M,2025-04-06,20250810,,BYDUREON BCISE,Product dose omission issue,,BYDUREON BCISE | Product dose omission issue,2025-03-31/2025-04-06
251822812,25182281,,M,2023-01-01,20250701,,UNSPECIFIED INGREDIENT,Therapy cessation,,UNSPECIFIED INGREDIENT | Therapy cessation,2022-12-26/2023-01-01
251826912,25182691,40,F,,20250815,,EPIRUBICIN,Pneumocystis jirovecii pneumonia,HO,EPIRUBICIN | Pneumocystis jirovecii pneumonia | HO,NaT
251835818,25183581,35,F,2024-01-01,20250922,,ALEMTUZUMAB,Pain in extremity,DS,ALEMTUZUMAB | Pain in extremity | DS,2024-01-01/2024-01-07
251836184,25183618,,F,,20250709,,DAYBUE,Diarrhoea,,DAYBUE | Diarrhoea,NaT
251842033,25184203,,F,,20250809,,PULMICORT TURBUHALER,Drug ineffective,OT,PULMICORT TURBUHALER | Drug ineffective | OT,NaT
251844853,25184485,61,F,,20250904,,XELJANZ XR,Vomiting,,XELJANZ XR | Vomiting,NaT
251852042,25185204,14,M,2023-12-13,20250814,,REMICADE,Inappropriate schedule of product administration,OT,REMICADE | Inappropriate schedule of product administration | OT,2023-12-11/2023-12-17
251864522,25186452,,F,,20250810,,BREZTRI,Product dose omission issue,,BREZTRI | Product dose omission issue,NaT
251867183,25186718,66,F,2022-01-01,20250722,,HUMIRA,Cataract,OT,HUMIRA | Cataract | OT,2021-12-27/2022-01-02
251870122,25187012,,F,,20250803,,CAPIVASERTIB,Death,DE,CAPIVASERTIB | Death | DE,NaT
251872902,25187290,,F,,20250802,,TAGRISSO,Syncope,OT,TAGRISSO | Syncope | OT,NaT
251876143,25187614,70,M,,20250714,,ORENCIA,Adverse event,OT,ORENCIA | Adverse event | OT,NaT
251879192,25187919,,M,,20250716,,NUPLAZID,Depression,OT,NUPLAZID | Depression | OT,NaT
251879635,25187963,57,F,2025-01-15,20250902,,Novalgin,Arthralgia,OT,Novalgin | Arthralgia | OT,2025-01-13/2025-01-19
251881722,25188172,,M,2024-09-01,20250802,,CALQUENCE,Pancytopenia,LT,CALQUENCE | Pancytopenia | LT,2024-08-26/2024-09-01
251886182,25188618,,,,20250816,,BREZTRI,Malaise,,BREZTRI | Malaise,NaT
251886654,25188665,57,F,,20250806,,YERVOY,Cystitis,OT,YERVOY | Cystitis | OT,NaT
251894842,25189484,69,M,2025-02-14,20250809,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2025-02-10/2025-02-16
251896593,25189659,68,F,2025-04-10,20250810,,BYDUREON BCISE,Injection site pain,,BYDUREON BCISE | Injection site pain,2025-04-07/2025-04-13
251897042,25189704,83,F,2025-04-07,20250710,,ORENCIA,Product distribution issue,,ORENCIA | Product distribution issue,2025-04-07/2025-04-13
251899612,25189961,,F,,20250809,,TEZSPIRE,Asthma,HO,TEZSPIRE | Asthma | HO,NaT
251902516,25190251,,F,2025-01-01,20250825,,BRIVARACETAM,Somnolence,HO,BRIVARACETAM | Somnolence | HO,2024-12-30/2025-01-05
251907112,25190711,72,M,,20250710,,NIVOLUMAB,Erosive pustular dermatosis,,NIVOLUMAB | Erosive pustular dermatosis,NaT
251924583,25192458,,M,,20250723,,COSENTYX,Device leakage,,COSENTYX | Device leakage,NaT
251928427,25192842,42,F,,20250919,,PREDNISOLONE,Off label use,LT,PREDNISOLONE | Off label use | LT,NaT
251929052,25192905,,F,,20250710,,SKYRIZI,Neoplasm malignant,OT,SKYRIZI | Neoplasm malignant | OT,NaT
251933673,25193367,,F,,20250810,,BREZTRI,Wrong technique in device usage process,,BREZTRI | Wrong technique in device usage process,NaT
251933692,25193369,79,F,2025-03-30,20250810,,TICAGRELOR,Death,DE,TICAGRELOR | Death | DE,2025-03-24/2025-03-30
251934302,25193430,,F,,20250810,,IMFINZI,Death,DE,IMFINZI | Death | DE,NaT
251934332,25193433,,F,,20250809,,CAPIVASERTIB,Renal disorder,OT,CAPIVASERTIB | Renal disorder | OT,NaT
251934953,25193495,,F,,20250802,,TEZEPELUMAB,Respiratory syncytial virus infection,HO,TEZEPELUMAB | Respiratory syncytial virus infection | HO,NaT
251935013,25193501,90,F,2025-04-08,20250803,,SOLIRIS,Loss of consciousness,DE,SOLIRIS | Loss of consciousness | DE,2025-04-07/2025-04-13
251935413,25193541,3,F,2025-02-05,20250803,,BEYFORTUS,Respiratory syncytial virus bronchiolitis,HO,BEYFORTUS | Respiratory syncytial virus bronchiolitis | HO,2025-02-03/2025-02-09
251935422,25193542,57,M,2025-01-01,20250809,,SODIUM ZIRCONIUM CYCLOSILICATE,Dyspnoea exertional,OT,SODIUM ZIRCONIUM CYCLOSILICATE | Dyspnoea exertional | OT,2024-12-30/2025-01-05
251935522,25193552,,F,,20250803,,DAPAGLIFLOZIN,Diabetes mellitus,OT,DAPAGLIFLOZIN | Diabetes mellitus | OT,NaT
251937185,25193718,61,M,2024-06-10,20250703,,FOSCARBIDOPA\FOSLEVODOPA,Partial seizures,HO,FOSCARBIDOPA\FOSLEVODOPA | Partial seizures | HO,2024-06-10/2024-06-16
251943072,25194307,34,M,2025-01-01,20250708,,DUPIXENT,Pharyngitis streptococcal,,DUPIXENT | Pharyngitis streptococcal,2024-12-30/2025-01-05
251943497,25194349,57,M,2025-01-01,20250829,,FOSCARBIDOPA\FOSLEVODOPA,Muscle spasms,HO,FOSCARBIDOPA\FOSLEVODOPA | Muscle spasms | HO,2024-12-30/2025-01-05
251946976,25194697,4,F,,20250723,,UPTRAVI,Pulmonary arterial hypertension,DE,UPTRAVI | Pulmonary arterial hypertension | DE,NaT
251951005,25195100,73,F,2025-01-01,20250909,,VENCLEXTA,Red blood cell count decreased,OT,VENCLEXTA | Red blood cell count decreased | OT,2024-12-30/2025-01-05
251952142,25195214,,M,,20250703,,DUPIXENT,Extra dose administered,,DUPIXENT | Extra dose administered,NaT
251953762,25195376,76,M,,20250910,,DUPIXENT,Limb operation,HO,DUPIXENT | Limb operation | HO,NaT
251955122,25195512,2,M,2025-03-01,20250805,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2025-02-24/2025-03-02
251959442,25195944,40,M,2025-02-01,20250722,,SIMPONI,Tuberculosis,HO,SIMPONI | Tuberculosis | HO,2025-01-27/2025-02-02
251970562,25197056,78,F,,20250809,,BUDESONIDE\FORMOTEROL,Thrombosis,OT,BUDESONIDE\FORMOTEROL | Thrombosis | OT,NaT
251973685,25197368,28,F,2025-04-01,20250719,,REMODULIN,Device electrical finding,HO,REMODULIN | Device electrical finding | HO,2025-03-31/2025-04-06
251985093,25198509,85,M,2024-11-07,20250803,,DAPAGLIFLOZIN,Visual impairment,OT,DAPAGLIFLOZIN | Visual impairment | OT,2024-11-04/2024-11-10
251987172,25198717,8,F,2024-11-02,20250730,,KEYTRUDA,Decreased activity,OT,KEYTRUDA | Decreased activity | OT,2024-10-28/2024-11-03
251990522,25199052,,F,2025-01-01,20250704,,CIMZIA,Nephrolithiasis,HO,CIMZIA | Nephrolithiasis | HO,2024-12-30/2025-01-05
251992102,25199210,,F,,20250803,,TICAGRELOR,Myocardial infarction,OT,TICAGRELOR | Myocardial infarction | OT,NaT
251998423,25199842,73,M,2024-01-01,20250826,,SKYRIZI,Knee arthroplasty,OT,SKYRIZI | Knee arthroplasty | OT,2024-01-01/2024-01-07
252007702,25200770,60,F,2024-09-13,20250829,,VEDOLIZUMAB,Inappropriate schedule of product administration,OT,VEDOLIZUMAB | Inappropriate schedule of product administration | OT,2024-09-09/2024-09-15
252031302,25203130,,F,,20250803,,SODIUM ZIRCONIUM CYCLOSILICATE,Blindness,OT,SODIUM ZIRCONIUM CYCLOSILICATE | Blindness | OT,NaT
252033222,25203322,68,F,2024-05-16,20250809,,STRENSIQ,Eye pain,OT,STRENSIQ | Eye pain | OT,2024-05-13/2024-05-19
252036732,25203673,81,F,,20250807,,DUPIXENT,Sinusitis,,DUPIXENT | Sinusitis,NaT
252039483,25203948,,F,,20250809,,TICAGRELOR,Cardiac disorder,OT,TICAGRELOR | Cardiac disorder | OT,NaT
252042834,25204283,,,,20250731,,SIMPONI,Device issue,,SIMPONI | Device issue,NaT
252047292,25204729,,F,2025-04-01,20250809,,PULMICORT TURBUHALER,Arrhythmia,OT,PULMICORT TURBUHALER | Arrhythmia | OT,2025-03-31/2025-04-06
252050723,25205072,,M,2025-04-13,20250803,,ULTOMIRIS,Pneumonia,DE,ULTOMIRIS | Pneumonia | DE,2025-04-07/2025-04-13
252061224,25206122,66,M,2025-01-01,20250920,,TREPROSTINIL,Brain natriuretic peptide increased,OT,TREPROSTINIL | Brain natriuretic peptide increased | OT,2024-12-30/2025-01-05
252065472,25206547,,,,20250912,,PHENYTOIN,Drug reaction with eosinophilia and systemic symptoms,HO,PHENYTOIN | Drug reaction with eosinophilia and systemic symptoms | HO,NaT
252067623,25206762,,F,,20250704,,VEOZAH,Alanine aminotransferase increased,,VEOZAH | Alanine aminotransferase increased,NaT
252070486,25207048,,M,2023-01-01,20250813,,ARIKAYCE,Dyspnoea,HO,ARIKAYCE | Dyspnoea | HO,2022-12-26/2023-01-01
252070592,25207059,,F,2025-04-07,20250809,,OLAPARIB,Hiatus hernia,HO,OLAPARIB | Hiatus hernia | HO,2025-04-07/2025-04-13
252073552,25207355,,,,20250710,,RUCONEST,No adverse event,,RUCONEST | No adverse event,NaT
252078693,25207869,34,F,2024-07-01,20250708,,TYSABRI,Retained placenta or membranes,HO,TYSABRI | Retained placenta or membranes | HO,2024-07-01/2024-07-07
252080742,25208074,,M,,20250809,,OLAPARIB,Fatigue,OT,OLAPARIB | Fatigue | OT,NaT
252089062,25208906,60,F,,20250819,,ORENCIA,Therapeutic response decreased,,ORENCIA | Therapeutic response decreased,NaT
252089303,25208930,70,F,,20250912,,LENALIDOMIDE,Insurance issue,,LENALIDOMIDE | Insurance issue,NaT
252090142,25209014,70,F,2025-04-01,20250803,,ORENCIA,Device safety feature issue,OT,ORENCIA | Device safety feature issue | OT,2025-03-31/2025-04-06
252098232,25209823,48,M,2025-04-07,20250808,,VYXEOS,Acute myeloid leukaemia,OT,VYXEOS | Acute myeloid leukaemia | OT,2025-04-07/2025-04-13
252111914,25211191,74,M,2024-11-28,20250701,,LONSURF,Acute kidney injury,DS,LONSURF | Acute kidney injury | DS,2024-11-25/2024-12-01
252112772,25211277,71,F,,20250714,,FORTEO,Bone density decreased,,FORTEO | Bone density decreased,NaT
252116942,25211694,,,,20250802,,DAPAGLIFLOZIN,Cerebrovascular accident,OT,DAPAGLIFLOZIN | Cerebrovascular accident | OT,NaT
252117732,25211773,50,F,2022-10-14,20250902,,MOUNJARO,Dehydration,OT,MOUNJARO | Dehydration | OT,2022-10-10/2022-10-16
252119652,25211965,,F,2021-01-01,20250716,,AMLODIPINE,Asthenia,HO,AMLODIPINE | Asthenia | HO,2020-12-28/2021-01-03
252122352,25212235,,,,20250816,,AIRSUPRA,Chronic obstructive pulmonary disease,,AIRSUPRA | Chronic obstructive pulmonary disease,NaT
252149686,25214968,49,F,2025-03-14,20250807,,ENBREL,Pain,,ENBREL | Pain,2025-03-10/2025-03-16
252153202,25215320,,,,20250803,,DAPAGLIFLOZIN,Cerebrovascular accident,OT,DAPAGLIFLOZIN | Cerebrovascular accident | OT,NaT
252154362,25215436,,F,,20250721,,VOQUEZNA,Chronic kidney disease,,VOQUEZNA | Chronic kidney disease,NaT
252157252,25215725,11,F,,20250711,,VOXZOGO,Knee deformity,OT,VOXZOGO | Knee deformity | OT,NaT
252162293,25216229,,F,,20250809,,ULTOMIRIS,Rash,HO,ULTOMIRIS | Rash | HO,NaT
252164615,25216461,11,F,2025-01-01,20250703,,DUPIXENT,Therapeutic response shortened,,DUPIXENT | Therapeutic response shortened,2024-12-30/2025-01-05
252171734,25217173,31,F,2025-04-10,20250804,,VEDOLIZUMAB,Haemoglobin decreased,OT,VEDOLIZUMAB | Haemoglobin decreased | OT,2025-04-07/2025-04-13
252172942,25217294,,M,,20250721,,NUCALA,Product dose omission issue,,NUCALA | Product dose omission issue,NaT
252174522,25217452,6,F,,20250813,,DUPIXENT,Dry skin,,DUPIXENT | Dry skin,NaT
252184966,25218496,,F,2025-03-02,20250713,,NUCALA,Cardiac failure,OT,NUCALA | Cardiac failure | OT,2025-02-24/2025-03-02
252188813,25218881,37,F,2025-03-28,20250903,,KESIMPTA,Rhinorrhoea,,KESIMPTA | Rhinorrhoea,2025-03-24/2025-03-30
252189702,25218970,,M,,20250809,,LYNPARZA,Prostatic specific antigen increased,OT,LYNPARZA | Prostatic specific antigen increased | OT,NaT
252194052,25219405,53,F,,20250917,,VERZENIO,Influenza like illness,,VERZENIO | Influenza like illness,NaT
252194182,25219418,,,2025-04-01,20250724,,INFLECTRA,Urticaria,HO,INFLECTRA | Urticaria | HO,2025-03-31/2025-04-06
252199973,25219997,25,F,2025-04-01,20250730,,ENTYVIO,Oropharyngeal pain,,ENTYVIO | Oropharyngeal pain,2025-03-31/2025-04-06
252203143,25220314,,,2025-01-01,20250910,,TIROSINT-SOL,Ventricular tachycardia,HO,TIROSINT-SOL | Ventricular tachycardia | HO,2024-12-30/2025-01-05
252217142,25221714,48,F,,20250804,,DUPIXENT,Dry eye,,DUPIXENT | Dry eye,NaT
252225772,25222577,14,F,2025-04-05,20250809,,STRENSIQ,General physical health deterioration,HO,STRENSIQ | General physical health deterioration | HO,2025-03-31/2025-04-06
252225834,25222583,66,M,2024-12-01,20250811,,REMICADE,Blood pressure increased,OT,REMICADE | Blood pressure increased | OT,2024-11-25/2024-12-01
252235805,25223580,65,M,,20250808,,SIMPONI,Kidney infection,OT,SIMPONI | Kidney infection | OT,NaT
252236332,25223633,74,M,,20250810,,SYMBICORT,Product use issue,,SYMBICORT | Product use issue,NaT
252245092,25224509,5,F,,20250806,,FINTEPLA,Heart valve incompetence,OT,FINTEPLA | Heart valve incompetence | OT,NaT
252245922,25224592,,,,20250802,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,NaT
252252832,25225283,,F,,20250809,,OSIMERTINIB,Death,DE,OSIMERTINIB | Death | DE,NaT
252260073,25226007,64,F,2025-04-01,20250714,,DUPIXENT,Arthralgia,,DUPIXENT | Arthralgia,2025-03-31/2025-04-06
252261292,25226129,51,F,2024-07-12,20250810,,ANIFROLUMAB,Osteomyelitis,OT,ANIFROLUMAB | Osteomyelitis | OT,2024-07-08/2024-07-14
252263422,25226342,,M,2024-04-08,20250801,,DARZALEX,Atrial fibrillation,DE,DARZALEX | Atrial fibrillation | DE,2024-04-08/2024-04-14
252263552,25226355,,F,,20250809,,LYNPARZA,Gastrointestinal perforation,OT,LYNPARZA | Gastrointestinal perforation | OT,NaT
252266503,25226650,36,F,,20250803,,STRENSIQ,Weight increased,OT,STRENSIQ | Weight increased | OT,NaT
252267642,25226764,43,F,2025-04-06,20250803,,SOLIRIS,Aphonia,OT,SOLIRIS | Aphonia | OT,2025-03-31/2025-04-06
252270753,25227075,,F,,20250809,,STRENSIQ,Palpitations,OT,STRENSIQ | Palpitations | OT,NaT
252271763,25227176,32,F,2025-04-07,20250930,,PALYNZIQ,Injection site thrombosis,,PALYNZIQ | Injection site thrombosis,2025-04-07/2025-04-13
252272822,25227282,52,F,,20250809,,REMICADE,Frequent bowel movements,OT,REMICADE | Frequent bowel movements | OT,NaT
252277643,25227764,4,M,2025-01-01,20250811,,DUPIXENT,Pain in extremity,,DUPIXENT | Pain in extremity,2024-12-30/2025-01-05
252282032,25228203,,,,20250707,,KESIMPTA,Infection,,KESIMPTA | Infection,NaT
252285093,25228509,64,F,2025-04-04,20250809,,FASENRA,Lung neoplasm malignant,OT,FASENRA | Lung neoplasm malignant | OT,2025-03-31/2025-04-06
252307252,25230725,61,M,2025-07-01,20250720,,DUPIXENT,Oropharyngeal discomfort,,DUPIXENT | Oropharyngeal discomfort,2025-06-30/2025-07-06
252311992,25231199,,F,,20250809,,OLAPARIB,Neck pain,OT,OLAPARIB | Neck pain | OT,NaT
252323912,25232391,46,M,2025-01-01,20250927,,DUPIXENT,Retching,,DUPIXENT | Retching,2024-12-30/2025-01-05
252327992,25232799,84,F,,20250807,,METFORMIN\SITAGLIPTIN,Lactic acidosis,DE,METFORMIN\SITAGLIPTIN | Lactic acidosis | DE,NaT
252329105,25232910,41,F,2025-04-14,20250926,,FINTEPLA,Mitral valve incompetence,OT,FINTEPLA | Mitral valve incompetence | OT,2025-04-14/2025-04-20
252330663,25233066,,F,,20250809,,TEZEPELUMAB,Muscle tightness,OT,TEZEPELUMAB | Muscle tightness | OT,NaT
252332054,25233205,70,M,2025-05-01,20250822,,ORGOVYX,Fatigue,OT,ORGOVYX | Fatigue | OT,2025-04-28/2025-05-04
252345442,25234544,,F,,20250802,,OLAPARIB,Neuropathy peripheral,OT,OLAPARIB | Neuropathy peripheral | OT,NaT
252357392,25235739,,F,,20250723,,REBLOZYL,Gait disturbance,,REBLOZYL | Gait disturbance,NaT
252358162,25235816,33,M,2020-09-10,20250807,,TASIGNA,Cough,OT,TASIGNA | Cough | OT,2020-09-07/2020-09-13
252365272,25236527,47,F,,20250911,,IBRANCE,Eye irritation,OT,IBRANCE | Eye irritation | OT,NaT
252374092,25237409,8,M,,20250903,,VYLOY,Metastases to meninges,DE,VYLOY | Metastases to meninges | DE,NaT
252377632,25237763,,F,,20250827,,RYSTIGGO,Diplopia,,RYSTIGGO | Diplopia,NaT
252378513,25237851,,,2025-01-23,20250829,,USTEKINUMAB,Respiratory distress,OT,USTEKINUMAB | Respiratory distress | OT,2025-01-20/2025-01-26
252381322,25238132,,M,2025-04-23,20250802,,ACALABRUTINIB,Death,DE,ACALABRUTINIB | Death | DE,2025-04-21/2025-04-27
252394532,25239453,39,M,2023-05-08,20250717,,TRUVADA,Renal failure,OT,TRUVADA | Renal failure | OT,2023-05-08/2023-05-14
252398142,25239814,,M,,20250809,,ULTOMIRIS,Back disorder,OT,ULTOMIRIS | Back disorder | OT,NaT
252400856,25240085,13,F,,20250728,,GENOTROPIN,Device physical property issue,,GENOTROPIN | Device physical property issue,NaT
252404403,25240440,,F,,20250802,,BENRALIZUMAB,Antineutrophil cytoplasmic antibody positive,OT,BENRALIZUMAB | Antineutrophil cytoplasmic antibody positive | OT,NaT
252411582,25241158,86,F,2024-01-01,20250701,,TYLENOL 8 HR ARTHRITIS PAIN,Product packaging quantity issue,,TYLENOL 8 HR ARTHRITIS PAIN | Product packaging quantity issue,2024-01-01/2024-01-07
252412632,25241263,,F,,20250705,,KEYTRUDA,Tumour pseudoprogression,OT,KEYTRUDA | Tumour pseudoprogression | OT,NaT
252428112,25242811,,F,,20250802,,OSIMERTINIB,Bowel movement irregularity,OT,OSIMERTINIB | Bowel movement irregularity | OT,NaT
252429702,25242970,,F,2025-04-21,20250803,,LYNPARZA,Interstitial lung disease,HO,LYNPARZA | Interstitial lung disease | HO,2025-04-21/2025-04-27
252434752,25243475,77,F,2024-10-10,20250806,,OFEV,Asthenia,HO,OFEV | Asthenia | HO,2024-10-07/2024-10-13
252439332,25243933,,F,,20250803,,OSIMERTINIB,Asthenia,HO,OSIMERTINIB | Asthenia | HO,NaT
252440782,25244078,76,F,2025-03-18,20250802,,BENRALIZUMAB,Lower respiratory tract infection,OT,BENRALIZUMAB | Lower respiratory tract infection | OT,2025-03-17/2025-03-23
252458592,25245859,63,F,,20250810,,DAPAGLIFLOZIN,Viral infection,HO,DAPAGLIFLOZIN | Viral infection | HO,NaT
252485352,25248535,,F,2021-01-01,20250729,,IBUPROFEN,Asthenia,OT,IBUPROFEN | Asthenia | OT,2020-12-28/2021-01-03
252487392,25248739,79,F,,20250721,,ZEMAIRA,Pyrexia,OT,ZEMAIRA | Pyrexia | OT,NaT
252493982,25249398,89,F,,20250722,,METHOTREXATE,Lymphoproliferative disorder,HO,METHOTREXATE | Lymphoproliferative disorder | HO,NaT
252495372,25249537,30,F,,20250809,,FASENRA,Abortion spontaneous,OT,FASENRA | Abortion spontaneous | OT,NaT
252499892,25249989,,M,,20250802,,IMFINZI,Death,DE,IMFINZI | Death | DE,NaT
252502152,25250215,,M,,20250809,,BENRALIZUMAB,Dyspnoea,OT,BENRALIZUMAB | Dyspnoea | OT,NaT
252502804,25250280,,F,2025-01-01,20250812,,CERTOLIZUMAB PEGOL,Off label use,OT,CERTOLIZUMAB PEGOL | Off label use | OT,2024-12-30/2025-01-05
252507902,25250790,67,F,,20250809,,CILGAVIMAB\TIXAGEVIMAB,COVID-19 pneumonia,HO,CILGAVIMAB\TIXAGEVIMAB | COVID-19 pneumonia | HO,NaT
252512552,25251255,57,M,2023-12-14,20250728,,ATRIPLA,Vitamin D deficiency,,ATRIPLA | Vitamin D deficiency,2023-12-11/2023-12-17
252515673,25251567,47,F,2025-03-25,20250708,,FILSPARI,Abdominal pain upper,,FILSPARI | Abdominal pain upper,2025-03-24/2025-03-30
252530802,25253080,,,2025-04-10,20250731,,XDEMVY,Ocular hyperaemia,,XDEMVY | Ocular hyperaemia,2025-04-07/2025-04-13
252536345,25253634,75,M,2024-01-01,20250819,,ORGOVYX,Diarrhoea,HO,ORGOVYX | Diarrhoea | HO,2024-01-01/2024-01-07
252536385,25253638,,,,20250728,,ORGOVYX,Joint stiffness,OT,ORGOVYX | Joint stiffness | OT,NaT
252541382,25254138,,M,,20250810,,DAPAGLIFLOZIN,Cerebrovascular accident,OT,DAPAGLIFLOZIN | Cerebrovascular accident | OT,NaT
252544902,25254490,,F,,20250816,,SOLIRIS,Balance disorder,,SOLIRIS | Balance disorder,NaT
252556364,25255636,,,2024-05-19,20250905,,TIBSOVO,Nausea,HO,TIBSOVO | Nausea | HO,2024-05-13/2024-05-19
252561123,25256112,61,M,2025-04-02,20250813,,ORGOVYX,Arthralgia,,ORGOVYX | Arthralgia,2025-03-31/2025-04-06
252563323,25256332,,F,,20250903,,VEDOLIZUMAB,Crohn's disease,OT,VEDOLIZUMAB | Crohn's disease | OT,NaT
252573432,25257343,68,M,2025-01-01,20250708,,SKYRIZI,Vomiting,HO,SKYRIZI | Vomiting | HO,2024-12-30/2025-01-05
252580363,25258036,,F,,20250723,,KESIMPTA,Skin discolouration,OT,KESIMPTA | Skin discolouration | OT,NaT
252584402,25258440,95,F,2024-07-01,20250926,,ROSUVASTATIN,Muscle fatigue,HO,ROSUVASTATIN | Muscle fatigue | HO,2024-07-01/2024-07-07
252589154,25258915,82,F,2025-04-01,20250930,,LEQEMBI,Pneumonia klebsiella,HO,LEQEMBI | Pneumonia klebsiella | HO,2025-03-31/2025-04-06
252596744,25259674,,F,2024-01-01,20250818,,VIMPAT,Seizure,OT,VIMPAT | Seizure | OT,2024-01-01/2024-01-07
252598542,25259854,73,F,2025-04-24,20250803,,DURVALUMAB,Feeling of despair,OT,DURVALUMAB | Feeling of despair | OT,2025-04-21/2025-04-27
252602562,25260256,26,F,2025-04-01,20250821,,BIMZELX,Irritable bowel syndrome,OT,BIMZELX | Irritable bowel syndrome | OT,2025-03-31/2025-04-06
252603582,25260358,,F,,20250802,,OSIMERTINIB,Death,DE,OSIMERTINIB | Death | DE,NaT
252611872,25261187,69,M,2025-01-01,20250920,,POMALYST,Thrombosis,HO,POMALYST | Thrombosis | HO,2024-12-30/2025-01-05
252621364,25262136,81,M,2025-04-29,20250716,,PLUVICTO,Dehydration,HO,PLUVICTO | Dehydration | HO,2025-04-28/2025-05-04
252624962,25262496,74,M,2025-04-26,20250809,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2025-04-21/2025-04-27
252627713,25262771,86,F,2025-01-01,20250821,,MIEBO,Liquid product physical issue,,MIEBO | Liquid product physical issue,2024-12-30/2025-01-05
252631902,25263190,,M,,20250816,,CALQUENCE,Product dose omission issue,,CALQUENCE | Product dose omission issue,NaT
252637923,25263792,,,2025-04-01,20250813,,INFLECTRA,Condition aggravated,HO,INFLECTRA | Condition aggravated | HO,2025-03-31/2025-04-06
252643452,25264345,18,M,,20250822,,INVEGA SUSTENNA,"Hallucination, auditory",OT,"INVEGA SUSTENNA | Hallucination, auditory | OT",NaT
252649422,25264942,33,F,,20250809,,OSIMERTINIB,Metastases to pleura,DE,OSIMERTINIB | Metastases to pleura | DE,NaT
252662412,25266241,,F,,20250809,,ACALABRUTINIB,Malaise,HO,ACALABRUTINIB | Malaise | HO,NaT
252662893,25266289,65,F,,20250902,,REVLIMID,Diarrhoea,OT,REVLIMID | Diarrhoea | OT,NaT
252665565,25266556,59,M,2025-04-13,20250926,,TEZEPELUMAB,Coronary artery occlusion,HO,TEZEPELUMAB | Coronary artery occlusion | HO,2025-04-07/2025-04-13
252665702,25266570,79,F,,20250809,,DAPAGLIFLOZIN,Syncope,HO,DAPAGLIFLOZIN | Syncope | HO,NaT
252666022,25266602,,F,,20250809,,TEZEPELUMAB,Vomiting,HO,TEZEPELUMAB | Vomiting | HO,NaT
252666973,25266697,66,F,2025-05-23,20250809,,ANIFROLUMAB,Tooth fracture,OT,ANIFROLUMAB | Tooth fracture | OT,2025-05-19/2025-05-25
252668972,25266897,78,M,,20250810,,SOLIRIS,Urinary tract infection,,SOLIRIS | Urinary tract infection,NaT
252669202,25266920,,,,20250809,,TEZSPIRE,Product use issue,HO,TEZSPIRE | Product use issue | HO,NaT
252671103,25267110,,M,,20250902,,NUPLAZID,Gait disturbance,OT,NUPLAZID | Gait disturbance | OT,NaT
252671133,25267113,75,M,2025-03-30,20250904,,NUPLAZID,Memory impairment,HO,NUPLAZID | Memory impairment | HO,2025-03-24/2025-03-30
252673186,25267318,59,M,2025-05-02,20250826,,VONJO,Insomnia,,VONJO | Insomnia,2025-04-28/2025-05-04
252674042,25267404,22,M,2025-03-07,20250709,,CELLCEPT,Arthritis-dermatitis syndrome,HO,CELLCEPT | Arthritis-dermatitis syndrome | HO,2025-03-03/2025-03-09
252675542,25267554,,F,,20250809,,BENRALIZUMAB,Myocardial infarction,OT,BENRALIZUMAB | Myocardial infarction | OT,NaT
252680062,25268006,,F,,20250804,,FARXIGA,General physical health deterioration,OT,FARXIGA | General physical health deterioration | OT,NaT
252681292,25268129,8,M,2023-10-02,20250809,,DURVALUMAB,Immune-mediated myocarditis,DE,DURVALUMAB | Immune-mediated myocarditis | DE,2023-10-02/2023-10-08
252684603,25268460,74,M,2025-01-01,20250902,,DUPIXENT,Mycobacterium avium complex infection,OT,DUPIXENT | Mycobacterium avium complex infection | OT,2024-12-30/2025-01-05
252687502,25268750,51,F,2025-01-01,20250716,,XYREM,Nausea,OT,XYREM | Nausea | OT,2024-12-30/2025-01-05
252697013,25269701,71,F,2025-01-01,20250810,,TEZEPELUMAB,Upper-airway cough syndrome,OT,TEZEPELUMAB | Upper-airway cough syndrome | OT,2024-12-30/2025-01-05
252708622,25270862,,M,,20250809,,TEZEPELUMAB,Diabetes mellitus,OT,TEZEPELUMAB | Diabetes mellitus | OT,NaT
252721852,25272185,81,M,2025-02-01,20250803,,ACALABRUTINIB,Product dose omission issue,HO,ACALABRUTINIB | Product dose omission issue | HO,2025-01-27/2025-02-02
252721882,25272188,,F,,20250810,,OSIMERTINIB,Death,DE,OSIMERTINIB | Death | DE,NaT
252724533,25272453,75,M,,20250908,,VONJO,Product dose omission issue,HO,VONJO | Product dose omission issue | HO,NaT
252730102,25273010,,,,20250730,,ORGOVYX,Malaise,,ORGOVYX | Malaise,NaT
252740422,25274042,61,F,2025-04-22,20250806,,REVUFORJ,Platelet count decreased,,REVUFORJ | Platelet count decreased,2025-04-21/2025-04-27
252748203,25274820,,F,,20250710,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,NaT
252754743,25275474,70,M,2025-01-01,20250828,,RINVOQ,Joint dislocation,HO,RINVOQ | Joint dislocation | HO,2024-12-30/2025-01-05
252758492,25275849,,,2025-03-22,20250805,,VOWST,Diarrhoea,,VOWST | Diarrhoea,2025-03-17/2025-03-23
252767332,25276733,68,M,2025-03-11,20250803,,BRILINTA,Dyspnoea,HO,BRILINTA | Dyspnoea | HO,2025-03-10/2025-03-16
252769712,25276971,81,M,,20250820,,ORGOVYX,Feeling hot,,ORGOVYX | Feeling hot,NaT
252770542,25277054,,F,,20250816,,BREZTRI,Incorrect dose administered,,BREZTRI | Incorrect dose administered,NaT
252770722,25277072,69,F,2025-01-01,20250803,,PEMETREXED,Systemic scleroderma,HO,PEMETREXED | Systemic scleroderma | HO,2024-12-30/2025-01-05
252798643,25279864,83,F,,20250805,,LENALIDOMIDE,Product dose omission issue,,LENALIDOMIDE | Product dose omission issue,NaT
252802222,25280222,,F,,20250810,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Death,DE,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Death | DE,NaT
252805222,25280522,,M,,20250803,,IMFINZI,Haemophagocytic lymphohistiocytosis,DE,IMFINZI | Haemophagocytic lymphohistiocytosis | DE,NaT
252806182,25280618,,,,20250816,,TAGRISSO,Pneumonia,DE,TAGRISSO | Pneumonia | DE,NaT
252806803,25280680,,,2025-01-01,20250707,,INFLECTRA,Anaemia,OT,INFLECTRA | Anaemia | OT,2024-12-30/2025-01-05
252812985,25281298,79,M,2020-12-01,20250708,,THALIDOMIDE,IVth nerve paralysis,OT,THALIDOMIDE | IVth nerve paralysis | OT,2020-11-30/2020-12-06
252813142,25281314,47,M,,20250703,,QUETIAPINE,Drug ineffective,HO,QUETIAPINE | Drug ineffective | HO,NaT
252814093,25281409,,,2025-04-26,20250704,,REPATHA,Drug dose omission by device,,REPATHA | Drug dose omission by device,2025-04-21/2025-04-27
252814553,25281455,,F,,20250809,,BENRALIZUMAB,Hypersensitivity,OT,BENRALIZUMAB | Hypersensitivity | OT,NaT
252818733,25281873,,,,20250825,,TRASTUZUMAB,Headache,OT,TRASTUZUMAB | Headache | OT,NaT
252836633,25283663,,M,,20250918,,NOVOEIGHT,Joint swelling,HO,NOVOEIGHT | Joint swelling | HO,NaT
252848742,25284874,,,,20250816,,FASENRA,Oversensing,,FASENRA | Oversensing,NaT
252854372,25285437,65,M,2024-01-01,20250722,,RINVOQ,Spinal osteoarthritis,HO,RINVOQ | Spinal osteoarthritis | HO,2024-01-01/2024-01-07
252856632,25285663,,,,20250810,,DAPAGLIFLOZIN,Femur fracture,OT,DAPAGLIFLOZIN | Femur fracture | OT,NaT
252861262,25286126,,F,,20250803,,BENRALIZUMAB,Product dose omission issue,HO,BENRALIZUMAB | Product dose omission issue | HO,NaT
252862924,25286292,27,M,2025-03-10,20250813,,RILPIVIRINE,Injection site pain,OT,RILPIVIRINE | Injection site pain | OT,2025-03-10/2025-03-16
252862973,25286297,,F,,20250717,,XOLAIR,Decreased interest,,XOLAIR | Decreased interest,NaT
252864072,25286407,53,F,2025-04-22,20250806,,ULTOMIRIS,Death,DE,ULTOMIRIS | Death | DE,2025-04-21/2025-04-27
252877872,25287787,,M,,20250721,,DULOXETINE HYDROCHLORIDE,Contusion,,DULOXETINE HYDROCHLORIDE | Contusion,NaT
252879892,25287989,,,,20250708,,IMBRUVICA,Paroxysmal nocturnal haemoglobinuria,LT,IMBRUVICA | Paroxysmal nocturnal haemoglobinuria | LT,NaT
252879952,25287995,,F,,20250704,,CIMZIA,Rheumatoid arthritis,OT,CIMZIA | Rheumatoid arthritis | OT,NaT
252896432,25289643,57,F,2025-04-25,20250702,,CIPRO,Diverticulitis,HO,CIPRO | Diverticulitis | HO,2025-04-21/2025-04-27
252897274,25289727,73,F,,20250710,,LENALIDOMIDE,Diarrhoea,,LENALIDOMIDE | Diarrhoea,NaT
252899862,25289986,,M,,20250810,,BREZTRI,Product use issue,,BREZTRI | Product use issue,NaT
252900092,25290009,,F,,20250710,,KESIMPTA,Psoriasis,OT,KESIMPTA | Psoriasis | OT,NaT
252904902,25290490,,M,,20250803,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Neoplasm malignant,OT,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Neoplasm malignant | OT,NaT
252906842,25290684,80,F,2025-04-01,20250729,,JARDIANCE,Dehydration,OT,JARDIANCE | Dehydration | OT,2025-03-31/2025-04-06
252912322,25291232,65,F,2025-02-11,20250829,,DUPIXENT,Sinus headache,,DUPIXENT | Sinus headache,2025-02-10/2025-02-16
252913112,25291311,66,F,2025-01-01,20250727,,DUPIXENT,Discomfort,,DUPIXENT | Discomfort,2024-12-30/2025-01-05
252914002,25291400,16,F,2025-04-01,20250727,,DUPIXENT,Skin exfoliation,,DUPIXENT | Skin exfoliation,2025-03-31/2025-04-06
252928402,25292840,9,F,,20250716,,DUPIXENT,Injection site reaction,,DUPIXENT | Injection site reaction,NaT
252928992,25292899,61,M,2025-01-01,20250806,,DUPIXENT,Eosinophil count increased,,DUPIXENT | Eosinophil count increased,2024-12-30/2025-01-05
252934232,25293423,1,M,2025-04-01,20250909,,DUPIXENT,Eczema,,DUPIXENT | Eczema,2025-03-31/2025-04-06
252937682,25293768,17,M,2025-04-01,20250705,,DUPIXENT,Cough,,DUPIXENT | Cough,2025-03-31/2025-04-06
252949352,25294935,45,F,,20250825,,DUPIXENT,Cough,,DUPIXENT | Cough,NaT
252953402,25295340,15,M,,20250914,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,NaT
252957453,25295745,64,F,2025-01-01,20250904,,DUPIXENT,Injection site pruritus,,DUPIXENT | Injection site pruritus,2024-12-30/2025-01-05
252957764,25295776,80,F,2025-05-28,20250723,,DUPIXENT,Blister,,DUPIXENT | Blister,2025-05-26/2025-06-01
252959674,25295967,55,F,2025-01-01,20250808,,DUPIXENT,Therapeutic response shortened,,DUPIXENT | Therapeutic response shortened,2024-12-30/2025-01-05
252976373,25297637,22,,,20250912,,LORAZEPAM,Renal impairment,HO,LORAZEPAM | Renal impairment | HO,NaT
252986162,25298616,,F,,20250803,,ACALABRUTINIB,Death,DE,ACALABRUTINIB | Death | DE,NaT
252987522,25298752,,,2025-04-16,20250710,,ORITAVANCIN,Tachypnoea,HO,ORITAVANCIN | Tachypnoea | HO,2025-04-14/2025-04-20
252991082,25299108,63,F,2025-04-01,20250804,,SKYRIZI,Pain,OT,SKYRIZI | Pain | OT,2025-03-31/2025-04-06
252993002,25299300,,F,,20250803,,DURVALUMAB,Death,DE,DURVALUMAB | Death | DE,NaT
252994802,25299480,84,M,2024-08-19,20250810,,DURVALUMAB,Decreased appetite,OT,DURVALUMAB | Decreased appetite | OT,2024-08-19/2024-08-25
253000262,25300026,34,F,2025-01-01,20250804,,BERINERT,Mental disorder,HO,BERINERT | Mental disorder | HO,2024-12-30/2025-01-05
253005248,25300524,13,F,2025-04-22,20250717,,GENOTROPIN,Drug dose omission by device,,GENOTROPIN | Drug dose omission by device,2025-04-21/2025-04-27
253008632,25300863,57,,2025-05-02,20250816,,SYMBICORT,Device issue,,SYMBICORT | Device issue,2025-04-28/2025-05-04
253020672,25302067,61,F,2025-01-01,20250704,,RINVOQ,Psoriatic arthropathy,OT,RINVOQ | Psoriatic arthropathy | OT,2024-12-30/2025-01-05
253020872,25302087,,M,2025-03-16,20250810,,DAPAGLIFLOZIN,Cerebrovascular accident,OT,DAPAGLIFLOZIN | Cerebrovascular accident | OT,2025-03-10/2025-03-16
253025293,25302529,,F,,20250702,,LETROZOLE,Foetal exposure timing unspecified,OT,LETROZOLE | Foetal exposure timing unspecified | OT,NaT
253027072,25302707,,F,,20250810,,CALQUENCE,Malignant neoplasm progression,OT,CALQUENCE | Malignant neoplasm progression | OT,NaT
253037302,25303730,,F,,20250803,,OSIMERTINIB,Non-small cell lung cancer metastatic,OT,OSIMERTINIB | Non-small cell lung cancer metastatic | OT,NaT
253042852,25304285,,F,,20250716,,NUPLAZID,Ill-defined disorder,,NUPLAZID | Ill-defined disorder,NaT
253050282,25305028,12,M,2024-10-01,20250714,,SOMATROPIN,Angioedema,OT,SOMATROPIN | Angioedema | OT,2024-09-30/2024-10-06
253061253,25306125,,F,,20250720,,ALBUTEROL SULFATE,Drug ineffective,,ALBUTEROL SULFATE | Drug ineffective,NaT
253073684,25307368,70,M,2025-05-01,20250711,,RINVOQ,Rheumatoid arthritis,HO,RINVOQ | Rheumatoid arthritis | HO,2025-04-28/2025-05-04
253074452,25307445,,F,,20250810,,ULTOMIRIS,Muscular weakness,HO,ULTOMIRIS | Muscular weakness | HO,NaT
253076023,25307602,83,F,2025-02-01,20250909,,ORENCIA,Arthritis,,ORENCIA | Arthritis,2025-01-27/2025-02-02
253078705,25307870,54,F,2025-01-21,20250810,,LORLATINIB,Tinnitus,HO,LORLATINIB | Tinnitus | HO,2025-01-20/2025-01-26
253082734,25308273,78,F,2025-01-01,20250825,,DUPIXENT,Impaired quality of life,HO,DUPIXENT | Impaired quality of life | HO,2024-12-30/2025-01-05
253085323,25308532,76,F,2025-06-01,20250707,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2025-05-26/2025-06-01
253085412,25308541,61,M,2025-01-01,20250804,,DUPIXENT,Product dose omission in error,,DUPIXENT | Product dose omission in error,2024-12-30/2025-01-05
253087573,25308757,52,M,2025-01-01,20250801,,DUPIXENT,Paraesthesia,,DUPIXENT | Paraesthesia,2024-12-30/2025-01-05
253091865,25309186,65,M,,20250922,,ORGOVYX,Brain fog,,ORGOVYX | Brain fog,NaT
253100245,25310024,6,M,2025-04-01,20250717,,VYLOY,Nausea,OT,VYLOY | Nausea | OT,2025-03-31/2025-04-06
253103254,25310325,,F,,20250908,,DAYBUE,Expulsion of medication,,DAYBUE | Expulsion of medication,NaT
253107492,25310749,53,M,,20250926,,REVLIMID,Fatigue,,REVLIMID | Fatigue,NaT
253111164,25311116,61,F,2024-05-09,20250917,,COSENTYX,Skin cancer,OT,COSENTYX | Skin cancer | OT,2024-05-06/2024-05-12
253111223,25311122,,,,20250824,,ALBUTEROL SULFATE,No adverse event,,ALBUTEROL SULFATE | No adverse event,NaT
253113743,25311374,82,M,,20250918,,ORGOVYX,Therapy interrupted,,ORGOVYX | Therapy interrupted,NaT
253114222,25311422,,,,20250830,,ALBUTEROL SULFATE,Wrong technique in device usage process,,ALBUTEROL SULFATE | Wrong technique in device usage process,NaT
253115552,25311555,90,M,2025-01-01,20250820,,LEQVIO,Sleep disorder,OT,LEQVIO | Sleep disorder | OT,2024-12-30/2025-01-05
253118762,25311876,51,F,2025-06-01,20250807,,NUPLAZID,Tardive dyskinesia,OT,NUPLAZID | Tardive dyskinesia | OT,2025-05-26/2025-06-01
253128364,25312836,75,F,,20250710,,IBRANCE,Skin cancer,OT,IBRANCE | Skin cancer | OT,NaT
253138945,25313894,9,F,2025-05-01,20250811,,GENOTROPIN,Device physical property issue,,GENOTROPIN | Device physical property issue,2025-04-28/2025-05-04
253145832,25314583,,F,,20250820,,DEXAMETHASONE,Intentional product use issue,OT,DEXAMETHASONE | Intentional product use issue | OT,NaT
253149352,25314935,,F,,20250825,,DUPIXENT,Formication,,DUPIXENT | Formication,NaT
253149752,25314975,66,M,2025-05-01,20250703,,DUPIXENT,Vision blurred,,DUPIXENT | Vision blurred,2025-04-28/2025-05-04
253150412,25315041,22,M,2025-01-01,20250821,,DUPIXENT,Product dose omission in error,,DUPIXENT | Product dose omission in error,2024-12-30/2025-01-05
253158302,25315830,,M,,20250803,,TEZEPELUMAB,Infection,OT,TEZEPELUMAB | Infection | OT,NaT
253158962,25315896,,F,,20250809,,TEZEPELUMAB,Increased bronchial secretion,HO,TEZEPELUMAB | Increased bronchial secretion | HO,NaT
253172272,25317227,56,F,2024-07-30,20250818,,RINVOQ,Basal cell carcinoma,OT,RINVOQ | Basal cell carcinoma | OT,2024-07-29/2024-08-04
253172632,25317263,,F,,20250822,,TEDUGLUTIDE,Fluid retention,OT,TEDUGLUTIDE | Fluid retention | OT,NaT
253177253,25317725,,,2025-01-01,20250820,,SAJAZIR,Ureteric obstruction,HO,SAJAZIR | Ureteric obstruction | HO,2024-12-30/2025-01-05
253177535,25317753,46,M,2025-08-13,20250822,,COSENTYX,Product dose omission issue,,COSENTYX | Product dose omission issue,2025-08-11/2025-08-17
253183857,25318385,67,M,2025-04-16,20250929,,ADCETRIS,Enterovesical fistula,HO,ADCETRIS | Enterovesical fistula | HO,2025-04-14/2025-04-20
253187513,25318751,76,M,2024-10-08,20250930,,CEFIDEROCOL,Septic shock,DE,CEFIDEROCOL | Septic shock | DE,2024-10-07/2024-10-13
253190862,25319086,,F,,20250808,,ZURZUVAE,Sedation,,ZURZUVAE | Sedation,NaT
253191832,25319183,,F,,20250807,,ELAHERE,Neurotoxicity,OT,ELAHERE | Neurotoxicity | OT,NaT
253202333,25320233,,F,2025-04-01,20250821,,VOXZOGO,Post procedural fistula,OT,VOXZOGO | Post procedural fistula | OT,2025-03-31/2025-04-06
253204932,25320493,37,,2025-04-14,20250813,,OPDIVO,Therapy interrupted,HO,OPDIVO | Therapy interrupted | HO,2025-04-14/2025-04-20
253216152,25321615,,M,,20250803,,BENRALIZUMAB,Lower respiratory tract infection,OT,BENRALIZUMAB | Lower respiratory tract infection | OT,NaT
253222094,25322209,85,F,2024-01-01,20250911,,QINLOCK,Skin discolouration,,QINLOCK | Skin discolouration,2024-01-01/2024-01-07
253223073,25322307,40,M,2025-01-24,20250718,,ENSPRYNG,Neuromyelitis optica spectrum disorder,HO,ENSPRYNG | Neuromyelitis optica spectrum disorder | HO,2025-01-20/2025-01-26
253247562,25324756,67,M,,20250813,,TALVEY,Death,DE,TALVEY | Death | DE,NaT
253248965,25324896,,M,,20250716,,GENOTROPIN,Drug dose omission by device,,GENOTROPIN | Drug dose omission by device,NaT
253258974,25325897,40,F,2025-05-11,20250718,,ABRILADA,Device malfunction,,ABRILADA | Device malfunction,2025-05-05/2025-05-11
253262242,25326224,,,,20250818,,NEMLUVIO,Device malfunction,,NEMLUVIO | Device malfunction,NaT
253262942,25326294,,,2025-04-13,20250813,,NEMLUVIO,Intentional product use issue,,NEMLUVIO | Intentional product use issue,2025-04-07/2025-04-13
253274026,25327402,86,F,,20250910,,SITAGLIPTIN,Hyponatraemia,DS,SITAGLIPTIN | Hyponatraemia | DS,NaT
253284003,25328400,58,F,2025-01-01,20250926,,TREMFYA,Psoriatic arthropathy,OT,TREMFYA | Psoriatic arthropathy | OT,2024-12-30/2025-01-05
253285393,25328539,14,M,,20250731,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,NaT
253292582,25329258,52,F,2025-01-01,20250812,,RINVOQ,Pain,OT,RINVOQ | Pain | OT,2024-12-30/2025-01-05
253295392,25329539,86,F,,20250809,,DAPAGLIFLOZIN,Neoplasm malignant,DE,DAPAGLIFLOZIN | Neoplasm malignant | DE,NaT
253296882,25329688,40,F,,20250810,,DAPAGLIFLOZIN,Tuberculosis,HO,DAPAGLIFLOZIN | Tuberculosis | HO,NaT
253297602,25329760,76,F,2025-03-03,20250803,,TEZEPELUMAB,Fatigue,OT,TEZEPELUMAB | Fatigue | OT,2025-03-03/2025-03-09
253303222,25330322,84,F,2025-05-08,20250803,,DAPAGLIFLOZIN,Renal impairment,OT,DAPAGLIFLOZIN | Renal impairment | OT,2025-05-05/2025-05-11
253304773,25330477,67,F,2025-05-14,20250715,,VYLOY,Anaphylactic shock,OT,VYLOY | Anaphylactic shock | OT,2025-05-12/2025-05-18
253306282,25330628,,F,,20250704,,COSENTYX,Aphonia,,COSENTYX | Aphonia,NaT
253314322,25331432,69,M,,20250715,,ABRILADA,Hypoaesthesia,DE,ABRILADA | Hypoaesthesia | DE,NaT
253320222,25332022,79,F,,20250807,,TYVASO,Hypertension,,TYVASO | Hypertension,NaT
253323154,25332315,,M,,20250922,,FLUTICASONE PROPIONATE\SALMETEROL XINAFOATE,Product complaint,,FLUTICASONE PROPIONATE\SALMETEROL XINAFOATE | Product complaint,NaT
253342803,25334280,41,,,20250830,,ALBUTEROL SULFATE,Chest discomfort,,ALBUTEROL SULFATE | Chest discomfort,NaT
253354093,25335409,59,F,2025-04-18,20250809,,TAGRISSO,Myelosuppression,OT,TAGRISSO | Myelosuppression | OT,2025-04-14/2025-04-20
253355532,25335553,,,,20250910,,RITUXIMAB,Product use in unapproved indication,HO,RITUXIMAB | Product use in unapproved indication | HO,NaT
253357632,25335763,,,,20250703,,GUSELKUMAB,Device mechanical issue,,GUSELKUMAB | Device mechanical issue,NaT
253358872,25335887,,,2025-02-01,20250721,,OLMESARTAN MEDOXOMIL,Tendon rupture,OT,OLMESARTAN MEDOXOMIL | Tendon rupture | OT,2025-01-27/2025-02-02
253360622,25336062,,,2025-01-01,20250730,,FYCOMPA,Product use issue,OT,FYCOMPA | Product use issue | OT,2024-12-30/2025-01-05
253361316,25336131,9,F,,20250702,,GENOTROPIN,Device physical property issue,,GENOTROPIN | Device physical property issue,NaT
253363042,25336304,81,M,2024-01-10,20250701,,CIMZIA,Limb operation,OT,CIMZIA | Limb operation | OT,2024-01-08/2024-01-14
253363635,25336363,10,F,,20250710,,GENOTROPIN,Device use error,,GENOTROPIN | Device use error,NaT
253373993,25337399,59,M,2024-08-01,20250818,,OPDIVO,Immune-mediated lung disease,OT,OPDIVO | Immune-mediated lung disease | OT,2024-07-29/2024-08-04
253379443,25337944,68,,,20250702,,ORENCIA,Inability to afford medication,,ORENCIA | Inability to afford medication,NaT
253382793,25338279,,F,,20250810,,PULMICORT TURBUHALER,Dyspnoea,,PULMICORT TURBUHALER | Dyspnoea,NaT
253388032,25338803,67,M,,20250718,,LENALIDOMIDE,Product dose omission issue,OT,LENALIDOMIDE | Product dose omission issue | OT,NaT
253391202,25339120,,F,,20250826,,CREXONT,Tremor,,CREXONT | Tremor,NaT
253391624,25339162,76,F,2025-01-01,20250701,,CORTICOTROPIN,Dyspnoea,,CORTICOTROPIN | Dyspnoea,2024-12-30/2025-01-05
253392213,25339221,,F,,20250725,,KESIMPTA,Breast cancer,OT,KESIMPTA | Breast cancer | OT,NaT
253393392,25339339,,F,,20250813,,TICAGRELOR,Road traffic accident,DE,TICAGRELOR | Road traffic accident | DE,NaT
253395293,25339529,71,M,2025-01-01,20250818,,DUPIXENT,Haemorrhage,HO,DUPIXENT | Haemorrhage | HO,2024-12-30/2025-01-05
253395802,25339580,,M,,20250809,,DURVALUMAB,Death,OT,DURVALUMAB | Death | OT,NaT
253396323,25339632,,,2025-05-09,20250918,,USTEKINUMAB,Asthenia,OT,USTEKINUMAB | Asthenia | OT,2025-05-05/2025-05-11
253396502,25339650,,F,,20250810,,STRENSIQ,Blood potassium increased,OT,STRENSIQ | Blood potassium increased | OT,NaT
253397182,25339718,,F,,20250731,,GAMMAGARD LIQUID,Product use in unapproved indication,,GAMMAGARD LIQUID | Product use in unapproved indication,NaT
253403432,25340343,41,,,20250829,,ALBUTEROL SULFATE,Drug dose omission by device,,ALBUTEROL SULFATE | Drug dose omission by device,NaT
253405682,25340568,,F,,20250810,,BRILINTA,Atrial flutter,,BRILINTA | Atrial flutter,NaT
253408213,25340821,,,2025-06-01,20250801,,ORGOVYX,Hot flush,,ORGOVYX | Hot flush,2025-05-26/2025-06-01
253412556,25341255,48,F,2024-01-01,20250919,,METOPROLOL,Arrhythmia,OT,METOPROLOL | Arrhythmia | OT,2024-01-01/2024-01-07
253419925,25341992,62,M,,20250908,,LORBRENA,Metastases to spine,OT,LORBRENA | Metastases to spine | OT,NaT
253425562,25342556,7,M,2025-04-08,20250820,,TUMS,Gastroenteritis viral,,TUMS | Gastroenteritis viral,2025-04-07/2025-04-13
253432193,25343219,,F,,20250715,,GENOTROPIN,Drug dose omission by device,,GENOTROPIN | Drug dose omission by device,NaT
253444003,25344400,71,M,2025-05-09,20250810,,TAGRISSO,Decreased appetite,DE,TAGRISSO | Decreased appetite | DE,2025-05-05/2025-05-11
253446155,25344615,29,F,2025-04-29,20250815,,VIMIZIM,Pharyngeal inflammation,OT,VIMIZIM | Pharyngeal inflammation | OT,2025-04-28/2025-05-04
253452473,25345247,,,,20250721,,ORGOVYX,Limb discomfort,HO,ORGOVYX | Limb discomfort | HO,NaT
253453123,25345312,,M,2025-01-01,20250806,,VUMERITY,Diverticulitis,HO,VUMERITY | Diverticulitis | HO,2024-12-30/2025-01-05
253455382,25345538,8,F,,20250818,,OPDIVO,Post procedural complication,OT,OPDIVO | Post procedural complication | OT,NaT
253473003,25347300,82,F,2025-05-14,20250724,,FORTEO,Vomiting,DE,FORTEO | Vomiting | DE,2025-05-12/2025-05-18
253475103,25347510,75,M,2025-04-07,20250810,,DAPAGLIFLOZIN,Cerebral infarction,OT,DAPAGLIFLOZIN | Cerebral infarction | OT,2025-04-07/2025-04-13
253479794,25347979,74,F,2024-12-30,20250813,,FOSCARBIDOPA\FOSLEVODOPA,Toxic skin eruption,OT,FOSCARBIDOPA\FOSLEVODOPA | Toxic skin eruption | OT,2024-12-30/2025-01-05
253479836,25347983,14,F,2025-01-01,20250827,,ABRILADA,Axillary mass,HO,ABRILADA | Axillary mass | HO,2024-12-30/2025-01-05
253481442,25348144,53,M,,20250704,,LONSURF,Product administration error,HO,LONSURF | Product administration error | HO,NaT
253482872,25348287,36,F,2025-03-24,20250809,,DAPAGLIFLOZIN,Acidosis,OT,DAPAGLIFLOZIN | Acidosis | OT,2025-03-24/2025-03-30
253485622,25348562,30,M,2025-05-19,20250725,,TYSABRI,Chills,,TYSABRI | Chills,2025-05-19/2025-05-25
253491812,25349181,52,M,2025-01-01,20250730,,DUPIXENT,Epistaxis,,DUPIXENT | Epistaxis,2024-12-30/2025-01-05
253491822,25349182,10,M,2025-01-01,20250823,,DUPIXENT,Eczema,,DUPIXENT | Eczema,2024-12-30/2025-01-05
253496613,25349661,82,M,2025-05-01,20250821,,TEPMETKO,Renal impairment,OT,TEPMETKO | Renal impairment | OT,2025-04-28/2025-05-04
253503124,25350312,61,F,2025-01-01,20250923,,DUPIXENT,Fatigue,OT,DUPIXENT | Fatigue | OT,2024-12-30/2025-01-05
253511172,25351117,,,,20250905,,RITUXIMAB,Ventricular extrasystoles,OT,RITUXIMAB | Ventricular extrasystoles | OT,NaT
253518613,25351861,86,F,2025-01-01,20250815,,VENCLEXTA,Adverse drug reaction,HO,VENCLEXTA | Adverse drug reaction | HO,2024-12-30/2025-01-05
253526246,25352624,67,F,,20250827,,CLOPIDOGREL BISULFATE,Skin discolouration,LT,CLOPIDOGREL BISULFATE | Skin discolouration | LT,NaT
253530886,25353088,67,M,2025-06-01,20250807,,CORTICOTROPIN,Injection site pain,OT,CORTICOTROPIN | Injection site pain | OT,2025-05-26/2025-06-01
253534862,25353486,,F,,20250810,,ANIFROLUMAB,Fatigue,OT,ANIFROLUMAB | Fatigue | OT,NaT
253539502,25353950,10,F,2025-05-10,20250702,,DUPIXENT,Injection site rash,,DUPIXENT | Injection site rash,2025-05-05/2025-05-11
253539982,25353998,9,M,2025-04-18,20250723,,ALTUVIIIO,Haemorrhage,,ALTUVIIIO | Haemorrhage,2025-04-14/2025-04-20
253545012,25354501,4,F,,20250702,,PEMBROLIZUMAB,Malignant neoplasm progression,DE,PEMBROLIZUMAB | Malignant neoplasm progression | DE,NaT
253548032,25354803,,F,,20250915,,SKYRIZI,Skin cancer,OT,SKYRIZI | Skin cancer | OT,NaT
253562504,25356250,67,F,2024-12-02,20250723,,BIMEKIZUMAB,Blood pressure fluctuation,OT,BIMEKIZUMAB | Blood pressure fluctuation | OT,2024-12-02/2024-12-08
253564892,25356489,78,M,2025-05-13,20250810,,SYMBICORT,Device use issue,,SYMBICORT | Device use issue,2025-05-12/2025-05-18
253577362,25357736,56,F,2023-01-01,20250730,,DUPIXENT,Herpes zoster,,DUPIXENT | Herpes zoster,2022-12-26/2023-01-01
253578303,25357830,,F,,20250926,,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Plasma cell myeloma,OT,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN | Plasma cell myeloma | OT,NaT
253591593,25359159,68,M,2024-10-19,20250927,,CARFILZOMIB,Mucosal inflammation,HO,CARFILZOMIB | Mucosal inflammation | HO,2024-10-14/2024-10-20
253596422,25359642,68,M,,20250923,,LENALIDOMIDE,Diarrhoea,,LENALIDOMIDE | Diarrhoea,NaT
253601462,25360146,69,F,2024-11-01,20250717,,TECENTRIQ,Thyroid disorder,HO,TECENTRIQ | Thyroid disorder | HO,2024-10-28/2024-11-03
253602175,25360217,65,F,2025-04-01,20250726,,IMFINZI,Pyrexia,HO,IMFINZI | Pyrexia | HO,2025-03-31/2025-04-06
253607014,25360701,51,F,2022-01-01,20250809,,OLAPARIB,Haemoglobin decreased,HO,OLAPARIB | Haemoglobin decreased | HO,2021-12-27/2022-01-02
253612173,25361217,,M,,20250813,,VEDOLIZUMAB,Haematochezia,OT,VEDOLIZUMAB | Haematochezia | OT,NaT
253614922,25361492,,M,,20250809,,FASENRA,Colitis ulcerative,OT,FASENRA | Colitis ulcerative | OT,NaT
253618512,25361851,,F,2025-01-01,20250813,,HUMIRA,Palpitations,OT,HUMIRA | Palpitations | OT,2024-12-30/2025-01-05
253619492,25361949,,,,20250710,,RITUXIMAB,Myalgia,HO,RITUXIMAB | Myalgia | HO,NaT
253619533,25361953,56,F,2024-01-01,20250706,,ATORVASTATIN,Drug-disease interaction,OT,ATORVASTATIN | Drug-disease interaction | OT,2024-01-01/2024-01-07
253632082,25363208,60,F,,20250724,,ERBITUX,Eczema,OT,ERBITUX | Eczema | OT,NaT
253636023,25363602,5,M,2025-01-01,20250721,,NGENLA,Incorrect dose administered,,NGENLA | Incorrect dose administered,2024-12-30/2025-01-05
2536361311,25363613,10,F,2025-01-01,20250718,,GENOTROPIN,Poor quality product administered,,GENOTROPIN | Poor quality product administered,2024-12-30/2025-01-05
253636207,25363620,9,F,2025-05-08,20250903,,GENOTROPIN,Device use issue,,GENOTROPIN | Device use issue,2025-05-05/2025-05-11
253637072,25363707,,M,,20250802,,SOLIRIS,Thymoma malignant,DE,SOLIRIS | Thymoma malignant | DE,NaT
253637813,25363781,,M,,20250718,,GENOTROPIN,Device defective,,GENOTROPIN | Device defective,NaT
253638523,25363852,,M,2025-01-01,20250724,,TYVASO,Device breakage,HO,TYVASO | Device breakage | HO,2024-12-30/2025-01-05
253640922,25364092,,,,20250703,,ABREVA,Oral herpes,,ABREVA | Oral herpes,NaT
253641522,25364152,63,F,,20250809,,SOLIRIS,Sepsis,DE,SOLIRIS | Sepsis | DE,NaT
253649872,25364987,44,M,2025-05-01,20250904,,DUPIXENT,Dermatitis,,DUPIXENT | Dermatitis,2025-04-28/2025-05-04
253650292,25365029,,F,,20250704,,DUPIXENT,Exposure via skin contact,,DUPIXENT | Exposure via skin contact,NaT
253656852,25365685,86,M,,20250808,,LENALIDOMIDE,Cerebrovascular accident,OT,LENALIDOMIDE | Cerebrovascular accident | OT,NaT
253657142,25365714,,F,2025-05-01,20250803,,FULVESTRANT,Decreased activity,OT,FULVESTRANT | Decreased activity | OT,2025-04-28/2025-05-04
253661922,25366192,,,,20250731,,OMALIZUMAB,Angina pectoris,OT,OMALIZUMAB | Angina pectoris | OT,NaT
253662242,25366224,64,M,,20250731,,REVLIMID,Pulmonary embolism,OT,REVLIMID | Pulmonary embolism | OT,NaT
253666853,25366685,,F,2024-09-30,20250802,,FASENRA,Off label use,HO,FASENRA | Off label use | HO,2024-09-30/2024-10-06
253666872,25366687,,F,2025-03-28,20250810,,FASENRA,Deep vein thrombosis,OT,FASENRA | Deep vein thrombosis | OT,2025-03-24/2025-03-30
253667434,25366743,,,2025-04-27,20250809,,TAGRISSO,Product packaging quantity issue,OT,TAGRISSO | Product packaging quantity issue | OT,2025-04-21/2025-04-27
253676142,25367614,,,2025-04-04,20250827,,YUFLYMA,Device malfunction,,YUFLYMA | Device malfunction,2025-03-31/2025-04-06
253679162,25367916,74,F,2024-06-06,20250721,,RINVOQ,Knee arthroplasty,OT,RINVOQ | Knee arthroplasty | OT,2024-06-03/2024-06-09
253680255,25368025,44,F,2025-01-01,20250925,,IBRANCE,Cerebral haemorrhage,LT,IBRANCE | Cerebral haemorrhage | LT,2024-12-30/2025-01-05
253680383,25368038,,M,2025-05-27,20250905,,COSENTYX,Accidental exposure to product,,COSENTYX | Accidental exposure to product,2025-05-26/2025-06-01
253680612,25368061,,,,20250710,,ILARIS,Product temperature excursion issue,,ILARIS | Product temperature excursion issue,NaT
253688502,25368850,57,F,2025-01-27,20250709,,LITFULO,Rosacea,OT,LITFULO | Rosacea | OT,2025-01-27/2025-02-02
253689913,25368991,,,,20250829,,ALBUTEROL,Drug dose omission by device,,ALBUTEROL | Drug dose omission by device,NaT
253695373,25369537,71,M,,20250925,,LENALIDOMIDE,Foot fracture,OT,LENALIDOMIDE | Foot fracture | OT,NaT
253699054,25369905,,F,,20250714,,KISQALI,Decreased immune responsiveness,DE,KISQALI | Decreased immune responsiveness | DE,NaT
253704233,25370423,84,M,2025-07-05,20250804,,DUPIXENT,Death,DE,DUPIXENT | Death | DE,2025-06-30/2025-07-06
253706143,25370614,14,F,2025-03-02,20250805,,LANADELUMAB,Weight increased,OT,LANADELUMAB | Weight increased | OT,2025-02-24/2025-03-02
253706563,25370656,,F,,20250924,,ESTRADIOL,Device adhesion issue,,ESTRADIOL | Device adhesion issue,NaT
253707232,25370723,76,F,2025-05-19,20250803,,OLAPARIB,Arrhythmia,OT,OLAPARIB | Arrhythmia | OT,2025-05-19/2025-05-25
253709623,25370962,,M,,20250803,,DAPAGLIFLOZIN,Foot amputation,HO,DAPAGLIFLOZIN | Foot amputation | HO,NaT
253710032,25371003,,,2025-05-06,20250715,,IDOSE TR,Corneal oedema,,IDOSE TR | Corneal oedema,2025-05-05/2025-05-11
253714482,25371448,87,M,2025-05-23,20250702,,NUPLAZID,Sleep disorder,,NUPLAZID | Sleep disorder,2025-05-19/2025-05-25
253715022,25371502,,,,20250920,,PLUVICTO,General physical health deterioration,,PLUVICTO | General physical health deterioration,NaT
253718612,25371861,67,F,,20250825,,NIVOLUMAB,Peripheral T-cell lymphoma unspecified,OT,NIVOLUMAB | Peripheral T-cell lymphoma unspecified | OT,NaT
253719123,25371912,63,M,,20250827,,ORGOVYX,Depressed mood,OT,ORGOVYX | Depressed mood | OT,NaT
253719922,25371992,,F,,20250809,,DAPAGLIFLOZIN,Aortic stenosis,OT,DAPAGLIFLOZIN | Aortic stenosis | OT,NaT
253722722,25372272,,,,20250830,,ALBUTEROL SULFATE,Drug dose omission by device,,ALBUTEROL SULFATE | Drug dose omission by device,NaT
253726684,25372668,,M,2025-01-01,20250710,,TYVASO,Blood pressure increased,OT,TYVASO | Blood pressure increased | OT,2024-12-30/2025-01-05
253728722,25372872,70,F,2023-04-01,20250826,,HUMIRA,Pain,HO,HUMIRA | Pain | HO,2023-03-27/2023-04-02
253730892,25373089,,,2025-03-30,20250827,,YUFLYMA,Rhinorrhoea,,YUFLYMA | Rhinorrhoea,2025-03-24/2025-03-30
253745445,25374544,40,F,2025-01-01,20250818,,CERTOLIZUMAB PEGOL,Rheumatoid arthritis,OT,CERTOLIZUMAB PEGOL | Rheumatoid arthritis | OT,2024-12-30/2025-01-05
253746783,25374678,85,F,2025-04-19,20250708,,PAXLOVID,Hyperglycaemia,HO,PAXLOVID | Hyperglycaemia | HO,2025-04-14/2025-04-20
253759492,25375949,40,M,2025-01-01,20250811,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,2024-12-30/2025-01-05
253762572,25376257,68,M,2025-04-20,20250809,,ROSUVASTATIN,Renal impairment,HO,ROSUVASTATIN | Renal impairment | HO,2025-04-14/2025-04-20
2537628911,25376289,12,M,2025-05-26,20250928,,REMICADE,Crohn's disease,HO,REMICADE | Crohn's disease | HO,2025-05-26/2025-06-01
253781033,25378103,,F,,20250811,,SKYRIZI,Cardiac failure congestive,HO,SKYRIZI | Cardiac failure congestive | HO,NaT
253784972,25378497,73,F,2024-11-18,20250729,,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Asthma,OT,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN | Asthma | OT,2024-11-18/2024-11-24
253795182,25379518,6,F,2025-01-01,20250827,,KEYTRUDA,Neutrophil count decreased,HO,KEYTRUDA | Neutrophil count decreased | HO,2024-12-30/2025-01-05
253795812,25379581,65,F,,20250828,,ORENCIA,Illness,,ORENCIA | Illness,NaT
253800513,25380051,88,F,2025-05-15,20250701,,OXERVATE,Fall,HO,OXERVATE | Fall | HO,2025-05-12/2025-05-18
253802882,25380288,80,F,2025-01-01,20250910,,DUPIXENT,Tooth extraction,OT,DUPIXENT | Tooth extraction | OT,2024-12-30/2025-01-05
253804202,25380420,73,M,2025-01-01,20250911,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2024-12-30/2025-01-05
253804572,25380457,48,F,2025-01-01,20250714,,DUPIXENT,Inappropriate schedule of product administration,,DUPIXENT | Inappropriate schedule of product administration,2024-12-30/2025-01-05
253805132,25380513,15,M,2025-05-01,20250722,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2025-04-28/2025-05-04
253807292,25380729,69,F,,20250828,,ORENCIA,Adverse event,,ORENCIA | Adverse event,NaT
253834152,25383415,,,,20250708,,STELARA,Device defective,,STELARA | Device defective,NaT
253836152,25383615,52,F,2018-06-15,20250913,,OCREVUS,Migraine,HO,OCREVUS | Migraine | HO,2018-06-11/2018-06-17
253839342,25383934,27,M,,20250813,,CARBAMAZEPINE,Drug-induced liver injury,OT,CARBAMAZEPINE | Drug-induced liver injury | OT,NaT
253847895,25384789,,M,2025-01-01,20250721,,FRAGMIN,Needle issue,,FRAGMIN | Needle issue,2024-12-30/2025-01-05
253848103,25384810,15,M,2025-05-01,20250710,,GENOTROPIN,Device breakage,,GENOTROPIN | Device breakage,2025-04-28/2025-05-04
253853292,25385329,,M,,20250810,,IMFINZI,Death,DE,IMFINZI | Death | DE,NaT
253853562,25385356,58,F,,20250708,,TRAMADOL,Drug interaction,OT,TRAMADOL | Drug interaction | OT,NaT
253859822,25385982,53,F,,20250822,,METFORMIN,Drug reaction with eosinophilia and systemic symptoms,OT,METFORMIN | Drug reaction with eosinophilia and systemic symptoms | OT,NaT
253867162,25386716,45,F,2025-01-01,20250728,,DUPIXENT,Dry eye,,DUPIXENT | Dry eye,2024-12-30/2025-01-05
253867893,25386789,38,F,2025-01-01,20250725,,DUPIXENT,Hospitalisation,HO,DUPIXENT | Hospitalisation | HO,2024-12-30/2025-01-05
253874132,25387413,75,,,20250701,,LUTATHERA,Anaemia,DE,LUTATHERA | Anaemia | DE,NaT
253876142,25387614,,F,,20250809,,OLAPARIB,Pyrexia,OT,OLAPARIB | Pyrexia | OT,NaT
253876642,25387664,73,M,2025-01-01,20250717,,VENCLEXTA,Metabolic acidosis,DE,VENCLEXTA | Metabolic acidosis | DE,2024-12-30/2025-01-05
253880655,25388065,,F,2025-01-01,20250825,,CERTOLIZUMAB PEGOL,High risk pregnancy,OT,CERTOLIZUMAB PEGOL | High risk pregnancy | OT,2024-12-30/2025-01-05
253887162,25388716,59,M,,20250803,,BUDESONIDE\FORMOTEROL,Myocardial infarction,OT,BUDESONIDE\FORMOTEROL | Myocardial infarction | OT,NaT
253893162,25389316,,,,20250704,,NEULASTA,Device issue,,NEULASTA | Device issue,NaT
253896542,25389654,8,M,2025-05-22,20250714,,XOLAIR,Chest pain,,XOLAIR | Chest pain,2025-05-19/2025-05-25
253897343,25389734,65,,,20250723,,JAKAFI,Laboratory test abnormal,DE,JAKAFI | Laboratory test abnormal | DE,NaT
253899902,25389990,,F,2025-04-01,20250715,,ESTRADIOL,Wrong technique in product usage process,,ESTRADIOL | Wrong technique in product usage process,2025-03-31/2025-04-06
253902812,25390281,59,F,,20250728,,RUXIENCE,Systemic lupus erythematosus,OT,RUXIENCE | Systemic lupus erythematosus | OT,NaT
253902832,25390283,74,M,,20250714,,RITUXIMAB,Neutropenia,OT,RITUXIMAB | Neutropenia | OT,NaT
253903732,25390373,14,M,2025-05-28,20250708,,GENOTROPIN,Accidental exposure to product,,GENOTROPIN | Accidental exposure to product,2025-05-26/2025-06-01
253903742,25390374,61,,2025-05-29,20250702,,TREMFYA,Product dose omission issue,,TREMFYA | Product dose omission issue,2025-05-26/2025-06-01
253914803,25391480,24,F,2014-07-01,20250803,,SOLIRIS,Therapeutic response decreased,OT,SOLIRIS | Therapeutic response decreased | OT,2014-06-30/2014-07-06
253916622,25391662,,M,,20250701,,ZYRTEC,Accidental overdose,,ZYRTEC | Accidental overdose,NaT
253917212,25391721,,F,,20250809,,LYNPARZA,Renal impairment,OT,LYNPARZA | Renal impairment | OT,NaT
253917622,25391762,57,M,2025-02-21,20250803,,CRESTOR,Hepatic enzyme abnormal,HO,CRESTOR | Hepatic enzyme abnormal | HO,2025-02-17/2025-02-23
253919014,25391901,,F,,20250729,,GENOTROPIN,Device leakage,,GENOTROPIN | Device leakage,NaT
253925613,25392561,72,M,2025-01-01,20250805,,REZUROCK,Arthralgia,HO,REZUROCK | Arthralgia | HO,2024-12-30/2025-01-05
253926632,25392663,,F,,20250809,,DAPAGLIFLOZIN,Dementia,OT,DAPAGLIFLOZIN | Dementia | OT,NaT
253929072,25392907,77,F,2025-05-17,20250809,,OLAPARIB,Myelosuppression,OT,OLAPARIB | Myelosuppression | OT,2025-05-12/2025-05-18
253929762,25392976,,F,,20250809,,CAPIVASERTIB,Bone pain,OT,CAPIVASERTIB | Bone pain | OT,NaT
253932742,25393274,74,F,2023-06-27,20250722,,VICTOZA,Diarrhoea,HO,VICTOZA | Diarrhoea | HO,2023-06-26/2023-07-02
253933082,25393308,,F,,20250809,,OLAPARIB,Brain cancer metastatic,OT,OLAPARIB | Brain cancer metastatic | OT,NaT
253935553,25393555,,,2025-06-25,20250801,,ORGOVYX,Diarrhoea,,ORGOVYX | Diarrhoea,2025-06-23/2025-06-29
253939592,25393959,47,M,2024-09-27,20250709,,DABIGATRAN ETEXILATE MESYLATE,Aspartate aminotransferase increased,OT,DABIGATRAN ETEXILATE MESYLATE | Aspartate aminotransferase increased | OT,2024-09-23/2024-09-29
253945532,25394553,,F,,20250816,,BREZTRI,Glossodynia,,BREZTRI | Glossodynia,NaT
253949422,25394942,61,F,2025-04-01,20250929,,CIMZIA,Arthritis enteropathic,OT,CIMZIA | Arthritis enteropathic | OT,2025-03-31/2025-04-06
253951172,25395117,83,F,2024-10-06,20250911,,DONEPEZIL,Hyperbilirubinaemia,HO,DONEPEZIL | Hyperbilirubinaemia | HO,2024-09-30/2024-10-06
253952222,25395222,36,M,,20250812,,GUSELKUMAB,Injection site pain,,GUSELKUMAB | Injection site pain,NaT
253954402,25395440,,F,2025-01-01,20250722,,CIMZIA,Pyrexia,HO,CIMZIA | Pyrexia | HO,2024-12-30/2025-01-05
253955443,25395544,53,F,,20250903,,YERVOY,Death,DE,YERVOY | Death | DE,NaT
253956222,25395622,48,M,,20250701,,CYCLOSPORINE,Drug effective for unapproved indication,OT,CYCLOSPORINE | Drug effective for unapproved indication | OT,NaT
253958192,25395819,,M,,20250828,,SIMPONI,Infection,HO,SIMPONI | Infection | HO,NaT
253958643,25395864,64,M,,20250709,,OFEV,Complications of transplanted lung,OT,OFEV | Complications of transplanted lung | OT,NaT
253963363,25396336,84,M,2025-06-01,20250715,,VYNDAQEL,Cerebrovascular accident,OT,VYNDAQEL | Cerebrovascular accident | OT,2025-05-26/2025-06-01
253971963,25397196,,,2025-01-01,20250710,,SELINEXOR,Fatigue,,SELINEXOR | Fatigue,2024-12-30/2025-01-05
253979435,25397943,79,M,,20250821,,POMALYST,Pruritus,,POMALYST | Pruritus,NaT
253990342,25399034,,,,20250810,,BREZTRI,Asthma,,BREZTRI | Asthma,NaT
253991597,25399159,,M,2025-01-01,20250926,,TYVASO,Treatment noncompliance,HO,TYVASO | Treatment noncompliance | HO,2024-12-30/2025-01-05
253996702,25399670,54,F,,20250809,,LYNPARZA,Hyperchlorhydria,OT,LYNPARZA | Hyperchlorhydria | OT,NaT
253996774,25399677,,,,20250719,,INFLECTRA,Ulcer,HO,INFLECTRA | Ulcer | HO,NaT
253998313,25399831,,M,,20250702,,TREMFYA,Device leakage,,TREMFYA | Device leakage,NaT
253999664,25399966,60,M,2015-06-01,20250708,,VIREAD,Renal failure,OT,VIREAD | Renal failure | OT,2015-06-01/2015-06-07
254000013,25400001,,F,,20250701,,REVUFORJ,Hypoaesthesia,,REVUFORJ | Hypoaesthesia,NaT
254001766,25400176,24,M,2025-03-15,20250901,,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Fatigue,HO,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN | Fatigue | HO,2025-03-10/2025-03-16
254005422,25400542,,,,20250703,,COLUMVI,Off label use,OT,COLUMVI | Off label use | OT,NaT
254007722,25400772,72,F,2025-05-08,20250803,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2025-05-05/2025-05-11
254009632,25400963,56,M,2025-04-01,20250708,,CABENUVA,Viral mutation identified,,CABENUVA | Viral mutation identified,2025-03-31/2025-04-06
254010774,25401077,,M,,20250925,,CORTICOTROPIN,Fear of injection,,CORTICOTROPIN | Fear of injection,NaT
254011592,25401159,,F,,20250728,,GENOTROPIN,Device leakage,,GENOTROPIN | Device leakage,NaT
254015193,25401519,,F,,20250707,,CLOZAPINE,Pneumonia,HO,CLOZAPINE | Pneumonia | HO,NaT
254016612,25401661,,M,,20250809,,SYMBICORT,Asthma,OT,SYMBICORT | Asthma | OT,NaT
254018152,25401815,59,F,2025-01-01,20250924,,INLYTA,Arthralgia,,INLYTA | Arthralgia,2024-12-30/2025-01-05
254020414,25402041,,,,20250923,,PLUVICTO,General physical health deterioration,,PLUVICTO | General physical health deterioration,NaT
254020932,25402093,,M,,20250704,,TRELEGY ELLIPTA,Device use error,,TRELEGY ELLIPTA | Device use error,NaT
254022433,25402243,,M,,20250707,,NEUPRO,Product adhesion issue,,NEUPRO | Product adhesion issue,NaT
254024032,25402403,,M,,20250810,,SYMBICORT,Device malfunction,,SYMBICORT | Device malfunction,NaT
254025703,25402570,60,M,2025-05-16,20250821,,KESIMPTA,Musculoskeletal stiffness,OT,KESIMPTA | Musculoskeletal stiffness | OT,2025-05-12/2025-05-18
254030362,25403036,57,F,2025-01-01,20250828,,DUPIXENT,Drug hypersensitivity,,DUPIXENT | Drug hypersensitivity,2024-12-30/2025-01-05
254032012,25403201,67,M,2025-01-01,20250918,,DUPIXENT,Injection site discomfort,,DUPIXENT | Injection site discomfort,2024-12-30/2025-01-05
254036782,25403678,,,,20250715,,ELIGARD,Wrong technique in product usage process,,ELIGARD | Wrong technique in product usage process,NaT
254037833,25403783,71,F,2025-05-21,20250810,,SOLIRIS,Rash maculo-papular,,SOLIRIS | Rash maculo-papular,2025-05-19/2025-05-25
254042872,25404287,,M,,20250802,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,NaT
254044573,25404457,,,2024-01-01,20250730,,INFLECTRA,Cholelithiasis,OT,INFLECTRA | Cholelithiasis | OT,2024-01-01/2024-01-07
254047562,25404756,6,M,2025-04-05,20250818,,DUPIXENT,Vomiting,OT,DUPIXENT | Vomiting | OT,2025-03-31/2025-04-06
254052834,25405283,,,2025-05-18,20250731,,ORGOVYX,Hypoaesthesia,,ORGOVYX | Hypoaesthesia,2025-05-12/2025-05-18
254056543,25405654,65,F,2023-11-02,20250925,,POLATUZUMAB VEDOTIN,Agranulocytosis,HO,POLATUZUMAB VEDOTIN | Agranulocytosis | HO,2023-10-30/2023-11-05
254066472,25406647,9,,,20250904,,NIVOLUMAB,Immune-mediated lung disease,HO,NIVOLUMAB | Immune-mediated lung disease | HO,NaT
254070063,25407006,38,F,2025-05-01,20250729,,DIACOMIT,Off label use,OT,DIACOMIT | Off label use | OT,2025-04-28/2025-05-04
254074322,25407432,,,,20250729,,SIMPONI,Product dose omission issue,,SIMPONI | Product dose omission issue,NaT
254079172,25407917,,,,20250711,,TREMFYA,Needle issue,,TREMFYA | Needle issue,NaT
254081993,25408199,18,F,2025-01-01,20250819,,DUPIXENT,Rash,,DUPIXENT | Rash,2024-12-30/2025-01-05
254085012,25408501,65,F,,20250818,,MOUNJARO,Sarcopenia,HO,MOUNJARO | Sarcopenia | HO,NaT
254106342,25410634,77,M,2024-11-26,20250711,,EPKINLY,Cytokine release syndrome,OT,EPKINLY | Cytokine release syndrome | OT,2024-11-25/2024-12-01
254117056,25411705,83,F,2024-03-22,20250805,,OPSUMIT,Collagen disorder,DE,OPSUMIT | Collagen disorder | DE,2024-03-18/2024-03-24
254124482,25412448,,F,,20250716,,CORTICOTROPIN,Sensitivity to weather change,OT,CORTICOTROPIN | Sensitivity to weather change | OT,NaT
254127333,25412733,13,M,,20250710,,GENOTROPIN,Product prescribing error,,GENOTROPIN | Product prescribing error,NaT
254127355,25412735,16,M,2025-06-01,20250710,,GENOTROPIN,Device breakage,,GENOTROPIN | Device breakage,2025-05-26/2025-06-01
254134642,25413464,72,F,,20250728,,KISUNLA,Amyloid related imaging abnormality-oedema/effusion,OT,KISUNLA | Amyloid related imaging abnormality-oedema/effusion | OT,NaT
254135512,25413551,,M,,20250816,,TAGRISSO,Pruritus,OT,TAGRISSO | Pruritus | OT,NaT
254135922,25413592,,F,,20250810,,EPLONTERSEN SODIUM,Hiatus hernia,OT,EPLONTERSEN SODIUM | Hiatus hernia | OT,NaT
254137842,25413784,71,M,,20250723,,BREZTRI,Chronic obstructive pulmonary disease,,BREZTRI | Chronic obstructive pulmonary disease,NaT
254138662,25413866,30,M,,20250710,,ADCETRIS,Dermatitis contact,,ADCETRIS | Dermatitis contact,NaT
254141482,25414148,,F,2025-06-03,20250802,,ULTOMIRIS,Spinal cord disorder,DE,ULTOMIRIS | Spinal cord disorder | DE,2025-06-02/2025-06-08
254142614,25414261,59,F,,20250715,,SOMATROPIN,Product solubility abnormal,,SOMATROPIN | Product solubility abnormal,NaT
254143383,25414338,76,F,,20250723,,SOLIQUA 100/33,Wrong technique in device usage process,,SOLIQUA 100/33 | Wrong technique in device usage process,NaT
254144362,25414436,,,,20250710,,PLUVICTO,General physical health deterioration,,PLUVICTO | General physical health deterioration,NaT
254145563,25414556,1,F,2025-01-01,20250930,,DUPIXENT,Food allergy,,DUPIXENT | Food allergy,2024-12-30/2025-01-05
254150962,25415096,75,F,2025-06-01,20250716,,SIMPONI,Device issue,,SIMPONI | Device issue,2025-05-26/2025-06-01
254151172,25415117,53,M,2025-06-03,20250715,,STELARA,Device defective,,STELARA | Device defective,2025-06-02/2025-06-08
254156342,25415634,5,F,,20250905,,CABOMETYX,Liver disorder,OT,CABOMETYX | Liver disorder | OT,NaT
254161083,25416108,62,F,2025-06-03,20250806,,RITUXAN,Off label use,,RITUXAN | Off label use,2025-06-02/2025-06-08
254163352,25416335,43,F,2010-04-01,20250709,,TYSABRI,Headache,,TYSABRI | Headache,2010-03-29/2010-04-04
254163463,25416346,58,M,2025-01-01,20250704,,ENBREL,Accident,DS,ENBREL | Accident | DS,2024-12-30/2025-01-05
254166043,25416604,,F,,20250813,,AIRSUPRA,Memory impairment,,AIRSUPRA | Memory impairment,NaT
254169263,25416926,,M,,20250827,,AIRSUPRA,Device issue,,AIRSUPRA | Device issue,NaT
254180854,25418085,16,F,,20250716,,GENOTROPIN,Device breakage,,GENOTROPIN | Device breakage,NaT
254181522,25418152,85,M,,20250810,,CALQUENCE,Pleural effusion,OT,CALQUENCE | Pleural effusion | OT,NaT
254182633,25418263,39,F,2025-05-11,20250930,,VEDOLIZUMAB,Abdominal distension,OT,VEDOLIZUMAB | Abdominal distension | OT,2025-05-05/2025-05-11
254185133,25418513,33,F,2024-11-08,20250805,,VENCLEXTA,Bacterial sepsis,OT,VENCLEXTA | Bacterial sepsis | OT,2024-11-04/2024-11-10
254188412,25418841,,,,20250822,,FOSCAVIR,Death,DE,FOSCAVIR | Death | DE,NaT
254190464,25419046,19,M,,20250908,,GENOTROPIN,Drug dose omission by device,,GENOTROPIN | Drug dose omission by device,NaT
254192972,25419297,,M,2025-01-14,20250915,,CLOZARIL,Poor venous access,OT,CLOZARIL | Poor venous access | OT,2025-01-13/2025-01-19
254200962,25420096,,M,2025-04-11,20250903,,CARVYKTI,Cytokine release syndrome,HO,CARVYKTI | Cytokine release syndrome | HO,2025-04-07/2025-04-13
254201092,25420109,59,F,,20250805,,VERZENIO,Myalgia,,VERZENIO | Myalgia,NaT
254201552,25420155,,M,,20250802,,DAPAGLIFLOZIN,Throat clearing,OT,DAPAGLIFLOZIN | Throat clearing | OT,NaT
254207362,25420736,,,,20250707,,NOURIANZ,Tardive dyskinesia,OT,NOURIANZ | Tardive dyskinesia | OT,NaT
254207444,25420744,69,M,,20250904,,CREON,Coronary artery disease,DE,CREON | Coronary artery disease | DE,NaT
254209753,25420975,62,F,,20250701,,ZEPBOUND,Weight increased,,ZEPBOUND | Weight increased,NaT
254212884,25421288,,F,2025-01-01,20250924,,BIMZELX,Urinary tract infection,HO,BIMZELX | Urinary tract infection | HO,2024-12-30/2025-01-05
254216372,25421637,62,F,2025-01-01,20250729,,SKYRIZI,Abdominal adhesions,OT,SKYRIZI | Abdominal adhesions | OT,2024-12-30/2025-01-05
254216872,25421687,,F,2025-05-28,20250915,,METHOTREXATE,Pain in extremity,OT,METHOTREXATE | Pain in extremity | OT,2025-05-26/2025-06-01
254226202,25422620,,F,,20250717,,NUPLAZID,Parkinson's disease,DE,NUPLAZID | Parkinson's disease | DE,NaT
254227002,25422700,60,M,,20250724,,COSENTYX,Off label use,,COSENTYX | Off label use,NaT
254235242,25423524,14,M,2025-02-01,20250728,,TRULICITY,Hypertrophic cardiomyopathy,OT,TRULICITY | Hypertrophic cardiomyopathy | OT,2025-01-27/2025-02-02
254240292,25424029,,,2025-06-01,20250718,,PALOPEGTERIPARATIDE,Hypercalcaemia,HO,PALOPEGTERIPARATIDE | Hypercalcaemia | HO,2025-05-26/2025-06-01
254243192,25424319,22,F,2025-01-01,20250728,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2024-12-30/2025-01-05
254246782,25424678,65,F,,20250705,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
254251232,25425123,14,M,,20250711,,NGENLA,Injection site erythema,,NGENLA | Injection site erythema,NaT
254255853,25425585,8,M,2025-04-01,20250902,,LUMAKRAS,Non-small cell lung cancer,DE,LUMAKRAS | Non-small cell lung cancer | DE,2025-03-31/2025-04-06
254256182,25425618,,F,,20250809,,DAPAGLIFLOZIN,Cardiac failure congestive,OT,DAPAGLIFLOZIN | Cardiac failure congestive | OT,NaT
254263743,25426374,13,F,2025-05-09,20250721,,DAYBUE,Diarrhoea,,DAYBUE | Diarrhoea,2025-05-05/2025-05-11
254264993,25426499,68,M,2025-01-01,20250902,,DUPIXENT,Exposure via skin contact,OT,DUPIXENT | Exposure via skin contact | OT,2024-12-30/2025-01-05
254266672,25426667,74,F,2025-06-02,20250703,,ACTEMRA,Spinal operation,HO,ACTEMRA | Spinal operation | HO,2025-06-02/2025-06-08
254267355,25426735,,,2025-01-01,20250827,,INFLECTRA,Postoperative wound infection,HO,INFLECTRA | Postoperative wound infection | HO,2024-12-30/2025-01-05
254269392,25426939,,,,20250903,,EMICIZUMAB,Swelling,OT,EMICIZUMAB | Swelling | OT,NaT
254270484,25427048,41,F,2025-01-01,20250731,,SKYRIZI,Suicidal ideation,OT,SKYRIZI | Suicidal ideation | OT,2024-12-30/2025-01-05
254270622,25427062,71,M,,20250912,,ORGOVYX,Hot flush,DS,ORGOVYX | Hot flush | DS,NaT
254280932,25428093,82,M,2025-02-26,20250809,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2025-02-24/2025-03-02
254281532,25428153,34,F,2024-09-10,20250908,,QUTENZA,Abortion spontaneous,OT,QUTENZA | Abortion spontaneous | OT,2024-09-09/2024-09-15
254282534,25428253,63,M,2025-01-01,20250715,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2024-12-30/2025-01-05
254282775,25428277,,F,,20250923,,NUPLAZID,Therapeutic product effect decreased,OT,NUPLAZID | Therapeutic product effect decreased | OT,NaT
254282793,25428279,,,2025-04-19,20250730,,EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC,Chronic inflammatory demyelinating polyradiculoneuropathy,OT,EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC | Chronic inflammatory demyelinating polyradiculoneuropathy | OT,2025-04-14/2025-04-20
254296243,25429624,37,F,2025-05-17,20250718,,ULTOMIRIS,Leukopenia,OT,ULTOMIRIS | Leukopenia | OT,2025-05-12/2025-05-18
254301372,25430137,,,,20250819,,LACOSAMIDE,Foetal exposure during pregnancy,CA,LACOSAMIDE | Foetal exposure during pregnancy | CA,NaT
254303042,25430304,49,F,,20250728,,REVLIMID,Nausea,,REVLIMID | Nausea,NaT
254308302,25430830,,M,2024-01-01,20250809,,ULTOMIRIS,Lyme disease,OT,ULTOMIRIS | Lyme disease | OT,2024-01-01/2024-01-07
254310013,25431001,33,F,2024-01-01,20250709,,LEVONORGESTREL,Somnolence,,LEVONORGESTREL | Somnolence,2024-01-01/2024-01-07
254311812,25431181,,F,2025-06-06,20250803,,OSIMERTINIB,Death,DE,OSIMERTINIB | Death | DE,2025-06-02/2025-06-08
254314422,25431442,,M,,20250803,,TEZSPIRE,Infective exacerbation of asthma,OT,TEZSPIRE | Infective exacerbation of asthma | OT,NaT
254323273,25432327,21,M,2025-06-12,20250903,,TACROLIMUS,Rhinorrhoea,HO,TACROLIMUS | Rhinorrhoea | HO,2025-06-09/2025-06-15
254325262,25432526,67,F,2025-06-05,20250702,,RENFLEXIS,Infusion related hypersensitivity reaction,HO,RENFLEXIS | Infusion related hypersensitivity reaction | HO,2025-06-02/2025-06-08
254325813,25432581,63,F,2025-01-01,20250725,,KEVZARA,Catheterisation cardiac,HO,KEVZARA | Catheterisation cardiac | HO,2024-12-30/2025-01-05
254325832,25432583,72,M,2025-01-01,20250724,,XYWAV,Addison's disease,OT,XYWAV | Addison's disease | OT,2024-12-30/2025-01-05
254326954,25432695,81,M,2025-06-01,20250724,,NEULASTA,Device occlusion,,NEULASTA | Device occlusion,2025-05-26/2025-06-01
254328902,25432890,,M,,20250810,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Death,DE,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Death | DE,NaT
254329082,25432908,83,M,2024-08-12,20250924,,VIBEGRON,Mallory-Weiss syndrome,HO,VIBEGRON | Mallory-Weiss syndrome | HO,2024-08-12/2024-08-18
254333022,25433302,,F,,20250810,,BREZTRI,Device defective,,BREZTRI | Device defective,NaT
254341906,25434190,13,F,2025-06-08,20250903,,GENOTROPIN,Device delivery system issue,OT,GENOTROPIN | Device delivery system issue | OT,2025-06-02/2025-06-08
254345612,25434561,7,M,,20250829,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,NaT
254345672,25434567,69,M,2020-12-25,20250709,,BRIGATINIB,Alopecia,OT,BRIGATINIB | Alopecia | OT,2020-12-21/2020-12-27
254347442,25434744,79,F,2024-01-01,20250819,,DUPIXENT,Chronic obstructive pulmonary disease,,DUPIXENT | Chronic obstructive pulmonary disease,2024-01-01/2024-01-07
254351172,25435117,,,2025-05-01,20250730,,JOENJA,Pneumonia bacterial,OT,JOENJA | Pneumonia bacterial | OT,2025-04-28/2025-05-04
254352472,25435247,11,F,2023-03-01,20250702,,KITABIS PAK,Hospitalisation,HO,KITABIS PAK | Hospitalisation | HO,2023-02-27/2023-03-05
254354612,25435461,78,M,,20250803,,BENRALIZUMAB,Dyspnoea,HO,BENRALIZUMAB | Dyspnoea | HO,NaT
254355993,25435599,50,F,2025-06-03,20250716,,TREMFYA,Product dose omission issue,,TREMFYA | Product dose omission issue,2025-06-02/2025-06-08
254357182,25435718,54,M,,20250729,,RUXIENCE,Therapy non-responder,OT,RUXIENCE | Therapy non-responder | OT,NaT
254360982,25436098,,M,,20250802,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,NaT
254361213,25436121,,F,,20250701,,WINREVAIR,Nausea,HO,WINREVAIR | Nausea | HO,NaT
254363362,25436336,80,M,,20250711,,ALBUTEROL,Blood cholesterol increased,DE,ALBUTEROL | Blood cholesterol increased | DE,NaT
254364032,25436403,87,M,2025-04-12,20250803,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2025-04-07/2025-04-13
254364102,25436410,,,,20250810,,BREZTRI,Chronic obstructive pulmonary disease,,BREZTRI | Chronic obstructive pulmonary disease,NaT
254364342,25436434,59,F,2025-03-14,20250802,,BRILINTA,Burn oesophageal,HO,BRILINTA | Burn oesophageal | HO,2025-03-10/2025-03-16
254374823,25437482,7,M,,20250716,,VYLOY,Pulmonary toxicity,HO,VYLOY | Pulmonary toxicity | HO,NaT
254377382,25437738,19,,,20250829,,ALBUTEROL SULFATE,Device malfunction,,ALBUTEROL SULFATE | Device malfunction,NaT
254377463,25437746,7,F,2023-07-01,20250903,,SAIZEN,Osteonecrosis,HO,SAIZEN | Osteonecrosis | HO,2023-06-26/2023-07-02
254377752,25437775,17,F,2025-01-01,20250904,,DUPIXENT,Pyrexia,,DUPIXENT | Pyrexia,2024-12-30/2025-01-05
254395212,25439521,63,M,2025-06-10,20250803,,OSIMERTINIB,Palpitations,HO,OSIMERTINIB | Palpitations | HO,2025-06-09/2025-06-15
254395802,25439580,85,M,2025-01-01,20250820,,DUPIXENT,Condition aggravated,,DUPIXENT | Condition aggravated,2024-12-30/2025-01-05
254400675,25440067,15,M,2025-06-11,20250811,,GENOTROPIN,Device use error,,GENOTROPIN | Device use error,2025-06-09/2025-06-15
254400992,25440099,69,F,2024-01-01,20250722,,RUXIENCE,Urinary tract infection,HO,RUXIENCE | Urinary tract infection | HO,2024-01-01/2024-01-07
254401793,25440179,32,M,,20250730,,GENOTROPIN,Device use error,,GENOTROPIN | Device use error,NaT
254403343,25440334,80,F,2025-06-13,20250702,,ORENCIA,Device operational issue,,ORENCIA | Device operational issue,2025-06-09/2025-06-15
254418242,25441824,,F,2024-01-01,20250707,,ESTRADIOL TRANSDERMAL SYSTEM,Device adhesion issue,,ESTRADIOL TRANSDERMAL SYSTEM | Device adhesion issue,2024-01-01/2024-01-07
254418563,25441856,,F,,20250809,,ULTOMIRIS,Seizure,OT,ULTOMIRIS | Seizure | OT,NaT
254419703,25441970,77,F,2025-04-10,20250827,,ENHERTU,Staphylococcal bacteraemia,HO,ENHERTU | Staphylococcal bacteraemia | HO,2025-04-07/2025-04-13
254419842,25441984,50,F,2024-12-26,20250718,,ZOMETA,Aphthous ulcer,OT,ZOMETA | Aphthous ulcer | OT,2024-12-23/2024-12-29
254423233,25442323,50,F,2025-04-18,20250707,,RINVOQ,Klebsiella sepsis,HO,RINVOQ | Klebsiella sepsis | HO,2025-04-14/2025-04-20
254423253,25442325,57,F,2025-06-12,20250703,,CLOZARIL,Incorrect dose administered,HO,CLOZARIL | Incorrect dose administered | HO,2025-06-09/2025-06-15
254423472,25442347,,F,,20250707,,NUPLAZID,Parkinsonism,DE,NUPLAZID | Parkinsonism | DE,NaT
254428882,25442888,38,F,2025-06-06,20250826,,KESIMPTA,Hallucination,OT,KESIMPTA | Hallucination | OT,2025-06-02/2025-06-08
254438212,25443821,80,F,2025-07-12,20250723,,POLIVY,Death,DE,POLIVY | Death | DE,2025-07-07/2025-07-13
254443412,25444341,,F,2025-01-01,20250812,,BIMZELX,Drug ineffective,OT,BIMZELX | Drug ineffective | OT,2024-12-30/2025-01-05
254444294,25444429,64,M,2025-03-04,20250815,,REBLOZYL,Headache,DS,REBLOZYL | Headache | DS,2025-03-03/2025-03-09
254445593,25444559,76,F,2025-06-05,20250909,,ACALABRUTINIB,Pneumonia necrotising,HO,ACALABRUTINIB | Pneumonia necrotising | HO,2025-06-02/2025-06-08
254446792,25444679,,,,20250810,,SYMBICORT,Device issue,,SYMBICORT | Device issue,NaT
254449183,25444918,82,M,2025-05-21,20250912,,POMALYST,White blood cell count decreased,HO,POMALYST | White blood cell count decreased | HO,2025-05-19/2025-05-25
254454222,25445422,,,,20250803,,ULTOMIRIS,Myasthenia gravis,OT,ULTOMIRIS | Myasthenia gravis | OT,NaT
254454982,25445498,57,F,2025-05-18,20250826,,SPRAVATO,Depression,HO,SPRAVATO | Depression | HO,2025-05-12/2025-05-18
254458422,25445842,,M,,20250922,,RUXOLITINIB,Death,DE,RUXOLITINIB | Death | DE,NaT
254460532,25446053,,F,2025-01-01,20250723,,ELEXACAFTOR\IVACAFTOR\TEZACAFTOR,Intensive care,HO,ELEXACAFTOR\IVACAFTOR\TEZACAFTOR | Intensive care | HO,2024-12-30/2025-01-05
254461852,25446185,,F,2025-05-01,20250809,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2025-04-28/2025-05-04
254466342,25446634,50,F,,20250717,,DEXLANSOPRAZOLE,Gut fermentation syndrome,HO,DEXLANSOPRAZOLE | Gut fermentation syndrome | HO,NaT
254467808,25446780,8,M,2025-06-13,20250818,,GENOTROPIN,Device leakage,,GENOTROPIN | Device leakage,2025-06-09/2025-06-15
254468963,25446896,41,M,,20250718,,SOMAVERT,Device deposit issue,,SOMAVERT | Device deposit issue,NaT
254470503,25447050,,,,20250924,,ULTOMIRIS,Myasthenia gravis,OT,ULTOMIRIS | Myasthenia gravis | OT,NaT
254471602,25447160,70,M,2025-01-01,20250729,,PREDNISONE,Injection site erythema,,PREDNISONE | Injection site erythema,2024-12-30/2025-01-05
254472192,25447219,17,F,2025-01-01,20250824,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2024-12-30/2025-01-05
254474922,25447492,60,M,2025-06-11,20250703,,OTEZLA,Therapy non-responder,,OTEZLA | Therapy non-responder,2025-06-09/2025-06-15
254476123,25447612,80,M,2025-05-02,20250915,,DURVALUMAB,Colitis,HO,DURVALUMAB | Colitis | HO,2025-04-28/2025-05-04
254476483,25447648,,M,,20250901,,VEDOLIZUMAB,Pneumonia,OT,VEDOLIZUMAB | Pneumonia | OT,NaT
254477673,25447767,,F,,20250723,,ACTEMRA,Blister,CA,ACTEMRA | Blister | CA,NaT
254480313,25448031,50,M,2025-06-13,20250916,,ORENCIA,Wrong technique in product usage process,,ORENCIA | Wrong technique in product usage process,2025-06-09/2025-06-15
254484252,25448425,54,M,2025-01-01,20250905,,RINVOQ,Small intestinal resection,OT,RINVOQ | Small intestinal resection | OT,2024-12-30/2025-01-05
254487783,25448778,,F,,20250809,,DAPAGLIFLOZIN,Renal impairment,OT,DAPAGLIFLOZIN | Renal impairment | OT,NaT
254488602,25448860,82,M,2025-07-11,20250717,,LENALIDOMIDE,Neutropenia,OT,LENALIDOMIDE | Neutropenia | OT,2025-07-07/2025-07-13
254489713,25448971,,F,,20250828,,DAYBUE,Rhinovirus infection,HO,DAYBUE | Rhinovirus infection | HO,NaT
254493003,25449300,,M,2025-01-01,20250829,,TYVASO DPI,Therapy non-responder,,TYVASO DPI | Therapy non-responder,2024-12-30/2025-01-05
254495102,25449510,86,F,,20250812,,LENALIDOMIDE,Constipation,,LENALIDOMIDE | Constipation,NaT
254500282,25450028,,F,2025-01-01,20250704,,ORENITRAM,Abdominal distension,,ORENITRAM | Abdominal distension,2024-12-30/2025-01-05
254504013,25450401,60,M,2024-10-21,20250724,,BEVACIZUMAB,Off label use,OT,BEVACIZUMAB | Off label use | OT,2024-10-21/2024-10-27
254505482,25450548,,M,,20250821,,COSENTYX,Deafness unilateral,OT,COSENTYX | Deafness unilateral | OT,NaT
254511964,25451196,31,M,2025-06-16,20250918,,ADYNOVATE,Haemarthrosis,OT,ADYNOVATE | Haemarthrosis | OT,2025-06-16/2025-06-22
254513662,25451366,2,M,2025-01-01,20250803,,NIRSEVIMAB,Respiratory syncytial virus bronchiolitis,HO,NIRSEVIMAB | Respiratory syncytial virus bronchiolitis | HO,2024-12-30/2025-01-05
254517792,25451779,56,M,2025-01-01,20250712,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,2024-12-30/2025-01-05
254522352,25452235,84,M,2025-04-13,20250909,,KOVALTRY,Illness,HO,KOVALTRY | Illness | HO,2025-04-07/2025-04-13
254523952,25452395,88,F,,20250916,,ORENCIA,Visual impairment,,ORENCIA | Visual impairment,NaT
254529152,25452915,,M,2018-04-17,20250730,,LENVIMA,Hypertension,HO,LENVIMA | Hypertension | HO,2018-04-16/2018-04-22
254529522,25452952,6,F,2024-03-01,20250929,,KEYTRUDA,Hepatorenal failure,OT,KEYTRUDA | Hepatorenal failure | OT,2024-02-26/2024-03-03
254530762,25453076,,M,,20250808,,CORTICOTROPIN,Dizziness,,CORTICOTROPIN | Dizziness,NaT
254531224,25453122,85,M,2025-05-01,20250929,,PADCEV,Immune-mediated adrenal insufficiency,OT,PADCEV | Immune-mediated adrenal insufficiency | OT,2025-04-28/2025-05-04
254532632,25453263,7,F,,20250829,,DARBEPOETIN ALFA,Cardiac failure acute,DE,DARBEPOETIN ALFA | Cardiac failure acute | DE,NaT
254534552,25453455,53,F,2025-06-06,20250803,,OSIMERTINIB,Drug resistance,OT,OSIMERTINIB | Drug resistance | OT,2025-06-02/2025-06-08
254535472,25453547,89,,,20250809,,OSIMERTINIB,Movement disorder,OT,OSIMERTINIB | Movement disorder | OT,NaT
254536432,25453643,56,F,2024-12-01,20250724,,OZEMPIC,Hyperthyroidism,OT,OZEMPIC | Hyperthyroidism | OT,2024-11-25/2024-12-01
254537773,25453777,69,F,2025-06-11,20250722,,FASLODEX,Hyperglycaemia,LT,FASLODEX | Hyperglycaemia | LT,2025-06-09/2025-06-15
254538012,25453801,,M,,20250809,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,NaT
254538282,25453828,66,M,2023-07-27,20250719,,OPDIVO,Hyperkalaemia,DE,OPDIVO | Hyperkalaemia | DE,2023-07-24/2023-07-30
254540112,25454011,,,2024-01-01,20250703,,PEMBROLIZUMAB,Fibrosis,OT,PEMBROLIZUMAB | Fibrosis | OT,2024-01-01/2024-01-07
254541583,25454158,33,,,20250916,,ALBUTEROL SULFATE,Dyspnoea,,ALBUTEROL SULFATE | Dyspnoea,NaT
254551382,25455138,,F,,20250918,,LENALIDOMIDE,Product use issue,HO,LENALIDOMIDE | Product use issue | HO,NaT
254555092,25455509,89,,,20250922,,ALBUTEROL SULFATE,Choking sensation,,ALBUTEROL SULFATE | Choking sensation,NaT
254556882,25455688,,M,,20250708,,LUMIFY,Product complaint,,LUMIFY | Product complaint,NaT
254557022,25455702,83,M,2024-09-01,20250829,,OMEPRAZOLE,Urinary retention,HO,OMEPRAZOLE | Urinary retention | HO,2024-08-26/2024-09-01
254559653,25455965,80,F,2021-07-01,20250710,,LETROZOLE,Metastases to liver,OT,LETROZOLE | Metastases to liver | OT,2021-06-28/2021-07-04
254562053,25456205,86,F,2025-06-16,20250922,,KEYTRUDA,Neutropenia,HO,KEYTRUDA | Neutropenia | HO,2025-06-16/2025-06-22
254563312,25456331,,F,,20250802,,COSENTYX,Product distribution issue,,COSENTYX | Product distribution issue,NaT
254564104,25456410,76,F,2024-05-28,20250917,,REMICADE,Pneumonia fungal,LT,REMICADE | Pneumonia fungal | LT,2024-05-27/2024-06-02
254565122,25456512,14,F,2025-04-30,20250703,,INCRELEX,Seizure,HO,INCRELEX | Seizure | HO,2025-04-28/2025-05-04
254565452,25456545,38,F,,20250701,,INQOVI,Inappropriate schedule of product administration,,INQOVI | Inappropriate schedule of product administration,NaT
254568552,25456855,3,F,2025-01-01,20250728,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2024-12-30/2025-01-05
254571032,25457103,,F,,20250729,,DUPIXENT,Rash,,DUPIXENT | Rash,NaT
254572592,25457259,66,F,,20250704,,MOUNJARO,Drug ineffective,,MOUNJARO | Drug ineffective,NaT
254578464,25457846,64,F,2025-06-17,20250805,,ANIFROLUMAB,Hypertension,OT,ANIFROLUMAB | Hypertension | OT,2025-06-16/2025-06-22
254585362,25458536,75,M,,20250701,,DENOSUMAB,Metastases to bone,OT,DENOSUMAB | Metastases to bone | OT,NaT
254585413,25458541,,M,,20250920,,KESIMPTA,Injection site haemorrhage,,KESIMPTA | Injection site haemorrhage,NaT
254588552,25458855,7,M,,20250803,,DURVALUMAB,Colitis,HO,DURVALUMAB | Colitis | HO,NaT
254590862,25459086,57,M,2025-01-01,20250915,,DUPIXENT,Dyspnoea,,DUPIXENT | Dyspnoea,2024-12-30/2025-01-05
254591255,25459125,42,M,2025-06-26,20250806,,HEMLIBRA,Haemorrhage,,HEMLIBRA | Haemorrhage,2025-06-23/2025-06-29
254593312,25459331,5,F,2025-06-06,20250701,,BLINCYTO,Cytokine release syndrome,OT,BLINCYTO | Cytokine release syndrome | OT,2025-06-02/2025-06-08
254596913,25459691,,F,,20250905,,AIMOVIG,Abortion spontaneous,OT,AIMOVIG | Abortion spontaneous | OT,NaT
254599092,25459909,,,,20250730,,GUSELKUMAB,Needle issue,,GUSELKUMAB | Needle issue,NaT
254599493,25459949,,M,,20250721,,ACTEMRA,Malignant melanoma,OT,ACTEMRA | Malignant melanoma | OT,NaT
254602932,25460293,94,M,,20250908,,MINERALS\VITAMINS,Fatigue,,MINERALS\VITAMINS | Fatigue,NaT
254604382,25460438,,,2025-03-26,20250819,,XERMELO,Metastatic carcinoid tumour,DE,XERMELO | Metastatic carcinoid tumour | DE,2025-03-24/2025-03-30
254608863,25460886,20,F,2021-08-01,20250801,,KYMRIAH,B-cell aplasia,OT,KYMRIAH | B-cell aplasia | OT,2021-07-26/2021-08-01
254612342,25461234,,,,20250707,,SUBOXONE,Therapeutic response unexpected,OT,SUBOXONE | Therapeutic response unexpected | OT,NaT
254612512,25461251,,,,20250816,,TEZSPIRE,Asthma,,TEZSPIRE | Asthma,NaT
254612532,25461253,58,M,2025-05-05,20250705,,PREDNISONE,Enteritis,OT,PREDNISONE | Enteritis | OT,2025-05-05/2025-05-11
254614282,25461428,,,,20250803,,DURVALUMAB,Cholangitis,HO,DURVALUMAB | Cholangitis | HO,NaT
254624604,25462460,,,2025-01-01,20250929,,EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC,Injection site pruritus,HO,EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC | Injection site pruritus | HO,2024-12-30/2025-01-05
254625492,25462549,,F,2025-06-15,20250810,,ULTOMIRIS,Seizure,OT,ULTOMIRIS | Seizure | OT,2025-06-09/2025-06-15
254627403,25462740,20,F,,20250826,,EUCRISA,Drug ineffective,,EUCRISA | Drug ineffective,NaT
254627603,25462760,12,F,2025-05-23,20250715,,NEULASTA,Device malfunction,,NEULASTA | Device malfunction,2025-05-19/2025-05-25
254627713,25462771,53,M,,20250810,,TRAMADOL,Drug ineffective,OT,TRAMADOL | Drug ineffective | OT,NaT
254631232,25463123,,F,,20250810,,DAPAGLIFLOZIN,Vertigo,OT,DAPAGLIFLOZIN | Vertigo | OT,NaT
254634142,25463414,56,F,,20250728,,GUSELKUMAB,Incorrect dose administered by device,,GUSELKUMAB | Incorrect dose administered by device,NaT
254634543,25463454,62,F,2025-06-18,20250827,,FASENRA,Dyspnoea,,FASENRA | Dyspnoea,2025-06-16/2025-06-22
254636152,25463615,38,F,2024-07-29,20250828,,ERELZI,Phlebitis,HO,ERELZI | Phlebitis | HO,2024-07-29/2024-08-04
254636253,25463625,77,F,2023-01-04,20250904,,HUMAN IMMUNOGLOBULIN G,Urinary tract infection,OT,HUMAN IMMUNOGLOBULIN G | Urinary tract infection | OT,2023-01-02/2023-01-08
254636392,25463639,,F,2025-05-01,20250912,,EYLEA HD,Visual impairment,,EYLEA HD | Visual impairment,2025-04-28/2025-05-04
254636412,25463641,,F,,20250708,,CLOZARIL,Death,DE,CLOZARIL | Death | DE,NaT
254640582,25464058,,,,20250702,,XOSPATA,Full blood count decreased,HO,XOSPATA | Full blood count decreased | HO,NaT
254644343,25464434,34,F,,20250811,,JARDIANCE,Abdominal pain upper,OT,JARDIANCE | Abdominal pain upper | OT,NaT
254645652,25464565,,M,,20250810,,CALQUENCE,Nausea,,CALQUENCE | Nausea,NaT
254649822,25464982,61,F,2023-12-15,20250702,,IBUPROFEN,Lung adenocarcinoma stage IV,HO,IBUPROFEN | Lung adenocarcinoma stage IV | HO,2023-12-11/2023-12-17
254650452,25465045,80,M,2025-01-01,20250729,,ENZALUTAMIDE,Muscular weakness,DE,ENZALUTAMIDE | Muscular weakness | DE,2024-12-30/2025-01-05
254652272,25465227,77,M,2024-11-01,20250701,,ELIQUIS,Dyspnoea exertional,OT,ELIQUIS | Dyspnoea exertional | OT,2024-10-28/2024-11-03
254656742,25465674,,F,,20250822,,NUPLAZID,Product dose omission in error,,NUPLAZID | Product dose omission in error,NaT
254657662,25465766,,F,,20250718,,TECFIDERA,Thyroid disorder,,TECFIDERA | Thyroid disorder,NaT
254659533,25465953,57,M,2025-01-01,20250803,,IMFINZI,Non-small cell lung cancer recurrent,OT,IMFINZI | Non-small cell lung cancer recurrent | OT,2024-12-30/2025-01-05
254659972,25465997,84,M,2025-06-13,20250810,,TAGRISSO,Myelosuppression,LT,TAGRISSO | Myelosuppression | LT,2025-06-09/2025-06-15
254662542,25466254,64,M,,20250720,,CLONIDINE,Product packaging issue,,CLONIDINE | Product packaging issue,NaT
254663062,25466306,,F,,20250810,,TRUQAP,Rash,,TRUQAP | Rash,NaT
254666142,25466614,,F,,20250802,,DAPAGLIFLOZIN,Heart rate decreased,HO,DAPAGLIFLOZIN | Heart rate decreased | HO,NaT
254666872,25466687,47,F,,20250802,,SAPHNELO,Breast cancer,OT,SAPHNELO | Breast cancer | OT,NaT
254669172,25466917,,M,,20250903,,KESIMPTA,Fatigue,,KESIMPTA | Fatigue,NaT
254673182,25467318,67,F,2025-06-01,20250731,,VUMERITY,Red blood cell count decreased,HO,VUMERITY | Red blood cell count decreased | HO,2025-05-26/2025-06-01
254673652,25467365,50,F,,20250821,,POMALYST,Fatigue,,POMALYST | Fatigue,NaT
254673822,25467382,,M,,20250809,,DAPAGLIFLOZIN,Renal failure,HO,DAPAGLIFLOZIN | Renal failure | HO,NaT
254675003,25467500,57,F,,20250818,,MOUNJARO,Blood urea abnormal,,MOUNJARO | Blood urea abnormal,NaT
254675956,25467595,42,M,,20250917,,CABOMETYX,Clostridium difficile infection,HO,CABOMETYX | Clostridium difficile infection | HO,NaT
254686332,25468633,60,F,2025-01-01,20250929,,DUPIXENT,Eye pain,,DUPIXENT | Eye pain,2024-12-30/2025-01-05
254693252,25469325,,,,20250810,,BREZTRI,Dysphonia,,BREZTRI | Dysphonia,NaT
254697172,25469717,,M,,20250701,,MOUNJARO,Cardiac failure congestive,DE,MOUNJARO | Cardiac failure congestive | DE,NaT
254698672,25469867,43,F,,20250721,,CLOZAPINE,Road traffic accident,DE,CLOZAPINE | Road traffic accident | DE,NaT
254701782,25470178,47,F,2025-05-01,20250929,,SOTYKTU,Psoriasis,,SOTYKTU | Psoriasis,2025-04-28/2025-05-04
254706782,25470678,,F,,20250925,,ALBUTEROL SULFATE,Product complaint,,ALBUTEROL SULFATE | Product complaint,NaT
254707643,25470764,,F,,20250905,,TYSABRI,Immunosuppression,OT,TYSABRI | Immunosuppression | OT,NaT
254708042,25470804,68,F,2025-04-24,20250810,,IMFINZI,Paraneoplastic encephalomyelitis,DE,IMFINZI | Paraneoplastic encephalomyelitis | DE,2025-04-21/2025-04-27
254709042,25470904,73,M,2023-03-01,20250703,,METHYLPREDNISOLONE,Atypical mycobacterial pneumonia,LT,METHYLPREDNISOLONE | Atypical mycobacterial pneumonia | LT,2023-02-27/2023-03-05
254710512,25471051,59,F,2025-06-01,20250720,,HUMIRA,Stomatitis,HO,HUMIRA | Stomatitis | HO,2025-05-26/2025-06-01
254712492,25471249,,M,,20250703,,ELIGARD,Wrong technique in product usage process,,ELIGARD | Wrong technique in product usage process,NaT
254713162,25471316,66,F,2025-05-01,20250701,,SKYRIZI,Pain in extremity,HO,SKYRIZI | Pain in extremity | HO,2025-04-28/2025-05-04
254718392,25471839,71,M,,20250726,,ELIGARD,Intercepted product administration error,,ELIGARD | Intercepted product administration error,NaT
254721087,25472108,,M,,20250822,,NUPLAZID,Limb injury,OT,NUPLAZID | Limb injury | OT,NaT
254722382,25472238,,F,,20250807,,GLIPIZIDE,Drug ineffective,,GLIPIZIDE | Drug ineffective,NaT
254723072,25472307,83,M,2025-05-05,20250808,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2025-05-05/2025-05-11
254724372,25472437,75,F,2025-02-25,20250724,,ABALOPARATIDE,Anaphylactic shock,OT,ABALOPARATIDE | Anaphylactic shock | OT,2025-02-24/2025-03-02
254725294,25472529,65,M,2025-03-01,20250821,,CISPLATIN,Neutropenia,HO,CISPLATIN | Neutropenia | HO,2025-02-24/2025-03-02
254727033,25472703,73,M,,20250923,,ORGOVYX,Blood glucose increased,,ORGOVYX | Blood glucose increased,NaT
254728372,25472837,,,,20250923,,INVEGA,Drug ineffective,,INVEGA | Drug ineffective,NaT
254728392,25472839,52,F,2025-03-06,20250819,,DOCETAXEL,Device related infection,HO,DOCETAXEL | Device related infection | HO,2025-03-03/2025-03-09
254731872,25473187,,F,2025-05-29,20250802,,IMFINZI,Death,DE,IMFINZI | Death | DE,2025-05-26/2025-06-01
254734295,25473429,6,M,,20250923,,GENOTROPIN,Device mechanical issue,,GENOTROPIN | Device mechanical issue,NaT
254735044,25473504,12,M,,20250724,,GENOTROPIN,Device mechanical issue,,GENOTROPIN | Device mechanical issue,NaT
254736383,25473638,23,M,,20250701,,VELSIPITY,Drug ineffective,,VELSIPITY | Drug ineffective,NaT
254743032,25474303,43,M,2025-06-13,20250801,,NEULASTA,Device adhesion issue,,NEULASTA | Device adhesion issue,2025-06-09/2025-06-15
254744562,25474456,,M,,20250802,,DAPAGLIFLOZIN,Confusional state,OT,DAPAGLIFLOZIN | Confusional state | OT,NaT
254744582,25474458,,,,20250701,,MENS ROGAINE EXTRA STRENGTH,Drug ineffective,,MENS ROGAINE EXTRA STRENGTH | Drug ineffective,NaT
254745872,25474587,28,M,2025-01-01,20250812,,DUPIXENT,Dysphagia,,DUPIXENT | Dysphagia,2024-12-30/2025-01-05
254746172,25474617,75,M,2025-01-01,20250721,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2024-12-30/2025-01-05
254750223,25475022,,M,,20250711,,VEDOLIZUMAB,Haematochezia,OT,VEDOLIZUMAB | Haematochezia | OT,NaT
254751274,25475127,43,M,,20250729,,PACLITAXEL,Therapy partial responder,OT,PACLITAXEL | Therapy partial responder | OT,NaT
254752482,25475248,47,F,2020-01-01,20250904,,ACETAMINOPHEN,Refusal of treatment by patient,OT,ACETAMINOPHEN | Refusal of treatment by patient | OT,2019-12-30/2020-01-05
254759002,25475900,55,M,,20250902,,CITALOPRAM,Loss of personal independence in daily activities,HO,CITALOPRAM | Loss of personal independence in daily activities | HO,NaT
254760532,25476053,81,M,,20250722,,DAPRODUSTAT,Disease progression,HO,DAPRODUSTAT | Disease progression | HO,NaT
254765034,25476503,61,F,2025-06-11,20250827,,AIRSUPRA,Device use issue,,AIRSUPRA | Device use issue,2025-06-09/2025-06-15
254768052,25476805,,F,2025-01-01,20250810,,BREZTRI,Device delivery system issue,,BREZTRI | Device delivery system issue,2024-12-30/2025-01-05
254768162,25476816,,,2025-04-18,20250912,,CRYSVITA,Abdominal distension,,CRYSVITA | Abdominal distension,2025-04-14/2025-04-20
254768332,25476833,70,M,2024-12-31,20250710,,CARBOPLATIN,Encephalitis autoimmune,HO,CARBOPLATIN | Encephalitis autoimmune | HO,2024-12-30/2025-01-05
254768934,25476893,53,M,,20250729,,AZITHROMYCIN,Infection in an immunocompromised host,HO,AZITHROMYCIN | Infection in an immunocompromised host | HO,NaT
254770999,25477099,74,M,2025-07-08,20250923,,NUPLAZID,Parkinson's disease,HO,NUPLAZID | Parkinson's disease | HO,2025-07-07/2025-07-13
254772282,25477228,81,F,2025-06-14,20250803,,DAPAGLIFLOZIN,Peripheral swelling,DS,DAPAGLIFLOZIN | Peripheral swelling | DS,2025-06-09/2025-06-15
254774773,25477477,79,F,,20250810,,BENRALIZUMAB,Hernia,OT,BENRALIZUMAB | Hernia | OT,NaT
254775002,25477500,36,F,2025-05-09,20250803,,CRESTOR,Pancytopenia,HO,CRESTOR | Pancytopenia | HO,2025-05-05/2025-05-11
254775472,25477547,49,F,2025-04-07,20250902,,SKYRIZI,Oestrogen receptor assay positive,OT,SKYRIZI | Oestrogen receptor assay positive | OT,2025-04-07/2025-04-13
254776813,25477681,72,M,,20250804,,DAPAGLIFLOZIN,Ventricular fibrillation,DE,DAPAGLIFLOZIN | Ventricular fibrillation | DE,NaT
254777254,25477725,69,F,2025-06-19,20250912,,RISANKIZUMAB,Chronic myeloid leukaemia,OT,RISANKIZUMAB | Chronic myeloid leukaemia | OT,2025-06-16/2025-06-22
254779562,25477956,46,M,,20250813,,MYCOPHENOLATE MOFETIL,Leukopenia,HO,MYCOPHENOLATE MOFETIL | Leukopenia | HO,NaT
254784272,25478427,56,M,,20250801,,FUROSEMIDE,Drug ineffective,OT,FUROSEMIDE | Drug ineffective | OT,NaT
254784562,25478456,,F,2025-01-01,20250731,,ESTRADIOL TRANSDERMAL SYSTEM,Product adhesion issue,,ESTRADIOL TRANSDERMAL SYSTEM | Product adhesion issue,2024-12-30/2025-01-05
254786082,25478608,68,,,20250709,,BRUKINSA,Hypokalaemia,HO,BRUKINSA | Hypokalaemia | HO,NaT
254791452,25479145,18,F,2025-06-07,20250708,,DOTAREM,Vision blurred,OT,DOTAREM | Vision blurred | OT,2025-06-02/2025-06-08
254792132,25479213,,M,,20250704,,CALCIUM CHLORIDE\DEXTROSE\MAGNESIUM CHLORIDE\SODIUM CHLORIDE,Peritonitis bacterial,OT,CALCIUM CHLORIDE\DEXTROSE\MAGNESIUM CHLORIDE\SODIUM CHLORIDE | Peritonitis bacterial | OT,NaT
254793952,25479395,43,F,,20250813,,ARAVA,Prescribed underdose,DE,ARAVA | Prescribed underdose | DE,NaT
254794892,25479489,,F,2025-01-01,20250917,,DUPIXENT,Pain,,DUPIXENT | Pain,2024-12-30/2025-01-05
254796203,25479620,84,M,2025-06-01,20250715,,DUPIXENT,Balance disorder,HO,DUPIXENT | Balance disorder | HO,2025-05-26/2025-06-01
254801282,25480128,77,F,2025-05-01,20250731,,OZEMPIC,Muscular weakness,,OZEMPIC | Muscular weakness,2025-04-28/2025-05-04
254803792,25480379,14,F,,20250806,,CYTARABINE,Febrile neutropenia,LT,CYTARABINE | Febrile neutropenia | LT,NaT
254813002,25481300,16,M,2022-06-01,20250701,,SERTRALINE,Palpitations,HO,SERTRALINE | Palpitations | HO,2022-05-30/2022-06-05
254815302,25481530,51,F,2025-04-06,20250711,,OZEMPIC,Vitreous floaters,OT,OZEMPIC | Vitreous floaters | OT,2025-03-31/2025-04-06
254816662,25481666,,,,20250922,,MEDROXYPROGESTERONE ACETATE,Product quality issue,,MEDROXYPROGESTERONE ACETATE | Product quality issue,NaT
254819452,25481945,,F,,20250715,,TREPROSTINIL,Dizziness,OT,TREPROSTINIL | Dizziness | OT,NaT
254821465,25482146,12,F,2025-05-01,20250916,,WEGOVY,Loss of consciousness,OT,WEGOVY | Loss of consciousness | OT,2025-04-28/2025-05-04
254823133,25482313,31,,,20250911,,KAITLIB FE,Headache,,KAITLIB FE | Headache,NaT
254826672,25482667,,,,20250711,,LUTATHERA,Product administration interrupted,OT,LUTATHERA | Product administration interrupted | OT,NaT
254827212,25482721,80,M,,20250716,,AZATHIOPRINE,Hypoxia,HO,AZATHIOPRINE | Hypoxia | HO,NaT
254827752,25482775,,M,,20250722,,NUPLAZID,Product use in unapproved indication,,NUPLAZID | Product use in unapproved indication,NaT
254829002,25482900,,F,,20250829,,NUPLAZID,Therapeutic product effect incomplete,OT,NUPLAZID | Therapeutic product effect incomplete | OT,NaT
254830352,25483035,23,M,2025-04-24,20250710,,ADEMPAS,Cardiac operation,HO,ADEMPAS | Cardiac operation | HO,2025-04-21/2025-04-27
254833533,25483353,54,F,,20250708,,LYTGOBI,Nephrolithiasis,OT,LYTGOBI | Nephrolithiasis | OT,NaT
254834586,25483458,14,M,,20250918,,GENOTROPIN,Drug dose omission by device,,GENOTROPIN | Drug dose omission by device,NaT
254835612,25483561,66,M,,20250715,,OLANZAPINE,Febrile neutropenia,OT,OLANZAPINE | Febrile neutropenia | OT,NaT
254835942,25483594,76,F,2025-06-21,20250701,,REPATHA,Drug dose omission by device,,REPATHA | Drug dose omission by device,2025-06-16/2025-06-22
254839643,25483964,77,M,2025-03-22,20250731,,ELIQUIS,Fall,DS,ELIQUIS | Fall | DS,2025-03-17/2025-03-23
254840842,25484084,76,F,,20250717,,ZEMAIRA,Illness,,ZEMAIRA | Illness,NaT
254842132,25484213,22,M,2025-05-01,20250819,,DUPIXENT,Intentional product misuse,,DUPIXENT | Intentional product misuse,2025-04-28/2025-05-04
254844162,25484416,,F,,20250918,,REMICADE,Infusion related reaction,OT,REMICADE | Infusion related reaction | OT,NaT
254853153,25485315,,,,20250806,,EPINEPHRINE,Product colour issue,,EPINEPHRINE | Product colour issue,NaT
254853492,25485349,,,,20250721,,MYCOPHENOLATE MOFETIL,Venoocclusive liver disease,DE,MYCOPHENOLATE MOFETIL | Venoocclusive liver disease | DE,NaT
254854552,25485455,73,M,2025-05-26,20250728,,VYLOY,Bacillus infection,HO,VYLOY | Bacillus infection | HO,2025-05-26/2025-06-01
254855362,25485536,54,M,,20250819,,ATORVASTATIN,Supraventricular tachycardia,LT,ATORVASTATIN | Supraventricular tachycardia | LT,NaT
254856202,25485620,86,M,2024-01-01,20250702,,KEYTRUDA,Hypothyroidism,OT,KEYTRUDA | Hypothyroidism | OT,2024-01-01/2024-01-07
254862732,25486273,65,M,2025-05-05,20250716,,NECITUMUMAB,Pneumonia,DE,NECITUMUMAB | Pneumonia | DE,2025-05-05/2025-05-11
254865033,25486503,87,M,2025-06-01,20250916,,OZEMPIC,Wrong technique in product usage process,HO,OZEMPIC | Wrong technique in product usage process | HO,2025-05-26/2025-06-01
254865914,25486591,62,F,,20250730,,SPIRONOLACTONE,Central serous chorioretinopathy,OT,SPIRONOLACTONE | Central serous chorioretinopathy | OT,NaT
254867896,25486789,79,M,,20250807,,AMOXICILLIN\CLAVULANIC ACID,Blood alkaline phosphatase increased,OT,AMOXICILLIN\CLAVULANIC ACID | Blood alkaline phosphatase increased | OT,NaT
254871352,25487135,1,M,2025-06-01,20250706,,FLECAINIDE,Metabolic acidosis,OT,FLECAINIDE | Metabolic acidosis | OT,2025-05-26/2025-06-01
254872492,25487249,93,M,,20250714,,DAPRODUSTAT,Anaemia,OT,DAPRODUSTAT | Anaemia | OT,NaT
254873242,25487324,67,,,20250922,,ALBUTEROL SULFATE,Drug dose omission by device,,ALBUTEROL SULFATE | Drug dose omission by device,NaT
254879092,25487909,14,M,,20250702,,CYCLOPHOSPHAMIDE,Graft versus host disease in gastrointestinal tract,DE,CYCLOPHOSPHAMIDE | Graft versus host disease in gastrointestinal tract | DE,NaT
254881422,25488142,59,F,,20250818,,MOUNJARO,Cardiac arrest,OT,MOUNJARO | Cardiac arrest | OT,NaT
254884062,25488406,,F,,20250725,,MIRENA,Oral pain,,MIRENA | Oral pain,NaT
254884443,25488444,35,F,2025-05-01,20250807,,CIMZIA,Ankylosing spondylitis,OT,CIMZIA | Ankylosing spondylitis | OT,2025-04-28/2025-05-04
254884522,25488452,,F,,20250718,,LUPKYNIS,Pneumonia,HO,LUPKYNIS | Pneumonia | HO,NaT
254885362,25488536,,,2025-06-13,20250725,,TEGSEDI,Dysuria,OT,TEGSEDI | Dysuria | OT,2025-06-09/2025-06-15
254887043,25488704,59,M,,20250730,,ADCETRIS,Weight decreased,,ADCETRIS | Weight decreased,NaT
254891002,25489100,35,M,2025-05-01,20250813,,TALTZ,Arthralgia,,TALTZ | Arthralgia,2025-04-28/2025-05-04
254894222,25489422,65,M,2025-05-01,20250907,,DUPIXENT,Gastritis,,DUPIXENT | Gastritis,2025-04-28/2025-05-04
254897552,25489755,,,,20250917,,CYCLOPHOSPHAMIDE,Metastasis,OT,CYCLOPHOSPHAMIDE | Metastasis | OT,NaT
254899253,25489925,56,M,2025-01-01,20250902,,DUPIXENT,Weight abnormal,,DUPIXENT | Weight abnormal,2024-12-30/2025-01-05
254899282,25489928,48,M,2025-06-06,20250721,,BIVIGAM,Lip swelling,,BIVIGAM | Lip swelling,2025-06-02/2025-06-08
254900772,25490077,,,2024-12-29,20250714,,INFLIXIMAB,Intentional product use issue,OT,INFLIXIMAB | Intentional product use issue | OT,2024-12-23/2024-12-29
254904502,25490450,50,F,2024-11-01,20250813,,SKYRIZI,Skin disorder,OT,SKYRIZI | Skin disorder | OT,2024-10-28/2024-11-03
254905773,25490577,59,F,2025-06-01,20250725,,DUPIXENT,Cough,,DUPIXENT | Cough,2025-05-26/2025-06-01
254915202,25491520,45,F,2025-01-27,20250722,,BOTOX,Speech disorder,OT,BOTOX | Speech disorder | OT,2025-01-27/2025-02-02
254915882,25491588,74,F,2025-01-01,20250915,,CREON,Pneumonia,OT,CREON | Pneumonia | OT,2024-12-30/2025-01-05
254916404,25491640,38,M,,20250925,,ADYNOVATE,Extra dose administered,OT,ADYNOVATE | Extra dose administered | OT,NaT
254918592,25491859,,F,,20250701,,COSENTYX,Pustular psoriasis,HO,COSENTYX | Pustular psoriasis | HO,NaT
254920062,25492006,,,,20250805,,ELIGARD,Product quality issue,,ELIGARD | Product quality issue,NaT
254923002,25492300,,M,,20250802,,ELIGARD,Intercepted product preparation error,,ELIGARD | Intercepted product preparation error,NaT
254923303,25492330,80,F,2025-06-01,20250812,,RINVOQ,Blood zinc decreased,HO,RINVOQ | Blood zinc decreased | HO,2025-05-26/2025-06-01
254925463,25492546,61,,,20250922,,ALBUTEROL SULFATE,Wrong technique in product usage process,,ALBUTEROL SULFATE | Wrong technique in product usage process,NaT
254929592,25492959,41,F,,20250702,,FILSPARI,Nasopharyngitis,,FILSPARI | Nasopharyngitis,NaT
254936292,25493629,64,F,2025-04-22,20250702,,TACROLIMUS,Poisoning deliberate,HO,TACROLIMUS | Poisoning deliberate | HO,2025-04-21/2025-04-27
254937362,25493736,26,,,20250724,,ZEPBOUND,Injection site injury,,ZEPBOUND | Injection site injury,NaT
254939115,25493911,12,M,2025-01-01,20250821,,NGENLA,Injection site pain,,NGENLA | Injection site pain,2024-12-30/2025-01-05
254939852,25493985,,F,,20250829,,DAYBUE,Seizure,OT,DAYBUE | Seizure | OT,NaT
254939962,25493996,,F,2010-01-01,20250701,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,2009-12-28/2010-01-03
254940562,25494056,,,,20250707,,TREMFYA,Product dose omission issue,,TREMFYA | Product dose omission issue,NaT
254944083,25494408,,F,,20250910,,VEOZAH,Hepatic enzyme increased,,VEOZAH | Hepatic enzyme increased,NaT
254947592,25494759,45,M,2019-03-11,20250708,,CERTICAN,Left atrial enlargement,OT,CERTICAN | Left atrial enlargement | OT,2019-03-11/2019-03-17
254949375,25494937,43,F,,20250805,,CETIRIZINE HYDROCHLORIDE,Delirium,HO,CETIRIZINE HYDROCHLORIDE | Delirium | HO,NaT
254949992,25494999,57,M,,20250904,,TRANSAMIN,End stage renal disease,DE,TRANSAMIN | End stage renal disease | DE,NaT
254952073,25495207,71,M,2025-06-16,20250825,,IXIFI,Off label use,OT,IXIFI | Off label use | OT,2025-06-16/2025-06-22
254957272,25495727,70,F,2025-06-25,20250826,,DUPIXENT,Exposure via skin contact,,DUPIXENT | Exposure via skin contact,2025-06-23/2025-06-29
254957362,25495736,66,M,2025-01-01,20250723,,DUPIXENT,Rebound atopic dermatitis,,DUPIXENT | Rebound atopic dermatitis,2024-12-30/2025-01-05
254960152,25496015,77,F,2025-06-27,20250807,,POMALYST,Pollakiuria,,POMALYST | Pollakiuria,2025-06-23/2025-06-29
254965132,25496513,70,F,2022-01-01,20250713,,LINZESS,Swelling face,HO,LINZESS | Swelling face | HO,2021-12-27/2022-01-02
254966082,25496608,73,M,2025-06-22,20250819,,FOSCARBIDOPA\FOSLEVODOPA,Suicide attempt,HO,FOSCARBIDOPA\FOSLEVODOPA | Suicide attempt | HO,2025-06-16/2025-06-22
254967581,25496758,3,M,,20250701,,SPRAVATO,Overdose,LT,SPRAVATO | Overdose | LT,NaT
254968112,25496811,80,M,2025-03-01,20250822,,SKYRIZI,Blister,OT,SKYRIZI | Blister | OT,2025-02-24/2025-03-02
254968631,25496863,,,,20250701,,DICLOFENAC POTASSIUM,Death,DE,DICLOFENAC POTASSIUM | Death | DE,NaT
254969161,25496916,,,,20250701,,VYVANSE,No adverse event,,VYVANSE | No adverse event,NaT
254970461,25497046,64,M,,20250701,,DUPIXENT,Exposure via skin contact,,DUPIXENT | Exposure via skin contact,NaT
254970481,25497048,68,M,,20250701,,SOTYKTU,Adverse event,,SOTYKTU | Adverse event,NaT
254970571,25497057,,F,,20250701,,SKYRIZI,Intestinal obstruction,OT,SKYRIZI | Intestinal obstruction | OT,NaT
254971841,25497184,,F,,20250701,,CERTOLIZUMAB PEGOL,Ankylosing spondylitis,OT,CERTOLIZUMAB PEGOL | Ankylosing spondylitis | OT,NaT
254972271,25497227,25,F,,20250701,,TEMOZOLOMIDE,Dermatitis allergic,OT,TEMOZOLOMIDE | Dermatitis allergic | OT,NaT
254972411,25497241,33,F,,20250701,,ZEPBOUND,Injection site pain,,ZEPBOUND | Injection site pain,NaT
254972902,25497290,76,F,2025-06-18,20250729,,ENBREL,Device difficult to use,OT,ENBREL | Device difficult to use | OT,2025-06-16/2025-06-22
254973471,25497347,,,,20250701,,LAMOTRIGINE,Cardio-respiratory arrest,OT,LAMOTRIGINE | Cardio-respiratory arrest | OT,NaT
254973921,25497392,,F,,20250701,,IVERMECTIN,Drug ineffective,,IVERMECTIN | Drug ineffective,NaT
254974081,25497408,59,F,,20250701,,CLOPIDOGREL,Drug hypersensitivity,OT,CLOPIDOGREL | Drug hypersensitivity | OT,NaT
254974551,25497455,,,,20250701,,AMLODIPINE,Intentional overdose,HO,AMLODIPINE | Intentional overdose | HO,NaT
254975401,25497540,,,,20250701,,RITUXIMAB,Drug hypersensitivity,OT,RITUXIMAB | Drug hypersensitivity | OT,NaT
254975661,25497566,25,F,2020-08-04,20250701,,MIRTAZAPINE,Depressed level of consciousness,HO,MIRTAZAPINE | Depressed level of consciousness | HO,2020-08-03/2020-08-09
254975671,25497567,41,M,2025-02-26,20250701,,FLUOROURACIL,Off label use,OT,FLUOROURACIL | Off label use | OT,2025-02-24/2025-03-02
254976941,25497694,,F,,20250701,,EVENITY,Blood sodium decreased,,EVENITY | Blood sodium decreased,NaT
254977002,25497700,27,F,,20250708,,ARIPIPRAZOLE,Acute myopia,OT,ARIPIPRAZOLE | Acute myopia | OT,NaT
254977011,25497701,66,F,,20250701,,DABIGATRAN ETEXILATE MESYLATE,Liver injury,DE,DABIGATRAN ETEXILATE MESYLATE | Liver injury | DE,NaT
254977241,25497724,40,F,2023-01-01,20250701,,METHYLPHENIDATE,Capillaritis,OT,METHYLPHENIDATE | Capillaritis | OT,2022-12-26/2023-01-01
254977661,25497766,50,F,,20250701,,OCRELIZUMAB,Pneumocystis jirovecii pneumonia,HO,OCRELIZUMAB | Pneumocystis jirovecii pneumonia | HO,NaT
254977851,25497785,75,F,,20250701,,SOTYKTU,Hypertension,OT,SOTYKTU | Hypertension | OT,NaT
254978592,25497859,,M,,20250730,,NUPLAZID,Hypertension,,NUPLAZID | Hypertension,NaT
254978731,25497873,60,M,2025-06-23,20250701,,CARBIDOPA\LEVODOPA,Death,DE,CARBIDOPA\LEVODOPA | Death | DE,2025-06-23/2025-06-29
254979421,25497942,,F,2024-08-25,20250701,,VERAPAMIL,Flushing,,VERAPAMIL | Flushing,2024-08-19/2024-08-25
254979472,25497947,25,M,,20250801,,CYCLOPHOSPHAMIDE,Porokeratosis,OT,CYCLOPHOSPHAMIDE | Porokeratosis | OT,NaT
254980351,25498035,59,M,,20250701,,METHOTREXATE SODIUM,Neuropathy peripheral,OT,METHOTREXATE SODIUM | Neuropathy peripheral | OT,NaT
254980911,25498091,,,,20250701,,LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN,Epstein-Barr viraemia,DE,LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | Epstein-Barr viraemia | DE,NaT
254981201,25498120,70,M,,20250701,,EMTRICITABINE\TENOFOVIR,Renal injury,OT,EMTRICITABINE\TENOFOVIR | Renal injury | OT,NaT
254981511,25498151,,F,,20250701,,NICOTINE POLACRILEX,Hiccups,,NICOTINE POLACRILEX | Hiccups,NaT
254981551,25498155,,F,2025-01-09,20250701,,EMGALITY,Injection site pain,,EMGALITY | Injection site pain,2025-01-06/2025-01-12
254981701,25498170,,,,20250701,,CLOBAZAM,Foetal exposure during pregnancy,CA,CLOBAZAM | Foetal exposure during pregnancy | CA,NaT
254982241,25498224,70,M,2025-06-01,20250701,,REVLIMID,Fatigue,,REVLIMID | Fatigue,2025-05-26/2025-06-01
254983061,25498306,,,,20250701,,INVEGA SUSTENNA,Off label use,,INVEGA SUSTENNA | Off label use,NaT
254983071,25498307,72,M,2025-06-17,20250701,,BREYNA,Dyspnoea,,BREYNA | Dyspnoea,2025-06-16/2025-06-22
254983201,25498320,23,F,2025-06-26,20250701,,MOUNJARO,Accidental underdose,,MOUNJARO | Accidental underdose,2025-06-23/2025-06-29
254983231,25498323,71,M,,20250701,,MOUNJARO,Injection site discomfort,,MOUNJARO | Injection site discomfort,NaT
254985291,25498529,12,F,2025-03-20,20250701,,FILSUVEZ,Product dose omission issue,,FILSUVEZ | Product dose omission issue,2025-03-17/2025-03-23
254985592,25498559,51,M,2024-09-01,20250924,,JIVI,Muscle rupture,OT,JIVI | Muscle rupture | OT,2024-08-26/2024-09-01
254985851,25498585,,F,2025-04-01,20250701,,GOLD BOND ORIGINAL STRENGTH,Mesothelioma malignant,DS,GOLD BOND ORIGINAL STRENGTH | Mesothelioma malignant | DS,2025-03-31/2025-04-06
254985882,25498588,,,,20250723,,ELIGARD,Device breakage,,ELIGARD | Device breakage,NaT
254985891,25498589,46,F,2025-06-24,20250701,,SPRAVATO,Dissociation,OT,SPRAVATO | Dissociation | OT,2025-06-23/2025-06-29
254986602,25498660,22,F,,20250925,,GILTERITINIB,Off label use,HO,GILTERITINIB | Off label use | HO,NaT
254986672,25498667,65,M,2024-04-11,20250708,,PRAMIPEXOLE,Insomnia,LT,PRAMIPEXOLE | Insomnia | LT,2024-04-08/2024-04-14
254986761,25498676,58,F,2021-01-01,20250701,,WEZLANA,Acute interstitial pneumonitis,OT,WEZLANA | Acute interstitial pneumonitis | OT,2020-12-28/2021-01-03
254986921,25498692,36,F,,20250701,,DEXAMETHASONE,Therapy non-responder,OT,DEXAMETHASONE | Therapy non-responder | OT,NaT
254987481,25498748,,,,20250701,,DOXORUBICIN,Foetal growth restriction,DE,DOXORUBICIN | Foetal growth restriction | DE,NaT
254988072,25498807,43,F,,20250917,,PHTHALYLSULFATHIAZOLE,Rheumatoid arthritis,DE,PHTHALYLSULFATHIAZOLE | Rheumatoid arthritis | DE,NaT
254988161,25498816,55,M,,20250701,,ATG-FRESENIUS,Pneumonia,OT,ATG-FRESENIUS | Pneumonia | OT,NaT
254988713,25498871,75,F,,20250804,,LUMIFY,Vision blurred,,LUMIFY | Vision blurred,NaT
254988741,25498874,13,M,,20250701,,FILSUVEZ,Nausea,,FILSUVEZ | Nausea,NaT
254988801,25498880,,M,,20250701,,IXAZOMIB,Death,DE,IXAZOMIB | Death | DE,NaT
254989764,25498976,26,F,2025-04-01,20250806,,VELSIPITY,Alopecia,,VELSIPITY | Alopecia,2025-03-31/2025-04-06
254990371,25499037,,,,20250701,,INFLIXIMAB,Colitis ulcerative,OT,INFLIXIMAB | Colitis ulcerative | OT,NaT
254990981,25499098,,F,,20250701,,BUPROPION HYDROCHLORIDE,Urine odour abnormal,,BUPROPION HYDROCHLORIDE | Urine odour abnormal,NaT
254991061,25499106,63,M,2025-05-23,20250701,,PEMBROLIZUMAB,Neutropenia,LT,PEMBROLIZUMAB | Neutropenia | LT,2025-05-19/2025-05-25
254991461,25499146,59,F,,20250701,,TRASTUZUMAB,Disease progression,HO,TRASTUZUMAB | Disease progression | HO,NaT
254992513,25499251,47,F,2025-06-09,20250917,,QUTENZA,Feeling hot,,QUTENZA | Feeling hot,2025-06-09/2025-06-15
254993731,25499373,46,F,,20250701,,NURTEC ODT,Seizure,OT,NURTEC ODT | Seizure | OT,NaT
254993821,25499382,,,2025-06-09,20250701,,PROVERA,Nausea,OT,PROVERA | Nausea | OT,2025-06-09/2025-06-15
254994051,25499405,73,M,2025-04-14,20250701,,CYTARABINE,Dysarthria,HO,CYTARABINE | Dysarthria | HO,2025-04-14/2025-04-20
254994311,25499431,,,2020-06-01,20250701,,MIRALAX,Product prescribing issue,,MIRALAX | Product prescribing issue,2020-06-01/2020-06-07
254995101,25499510,72,F,,20250701,,PROLIA,Transient ischaemic attack,OT,PROLIA | Transient ischaemic attack | OT,NaT
254995111,25499511,56,M,,20250701,,REPATHA,Thinking abnormal,,REPATHA | Thinking abnormal,NaT
254995731,25499573,69,M,,20250701,,REMICADE,Disseminated tuberculosis,HO,REMICADE | Disseminated tuberculosis | HO,NaT
254995811,25499581,,,,20250701,,VABYSMO,Spinal fracture,,VABYSMO | Spinal fracture,NaT
254995902,25499590,,F,,20250715,,VYEPTI,Rash pruritic,,VYEPTI | Rash pruritic,NaT
254995951,25499595,57,M,,20250701,,ELIQUIS,Treatment noncompliance,HO,ELIQUIS | Treatment noncompliance | HO,NaT
254996191,25499619,,,,20250701,,FIRMAGON,Disease progression,DE,FIRMAGON | Disease progression | DE,NaT
254996932,25499693,65,F,,20250702,,ORENCIA,Rheumatoid arthritis,,ORENCIA | Rheumatoid arthritis,NaT
254997402,25499740,,,,20250701,,VIREAD,Renal injury,OT,VIREAD | Renal injury | OT,NaT
254997721,25499772,,,,20250701,,OPZELURA,Therapeutic product effect incomplete,,OPZELURA | Therapeutic product effect incomplete,NaT
254997841,25499784,55,F,,20250701,,AMJEVITA,Therapy interrupted,HO,AMJEVITA | Therapy interrupted | HO,NaT
254998632,25499863,74,M,2024-12-01,20250814,,SKYRIZI,Small intestinal obstruction,OT,SKYRIZI | Small intestinal obstruction | OT,2024-11-25/2024-12-01
254998701,25499870,62,M,2023-11-01,20250701,,RINVOQ,Rash,OT,RINVOQ | Rash | OT,2023-10-30/2023-11-05
255000221,25500022,9,,,20250701,,RUXOLITINIB,Off label use,OT,RUXOLITINIB | Off label use | OT,NaT
255000761,25500076,,F,,20250701,,EXELON,Bronchial neoplasm,OT,EXELON | Bronchial neoplasm | OT,NaT
255001831,25500183,34,M,2025-06-03,20250701,,CABENUVA,Viral load increased,RI,CABENUVA | Viral load increased | RI,2025-06-02/2025-06-08
255002651,25500265,61,F,,20250701,,RINVOQ,Pneumonia,,RINVOQ | Pneumonia,NaT
255002891,25500289,54,M,,20250701,,FLUCONAZOLE,Mucormycosis,OT,FLUCONAZOLE | Mucormycosis | OT,NaT
255005014,25500501,80,M,2025-08-06,20250822,,VECTIBIX,Skin infection,HO,VECTIBIX | Skin infection | HO,2025-08-04/2025-08-10
255005201,25500520,61,F,,20250701,,MOUNJARO,Nausea,,MOUNJARO | Nausea,NaT
255005924,25500592,66,F,2025-06-13,20250828,,MORPHINE,Immunosuppression,OT,MORPHINE | Immunosuppression | OT,2025-06-09/2025-06-15
255006034,25500603,76,M,2025-06-01,20250801,,LEQEMBI,Polymyalgia rheumatica,HO,LEQEMBI | Polymyalgia rheumatica | HO,2025-05-26/2025-06-01
255006101,25500610,52,M,2025-05-16,20250701,,RINVOQ,T-cell lymphoma,OT,RINVOQ | T-cell lymphoma | OT,2025-05-12/2025-05-18
255006301,25500630,,M,,20250701,,NIROGACESTAT,Diarrhoea,OT,NIROGACESTAT | Diarrhoea | OT,NaT
255006841,25500684,,M,,20250701,,XYWAV,Infection,OT,XYWAV | Infection | OT,NaT
255007482,25500748,22,M,,20250913,,RINVOQ,Product residue present,,RINVOQ | Product residue present,NaT
255007911,25500791,47,F,,20250701,,ORENCIA,Gallbladder enlargement,HO,ORENCIA | Gallbladder enlargement | HO,NaT
255008341,25500834,,M,,20250701,,CORTICOTROPIN,Memory impairment,,CORTICOTROPIN | Memory impairment,NaT
255008771,25500877,,M,2021-01-01,20250701,,NEXAVAR,Liver transplant rejection,HO,NEXAVAR | Liver transplant rejection | HO,2020-12-28/2021-01-03
255009011,25500901,86,F,2025-06-02,20250701,,VABYSMO,Keratic precipitates,OT,VABYSMO | Keratic precipitates | OT,2025-06-02/2025-06-08
255009442,25500944,63,F,2025-06-30,20250812,,HUMIRA,Product storage error,,HUMIRA | Product storage error,2025-06-30/2025-07-06
255010041,25501004,74,F,,20250701,,MOUNJARO,Early satiety,HO,MOUNJARO | Early satiety | HO,NaT
255011271,25501127,56,F,2024-07-26,20250701,,DUPIXENT,Rash,,DUPIXENT | Rash,2024-07-22/2024-07-28
255011331,25501133,46,F,2025-01-01,20250701,,DUPIXENT,Condition aggravated,,DUPIXENT | Condition aggravated,2024-12-30/2025-01-05
255013421,25501342,53,F,2025-01-01,20250701,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,2024-12-30/2025-01-05
255013991,25501399,48,F,2025-06-27,20250701,,DUPIXENT,Rebound eczema,,DUPIXENT | Rebound eczema,2025-06-23/2025-06-29
255014131,25501413,45,F,2025-06-01,20250701,,DUPIXENT,Dry skin,,DUPIXENT | Dry skin,2025-05-26/2025-06-01
255014411,25501441,,,,20250701,,CABLIVI,Cerebral haemorrhage,OT,CABLIVI | Cerebral haemorrhage | OT,NaT
255014431,25501443,25,F,,20250701,,DUPIXENT,Therapeutic response decreased,,DUPIXENT | Therapeutic response decreased,NaT
255014491,25501449,29,F,,20250701,,VERZENIO,Diarrhoea,,VERZENIO | Diarrhoea,NaT
255014511,25501451,5,M,,20250701,,DAPTOMYCIN,Off label use,,DAPTOMYCIN | Off label use,NaT
255015571,25501557,41,F,,20250701,,FLUOXETINE,Colitis microscopic,OT,FLUOXETINE | Colitis microscopic | OT,NaT
255016002,25501600,,,2024-12-01,20250723,,SPIRONOLACTONE\TORSEMIDE,Dyspnoea,OT,SPIRONOLACTONE\TORSEMIDE | Dyspnoea | OT,2024-11-25/2024-12-01
255016031,25501603,31,F,2025-05-01,20250701,,SPRAVATO,Therapeutic product effect decreased,OT,SPRAVATO | Therapeutic product effect decreased | OT,2025-04-28/2025-05-04
255016253,25501625,75,M,2025-01-01,20250731,,CREON,Dehydration,HO,CREON | Dehydration | HO,2024-12-30/2025-01-05
255016342,25501634,,F,,20250721,,BOTOX,Fatigue,,BOTOX | Fatigue,NaT
255016601,25501660,,F,2025-05-01,20250701,,DUPIXENT,Atrial fibrillation,HO,DUPIXENT | Atrial fibrillation | HO,2025-04-28/2025-05-04
255016861,25501686,69,F,2024-11-01,20250701,,RINVOQ,Epistaxis,HO,RINVOQ | Epistaxis | HO,2024-10-28/2024-11-03
255017911,25501791,,M,,20250702,,BEVACIZUMAB,Mouth ulceration,OT,BEVACIZUMAB | Mouth ulceration | OT,NaT
255018471,25501847,79,M,,20250702,,HARNAL,Nephrolithiasis,OT,HARNAL | Nephrolithiasis | OT,NaT
255018651,25501865,15,F,2025-05-15,20250702,,LORATADINE,Suicide attempt,OT,LORATADINE | Suicide attempt | OT,2025-05-12/2025-05-18
255019601,25501960,54,F,,20250702,,ZEPBOUND,Injection site pain,,ZEPBOUND | Injection site pain,NaT
255019621,25501962,66,F,,20250702,,MOUNJARO,Injection site pain,,MOUNJARO | Injection site pain,NaT
255019842,25501984,68,F,2025-05-29,20250921,,TRELEGY ELLIPTA,Incorrect dose administered,,TRELEGY ELLIPTA | Incorrect dose administered,2025-05-26/2025-06-01
255020332,25502033,39,F,2025-06-02,20250813,,ENOXAPARIN SODIUM,Ovarian hyperstimulation syndrome,OT,ENOXAPARIN SODIUM | Ovarian hyperstimulation syndrome | OT,2025-06-02/2025-06-08
255020912,25502091,,,2024-09-23,20250711,,BEVACIZUMAB,Intentional product use issue,OT,BEVACIZUMAB | Intentional product use issue | OT,2024-09-23/2024-09-29
255020951,25502095,72,F,2025-06-19,20250702,,TOLODODEKIN ALFA,Hyperpyrexia,HO,TOLODODEKIN ALFA | Hyperpyrexia | HO,2025-06-16/2025-06-22
255021612,25502161,,F,,20250708,,TRELEGY ELLIPTA,Drug ineffective,,TRELEGY ELLIPTA | Drug ineffective,NaT
255021791,25502179,,F,,20250702,,NUPLAZID,Abdominal discomfort,,NUPLAZID | Abdominal discomfort,NaT
255021831,25502183,,,,20250702,,VABYSMO,Uveitis,,VABYSMO | Uveitis,NaT
255022351,25502235,,M,,20250702,,ICATIBANT,Swelling,HO,ICATIBANT | Swelling | HO,NaT
255022401,25502240,,M,,20250702,,RISANKIZUMAB,Product storage error,,RISANKIZUMAB | Product storage error,NaT
255022541,25502254,86,F,,20250702,,ELIQUIS,Haemorrhage,,ELIQUIS | Haemorrhage,NaT
255022962,25502296,,F,,20250707,,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Urinary tract infection,HO,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN | Urinary tract infection | HO,NaT
255023061,25502306,,F,,20250702,,RITUXIMAB,Constipation,OT,RITUXIMAB | Constipation | OT,NaT
255023322,25502332,74,F,2025-08-15,20250828,,NUPLAZID,Product use issue,DE,NUPLAZID | Product use issue | DE,2025-08-11/2025-08-17
255023331,25502333,58,F,2025-04-15,20250702,,ATORVASTATIN,Rash,OT,ATORVASTATIN | Rash | OT,2025-04-14/2025-04-20
255023471,25502347,,,,20250702,,LUMIFY,Eye disorder,,LUMIFY | Eye disorder,NaT
255024311,25502431,,F,2021-01-01,20250702,,OZEMPIC,COVID-19,OT,OZEMPIC | COVID-19 | OT,2020-12-28/2021-01-03
255026081,25502608,57,F,,20250702,,CYCLOSPORINE,Weight decreased,OT,CYCLOSPORINE | Weight decreased | OT,NaT
255026571,25502657,60,F,2025-06-04,20250702,,BISOPROLOL,Cardiogenic shock,OT,BISOPROLOL | Cardiogenic shock | OT,2025-06-02/2025-06-08
255026762,25502676,48,F,,20250707,,CYCLOSPORINE,Cytomegalovirus infection reactivation,OT,CYCLOSPORINE | Cytomegalovirus infection reactivation | OT,NaT
255027231,25502723,,F,,20250702,,LINACLOTIDE,Off label use,,LINACLOTIDE | Off label use,NaT
255027331,25502733,,M,,20250702,,SKYRIZI,Psoriatic arthropathy,HO,SKYRIZI | Psoriatic arthropathy | HO,NaT
255027661,25502766,36,F,,20250702,,ZEPBOUND,Product dose omission issue,,ZEPBOUND | Product dose omission issue,NaT
255027941,25502794,70,M,2025-06-05,20250702,,ENOXAPARIN SODIUM,Arthralgia,OT,ENOXAPARIN SODIUM | Arthralgia | OT,2025-06-02/2025-06-08
255029391,25502939,,,,20250702,,RITUXIMAB,Follicular lymphoma recurrent,OT,RITUXIMAB | Follicular lymphoma recurrent | OT,NaT
255029841,25502984,34,F,2025-06-25,20250702,,SPRAVATO,Dissociation,OT,SPRAVATO | Dissociation | OT,2025-06-23/2025-06-29
255030031,25503003,79,M,2025-06-19,20250702,,BRINZOLAMIDE,Dizziness,OT,BRINZOLAMIDE | Dizziness | OT,2025-06-16/2025-06-22
255030441,25503044,51,F,,20250702,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
255031111,25503111,6,M,,20250702,,METHYLPREDNISOLONE HEMISUCCINATE,Off label use,OT,METHYLPREDNISOLONE HEMISUCCINATE | Off label use | OT,NaT
255031181,25503118,80,F,,20250702,,ALBUTEROL,Blood phosphorus increased,DS,ALBUTEROL | Blood phosphorus increased | DS,NaT
255032381,25503238,72,M,2025-02-03,20250702,,BENDROFLUMETHIAZIDE,Acute kidney injury,HO,BENDROFLUMETHIAZIDE | Acute kidney injury | HO,2025-02-03/2025-02-09
255032671,25503267,,F,,20250702,,ZOLEDRONIC ACID,Back pain,HO,ZOLEDRONIC ACID | Back pain | HO,NaT
255032751,25503275,72,,,20250702,,ATORVASTATIN,Restless legs syndrome,OT,ATORVASTATIN | Restless legs syndrome | OT,NaT
255033121,25503312,,F,,20250702,,GLIPIZIDE,Drug ineffective,,GLIPIZIDE | Drug ineffective,NaT
255033791,25503379,59,F,2025-06-29,20250702,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,2025-06-23/2025-06-29
255033891,25503389,,F,,20250702,,CALCIUM CL\DEXTROSE\MAGNESIUM CL\SODIUM BICAR\SODIUM CL\SODIUM LACT,Peritoneal cloudy effluent,OT,CALCIUM CL\DEXTROSE\MAGNESIUM CL\SODIUM BICAR\SODIUM CL\SODIUM LACT | Peritoneal cloudy effluent | OT,NaT
255034153,25503415,54,F,2025-06-19,20250722,,ORENITRAM,Pericardial effusion,HO,ORENITRAM | Pericardial effusion | HO,2025-06-16/2025-06-22
255035121,25503512,65,M,2025-06-01,20250702,,NICODERM CQ,Rash macular,,NICODERM CQ | Rash macular,2025-05-26/2025-06-01
255036632,25503663,24,F,2025-06-13,20250709,,SKYRIZI,Product storage error,,SKYRIZI | Product storage error,2025-06-09/2025-06-15
255037194,25503719,15,F,,20250729,,ENBREL,Product communication issue,,ENBREL | Product communication issue,NaT
255037511,25503751,,,,20250702,,OBINUTUZUMAB,Immune effector cell-associated neurotoxicity syndrome,OT,OBINUTUZUMAB | Immune effector cell-associated neurotoxicity syndrome | OT,NaT
255037721,25503772,78,M,2025-06-01,20250701,,LUPRON DEPOT,Death,DE,LUPRON DEPOT | Death | DE,2025-05-26/2025-06-01
255038401,25503840,72,F,2024-04-01,20250702,,IBRANCE,Leukopenia,OT,IBRANCE | Leukopenia | OT,2024-04-01/2024-04-07
255039231,25503923,,M,,20250702,,TASIGNA,Hepatic enzyme increased,OT,TASIGNA | Hepatic enzyme increased | OT,NaT
255039911,25503991,54,F,,20250702,,POMALYST,Inappropriate schedule of product administration,,POMALYST | Inappropriate schedule of product administration,NaT
255040331,25504033,18,M,2025-01-06,20250702,,LEVETIRACETAM,Hypokalaemia,OT,LEVETIRACETAM | Hypokalaemia | OT,2025-01-06/2025-01-12
255040631,25504063,,,,20250702,,RIZATRIPTAN BENZOATE,Product availability issue,,RIZATRIPTAN BENZOATE | Product availability issue,NaT
255041592,25504159,80,M,,20250911,,ORGOVYX,Muscle atrophy,,ORGOVYX | Muscle atrophy,NaT
255041972,25504197,,,,20250718,,ORGOVYX,Fatigue,,ORGOVYX | Fatigue,NaT
255042471,25504247,65,F,2025-06-01,20250702,,REMODULIN,Loss of consciousness,OT,REMODULIN | Loss of consciousness | OT,2025-05-26/2025-06-01
255043491,25504349,86,F,2025-07-01,20250701,,TAVNEOS,Hospitalisation,HO,TAVNEOS | Hospitalisation | HO,2025-06-30/2025-07-06
255043651,25504365,75,M,,20250702,,RITUXIMAB,Illness,DE,RITUXIMAB | Illness | DE,NaT
255044061,25504406,,,,20250702,,NEXIUM 24HR,Drug ineffective,,NEXIUM 24HR | Drug ineffective,NaT
255044643,25504464,57,M,2025-06-07,20250714,,CLOZAPINE,Haemoglobin decreased,,CLOZAPINE | Haemoglobin decreased,2025-06-02/2025-06-08
255045051,25504505,50,M,,20250702,,PREDNISOLONE,Sarcoidosis,OT,PREDNISOLONE | Sarcoidosis | OT,NaT
255045121,25504512,,F,,20250702,,ELRANATAMAB,Infection,DE,ELRANATAMAB | Infection | DE,NaT
255045221,25504522,57,F,,20250702,,CARBOPLATIN,Peritoneal neoplasm,OT,CARBOPLATIN | Peritoneal neoplasm | OT,NaT
255045641,25504564,,F,2025-01-01,20250702,,ORENITRAM,Chest pain,,ORENITRAM | Chest pain,2024-12-30/2025-01-05
255045981,25504598,,M,2025-01-01,20250702,,XPHOZAH,Nausea,,XPHOZAH | Nausea,2024-12-30/2025-01-05
255046771,25504677,68,F,2025-06-19,20250702,,TREPROSTINIL,Head injury,OT,TREPROSTINIL | Head injury | OT,2025-06-16/2025-06-22
255048671,25504867,,,,20250702,,OPZELURA,Product physical consistency issue,,OPZELURA | Product physical consistency issue,NaT
255049841,25504984,19,M,2025-06-04,20250702,,EXONDYS 51,Hypotension,HO,EXONDYS 51 | Hypotension | HO,2025-06-02/2025-06-08
255049991,25504999,,M,2024-01-01,20250702,,EXONDYS 51,Pyrexia,,EXONDYS 51 | Pyrexia,2024-01-01/2024-01-07
255050771,25505077,21,M,,20250702,,METHYLPHENIDATE HYDROCHLORIDE,Traumatic intracranial haemorrhage,OT,METHYLPHENIDATE HYDROCHLORIDE | Traumatic intracranial haemorrhage | OT,NaT
255051241,25505124,,M,,20250702,,LENVIMA,Immune-mediated lung disease,HO,LENVIMA | Immune-mediated lung disease | HO,NaT
255051361,25505136,,M,,20250702,,EXONDYS 51,Therapy cessation,,EXONDYS 51 | Therapy cessation,NaT
255052002,25505200,63,F,2024-09-02,20250717,,VYXEOS,Bacillus infection,DS,VYXEOS | Bacillus infection | DS,2024-09-02/2024-09-08
255052461,25505246,,M,,20250702,,EXONDYS 51,Product temperature excursion issue,,EXONDYS 51 | Product temperature excursion issue,NaT
255052841,25505284,23,M,2025-05-30,20250702,,EXONDYS 51,Product dose omission issue,,EXONDYS 51 | Product dose omission issue,2025-05-26/2025-06-01
255053331,25505333,32,F,,20250702,,MYCOPHENOLATE MOFETIL,Gastrointestinal microorganism overgrowth,OT,MYCOPHENOLATE MOFETIL | Gastrointestinal microorganism overgrowth | OT,NaT
255054071,25505407,73,F,,20250702,,HUMALOG,Contusion,,HUMALOG | Contusion,NaT
255054601,25505460,44,M,,20250702,,ISOPTO ATROPINE,Off label use,OT,ISOPTO ATROPINE | Off label use | OT,NaT
255055141,25505514,,F,,20250702,,MIEBO,Anaphylactic reaction,OT,MIEBO | Anaphylactic reaction | OT,NaT
255055221,25505522,,,,20250702,,GIVLAARI,Systemic lupus erythematosus,,GIVLAARI | Systemic lupus erythematosus,NaT
255055421,25505542,59,F,2025-04-04,20250702,,POMALYST,Sepsis,HO,POMALYST | Sepsis | HO,2025-03-31/2025-04-06
255055861,25505586,11,F,,20250702,,CYCLOSPORINE,Autoimmune thyroiditis,OT,CYCLOSPORINE | Autoimmune thyroiditis | OT,NaT
255055911,25505591,76,F,2025-02-27,20250702,,OHTUVAYRE,Product administration error,,OHTUVAYRE | Product administration error,2025-02-24/2025-03-02
255056361,25505636,,,,20250702,,OHTUVAYRE,Chest pain,,OHTUVAYRE | Chest pain,NaT
255058402,25505840,,F,,20250706,,VITAMIN C,Surgery,OT,VITAMIN C | Surgery | OT,NaT
255058422,25505842,,F,,20250703,,IMDELLTRA,Cytokine release syndrome,OT,IMDELLTRA | Cytokine release syndrome | OT,NaT
255058632,25505863,63,F,2025-07-01,20250731,,SKYRIZI,Product storage error,,SKYRIZI | Product storage error,2025-06-30/2025-07-06
255058801,25505880,,M,2025-01-01,20250702,,BUPRENORPHINE,Drug abuse,HO,BUPRENORPHINE | Drug abuse | HO,2024-12-30/2025-01-05
255060781,25506078,,F,,20250702,,TYMLOS,Bone pain,OT,TYMLOS | Bone pain | OT,NaT
255060851,25506085,62,F,2024-12-06,20250702,,TYMLOS,Nephrolithiasis,OT,TYMLOS | Nephrolithiasis | OT,2024-12-02/2024-12-08
255061011,25506101,,F,,20250702,,DUPIXENT,Heart rate increased,,DUPIXENT | Heart rate increased,NaT
255061181,25506118,3,M,2025-06-18,20250702,,DUPIXENT,Eye irritation,,DUPIXENT | Eye irritation,2025-06-16/2025-06-22
255061421,25506142,43,F,2025-01-01,20250702,,DUPIXENT,Staphylococcal infection,,DUPIXENT | Staphylococcal infection,2024-12-30/2025-01-05
255062131,25506213,30,F,,20250702,,DUPIXENT,Illness,,DUPIXENT | Illness,NaT
255062191,25506219,,F,,20250702,,DUPIXENT,Eye discharge,,DUPIXENT | Eye discharge,NaT
255063061,25506306,19,F,2025-06-01,20250702,,DUPIXENT,Rebound atopic dermatitis,,DUPIXENT | Rebound atopic dermatitis,2025-05-26/2025-06-01
255063701,25506370,67,M,,20250702,,DUPIXENT,Injection site mass,,DUPIXENT | Injection site mass,NaT
255063911,25506391,,,2025-06-11,20250702,,VARIVAX,Product storage error,,VARIVAX | Product storage error,2025-06-09/2025-06-15
255063931,25506393,66,,,20250702,,LANTUS SOLOSTAR,Off label use,,LANTUS SOLOSTAR | Off label use,NaT
255064241,25506424,76,M,,20250702,,LANTUS SOLOSTAR,Off label use,,LANTUS SOLOSTAR | Off label use,NaT
255064821,25506482,,F,2024-11-20,20250702,,MICONAZOLE 1,Vulvovaginal discomfort,,MICONAZOLE 1 | Vulvovaginal discomfort,2024-11-18/2024-11-24
255067311,25506731,5,F,,20250702,,KUVAN,Hand deformity,,KUVAN | Hand deformity,NaT
255067341,25506734,,,2025-05-05,20250702,,PEGCETACOPLAN,Off label use,DE,PEGCETACOPLAN | Off label use | DE,2025-05-05/2025-05-11
255067441,25506744,43,F,,20250702,,FOLIC ACID,Rheumatic fever,HO,FOLIC ACID | Rheumatic fever | HO,NaT
255067671,25506767,,F,,20250702,,TYMLOS,Myalgia,,TYMLOS | Myalgia,NaT
255068131,25506813,70,F,2025-02-01,20250702,,TYMLOS,Hypotension,,TYMLOS | Hypotension,2025-01-27/2025-02-02
255068261,25506826,,F,2025-01-01,20250702,,TYMLOS,Blood pressure increased,,TYMLOS | Blood pressure increased,2024-12-30/2025-01-05
255068291,25506829,,F,,20250702,,TYMLOS,Dry skin,,TYMLOS | Dry skin,NaT
255069851,25506985,8,F,,20250702,,UPTRAVI,Hepatic cirrhosis,HO,UPTRAVI | Hepatic cirrhosis | HO,NaT
255070161,25507016,12,F,,20250702,,PREDNISOLONE,Crohn's disease,OT,PREDNISOLONE | Crohn's disease | OT,NaT
255070651,25507065,,,,20250702,,LINZESS,Product physical issue,,LINZESS | Product physical issue,NaT
255070801,25507080,,F,,20250702,,SKYRIZI,Endometriosis,OT,SKYRIZI | Endometriosis | OT,NaT
255071651,25507165,52,M,2025-01-01,20250703,,RINVOQ,Gastrooesophageal reflux disease,OT,RINVOQ | Gastrooesophageal reflux disease | OT,2024-12-30/2025-01-05
255071931,25507193,,,2025-06-25,20250703,,MVASI,Arthralgia,,MVASI | Arthralgia,2025-06-23/2025-06-29
255072091,25507209,65,F,2024-10-24,20250703,,SOLIFENACIN,Fluid retention,,SOLIFENACIN | Fluid retention,2024-10-21/2024-10-27
255072771,25507277,79,F,,20250703,,VALSARTAN,Hypersensitivity,,VALSARTAN | Hypersensitivity,NaT
255072841,25507284,,F,,20250703,,PREDNISONE,Rubber sensitivity,,PREDNISONE | Rubber sensitivity,NaT
255075191,25507519,,,,20250703,,LEVETIRACETAM,Mood swings,OT,LEVETIRACETAM | Mood swings | OT,NaT
255075431,25507543,56,F,,20250703,,ZEPBOUND,Nausea,,ZEPBOUND | Nausea,NaT
255075642,25507564,50,F,,20250710,,AMIODARONE,Withdrawal catatonia,OT,AMIODARONE | Withdrawal catatonia | OT,NaT
255076001,25507600,48,F,,20250703,,AMBRISENTAN,Skin irritation,HO,AMBRISENTAN | Skin irritation | HO,NaT
255076322,25507632,,F,,20250721,,MYCOPHENOLIC ACID,Uveitis,OT,MYCOPHENOLIC ACID | Uveitis | OT,NaT
255076981,25507698,76,F,2025-05-01,20250703,,NUPLAZID,Hip fracture,DE,NUPLAZID | Hip fracture | DE,2025-04-28/2025-05-04
255077241,25507724,41,F,2025-06-11,20250703,,VALTREX,Exposure during pregnancy,OT,VALTREX | Exposure during pregnancy | OT,2025-06-09/2025-06-15
255077861,25507786,71,F,2025-01-01,20250703,,RINVOQ,Surgery,OT,RINVOQ | Surgery | OT,2024-12-30/2025-01-05
255078071,25507807,,,,20250703,,AMOXICILLIN\CLAVULANIC ACID,Drug-induced liver injury,OT,AMOXICILLIN\CLAVULANIC ACID | Drug-induced liver injury | OT,NaT
255078201,25507820,,F,,20250703,,TOCILIZUMAB,Encephalopathy,OT,TOCILIZUMAB | Encephalopathy | OT,NaT
255078491,25507849,,M,,20250703,,DUVYZAT,Nausea,,DUVYZAT | Nausea,NaT
255078521,25507852,,F,2024-01-01,20250703,,BRIVARACETAM,Amnesia,OT,BRIVARACETAM | Amnesia | OT,2024-01-01/2024-01-07
255079051,25507905,,,,20250703,,ORGOVYX,Asthenia,,ORGOVYX | Asthenia,NaT
255079711,25507971,,,,20250703,,AMOXICILLIN\CLAVULANIC ACID,Drug-induced liver injury,OT,AMOXICILLIN\CLAVULANIC ACID | Drug-induced liver injury | OT,NaT
255080031,25508003,86,F,,20250703,,DABIGATRAN ETEXILATE MESYLATE,Necrotising oesophagitis,OT,DABIGATRAN ETEXILATE MESYLATE | Necrotising oesophagitis | OT,NaT
255080651,25508065,,M,,20250703,,RINVOQ,Wound infection,HO,RINVOQ | Wound infection | HO,NaT
255081321,25508132,,M,,20250703,,ELIGARD,Death,DE,ELIGARD | Death | DE,NaT
255081521,25508152,,,,20250703,,ADALIMUMAB,Off label use,OT,ADALIMUMAB | Off label use | OT,NaT
255081891,25508189,,M,,20250703,,MOUNJARO,Dizziness,,MOUNJARO | Dizziness,NaT
255082471,25508247,61,F,2025-06-16,20250703,,CAPECITABINE,Pyogenic granuloma,HO,CAPECITABINE | Pyogenic granuloma | HO,2025-06-16/2025-06-22
255082701,25508270,66,M,2025-06-28,20250703,,CARBIDOPA\LEVODOPA,Device difficult to use,HO,CARBIDOPA\LEVODOPA | Device difficult to use | HO,2025-06-23/2025-06-29
255082911,25508291,,F,2025-01-01,20250703,,VUMERITY,Death,DE,VUMERITY | Death | DE,2024-12-30/2025-01-05
255083742,25508374,,,,20250816,,BREZTRI,Muscle spasms,,BREZTRI | Muscle spasms,NaT
255083912,25508391,,F,,20250810,,AIRSUPRA,Device use issue,,AIRSUPRA | Device use issue,NaT
255083921,25508392,,,,20250703,,RITUXAN,Follicular lymphoma,OT,RITUXAN | Follicular lymphoma | OT,NaT
255084792,25508479,,M,2025-01-01,20250917,,XPHOZAH,Abdominal pain upper,,XPHOZAH | Abdominal pain upper,2024-12-30/2025-01-05
255085113,25508511,,F,,20250812,,AIRSUPRA,Device delivery system issue,HO,AIRSUPRA | Device delivery system issue | HO,NaT
255086021,25508602,72,F,,20250703,,DAPAGLIFLOZIN,Lactic acidosis,HO,DAPAGLIFLOZIN | Lactic acidosis | HO,NaT
255086211,25508621,,,,20250703,,AMOXICILLIN\CLAVULANIC ACID,Drug-induced liver injury,OT,AMOXICILLIN\CLAVULANIC ACID | Drug-induced liver injury | OT,NaT
255086292,25508629,,,,20250705,,INFLECTRA,Cataract,OT,INFLECTRA | Cataract | OT,NaT
255086811,25508681,,F,2025-01-01,20250703,,WOMENS ROGAINE UNSCENTED,Alopecia,,WOMENS ROGAINE UNSCENTED | Alopecia,2024-12-30/2025-01-05
255086982,25508698,32,F,2025-03-01,20250913,,LISDEXAMFETAMINE DIMESYLATE,Increased appetite,,LISDEXAMFETAMINE DIMESYLATE | Increased appetite,2025-02-24/2025-03-02
255087851,25508785,,F,,20250703,,POMALYST,General physical health deterioration,,POMALYST | General physical health deterioration,NaT
255088021,25508802,9,F,,20250703,,EDOXABAN TOSYLATE,Therapeutic response decreased,HO,EDOXABAN TOSYLATE | Therapeutic response decreased | HO,NaT
255088391,25508839,,F,,20250703,,ENBREL,Drug ineffective,,ENBREL | Drug ineffective,NaT
255089071,25508907,73,M,2025-05-15,20250703,,ROSUVASTATIN,Paraesthesia,OT,ROSUVASTATIN | Paraesthesia | OT,2025-05-12/2025-05-18
255090191,25509019,57,F,,20250703,,TALTZ,Psoriasis,,TALTZ | Psoriasis,NaT
255090691,25509069,,M,,20250703,,NUCALA,Hospitalisation,HO,NUCALA | Hospitalisation | HO,NaT
255091501,25509150,73,F,2024-06-19,20250703,,FOSCARBIDOPA\FOSLEVODOPA,Femoral neck fracture,HO,FOSCARBIDOPA\FOSLEVODOPA | Femoral neck fracture | HO,2024-06-17/2024-06-23
255091595,25509159,64,M,2025-07-09,20250729,,CARBIDOPA\LEVODOPA,Overdose,HO,CARBIDOPA\LEVODOPA | Overdose | HO,2025-07-07/2025-07-13
255093372,25509337,10,M,2025-06-30,20250804,,NGENLA,Injection site pain,,NGENLA | Injection site pain,2025-06-30/2025-07-06
255093622,25509362,,F,,20250915,,NUPLAZID,Arrhythmia,OT,NUPLAZID | Arrhythmia | OT,NaT
255094912,25509491,,F,,20250923,,TENOFOVIR,Foetal exposure during pregnancy,CA,TENOFOVIR | Foetal exposure during pregnancy | CA,NaT
255096061,25509606,86,F,,20250703,,ADVIL,Drug ineffective,,ADVIL | Drug ineffective,NaT
255096382,25509638,,M,,20250707,,TRELEGY ELLIPTA,Extra dose administered,,TRELEGY ELLIPTA | Extra dose administered,NaT
255096451,25509645,,,,20250703,,PROPRANOLOL HYDROCHLORIDE,Hypotension,,PROPRANOLOL HYDROCHLORIDE | Hypotension,NaT
255096471,25509647,39,M,,20250703,,PREDNISOLONE,Off label use,OT,PREDNISOLONE | Off label use | OT,NaT
255096631,25509663,60,M,2025-06-25,20250702,,COSENTYX,Alcohol use,OT,COSENTYX | Alcohol use | OT,2025-06-23/2025-06-29
255097131,25509713,74,M,2025-05-27,20250703,,VEDOLIZUMAB,Umbilical hernia,OT,VEDOLIZUMAB | Umbilical hernia | OT,2025-05-26/2025-06-01
255097381,25509738,80,M,2025-03-06,20250703,,PACLITAXEL,Hepatic cytolysis,OT,PACLITAXEL | Hepatic cytolysis | OT,2025-03-03/2025-03-09
255097711,25509771,76,F,2023-01-01,20250703,,HUMIRA,Intestinal stenosis,OT,HUMIRA | Intestinal stenosis | OT,2022-12-26/2023-01-01
255098461,25509846,68,M,2025-06-25,20250703,,ALTEPLASE,Headache,HO,ALTEPLASE | Headache | HO,2025-06-23/2025-06-29
255099661,25509966,21,F,2021-08-09,20250703,,QUETIAPINE,Somnolence,HO,QUETIAPINE | Somnolence | HO,2021-08-09/2021-08-15
255100051,25510005,75,M,2024-10-01,20250703,,PRALUENT,Cholelithiasis,HO,PRALUENT | Cholelithiasis | HO,2024-09-30/2024-10-06
255100111,25510011,66,F,2023-01-01,20250703,,PRALUENT,Pancreatitis,OT,PRALUENT | Pancreatitis | OT,2022-12-26/2023-01-01
255100421,25510042,,,,20250702,,OPSUMIT,Death,,OPSUMIT | Death,NaT
255101361,25510136,,F,2024-01-01,20250703,,MINERALS\VITAMINS,Injection site haemorrhage,,MINERALS\VITAMINS | Injection site haemorrhage,2024-01-01/2024-01-07
255101431,25510143,62,M,,20250703,,TERIPARATIDE,Cerebrovascular accident,LT,TERIPARATIDE | Cerebrovascular accident | LT,NaT
255102751,25510275,,,,20250703,,INGREZZA,Abdominal discomfort,,INGREZZA | Abdominal discomfort,NaT
255102781,25510278,68,M,2025-06-28,20250703,,FOSCARBIDOPA\FOSLEVODOPA,Myocardial infarction,DE,FOSCARBIDOPA\FOSLEVODOPA | Myocardial infarction | DE,2025-06-23/2025-06-29
255103142,25510314,81,M,,20250809,,ESOMEPRAZOLE,Spinal fracture,OT,ESOMEPRAZOLE | Spinal fracture | OT,NaT
255104641,25510464,,F,,20250703,,TYMLOS,Loss of personal independence in daily activities,,TYMLOS | Loss of personal independence in daily activities,NaT
255104671,25510467,68,F,2024-05-07,20250703,,TYMLOS,Feeling cold,,TYMLOS | Feeling cold,2024-05-06/2024-05-12
255105051,25510505,52,F,2025-03-01,20250703,,HUMIRA,Fall,HO,HUMIRA | Fall | HO,2025-02-24/2025-03-02
255105741,25510574,88,F,2024-07-28,20250703,,TYMLOS,Hyperhidrosis,,TYMLOS | Hyperhidrosis,2024-07-22/2024-07-28
255106021,25510602,56,F,2024-05-01,20250703,,TYMLOS,Gait disturbance,,TYMLOS | Gait disturbance,2024-04-29/2024-05-05
255106101,25510610,,M,,20250703,,VENCLEXTA,Transfusion,OT,VENCLEXTA | Transfusion | OT,NaT
255106481,25510648,54,F,2024-05-01,20250703,,TYMLOS,Injection site bruising,,TYMLOS | Injection site bruising,2024-04-29/2024-05-05
255106591,25510659,57,F,,20250703,,MOUNJARO,Nausea,,MOUNJARO | Nausea,NaT
255106951,25510695,75,F,,20250703,,METOPROLOL TARTRATE,Product use in unapproved indication,HO,METOPROLOL TARTRATE | Product use in unapproved indication | HO,NaT
255107171,25510717,,F,,20250703,,TYMLOS,Arthralgia,,TYMLOS | Arthralgia,NaT
255107281,25510728,63,F,2024-07-01,20250703,,TYMLOS,Unevaluable event,,TYMLOS | Unevaluable event,2024-07-01/2024-07-07
255107611,25510761,,M,,20250703,,TYMLOS,Frequent bowel movements,,TYMLOS | Frequent bowel movements,NaT
255108081,25510808,71,F,2023-11-01,20250703,,TYMLOS,Vision blurred,,TYMLOS | Vision blurred,2023-10-30/2023-11-05
255108211,25510821,,,,20250703,,SIMVASTATIN,Periarthritis,OT,SIMVASTATIN | Periarthritis | OT,NaT
255108481,25510848,65,F,2024-08-08,20250703,,TYMLOS,Migraine,,TYMLOS | Migraine,2024-08-05/2024-08-11
255108811,25510881,60,F,,20250703,,COSENTYX,Muscle tightness,OT,COSENTYX | Muscle tightness | OT,NaT
255108871,25510887,,,,20250703,,ORGOVYX,Hot flush,,ORGOVYX | Hot flush,NaT
255109452,25510945,,F,2025-06-01,20250802,,ULTOMIRIS,Arrhythmia,OT,ULTOMIRIS | Arrhythmia | OT,2025-05-26/2025-06-01
255109701,25510970,,F,,20250703,,TYMLOS,Hip fracture,,TYMLOS | Hip fracture,NaT
255110991,25511099,82,F,2024-05-23,20250703,,TYMLOS,Injection site bruising,,TYMLOS | Injection site bruising,2024-05-20/2024-05-26
255111991,25511199,56,,,20250703,,JAKAFI,Product dose omission issue,,JAKAFI | Product dose omission issue,NaT
255112341,25511234,,F,,20250703,,LYBALVI,Tremor,HO,LYBALVI | Tremor | HO,NaT
255112481,25511248,,,,20250703,,AMOXICILLIN\CLAVULANIC ACID,Drug-induced liver injury,OT,AMOXICILLIN\CLAVULANIC ACID | Drug-induced liver injury | OT,NaT
255112621,25511262,,F,,20250703,,TYMLOS,Dizziness,,TYMLOS | Dizziness,NaT
255112741,25511274,57,F,2024-10-01,20250703,,TYMLOS,Therapy interrupted,,TYMLOS | Therapy interrupted,2024-09-30/2024-10-06
255113041,25511304,79,F,2024-06-01,20250703,,TYMLOS,Chest pain,,TYMLOS | Chest pain,2024-05-27/2024-06-02
255113081,25511308,,F,,20250703,,TYMLOS,Sinusitis,,TYMLOS | Sinusitis,NaT
255114171,25511417,63,F,2024-08-27,20250703,,TYMLOS,Intentional dose omission,,TYMLOS | Intentional dose omission,2024-08-26/2024-09-01
255115551,25511555,66,F,2025-01-01,20250703,,VENCLEXTA,Death,DE,VENCLEXTA | Death | DE,2024-12-30/2025-01-05
255116051,25511605,57,F,,20250703,,BASAGLAR,Malaise,,BASAGLAR | Malaise,NaT
255116581,25511658,73,F,2024-06-08,20250703,,TYMLOS,Injury associated with device,,TYMLOS | Injury associated with device,2024-06-03/2024-06-09
255116731,25511673,68,F,2024-03-06,20250703,,TYMLOS,Illness,,TYMLOS | Illness,2024-03-04/2024-03-10
255117141,25511714,,M,,20250703,,TYMLOS,Taste disorder,,TYMLOS | Taste disorder,NaT
255117481,25511748,,F,,20250703,,TYMLOS,Back disorder,,TYMLOS | Back disorder,NaT
255117571,25511757,,F,,20250703,,TYMLOS,Pyrexia,,TYMLOS | Pyrexia,NaT
255117901,25511790,,F,,20250703,,TYMLOS,Memory impairment,,TYMLOS | Memory impairment,NaT
255117981,25511798,,F,,20250703,,TYMLOS,Bronchitis,,TYMLOS | Bronchitis,NaT
255119131,25511913,,F,,20250703,,TYMLOS,Dizziness,,TYMLOS | Dizziness,NaT
255120331,25512033,,F,,20250703,,TYMLOS,Muscle spasms,,TYMLOS | Muscle spasms,NaT
255120441,25512044,,M,,20250703,,TYMLOS,Peripheral venous disease,,TYMLOS | Peripheral venous disease,NaT
255122161,25512216,79,F,2025-04-30,20250703,,TARPEYO,Muscle spasms,HO,TARPEYO | Muscle spasms | HO,2025-04-28/2025-05-04
255122361,25512236,72,M,2025-06-12,20250703,,SODIUM CHLORIDE,White blood cell count abnormal,OT,SODIUM CHLORIDE | White blood cell count abnormal | OT,2025-06-09/2025-06-15
255122552,25512255,29,F,2025-06-11,20250716,,BOTOX COSMETIC,Injection site pain,,BOTOX COSMETIC | Injection site pain,2025-06-09/2025-06-15
255123141,25512314,,F,,20250703,,TYMLOS,Pain in extremity,,TYMLOS | Pain in extremity,NaT
255123281,25512328,70,F,2024-09-30,20250703,,TYMLOS,Muscle contractions involuntary,,TYMLOS | Muscle contractions involuntary,2024-09-30/2024-10-06
255123551,25512355,,F,,20250703,,TYMLOS,Fall,,TYMLOS | Fall,NaT
255123791,25512379,,F,,20250703,,TYMLOS,Blood pressure decreased,,TYMLOS | Blood pressure decreased,NaT
255123921,25512392,71,F,2024-06-01,20250703,,TYMLOS,Diarrhoea,,TYMLOS | Diarrhoea,2024-05-27/2024-06-02
255124912,25512491,51,F,,20250915,,POMALYST,Inappropriate schedule of product administration,,POMALYST | Inappropriate schedule of product administration,NaT
255126401,25512640,,F,,20250703,,TYMLOS,Arthralgia,,TYMLOS | Arthralgia,NaT
255126481,25512648,68,F,2024-10-31,20250703,,TYMLOS,Blood parathyroid hormone increased,,TYMLOS | Blood parathyroid hormone increased,2024-10-28/2024-11-03
255127341,25512734,,F,,20250703,,TYMLOS,Ankle fracture,,TYMLOS | Ankle fracture,NaT
255127491,25512749,,F,,20250703,,TYMLOS,Alopecia,,TYMLOS | Alopecia,NaT
255128251,25512825,,,,20250703,,BEVACIZUMAB,Radiation necrosis,OT,BEVACIZUMAB | Radiation necrosis | OT,NaT
255128325,25512832,13,M,2025-06-29,20250827,,GENOTROPIN,Drug dose omission by device,,GENOTROPIN | Drug dose omission by device,2025-06-23/2025-06-29
255128724,25512872,13,F,2025-06-20,20250825,,GENOTROPIN,Device difficult to use,,GENOTROPIN | Device difficult to use,2025-06-16/2025-06-22
255129471,25512947,,,2024-10-07,20250703,,METHYLPHENIDATE,Tremor,,METHYLPHENIDATE | Tremor,2024-10-07/2024-10-13
255130241,25513024,,F,,20250703,,MOUNJARO,Hepatic failure,LT,MOUNJARO | Hepatic failure | LT,NaT
255131741,25513174,,F,,20250703,,TYMLOS,Alopecia,,TYMLOS | Alopecia,NaT
255132041,25513204,,F,2024-06-01,20250703,,TYMLOS,Sleep disorder,,TYMLOS | Sleep disorder,2024-05-27/2024-06-02
255134331,25513433,64,F,2025-01-01,20250703,,DUPIXENT,Influenza,,DUPIXENT | Influenza,2024-12-30/2025-01-05
255134401,25513440,4,F,2023-04-01,20250703,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2023-03-27/2023-04-02
255134511,25513451,76,M,2025-01-01,20250703,,DUPIXENT,Dry skin,,DUPIXENT | Dry skin,2024-12-30/2025-01-05
255134671,25513467,9,F,,20250703,,DUPIXENT,Exposure via skin contact,,DUPIXENT | Exposure via skin contact,NaT
255136761,25513676,59,F,2024-11-01,20250703,,TYMLOS,Bone pain,,TYMLOS | Bone pain,2024-10-28/2024-11-03
255137061,25513706,,F,,20250703,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,NaT
255138031,25513803,,F,,20250703,,TYMLOS,Dizziness,,TYMLOS | Dizziness,NaT
255138151,25513815,,M,,20250703,,DUPIXENT,Rebound atopic dermatitis,,DUPIXENT | Rebound atopic dermatitis,NaT
255138161,25513816,19,F,2025-05-01,20250703,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2025-04-28/2025-05-04
255138831,25513883,71,M,2024-01-01,20250703,,DUPIXENT,Headache,,DUPIXENT | Headache,2024-01-01/2024-01-07
255138921,25513892,8,F,,20250703,,DUPIXENT,Drug effect less than expected,,DUPIXENT | Drug effect less than expected,NaT
255139031,25513903,61,F,2024-12-01,20250703,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,2024-11-25/2024-12-01
255139391,25513939,,,,20250703,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,NaT
255140361,25514036,60,F,2024-10-01,20250703,,TYMLOS,Therapy interrupted,,TYMLOS | Therapy interrupted,2024-09-30/2024-10-06
255140621,25514062,,F,,20250703,,TYMLOS,Restless legs syndrome,,TYMLOS | Restless legs syndrome,NaT
255140671,25514067,,F,2024-01-01,20250703,,TYMLOS,Joint swelling,,TYMLOS | Joint swelling,2024-01-01/2024-01-07
255140911,25514091,68,M,2024-11-01,20250703,,TYMLOS,Headache,,TYMLOS | Headache,2024-10-28/2024-11-03
255141381,25514138,,,2025-01-01,20250703,,LATISSE,Ocular hyperaemia,,LATISSE | Ocular hyperaemia,2024-12-30/2025-01-05
255142861,25514286,,F,,20250703,,TYMLOS,Nocturia,,TYMLOS | Nocturia,NaT
255142891,25514289,,F,,20250703,,TYMLOS,Headache,,TYMLOS | Headache,NaT
255144081,25514408,73,F,2024-12-31,20250703,,TYMLOS,Irritable bowel syndrome,,TYMLOS | Irritable bowel syndrome,2024-12-30/2025-01-05
255145471,25514547,,F,,20250703,,TYMLOS,Headache,,TYMLOS | Headache,NaT
255145931,25514593,75,F,2025-01-01,20250703,,TYMLOS,Heart rate increased,,TYMLOS | Heart rate increased,2024-12-30/2025-01-05
255145981,25514598,,F,,20250703,,TYMLOS,Oesophageal disorder,,TYMLOS | Oesophageal disorder,NaT
255146151,25514615,,M,,20250703,,TYMLOS,Heart rate increased,,TYMLOS | Heart rate increased,NaT
255146311,25514631,68,F,2024-10-01,20250703,,TYMLOS,Dyspepsia,,TYMLOS | Dyspepsia,2024-09-30/2024-10-06
255146431,25514643,62,F,2025-01-01,20250703,,TYMLOS,Vertigo,,TYMLOS | Vertigo,2024-12-30/2025-01-05
255146481,25514648,67,F,2025-01-23,20250703,,TYMLOS,Haemorrhage,,TYMLOS | Haemorrhage,2025-01-20/2025-01-26
255146511,25514651,70,F,2025-01-01,20250703,,TYMLOS,Headache,,TYMLOS | Headache,2024-12-30/2025-01-05
255146961,25514696,,F,,20250703,,TYMLOS,Heart rate increased,,TYMLOS | Heart rate increased,NaT
255147782,25514778,6,F,,20250723,,WINREVAIR,Pericardial effusion,OT,WINREVAIR | Pericardial effusion | OT,NaT
255148661,25514866,,F,,20250703,,TYMLOS,Memory impairment,,TYMLOS | Memory impairment,NaT
255149041,25514904,,F,,20250703,,TYMLOS,Fatigue,,TYMLOS | Fatigue,NaT
255149071,25514907,37,M,2025-06-27,20250703,,SPRAVATO,Hypertension,OT,SPRAVATO | Hypertension | OT,2025-06-23/2025-06-29
255149671,25514967,,M,,20250703,,TYMLOS,Abdominal discomfort,,TYMLOS | Abdominal discomfort,NaT
255150781,25515078,,F,,20250703,,STELARA,Cerebrovascular accident,LT,STELARA | Cerebrovascular accident | LT,NaT
255151122,25515112,,F,,20250725,,DUPIXENT,Eczema,,DUPIXENT | Eczema,NaT
255152051,25515205,67,M,2025-02-01,20250703,,FOSCARBIDOPA\FOSLEVODOPA,Mental impairment,HO,FOSCARBIDOPA\FOSLEVODOPA | Mental impairment | HO,2025-01-27/2025-02-02
255153291,25515329,81,M,,20250704,,PIOGLITAZONE,Pleural effusion,HO,PIOGLITAZONE | Pleural effusion | HO,NaT
255153791,25515379,31,F,2025-06-25,20250704,,EMGALITY,Injection site bruising,,EMGALITY | Injection site bruising,2025-06-23/2025-06-29
255153852,25515385,,M,,20250809,,DAPAGLIFLOZIN,Visual impairment,OT,DAPAGLIFLOZIN | Visual impairment | OT,NaT
255154001,25515400,72,F,,20250704,,AMLODIPINE,Paraesthesia,OT,AMLODIPINE | Paraesthesia | OT,NaT
255154061,25515406,15,M,,20250704,,CYTARABINE,Wrong technique in product usage process,OT,CYTARABINE | Wrong technique in product usage process | OT,NaT
255154581,25515458,56,F,,20250704,,AMLODIPINE BESYLATE,Headache,OT,AMLODIPINE BESYLATE | Headache | OT,NaT
255154651,25515465,64,M,,20250704,,VYALEV,Catheter site pain,,VYALEV | Catheter site pain,NaT
255154761,25515476,,F,,20250704,,DUPIXENT,Inappropriate schedule of product administration,,DUPIXENT | Inappropriate schedule of product administration,NaT
255155111,25515511,,F,,20250704,,DUPIXENT,Drug hypersensitivity,,DUPIXENT | Drug hypersensitivity,NaT
255155382,25515538,65,F,,20250714,,PREDNISOLONE,Haemophagocytic lymphohistiocytosis,HO,PREDNISOLONE | Haemophagocytic lymphohistiocytosis | HO,NaT
255156051,25515605,74,F,2025-06-26,20250704,,HIZENTRA,Infusion site pain,,HIZENTRA | Infusion site pain,2025-06-23/2025-06-29
255156411,25515641,,,,20250704,,GEMTESA,Death,OT,GEMTESA | Death | OT,NaT
255156521,25515652,81,F,2021-12-21,20250704,,SIMVASTATIN,Idiopathic pulmonary fibrosis,HO,SIMVASTATIN | Idiopathic pulmonary fibrosis | HO,2021-12-20/2021-12-26
255157651,25515765,,,2025-06-01,20250704,,XOSPATA,Myelosuppression,OT,XOSPATA | Myelosuppression | OT,2025-05-26/2025-06-01
255160104,25516010,48,F,,20250908,,WEGOVY,Haematochezia,OT,WEGOVY | Haematochezia | OT,NaT
255160181,25516018,61,F,,20250704,,VICTOZA,Pericardial effusion,OT,VICTOZA | Pericardial effusion | OT,NaT
255160191,25516019,63,F,,20250704,,WEGOVY,Self-injurious ideation,LT,WEGOVY | Self-injurious ideation | LT,NaT
255160961,25516096,77,F,,20250704,,TRANYLCYPROMINE,Drug effective for unapproved indication,OT,TRANYLCYPROMINE | Drug effective for unapproved indication | OT,NaT
255161291,25516129,,F,,20250704,,TYMLOS,Nocturia,,TYMLOS | Nocturia,NaT
255161301,25516130,,F,,20250704,,TYMLOS,Headache,,TYMLOS | Headache,NaT
255161911,25516191,89,F,2024-12-23,20250704,,TYMLOS,Illness,,TYMLOS | Illness,2024-12-23/2024-12-29
255162441,25516244,,F,2025-01-01,20250704,,TYMLOS,Loss of personal independence in daily activities,,TYMLOS | Loss of personal independence in daily activities,2024-12-30/2025-01-05
255163471,25516347,85,F,2025-03-04,20250704,,TYMLOS,Dizziness,,TYMLOS | Dizziness,2025-03-03/2025-03-09
255163551,25516355,,F,,20250704,,SPIRIVA RESPIMAT,Device issue,,SPIRIVA RESPIMAT | Device issue,NaT
255163791,25516379,,F,2025-06-01,20250704,,ZEPBOUND,Dizziness,,ZEPBOUND | Dizziness,2025-05-26/2025-06-01
255164001,25516400,,F,,20250704,,TYMLOS,Hypoacusis,,TYMLOS | Hypoacusis,NaT
255164781,25516478,,F,2025-01-01,20250704,,TYMLOS,Vision blurred,,TYMLOS | Vision blurred,2024-12-30/2025-01-05
255165131,25516513,,F,,20250704,,TYMLOS,Arthralgia,,TYMLOS | Arthralgia,NaT
255165521,25516552,,F,,20250704,,RESTASIS,Eye irritation,,RESTASIS | Eye irritation,NaT
255166201,25516620,,F,2025-03-01,20250704,,TYMLOS,Balance disorder,,TYMLOS | Balance disorder,2025-02-24/2025-03-02
255167171,25516717,55,F,,20250704,,METRONIDAZOLE,Dizziness,OT,METRONIDAZOLE | Dizziness | OT,NaT
255167371,25516737,,F,,20250704,,TYMLOS,Blood alkaline phosphatase increased,,TYMLOS | Blood alkaline phosphatase increased,NaT
255167501,25516750,,F,,20250704,,TYMLOS,Cough,,TYMLOS | Cough,NaT
255170181,25517018,,F,,20250704,,TYMLOS,Adverse event,,TYMLOS | Adverse event,NaT
255170541,25517054,69,F,2024-11-01,20250704,,TYMLOS,Upper respiratory tract congestion,,TYMLOS | Upper respiratory tract congestion,2024-10-28/2024-11-03
255171001,25517100,,,,20250704,,GABAPENTIN,Anxiety,,GABAPENTIN | Anxiety,NaT
255171161,25517116,,F,2025-01-01,20250704,,TYMLOS,Rash pruritic,,TYMLOS | Rash pruritic,2024-12-30/2025-01-05
255171781,25517178,80,F,2025-06-04,20250704,,DUPIXENT,Infection,HO,DUPIXENT | Infection | HO,2025-06-02/2025-06-08
255172271,25517227,,,,20250704,,BEVACIZUMAB,Off label use,HO,BEVACIZUMAB | Off label use | HO,NaT
255172311,25517231,49,F,2025-05-01,20250704,,STELARA,Device related infection,HO,STELARA | Device related infection | HO,2025-04-28/2025-05-04
255172631,25517263,,M,,20250704,,ATEZOLIZUMAB,Hepatic lesion,OT,ATEZOLIZUMAB | Hepatic lesion | OT,NaT
255172871,25517287,,,2025-06-18,20250704,,ELIGARD,Intercepted product preparation error,,ELIGARD | Intercepted product preparation error,2025-06-16/2025-06-22
255173291,25517329,64,M,2025-04-01,20250704,,TYMLOS,Pruritus,,TYMLOS | Pruritus,2025-03-31/2025-04-06
255173451,25517345,65,F,2025-04-15,20250704,,TYMLOS,Feeling abnormal,,TYMLOS | Feeling abnormal,2025-04-14/2025-04-20
255174131,25517413,,,,20250704,,AMOXICILLIN\CLAVULANIC ACID,Drug-induced liver injury,OT,AMOXICILLIN\CLAVULANIC ACID | Drug-induced liver injury | OT,NaT
255174391,25517439,,F,,20250704,,ARNUITY ELLIPTA,Off label use,,ARNUITY ELLIPTA | Off label use,NaT
255174511,25517451,36,F,,20250704,,ZEPBOUND,Accidental underdose,,ZEPBOUND | Accidental underdose,NaT
255174881,25517488,14,M,2025-02-01,20250704,,PREGABALIN,Seizure,DE,PREGABALIN | Seizure | DE,2025-01-27/2025-02-02
255175314,25517531,18,M,2025-07-25,20250925,,VEDOLIZUMAB,Haematocrit decreased,HO,VEDOLIZUMAB | Haematocrit decreased | HO,2025-07-21/2025-07-27
255175541,25517554,,F,,20250704,,DARZALEX FASPRO,Abdominal distension,,DARZALEX FASPRO | Abdominal distension,NaT
255175632,25517563,60,M,2025-06-20,20250810,,BRILINTA,Acute myocardial infarction,HO,BRILINTA | Acute myocardial infarction | HO,2025-06-16/2025-06-22
255176001,25517600,,,,20250704,,LAMOTRIGINE,Hypomania,OT,LAMOTRIGINE | Hypomania | OT,NaT
255177472,25517747,81,M,2025-06-23,20250809,,FASENRA,Death,DE,FASENRA | Death | DE,2025-06-23/2025-06-29
255177612,25517761,,F,,20250816,,CALQUENCE,Bronchitis,,CALQUENCE | Bronchitis,NaT
255177953,25517795,49,F,2025-01-01,20250925,,LYNPARZA,Mean cell volume abnormal,OT,LYNPARZA | Mean cell volume abnormal | OT,2024-12-30/2025-01-05
255178212,25517821,42,F,2025-06-16,20250809,,SOLIRIS,Infection,HO,SOLIRIS | Infection | HO,2025-06-16/2025-06-22
255178672,25517867,,M,,20250810,,SYMBICORT,Device malfunction,LT,SYMBICORT | Device malfunction | LT,NaT
255179932,25517993,,M,2025-06-26,20250722,,REPATHA,Palpitations,,REPATHA | Palpitations,2025-06-23/2025-06-29
255180491,25518049,,,,20250704,,FLUOCINOLONE ACETONIDE,Product leakage,,FLUOCINOLONE ACETONIDE | Product leakage,NaT
255181663,25518166,,,,20250920,,ALBUTEROL SULFATE,Wrong technique in product usage process,,ALBUTEROL SULFATE | Wrong technique in product usage process,NaT
255181752,25518175,,F,,20250816,,TEZSPIRE,Dyspnoea,,TEZSPIRE | Dyspnoea,NaT
255182181,25518218,,,,20250704,,BORTEZOMIB,Plasma cell myeloma,OT,BORTEZOMIB | Plasma cell myeloma | OT,NaT
255183192,25518319,78,M,2025-04-01,20250717,,RINVOQ,Back pain,OT,RINVOQ | Back pain | OT,2025-03-31/2025-04-06
255183271,25518327,52,F,,20250704,,MOUNJARO,Product dose omission issue,,MOUNJARO | Product dose omission issue,NaT
255183662,25518366,,,,20250816,,CALQUENCE,Breath odour,,CALQUENCE | Breath odour,NaT
255183931,25518393,75,F,2025-05-30,20250704,,TICAGRELOR,Thrombocytopenia,HO,TICAGRELOR | Thrombocytopenia | HO,2025-05-26/2025-06-01
255184221,25518422,,F,,20250704,,TRELEGY ELLIPTA,Wrong technique in device usage process,,TRELEGY ELLIPTA | Wrong technique in device usage process,NaT
255184621,25518462,,,,20250704,,ORGOVYX,Product use issue,,ORGOVYX | Product use issue,NaT
255185151,25518515,35,F,2025-01-01,20250704,,SPRAVATO,Toxicity to various agents,OT,SPRAVATO | Toxicity to various agents | OT,2024-12-30/2025-01-05
255185221,25518522,24,M,,20250704,,DIPHENHYDRAMINE,Toxicity to various agents,OT,DIPHENHYDRAMINE | Toxicity to various agents | OT,NaT
255185301,25518530,48,F,2025-05-02,20250704,,VUMERITY,Memory impairment,,VUMERITY | Memory impairment,2025-04-28/2025-05-04
255185361,25518536,,M,,20250704,,GENOSYL,Device issue,,GENOSYL | Device issue,NaT
255186271,25518627,,F,,20250704,,ICLUSIG,Septic shock,DE,ICLUSIG | Septic shock | DE,NaT
255186511,25518651,,F,,20250704,,ZEPBOUND,Underdose,,ZEPBOUND | Underdose,NaT
255187361,25518736,,,2018-06-01,20250704,,IBUPROFEN,Intentional overdose,HO,IBUPROFEN | Intentional overdose | HO,2018-05-28/2018-06-03
255187781,25518778,22,M,2015-07-01,20250704,,CYTARABINE,Stomatitis,HO,CYTARABINE | Stomatitis | HO,2015-06-29/2015-07-05
255187853,25518785,43,F,,20250930,,ACTEMRA,Muscle injury,HO,ACTEMRA | Muscle injury | HO,NaT
255189083,25518908,70,F,,20250716,,LASIX,Muscular weakness,HO,LASIX | Muscular weakness | HO,NaT
255189271,25518927,69,F,2025-06-27,20250704,,ZEPBOUND,Throat tightness,,ZEPBOUND | Throat tightness,2025-06-23/2025-06-29
255189301,25518930,,,,20250704,,ZEPBOUND,Nausea,,ZEPBOUND | Nausea,NaT
255189334,25518933,44,F,2025-06-01,20250722,,ZEPBOUND,Drug ineffective,,ZEPBOUND | Drug ineffective,2025-05-26/2025-06-01
255189451,25518945,34,F,,20250704,,INSULIN NOS,Condition aggravated,OT,INSULIN NOS | Condition aggravated | OT,NaT
255189771,25518977,83,F,2025-06-19,20250704,,NUPLAZID,Death,DE,NUPLAZID | Death | DE,2025-06-16/2025-06-22
255189991,25518999,63,F,,20250704,,GILTERITINIB,Off label use,OT,GILTERITINIB | Off label use | OT,NaT
255190221,25519022,,F,,20250704,,XOLAIR PFS,Pruritus,,XOLAIR PFS | Pruritus,NaT
255190331,25519033,,M,,20250704,,NUPLAZID,Back pain,,NUPLAZID | Back pain,NaT
255190801,25519080,,M,,20250704,,NUPLAZID,Death,DE,NUPLAZID | Death | DE,NaT
255190961,25519096,,F,,20250704,,DEFITELIO,Multiple organ dysfunction syndrome,OT,DEFITELIO | Multiple organ dysfunction syndrome | OT,NaT
255191541,25519154,,F,,20250704,,REPATHA,Therapy non-responder,,REPATHA | Therapy non-responder,NaT
255192031,25519203,48,F,,20250704,,MOUNJARO,Injection site pain,,MOUNJARO | Injection site pain,NaT
255192322,25519232,84,M,2025-06-01,20250806,,NEULASTA,Device adhesion issue,,NEULASTA | Device adhesion issue,2025-05-26/2025-06-01
255192641,25519264,61,F,,20250704,,MACITENTAN\TADALAFIL,Hospitalisation,HO,MACITENTAN\TADALAFIL | Hospitalisation | HO,NaT
255192701,25519270,65,F,,20250704,,AMLODIPINE,Oedema,OT,AMLODIPINE | Oedema | OT,NaT
255193561,25519356,13,M,,20250704,,FLUDARABINE,Aplastic anaemia,OT,FLUDARABINE | Aplastic anaemia | OT,NaT
255194011,25519401,,F,,20250704,,XYWAV,Dysphoria,OT,XYWAV | Dysphoria | OT,NaT
255194531,25519453,,F,2025-05-01,20250704,,NUCALA,Hypothermia,OT,NUCALA | Hypothermia | OT,2025-04-28/2025-05-04
255195342,25519534,,,2025-06-15,20250716,,CHILDRENS MOTRIN,Therapeutic product effect incomplete,HO,CHILDRENS MOTRIN | Therapeutic product effect incomplete | HO,2025-06-09/2025-06-15
255195461,25519546,39,F,2022-05-03,20250704,,LORYNA,Memory impairment,OT,LORYNA | Memory impairment | OT,2022-05-02/2022-05-08
255196451,25519645,,,,20250704,,CREON,Off label use,,CREON | Off label use,NaT
255199441,25519944,88,M,,20250704,,DUPIXENT,Dandruff,,DUPIXENT | Dandruff,NaT
255199711,25519971,81,F,2025-01-01,20250704,,XIFAXAN,Hospitalisation,HO,XIFAXAN | Hospitalisation | HO,2024-12-30/2025-01-05
255199991,25519999,66,M,2025-07-01,20250704,,TOUJEO,Product storage error,,TOUJEO | Product storage error,2025-06-30/2025-07-06
255201541,25520154,,F,,20250704,,METHOTREXATE,Wound infection,OT,METHOTREXATE | Wound infection | OT,NaT
255202051,25520205,68,F,2023-11-28,20250704,,VALACYCLOVIR HYDROCHLORIDE,Drug reaction with eosinophilia and systemic symptoms,OT,VALACYCLOVIR HYDROCHLORIDE | Drug reaction with eosinophilia and systemic symptoms | OT,2023-11-27/2023-12-03
255202471,25520247,72,F,,20250704,,CEFTRIAXONE,Pancytopenia,HO,CEFTRIAXONE | Pancytopenia | HO,NaT
255202561,25520256,89,M,,20250704,,PREDNISONE,Dysphagia,HO,PREDNISONE | Dysphagia | HO,NaT
255202671,25520267,67,F,,20250704,,REVLIMID,Inappropriate schedule of product administration,,REVLIMID | Inappropriate schedule of product administration,NaT
255204311,25520431,45,F,2024-01-05,20250704,,TRULICITY,Overdose,HO,TRULICITY | Overdose | HO,2024-01-01/2024-01-07
255204921,25520492,24,F,2025-05-28,20250704,,METHOTREXATE SODIUM,Rash,HO,METHOTREXATE SODIUM | Rash | HO,2025-05-26/2025-06-01
255205613,25520561,43,M,2025-06-26,20250922,,ADVATE,Haemorrhage,OT,ADVATE | Haemorrhage | OT,2025-06-23/2025-06-29
255206343,25520634,12,,2025-07-02,20250716,,OMNITROPE,Device leakage,,OMNITROPE | Device leakage,2025-06-30/2025-07-06
255206521,25520652,78,F,2024-01-10,20250705,,TYVASO DPI,Wound,,TYVASO DPI | Wound,2024-01-08/2024-01-14
255206581,25520658,26,F,2025-01-01,20250705,,DUPIXENT,Pain,,DUPIXENT | Pain,2024-12-30/2025-01-05
255206622,25520662,,M,,20250816,,BREZTRI,Nasal congestion,,BREZTRI | Nasal congestion,NaT
255206843,25520684,64,M,2025-01-01,20250831,,DUPIXENT,Dyspnoea exertional,HO,DUPIXENT | Dyspnoea exertional | HO,2024-12-30/2025-01-05
255207441,25520744,87,M,2025-06-19,20250705,,NITROFURANTOIN,Vasculitis,OT,NITROFURANTOIN | Vasculitis | OT,2025-06-16/2025-06-22
255207892,25520789,,M,,20250818,,COSENTYX,Product storage error,,COSENTYX | Product storage error,NaT
255208641,25520864,63,F,2025-06-01,20250705,,DUPIXENT,Dysphagia,,DUPIXENT | Dysphagia,2025-05-26/2025-06-01
255208881,25520888,43,F,2025-06-23,20250705,,ISTURISA,Hereditary ataxia,OT,ISTURISA | Hereditary ataxia | OT,2025-06-23/2025-06-29
255209351,25520935,56,F,2025-01-01,20250705,,DUPIXENT,Asthma,,DUPIXENT | Asthma,2024-12-30/2025-01-05
255210221,25521022,61,M,,20250705,,METFORMIN,Hypomagnesaemia,HO,METFORMIN | Hypomagnesaemia | HO,NaT
255211392,25521139,80,M,2025-05-01,20250719,,TYVASO DPI,Asthenia,HO,TYVASO DPI | Asthenia | HO,2025-04-28/2025-05-04
255212101,25521210,51,F,2025-06-01,20250705,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,2025-05-26/2025-06-01
255212261,25521226,37,M,2025-06-23,20250705,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2025-06-23/2025-06-29
255213781,25521378,55,M,2025-04-01,20250705,,FILSPARI,Scratch,,FILSPARI | Scratch,2025-03-31/2025-04-06
255213991,25521399,,M,,20250706,,BASAGLAR,Blood glucose increased,,BASAGLAR | Blood glucose increased,NaT
255214511,25521451,4,F,,20250706,,GLYCOPYRROLATE,Stress cardiomyopathy,HO,GLYCOPYRROLATE | Stress cardiomyopathy | HO,NaT
255215831,25521583,47,,2025-05-14,20250706,,ACCUTANE,Product dose omission issue,,ACCUTANE | Product dose omission issue,2025-05-12/2025-05-18
255216242,25521624,,F,,20250816,,BREZTRI,Device malfunction,,BREZTRI | Device malfunction,NaT
255217471,25521747,69,M,,20250706,,TAZVERIK,Off label use,DE,TAZVERIK | Off label use | DE,NaT
255217882,25521788,,M,,20250914,,DUPIXENT,Neurodermatitis,,DUPIXENT | Neurodermatitis,NaT
255218481,25521848,70,M,2025-06-24,20250706,,CARBIDOPA\LEVODOPA,Cardiac arrest,DE,CARBIDOPA\LEVODOPA | Cardiac arrest | DE,2025-06-23/2025-06-29
255218592,25521859,,F,,20250813,,HUMIRA,Mental disorder,HO,HUMIRA | Mental disorder | HO,NaT
255218891,25521889,69,F,2025-07-01,20250706,,RINVOQ,Diarrhoea,OT,RINVOQ | Diarrhoea | OT,2025-06-30/2025-07-06
255219111,25521911,,F,,20250706,,ELIQUIS,Post procedural stroke,OT,ELIQUIS | Post procedural stroke | OT,NaT
255219501,25521950,,,,20250706,,BOTOX COSMETIC,Product temperature excursion issue,,BOTOX COSMETIC | Product temperature excursion issue,NaT
255220883,25522088,,F,,20250916,,COSENTYX,Injection site erythema,,COSENTYX | Injection site erythema,NaT
255221201,25522120,,F,,20250707,,ARANESP,Off label use,HO,ARANESP | Off label use | HO,NaT
255221241,25522124,70,F,2024-12-01,20250707,,RINVOQ,Urinary tract infection,HO,RINVOQ | Urinary tract infection | HO,2024-11-25/2024-12-01
255221411,25522141,,F,,20250707,,XOLAIR,Idiopathic urticaria,,XOLAIR | Idiopathic urticaria,NaT
255221801,25522180,,M,,20250707,,ACTEMRA,Skin reaction,,ACTEMRA | Skin reaction,NaT
255221843,25522184,69,M,2023-01-01,20250810,,FASENRA,Dyspnoea paroxysmal nocturnal,OT,FASENRA | Dyspnoea paroxysmal nocturnal | OT,2022-12-26/2023-01-01
255222051,25522205,47,F,2022-12-01,20250707,,SKYRIZI,Cerebrovascular accident,OT,SKYRIZI | Cerebrovascular accident | OT,2022-11-28/2022-12-04
255222191,25522219,,F,,20250707,,OZEMPIC,Weight increased,OT,OZEMPIC | Weight increased | OT,NaT
255222291,25522229,74,F,,20250707,,ZEPBOUND,Mobility decreased,,ZEPBOUND | Mobility decreased,NaT
255222361,25522236,50,F,,20250707,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
255222941,25522294,,,,20250707,,BORTEZOMIB,Plasma cell myeloma,OT,BORTEZOMIB | Plasma cell myeloma | OT,NaT
255223971,25522397,,,,20250707,,OFEV,Condition aggravated,DE,OFEV | Condition aggravated | DE,NaT
255224171,25522417,70,F,2024-10-01,20250707,,DRONABINOL,Asthenia,OT,DRONABINOL | Asthenia | OT,2024-09-30/2024-10-06
255224591,25522459,36,F,2025-06-06,20250707,,SODIUM CHLORIDE,Hepatic function abnormal,DS,SODIUM CHLORIDE | Hepatic function abnormal | DS,2025-06-02/2025-06-08
255225441,25522544,,,,20250707,,YESINTEK,Extra dose administered,,YESINTEK | Extra dose administered,NaT
255225541,25522554,39,M,2025-06-24,20250707,,HUMIRA,Product packaging issue,,HUMIRA | Product packaging issue,2025-06-23/2025-06-29
255226332,25522633,50,M,,20250810,,BENRALIZUMAB,Lower respiratory tract infection,OT,BENRALIZUMAB | Lower respiratory tract infection | OT,NaT
255226631,25522663,,M,,20250707,,XOLAIR PFS,Urticaria,HO,XOLAIR PFS | Urticaria | HO,NaT
255227871,25522787,,,,20250707,,SOMATULINE DEPOT,Injection site atrophy,,SOMATULINE DEPOT | Injection site atrophy,NaT
255228561,25522856,85,F,2025-01-01,20250707,,METRONIDAZOLE,Blood pressure increased,OT,METRONIDAZOLE | Blood pressure increased | OT,2024-12-30/2025-01-05
255229221,25522922,,F,2025-01-01,20250707,,BIMEKIZUMAB,Ankylosing spondylitis,OT,BIMEKIZUMAB | Ankylosing spondylitis | OT,2024-12-30/2025-01-05
255229401,25522940,,M,,20250707,,NUPLAZID,Drug intolerance,,NUPLAZID | Drug intolerance,NaT
255230622,25523062,,,,20250727,,ZONISAMIDE,Lupus-like syndrome,HO,ZONISAMIDE | Lupus-like syndrome | HO,NaT
255231062,25523106,63,M,2025-06-04,20250805,,ANORO ELLIPTA,Product complaint,,ANORO ELLIPTA | Product complaint,2025-06-02/2025-06-08
255231792,25523179,,,,20250714,,ORGOVYX,Hyperhidrosis,,ORGOVYX | Hyperhidrosis,NaT
255232001,25523200,,F,,20250707,,BENLYSTA,Hospitalisation,HO,BENLYSTA | Hospitalisation | HO,NaT
255232751,25523275,,M,,20250707,,CABENUVA,Treatment failure,,CABENUVA | Treatment failure,NaT
255233081,25523308,,F,,20250707,,GATTEX,No adverse event,,GATTEX | No adverse event,NaT
255233881,25523388,79,M,2025-04-04,20250707,,BAVENCIO,Pneumonia,OT,BAVENCIO | Pneumonia | OT,2025-03-31/2025-04-06
255235341,25523534,,F,,20250707,,ESTRADIOL\NORETHINDRONE ACETATE,Symptom recurrence,,ESTRADIOL\NORETHINDRONE ACETATE | Symptom recurrence,NaT
255236121,25523612,,,,20250707,,GEMTESA,Dizziness,,GEMTESA | Dizziness,NaT
255236151,25523615,,,,20250707,,ORGOVYX,Myalgia,,ORGOVYX | Myalgia,NaT
255236461,25523646,,,,20250707,,ORGOVYX,Fungal infection,,ORGOVYX | Fungal infection,NaT
255236852,25523685,26,M,,20250818,,VIMPAT,Memory impairment,OT,VIMPAT | Memory impairment | OT,NaT
255237241,25523724,78,M,2025-02-19,20250707,,GILOTRIF,Interstitial lung disease,DE,GILOTRIF | Interstitial lung disease | DE,2025-02-17/2025-02-23
255237771,25523777,45,F,,20250707,,AVASTIN,Pneumocystis jirovecii pneumonia,OT,AVASTIN | Pneumocystis jirovecii pneumonia | OT,NaT
255238411,25523841,,M,,20250707,,NUPLAZID,Somnolence,,NUPLAZID | Somnolence,NaT
255238691,25523869,23,F,2025-07-03,20250703,,NEXPLANON,Pregnancy with contraceptive device,RI,NEXPLANON | Pregnancy with contraceptive device | RI,2025-06-30/2025-07-06
255238811,25523881,,,,20250707,,VERZENIO,Hepatic cirrhosis,OT,VERZENIO | Hepatic cirrhosis | OT,NaT
255238821,25523882,68,F,,20250707,,VERZENIO,Cardiac disorder,HO,VERZENIO | Cardiac disorder | HO,NaT
255240251,25524025,,,,20250707,,AVASTIN,No adverse event,,AVASTIN | No adverse event,NaT
255241001,25524100,58,M,,20250707,,FLUDARABINE,Congenital aplasia,DE,FLUDARABINE | Congenital aplasia | DE,NaT
255241482,25524148,,F,2025-01-01,20250918,,ALDACTONE,Crohn's disease,HO,ALDACTONE | Crohn's disease | HO,2024-12-30/2025-01-05
255241621,25524162,75,M,,20250707,,APIXABAN,Off label use,HO,APIXABAN | Off label use | HO,NaT
255242201,25524220,19,F,,20250707,,FLUCONAZOLE,Drug reaction with eosinophilia and systemic symptoms,LT,FLUCONAZOLE | Drug reaction with eosinophilia and systemic symptoms | LT,NaT
255243081,25524308,46,F,2025-05-01,20250707,,VYLEESI,Pain,,VYLEESI | Pain,2025-04-28/2025-05-04
255243981,25524398,,F,2025-05-01,20250707,,RAMIPRIL,Intentional overdose,OT,RAMIPRIL | Intentional overdose | OT,2025-04-28/2025-05-04
255244492,25524449,,M,,20250730,,VEDOLIZUMAB,Constipation,OT,VEDOLIZUMAB | Constipation | OT,NaT
255245131,25524513,60,M,,20250707,,ACYCLOVIR,Epilepsy,HO,ACYCLOVIR | Epilepsy | HO,NaT
255245192,25524519,,,,20250721,,BEVACIZUMAB,Diarrhoea,DE,BEVACIZUMAB | Diarrhoea | DE,NaT
255245775,25524577,25,F,2025-08-20,20250904,,TREPROSTINIL,Dyspnoea,HO,TREPROSTINIL | Dyspnoea | HO,2025-08-18/2025-08-24
255246161,25524616,79,F,2025-06-25,20250707,,LEQVIO,Peripheral swelling,,LEQVIO | Peripheral swelling,2025-06-23/2025-06-29
255246291,25524629,47,F,2025-06-25,20250707,,ULTRAVIST,Erythema,LT,ULTRAVIST | Erythema | LT,2025-06-23/2025-06-29
255246711,25524671,76,F,,20250707,,MIDAZOLAM,Drug ineffective,LT,MIDAZOLAM | Drug ineffective | LT,NaT
255247001,25524700,92,F,,20250704,,XELJANZ XR,Death,DE,XELJANZ XR | Death | DE,NaT
255247301,25524730,,F,2025-06-12,20250707,,PEMBROLIZUMAB,Procedural haemorrhage,OT,PEMBROLIZUMAB | Procedural haemorrhage | OT,2025-06-09/2025-06-15
255247951,25524795,55,M,,20250707,,PAXLOVID,Taste disorder,,PAXLOVID | Taste disorder,NaT
255248831,25524883,36,F,2001-01-01,20250707,,ENBREL,Injection site bruising,HO,ENBREL | Injection site bruising | HO,2001-01-01/2001-01-07
255248871,25524887,34,F,,20250707,,ULIPRISTAL ACETATE,Medication error,DS,ULIPRISTAL ACETATE | Medication error | DS,NaT
255249031,25524903,67,M,,20250707,,VANCOMYCIN,Clostridium difficile colitis,HO,VANCOMYCIN | Clostridium difficile colitis | HO,NaT
255250231,25525023,65,F,,20250707,,APIDRA,Hypoglycaemia,,APIDRA | Hypoglycaemia,NaT
255251451,25525145,27,F,2025-01-01,20250707,,DUPIXENT,Mood swings,,DUPIXENT | Mood swings,2024-12-30/2025-01-05
255251531,25525153,,,,20250706,,DESVENLAFAXINE,Nausea,DS,DESVENLAFAXINE | Nausea | DS,NaT
255251721,25525172,78,,,20250707,,JAKAFI,Pulmonary embolism,HO,JAKAFI | Pulmonary embolism | HO,NaT
255251792,25525179,56,F,2025-01-01,20250806,,DUPIXENT,Conjunctivitis,,DUPIXENT | Conjunctivitis,2024-12-30/2025-01-05
255254641,25525464,38,F,2025-02-09,20250707,,HUMIRA,Renal colic,HO,HUMIRA | Renal colic | HO,2025-02-03/2025-02-09
255255221,25525522,,F,,20250707,,CRIZOTINIB,Myelosuppression,OT,CRIZOTINIB | Myelosuppression | OT,NaT
255255541,25525554,81,F,2025-01-01,20250707,,MOUNJARO,Localised infection,OT,MOUNJARO | Localised infection | OT,2024-12-30/2025-01-05
255256121,25525612,60,F,2025-04-23,20250707,,OXALIPLATIN,Condition aggravated,HO,OXALIPLATIN | Condition aggravated | HO,2025-04-21/2025-04-27
255256181,25525618,,F,,20250707,,ICATIBANT ACETATE,Ill-defined disorder,,ICATIBANT ACETATE | Ill-defined disorder,NaT
255256201,25525620,,,2017-11-02,20250707,,CYTOTEC,Maternal exposure during pregnancy,LT,CYTOTEC | Maternal exposure during pregnancy | LT,2017-10-30/2017-11-05
255257381,25525738,77,M,,20250707,,NUBEQA,Gastrooesophageal reflux disease,HO,NUBEQA | Gastrooesophageal reflux disease | HO,NaT
255257662,25525766,,F,,20250810,,BENRALIZUMAB,Fatigue,OT,BENRALIZUMAB | Fatigue | OT,NaT
255257802,25525780,77,F,,20250813,,DUPIXENT,Dyspnoea,,DUPIXENT | Dyspnoea,NaT
255258263,25525826,27,M,2025-06-27,20250903,,KOVALTRY,Testicular swelling,OT,KOVALTRY | Testicular swelling | OT,2025-06-23/2025-06-29
255260502,25526050,71,,,20250716,,ZEPBOUND,Alopecia,,ZEPBOUND | Alopecia,NaT
255261071,25526107,,,,20250707,,NUBEQA,Neuropathy peripheral,OT,NUBEQA | Neuropathy peripheral | OT,NaT
255261112,25526111,54,F,2025-06-29,20250809,,LYNPARZA,Myelosuppression,OT,LYNPARZA | Myelosuppression | OT,2025-06-23/2025-06-29
255261211,25526121,69,M,2025-06-19,20250707,,NUBEQA,Drug ineffective,,NUBEQA | Drug ineffective,2025-06-16/2025-06-22
255261813,25526181,60,M,2025-01-01,20250822,,ORENITRAM,Dyspnoea,HO,ORENITRAM | Dyspnoea | HO,2024-12-30/2025-01-05
255262493,25526249,1,M,2024-11-26,20250814,,VINCRISTINE SULFATE,Pyrexia,HO,VINCRISTINE SULFATE | Pyrexia | HO,2024-11-25/2024-12-01
255263631,25526363,85,M,,20250707,,REVLIMID,Diarrhoea,,REVLIMID | Diarrhoea,NaT
255265192,25526519,71,F,2025-01-02,20250821,,DEXAMETHASONE,Hypothyroidism,HO,DEXAMETHASONE | Hypothyroidism | HO,2024-12-30/2025-01-05
255265721,25526572,,F,,20250707,,CORTICOTROPIN,Illness,,CORTICOTROPIN | Illness,NaT
255266621,25526662,,M,,20250707,,LORBRENA,Multiple organ dysfunction syndrome,DE,LORBRENA | Multiple organ dysfunction syndrome | DE,NaT
255266712,25526671,,,,20250708,,PROPRANOLOL HYDROCHLORIDE,Haemorrhage,DE,PROPRANOLOL HYDROCHLORIDE | Haemorrhage | DE,NaT
255269471,25526947,,F,,20250707,,BOTOX,Off label use,,BOTOX | Off label use,NaT
255269821,25526982,,F,2025-07-01,20250707,,ALBUTEROL SULFATE,Incorrect dose administered,,ALBUTEROL SULFATE | Incorrect dose administered,2025-06-30/2025-07-06
255269881,25526988,,F,,20250708,,IMBRUVICA,Hospice care,OT,IMBRUVICA | Hospice care | OT,NaT
255269961,25526996,,F,,20250708,,BELIMUMAB,Mucosal discolouration,HO,BELIMUMAB | Mucosal discolouration | HO,NaT
255270051,25527005,84,M,,20250708,,CARBIDOPA\LEVODOPA,Respiratory tract infection,DE,CARBIDOPA\LEVODOPA | Respiratory tract infection | DE,NaT
255270221,25527022,,F,,20250708,,ZEJULA,Recurrent cancer,OT,ZEJULA | Recurrent cancer | OT,NaT
255270431,25527043,62,M,,20250708,,RINVOQ,Septic shock,DE,RINVOQ | Septic shock | DE,NaT
255271781,25527178,45,F,2025-05-05,20250708,,ELIGARD,Device occlusion,,ELIGARD | Device occlusion,2025-05-05/2025-05-11
255271921,25527192,,,2025-01-01,20250708,,ISOTRETINOIN,Fatigue,,ISOTRETINOIN | Fatigue,2024-12-30/2025-01-05
255272021,25527202,64,F,2024-11-01,20250708,,RINVOQ,Fibula fracture,OT,RINVOQ | Fibula fracture | OT,2024-10-28/2024-11-03
255272933,25527293,53,F,2025-01-01,20250912,,SKYRIZI,Cyst rupture,HO,SKYRIZI | Cyst rupture | HO,2024-12-30/2025-01-05
255273331,25527333,,F,,20250708,,ALBUTEROL SULFATE,Wrong technique in product usage process,,ALBUTEROL SULFATE | Wrong technique in product usage process,NaT
255273943,25527394,68,M,,20250822,,ORGOVYX,Fatigue,OT,ORGOVYX | Fatigue | OT,NaT
255274182,25527418,,M,,20250710,,VEDOLIZUMAB,Crohn's disease,OT,VEDOLIZUMAB | Crohn's disease | OT,NaT
255274501,25527450,34,M,2025-06-01,20250708,,OZEMPIC,Urticaria,HO,OZEMPIC | Urticaria | HO,2025-05-26/2025-06-01
255275012,25527501,,F,2025-06-24,20250723,,WEGOVY,Asphyxia,OT,WEGOVY | Asphyxia | OT,2025-06-23/2025-06-29
255275821,25527582,,,2025-06-27,20250708,,NOURIANZ,Fall,,NOURIANZ | Fall,2025-06-23/2025-06-29
255275841,25527584,78,F,2025-05-18,20250708,,IRINOTECAN,Agranulocytosis,HO,IRINOTECAN | Agranulocytosis | HO,2025-05-12/2025-05-18
255277391,25527739,58,F,2025-07-03,20250708,,SPRAVATO,Adverse event,OT,SPRAVATO | Adverse event | OT,2025-06-30/2025-07-06
255277542,25527754,,F,2025-04-16,20250717,,KISQALI,Hypertension,HO,KISQALI | Hypertension | HO,2025-04-14/2025-04-20
255279021,25527902,75,F,2025-06-04,20250708,,NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE,Product container issue,,NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE | Product container issue,2025-06-02/2025-06-08
255279122,25527912,,F,2025-06-05,20250730,,COSENTYX,Pyrexia,,COSENTYX | Pyrexia,2025-06-02/2025-06-08
255280231,25528023,5,F,,20250708,,ACARBOSE,Drug ineffective for unapproved indication,HO,ACARBOSE | Drug ineffective for unapproved indication | HO,NaT
255280811,25528081,19,F,2020-12-30,20250708,,ACETAMINOPHEN,Acute hepatic failure,LT,ACETAMINOPHEN | Acute hepatic failure | LT,2020-12-28/2021-01-03
255280862,25528086,,F,,20250806,,TYVASO DPI,Sinus headache,,TYVASO DPI | Sinus headache,NaT
255280981,25528098,71,F,,20250708,,VERAPAMIL,Off label use,,VERAPAMIL | Off label use,NaT
255281481,25528148,15,F,,20250708,,DIENOGEST,Disease recurrence,OT,DIENOGEST | Disease recurrence | OT,NaT
255282161,25528216,,M,,20250708,,TAVALISSE,Localised infection,HO,TAVALISSE | Localised infection | HO,NaT
255282361,25528236,69,F,,20250708,,OXALIPLATIN,Jaundice cholestatic,DE,OXALIPLATIN | Jaundice cholestatic | DE,NaT
255283111,25528311,39,F,2021-07-26,20250708,,PARAGARD T 380A,Complication of device removal,OT,PARAGARD T 380A | Complication of device removal | OT,2021-07-26/2021-08-01
255284051,25528405,36,F,2024-09-01,20250708,,XOLAIR,Needle issue,,XOLAIR | Needle issue,2024-08-26/2024-09-01
255284841,25528484,,,,20250708,,PREDNISONE,Malignant neoplasm progression,OT,PREDNISONE | Malignant neoplasm progression | OT,NaT
255285461,25528546,58,M,2025-03-31,20250708,,TECENTRIQ,Fulminant type 1 diabetes mellitus,HO,TECENTRIQ | Fulminant type 1 diabetes mellitus | HO,2025-03-31/2025-04-06
255286122,25528612,,,,20250709,,RISANKIZUMAB,Product storage error,,RISANKIZUMAB | Product storage error,NaT
255286472,25528647,,F,,20250810,,CALQUENCE,Dyspepsia,,CALQUENCE | Dyspepsia,NaT
255286871,25528687,55,F,2025-07-02,20250708,,SPRAVATO,Hypertension,OT,SPRAVATO | Hypertension | OT,2025-06-30/2025-07-06
255287021,25528702,58,M,2025-07-04,20250708,,TRULICITY,Incorrect dose administered,,TRULICITY | Incorrect dose administered,2025-06-30/2025-07-06
255287061,25528706,55,F,,20250708,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
255287331,25528733,88,M,2023-09-01,20250708,,PRADAXA,Spinal fracture,HO,PRADAXA | Spinal fracture | HO,2023-08-28/2023-09-03
255288103,25528810,72,M,2024-10-12,20250804,,LEUCOVORIN,Atrial fibrillation,OT,LEUCOVORIN | Atrial fibrillation | OT,2024-10-07/2024-10-13
255289141,25528914,,F,,20250708,,RITUXAN,Malaise,,RITUXAN | Malaise,NaT
255289291,25528929,27,F,2025-06-01,20250708,,BOTOX COSMETIC,Therapeutic product effect incomplete,,BOTOX COSMETIC | Therapeutic product effect incomplete,2025-05-26/2025-06-01
255289381,25528938,28,F,2025-06-29,20250707,,MOUNJARO,Drug ineffective,OT,MOUNJARO | Drug ineffective | OT,2025-06-23/2025-06-29
255290341,25529034,,,,20250708,,SKYRIZI,Drug ineffective,,SKYRIZI | Drug ineffective,NaT
255291081,25529108,46,F,2025-07-03,20250708,,VERICIGUAT,Syncope,OT,VERICIGUAT | Syncope | OT,2025-06-30/2025-07-06
255291331,25529133,,F,2025-05-27,20250708,,CANDESARTAN,Acute kidney injury,HO,CANDESARTAN | Acute kidney injury | HO,2025-05-26/2025-06-01
255291343,25529134,,F,2025-06-16,20250718,,CLOZARIL,Neutropenia,OT,CLOZARIL | Neutropenia | OT,2025-06-16/2025-06-22
255291462,25529146,,,,20250810,,TEZSPIRE,Pain,,TEZSPIRE | Pain,NaT
255291991,25529199,,M,2025-06-26,20250708,,MOUNJARO,Feeling abnormal,,MOUNJARO | Feeling abnormal,2025-06-23/2025-06-29
255292741,25529274,64,F,2025-04-01,20250708,,MIRALAX,Product prescribing issue,,MIRALAX | Product prescribing issue,2025-03-31/2025-04-06
255293731,25529373,62,F,2025-06-14,20250708,,TRULICITY,Incorrect dose administered,,TRULICITY | Incorrect dose administered,2025-06-09/2025-06-15
255294991,25529499,,F,,20250708,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
255295821,25529582,,F,2024-05-01,20250708,,LORAZEPAM,Maternal exposure during pregnancy,OT,LORAZEPAM | Maternal exposure during pregnancy | OT,2024-04-29/2024-05-05
255297801,25529780,34,M,,20250708,,MOUNJARO,Palpitations,OT,MOUNJARO | Palpitations | OT,NaT
255298002,25529800,2,F,2025-05-31,20250818,,ELETRIPTAN,Abdominal pain,HO,ELETRIPTAN | Abdominal pain | HO,2025-05-26/2025-06-01
255298402,25529840,,,,20250722,,ETANERCEPT,Foetal exposure during pregnancy,DE,ETANERCEPT | Foetal exposure during pregnancy | DE,NaT
255298411,25529841,80,M,2025-05-01,20250708,,POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Product taste abnormal,OT,POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE | Product taste abnormal | OT,2025-04-28/2025-05-04
255298671,25529867,79,F,2025-04-05,20250708,,REPATHA,Neck pain,HO,REPATHA | Neck pain | HO,2025-03-31/2025-04-06
255298991,25529899,,,,20250708,,OPZELURA,Deep vein thrombosis,OT,OPZELURA | Deep vein thrombosis | OT,NaT
255299291,25529929,7,M,,20250708,,METHOTREXATE SODIUM,Febrile neutropenia,HO,METHOTREXATE SODIUM | Febrile neutropenia | HO,NaT
255299722,25529972,,,2025-06-17,20250805,,XEOMIN,Suspected product quality issue,,XEOMIN | Suspected product quality issue,2025-06-16/2025-06-22
255299772,25529977,22,M,,20250815,,XYNTHA,Arthralgia,OT,XYNTHA | Arthralgia | OT,NaT
255300881,25530088,,F,2025-01-01,20250708,,KESIMPTA,Bronchitis fungal,OT,KESIMPTA | Bronchitis fungal | OT,2024-12-30/2025-01-05
255301111,25530111,,F,,20250708,,VEDOLIZUMAB,Pregnancy,OT,VEDOLIZUMAB | Pregnancy | OT,NaT
255301411,25530141,,F,2021-01-01,20250708,,TRESIBA,Arterial occlusive disease,OT,TRESIBA | Arterial occlusive disease | OT,2020-12-28/2021-01-03
255301451,25530145,,M,2025-06-23,20250708,,BIMZELX,Hidradenitis,OT,BIMZELX | Hidradenitis | OT,2025-06-23/2025-06-29
255301761,25530176,,F,,20250708,,TRINTELLIX,Weight increased,,TRINTELLIX | Weight increased,NaT
255302224,25530222,66,M,2025-07-08,20250819,,TREMFYA,Syringe issue,,TREMFYA | Syringe issue,2025-07-07/2025-07-13
255303222,25530322,21,M,,20250713,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
255303372,25530337,40,F,2025-01-01,20250825,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,2024-12-30/2025-01-05
255303711,25530371,7,F,2025-01-01,20250708,,DUPIXENT,Injection site nodule,,DUPIXENT | Injection site nodule,2024-12-30/2025-01-05
255303862,25530386,27,M,2025-07-02,20250710,,DUPIXENT,Accidental exposure to product,,DUPIXENT | Accidental exposure to product,2025-06-30/2025-07-06
255304031,25530403,14,M,,20250708,,DUPIXENT,Therapeutic response decreased,,DUPIXENT | Therapeutic response decreased,NaT
255304422,25530442,,F,,20250801,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,NaT
255304881,25530488,56,F,2025-01-01,20250708,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2024-12-30/2025-01-05
255304921,25530492,,F,,20250708,,DUPIXENT,Gastrooesophageal reflux disease,,DUPIXENT | Gastrooesophageal reflux disease,NaT
255305091,25530509,,F,,20250708,,DUPIXENT,Injection site swelling,,DUPIXENT | Injection site swelling,NaT
255305362,25530536,6,M,2025-01-01,20250829,,DUPIXENT,Device use issue,,DUPIXENT | Device use issue,2024-12-30/2025-01-05
255306203,25530620,68,F,2022-03-01,20250714,,LENVIMA,Posterior reversible encephalopathy syndrome,HO,LENVIMA | Posterior reversible encephalopathy syndrome | HO,2022-02-28/2022-03-06
255306462,25530646,65,F,2025-01-01,20250822,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2024-12-30/2025-01-05
255306561,25530656,2,F,2024-11-20,20250708,,VINCRISTINE SULFATE,Febrile neutropenia,OT,VINCRISTINE SULFATE | Febrile neutropenia | OT,2024-11-18/2024-11-24
255306611,25530661,58,M,,20250708,,ZEPBOUND,Injection site pain,,ZEPBOUND | Injection site pain,NaT
255307872,25530787,12,F,2023-06-19,20250728,,TRIKAFTA,Peritoneal cyst,,TRIKAFTA | Peritoneal cyst,2023-06-19/2023-06-25
255308271,25530827,,,2025-03-01,20250708,,FINASTERIDE,Loss of libido,DS,FINASTERIDE | Loss of libido | DS,2025-02-24/2025-03-02
255308391,25530839,75,F,,20250708,,TRAZODONE,Memory impairment,LT,TRAZODONE | Memory impairment | LT,NaT
255308891,25530889,62,F,,20250708,,ZEPBOUND,Drug ineffective,,ZEPBOUND | Drug ineffective,NaT
255309661,25530966,54,M,,20250708,,ZEPBOUND,Accidental underdose,,ZEPBOUND | Accidental underdose,NaT
255309834,25530983,9,F,2025-06-01,20250724,,GENOTROPIN,Device delivery system issue,,GENOTROPIN | Device delivery system issue,2025-05-26/2025-06-01
255310062,25531006,,,2025-01-01,20250909,,AJOVY,Device malfunction,,AJOVY | Device malfunction,2024-12-30/2025-01-05
255310921,25531092,61,M,,20250708,,POMALYST,Platelet count decreased,,POMALYST | Platelet count decreased,NaT
255311571,25531157,37,,,20250708,,ZEPBOUND,Blood glucose decreased,,ZEPBOUND | Blood glucose decreased,NaT
255312732,25531273,62,F,2025-01-01,20250831,,KEYTRUDA,Product use issue,HO,KEYTRUDA | Product use issue | HO,2024-12-30/2025-01-05
255313192,25531319,,F,,20250816,,REPATHA,Asthma,,REPATHA | Asthma,NaT
255314331,25531433,76,F,2025-01-01,20250708,,VENCLEXTA,Spinal operation,OT,VENCLEXTA | Spinal operation | OT,2024-12-30/2025-01-05
255314871,25531487,83,F,,20250708,,REVLIMID,Peripheral swelling,,REVLIMID | Peripheral swelling,NaT
255315663,25531566,78,F,2025-01-01,20250729,,FOSCARBIDOPA\FOSLEVODOPA,Contusion,HO,FOSCARBIDOPA\FOSLEVODOPA | Contusion | HO,2024-12-30/2025-01-05
255315771,25531577,76,M,2023-01-04,20250709,,LUMAKRAS,Lung adenocarcinoma,OT,LUMAKRAS | Lung adenocarcinoma | OT,2023-01-02/2023-01-08
255315821,25531582,78,F,,20250709,,DUPIXENT,Throat irritation,,DUPIXENT | Throat irritation,NaT
255316281,25531628,55,M,2024-11-20,20250709,,SKYRIZI,Eosinophil count increased,,SKYRIZI | Eosinophil count increased,2024-11-18/2024-11-24
255317421,25531742,,,,20250709,,REZDIFFRA,Haematuria,,REZDIFFRA | Haematuria,NaT
255317613,25531761,76,F,2024-01-01,20250720,,LANREOTIDE ACETATE,Peripheral coldness,OT,LANREOTIDE ACETATE | Peripheral coldness | OT,2024-01-01/2024-01-07
255317892,25531789,,,,20250716,,INFLIXIMAB,Off label use,OT,INFLIXIMAB | Off label use | OT,NaT
255317961,25531796,74,F,2023-06-01,20250709,,LANREOTIDE ACETATE,Off label use,,LANREOTIDE ACETATE | Off label use,2023-05-29/2023-06-04
255318761,25531876,,F,2025-06-18,20250709,,MOUNJARO,Appendicitis,HO,MOUNJARO | Appendicitis | HO,2025-06-16/2025-06-22
255318951,25531895,,,,20250709,,ORGOVYX,Myalgia,,ORGOVYX | Myalgia,NaT
255319301,25531930,,F,,20250709,,LIRAGLUTIDE,Accidental underdose,,LIRAGLUTIDE | Accidental underdose,NaT
255319331,25531933,,,,20250709,,TASIGNA,Lumbar spinal stenosis,OT,TASIGNA | Lumbar spinal stenosis | OT,NaT
255319381,25531938,,F,,20250709,,LIRAGLUTIDE,Product dose omission issue,,LIRAGLUTIDE | Product dose omission issue,NaT
255320411,25532041,58,F,2025-06-28,20250709,,TYVASO DPI,Pneumonia,OT,TYVASO DPI | Pneumonia | OT,2025-06-23/2025-06-29
255321311,25532131,46,M,2025-01-01,20250709,,DUPIXENT,Skin exfoliation,,DUPIXENT | Skin exfoliation,2024-12-30/2025-01-05
255321531,25532153,45,F,,20250709,,OXCARBAZEPINE,Drug interaction,HO,OXCARBAZEPINE | Drug interaction | HO,NaT
255321891,25532189,,M,,20250709,,NUCALA,Asthma,,NUCALA | Asthma,NaT
255322202,25532220,66,F,,20250812,,NOVOLIN N,Cardiac disorder,HO,NOVOLIN N | Cardiac disorder | HO,NaT
255322671,25532267,57,M,2025-05-16,20250709,,RYBELSUS,Vitreous floaters,DS,RYBELSUS | Vitreous floaters | DS,2025-05-12/2025-05-18
255323232,25532323,,,2025-06-27,20250723,,NARATRIPTAN HYDROCHLORIDE,Sneezing,,NARATRIPTAN HYDROCHLORIDE | Sneezing,2025-06-23/2025-06-29
255323771,25532377,,,,20250709,,PREDNISONE,Malignant neoplasm progression,OT,PREDNISONE | Malignant neoplasm progression | OT,NaT
255324031,25532403,39,M,,20250709,,CIPROFLOXACIN,Throat tightness,OT,CIPROFLOXACIN | Throat tightness | OT,NaT
255324131,25532413,,,,20250709,,GEMTESA,Urinary retention,,GEMTESA | Urinary retention,NaT
255324901,25532490,78,,,20250709,,LANTUS SOLOSTAR,Off label use,,LANTUS SOLOSTAR | Off label use,NaT
255325781,25532578,71,,,20250709,,TISLELIZUMAB,Myelosuppression,HO,TISLELIZUMAB | Myelosuppression | HO,NaT
255325832,25532583,,,,20250816,,BREZTRI,Unevaluable event,,BREZTRI | Unevaluable event,NaT
255326043,25532604,74,M,2024-01-01,20250917,,FOSCARBIDOPA\FOSLEVODOPA,Infusion site induration,HO,FOSCARBIDOPA\FOSLEVODOPA | Infusion site induration | HO,2024-01-01/2024-01-07
255326642,25532664,63,F,2025-06-25,20250807,,VEOZAH,Leukopenia,OT,VEOZAH | Leukopenia | OT,2025-06-23/2025-06-29
255326741,25532674,,,,20250709,,DOCOSANOL,Drug ineffective,,DOCOSANOL | Drug ineffective,NaT
255326941,25532694,81,F,2025-07-08,20250709,,SOTYKTU,Oral herpes,,SOTYKTU | Oral herpes,2025-07-07/2025-07-13
255327121,25532712,67,M,,20250709,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,NaT
255327591,25532759,89,F,2025-06-09,20250709,,VANCOMYCIN HYDROCHLORIDE,Jaundice cholestatic,HO,VANCOMYCIN HYDROCHLORIDE | Jaundice cholestatic | HO,2025-06-09/2025-06-15
255328051,25532805,44,F,2025-01-01,20250709,,VYEPTI,Somnolence,,VYEPTI | Somnolence,2024-12-30/2025-01-05
255328065,25532806,,F,2025-01-01,20250826,,REMODULIN,Infusion site cellulitis,OT,REMODULIN | Infusion site cellulitis | OT,2024-12-30/2025-01-05
255328202,25532820,42,M,2024-05-01,20250723,,DAPAGLIFLOZIN,Albuminuria,OT,DAPAGLIFLOZIN | Albuminuria | OT,2024-04-29/2024-05-05
255328341,25532834,,,2025-05-05,20250709,,LANSOPRAZOLE,Crystalluria,HO,LANSOPRAZOLE | Crystalluria | HO,2025-05-05/2025-05-11
255329101,25532910,,F,,20250709,,PEMETREXED,Nausea,OT,PEMETREXED | Nausea | OT,NaT
255329162,25532916,,,2025-06-21,20250731,,GUSELKUMAB,Device leakage,,GUSELKUMAB | Device leakage,2025-06-16/2025-06-22
255329361,25532936,61,F,2025-06-02,20250709,,SAVELLA,Constipation,,SAVELLA | Constipation,2025-06-02/2025-06-08
255329601,25532960,,,,20250709,,ZEPBOUND,Nausea,,ZEPBOUND | Nausea,NaT
255329721,25532972,58,F,,20250709,,MOUNJARO,Extra dose administered,,MOUNJARO | Extra dose administered,NaT
255329861,25532986,,,,20250709,,DARUNAVIR,Plagiocephaly,CA,DARUNAVIR | Plagiocephaly | CA,NaT
255329941,25532994,,,,20250709,,QUETIAPINE,Hyperthermia,HO,QUETIAPINE | Hyperthermia | HO,NaT
255330671,25533067,,,,20250709,,TEMOZOLOMIDE,Disease progression,OT,TEMOZOLOMIDE | Disease progression | OT,NaT
255331341,25533134,54,F,,20250709,,HERBALS\TURMERIC,Drug interaction,HO,HERBALS\TURMERIC | Drug interaction | HO,NaT
255332361,25533236,35,M,,20250709,,CLOZAPINE,Pericardial effusion,OT,CLOZAPINE | Pericardial effusion | OT,NaT
255333032,25533303,,,2023-10-01,20250730,,LAMIVUDINE,No adverse event,,LAMIVUDINE | No adverse event,2023-09-25/2023-10-01
255334091,25533409,,,,20250709,,GEMTESA,Feeling abnormal,,GEMTESA | Feeling abnormal,NaT
255334781,25533478,18,M,2025-06-17,20250709,,CLOZAPINE,Neutropenia,OT,CLOZAPINE | Neutropenia | OT,2025-06-16/2025-06-22
255334821,25533482,,,,20250709,,AVAPRITINIB,Lacrimation increased,,AVAPRITINIB | Lacrimation increased,NaT
255335181,25533518,,,,20250709,,MOUNJARO,Nausea,,MOUNJARO | Nausea,NaT
255335352,25533535,32,F,2022-10-15,20250721,,YAZ,Migraine,,YAZ | Migraine,2022-10-10/2022-10-16
255335921,25533592,28,F,2025-01-01,20250709,,NURTEC ODT,Pharyngeal swelling,,NURTEC ODT | Pharyngeal swelling,2024-12-30/2025-01-05
255336392,25533639,35,F,2025-01-01,20250710,,SKYRIZI,Product storage error,HO,SKYRIZI | Product storage error | HO,2024-12-30/2025-01-05
255336891,25533689,,F,2025-06-24,20250709,,EYLEA,Oedema peripheral,HO,EYLEA | Oedema peripheral | HO,2025-06-23/2025-06-29
255337231,25533723,,F,,20250709,,DUPIXENT,Off label use,,DUPIXENT | Off label use,NaT
255337331,25533733,,F,,20250709,,DUPIXENT,Scratch,,DUPIXENT | Scratch,NaT
255337361,25533736,58,,,20250709,,LANTUS,Off label use,,LANTUS | Off label use,NaT
255337841,25533784,67,F,,20250709,,DUPIXENT,Pain,,DUPIXENT | Pain,NaT
255338431,25533843,,,,20250709,,ADALIMUMAB,Influenza,HO,ADALIMUMAB | Influenza | HO,NaT
255338792,25533879,59,,,20250716,,NAPROXEN,Lip swelling,OT,NAPROXEN | Lip swelling | OT,NaT
255339691,25533969,76,F,,20250709,,POMALYST,Pruritus,,POMALYST | Pruritus,NaT
255340131,25534013,64,F,2025-06-01,20250708,,VITAMINS,Product communication issue,HO,VITAMINS | Product communication issue | HO,2025-05-26/2025-06-01
255340421,25534042,80,M,,20250709,,LENALIDOMIDE,Progressive multifocal leukoencephalopathy,OT,LENALIDOMIDE | Progressive multifocal leukoencephalopathy | OT,NaT
255340891,25534089,92,F,2025-06-23,20250709,,INVANZ,Epilepsy,HO,INVANZ | Epilepsy | HO,2025-06-23/2025-06-29
255341401,25534140,80,M,,20250709,,RITUXIMAB,Disease progression,OT,RITUXIMAB | Disease progression | OT,NaT
255341761,25534176,24,F,,20250709,,GEMCITABINE,Febrile neutropenia,LT,GEMCITABINE | Febrile neutropenia | LT,NaT
255342061,25534206,,,,20250709,,PREDNISONE,Infection,OT,PREDNISONE | Infection | OT,NaT
255342091,25534209,15,F,,20250709,,METHOTREXATE,Acute kidney injury,OT,METHOTREXATE | Acute kidney injury | OT,NaT
255342273,25534227,,M,,20250902,,GENOTROPIN,Device delivery system issue,,GENOTROPIN | Device delivery system issue,NaT
255342311,25534231,72,M,,20250709,,LANTUS SOLOSTAR,Hemiplegia,OT,LANTUS SOLOSTAR | Hemiplegia | OT,NaT
255344461,25534446,60,F,,20250709,,LOSARTAN,Panic attack,DS,LOSARTAN | Panic attack | DS,NaT
255344492,25534449,32,F,2025-06-30,20250714,,CERTOLIZUMAB PEGOL,Product availability issue,OT,CERTOLIZUMAB PEGOL | Product availability issue | OT,2025-06-30/2025-07-06
255345711,25534571,81,M,,20250709,,TRELSTAR,Prostate cancer,HO,TRELSTAR | Prostate cancer | HO,NaT
255346531,25534653,78,F,2025-03-26,20250709,,ELIQUIS,Hepatic cytolysis,OT,ELIQUIS | Hepatic cytolysis | OT,2025-03-24/2025-03-30
255347031,25534703,,F,,20250709,,MOUNJARO,Illness,,MOUNJARO | Illness,NaT
255349211,25534921,81,M,2021-06-01,20250709,,AMITRIPTYLINE,Death,DE,AMITRIPTYLINE | Death | DE,2021-05-31/2021-06-06
255350081,25535008,,,,20250709,,RISANKIZUMAB,Product storage error,,RISANKIZUMAB | Product storage error,NaT
255350091,25535009,,,,20250709,,BLINATUMOMAB,Cytokine release syndrome,DE,BLINATUMOMAB | Cytokine release syndrome | DE,NaT
255350192,25535019,,,,20250809,,ULTOMIRIS,Diarrhoea,OT,ULTOMIRIS | Diarrhoea | OT,NaT
255351241,25535124,,,,20250709,,ORLADEYO,Stress,,ORLADEYO | Stress,NaT
255351531,25535153,,M,,20250709,,ENBREL,Hospitalisation,HO,ENBREL | Hospitalisation | HO,NaT
255351762,25535176,78,F,,20250730,,ASPIRIN,Contusion,OT,ASPIRIN | Contusion | OT,NaT
255351841,25535184,,,2025-01-01,20250709,,REZDIFFRA,Abdominal distension,,REZDIFFRA | Abdominal distension,2024-12-30/2025-01-05
255351971,25535197,,,2025-01-01,20250709,,REZDIFFRA,High density lipoprotein decreased,,REZDIFFRA | High density lipoprotein decreased,2024-12-30/2025-01-05
255353251,25535325,66,M,,20250709,,QINLOCK,Drug resistance,,QINLOCK | Drug resistance,NaT
255353301,25535330,88,F,2025-06-01,20250709,,EDOXABAN,Anaemia,HO,EDOXABAN | Anaemia | HO,2025-05-26/2025-06-01
255353381,25535338,21,F,,20250709,,TEZSPIRE,Throat tightness,OT,TEZSPIRE | Throat tightness | OT,NaT
255355001,25535500,17,M,2025-05-02,20250709,,SOFDRA,Application site pruritus,,SOFDRA | Application site pruritus,2025-04-28/2025-05-04
255355041,25535504,,F,,20250709,,SOFDRA,Vision blurred,,SOFDRA | Vision blurred,NaT
255355251,25535525,,,2025-04-08,20250709,,SOFDRA,Dysuria,,SOFDRA | Dysuria,2025-04-07/2025-04-13
255355271,25535527,,F,,20250709,,SOFDRA,Rash,,SOFDRA | Rash,NaT
255355471,25535547,,,,20250709,,SOFDRA,Vision blurred,,SOFDRA | Vision blurred,NaT
255356231,25535623,,,,20250709,,GIVLAARI,Heart rate increased,HO,GIVLAARI | Heart rate increased | HO,NaT
255356651,25535665,,M,2025-07-03,20250709,,RADICAVA ORS,Inappropriate schedule of product administration,,RADICAVA ORS | Inappropriate schedule of product administration,2025-06-30/2025-07-06
255357441,25535744,50,F,2025-06-11,20250709,,INLYTA,Death,DE,INLYTA | Death | DE,2025-06-09/2025-06-15
255357502,25535750,78,F,,20250716,,INFLIXIMAB,Diarrhoea,HO,INFLIXIMAB | Diarrhoea | HO,NaT
255357521,25535752,47,F,2025-06-14,20250709,,IBRANCE,Death,DE,IBRANCE | Death | DE,2025-06-09/2025-06-15
255357841,25535784,,F,,20250709,,VEDOLIZUMAB,Death,DE,VEDOLIZUMAB | Death | DE,NaT
255358341,25535834,15,F,,20250709,,LITFULO,Drug ineffective,,LITFULO | Drug ineffective,NaT
255358952,25535895,66,F,2025-01-01,20250729,,VYALEV,Hallucination,DE,VYALEV | Hallucination | DE,2024-12-30/2025-01-05
255359161,25535916,86,F,2025-06-01,20250709,,POMALYST,Oedema peripheral,,POMALYST | Oedema peripheral,2025-05-26/2025-06-01
255359671,25535967,,,,20250709,,LENALIDOMIDE,Plasma cell myeloma,OT,LENALIDOMIDE | Plasma cell myeloma | OT,NaT
255359701,25535970,59,M,,20250709,,DUPIXENT,Inappropriate schedule of product administration,,DUPIXENT | Inappropriate schedule of product administration,NaT
255359811,25535981,69,F,,20250709,,TARPEYO,Insomnia,,TARPEYO | Insomnia,NaT
255360173,25536017,70,M,,20250822,,AXICABTAGENE CILOLEUCEL,Malignant genitourinary tract neoplasm,OT,AXICABTAGENE CILOLEUCEL | Malignant genitourinary tract neoplasm | OT,NaT
255360321,25536032,,,2025-01-01,20250709,,UBLITUXIMAB,Influenza,,UBLITUXIMAB | Influenza,2024-12-30/2025-01-05
255361431,25536143,,,2025-03-20,20250709,,UBLITUXIMAB,Infusion related reaction,,UBLITUXIMAB | Infusion related reaction,2025-03-17/2025-03-23
255361451,25536145,,,2025-04-15,20250709,,UBLITUXIMAB,Upper respiratory tract infection,,UBLITUXIMAB | Upper respiratory tract infection,2025-04-14/2025-04-20
255361752,25536175,60,F,2025-03-03,20250710,,COSENTYX,Condition aggravated,,COSENTYX | Condition aggravated,2025-03-03/2025-03-09
255361891,25536189,,,2025-04-01,20250709,,UBLITUXIMAB,Stress,,UBLITUXIMAB | Stress,2025-03-31/2025-04-06
255361901,25536190,,,2024-04-12,20250709,,UBLITUXIMAB,Infusion related reaction,,UBLITUXIMAB | Infusion related reaction,2024-04-08/2024-04-14
255361921,25536192,,,2024-01-01,20250709,,UBLITUXIMAB,Maternal exposure during pregnancy,,UBLITUXIMAB | Maternal exposure during pregnancy,2024-01-01/2024-01-07
255362541,25536254,,,,20250709,,UBLITUXIMAB,Headache,,UBLITUXIMAB | Headache,NaT
255362571,25536257,83,M,,20250709,,REVLIMID,Leukaemia,HO,REVLIMID | Leukaemia | HO,NaT
255363421,25536342,,,2025-05-26,20250709,,BRIUMVI,Infusion related reaction,,BRIUMVI | Infusion related reaction,2025-05-26/2025-06-01
255363791,25536379,,,2025-02-14,20250709,,UBLITUXIMAB,Infusion related reaction,,UBLITUXIMAB | Infusion related reaction,2025-02-10/2025-02-16
255363901,25536390,,,,20250709,,UBLITUXIMAB,Multiple sclerosis,,UBLITUXIMAB | Multiple sclerosis,NaT
255363931,25536393,,,,20250709,,UBLITUXIMAB,Constipation,,UBLITUXIMAB | Constipation,NaT
255365081,25536508,,M,2025-07-07,20250709,,SPINRAZA,Crying,,SPINRAZA | Crying,2025-07-07/2025-07-13
255365371,25536537,59,M,,20250709,,TRULICITY,Accidental underdose,,TRULICITY | Accidental underdose,NaT
255366611,25536661,80,F,2025-07-01,20250709,,CAMZYOS,Chest pain,,CAMZYOS | Chest pain,2025-06-30/2025-07-06
255366921,25536692,60,F,,20250709,,LINEZOLID,Drug hypersensitivity,HO,LINEZOLID | Drug hypersensitivity | HO,NaT
255368783,25536878,5,M,2025-07-02,20250729,,ADVATE,Cerebral haemorrhage,HO,ADVATE | Cerebral haemorrhage | HO,2025-06-30/2025-07-06
255369931,25536993,,F,,20250710,,TRASTUZUMAB,Disease progression,OT,TRASTUZUMAB | Disease progression | OT,NaT
255370361,25537036,,,2025-06-21,20250710,,MOTRIN INFANTS,Eyelid thickening,OT,MOTRIN INFANTS | Eyelid thickening | OT,2025-06-16/2025-06-22
255370772,25537077,73,M,,20250826,,ORGOVYX,Fatigue,HO,ORGOVYX | Fatigue | HO,NaT
255370801,25537080,,,,20250710,,ORGOVYX,Hot flush,,ORGOVYX | Hot flush,NaT
255370911,25537091,77,F,2025-01-01,20250710,,OXYTROL,Muscle twitching,,OXYTROL | Muscle twitching,2024-12-30/2025-01-05
255371181,25537118,,F,,20250710,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
255371251,25537125,,F,,20250710,,PALFORZIA,Product dose omission issue,,PALFORZIA | Product dose omission issue,NaT
255371341,25537134,,,,20250710,,MOUNJARO,Drug ineffective,,MOUNJARO | Drug ineffective,NaT
255371871,25537187,79,M,,20250710,,LEUPROLIDE ACETATE,Fall,DE,LEUPROLIDE ACETATE | Fall | DE,NaT
255371921,25537192,,,2025-06-19,20250710,,VARIVAX,No adverse event,,VARIVAX | No adverse event,2025-06-16/2025-06-22
255373321,25537332,48,F,,20250710,,SEMAGLUTIDE,Bowel movement irregularity,OT,SEMAGLUTIDE | Bowel movement irregularity | OT,NaT
255374332,25537433,74,F,2025-06-23,20250927,,LANREOTIDE ACETATE,Cholelithiasis,HO,LANREOTIDE ACETATE | Cholelithiasis | HO,2025-06-23/2025-06-29
255374461,25537446,,M,,20250710,,TRELEGY ELLIPTA,Chronic obstructive pulmonary disease,DE,TRELEGY ELLIPTA | Chronic obstructive pulmonary disease | DE,NaT
255374701,25537470,,M,,20250710,,BETAHISTINE,Tympanic membrane perforation,OT,BETAHISTINE | Tympanic membrane perforation | OT,NaT
255375963,25537596,83,F,2025-01-01,20250904,,PREDONINE,Cholestasis,HO,PREDONINE | Cholestasis | HO,2024-12-30/2025-01-05
255376131,25537613,67,M,,20250710,,ERYTHROCIN LACTOBIONATE,Pneumonia,OT,ERYTHROCIN LACTOBIONATE | Pneumonia | OT,NaT
255376671,25537667,,,,20250710,,AJOVY,Injection site warmth,OT,AJOVY | Injection site warmth | OT,NaT
255376811,25537681,72,F,,20250710,,HUMAN IMMUNOGLOBULIN G,Drug ineffective,OT,HUMAN IMMUNOGLOBULIN G | Drug ineffective | OT,NaT
255377841,25537784,,M,,20250710,,TREMFYA,Fistula,HO,TREMFYA | Fistula | HO,NaT
255378001,25537800,29,F,2023-01-17,20250710,,TACROLIMUS,Platelet count decreased,HO,TACROLIMUS | Platelet count decreased | HO,2023-01-16/2023-01-22
255378031,25537803,,F,,20250710,,XOLAIR,Drug ineffective,,XOLAIR | Drug ineffective,NaT
255378561,25537856,47,M,,20250710,,MOUNJARO,Off label use,,MOUNJARO | Off label use,NaT
255378892,25537889,51,F,,20250809,,OLAPARIB,Recurrent cancer,OT,OLAPARIB | Recurrent cancer | OT,NaT
255379061,25537906,48,F,,20250710,,TECENTRIQ,Death,DE,TECENTRIQ | Death | DE,NaT
255379301,25537930,22,,,20250710,,LINEZOLID,Electrocardiogram QT prolonged,HO,LINEZOLID | Electrocardiogram QT prolonged | HO,NaT
255379312,25537931,31,F,2025-06-25,20250721,,ANTICOAGULANT SODIUM CITRATE,Anal incontinence,,ANTICOAGULANT SODIUM CITRATE | Anal incontinence,2025-06-23/2025-06-29
255379431,25537943,82,F,,20250710,,JARDIANCE,Fungal infection,,JARDIANCE | Fungal infection,NaT
255379791,25537979,56,M,2025-03-01,20250710,,FINASTERIDE,Depression,DS,FINASTERIDE | Depression | DS,2025-02-24/2025-03-02
255379802,25537980,35,M,,20250904,,ARIPIPRAZOLE,Dependence,OT,ARIPIPRAZOLE | Dependence | OT,NaT
255380321,25538032,,F,,20250710,,XOLAIR PFS,Urticaria,,XOLAIR PFS | Urticaria,NaT
255380901,25538090,77,,,20250710,,ALBUTEROL SULFATE,No adverse event,,ALBUTEROL SULFATE | No adverse event,NaT
255381241,25538124,44,F,2025-06-20,20250710,,IBUPROFEN,Pancreatitis,HO,IBUPROFEN | Pancreatitis | HO,2025-06-16/2025-06-22
255381971,25538197,65,M,,20250710,,ENZALUTAMIDE,Anaemia,DE,ENZALUTAMIDE | Anaemia | DE,NaT
255382372,25538237,,,,20250801,,ORGOVYX,Fatigue,,ORGOVYX | Fatigue,NaT
255382601,25538260,78,M,2025-06-12,20250710,,NUPLAZID,Death,OT,NUPLAZID | Death | OT,2025-06-09/2025-06-15
255382851,25538285,,F,,20250710,,ZEJULA,Anaemia,OT,ZEJULA | Anaemia | OT,NaT
255382961,25538296,37,M,2025-06-15,20250710,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,2025-06-09/2025-06-15
255383341,25538334,,,,20250710,,ORGOVYX,Hot flush,,ORGOVYX | Hot flush,NaT
255383531,25538353,,,,20250710,,ORGOVYX,Pruritus,,ORGOVYX | Pruritus,NaT
255383811,25538381,,,2024-05-11,20250710,,YUFLYMA,Cerebellar haemorrhage,HO,YUFLYMA | Cerebellar haemorrhage | HO,2024-05-06/2024-05-12
255384171,25538417,33,M,2025-05-15,20250710,,CABENUVA,Viral load increased,,CABENUVA | Viral load increased,2025-05-12/2025-05-18
255384501,25538450,40,M,2025-01-19,20250710,,AMOXICILLIN,Sepsis,HO,AMOXICILLIN | Sepsis | HO,2025-01-13/2025-01-19
255386221,25538622,,,,20250710,,ADALIMUMAB,Systemic lupus erythematosus,HO,ADALIMUMAB | Systemic lupus erythematosus | HO,NaT
255386532,25538653,76,M,2023-03-01,20250722,,GATTEX,Weight gain poor,,GATTEX | Weight gain poor,2023-02-27/2023-03-05
255386822,25538682,84,F,,20250715,,LANTUS SOLOSTAR,Product dispensing error,,LANTUS SOLOSTAR | Product dispensing error,NaT
255386891,25538689,,F,,20250710,,DUPIXENT,Inappropriate schedule of product administration,,DUPIXENT | Inappropriate schedule of product administration,NaT
255387022,25538702,57,M,2025-01-01,20250818,,DUPIXENT,Rash,HO,DUPIXENT | Rash | HO,2024-12-30/2025-01-05
255387882,25538788,67,F,2025-07-07,20250908,,DUPIXENT,Exposure via skin contact,,DUPIXENT | Exposure via skin contact,2025-07-07/2025-07-13
255389222,25538922,7,M,,20250722,,STERILE DILUENT (WATER),Fatigue,OT,STERILE DILUENT (WATER) | Fatigue | OT,NaT
255389603,25538960,14,F,2025-07-02,20250815,,GENOTROPIN,Device breakage,,GENOTROPIN | Device breakage,2025-06-30/2025-07-06
255390101,25539010,71,F,,20250710,,KEVZARA,Inappropriate schedule of product administration,,KEVZARA | Inappropriate schedule of product administration,NaT
255390662,25539066,,M,,20250810,,LOKELMA,Renal failure,OT,LOKELMA | Renal failure | OT,NaT
255390911,25539091,67,F,,20250710,,CLOPIDOGREL,Unresponsive to stimuli,OT,CLOPIDOGREL | Unresponsive to stimuli | OT,NaT
255390951,25539095,49,M,,20250710,,ARIPIPRAZOLE,Megacolon,OT,ARIPIPRAZOLE | Megacolon | OT,NaT
255391891,25539189,24,F,2025-07-01,20250710,,CARIPRAZINE,Eye operation,OT,CARIPRAZINE | Eye operation | OT,2025-06-30/2025-07-06
255392061,25539206,,F,,20250710,,ZEPBOUND,Nephrolithiasis,,ZEPBOUND | Nephrolithiasis,NaT
255392751,25539275,85,M,2025-07-07,20250710,,NUBEQA,Death,DE,NUBEQA | Death | DE,2025-07-07/2025-07-13
255393681,25539368,73,M,,20250710,,METHOTREXATE SODIUM,Product use in unapproved indication,OT,METHOTREXATE SODIUM | Product use in unapproved indication | OT,NaT
255393821,25539382,65,M,2025-01-01,20250710,,REPATHA,Drug dose omission by device,,REPATHA | Drug dose omission by device,2024-12-30/2025-01-05
255393923,25539392,74,,,20250819,,LISINOPRIL,Dizziness,,LISINOPRIL | Dizziness,NaT
255394161,25539416,78,F,,20250710,,POMALYST,Plasma cell myeloma,OT,POMALYST | Plasma cell myeloma | OT,NaT
255395301,25539530,28,F,2025-06-25,20250710,,MOUNJARO,Nephrolithiasis,HO,MOUNJARO | Nephrolithiasis | HO,2025-06-23/2025-06-29
255396121,25539612,,M,,20250710,,ANAFRANIL,Product availability issue,OT,ANAFRANIL | Product availability issue | OT,NaT
255396163,25539616,56,F,,20250829,,GABAPENTIN,Pruritus,OT,GABAPENTIN | Pruritus | OT,NaT
255398012,25539801,36,F,2025-01-01,20250711,,DUPIXENT,Condition aggravated,OT,DUPIXENT | Condition aggravated | OT,2024-12-30/2025-01-05
255399521,25539952,19,F,,20250710,,VYEPTI,Drug ineffective,,VYEPTI | Drug ineffective,NaT
255400281,25540028,61,F,2025-03-27,20250710,,IYUZEH,Gastrointestinal pain,,IYUZEH | Gastrointestinal pain,2025-03-24/2025-03-30
255401901,25540190,,,,20250710,,SUNOSI,Drug ineffective,,SUNOSI | Drug ineffective,NaT
255402711,25540271,,M,2025-05-02,20250710,,SUTENT,Death,DE,SUTENT | Death | DE,2025-04-28/2025-05-04
255402881,25540288,,M,,20250710,,DUPIXENT,Eczema,,DUPIXENT | Eczema,NaT
255405041,25540504,,M,,20250710,,MESALAMINE,Interstitial lung disease,OT,MESALAMINE | Interstitial lung disease | OT,NaT
255405221,25540522,66,M,2025-07-09,20250709,,XTANDI,Diarrhoea,OT,XTANDI | Diarrhoea | OT,2025-07-07/2025-07-13
255405432,25540543,,M,,20250930,,FILSPARI,Product use in unapproved indication,,FILSPARI | Product use in unapproved indication,NaT
255405921,25540592,,,,20250710,,REZDIFFRA,Dizziness,,REZDIFFRA | Dizziness,NaT
255406832,25540683,51,M,2024-09-26,20250804,,ALIMTA,Hepatic cytolysis,HO,ALIMTA | Hepatic cytolysis | HO,2024-09-23/2024-09-29
255408721,25540872,,M,2025-07-03,20250710,,ZEPBOUND,Abdominal discomfort,,ZEPBOUND | Abdominal discomfort,2025-06-30/2025-07-06
255409551,25540955,,,,20250710,,GLIPIZIDE,Adverse event,,GLIPIZIDE | Adverse event,NaT
255410592,25541059,,F,,20250711,,HUMIRA,Anaemia,,HUMIRA | Anaemia,NaT
255411193,25541119,54,F,2025-07-02,20250905,,NEULASTA,Device adhesion issue,,NEULASTA | Device adhesion issue,2025-06-30/2025-07-06
255412581,25541258,,F,2025-05-16,20250711,,MIRTAZAPINE,Wrong dose,OT,MIRTAZAPINE | Wrong dose | OT,2025-05-12/2025-05-18
255412801,25541280,56,F,2025-01-01,20250711,,DUPIXENT,Dizziness,HO,DUPIXENT | Dizziness | HO,2024-12-30/2025-01-05
255412972,25541297,44,F,,20250815,,XOLAIR,Symptom recurrence,,XOLAIR | Symptom recurrence,NaT
255413201,25541320,,F,,20250711,,SKYRIZI,Anastomotic ulcer,OT,SKYRIZI | Anastomotic ulcer | OT,NaT
255413272,25541327,78,M,2025-01-01,20250811,,VENETOCLAX,Pneumonia aspiration,DE,VENETOCLAX | Pneumonia aspiration | DE,2024-12-30/2025-01-05
255414051,25541405,81,F,,20250711,,CARBIDOPA\LEVODOPA,Death,DE,CARBIDOPA\LEVODOPA | Death | DE,NaT
255414332,25541433,,,,20250715,,NEXIUM,Drug effective for unapproved indication,,NEXIUM | Drug effective for unapproved indication,NaT
255414641,25541464,35,F,,20250711,,BIMZELX,Groin abscess,OT,BIMZELX | Groin abscess | OT,NaT
255414931,25541493,,M,2025-05-16,20250711,,CIPROFLOXACIN AND DEXAMETHASONE,Device leakage,,CIPROFLOXACIN AND DEXAMETHASONE | Device leakage,2025-05-12/2025-05-18
255415681,25541568,,,,20250711,,TOPIRAMATE,Therapy non-responder,,TOPIRAMATE | Therapy non-responder,NaT
255416331,25541633,,M,,20250711,,DUPIXENT,Rash macular,,DUPIXENT | Rash macular,NaT
255416531,25541653,52,M,2025-07-01,20250711,,SERTRALINE,Nightmare,LT,SERTRALINE | Nightmare | LT,2025-06-30/2025-07-06
255417191,25541719,,,,20250711,,DARZALEX,Dialysis,OT,DARZALEX | Dialysis | OT,NaT
255417201,25541720,28,F,,20250711,,MOUNJARO,Accidental underdose,,MOUNJARO | Accidental underdose,NaT
255417471,25541747,,,2024-12-01,20250711,,WEGOVY,Flatulence,OT,WEGOVY | Flatulence | OT,2024-11-25/2024-12-01
255417621,25541762,,,,20250711,,DAXIBOTULINUMTOXIN A-LANM,Blindness,OT,DAXIBOTULINUMTOXIN A-LANM | Blindness | OT,NaT
255417821,25541782,,,2025-06-19,20250711,,FUROSEMIDE,Acute kidney injury,HO,FUROSEMIDE | Acute kidney injury | HO,2025-06-16/2025-06-22
255418141,25541814,38,M,2025-06-01,20250711,,CIMZIA,Ankylosing spondylitis,OT,CIMZIA | Ankylosing spondylitis | OT,2025-05-26/2025-06-01
255418691,25541869,,M,,20250711,,LEVOTHYROXINE SODIUM,Type 2 diabetes mellitus,OT,LEVOTHYROXINE SODIUM | Type 2 diabetes mellitus | OT,NaT
255419081,25541908,43,F,2025-06-20,20250711,,INSULIN LISPRO,Injection site pain,,INSULIN LISPRO | Injection site pain,2025-06-16/2025-06-22
255419101,25541910,,M,2025-01-01,20250711,,TYVASO,Peripheral swelling,,TYVASO | Peripheral swelling,2024-12-30/2025-01-05
255420581,25542058,,F,,20250711,,WEGOVY,Hypertension,OT,WEGOVY | Hypertension | OT,NaT
255420811,25542081,32,F,2012-03-01,20250711,,PARAGARD T 380A,Foreign body in reproductive tract,OT,PARAGARD T 380A | Foreign body in reproductive tract | OT,2012-02-27/2012-03-04
255421711,25542171,,,,20250711,,BACLOFEN,Drug ineffective,,BACLOFEN | Drug ineffective,NaT
255421862,25542186,,F,,20250809,,CAPIVASERTIB,Wound infection pseudomonas,HO,CAPIVASERTIB | Wound infection pseudomonas | HO,NaT
255422482,25542248,78,M,,20250728,,DAPTOMYCIN,Pneumonitis,OT,DAPTOMYCIN | Pneumonitis | OT,NaT
255423461,25542346,60,F,2025-04-23,20250711,,FLUOROURACIL,Condition aggravated,HO,FLUOROURACIL | Condition aggravated | HO,2025-04-21/2025-04-27
255424151,25542415,,M,,20250711,,LEQVIO,Dizziness,,LEQVIO | Dizziness,NaT
255425021,25542502,56,M,2025-06-13,20250711,,SKYRIZI,Intervertebral disc operation,OT,SKYRIZI | Intervertebral disc operation | OT,2025-06-09/2025-06-15
255425621,25542562,,M,,20250711,,ARIPIPRAZOLE,Therapy partial responder,OT,ARIPIPRAZOLE | Therapy partial responder | OT,NaT
255426281,25542628,,F,,20250711,,TYSABRI,Abdominal wall neoplasm benign,HO,TYSABRI | Abdominal wall neoplasm benign | HO,NaT
255426661,25542666,63,M,2025-07-07,20250711,,SKYRIZI,Umbilical hernia,OT,SKYRIZI | Umbilical hernia | OT,2025-07-07/2025-07-13
255428263,25542826,,M,2025-02-11,20250729,,CLOPIDOGREL,Spinal osteoarthritis,HO,CLOPIDOGREL | Spinal osteoarthritis | HO,2025-02-10/2025-02-16
255429281,25542928,,,,20250711,,ALLEGRA ALLERGY 24 HOUR,Somnolence,,ALLEGRA ALLERGY 24 HOUR | Somnolence,NaT
255430211,25543021,,,,20250711,,REPATHA,Weight increased,,REPATHA | Weight increased,NaT
255430651,25543065,,,,20250711,,CISPLATIN,Mucosal inflammation,LT,CISPLATIN | Mucosal inflammation | LT,NaT
255430801,25543080,,,,20250711,,ADAPALENE,Rash,,ADAPALENE | Rash,NaT
255430811,25543081,,F,,20250711,,ADAPALENE,Therapeutic response unexpected,,ADAPALENE | Therapeutic response unexpected,NaT
255431101,25543110,,,,20250711,,ADAPALENE,Burning sensation,,ADAPALENE | Burning sensation,NaT
255431841,25543184,57,F,,20250711,,DAPTOMYCIN,Product use in unapproved indication,,DAPTOMYCIN | Product use in unapproved indication,NaT
255432211,25543221,,F,,20250711,,XOLAIR,Lip swelling,,XOLAIR | Lip swelling,NaT
255433121,25543312,59,F,2025-06-19,20250711,,IBUPROFEN,Abdominal pain upper,LT,IBUPROFEN | Abdominal pain upper | LT,2025-06-16/2025-06-22
255433301,25543330,60,F,,20250711,,CARBOPLATIN,Drug ineffective,OT,CARBOPLATIN | Drug ineffective | OT,NaT
255434171,25543417,67,,,20250711,,JAKAFI,Haemoglobin decreased,,JAKAFI | Haemoglobin decreased,NaT
255435571,25543557,31,F,,20250711,,AMPHETAMINE,Pericardial haemorrhage,DE,AMPHETAMINE | Pericardial haemorrhage | DE,NaT
255436031,25543603,52,F,2025-02-17,20250711,,ESOMEPRAZOLE,Angioedema,OT,ESOMEPRAZOLE | Angioedema | OT,2025-02-17/2025-02-23
255436821,25543682,,,,20250711,,DEXAMETHASONE,Chronic graft versus host disease oral,OT,DEXAMETHASONE | Chronic graft versus host disease oral | OT,NaT
255436891,25543689,,F,,20250711,,METHOTREXATE,Product dose omission issue,,METHOTREXATE | Product dose omission issue,NaT
255436921,25543692,,M,,20250710,,AMBRISENTAN,Pain,HO,AMBRISENTAN | Pain | HO,NaT
255437181,25543718,57,M,,20250711,,BUPRENORPHINE,Dementia,OT,BUPRENORPHINE | Dementia | OT,NaT
255437353,25543735,38,F,2025-05-01,20250909,,XYWAV,Surgery,OT,XYWAV | Surgery | OT,2025-04-28/2025-05-04
255437391,25543739,,,,20250711,,"BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",Drug ineffective,,"BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | Drug ineffective",NaT
255438071,25543807,12,F,,20250711,,VANCOMYCIN,Acute kidney injury,DE,VANCOMYCIN | Acute kidney injury | DE,NaT
255438101,25543810,56,M,2025-04-29,20250711,,ROSUVASTATIN,Dizziness,OT,ROSUVASTATIN | Dizziness | OT,2025-04-28/2025-05-04
255438201,25543820,54,F,2024-01-24,20250711,,CARBOPLATIN,Anaemia,OT,CARBOPLATIN | Anaemia | OT,2024-01-22/2024-01-28
255438221,25543822,68,M,2023-08-19,20250711,,IBUPROFEN,Vancomycin infusion reaction,HO,IBUPROFEN | Vancomycin infusion reaction | HO,2023-08-14/2023-08-20
255438561,25543856,60,M,,20250711,,PAXLOVID,Drug ineffective,,PAXLOVID | Drug ineffective,NaT
255440171,25544017,40,F,,20250711,,DELFLEX,Peritonitis,HO,DELFLEX | Peritonitis | HO,NaT
255440821,25544082,,,2025-07-08,20250711,,ELIQUIS,Product storage error,,ELIQUIS | Product storage error,2025-07-07/2025-07-13
255440851,25544085,24,M,2025-06-27,20250711,,MOUNJARO,Off label use,HO,MOUNJARO | Off label use | HO,2025-06-23/2025-06-29
255440971,25544097,29,,2025-06-01,20250711,,MOUNJARO,Asthenia,OT,MOUNJARO | Asthenia | OT,2025-05-26/2025-06-01
255441852,25544185,45,M,,20250714,,BEVACIZUMAB,Abdominal pain upper,OT,BEVACIZUMAB | Abdominal pain upper | OT,NaT
255442412,25544241,,F,,20250722,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,NaT
255442521,25544252,,,,20250711,,RETEVMO,Pneumonia,,RETEVMO | Pneumonia,NaT
255443752,25544375,,,,20250722,,ETANERCEPT,Neurosensory hypoacusis,OT,ETANERCEPT | Neurosensory hypoacusis | OT,NaT
255445381,25544538,76,M,2025-07-10,20250711,,TEMOZOLOMIDE,Therapy change,HO,TEMOZOLOMIDE | Therapy change | HO,2025-07-07/2025-07-13
255445601,25544560,,F,,20250711,,CIPROFLOXACIN,Adverse event,OT,CIPROFLOXACIN | Adverse event | OT,NaT
255445624,25544562,6,M,2025-05-12,20250821,,GIVINOSTAT,Lymphadenopathy,DE,GIVINOSTAT | Lymphadenopathy | DE,2025-05-12/2025-05-18
255446342,25544634,78,F,,20250826,,DUPIXENT,Fatigue,,DUPIXENT | Fatigue,NaT
255446482,25544648,,M,,20250724,,SODIUM CHLORIDE,Fabry's disease,,SODIUM CHLORIDE | Fabry's disease,NaT
255446901,25544690,11,M,2025-01-01,20250711,,DUPIXENT,Eczema,,DUPIXENT | Eczema,2024-12-30/2025-01-05
255447251,25544725,,F,,20250711,,DUPIXENT,Dyspnoea,,DUPIXENT | Dyspnoea,NaT
255447601,25544760,54,F,2025-06-01,20250711,,KEVZARA,Dyspnoea,,KEVZARA | Dyspnoea,2025-05-26/2025-06-01
255447991,25544799,,F,,20250711,,DUPIXENT,Dysphagia,,DUPIXENT | Dysphagia,NaT
255448041,25544804,82,M,2025-06-01,20250711,,DUPIXENT,Rash erythematous,,DUPIXENT | Rash erythematous,2025-05-26/2025-06-01
255448262,25544826,,F,,20250718,,DUPIXENT,Weight increased,,DUPIXENT | Weight increased,NaT
255448341,25544834,9,M,,20250711,,DUPIXENT,Rebound effect,,DUPIXENT | Rebound effect,NaT
255448442,25544844,49,F,2025-01-01,20250811,,DUPIXENT,Eosinophilic oesophagitis,,DUPIXENT | Eosinophilic oesophagitis,2024-12-30/2025-01-05
255449821,25544982,87,M,2025-07-02,20250711,,OPTIRAY 300,Oxygen saturation decreased,LT,OPTIRAY 300 | Oxygen saturation decreased | LT,2025-06-30/2025-07-06
255450561,25545056,50,F,,20250711,,ZEPBOUND,Nausea,HO,ZEPBOUND | Nausea | HO,NaT
255451971,25545197,53,F,2019-07-10,20250711,,ACETAMINOPHEN,Vomiting,OT,ACETAMINOPHEN | Vomiting | OT,2019-07-08/2019-07-14
255453601,25545360,73,M,,20250711,,CEFTRIAXONE,Kounis syndrome,LT,CEFTRIAXONE | Kounis syndrome | LT,NaT
255453661,25545366,80,M,,20250711,,VYXEOS,Acute myeloid leukaemia recurrent,DE,VYXEOS | Acute myeloid leukaemia recurrent | DE,NaT
255453811,25545381,,F,,20250711,,PROACTIV SOLUTION RENEWING CLEANSER,Neoplasm malignant,OT,PROACTIV SOLUTION RENEWING CLEANSER | Neoplasm malignant | OT,NaT
255454001,25545400,,M,2025-05-01,20250711,,CIBINQO,Renal impairment,OT,CIBINQO | Renal impairment | OT,2025-04-28/2025-05-04
255454761,25545476,,,,20250711,,NIKTIMVO,Insurance issue,,NIKTIMVO | Insurance issue,NaT
255454981,25545498,,,,20250711,,OMNIPAQUE,Adverse event,OT,OMNIPAQUE | Adverse event | OT,NaT
255455311,25545531,,,,20250711,,MOUNJARO,Muscle atrophy,,MOUNJARO | Muscle atrophy,NaT
255456052,25545605,,,2022-01-01,20250716,,BEVACIZUMAB,Disease progression,OT,BEVACIZUMAB | Disease progression | OT,2021-12-27/2022-01-02
255456171,25545617,27,F,2025-01-01,20250712,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,2024-12-30/2025-01-05
255458053,25545805,,M,2025-01-01,20250826,,TYVASO DPI,Dyspnoea,OT,TYVASO DPI | Dyspnoea | OT,2024-12-30/2025-01-05
255458851,25545885,,F,2025-01-01,20250712,,TYVASO DPI,Hypoacusis,,TYVASO DPI | Hypoacusis,2024-12-30/2025-01-05
255458941,25545894,67,M,,20250712,,METHYLPREDNISOLONE SODIUM SUCCINATE,Drug ineffective,HO,METHYLPREDNISOLONE SODIUM SUCCINATE | Drug ineffective | HO,NaT
255459651,25545965,,M,,20250712,,NUCALA,Tooth infection,,NUCALA | Tooth infection,NaT
255460301,25546030,78,F,2025-06-30,20250712,,TREPROSTINIL SODIUM,Death,OT,TREPROSTINIL SODIUM | Death | OT,2025-06-30/2025-07-06
255460431,25546043,,F,,20250712,,VEDOLIZUMAB,Crohn's disease,OT,VEDOLIZUMAB | Crohn's disease | OT,NaT
255460451,25546045,17,M,2025-01-01,20250712,,DUPIXENT,Chest pain,,DUPIXENT | Chest pain,2024-12-30/2025-01-05
255460811,25546081,61,F,,20250712,,HUMALOG,Product dose omission issue,,HUMALOG | Product dose omission issue,NaT
255461691,25546169,,F,2025-01-01,20250713,,NEUPRO,Product adhesion issue,,NEUPRO | Product adhesion issue,2024-12-30/2025-01-05
255461741,25546174,77,F,,20250713,,QUETIAPINE FUMARATE,Cerebral infarction,HO,QUETIAPINE FUMARATE | Cerebral infarction | HO,NaT
255461941,25546194,36,M,2025-05-24,20250713,,OMEPRAZOLE,Eosinophil count,HO,OMEPRAZOLE | Eosinophil count | HO,2025-05-19/2025-05-25
255462141,25546214,50,F,,20250713,,MONOFERRIC,Skin discolouration,,MONOFERRIC | Skin discolouration,NaT
255462731,25546273,67,F,,20250713,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,NaT
255462891,25546289,68,F,,20250713,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
255463001,25546300,17,M,,20250713,,DUPIXENT,Rebound eczema,,DUPIXENT | Rebound eczema,NaT
255463011,25546301,38,F,2025-07-07,20250713,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,2025-07-07/2025-07-13
255463182,25546318,46,F,2024-11-10,20250728,,TECFIDERA,Depression,HO,TECFIDERA | Depression | HO,2024-11-04/2024-11-10
255463642,25546364,,M,2015-01-01,20250721,,OLANZAPINE,Glucose tolerance impaired,OT,OLANZAPINE | Glucose tolerance impaired | OT,2014-12-29/2015-01-04
255464042,25546404,,,,20250926,,ALBUTEROL,Product design issue,OT,ALBUTEROL | Product design issue | OT,NaT
255464141,25546414,52,F,2018-03-01,20250713,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,2018-02-26/2018-03-04
255464251,25546425,42,F,2025-06-01,20250713,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,2025-05-26/2025-06-01
255464391,25546439,56,F,,20250713,,DUPIXENT,Dry skin,,DUPIXENT | Dry skin,NaT
255465661,25546566,33,F,2024-01-01,20250713,,HUMIRA,Thinking abnormal,OT,HUMIRA | Thinking abnormal | OT,2024-01-01/2024-01-07
255466291,25546629,73,M,,20250713,,SPRAVATO,Death,DE,SPRAVATO | Death | DE,NaT
255466621,25546662,94,F,2025-06-26,20250713,,REVLIMID,Rash,,REVLIMID | Rash,2025-06-23/2025-06-29
255467361,25546736,36,F,2025-06-01,20250714,,AMOXICILLIN,Mixed liver injury,HO,AMOXICILLIN | Mixed liver injury | HO,2025-05-26/2025-06-01
255468041,25546804,78,F,,20250714,,KEYTRUDA,Mycobacterium abscessus infection,OT,KEYTRUDA | Mycobacterium abscessus infection | OT,NaT
255468811,25546881,57,M,,20250714,,CEFUROXIME AXETIL,Anaphylactic reaction,OT,CEFUROXIME AXETIL | Anaphylactic reaction | OT,NaT
255469601,25546960,61,F,2025-05-04,20250714,,DOXORUBICIN HYDROCHLORIDE,Hypertension,HO,DOXORUBICIN HYDROCHLORIDE | Hypertension | HO,2025-04-28/2025-05-04
255470201,25547020,8,M,2025-05-01,20250714,,PADCEV,Pleural effusion,DE,PADCEV | Pleural effusion | DE,2025-04-28/2025-05-04
255471031,25547103,,F,,20250714,,BENLYSTA,Systemic lupus erythematosus rash,,BENLYSTA | Systemic lupus erythematosus rash,NaT
255471111,25547111,52,F,2024-05-06,20250714,,NORTRIPTYLINE HYDROCHLORIDE,Asthenia,DS,NORTRIPTYLINE HYDROCHLORIDE | Asthenia | DS,2024-05-06/2024-05-12
255471531,25547153,33,,,20250714,,TOLVAPTAN,Off label use,,TOLVAPTAN | Off label use,NaT
255472274,25547227,,F,,20250903,,KINERET,Drug ineffective,,KINERET | Drug ineffective,NaT
255472531,25547253,,,,20250714,,DEXAMETHASONE,Malignant neoplasm progression,OT,DEXAMETHASONE | Malignant neoplasm progression | OT,NaT
255472921,25547292,,F,,20250714,,TEZSPIRE,Asthma,HO,TEZSPIRE | Asthma | HO,NaT
255473273,25547327,85,F,,20250808,,NAPROXEN,Overdose,OT,NAPROXEN | Overdose | OT,NaT
255473471,25547347,57,F,,20250714,,ZEPBOUND,Injection site haemorrhage,,ZEPBOUND | Injection site haemorrhage,NaT
255474701,25547470,,F,2025-07-07,20250714,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,2025-07-07/2025-07-13
255474901,25547490,74,M,,20250714,,SPRYCEL,Platelet count decreased,,SPRYCEL | Platelet count decreased,NaT
255475411,25547541,49,F,2025-06-01,20250714,,SKYRIZI,Joint arthroplasty,OT,SKYRIZI | Joint arthroplasty | OT,2025-05-26/2025-06-01
255475461,25547546,,M,,20250714,,SKYRIZI,Gastrointestinal disorder,HO,SKYRIZI | Gastrointestinal disorder | HO,NaT
255475491,25547549,,F,2025-01-01,20250714,,ALBUTEROL SULFATE,Incorrect dose administered by device,,ALBUTEROL SULFATE | Incorrect dose administered by device,2024-12-30/2025-01-05
255476892,25547689,35,F,2025-07-04,20250815,,ZEPBOUND,Decreased appetite,,ZEPBOUND | Decreased appetite,2025-06-30/2025-07-06
255477042,25547704,74,M,,20250922,,BEVACIZUMAB,Interstitial lung disease,DE,BEVACIZUMAB | Interstitial lung disease | DE,NaT
255477481,25547748,,,,20250714,,VERZENIO,Neuralgia,,VERZENIO | Neuralgia,NaT
255478921,25547892,,M,,20250714,,OCREVUS,Rash,,OCREVUS | Rash,NaT
255479161,25547916,25,M,,20250714,,FLUOXETINE HYDROCHLORIDE,Lip haemorrhage,DE,FLUOXETINE HYDROCHLORIDE | Lip haemorrhage | DE,NaT
255480241,25548024,82,M,2025-06-03,20250714,,BISOPROLOL,Atrioventricular block,LT,BISOPROLOL | Atrioventricular block | LT,2025-06-02/2025-06-08
255480261,25548026,73,F,2025-06-26,20250714,,FRUQUINTINIB,Peripheral swelling,DE,FRUQUINTINIB | Peripheral swelling | DE,2025-06-23/2025-06-29
255481013,25548101,,F,,20250731,,TEZSPIRE,Injection site swelling,,TEZSPIRE | Injection site swelling,NaT
255482171,25548217,37,F,2025-07-09,20250714,,SPRAVATO,Sedation,OT,SPRAVATO | Sedation | OT,2025-07-07/2025-07-13
255482731,25548273,,F,,20250714,,OCALIVA,Hospitalisation,HO,OCALIVA | Hospitalisation | HO,NaT
255482751,25548275,26,F,2021-01-01,20250714,,TRAMADOL,Death,DE,TRAMADOL | Death | DE,2020-12-28/2021-01-03
255484611,25548461,,,,20250714,,ONDANSETRON,Product storage error,,ONDANSETRON | Product storage error,NaT
255484711,25548471,,,,20250714,,ONDANSETRON,Product storage error,,ONDANSETRON | Product storage error,NaT
255484761,25548476,,F,,20250714,,NUCALA,Arthralgia,,NUCALA | Arthralgia,NaT
255486051,25548605,77,F,2025-07-06,20250714,,ZEPBOUND,Underdose,,ZEPBOUND | Underdose,2025-06-30/2025-07-06
255486231,25548623,,M,,20250714,,MOUNJARO,Pancreatitis,OT,MOUNJARO | Pancreatitis | OT,NaT
255487241,25548724,,,,20250714,,MOUNJARO,Dizziness,OT,MOUNJARO | Dizziness | OT,NaT
255488061,25548806,66,F,,20250714,,CYCLOPHOSPHAMIDE,Drug ineffective,DE,CYCLOPHOSPHAMIDE | Drug ineffective | DE,NaT
255488171,25548817,22,F,,20250714,,OLANZAPINE,Cardiac arrest,HO,OLANZAPINE | Cardiac arrest | HO,NaT
255488791,25548879,73,M,,20250711,,OTEZLA,Death,,OTEZLA | Death,NaT
255488981,25548898,56,M,2025-05-30,20250714,,OLANZAPINE,Tachypnoea,HO,OLANZAPINE | Tachypnoea | HO,2025-05-26/2025-06-01
255489071,25548907,50,,,20250714,,ZEPBOUND,Injection site bruising,,ZEPBOUND | Injection site bruising,NaT
255489711,25548971,,F,,20250714,,MIRENA,Genital haemorrhage,,MIRENA | Genital haemorrhage,NaT
255489801,25548980,,M,,20250714,,NUPLAZID,Death,OT,NUPLAZID | Death | OT,NaT
255490251,25549025,,,2024-12-01,20250714,,IDELVION,Haemorrhage,OT,IDELVION | Haemorrhage | OT,2024-11-25/2024-12-01
255490681,25549068,,F,2025-02-01,20250714,,LORAZEPAM,Small for dates baby,OT,LORAZEPAM | Small for dates baby | OT,2025-01-27/2025-02-02
255490901,25549090,60,F,2025-01-01,20250714,,DUPIXENT,Hypercalcaemia,OT,DUPIXENT | Hypercalcaemia | OT,2024-12-30/2025-01-05
255490981,25549098,,M,,20250714,,IMDELLTRA,Skin exfoliation,,IMDELLTRA | Skin exfoliation,NaT
255491352,25549135,80,F,,20250721,,SOLU-MEDROL,Off label use,OT,SOLU-MEDROL | Off label use | OT,NaT
255492362,25549236,88,M,2025-06-20,20250925,,BERIPLEX HS,Wrong product administered,OT,BERIPLEX HS | Wrong product administered | OT,2025-06-16/2025-06-22
255493292,25549329,,F,,20250814,,CORTICOTROPIN,Insomnia,OT,CORTICOTROPIN | Insomnia | OT,NaT
255493921,25549392,51,F,,20250714,,VYEPTI,Diverticulitis,OT,VYEPTI | Diverticulitis | OT,NaT
255495181,25549518,54,F,2025-01-01,20250714,,XELJANZ XR,Condition aggravated,,XELJANZ XR | Condition aggravated,2024-12-30/2025-01-05
255496342,25549634,63,F,2025-07-01,20250811,,REVLIMID,Constipation,,REVLIMID | Constipation,2025-06-30/2025-07-06
255496441,25549644,,F,,20250714,,HUMIRA,Product storage error,,HUMIRA | Product storage error,NaT
255496461,25549646,43,,,20250714,,JAKAFI,Wrong technique in product usage process,,JAKAFI | Wrong technique in product usage process,NaT
255496961,25549696,,M,2025-07-06,20250714,,MIRALAX,Flatulence,,MIRALAX | Flatulence,2025-06-30/2025-07-06
255497283,25549728,,M,,20250820,,NICODERM CQ,Product adhesion issue,,NICODERM CQ | Product adhesion issue,NaT
255498291,25549829,55,F,,20250714,,SEMAGLUTIDE,Counterfeit product administered,,SEMAGLUTIDE | Counterfeit product administered,NaT
255498991,25549899,,M,2025-01-01,20250714,,SEMAGLUTIDE,Urticaria,,SEMAGLUTIDE | Urticaria,2024-12-30/2025-01-05
255499901,25549990,,F,,20250714,,GILENYA,Condition aggravated,OT,GILENYA | Condition aggravated | OT,NaT
255500031,25550003,19,F,2025-05-05,20250714,,RINVOQ,Abortion,OT,RINVOQ | Abortion | OT,2025-05-05/2025-05-11
255500082,25550008,37,F,2025-07-10,20250721,,EPIDIOLEX,Seizure,DE,EPIDIOLEX | Seizure | DE,2025-07-07/2025-07-13
255500581,25550058,3,,,20250714,,JAKAFI,Off label use,,JAKAFI | Off label use,NaT
255500921,25550092,,,2025-07-11,20250711,,METFORMIN HYDROCHLORIDE,Treatment failure,,METFORMIN HYDROCHLORIDE | Treatment failure,2025-07-07/2025-07-13
255502991,25550299,35,M,2025-02-27,20250714,,LURASIDONE,Impulse-control disorder,HO,LURASIDONE | Impulse-control disorder | HO,2025-02-24/2025-03-02
255503691,25550369,,F,,20250714,,SKYRIZI,Pruritus,OT,SKYRIZI | Pruritus | OT,NaT
255503791,25550379,73,F,2025-01-01,20250714,,LETROZOLE,Arthralgia,,LETROZOLE | Arthralgia,2024-12-30/2025-01-05
255504781,25550478,27,F,2025-06-01,20250714,,DUPIXENT,Vomiting,,DUPIXENT | Vomiting,2025-05-26/2025-06-01
255506021,25550602,,F,,20250714,,DUPIXENT,Sleep disorder due to a general medical condition,,DUPIXENT | Sleep disorder due to a general medical condition,NaT
255506231,25550623,77,F,,20250714,,LANTUS,Product storage error,,LANTUS | Product storage error,NaT
255506341,25550634,63,M,2010-01-01,20250714,,FABRAZYME,Inappropriate schedule of product administration,,FABRAZYME | Inappropriate schedule of product administration,2009-12-28/2010-01-03
255506431,25550643,63,F,,20250714,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
255506491,25550649,40,F,,20250714,,LANTUS SOLOSTAR,Off label use,,LANTUS SOLOSTAR | Off label use,NaT
255507362,25550736,26,F,2025-07-07,20250718,,CLOZARIL,Feeling guilty,HO,CLOZARIL | Feeling guilty | HO,2025-07-07/2025-07-13
255507551,25550755,32,F,,20250714,,ZEPBOUND,Injection site pain,,ZEPBOUND | Injection site pain,NaT
255507662,25550766,74,F,2025-06-01,20250722,,SKYRIZI,Gastrointestinal disorder,HO,SKYRIZI | Gastrointestinal disorder | HO,2025-05-26/2025-06-01
255507721,25550772,,F,,20250714,,CAPLYTA,Dizziness,,CAPLYTA | Dizziness,NaT
255508651,25550865,,F,2025-01-01,20250714,,CAPLYTA,Irritability,,CAPLYTA | Irritability,2024-12-30/2025-01-05
255509691,25550969,,F,,20250714,,CAPLYTA,Pruritus,,CAPLYTA | Pruritus,NaT
255509851,25550985,,F,,20250714,,CAPLYTA,Constipation,,CAPLYTA | Constipation,NaT
255509901,25550990,,M,,20250714,,CAPLYTA,Enuresis,,CAPLYTA | Enuresis,NaT
255510171,25551017,,F,,20250714,,CAPLYTA,Headache,,CAPLYTA | Headache,NaT
255510621,25551062,,M,,20250714,,CAPLYTA,Agitation,,CAPLYTA | Agitation,NaT
255511271,25551127,,F,,20250714,,LANTUS SOLOSTAR,Product storage error,,LANTUS SOLOSTAR | Product storage error,NaT
255511395,25551139,83,F,2025-05-12,20250909,,TEDUGLUTIDE,Swelling face,HO,TEDUGLUTIDE | Swelling face | HO,2025-05-12/2025-05-18
255511651,25551165,60,F,,20250714,,PEMETREXED,Drug ineffective,OT,PEMETREXED | Drug ineffective | OT,NaT
255512791,25551279,,M,,20250714,,HUMIRA,Poor quality product administered,,HUMIRA | Poor quality product administered,NaT
255512821,25551282,4,F,,20250714,,TOPOTECAN,Febrile neutropenia,HO,TOPOTECAN | Febrile neutropenia | HO,NaT
255512891,25551289,,F,,20250714,,INGREZZA,Somnolence,,INGREZZA | Somnolence,NaT
255513101,25551310,69,F,,20250714,,DUPIXENT,Chest discomfort,,DUPIXENT | Chest discomfort,NaT
255513632,25551363,,F,,20250726,,IQIRVO,Blood test abnormal,,IQIRVO | Blood test abnormal,NaT
255515524,25551552,17,M,,20250813,,GENOTROPIN,Device use issue,,GENOTROPIN | Device use issue,NaT
255515544,25551554,11,M,2025-07-09,20250910,,GENOTROPIN,Device breakage,,GENOTROPIN | Device breakage,2025-07-07/2025-07-13
255515831,25551583,64,F,2025-07-03,20250714,,REVLIMID,Rash,,REVLIMID | Rash,2025-06-30/2025-07-06
255515871,25551587,,F,,20250714,,GLIVEC,Metastases to peritoneum,DE,GLIVEC | Metastases to peritoneum | DE,NaT
255516091,25551609,56,F,,20250714,,ENHERTU,Asthenia,OT,ENHERTU | Asthenia | OT,NaT
255516571,25551657,77,F,2025-06-16,20250714,,TARPEYO,Abdominal pain upper,,TARPEYO | Abdominal pain upper,2025-06-16/2025-06-22
255517651,25551765,61,M,,20250714,,METFORMIN HYDROCHLORIDE,Hypomagnesaemia,HO,METFORMIN HYDROCHLORIDE | Hypomagnesaemia | HO,NaT
255519932,25551993,,F,2025-01-01,20250918,,BIMZELX,Oral candidiasis,OT,BIMZELX | Oral candidiasis | OT,2024-12-30/2025-01-05
255520521,25552052,,F,,20250715,,RINVOQ,Parkinson's disease,OT,RINVOQ | Parkinson's disease | OT,NaT
255520861,25552086,65,F,2025-07-02,20250715,,AIMOVIG,Stress,OT,AIMOVIG | Stress | OT,2025-06-30/2025-07-06
255521391,25552139,70,M,2025-01-01,20250715,,SKYRIZI,Malignant melanoma,OT,SKYRIZI | Malignant melanoma | OT,2024-12-30/2025-01-05
255521451,25552145,,M,,20250715,,MYCOPHENOLATE MOFETIL,Blindness,OT,MYCOPHENOLATE MOFETIL | Blindness | OT,NaT
255521492,25552149,58,F,2025-01-01,20250922,,DUPIXENT,Urticaria,,DUPIXENT | Urticaria,2024-12-30/2025-01-05
255521781,25552178,,,,20250715,,CREON,Vomiting,,CREON | Vomiting,NaT
255521871,25552187,,M,,20250715,,PRADAXA,Aortic dissection,HO,PRADAXA | Aortic dissection | HO,NaT
255522561,25552256,35,F,,20250715,,PAROXETINE,Drug ineffective,OT,PAROXETINE | Drug ineffective | OT,NaT
255522762,25552276,80,,,20250919,,ALBUTEROL SULFATE,No adverse event,,ALBUTEROL SULFATE | No adverse event,NaT
255523402,25552340,73,,2025-01-01,20250723,,RYBREVANT,Pneumonitis,HO,RYBREVANT | Pneumonitis | HO,2024-12-30/2025-01-05
255523891,25552389,82,M,2025-06-16,20250715,,RIVAROXABAN,Abdominal pain upper,OT,RIVAROXABAN | Abdominal pain upper | OT,2025-06-16/2025-06-22
255523991,25552399,,F,2024-04-29,20250715,,KEYTRUDA,Haemoglobin decreased,OT,KEYTRUDA | Haemoglobin decreased | OT,2024-04-29/2024-05-05
255524461,25552446,86,F,2025-06-16,20250715,,KEYTRUDA,Rash,,KEYTRUDA | Rash,2025-06-16/2025-06-22
255524522,25552452,,F,,20250715,,FLUTICASONE PROPIONATE\SALMETEROL XINAFOATE,Duplicate therapy error,OT,FLUTICASONE PROPIONATE\SALMETEROL XINAFOATE | Duplicate therapy error | OT,NaT
255524951,25552495,56,M,2025-04-01,20250715,,BRIVARACETAM,Product availability issue,OT,BRIVARACETAM | Product availability issue | OT,2025-03-31/2025-04-06
255525311,25552531,,F,,20250715,,LOKELMA,Product use issue,OT,LOKELMA | Product use issue | OT,NaT
255525431,25552543,,,,20250715,,YONSA,Product dispensing issue,,YONSA | Product dispensing issue,NaT
255525551,25552555,60,F,,20250715,,CELLCEPT,Drug intolerance,,CELLCEPT | Drug intolerance,NaT
255526451,25552645,,M,,20250715,,VYLOY,Malignant neoplasm progression,OT,VYLOY | Malignant neoplasm progression | OT,NaT
255526901,25552690,,M,,20250715,,ELIGARD,Manufacturing issue,,ELIGARD | Manufacturing issue,NaT
255527922,25552792,48,,,20250716,,ALBUTEROL SULFATE,Drug dose omission by device,,ALBUTEROL SULFATE | Drug dose omission by device,NaT
255528701,25552870,,,,20250715,,BRUKINSA,Disease progression,OT,BRUKINSA | Disease progression | OT,NaT
255529271,25552927,50,F,,20250715,,MOUNJARO,Gastrointestinal disorder,,MOUNJARO | Gastrointestinal disorder,NaT
255529481,25552948,,,,20250715,,MOUNJARO,Drug ineffective,,MOUNJARO | Drug ineffective,NaT
255529521,25552952,50,F,,20250715,,ZEPBOUND,Accidental underdose,,ZEPBOUND | Accidental underdose,NaT
255529701,25552970,82,M,,20250715,,TOUJEO,Brain cancer metastatic,DE,TOUJEO | Brain cancer metastatic | DE,NaT
255530131,25553013,63,F,2025-06-29,20250715,,CYCLOPHOSPHAMIDE,Hypoglycaemia,OT,CYCLOPHOSPHAMIDE | Hypoglycaemia | OT,2025-06-23/2025-06-29
255530512,25553051,68,F,2025-07-07,20250717,,CONBERCEPT,Uterine polyp,HO,CONBERCEPT | Uterine polyp | HO,2025-07-07/2025-07-13
255531651,25553165,,M,2025-07-10,20250715,,MOUNJARO,Hypoglycaemia,,MOUNJARO | Hypoglycaemia,2025-07-07/2025-07-13
255531761,25553176,90,M,,20250715,,MUCINEX D,Diarrhoea,,MUCINEX D | Diarrhoea,NaT
255531911,25553191,,,,20250715,,RYBREVANT,Anaphylactic shock,OT,RYBREVANT | Anaphylactic shock | OT,NaT
255532051,25553205,,,,20250715,,URSODIOL,Venoocclusive liver disease,OT,URSODIOL | Venoocclusive liver disease | OT,NaT
255532171,25553217,,,2025-07-10,20250715,,DARZALEX,Infusion related reaction,,DARZALEX | Infusion related reaction,2025-07-07/2025-07-13
255532921,25553292,,M,,20250715,,CREON,Quarantine,OT,CREON | Quarantine | OT,NaT
255533261,25553326,,F,,20250715,,NUCALA,Asthma,,NUCALA | Asthma,NaT
255533371,25553337,,F,,20250715,,PIPERACILLIN AND TAZOBACTAM,Rash,,PIPERACILLIN AND TAZOBACTAM | Rash,NaT
255533441,25553344,83,M,2025-07-14,20250715,,REVLIMID,Product dose omission issue,,REVLIMID | Product dose omission issue,2025-07-14/2025-07-20
255534121,25553412,,,,20250715,,ORGOVYX,Feeling hot,,ORGOVYX | Feeling hot,NaT
255534531,25553453,,,,20250715,,ORGOVYX,Hot flush,,ORGOVYX | Hot flush,NaT
255534761,25553476,,,,20250715,,ORGOVYX,Weight increased,,ORGOVYX | Weight increased,NaT
255534901,25553490,,,,20250715,,ROMOSOZUMAB,Death,DE,ROMOSOZUMAB | Death | DE,NaT
255536421,25553642,,M,,20250715,,IMODIUM,Dehydration,,IMODIUM | Dehydration,NaT
255537421,25553742,54,F,,20250715,,ZEPBOUND,Nausea,,ZEPBOUND | Nausea,NaT
255538671,25553867,71,F,2025-05-19,20250714,,CARVYKTI,Cytokine release syndrome,HO,CARVYKTI | Cytokine release syndrome | HO,2025-05-19/2025-05-25
255538731,25553873,,F,,20250714,,SILDENAFIL,Myocardial infarction,,SILDENAFIL | Myocardial infarction,NaT
255538911,25553891,70,F,2025-07-01,20250715,,ZEPBOUND,Vomiting,,ZEPBOUND | Vomiting,2025-06-30/2025-07-06
255539131,25553913,33,,2025-07-10,20250715,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,2025-07-07/2025-07-13
255540001,25554000,13,F,,20250715,,EPOPROSTENOL,Haemoptysis,OT,EPOPROSTENOL | Haemoptysis | OT,NaT
255540561,25554056,63,F,2025-02-24,20250715,,IBUPROFEN,Cholestasis,OT,IBUPROFEN | Cholestasis | OT,2025-02-24/2025-03-02
255541084,25554108,69,F,2025-01-01,20250915,,ORENCIA,Musculoskeletal stiffness,,ORENCIA | Musculoskeletal stiffness,2024-12-30/2025-01-05
255541591,25554159,60,F,,20250714,,MOUNJARO,Back pain,,MOUNJARO | Back pain,NaT
255542001,25554200,,M,,20250715,,TIVICAY,Nausea,RI,TIVICAY | Nausea | RI,NaT
255542551,25554255,74,M,,20250714,,CAPECITABINE,Therapy cessation,,CAPECITABINE | Therapy cessation,NaT
255543701,25554370,73,F,,20250715,,OZEMPIC,Hiccups,,OZEMPIC | Hiccups,NaT
255544731,25554473,,F,2024-06-01,20250715,,OZEMPIC,Haematochezia,,OZEMPIC | Haematochezia,2024-05-27/2024-06-02
255544801,25554480,72,F,2024-05-01,20250715,,OZEMPIC,Wrong technique in product usage process,,OZEMPIC | Wrong technique in product usage process,2024-04-29/2024-05-05
255545351,25554535,45,F,,20250715,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
255545441,25554544,77,F,2024-07-01,20250715,,OZEMPIC,Dizziness,,OZEMPIC | Dizziness,2024-07-01/2024-07-07
255545621,25554562,,M,,20250715,,OZEMPIC,Off label use,,OZEMPIC | Off label use,NaT
255546131,25554613,83,F,2025-06-04,20250715,,TARPEYO,Blood pressure increased,,TARPEYO | Blood pressure increased,2025-06-02/2025-06-08
255546331,25554633,68,F,2024-05-01,20250715,,OZEMPIC,Eye pain,,OZEMPIC | Eye pain,2024-04-29/2024-05-05
255548141,25554814,,,,20250715,,OZEMPIC,Hunger,,OZEMPIC | Hunger,NaT
255548301,25554830,,F,2024-05-01,20250715,,OZEMPIC,Nausea,,OZEMPIC | Nausea,2024-04-29/2024-05-05
255548382,25554838,58,F,2025-06-19,20250930,,HYDROCORTISONE,Adrenal insufficiency,HO,HYDROCORTISONE | Adrenal insufficiency | HO,2025-06-16/2025-06-22
255549984,25554998,10,M,2025-07-01,20250903,,GENOTROPIN,Device leakage,,GENOTROPIN | Device leakage,2025-06-30/2025-07-06
255550101,25555010,66,M,,20250714,,YESINTEK,Arthritis,OT,YESINTEK | Arthritis | OT,NaT
255550384,25555038,12,F,,20250815,,GENOTROPIN,Drug dose omission by device,,GENOTROPIN | Drug dose omission by device,NaT
255550392,25555039,78,M,2025-01-01,20250911,,ABRILADA,Fall,HO,ABRILADA | Fall | HO,2024-12-30/2025-01-05
255550795,25555079,11,F,2025-07-08,20250917,,GENOTROPIN,Swelling face,,GENOTROPIN | Swelling face,2025-07-07/2025-07-13
255552054,25555205,35,F,2017-05-23,20250916,,COMPLERA,Bone density decreased,OT,COMPLERA | Bone density decreased | OT,2017-05-22/2017-05-28
255553041,25555304,93,F,,20250715,,TEPOTINIB,Malignant neoplasm oligoprogression,OT,TEPOTINIB | Malignant neoplasm oligoprogression | OT,NaT
255553191,25555319,48,F,2024-06-03,20250715,,OZEMPIC,Inappropriate schedule of product administration,,OZEMPIC | Inappropriate schedule of product administration,2024-06-03/2024-06-09
255554211,25555421,77,F,2023-07-05,20250715,,OZEMPIC,Alopecia,,OZEMPIC | Alopecia,2023-07-03/2023-07-09
255555181,25555518,80,M,2024-01-01,20250715,,OZEMPIC,Decreased appetite,,OZEMPIC | Decreased appetite,2024-01-01/2024-01-07
255555561,25555556,57,F,2024-06-14,20250715,,OZEMPIC,Injection site vesicles,,OZEMPIC | Injection site vesicles,2024-06-10/2024-06-16
255556311,25555631,35,M,2023-06-28,20250715,,OZEMPIC,Nausea,HO,OZEMPIC | Nausea | HO,2023-06-26/2023-07-02
255557421,25555742,67,F,2025-05-28,20250715,,DIANEAL,Abdominal distension,,DIANEAL | Abdominal distension,2025-05-26/2025-06-01
255557651,25555765,19,F,2025-07-13,20250715,,ACTEMRA,Heart rate increased,HO,ACTEMRA | Heart rate increased | HO,2025-07-07/2025-07-13
255558221,25555822,66,F,2025-01-01,20250715,,DUPIXENT,Condition aggravated,,DUPIXENT | Condition aggravated,2024-12-30/2025-01-05
255559801,25555980,,M,,20250715,,DUPIXENT,Urticaria,,DUPIXENT | Urticaria,NaT
255560062,25556006,70,F,,20250818,,TOUJEO MAX,Dry eye,,TOUJEO MAX | Dry eye,NaT
255560241,25556024,,F,2025-05-01,20250715,,DUPIXENT,Meniscus injury,,DUPIXENT | Meniscus injury,2025-04-28/2025-05-04
255561501,25556150,,F,,20250715,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,NaT
255561711,25556171,67,M,,20250715,,DUPIXENT,Lower limb fracture,,DUPIXENT | Lower limb fracture,NaT
255562941,25556294,53,F,2025-06-10,20250715,,MOUNJARO,Tachycardia,HO,MOUNJARO | Tachycardia | HO,2025-06-09/2025-06-15
255562971,25556297,,F,2025-06-05,20250715,,MOUNJARO,Depression,OT,MOUNJARO | Depression | OT,2025-06-02/2025-06-08
255563311,25556331,,M,,20250715,,OZEMPIC,Decreased appetite,,OZEMPIC | Decreased appetite,NaT
255564571,25556457,60,F,2024-08-13,20250715,,OZEMPIC,Decreased appetite,,OZEMPIC | Decreased appetite,2024-08-12/2024-08-18
255565291,25556529,19,F,2025-01-01,20250715,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,2024-12-30/2025-01-05
255565381,25556538,,M,,20250715,,OZEMPIC,Headache,,OZEMPIC | Headache,NaT
255565431,25556543,,,,20250715,,OZEMPIC,Flatulence,,OZEMPIC | Flatulence,NaT
255565621,25556562,,F,2024-12-01,20250715,,OZEMPIC,Constipation,,OZEMPIC | Constipation,2024-11-25/2024-12-01
255565941,25556594,77,M,,20250715,,BIVALIRUDIN,Drug ineffective,HO,BIVALIRUDIN | Drug ineffective | HO,NaT
255566001,25556600,62,F,,20250715,,TERBINAFINE HYDROCHLORIDE,Movement disorder,OT,TERBINAFINE HYDROCHLORIDE | Movement disorder | OT,NaT
255567752,25556775,61,M,2018-01-01,20250716,,OZEMPIC,Off label use,OT,OZEMPIC | Off label use | OT,2018-01-01/2018-01-07
255568171,25556817,62,M,2025-05-07,20250715,,SKYRIZI,Death,DE,SKYRIZI | Death | DE,2025-05-05/2025-05-11
255568251,25556825,70,M,2024-02-07,20250715,,OZEMPIC,Pollakiuria,,OZEMPIC | Pollakiuria,2024-02-05/2024-02-11
255568501,25556850,,M,,20250714,,ERLEADA,Intentional dose omission,HO,ERLEADA | Intentional dose omission | HO,NaT
255568582,25556858,27,F,2023-10-06,20250715,,OZEMPIC,Constipation,HO,OZEMPIC | Constipation | HO,2023-10-02/2023-10-08
255569182,25556918,48,M,,20250822,,EPINEPHRINE BITARTRATE,Aplasia pure red cell,OT,EPINEPHRINE BITARTRATE | Aplasia pure red cell | OT,NaT
255569291,25556929,67,M,2024-07-18,20250715,,OZEMPIC,Product use in unapproved indication,,OZEMPIC | Product use in unapproved indication,2024-07-15/2024-07-21
255569341,25556934,39,F,2025-01-01,20250715,,COPAXONE,Injection site reaction,HO,COPAXONE | Injection site reaction | HO,2024-12-30/2025-01-05
255569361,25556936,53,F,2025-06-27,20250715,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,2025-06-23/2025-06-29
255570092,25557009,,F,,20250718,,RYBELSUS,Condition aggravated,,RYBELSUS | Condition aggravated,NaT
255570301,25557030,,,,20250715,,OPZELURA,Product physical consistency issue,,OPZELURA | Product physical consistency issue,NaT
255570601,25557060,,F,,20250715,,OZEMPIC,Decreased appetite,,OZEMPIC | Decreased appetite,NaT
255570951,25557095,51,F,,20250715,,COSENTYX,Upper limb fracture,HO,COSENTYX | Upper limb fracture | HO,NaT
255571521,25557152,80,F,,20250715,,TERIPARATIDE,Metastases to central nervous system,HO,TERIPARATIDE | Metastases to central nervous system | HO,NaT
255571891,25557189,,M,,20250715,,OZEMPIC,Diabetic retinopathy,OT,OZEMPIC | Diabetic retinopathy | OT,NaT
255572091,25557209,63,F,,20250715,,ELIQUIS,Treatment noncompliance,,ELIQUIS | Treatment noncompliance,NaT
255572661,25557266,63,M,,20250715,,LANTUS SOLOSTAR,Exposure via skin contact,,LANTUS SOLOSTAR | Exposure via skin contact,NaT
255573021,25557302,56,F,,20250715,,OZEMPIC,Abdominal pain upper,,OZEMPIC | Abdominal pain upper,NaT
255573151,25557315,,F,,20250715,,OZEMPIC,Frustration tolerance decreased,,OZEMPIC | Frustration tolerance decreased,NaT
255573561,25557356,,M,,20250715,,OZEMPIC,Increased appetite,,OZEMPIC | Increased appetite,NaT
255573741,25557374,,,,20250715,,OZEMPIC,Weight decreased,,OZEMPIC | Weight decreased,NaT
255574961,25557496,55,F,2023-06-01,20250715,,OZEMPIC,Diarrhoea,OT,OZEMPIC | Diarrhoea | OT,2023-05-29/2023-06-04
255575001,25557500,,,,20250715,,RITUXIMAB,Neuromyelitis optica spectrum disorder,OT,RITUXIMAB | Neuromyelitis optica spectrum disorder | OT,NaT
255575651,25557565,39,M,2023-10-06,20250715,,OZEMPIC,Inappropriate schedule of product administration,OT,OZEMPIC | Inappropriate schedule of product administration | OT,2023-10-02/2023-10-08
255575801,25557580,,,,20250715,,OZEMPIC,Pancreatitis,OT,OZEMPIC | Pancreatitis | OT,NaT
255578391,25557839,9,,,20250715,,VYNDAMAX,Cardiac failure,DE,VYNDAMAX | Cardiac failure | DE,NaT
255578541,25557854,,,,20250715,,OZEMPIC,Burning sensation,,OZEMPIC | Burning sensation,NaT
255579021,25557902,80,F,2025-05-01,20250715,,OZEMPIC,Hunger,,OZEMPIC | Hunger,2025-04-28/2025-05-04
255579431,25557943,,F,,20250715,,OZEMPIC,Breast tenderness,,OZEMPIC | Breast tenderness,NaT
255579621,25557962,,M,,20250715,,BOTOX COSMETIC,Product quality issue,,BOTOX COSMETIC | Product quality issue,NaT
255579891,25557989,68,F,,20250715,,GLIVEC,Frontotemporal dementia,OT,GLIVEC | Frontotemporal dementia | OT,NaT
255580971,25558097,,,,20250715,,ADALIMUMAB,Post procedural haemorrhage,OT,ADALIMUMAB | Post procedural haemorrhage | OT,NaT
255582211,25558221,45,,,20250715,,OZEMPIC,Impaired gastric emptying,OT,OZEMPIC | Impaired gastric emptying | OT,NaT
255582261,25558226,69,M,2025-03-31,20250715,,OZEMPIC,Discomfort,,OZEMPIC | Discomfort,2025-03-31/2025-04-06
255582451,25558245,,F,2025-05-05,20250715,,OZEMPIC,Pancreatitis,HO,OZEMPIC | Pancreatitis | HO,2025-05-05/2025-05-11
255583071,25558307,,,2025-03-31,20250715,,OZEMPIC,Decreased appetite,,OZEMPIC | Decreased appetite,2025-03-31/2025-04-06
255583711,25558371,49,F,2025-06-28,20250715,,ESTRADIOL,Poor quality product administered,,ESTRADIOL | Poor quality product administered,2025-06-23/2025-06-29
255583752,25558375,73,F,2024-12-01,20250715,,OZEMPIC,Visual impairment,,OZEMPIC | Visual impairment,2024-11-25/2024-12-01
255583961,25558396,,F,,20250715,,OZEMPIC,Asthenia,,OZEMPIC | Asthenia,NaT
255584071,25558407,53,,,20250715,,OZEMPIC,Impaired gastric emptying,HO,OZEMPIC | Impaired gastric emptying | HO,NaT
255584371,25558437,2,F,,20250715,,AQNEURSA,Off label use,,AQNEURSA | Off label use,NaT
255584521,25558452,60,F,2024-11-01,20250715,,OZEMPIC,Weight increased,,OZEMPIC | Weight increased,2024-10-28/2024-11-03
255585221,25558522,69,F,2025-04-22,20250715,,OZEMPIC,Product use in unapproved indication,,OZEMPIC | Product use in unapproved indication,2025-04-21/2025-04-27
255586461,25558646,,,,20250715,,OZEMPIC,Weight decreased,,OZEMPIC | Weight decreased,NaT
255586481,25558648,,,,20250715,,OZEMPIC,Weight increased,,OZEMPIC | Weight increased,NaT
255587881,25558788,43,F,2025-04-01,20250715,,OZEMPIC,Gastroenteritis viral,,OZEMPIC | Gastroenteritis viral,2025-03-31/2025-04-06
255588341,25558834,,M,,20250715,,OZEMPIC,Hunger,,OZEMPIC | Hunger,NaT
255588471,25558847,,,,20250715,,OZEMPIC,Carbon dioxide decreased,,OZEMPIC | Carbon dioxide decreased,NaT
255588781,25558878,,F,,20250715,,OZEMPIC,Illness,,OZEMPIC | Illness,NaT
255589301,25558930,63,M,2025-05-20,20250715,,OZEMPIC,Headache,,OZEMPIC | Headache,2025-05-19/2025-05-25
255589401,25558940,,,,20250715,,OZEMPIC,Skin burning sensation,,OZEMPIC | Skin burning sensation,NaT
255589831,25558983,,F,,20250715,,OZEMPIC,Gastroenteritis viral,,OZEMPIC | Gastroenteritis viral,NaT
255589842,25558984,69,F,2025-05-01,20250904,,OZEMPIC,Nausea,OT,OZEMPIC | Nausea | OT,2025-04-28/2025-05-04
255590571,25559057,68,F,2025-05-22,20250715,,OZEMPIC,Injection site erythema,,OZEMPIC | Injection site erythema,2025-05-19/2025-05-25
255590591,25559059,79,M,2025-01-01,20250715,,OZEMPIC,Vitamin D decreased,OT,OZEMPIC | Vitamin D decreased | OT,2024-12-30/2025-01-05
255591181,25559118,60,F,2025-01-14,20250715,,OZEMPIC,Nausea,,OZEMPIC | Nausea,2025-01-13/2025-01-19
255591281,25559128,,M,2025-04-11,20250715,,OZEMPIC,Extra dose administered,,OZEMPIC | Extra dose administered,2025-04-07/2025-04-13
255591361,25559136,80,M,2024-01-01,20250715,,OZEMPIC,Weight increased,,OZEMPIC | Weight increased,2024-01-01/2024-01-07
255591471,25559147,63,,2025-03-08,20250715,,OZEMPIC,Feeling abnormal,,OZEMPIC | Feeling abnormal,2025-03-03/2025-03-09
255592551,25559255,52,,2025-02-14,20250715,,OZEMPIC,Constipation,HO,OZEMPIC | Constipation | HO,2025-02-10/2025-02-16
255593071,25559307,,F,,20250715,,OZEMPIC,Constipation,,OZEMPIC | Constipation,NaT
255593521,25559352,65,M,2024-12-15,20250715,,OZEMPIC,Increased appetite,,OZEMPIC | Increased appetite,2024-12-09/2024-12-15
255593561,25559356,68,F,2024-12-17,20250715,,OZEMPIC,Erythema,,OZEMPIC | Erythema,2024-12-16/2024-12-22
255595131,25559513,,M,2022-10-01,20250715,,OZEMPIC,Cholecystectomy,HO,OZEMPIC | Cholecystectomy | HO,2022-09-26/2022-10-02
255595141,25559514,,,,20250715,,OZEMPIC,Weight increased,,OZEMPIC | Weight increased,NaT
255595231,25559523,,F,,20250715,,OZEMPIC,Decreased appetite,,OZEMPIC | Decreased appetite,NaT
255595492,25559549,,F,,20250718,,OZEMPIC,Weight decreased,,OZEMPIC | Weight decreased,NaT
255595931,25559593,73,F,2025-01-31,20250715,,OZEMPIC,Cataract operation,,OZEMPIC | Cataract operation,2025-01-27/2025-02-02
255596791,25559679,,,,20250715,,OZEMPIC,Pain in extremity,,OZEMPIC | Pain in extremity,NaT
255596911,25559691,69,F,2025-01-07,20250715,,OZEMPIC,Vomiting,,OZEMPIC | Vomiting,2025-01-06/2025-01-12
255596951,25559695,67,M,2024-11-01,20250715,,OZEMPIC,Product use in unapproved indication,,OZEMPIC | Product use in unapproved indication,2024-10-28/2024-11-03
255597621,25559762,70,,,20250715,,OZEMPIC,Malaise,,OZEMPIC | Malaise,NaT
255597861,25559786,68,F,2024-07-05,20250715,,OZEMPIC,Weight increased,,OZEMPIC | Weight increased,2024-07-01/2024-07-07
255599211,25559921,62,F,2025-01-01,20250715,,JARDIANCE,Glomerular filtration rate decreased,,JARDIANCE | Glomerular filtration rate decreased,2024-12-30/2025-01-05
255600131,25560013,,M,,20250715,,OZEMPIC,Dehydration,,OZEMPIC | Dehydration,NaT
255600591,25560059,46,,,20250715,,OZEMPIC,Impaired gastric emptying,OT,OZEMPIC | Impaired gastric emptying | OT,NaT
255601771,25560177,49,F,,20250715,,OZEMPIC,Weight increased,,OZEMPIC | Weight increased,NaT
255601871,25560187,,M,,20250715,,OZEMPIC,Inappropriate schedule of product administration,,OZEMPIC | Inappropriate schedule of product administration,NaT
255602651,25560265,,M,2025-01-01,20250715,,OZEMPIC,Dysphagia,,OZEMPIC | Dysphagia,2024-12-30/2025-01-05
255602941,25560294,54,M,2025-05-01,20250715,,OZEMPIC,Inappropriate schedule of product administration,,OZEMPIC | Inappropriate schedule of product administration,2025-04-28/2025-05-04
255602991,25560299,,F,,20250715,,OZEMPIC,Vomiting,,OZEMPIC | Vomiting,NaT
255603301,25560330,,F,,20250715,,OZEMPIC,Visual impairment,,OZEMPIC | Visual impairment,NaT
255603571,25560357,,F,,20250715,,OZEMPIC,Injection site discharge,,OZEMPIC | Injection site discharge,NaT
255603951,25560395,,M,2025-04-07,20250715,,OZEMPIC,Fall,,OZEMPIC | Fall,2025-04-07/2025-04-13
255604041,25560404,,M,,20250715,,OZEMPIC,Product label confusion,,OZEMPIC | Product label confusion,NaT
255605351,25560535,,F,,20250715,,OZEMPIC,Dysphagia,,OZEMPIC | Dysphagia,NaT
255605671,25560567,,F,2024-01-01,20250715,,OZEMPIC,Depression,,OZEMPIC | Depression,2024-01-01/2024-01-07
255606551,25560655,,M,,20250715,,REFRESH PLUS,Eye operation,OT,REFRESH PLUS | Eye operation | OT,NaT
255607131,25560713,66,F,2024-10-01,20250715,,OZEMPIC,Injection site bruising,,OZEMPIC | Injection site bruising,2024-09-30/2024-10-06
255607751,25560775,38,,,20250715,,OZEMPIC,Impaired gastric emptying,OT,OZEMPIC | Impaired gastric emptying | OT,NaT
255607791,25560779,,,,20250715,,OZEMPIC,Dyspnoea,,OZEMPIC | Dyspnoea,NaT
255608221,25560822,,F,,20250715,,OZEMPIC,Increased appetite,,OZEMPIC | Increased appetite,NaT
255608853,25560885,77,F,2025-01-01,20250908,,DUPIXENT,Arthralgia,,DUPIXENT | Arthralgia,2024-12-30/2025-01-05
255608881,25560888,57,M,2024-10-01,20250715,,RINVOQ,Foot operation,OT,RINVOQ | Foot operation | OT,2024-09-30/2024-10-06
255609101,25560910,81,F,,20250715,,OZEMPIC,Hyperphagia,,OZEMPIC | Hyperphagia,NaT
255610191,25561019,56,F,2025-01-01,20250715,,SKYRIZI,Colostomy,OT,SKYRIZI | Colostomy | OT,2024-12-30/2025-01-05
255610521,25561052,,M,2024-07-31,20250715,,OZEMPIC,Blood glucose increased,,OZEMPIC | Blood glucose increased,2024-07-29/2024-08-04
255610711,25561071,,F,,20250715,,OZEMPIC,Malaise,,OZEMPIC | Malaise,NaT
255612161,25561216,8,M,2025-07-04,20250716,,LAMOTRIGINE,Growth retardation,OT,LAMOTRIGINE | Growth retardation | OT,2025-06-30/2025-07-06
255612571,25561257,,F,2025-01-01,20250716,,UPADACITINIB,Crohn's disease,OT,UPADACITINIB | Crohn's disease | OT,2024-12-30/2025-01-05
255612761,25561276,59,F,2024-04-01,20250716,,OZEMPIC,Abdominal distension,,OZEMPIC | Abdominal distension,2024-04-01/2024-04-07
255613001,25561300,60,F,2025-01-01,20250716,,DUPIXENT,Erythema of eyelid,,DUPIXENT | Erythema of eyelid,2024-12-30/2025-01-05
255613211,25561321,,F,,20250716,,OZEMPIC,Weight fluctuation,,OZEMPIC | Weight fluctuation,NaT
255614351,25561435,,M,,20250716,,OZEMPIC,Blood cholesterol abnormal,,OZEMPIC | Blood cholesterol abnormal,NaT
255615352,25561535,59,,2025-06-14,20250813,,ANIFROLUMAB,Chest pain,HO,ANIFROLUMAB | Chest pain | HO,2025-06-09/2025-06-15
255615751,25561575,,F,,20250716,,OZEMPIC,Skin swelling,,OZEMPIC | Skin swelling,NaT
255615771,25561577,,M,,20250716,,OZEMPIC,Weight decreased,,OZEMPIC | Weight decreased,NaT
255616381,25561638,43,M,,20250716,,BUDESONIDE\FORMOTEROL,Diabetes mellitus,OT,BUDESONIDE\FORMOTEROL | Diabetes mellitus | OT,NaT
255616472,25561647,35,F,,20250718,,COSENTYX,Abdominal pain,HO,COSENTYX | Abdominal pain | HO,NaT
255616731,25561673,61,M,2023-11-22,20250716,,NELVUTAMIG,Spinal cord injury,HO,NELVUTAMIG | Spinal cord injury | HO,2023-11-20/2023-11-26
255617841,25561784,,M,2025-01-01,20250716,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2024-12-30/2025-01-05
255618441,25561844,41,F,2021-01-01,20250716,,OZEMPIC,Impaired gastric emptying,OT,OZEMPIC | Impaired gastric emptying | OT,2020-12-28/2021-01-03
255618451,25561845,,M,,20250716,,OZEMPIC,Hypoacusis,,OZEMPIC | Hypoacusis,NaT
255619022,25561902,80,M,,20250730,,PREDNISONE,Malacoplakia,HO,PREDNISONE | Malacoplakia | HO,NaT
255619091,25561909,,,,20250716,,SPRAVATO,Headache,,SPRAVATO | Headache,NaT
255619451,25561945,,M,,20250716,,OZEMPIC,Asthenia,,OZEMPIC | Asthenia,NaT
255619581,25561958,,M,,20250716,,OZEMPIC,Wrong technique in product usage process,,OZEMPIC | Wrong technique in product usage process,NaT
255619701,25561970,,F,,20250716,,BENLYSTA,Hospitalisation,HO,BENLYSTA | Hospitalisation | HO,NaT
255620801,25562080,23,F,,20250716,,XOSPATA,Off label use,OT,XOSPATA | Off label use | OT,NaT
255620841,25562084,55,F,2024-09-12,20250716,,OZEMPIC,Pancreatitis,HO,OZEMPIC | Pancreatitis | HO,2024-09-09/2024-09-15
255621071,25562107,,F,,20250716,,OZEMPIC,Mental disorder,,OZEMPIC | Mental disorder,NaT
255622261,25562226,,M,,20250716,,OZEMPIC,Headache,,OZEMPIC | Headache,NaT
255622601,25562260,,M,,20250716,,OZEMPIC,Product use in unapproved indication,,OZEMPIC | Product use in unapproved indication,NaT
255622771,25562277,,,,20250716,,OZEMPIC,Headache,,OZEMPIC | Headache,NaT
255623152,25562315,60,M,2022-07-29,20250716,,OZEMPIC,Constipation,HO,OZEMPIC | Constipation | HO,2022-07-25/2022-07-31
255623311,25562331,62,M,,20250716,,OZEMPIC,Faeces discoloured,,OZEMPIC | Faeces discoloured,NaT
255623541,25562354,40,M,2022-06-01,20250716,,OZEMPIC,Ileus,HO,OZEMPIC | Ileus | HO,2022-05-30/2022-06-05
255624262,25562426,56,M,2021-06-01,20250926,,OZEMPIC,Dyspepsia,HO,OZEMPIC | Dyspepsia | HO,2021-05-31/2021-06-06
255624331,25562433,63,,,20250716,,OZEMPIC,Impaired gastric emptying,OT,OZEMPIC | Impaired gastric emptying | OT,NaT
255624651,25562465,,F,,20250716,,OZEMPIC,Abdominal pain upper,,OZEMPIC | Abdominal pain upper,NaT
255624691,25562469,75,M,,20250716,,OZEMPIC,Pancreatitis,HO,OZEMPIC | Pancreatitis | HO,NaT
255625321,25562532,,F,,20250716,,OZEMPIC,Diarrhoea,,OZEMPIC | Diarrhoea,NaT
255625741,25562574,51,M,2022-12-26,20250716,,OZEMPIC,Product use issue,OT,OZEMPIC | Product use issue | OT,2022-12-26/2023-01-01
255626141,25562614,29,M,2022-02-14,20250716,,METFORMIN,Decreased appetite,OT,METFORMIN | Decreased appetite | OT,2022-02-14/2022-02-20
255626361,25562636,,,,20250716,,CALQUENCE,Myalgia,,CALQUENCE | Myalgia,NaT
255627671,25562767,,F,2025-01-01,20250716,,TYVASO DPI,Chest pain,,TYVASO DPI | Chest pain,2024-12-30/2025-01-05
255627891,25562789,,F,,20250716,,OZEMPIC,Illness,,OZEMPIC | Illness,NaT
255628141,25562814,,M,,20250716,,OZEMPIC,Nausea,,OZEMPIC | Nausea,NaT
255628801,25562880,64,F,2022-01-01,20250716,,OZEMPIC,Muscle atrophy,,OZEMPIC | Muscle atrophy,2021-12-27/2022-01-02
255628912,25562891,,F,,20250814,,SYMBICORT,Malaise,,SYMBICORT | Malaise,NaT
255629251,25562925,66,F,2024-12-01,20250716,,OZEMPIC,Abdominal pain upper,,OZEMPIC | Abdominal pain upper,2024-11-25/2024-12-01
255629411,25562941,45,M,,20250716,,OZEMPIC,Pruritus,,OZEMPIC | Pruritus,NaT
255629612,25562961,,M,,20250722,,BUPROPION HYDROCHLORIDE,Condition aggravated,HO,BUPROPION HYDROCHLORIDE | Condition aggravated | HO,NaT
255630071,25563007,,,,20250716,,OZEMPIC,Weight decreased,,OZEMPIC | Weight decreased,NaT
255630201,25563020,47,F,2025-01-01,20250716,,SKYRIZI,Pain,OT,SKYRIZI | Pain | OT,2024-12-30/2025-01-05
255630291,25563029,,M,,20250716,,OZEMPIC,Adverse drug reaction,,OZEMPIC | Adverse drug reaction,NaT
255630301,25563030,65,M,2024-10-24,20250716,,OZEMPIC,Weight decreased,,OZEMPIC | Weight decreased,2024-10-21/2024-10-27
255630721,25563072,,,,20250716,,BIMEKIZUMAB,Hidradenitis,OT,BIMEKIZUMAB | Hidradenitis | OT,NaT
255630831,25563083,,F,,20250716,,OZEMPIC,Headache,,OZEMPIC | Headache,NaT
255631571,25563157,,M,2024-09-16,20250716,,OZEMPIC,Nausea,,OZEMPIC | Nausea,2024-09-16/2024-09-22
255632091,25563209,77,F,2024-03-01,20250716,,OZEMPIC,Abdominal distension,,OZEMPIC | Abdominal distension,2024-02-26/2024-03-03
255632321,25563232,29,F,,20250716,,DULOXETINE,Maternal exposure during breast feeding,OT,DULOXETINE | Maternal exposure during breast feeding | OT,NaT
255632701,25563270,,M,,20250716,,VENTOLIN HFA,Product use in unapproved indication,,VENTOLIN HFA | Product use in unapproved indication,NaT
255632861,25563286,,F,2025-06-30,20250716,,ZEPBOUND,Dizziness,,ZEPBOUND | Dizziness,2025-06-30/2025-07-06
255635041,25563504,50,M,2023-11-01,20250716,,OZEMPIC,Weight increased,,OZEMPIC | Weight increased,2023-10-30/2023-11-05
255635121,25563512,,F,,20250716,,IQIRVO,Abdominal discomfort,,IQIRVO | Abdominal discomfort,NaT
255635351,25563535,60,M,,20250716,,TRULICITY,Accidental underdose,,TRULICITY | Accidental underdose,NaT
255635831,25563583,,F,,20250716,,OZEMPIC,Skin injury,,OZEMPIC | Skin injury,NaT
255636051,25563605,,F,,20250716,,OZEMPIC,Faecaloma,,OZEMPIC | Faecaloma,NaT
255636771,25563677,74,F,2024-07-01,20250716,,OZEMPIC,Tremor,,OZEMPIC | Tremor,2024-07-01/2024-07-07
255637541,25563754,70,M,2025-06-16,20250716,,ELIGARD,Intentional dose omission,,ELIGARD | Intentional dose omission,2025-06-16/2025-06-22
255637702,25563770,77,,,20250805,,BRUKINSA,No adverse event,,BRUKINSA | No adverse event,NaT
255637941,25563794,70,,2025-05-28,20250716,,ELIGARD,Drug ineffective,,ELIGARD | Drug ineffective,2025-05-26/2025-06-01
255638021,25563802,,M,,20250716,,EPLONTERSEN SODIUM,Transient ischaemic attack,OT,EPLONTERSEN SODIUM | Transient ischaemic attack | OT,NaT
255638391,25563839,,F,2024-09-06,20250716,,OZEMPIC,Visual impairment,,OZEMPIC | Visual impairment,2024-09-02/2024-09-08
255638811,25563881,64,,2025-07-12,20250716,,ZEPBOUND,Vertigo,,ZEPBOUND | Vertigo,2025-07-07/2025-07-13
255639361,25563936,,F,,20250716,,OZEMPIC,Illness,,OZEMPIC | Illness,NaT
255639641,25563964,,,,20250716,,METHOTREXATE,Guillain-Barre syndrome,OT,METHOTREXATE | Guillain-Barre syndrome | OT,NaT
255639982,25563998,27,M,2025-06-27,20250821,,STELARA,Product packaging issue,,STELARA | Product packaging issue,2025-06-23/2025-06-29
255640741,25564074,,M,,20250716,,OZEMPIC,Wrong technique in device usage process,,OZEMPIC | Wrong technique in device usage process,NaT
255641041,25564104,,F,,20250716,,OZEMPIC,Food craving,,OZEMPIC | Food craving,NaT
255641552,25564155,,,,20250716,,TRUVADA,Bone density decreased,OT,TRUVADA | Bone density decreased | OT,NaT
255641601,25564160,68,F,2025-01-01,20250716,,MAGNESIUM,Viral infection,,MAGNESIUM | Viral infection,2024-12-30/2025-01-05
255641931,25564193,,,2024-11-08,20250716,,VALGANCICLOVIR,Cardiac failure,OT,VALGANCICLOVIR | Cardiac failure | OT,2024-11-04/2024-11-10
255642381,25564238,,F,,20250716,,OZEMPIC,Weight decreased,,OZEMPIC | Weight decreased,NaT
255642683,25564268,35,F,2022-06-25,20250716,,OZEMPIC,Constipation,HO,OZEMPIC | Constipation | HO,2022-06-20/2022-06-26
255642851,25564285,,M,,20250716,,OZEMPIC,Decreased appetite,,OZEMPIC | Decreased appetite,NaT
255643431,25564343,63,M,,20250716,,TRULICITY,Blood glucose increased,,TRULICITY | Blood glucose increased,NaT
255643981,25564398,,F,,20250716,,OZEMPIC,Product use in unapproved indication,,OZEMPIC | Product use in unapproved indication,NaT
255645361,25564536,,,,20250716,,ORGOVYX,Asthenia,,ORGOVYX | Asthenia,NaT
255646022,25564602,,M,,20250910,,NUPLAZID,Dizziness,,NUPLAZID | Dizziness,NaT
255646271,25564627,86,M,2025-06-29,20250716,,REVLIMID,Rash pruritic,HO,REVLIMID | Rash pruritic | HO,2025-06-23/2025-06-29
255647121,25564712,,F,2024-09-27,20250716,,OZEMPIC,Pancreatitis,OT,OZEMPIC | Pancreatitis | OT,2024-09-23/2024-09-29
255647841,25564784,51,M,2025-06-16,20250715,,SIMLANDI,Guillain-Barre syndrome,OT,SIMLANDI | Guillain-Barre syndrome | OT,2025-06-16/2025-06-22
255648681,25564868,,F,,20250716,,OZEMPIC,Pancreatitis,OT,OZEMPIC | Pancreatitis | OT,NaT
255649421,25564942,54,F,2025-07-06,20250716,,ZEPBOUND,Injection site reaction,,ZEPBOUND | Injection site reaction,2025-06-30/2025-07-06
255649431,25564943,41,F,2025-07-13,20250716,,MOUNJARO,Injection site pain,,MOUNJARO | Injection site pain,2025-07-07/2025-07-13
255649591,25564959,,F,,20250716,,OZEMPIC,COVID-19,,OZEMPIC | COVID-19,NaT
255650521,25565052,,,,20250716,,OZEMPIC,Weight increased,,OZEMPIC | Weight increased,NaT
255651211,25565121,36,M,2025-03-03,20250716,,PREGABALIN,Withdrawal syndrome,OT,PREGABALIN | Withdrawal syndrome | OT,2025-03-03/2025-03-09
255651441,25565144,68,M,,20250716,,ASPIRIN,Cardiopulmonary failure,DE,ASPIRIN | Cardiopulmonary failure | DE,NaT
255651731,25565173,,F,,20250716,,OZEMPIC,Inappropriate schedule of product administration,,OZEMPIC | Inappropriate schedule of product administration,NaT
255652371,25565237,,F,2025-07-14,20250716,,DIANEAL,Death,DE,DIANEAL | Death | DE,2025-07-14/2025-07-20
255652902,25565290,5,,,20250720,,IBUPROFEN,Angioedema,OT,IBUPROFEN | Angioedema | OT,NaT
255652922,25565292,9,,,20250720,,IBUPROFEN,Cross sensitivity reaction,OT,IBUPROFEN | Cross sensitivity reaction | OT,NaT
255653271,25565327,,F,,20250716,,OZEMPIC,Visual impairment,,OZEMPIC | Visual impairment,NaT
255653521,25565352,,F,,20250716,,OZEMPIC,Product administration interrupted,,OZEMPIC | Product administration interrupted,NaT
255653731,25565373,,F,,20250716,,OZEMPIC,Drug intolerance,,OZEMPIC | Drug intolerance,NaT
255654141,25565414,52,F,2024-03-01,20250716,,OZEMPIC,Nausea,,OZEMPIC | Nausea,2024-02-26/2024-03-03
255654621,25565462,,,2024-09-01,20250716,,OZEMPIC,Off label use,,OZEMPIC | Off label use,2024-08-26/2024-09-01
255655251,25565525,,M,,20250716,,OZEMPIC,Diarrhoea,,OZEMPIC | Diarrhoea,NaT
255655281,25565528,73,F,2024-03-21,20250716,,OZEMPIC,Impaired gastric emptying,OT,OZEMPIC | Impaired gastric emptying | OT,2024-03-18/2024-03-24
255655941,25565594,,,,20250716,,DEVICE,Corneal oedema,,DEVICE | Corneal oedema,NaT
255656051,25565605,87,M,2024-04-29,20250716,,OZEMPIC,Blood glucose decreased,HO,OZEMPIC | Blood glucose decreased | HO,2024-04-29/2024-05-05
255658211,25565821,52,F,,20250716,,VERZENIO,Diarrhoea,,VERZENIO | Diarrhoea,NaT
255658241,25565824,62,F,,20250716,,ZEPBOUND,Illness,,ZEPBOUND | Illness,NaT
255658482,25565848,45,M,,20250722,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
255659181,25565918,60,M,,20250716,,XELJANZ XR,Malaise,,XELJANZ XR | Malaise,NaT
255659253,25565925,50,F,,20250812,,CIBINQO,Anxiety disorder,,CIBINQO | Anxiety disorder,NaT
255659283,25565928,,F,,20250722,,LORBRENA,Hyperlipidaemia,OT,LORBRENA | Hyperlipidaemia | OT,NaT
255659763,25565976,63,F,2023-05-08,20250716,,OZEMPIC,Off label use,HO,OZEMPIC | Off label use | HO,2023-05-08/2023-05-14
255660291,25566029,61,F,2025-05-01,20250716,,LENVATINIB,Nephrotic syndrome,OT,LENVATINIB | Nephrotic syndrome | OT,2025-04-28/2025-05-04
255660321,25566032,,,2025-06-30,20250716,,TORIPALIMAB,Anaemia,OT,TORIPALIMAB | Anaemia | OT,2025-06-30/2025-07-06
255660521,25566052,58,F,2023-10-06,20250716,,OZEMPIC,Weight decreased,,OZEMPIC | Weight decreased,2023-10-02/2023-10-08
255660851,25566085,73,M,,20250716,,LENVATINIB,Hepatic encephalopathy,HO,LENVATINIB | Hepatic encephalopathy | HO,NaT
255661503,25566150,14,F,2025-07-10,20250806,,GENOTROPIN,Drug dose omission by device,,GENOTROPIN | Drug dose omission by device,2025-07-07/2025-07-13
255661761,25566176,,M,,20250716,,OZEMPIC,Product use in unapproved indication,,OZEMPIC | Product use in unapproved indication,NaT
255662842,25566284,8,F,,20250807,,CEREZYME,Multiple organ dysfunction syndrome,DE,CEREZYME | Multiple organ dysfunction syndrome | DE,NaT
255664021,25566402,35,M,2025-05-01,20250716,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2025-04-28/2025-05-04
255664721,25566472,76,F,2024-10-20,20250716,,OZEMPIC,Tremor,,OZEMPIC | Tremor,2024-10-14/2024-10-20
255664771,25566477,,M,2024-01-01,20250716,,DUPIXENT,Off label use,,DUPIXENT | Off label use,2024-01-01/2024-01-07
255665153,25566515,74,F,2025-01-01,20250909,,DUPIXENT,Arthralgia,,DUPIXENT | Arthralgia,2024-12-30/2025-01-05
255665491,25566549,,,,20250716,,DUPIXENT,Arthralgia,,DUPIXENT | Arthralgia,NaT
255665891,25566589,,M,,20250716,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,NaT
255666381,25566638,18,F,,20250716,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
255667711,25566771,,F,,20250716,,OZEMPIC,Vomiting,,OZEMPIC | Vomiting,NaT
255668514,25566851,11,M,,20250818,,GENOTROPIN,Drug dose omission by device,,GENOTROPIN | Drug dose omission by device,NaT
255668732,25566873,,,,20250826,,MEDROXYPROGESTERONE,Syringe issue,,MEDROXYPROGESTERONE | Syringe issue,NaT
255668921,25566892,,F,,20250716,,OZEMPIC,Eye disorder,,OZEMPIC | Eye disorder,NaT
255670731,25567073,54,F,,20250716,,ORENCIA,Surgery,,ORENCIA | Surgery,NaT
255670922,25567092,56,M,2025-07-10,20250805,,NUBEQA,Prostatic specific antigen increased,,NUBEQA | Prostatic specific antigen increased,2025-07-07/2025-07-13
255671051,25567105,55,F,2024-07-01,20250716,,OZEMPIC,Feeling abnormal,,OZEMPIC | Feeling abnormal,2024-07-01/2024-07-07
255671681,25567168,,,,20250716,,OZEMPIC,Illness,,OZEMPIC | Illness,NaT
255672181,25567218,55,F,2023-02-01,20250716,,OZEMPIC,Constipation,OT,OZEMPIC | Constipation | OT,2023-01-30/2023-02-05
255673281,25567328,,M,,20250716,,OZEMPIC,Decreased appetite,,OZEMPIC | Decreased appetite,NaT
255673351,25567335,56,,,20250716,,OZEMPIC,Impaired gastric emptying,OT,OZEMPIC | Impaired gastric emptying | OT,NaT
255674001,25567400,,F,,20250716,,OZEMPIC,Off label use,,OZEMPIC | Off label use,NaT
255675432,25567543,69,F,2025-07-11,20250718,,SKYRIZI,COVID-19,OT,SKYRIZI | COVID-19 | OT,2025-07-07/2025-07-13
255675911,25567591,,F,2023-08-01,20250716,,OZEMPIC,Sleep apnoea syndrome,,OZEMPIC | Sleep apnoea syndrome,2023-07-31/2023-08-06
255676481,25567648,68,F,2024-02-14,20250716,,OZEMPIC,Anxiety,,OZEMPIC | Anxiety,2024-02-12/2024-02-18
255676501,25567650,,,,20250716,,MAXALT,Treatment failure,,MAXALT | Treatment failure,NaT
255676761,25567676,42,F,2025-04-17,20250716,,SULFAMETHOXAZOLE\TRIMETHOPRIM,Therapy cessation,LT,SULFAMETHOXAZOLE\TRIMETHOPRIM | Therapy cessation | LT,2025-04-14/2025-04-20
255677481,25567748,73,M,2024-03-11,20250716,,OZEMPIC,Oropharyngeal pain,,OZEMPIC | Oropharyngeal pain,2024-03-11/2024-03-17
255677641,25567764,,F,2024-07-23,20250716,,OZEMPIC,Wrong technique in product usage process,,OZEMPIC | Wrong technique in product usage process,2024-07-22/2024-07-28
255678323,25567832,,,,20250820,,ACORAMIDIS,Abdominal pain upper,,ACORAMIDIS | Abdominal pain upper,NaT
255678351,25567835,,F,2024-04-16,20250716,,OZEMPIC,Off label use,HO,OZEMPIC | Off label use | HO,2024-04-15/2024-04-21
255678491,25567849,61,F,2024-01-01,20250716,,BEVACIZUMAB,Tumour haemorrhage,LT,BEVACIZUMAB | Tumour haemorrhage | LT,2024-01-01/2024-01-07
255679742,25567974,,F,,20250716,,OZEMPIC,Wrong technique in product usage process,,OZEMPIC | Wrong technique in product usage process,NaT
255679961,25567996,39,M,,20250716,,QUETIAPINE,Salivary hypersecretion,HO,QUETIAPINE | Salivary hypersecretion | HO,NaT
255680251,25568025,,,,20250716,,TECARTUS,Immune effector cell-associated neurotoxicity syndrome,OT,TECARTUS | Immune effector cell-associated neurotoxicity syndrome | OT,NaT
255680811,25568081,78,F,2024-06-17,20250716,,OZEMPIC,Somnolence,,OZEMPIC | Somnolence,2024-06-17/2024-06-23
255681031,25568103,,,,20250716,,TYSABRI,Conjoined twins,CA,TYSABRI | Conjoined twins | CA,NaT
255681421,25568142,,F,,20250716,,HIZENTRA,Product use issue,,HIZENTRA | Product use issue,NaT
255681741,25568174,,,,20250716,,MINOXIDIL,Product administered at inappropriate site,,MINOXIDIL | Product administered at inappropriate site,NaT
255682021,25568202,78,M,2024-04-25,20250716,,MINOXIDIL,Application site exfoliation,,MINOXIDIL | Application site exfoliation,2024-04-22/2024-04-28
255682272,25568227,83,F,,20250818,,PREDNISOLONE,Herpes zoster,HO,PREDNISOLONE | Herpes zoster | HO,NaT
255682551,25568255,,F,2024-07-01,20250716,,MINOXIDIL,Product name confusion,,MINOXIDIL | Product name confusion,2024-07-01/2024-07-07
255682891,25568289,,F,,20250716,,MINOXIDIL,Product use issue,,MINOXIDIL | Product use issue,NaT
255682901,25568290,,F,2024-04-01,20250716,,MINOXIDIL,Product use issue,,MINOXIDIL | Product use issue,2024-04-01/2024-04-07
255682916,25568291,59,M,2024-01-01,20250920,,TASIGNA,Headache,HO,TASIGNA | Headache | HO,2024-01-01/2024-01-07
255683511,25568351,,M,,20250716,,MINOXIDIL,Hypersensitivity,,MINOXIDIL | Hypersensitivity,NaT
255683811,25568381,78,M,2024-09-18,20250716,,MINOXIDIL,Application site pain,,MINOXIDIL | Application site pain,2024-09-16/2024-09-22
255684161,25568416,68,F,2024-09-01,20250716,,MINOXIDIL,Product use issue,,MINOXIDIL | Product use issue,2024-08-26/2024-09-01
255684811,25568481,58,F,,20250716,,OZEMPIC,Brain fog,,OZEMPIC | Brain fog,NaT
255684911,25568491,,,,20250716,,MINOXIDIL,Drug effect less than expected,,MINOXIDIL | Drug effect less than expected,NaT
255685031,25568503,,,,20250716,,MINOXIDIL,Application site inflammation,,MINOXIDIL | Application site inflammation,NaT
255685443,25568544,46,F,2020-09-01,20250718,,RYBELSUS,Abdominal pain upper,HO,RYBELSUS | Abdominal pain upper | HO,2020-08-31/2020-09-06
255686042,25568604,,F,2021-01-01,20250718,,MINOXIDIL,Product use issue,,MINOXIDIL | Product use issue,2020-12-28/2021-01-03
255686352,25568635,,F,2024-06-01,20250722,,DYMISTA,Apnoea,OT,DYMISTA | Apnoea | OT,2024-05-27/2024-06-02
255687201,25568720,,M,,20250716,,MINOXIDIL,Adverse drug reaction,,MINOXIDIL | Adverse drug reaction,NaT
255687271,25568727,,,,20250716,,MINOXIDIL,Drug ineffective,,MINOXIDIL | Drug ineffective,NaT
255687441,25568744,26,,,20250716,,OZEMPIC,Illness,,OZEMPIC | Illness,NaT
255687791,25568779,,M,,20250716,,MINOXIDIL,Application site pruritus,,MINOXIDIL | Application site pruritus,NaT
255687971,25568797,,,2024-10-01,20250716,,MINOXIDIL,Drug ineffective,,MINOXIDIL | Drug ineffective,2024-09-30/2024-10-06
255688341,25568834,,F,2025-03-21,20250716,,TRESIBA,Myocardial infarction,HO,TRESIBA | Myocardial infarction | HO,2025-03-17/2025-03-23
255688691,25568869,,F,,20250716,,MINOXIDIL,Product use issue,,MINOXIDIL | Product use issue,NaT
255688921,25568892,82,F,2025-04-02,20250716,,MINOXIDIL,Product use issue,,MINOXIDIL | Product use issue,2025-03-31/2025-04-06
255689281,25568928,,M,,20250716,,MINOXIDIL,Adverse drug reaction,,MINOXIDIL | Adverse drug reaction,NaT
255689651,25568965,,M,,20250716,,MINOXIDIL,Application site acne,,MINOXIDIL | Application site acne,NaT
255689831,25568983,,,,20250716,,MINOXIDIL,Drug ineffective,,MINOXIDIL | Drug ineffective,NaT
255689971,25568997,,,,20250716,,ACCUTANE,Mood altered,,ACCUTANE | Mood altered,NaT
255690161,25569016,,M,,20250716,,MINOXIDIL,Drug ineffective,,MINOXIDIL | Drug ineffective,NaT
255690451,25569045,40,F,,20250716,,MOUNJARO,Nausea,DS,MOUNJARO | Nausea | DS,NaT
255690881,25569088,70,M,2025-02-01,20250716,,OZEMPIC,Unevaluable event,,OZEMPIC | Unevaluable event,2025-01-27/2025-02-02
255691041,25569104,21,F,2024-12-17,20250716,,NITROFURANTOIN,Coeliac disease,,NITROFURANTOIN | Coeliac disease,2024-12-16/2024-12-22
255691161,25569116,68,F,2023-05-01,20250716,,OZEMPIC,Abdominal pain upper,OT,OZEMPIC | Abdominal pain upper | OT,2023-05-01/2023-05-07
255693211,25569321,,,,20250716,,PLUVICTO,General physical health deterioration,,PLUVICTO | General physical health deterioration,NaT
255694221,25569422,,M,,20250716,,PALYNZIQ,Influenza,,PALYNZIQ | Influenza,NaT
255694471,25569447,,F,,20250716,,BREZTRI,Malaise,,BREZTRI | Malaise,NaT
255694831,25569483,,,,20250716,,ROMOSOZUMAB,Thoracic vertebral fracture,OT,ROMOSOZUMAB | Thoracic vertebral fracture | OT,NaT
255694891,25569489,70,F,2023-08-06,20250716,,CYCLOPHOSPHAMIDE,Pyrexia,HO,CYCLOPHOSPHAMIDE | Pyrexia | HO,2023-07-31/2023-08-06
255695541,25569554,84,F,2024-01-01,20250716,,SKYRIZI,Abdominal hernia,OT,SKYRIZI | Abdominal hernia | OT,2024-01-01/2024-01-07
255696433,25569643,,F,2025-01-01,20250815,,FINTEPLA,Off label use,OT,FINTEPLA | Off label use | OT,2024-12-30/2025-01-05
255697982,25569798,,,2025-02-11,20250812,,CANDESARTAN,Spinal osteoarthritis,HO,CANDESARTAN | Spinal osteoarthritis | HO,2025-02-10/2025-02-16
255698291,25569829,89,F,2004-02-02,20250717,,FLUOROURACIL,Prinzmetal angina,HO,FLUOROURACIL | Prinzmetal angina | HO,2004-02-02/2004-02-08
255698502,25569850,7,F,,20250813,,KEYTRUDA,Malignant neoplasm progression,OT,KEYTRUDA | Malignant neoplasm progression | OT,NaT
255699231,25569923,66,F,2025-07-04,20250717,,OZEMPIC,Hiccups,HO,OZEMPIC | Hiccups | HO,2025-06-30/2025-07-06
255699301,25569930,72,M,,20250717,,NORDITROPIN,Fall,HO,NORDITROPIN | Fall | HO,NaT
255699382,25569938,7,M,,20250814,,KEYTRUDA,Decreased appetite,OT,KEYTRUDA | Decreased appetite | OT,NaT
255699581,25569958,76,F,2025-01-01,20250717,,FULVESTRANT,Interstitial lung disease,HO,FULVESTRANT | Interstitial lung disease | HO,2024-12-30/2025-01-05
255699821,25569982,,F,,20250717,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
255700811,25570081,,M,2025-01-01,20250717,,TYVASO,Fatigue,,TYVASO | Fatigue,2024-12-30/2025-01-05
255700991,25570099,65,F,2025-06-01,20250717,,ZEPBOUND,Injection site reaction,,ZEPBOUND | Injection site reaction,2025-05-26/2025-06-01
255701261,25570126,26,F,2025-07-12,20250717,,BIMEKIZUMAB,Psoriatic arthropathy,OT,BIMEKIZUMAB | Psoriatic arthropathy | OT,2025-07-07/2025-07-13
255701321,25570132,,M,,20250717,,ATORVASTATIN,Aura,DS,ATORVASTATIN | Aura | DS,NaT
255701341,25570134,71,F,,20250717,,BUPROPION,Tremor,,BUPROPION | Tremor,NaT
255701421,25570142,66,F,2025-06-01,20250717,,PEPCID,Therapeutic response unexpected,,PEPCID | Therapeutic response unexpected,2025-05-26/2025-06-01
255702234,25570223,,,2025-01-01,20250818,,METFORMIN,Nausea,HO,METFORMIN | Nausea | HO,2024-12-30/2025-01-05
255703012,25570301,4,F,2025-07-10,20250718,,FINTEPLA,Tricuspid valve incompetence,OT,FINTEPLA | Tricuspid valve incompetence | OT,2025-07-07/2025-07-13
255703371,25570337,78,M,,20250717,,ZEPBOUND,Constipation,,ZEPBOUND | Constipation,NaT
255703941,25570394,8,F,,20250717,,MONTELUKAST,Anxiety,OT,MONTELUKAST | Anxiety | OT,NaT
255704591,25570459,75,F,,20250717,,POMALYST,Platelet count abnormal,,POMALYST | Platelet count abnormal,NaT
255705411,25570541,,,,20250717,,RITUXIMAB,Intentional product use issue,HO,RITUXIMAB | Intentional product use issue | HO,NaT
255705521,25570552,43,F,2019-01-01,20250717,,OCREVUS,Balance disorder,OT,OCREVUS | Balance disorder | OT,2018-12-31/2019-01-06
255705591,25570559,87,F,2021-01-01,20250717,,KEYTRUDA,Therapy partial responder,HO,KEYTRUDA | Therapy partial responder | HO,2020-12-28/2021-01-03
255706042,25570604,65,F,2025-06-01,20250730,,ZEPBOUND,Constipation,,ZEPBOUND | Constipation,2025-05-26/2025-06-01
255706061,25570606,58,F,,20250717,,MOUNJARO,Cough,,MOUNJARO | Cough,NaT
255706171,25570617,45,F,2025-06-23,20250717,,CYCLOPHOSPHAMIDE,White blood cell count decreased,OT,CYCLOPHOSPHAMIDE | White blood cell count decreased | OT,2025-06-23/2025-06-29
255706451,25570645,,,,20250717,,OMALIZUMAB,Headache,OT,OMALIZUMAB | Headache | OT,NaT
255706461,25570646,86,M,,20250717,,BAVENCIO,Fatigue,,BAVENCIO | Fatigue,NaT
255706782,25570678,,F,,20250828,,TRELEGY ELLIPTA,Product complaint,,TRELEGY ELLIPTA | Product complaint,NaT
255707521,25570752,,,,20250717,,TYSABRI,Fatigue,,TYSABRI | Fatigue,NaT
255707881,25570788,49,F,,20250717,,METHYLPREDNISOLONE ACETATE,Bipolar disorder,HO,METHYLPREDNISOLONE ACETATE | Bipolar disorder | HO,NaT
255708831,25570883,4,M,,20250717,,CABENUVA,Anxiety disorder,OT,CABENUVA | Anxiety disorder | OT,NaT
255709111,25570911,51,F,2025-01-01,20250717,,ATOGEPANT,Nausea,OT,ATOGEPANT | Nausea | OT,2024-12-30/2025-01-05
255709661,25570966,,,,20250717,,ESTRADIOL,Product sterility issue,,ESTRADIOL | Product sterility issue,NaT
255710321,25571032,,,,20250717,,ORGOVYX,Nasopharyngitis,,ORGOVYX | Nasopharyngitis,NaT
255710351,25571035,,M,2025-02-11,20250717,,ROSUVASTATIN,Spinal osteoarthritis,HO,ROSUVASTATIN | Spinal osteoarthritis | HO,2025-02-10/2025-02-16
255710412,25571041,56,F,2025-01-17,20250811,,FEZOLINETANT,Aspartate aminotransferase increased,,FEZOLINETANT | Aspartate aminotransferase increased,2025-01-13/2025-01-19
255710441,25571044,,,,20250717,,ORGOVYX,Hot flush,,ORGOVYX | Hot flush,NaT
255710641,25571064,,,,20250717,,RISANKIZUMAB,Product storage error,,RISANKIZUMAB | Product storage error,NaT
255711221,25571122,,M,,20250717,,THIOTEPA,Pleuroparenchymal fibroelastosis,OT,THIOTEPA | Pleuroparenchymal fibroelastosis | OT,NaT
255711491,25571149,36,F,2023-04-01,20250717,,RISPERIDONE,Pyoderma gangrenosum,OT,RISPERIDONE | Pyoderma gangrenosum | OT,2023-03-27/2023-04-02
255711711,25571171,,,,20250717,,ORGOVYX,Pneumonia,HO,ORGOVYX | Pneumonia | HO,NaT
255712411,25571241,23,F,2020-01-01,20250717,,FLUOROURACIL,Skin striae,OT,FLUOROURACIL | Skin striae | OT,2019-12-30/2020-01-05
255712501,25571250,33,F,2025-07-15,20250717,,SPRAVATO,Dissociation,OT,SPRAVATO | Dissociation | OT,2025-07-14/2025-07-20
255713021,25571302,72,F,,20250717,,CEFTRIAXONE,Pancytopenia,HO,CEFTRIAXONE | Pancytopenia | HO,NaT
255713371,25571337,39,F,,20250717,,ZEPBOUND,Accidental underdose,,ZEPBOUND | Accidental underdose,NaT
255714151,25571415,72,M,,20250717,,DOXYCYCLINE,Cerebrovascular accident,OT,DOXYCYCLINE | Cerebrovascular accident | OT,NaT
255714751,25571475,67,M,,20250716,,SKYRIZI,Therapy interrupted,,SKYRIZI | Therapy interrupted,NaT
255715142,25571514,69,F,2025-06-15,20250805,,NUPLAZID,Product dose omission issue,,NUPLAZID | Product dose omission issue,2025-06-09/2025-06-15
255715871,25571587,,,,20250717,,BOSENTAN,Fatigue,,BOSENTAN | Fatigue,NaT
255716481,25571648,72,F,2025-01-01,20250717,,OFEV,Respiratory tract infection,HO,OFEV | Respiratory tract infection | HO,2024-12-30/2025-01-05
255717051,25571705,,M,,20250717,,OMEPRAZOLE,Off label use,,OMEPRAZOLE | Off label use,NaT
255717101,25571710,72,F,,20250717,,LINEZOLID,Drug ineffective,DE,LINEZOLID | Drug ineffective | DE,NaT
255718313,25571831,75,F,,20250903,,ELREXFIO,Cytomegalovirus infection reactivation,HO,ELREXFIO | Cytomegalovirus infection reactivation | HO,NaT
255719511,25571951,65,M,,20250717,,MELOXICAM,Adrenocortical insufficiency acute,LT,MELOXICAM | Adrenocortical insufficiency acute | LT,NaT
255719591,25571959,5,,,20250717,,IBUPROFEN,Cross sensitivity reaction,OT,IBUPROFEN | Cross sensitivity reaction | OT,NaT
255720952,25572095,,M,,20250724,,LIPITOR,Chest pain,,LIPITOR | Chest pain,NaT
255721091,25572109,52,F,2025-01-01,20250717,,CREON,Fatigue,OT,CREON | Fatigue | OT,2024-12-30/2025-01-05
255721271,25572127,55,M,2025-03-01,20250717,,BIMEKIZUMAB,Arthralgia,OT,BIMEKIZUMAB | Arthralgia | OT,2025-02-24/2025-03-02
255722071,25572207,69,M,,20250717,,YESCARTA,Hypogammaglobulinaemia,OT,YESCARTA | Hypogammaglobulinaemia | OT,NaT
255722511,25572251,,F,2025-01-01,20250717,,ORENITRAM,Gait disturbance,,ORENITRAM | Gait disturbance,2024-12-30/2025-01-05
255722701,25572270,,F,,20250717,,TYMLOS,Pruritus,OT,TYMLOS | Pruritus | OT,NaT
255723251,25572325,62,F,,20250717,,DURVALUMAB,Death,DE,DURVALUMAB | Death | DE,NaT
255724131,25572413,64,F,2025-01-01,20250717,,BRAFTOVI,Nausea,OT,BRAFTOVI | Nausea | OT,2024-12-30/2025-01-05
255725002,25572500,58,F,,20250828,,VYEPTI,Alopecia,,VYEPTI | Alopecia,NaT
255725035,25572503,,M,,20250925,,GENOTROPIN,Intentional dose omission,,GENOTROPIN | Intentional dose omission,NaT
255725142,25572514,53,F,2024-01-01,20250806,,ESTRADIOL,Product use issue,OT,ESTRADIOL | Product use issue | OT,2024-01-01/2024-01-07
255725321,25572532,70,F,2022-10-01,20250717,,AVAPRITINIB,Oedema,OT,AVAPRITINIB | Oedema | OT,2022-09-26/2022-10-02
255725431,25572543,,,,20250717,,VYEPTI,Therapeutic response delayed,,VYEPTI | Therapeutic response delayed,NaT
255726091,25572609,55,F,,20250717,,TACROLIMUS,Decreased immune responsiveness,HO,TACROLIMUS | Decreased immune responsiveness | HO,NaT
255726731,25572673,,M,,20250717,,DUPIXENT,Exposure via skin contact,,DUPIXENT | Exposure via skin contact,NaT
255726911,25572691,22,M,,20250717,,DUPIXENT,Off label use,,DUPIXENT | Off label use,NaT
255727191,25572719,,M,,20250717,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,NaT
255727461,25572746,27,F,2025-06-06,20250717,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,2025-06-02/2025-06-08
255727631,25572763,57,F,,20250717,,MOUNJARO,Peripheral coldness,,MOUNJARO | Peripheral coldness,NaT
255727691,25572769,66,F,2025-04-01,20250717,,ZEPBOUND,Intentional product misuse,,ZEPBOUND | Intentional product misuse,2025-03-31/2025-04-06
255727871,25572787,11,M,2025-07-01,20250717,,DUPIXENT,Rebound eczema,,DUPIXENT | Rebound eczema,2025-06-30/2025-07-06
255728142,25572814,60,M,,20250823,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,NaT
255728481,25572848,,F,,20250717,,DUPIXENT,Sleep disorder due to a general medical condition,,DUPIXENT | Sleep disorder due to a general medical condition,NaT
255729581,25572958,,F,,20250717,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,NaT
255729901,25572990,35,F,2025-06-01,20250717,,DUPIXENT,Eosinophilic oesophagitis,,DUPIXENT | Eosinophilic oesophagitis,2025-05-26/2025-06-01
255729951,25572995,58,F,,20250717,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,NaT
255730111,25573011,,M,,20250717,,DUPIXENT,Dry eye,,DUPIXENT | Dry eye,NaT
255731381,25573138,91,F,2025-07-11,20250717,,FERINJECT,Loss of consciousness,HO,FERINJECT | Loss of consciousness | HO,2025-07-07/2025-07-13
255731811,25573181,32,F,2025-07-16,20250716,,VYEPTI,Pruritus,OT,VYEPTI | Pruritus | OT,2025-07-14/2025-07-20
255732192,25573219,,F,,20250725,,HUMIRA,Therapeutic response shortened,,HUMIRA | Therapeutic response shortened,NaT
255732821,25573282,,F,,20250717,,IXAZOMIB,Death,OT,IXAZOMIB | Death | OT,NaT
255733312,25573331,76,F,2025-07-01,20250807,,REVLIMID,Pneumocystis jirovecii pneumonia,OT,REVLIMID | Pneumocystis jirovecii pneumonia | OT,2025-06-30/2025-07-06
255733412,25573341,61,F,2025-01-01,20250908,,CREON,Platelet count decreased,HO,CREON | Platelet count decreased | HO,2024-12-30/2025-01-05
255733429,25573342,13,M,,20250929,,GENOTROPIN,Device mechanical issue,,GENOTROPIN | Device mechanical issue,NaT
255734323,25573432,,F,2025-07-13,20250904,,GENOTROPIN,Drug dose omission by device,,GENOTROPIN | Drug dose omission by device,2025-07-07/2025-07-13
255734791,25573479,,,2025-01-01,20250717,,TWIRLA,Product adhesion issue,,TWIRLA | Product adhesion issue,2024-12-30/2025-01-05
255734952,25573495,9,M,,20250818,,GENOTROPIN,Headache,,GENOTROPIN | Headache,NaT
255736321,25573632,24,M,,20250717,,PREDNISONE,Off label use,OT,PREDNISONE | Off label use | OT,NaT
255736421,25573642,71,F,,20250717,,DUPIXENT,Cataract,OT,DUPIXENT | Cataract | OT,NaT
255736491,25573649,76,M,2025-06-10,20250717,,REVLIMID,Death,OT,REVLIMID | Death | OT,2025-06-09/2025-06-15
255737561,25573756,64,M,,20250717,,MOUNJARO,Haematochezia,OT,MOUNJARO | Haematochezia | OT,NaT
255738081,25573808,,F,2025-05-30,20250717,,VUEWAY,Pruritus,,VUEWAY | Pruritus,2025-05-26/2025-06-01
255738331,25573833,,F,,20250717,,LEVETIRACETAM,Diabetic ketoacidosis,HO,LEVETIRACETAM | Diabetic ketoacidosis | HO,NaT
255738692,25573869,,F,,20250815,,CORTICOTROPIN,Injection site discolouration,OT,CORTICOTROPIN | Injection site discolouration | OT,NaT
255738951,25573895,78,M,,20250717,,METHYLPHENIDATE,Off label use,HO,METHYLPHENIDATE | Off label use | HO,NaT
255739401,25573940,,,,20250717,,CALQUENCE,Adverse drug reaction,,CALQUENCE | Adverse drug reaction,NaT
255739521,25573952,82,F,2016-03-01,20250717,,TORSEMIDE,Joint dislocation,HO,TORSEMIDE | Joint dislocation | HO,2016-02-29/2016-03-06
255739581,25573958,3,F,,20250717,,MINOCYCLINE,Mania,OT,MINOCYCLINE | Mania | OT,NaT
255739711,25573971,,M,,20250717,,KEYTRUDA,Death,DE,KEYTRUDA | Death | DE,NaT
255739871,25573987,43,F,,20250717,,ADALIMUMAB,Crohn's disease,CA,ADALIMUMAB | Crohn's disease | CA,NaT
255740491,25574049,,F,,20250717,,DELFLEX WITH DEXTROSE 1.5% LOW MAGNESIUM,Swelling,,DELFLEX WITH DEXTROSE 1.5% LOW MAGNESIUM | Swelling,NaT
255740743,25574074,,,,20250811,,TREMFYA,Needle issue,,TREMFYA | Needle issue,NaT
255741031,25574103,38,F,,20250717,,ZEPBOUND,Weight increased,,ZEPBOUND | Weight increased,NaT
255741614,25574161,12,F,,20250911,,GENOTROPIN,Drug dose omission by device,,GENOTROPIN | Drug dose omission by device,NaT
255742961,25574296,48,M,2025-07-09,20250717,,SPRAVATO,Physical examination abnormal,HO,SPRAVATO | Physical examination abnormal | HO,2025-07-07/2025-07-13
255743252,25574325,,,,20250817,,INVEGA TRINZA,Product packaging issue,,INVEGA TRINZA | Product packaging issue,NaT
255744531,25574453,67,F,,20250717,,PEMBROLIZUMAB,Platelet count decreased,HO,PEMBROLIZUMAB | Platelet count decreased | HO,NaT
255745161,25574516,27,M,,20250718,,BUPRENORPHINE,Abdominal pain,HO,BUPRENORPHINE | Abdominal pain | HO,NaT
255745631,25574563,24,M,2025-03-03,20250718,,BOTOX,Anaphylactic reaction,OT,BOTOX | Anaphylactic reaction | OT,2025-03-03/2025-03-09
255746081,25574608,59,M,,20250718,,CAPECITABINE,Urinary tract toxicity,OT,CAPECITABINE | Urinary tract toxicity | OT,NaT
255746311,25574631,,,,20250718,,RISANKIZUMAB,Diarrhoea,,RISANKIZUMAB | Diarrhoea,NaT
255746671,25574667,37,M,,20250718,,MYCOPHENOLATE MOFETIL,Thrombotic microangiopathy,HO,MYCOPHENOLATE MOFETIL | Thrombotic microangiopathy | HO,NaT
255747421,25574742,62,F,2025-06-01,20250718,,SKYRIZI,Spinal operation,OT,SKYRIZI | Spinal operation | OT,2025-05-26/2025-06-01
255747592,25574759,,M,,20250812,,DARZALEX,Plasma cell myeloma,OT,DARZALEX | Plasma cell myeloma | OT,NaT
255748593,25574859,64,F,2025-07-07,20250825,,STELARA,Product dose omission issue,,STELARA | Product dose omission issue,2025-07-07/2025-07-13
255748881,25574888,64,F,,20250718,,ZEPBOUND,Injection site pain,,ZEPBOUND | Injection site pain,NaT
255750451,25575045,61,M,2025-05-01,20250718,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,2025-04-28/2025-05-04
255750521,25575052,18,F,,20250718,,METHOTREXATE,Neurotoxicity,HO,METHOTREXATE | Neurotoxicity | HO,NaT
255750561,25575056,20,F,2025-01-01,20250718,,DUPIXENT,Fear of injection,,DUPIXENT | Fear of injection,2024-12-30/2025-01-05
255750871,25575087,,F,,20250718,,ORENCIA,Puncture site pain,OT,ORENCIA | Puncture site pain | OT,NaT
255751012,25575101,43,F,2025-05-01,20250923,,DUPIXENT,Incorrect dose administered,,DUPIXENT | Incorrect dose administered,2025-04-28/2025-05-04
255751131,25575113,,,,20250718,,BRUKINSA,Multiple drug therapy,,BRUKINSA | Multiple drug therapy,NaT
255751502,25575150,,,2025-06-28,20250730,,GEMTESA,Drug ineffective,,GEMTESA | Drug ineffective,2025-06-23/2025-06-29
255752241,25575224,56,F,,20250718,,ZEPBOUND,Hunger,,ZEPBOUND | Hunger,NaT
255753111,25575311,62,M,,20250718,,BUPIVACAINE,Somnolence,HO,BUPIVACAINE | Somnolence | HO,NaT
255753291,25575329,,F,,20250718,,TYMLOS,Atrial fibrillation,HO,TYMLOS | Atrial fibrillation | HO,NaT
255753791,25575379,72,F,,20250718,,ZEPBOUND,Alopecia,,ZEPBOUND | Alopecia,NaT
255754171,25575417,82,F,,20250718,,NEXTERONE,Liver function test increased,OT,NEXTERONE | Liver function test increased | OT,NaT
255754331,25575433,,F,,20250718,,NUCALA,Product use in unapproved indication,,NUCALA | Product use in unapproved indication,NaT
255754992,25575499,42,F,,20250819,,XIIDRA,Pain,,XIIDRA | Pain,NaT
255755121,25575512,57,,,20250718,,ALBUTEROL SULFATE,No adverse event,,ALBUTEROL SULFATE | No adverse event,NaT
255755691,25575569,,,,20250718,,CHLORAPREP WITH TINT,Product contamination,,CHLORAPREP WITH TINT | Product contamination,NaT
255756371,25575637,,,,20250718,,INDOMETHACIN,Foetal exposure during pregnancy,CA,INDOMETHACIN | Foetal exposure during pregnancy | CA,NaT
255756462,25575646,56,M,,20250902,,ORGOVYX,Feeling hot,,ORGOVYX | Feeling hot,NaT
255756471,25575647,,,,20250718,,ORGOVYX,Fatigue,,ORGOVYX | Fatigue,NaT
255756971,25575697,71,M,,20250718,,POMALYST,Sinus disorder,OT,POMALYST | Sinus disorder | OT,NaT
255757021,25575702,38,F,2025-06-01,20250718,,RINVOQ,Malignant melanoma,OT,RINVOQ | Malignant melanoma | OT,2025-05-26/2025-06-01
255757271,25575727,,,,20250718,,ORGOVYX,Amnesia,,ORGOVYX | Amnesia,NaT
255757871,25575787,65,M,,20250718,,ZEPBOUND,Accidental underdose,,ZEPBOUND | Accidental underdose,NaT
255758841,25575884,48,F,2025-06-30,20250718,,SKYRIZI,Secretion discharge,HO,SKYRIZI | Secretion discharge | HO,2025-06-30/2025-07-06
255759071,25575907,70,M,,20250718,,AJOVY,Product use issue,,AJOVY | Product use issue,NaT
255759322,25575932,39,,,20250729,,MYCOPHENOLATE MOFETIL,Cytomegalovirus infection,HO,MYCOPHENOLATE MOFETIL | Cytomegalovirus infection | HO,NaT
255759631,25575963,,F,,20250718,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
255759891,25575989,,F,,20250718,,BENLYSTA,Illness,,BENLYSTA | Illness,NaT
255760261,25576026,10,M,2022-09-22,20250718,,DUPIXENT,Off label use,,DUPIXENT | Off label use,2022-09-19/2022-09-25
255760651,25576065,,M,,20250718,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
255760951,25576095,42,F,2025-06-01,20250718,,DUPIXENT,Rash,,DUPIXENT | Rash,2025-05-26/2025-06-01
255761031,25576103,40,M,2025-07-16,20250718,,DUPIXENT,Accidental exposure to product,,DUPIXENT | Accidental exposure to product,2025-07-14/2025-07-20
255761571,25576157,2,F,,20250718,,DUPIXENT,Dry skin,,DUPIXENT | Dry skin,NaT
255762631,25576263,,,,20250718,,LINEZOLID,Pancytopenia,OT,LINEZOLID | Pancytopenia | OT,NaT
255762731,25576273,81,M,,20250718,,DUPIXENT,Hypersensitivity,,DUPIXENT | Hypersensitivity,NaT
255763083,25576308,77,F,2025-07-01,20250901,,REPATHA,Injection site pain,,REPATHA | Injection site pain,2025-06-30/2025-07-06
255763231,25576323,,F,,20250718,,ALBUTEROL SULFATE,Wrong technique in device usage process,,ALBUTEROL SULFATE | Wrong technique in device usage process,NaT
255763311,25576331,68,F,2023-12-01,20250718,,BACLOFEN,Pyrexia,HO,BACLOFEN | Pyrexia | HO,2023-11-27/2023-12-03
255764041,25576404,,F,,20250718,,NEXPLANON,Pregnancy with implant contraceptive,OT,NEXPLANON | Pregnancy with implant contraceptive | OT,NaT
255764311,25576431,50,M,2021-01-01,20250718,,FILGRASTIM,Disseminated leishmaniasis,HO,FILGRASTIM | Disseminated leishmaniasis | HO,2020-12-28/2021-01-03
255764781,25576478,,F,,20250718,,DUPIXENT,Erythema,,DUPIXENT | Erythema,NaT
255765041,25576504,82,F,2025-07-14,20250718,,NUPLAZID,Disease progression,OT,NUPLAZID | Disease progression | OT,2025-07-14/2025-07-20
255765161,25576516,52,M,2025-07-08,20250718,,CLOZARIL,Death,DE,CLOZARIL | Death | DE,2025-07-07/2025-07-13
255765631,25576563,,F,,20250718,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,NaT
255766041,25576604,,F,,20250718,,ACTEMRA,Oropharyngeal pain,,ACTEMRA | Oropharyngeal pain,NaT
255766091,25576609,,F,,20250718,,XOLAIR PFS,Rash,,XOLAIR PFS | Rash,NaT
255766691,25576669,33,M,,20250718,,COLCHICINE,Toxic epidermal necrolysis,HO,COLCHICINE | Toxic epidermal necrolysis | HO,NaT
255767381,25576738,,M,,20250718,,ZEPBOUND,Pemphigus,,ZEPBOUND | Pemphigus,NaT
255767431,25576743,,F,2025-06-15,20250718,,DUAC,Paraesthesia,OT,DUAC | Paraesthesia | OT,2025-06-09/2025-06-15
255767781,25576778,,M,,20250718,,CIPROFLOXACIN,Tendon sheath disorder,OT,CIPROFLOXACIN | Tendon sheath disorder | OT,NaT
255769593,25576959,32,M,,20250728,,RUXIENCE,Off label use,OT,RUXIENCE | Off label use | OT,NaT
255770931,25577093,,,,20250717,,CAPECITABINE,Constipation,,CAPECITABINE | Constipation,NaT
255771531,25577153,49,M,,20250718,,ARIPIPRAZOLE,Megacolon,HO,ARIPIPRAZOLE | Megacolon | HO,NaT
255771991,25577199,,M,,20250718,,DAPAGLIFLOZIN,Deafness,OT,DAPAGLIFLOZIN | Deafness | OT,NaT
255772151,25577215,57,F,2022-11-01,20250718,,BENSERAZIDE\LEVODOPA,Metastatic bronchial carcinoma,DE,BENSERAZIDE\LEVODOPA | Metastatic bronchial carcinoma | DE,2022-10-31/2022-11-06
255772401,25577240,,,,20250717,,ZEPBOUND,Adverse event,,ZEPBOUND | Adverse event,NaT
255772491,25577249,71,F,2025-07-01,20250718,,DUPIXENT,Dry skin,,DUPIXENT | Dry skin,2025-06-30/2025-07-06
255772591,25577259,19,M,2025-07-09,20250718,,ADVATE,Back pain,OT,ADVATE | Back pain | OT,2025-07-07/2025-07-13
255772731,25577273,,F,,20250718,,AMBRISENTAN,Respiratory failure,OT,AMBRISENTAN | Respiratory failure | OT,NaT
255773321,25577332,,,,20250718,,RILPIVIRINE,Injection site discharge,,RILPIVIRINE | Injection site discharge,NaT
255773921,25577392,84,F,2025-05-08,20250718,,PROLIA,Death,DE,PROLIA | Death | DE,2025-05-05/2025-05-11
255773981,25577398,40,F,2025-07-01,20250718,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2025-06-30/2025-07-06
255774001,25577400,,F,,20250718,,RENFLEXIS,Colitis ulcerative,OT,RENFLEXIS | Colitis ulcerative | OT,NaT
255774441,25577444,,M,,20250718,,RYBELSUS,Constipation,,RYBELSUS | Constipation,NaT
255775301,25577530,64,M,,20250718,,POMALYST,Hepatic enzyme abnormal,,POMALYST | Hepatic enzyme abnormal,NaT
255775471,25577547,,F,,20250718,,TOUJEO MAX,Product storage error,,TOUJEO MAX | Product storage error,NaT
255775551,25577555,,F,,20250718,,RYBELSUS,Suspected counterfeit product,,RYBELSUS | Suspected counterfeit product,NaT
255776111,25577611,,,,20250718,,RYBELSUS,Alopecia,,RYBELSUS | Alopecia,NaT
255776701,25577670,,M,,20250718,,RYBELSUS,Pancreatitis acute,OT,RYBELSUS | Pancreatitis acute | OT,NaT
255777071,25577707,67,F,2023-10-01,20250718,,BUPROPION,Rosacea,,BUPROPION | Rosacea,2023-09-25/2023-10-01
255778401,25577840,75,F,2024-10-01,20250718,,RYBELSUS,Glossodynia,,RYBELSUS | Glossodynia,2024-09-30/2024-10-06
255779021,25577902,74,F,2021-11-01,20250718,,RYBELSUS,Off label use,,RYBELSUS | Off label use,2021-11-01/2021-11-07
255779491,25577949,,,2017-01-01,20250718,,SUBOXONE,Back pain,OT,SUBOXONE | Back pain | OT,2016-12-26/2017-01-01
255779643,25577964,48,M,2025-07-01,20250801,,GENOTROPIN,Device leakage,,GENOTROPIN | Device leakage,2025-06-30/2025-07-06
255779681,25577968,52,,,20250718,,ZEPBOUND,Weight increased,,ZEPBOUND | Weight increased,NaT
255779931,25577993,5,F,,20250718,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,NaT
255780051,25578005,,,,20250718,,BICILLIN L-A,Recalled product administered,,BICILLIN L-A | Recalled product administered,NaT
255780061,25578006,,F,,20250718,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,NaT
255780442,25578044,71,M,,20250730,,LENALIDOMIDE,Fatigue,,LENALIDOMIDE | Fatigue,NaT
255780792,25578079,,F,2022-01-01,20250722,,TECFIDERA,Hypersensitivity,OT,TECFIDERA | Hypersensitivity | OT,2021-12-27/2022-01-02
255781004,25578100,,,,20250819,,BICILLIN L-A,Recalled product administered,,BICILLIN L-A | Recalled product administered,NaT
255781281,25578128,67,M,2025-02-24,20250718,,BIMEKIZUMAB,Blindness,HO,BIMEKIZUMAB | Blindness | HO,2025-02-24/2025-03-02
255781332,25578133,79,M,,20250724,,TAXOTERE,Pigmentary maculopathy,OT,TAXOTERE | Pigmentary maculopathy | OT,NaT
255782262,25578226,23,F,,20250724,,SILDENAFIL,Condition aggravated,HO,SILDENAFIL | Condition aggravated | HO,NaT
255782521,25578252,3,,,20250718,,JAKAFI,Wrong technique in product usage process,,JAKAFI | Wrong technique in product usage process,NaT
255782721,25578272,,,2025-01-01,20250718,,SLYND,Intermenstrual bleeding,,SLYND | Intermenstrual bleeding,2024-12-30/2025-01-05
255782782,25578278,70,M,2024-09-04,20250810,,REPATHA,Colon cancer,OT,REPATHA | Colon cancer | OT,2024-09-02/2024-09-08
255783021,25578302,68,M,2025-07-14,20250718,,ZEPBOUND,Vomiting,,ZEPBOUND | Vomiting,2025-07-14/2025-07-20
255784052,25578405,,F,2023-01-01,20250722,,TYSABRI,Secondary progressive multiple sclerosis,OT,TYSABRI | Secondary progressive multiple sclerosis | OT,2022-12-26/2023-01-01
255784081,25578408,,F,,20250718,,VEDOLIZUMAB,Muscular weakness,HO,VEDOLIZUMAB | Muscular weakness | HO,NaT
255784281,25578428,61,F,2021-10-16,20250718,,KISQALI,Rheumatoid arthritis,OT,KISQALI | Rheumatoid arthritis | OT,2021-10-11/2021-10-17
255785084,25578508,54,M,2025-01-01,20250923,,CORTICOTROPIN,Glucose tolerance impaired,,CORTICOTROPIN | Glucose tolerance impaired,2024-12-30/2025-01-05
255785381,25578538,38,F,,20250718,,MORPHINE SULFATE,Drug diversion,,MORPHINE SULFATE | Drug diversion,NaT
255785891,25578589,68,F,2023-08-15,20250718,,CYCLOPHOSPHAMIDE,Asthenia,OT,CYCLOPHOSPHAMIDE | Asthenia | OT,2023-08-14/2023-08-20
255786371,25578637,57,F,,20250718,,ESTRADIOL,Incorrect dose administered,,ESTRADIOL | Incorrect dose administered,NaT
255786631,25578663,,F,2025-07-07,20250718,,OLUMIANT,Blood fibrinogen decreased,OT,OLUMIANT | Blood fibrinogen decreased | OT,2025-07-07/2025-07-13
255787071,25578707,,M,2023-11-01,20250718,,ETANERCEPT,Rheumatoid arthritis,OT,ETANERCEPT | Rheumatoid arthritis | OT,2023-10-30/2023-11-05
255788101,25578810,,,,20250718,,COMBIGAN,Product storage error,,COMBIGAN | Product storage error,NaT
255788131,25578813,51,M,2025-06-01,20250718,,SKYRIZI,Injection site discharge,,SKYRIZI | Injection site discharge,2025-05-26/2025-06-01
255788281,25578828,58,F,,20250718,,ORENCIA,Immune system disorder,,ORENCIA | Immune system disorder,NaT
255788531,25578853,51,M,,20250718,,DUPIXENT,Therapeutic response unexpected,,DUPIXENT | Therapeutic response unexpected,NaT
255788711,25578871,84,M,2025-04-20,20250718,,XARELTO,Haemorrhage intracranial,DE,XARELTO | Haemorrhage intracranial | DE,2025-04-14/2025-04-20
255788721,25578872,45,F,,20250718,,TRULICITY,Gastrointestinal sounds abnormal,,TRULICITY | Gastrointestinal sounds abnormal,NaT
255789892,25578989,74,F,2021-01-20,20250725,,CYCLOPHOSPHAMIDE,Second primary malignancy,DE,CYCLOPHOSPHAMIDE | Second primary malignancy | DE,2021-01-18/2021-01-24
255790083,25579008,15,M,2025-06-01,20250820,,GENOTROPIN,Device information output issue,,GENOTROPIN | Device information output issue,2025-05-26/2025-06-01
255790092,25579009,,M,,20250805,,GENOTROPIN,Device leakage,,GENOTROPIN | Device leakage,NaT
255790143,25579014,9,M,,20250820,,GENOTROPIN,Device breakage,,GENOTROPIN | Device breakage,NaT
255790631,25579063,,,,20250718,,METHOTREXATE,Inflammation,OT,METHOTREXATE | Inflammation | OT,NaT
255790911,25579091,66,F,2025-05-01,20250718,,AUSTEDO XR,Aphonia,OT,AUSTEDO XR | Aphonia | OT,2025-04-28/2025-05-04
255791291,25579129,55,,,20250718,,JAKAFI,Off label use,,JAKAFI | Off label use,NaT
255791531,25579153,40,F,,20250718,,VRAYLAR,Paranoia,,VRAYLAR | Paranoia,NaT
255791951,25579195,66,M,2024-06-19,20250718,,WEGOVY,Increased appetite,,WEGOVY | Increased appetite,2024-06-17/2024-06-23
255791991,25579199,,M,,20250718,,WEGOVY,Injection site pain,,WEGOVY | Injection site pain,NaT
255792501,25579250,17,M,2024-05-01,20250718,,WEGOVY,Ulcer,,WEGOVY | Ulcer,2024-04-29/2024-05-05
255793242,25579324,,F,,20250718,,WEGOVY,Abdominal distension,,WEGOVY | Abdominal distension,NaT
255793451,25579345,,F,2024-07-04,20250718,,WEGOVY,Tongue disorder,,WEGOVY | Tongue disorder,2024-07-01/2024-07-07
255793521,25579352,,M,,20250718,,WEGOVY,Injection site pain,,WEGOVY | Injection site pain,NaT
255793951,25579395,,F,,20250718,,WEGOVY,Hypertension,,WEGOVY | Hypertension,NaT
255794701,25579470,52,F,2023-06-28,20250718,,WEGOVY,Product use issue,HO,WEGOVY | Product use issue | HO,2023-06-26/2023-07-02
255795281,25579528,,F,,20250718,,WEGOVY,Dry mouth,,WEGOVY | Dry mouth,NaT
255795891,25579589,16,F,2025-03-01,20250718,,DUPIXENT,Rebound eczema,,DUPIXENT | Rebound eczema,2025-02-24/2025-03-02
255796141,25579614,66,M,2025-06-17,20250718,,OXYCONTIN,Ileus paralytic,HO,OXYCONTIN | Ileus paralytic | HO,2025-06-16/2025-06-22
255796201,25579620,,,,20250718,,WEGOVY,Adverse drug reaction,,WEGOVY | Adverse drug reaction,NaT
255796561,25579656,,F,,20250718,,WEGOVY,Weight increased,,WEGOVY | Weight increased,NaT
255796631,25579663,42,M,2024-09-01,20250718,,WEGOVY,Product communication issue,,WEGOVY | Product communication issue,2024-08-26/2024-09-01
255797101,25579710,39,F,2024-07-06,20250718,,WEGOVY,Hyperthyroidism,,WEGOVY | Hyperthyroidism,2024-07-01/2024-07-07
255797231,25579723,40,F,2024-08-31,20250718,,WEGOVY,Inappropriate schedule of product administration,OT,WEGOVY | Inappropriate schedule of product administration | OT,2024-08-26/2024-09-01
255797431,25579743,60,F,2024-09-27,20250718,,WEGOVY,Inappropriate schedule of product administration,,WEGOVY | Inappropriate schedule of product administration,2024-09-23/2024-09-29
255797661,25579766,,F,,20250718,,WEGOVY,Pancreatitis,OT,WEGOVY | Pancreatitis | OT,NaT
255801391,25580139,,F,,20250718,,WEGOVY,Influenza like illness,,WEGOVY | Influenza like illness,NaT
255802191,25580219,43,F,2024-09-06,20250718,,WEGOVY,Illness,,WEGOVY | Illness,2024-09-02/2024-09-08
255802232,25580223,,F,2024-09-26,20250718,,WEGOVY,Decreased appetite,,WEGOVY | Decreased appetite,2024-09-23/2024-09-29
255802331,25580233,,M,,20250718,,WEGOVY,Diarrhoea,,WEGOVY | Diarrhoea,NaT
255802711,25580271,17,F,2024-09-28,20250718,,WEGOVY,Decreased appetite,,WEGOVY | Decreased appetite,2024-09-23/2024-09-29
255803721,25580372,,F,,20250718,,WEGOVY,Increased appetite,,WEGOVY | Increased appetite,NaT
255803811,25580381,,F,,20250718,,WEGOVY,Polymenorrhoea,,WEGOVY | Polymenorrhoea,NaT
255804261,25580426,,F,2025-02-27,20250718,,WEGOVY,Illness,,WEGOVY | Illness,2025-02-24/2025-03-02
255804671,25580467,,F,,20250718,,WEGOVY,Condition aggravated,,WEGOVY | Condition aggravated,NaT
255804781,25580478,,F,,20250718,,WEGOVY,Visual impairment,,WEGOVY | Visual impairment,NaT
255805171,25580517,,M,,20250718,,WEGOVY,Depression,,WEGOVY | Depression,NaT
255805531,25580553,,F,2024-01-01,20250718,,WEGOVY,Syncope,OT,WEGOVY | Syncope | OT,2024-01-01/2024-01-07
255806021,25580602,,F,,20250718,,WEGOVY,Decreased appetite,,WEGOVY | Decreased appetite,NaT
255806221,25580622,,F,,20250718,,WEGOVY,General physical health deterioration,,WEGOVY | General physical health deterioration,NaT
255806311,25580631,,F,2025-02-25,20250718,,WEGOVY,Fatigue,,WEGOVY | Fatigue,2025-02-24/2025-03-02
255806381,25580638,,F,,20250718,,WEGOVY,Gastrointestinal disorder,,WEGOVY | Gastrointestinal disorder,NaT
255806461,25580646,,,,20250718,,WEGOVY,Nerve compression,,WEGOVY | Nerve compression,NaT
255807461,25580746,,F,,20250718,,WEGOVY,Skin odour abnormal,,WEGOVY | Skin odour abnormal,NaT
255807581,25580758,,F,,20250718,,WEGOVY,Nausea,,WEGOVY | Nausea,NaT
255807671,25580767,,,,20250718,,WEGOVY,Gastrooesophageal reflux disease,,WEGOVY | Gastrooesophageal reflux disease,NaT
255808061,25580806,31,F,,20250718,,WEGOVY,Decreased appetite,,WEGOVY | Decreased appetite,NaT
255808231,25580823,26,F,,20250718,,WEGOVY,Pancreatitis,OT,WEGOVY | Pancreatitis | OT,NaT
255810041,25581004,,F,,20250718,,WEGOVY,COVID-19,,WEGOVY | COVID-19,NaT
255810721,25581072,,M,,20250718,,WEGOVY,Lack of satiety,,WEGOVY | Lack of satiety,NaT
255810822,25581082,51,M,2025-05-17,20250718,,WEGOVY,Injection site erythema,,WEGOVY | Injection site erythema,2025-05-12/2025-05-18
255811011,25581101,,F,,20250718,,WEGOVY,Appetite disorder,,WEGOVY | Appetite disorder,NaT
255811511,25581151,59,F,2025-01-03,20250718,,WEGOVY,Migraine,,WEGOVY | Migraine,2024-12-30/2025-01-05
255811531,25581153,54,M,2024-11-18,20250718,,WEGOVY,Increased appetite,,WEGOVY | Increased appetite,2024-11-18/2024-11-24
255812191,25581219,,M,,20250718,,WEGOVY,Neck mass,,WEGOVY | Neck mass,NaT
255812421,25581242,,M,,20250718,,WEGOVY,Abnormal faeces,,WEGOVY | Abnormal faeces,NaT
255813141,25581314,,F,,20250718,,WEGOVY,Vomiting,,WEGOVY | Vomiting,NaT
255813801,25581380,,,,20250718,,WEGOVY,Nausea,,WEGOVY | Nausea,NaT
255813821,25581382,32,F,,20250718,,WEGOVY,Mood swings,,WEGOVY | Mood swings,NaT
255814151,25581415,52,M,2025-02-24,20250718,,WEGOVY,Obsessive-compulsive disorder,,WEGOVY | Obsessive-compulsive disorder,2025-02-24/2025-03-02
255814391,25581439,,F,,20250718,,WEGOVY,Rhinorrhoea,,WEGOVY | Rhinorrhoea,NaT
255814662,25581466,,F,,20250718,,WEGOVY,Presyncope,,WEGOVY | Presyncope,NaT
255815291,25581529,76,F,2025-02-01,20250719,,WEGOVY,Increased appetite,,WEGOVY | Increased appetite,2025-01-27/2025-02-02
255816291,25581629,,,,20250719,,ACTEMRA,Arthropathy,HO,ACTEMRA | Arthropathy | HO,NaT
255817102,25581710,,F,2025-01-01,20250821,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2024-12-30/2025-01-05
255817551,25581755,52,F,2025-07-01,20250719,,TYVASO DPI,Death,DE,TYVASO DPI | Death | DE,2025-06-30/2025-07-06
255818282,25581828,,,,20250905,,OMALIZUMAB,Cough,OT,OMALIZUMAB | Cough | OT,NaT
255818291,25581829,49,F,2023-08-24,20250719,,PACLITAXEL,Neutropenia,OT,PACLITAXEL | Neutropenia | OT,2023-08-21/2023-08-27
255818351,25581835,,,,20250719,,ZEPBOUND,Extra dose administered,,ZEPBOUND | Extra dose administered,NaT
255818971,25581897,65,M,2022-12-01,20250719,,MYCOPHENOLATE MOFETIL,COVID-19,HO,MYCOPHENOLATE MOFETIL | COVID-19 | HO,2022-11-28/2022-12-04
255819181,25581918,8,,2025-06-01,20250719,,LUMAKRAS,Lung neoplasm malignant,OT,LUMAKRAS | Lung neoplasm malignant | OT,2025-05-26/2025-06-01
255820642,25582064,1,M,2025-08-01,20250927,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2025-07-28/2025-08-03
255822431,25582243,,,,20250719,,COSENTYX,Arthralgia,,COSENTYX | Arthralgia,NaT
255822572,25582257,,M,,20250811,,ULTOMIRIS,Malignant melanoma,OT,ULTOMIRIS | Malignant melanoma | OT,NaT
255823211,25582321,63,M,,20250720,,DOXYCYCLINE,Therapy partial responder,OT,DOXYCYCLINE | Therapy partial responder | OT,NaT
255823361,25582336,24,M,,20250720,,METHOTREXATE,Guillain-Barre syndrome,OT,METHOTREXATE | Guillain-Barre syndrome | OT,NaT
255823571,25582357,3,,,20250720,,IBUPROFEN,Cross sensitivity reaction,OT,IBUPROFEN | Cross sensitivity reaction | OT,NaT
255823882,25582388,,M,,20250808,,TEZEPELUMAB,Urinary tract infection,HO,TEZEPELUMAB | Urinary tract infection | HO,NaT
255823891,25582389,65,,,20250720,,TOLVAPTAN,No adverse event,,TOLVAPTAN | No adverse event,NaT
255824881,25582488,60,M,,20250720,,TIZANIDINE,Central sleep apnoea syndrome,OT,TIZANIDINE | Central sleep apnoea syndrome | OT,NaT
255825311,25582531,,,,20250720,,CAPECITABINE,Neoplasm progression,OT,CAPECITABINE | Neoplasm progression | OT,NaT
255825481,25582548,25,F,2025-06-01,20250720,,CIMZIA,Rheumatoid arthritis,OT,CIMZIA | Rheumatoid arthritis | OT,2025-05-26/2025-06-01
255825652,25582565,63,M,2025-04-01,20250827,,KEYTRUDA,Bladder neoplasm surgery,OT,KEYTRUDA | Bladder neoplasm surgery | OT,2025-03-31/2025-04-06
255825813,25582581,85,F,2025-07-09,20250915,,TRELEGY ELLIPTA,Product complaint,,TRELEGY ELLIPTA | Product complaint,2025-07-07/2025-07-13
255826021,25582602,,F,,20250720,,TRELEGY ELLIPTA,Incorrect dose administered,,TRELEGY ELLIPTA | Incorrect dose administered,NaT
255826203,25582620,63,F,2025-07-17,20250901,,TREMFYA,Product leakage,,TREMFYA | Product leakage,2025-07-14/2025-07-20
255826641,25582664,,F,,20250720,,OFLOXACIN,Adverse drug reaction,,OFLOXACIN | Adverse drug reaction,NaT
255826681,25582668,28,M,,20250720,,DUPIXENT,Injection site urticaria,,DUPIXENT | Injection site urticaria,NaT
255826961,25582696,82,M,2025-01-01,20250720,,MOUNJARO,Injection site hypersensitivity,,MOUNJARO | Injection site hypersensitivity,2024-12-30/2025-01-05
255828211,25582821,59,,,20250720,,TISLELIZUMAB,Myelosuppression,HO,TISLELIZUMAB | Myelosuppression | HO,NaT
255829091,25582909,,,,20250720,,LUPRON DEPOT,Product temperature excursion issue,,LUPRON DEPOT | Product temperature excursion issue,NaT
255829141,25582914,,F,,20250720,,HUMIRA,Systemic lupus erythematosus,OT,HUMIRA | Systemic lupus erythematosus | OT,NaT
255829292,25582929,,F,,20250728,,SKYRIZI,Diarrhoea,HO,SKYRIZI | Diarrhoea | HO,NaT
255829391,25582939,,,2025-06-28,20250721,,GALZIN,Intentional product misuse,OT,GALZIN | Intentional product misuse | OT,2025-06-23/2025-06-29
255829481,25582948,,F,,20250721,,RINVOQ,Pain,OT,RINVOQ | Pain | OT,NaT
255830331,25583033,,F,,20250721,,DUPIXENT,Therapeutic response decreased,,DUPIXENT | Therapeutic response decreased,NaT
255830461,25583046,,,2025-07-08,20250721,,EBGLYSS,Conjunctivitis,,EBGLYSS | Conjunctivitis,2025-07-07/2025-07-13
255831351,25583135,,F,,20250721,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,NaT
255831531,25583153,42,F,2025-01-01,20250721,,RINVOQ,Dental operation,OT,RINVOQ | Dental operation | OT,2024-12-30/2025-01-05
255831592,25583159,55,F,2024-02-01,20250805,,RINVOQ,Uterine enlargement,OT,RINVOQ | Uterine enlargement | OT,2024-01-29/2024-02-04
255831771,25583177,,F,,20250721,,NUCALA,Contusion,OT,NUCALA | Contusion | OT,NaT
255831981,25583198,67,F,,20250721,,LATANOPROST,Abdominal discomfort,OT,LATANOPROST | Abdominal discomfort | OT,NaT
255832351,25583235,22,F,2025-01-01,20250721,,DUPIXENT,Skin exfoliation,,DUPIXENT | Skin exfoliation,2024-12-30/2025-01-05
255832391,25583239,,,,20250721,,VYVGART HYTRULO,Dementia Alzheimer's type,OT,VYVGART HYTRULO | Dementia Alzheimer's type | OT,NaT
255832861,25583286,53,M,2025-07-01,20250721,,OTEZLA,Pain,,OTEZLA | Pain,2025-06-30/2025-07-06
255832881,25583288,67,M,2025-01-01,20250721,,AMOXICILLIN,Type I hypersensitivity,HO,AMOXICILLIN | Type I hypersensitivity | HO,2024-12-30/2025-01-05
255833821,25583382,69,F,2025-06-25,20250721,,CISPLATIN,Myelosuppression,HO,CISPLATIN | Myelosuppression | HO,2025-06-23/2025-06-29
255833831,25583383,,,,20250721,,BORTEZOMIB,Neuropathy peripheral,OT,BORTEZOMIB | Neuropathy peripheral | OT,NaT
255834061,25583406,30,M,,20250721,,GEMCITABINE,Disease progression,OT,GEMCITABINE | Disease progression | OT,NaT
255834211,25583421,,F,,20250721,,IBUPROFEN,Off label use,OT,IBUPROFEN | Off label use | OT,NaT
255834391,25583439,,F,,20250721,,ARANESP,Off label use,OT,ARANESP | Off label use | OT,NaT
255834901,25583490,66,F,2025-02-17,20250721,,PREDNISONE,Haematotoxicity,HO,PREDNISONE | Haematotoxicity | HO,2025-02-17/2025-02-23
255835341,25583534,80,F,,20250721,,OZEMPIC,Pancreatitis chronic,OT,OZEMPIC | Pancreatitis chronic | OT,NaT
255835642,25583564,62,M,2025-01-01,20250724,,RYBELSUS,Diabetic retinopathy,OT,RYBELSUS | Diabetic retinopathy | OT,2024-12-30/2025-01-05
255836061,25583606,46,M,2023-01-01,20250721,,IVABRADINE HYDROCHLORIDE,Blood pressure decreased,LT,IVABRADINE HYDROCHLORIDE | Blood pressure decreased | LT,2022-12-26/2023-01-01
255837281,25583728,77,M,,20250721,,TOUJEO,Product storage error,,TOUJEO | Product storage error,NaT
255837341,25583734,96,F,,20250721,,DUPIXENT,Urinary tract infection,OT,DUPIXENT | Urinary tract infection | OT,NaT
255837651,25583765,,F,2025-01-01,20250721,,TAVALISSE,Dehydration,HO,TAVALISSE | Dehydration | HO,2024-12-30/2025-01-05
255837711,25583771,,M,2025-01-01,20250721,,SKYRIZI,Influenza like illness,,SKYRIZI | Influenza like illness,2024-12-30/2025-01-05
255837861,25583786,68,F,2025-07-01,20250721,,VERZENIO,White blood cell count decreased,,VERZENIO | White blood cell count decreased,2025-06-30/2025-07-06
255838121,25583812,,,,20250721,,FULPHILA,Needle issue,,FULPHILA | Needle issue,NaT
255838131,25583813,,,,20250721,,FULPHILA,Device mechanical issue,,FULPHILA | Device mechanical issue,NaT
255838811,25583881,18,F,2025-05-01,20250721,,DUPIXENT,Menstruation delayed,,DUPIXENT | Menstruation delayed,2025-04-28/2025-05-04
255839031,25583903,56,M,2020-01-01,20250721,,DUPIXENT,Cough,OT,DUPIXENT | Cough | OT,2019-12-30/2020-01-05
255839581,25583958,,,,20250721,,MOUNJARO,Constipation,,MOUNJARO | Constipation,NaT
255839691,25583969,20,F,,20250721,,RANITIDINE,Off label use,OT,RANITIDINE | Off label use | OT,NaT
255840122,25584012,64,M,,20250724,,ELIQUIS,Treatment noncompliance,,ELIQUIS | Treatment noncompliance,NaT
255840621,25584062,40,M,,20250721,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,NaT
255841741,25584174,75,M,,20250721,,AMIODARONE HYDROCHLORIDE,Drug interaction,,AMIODARONE HYDROCHLORIDE | Drug interaction,NaT
255841791,25584179,10,F,,20250721,,LEVETIRACETAM,Drug resistance,HO,LEVETIRACETAM | Drug resistance | HO,NaT
255842471,25584247,33,F,2024-05-01,20250721,,SERTRALINE HYDROCHLORIDE,Pineocytoma,OT,SERTRALINE HYDROCHLORIDE | Pineocytoma | OT,2024-04-29/2024-05-05
255843051,25584305,76,M,,20250721,,METFORMIN,Nightmare,,METFORMIN | Nightmare,NaT
255844791,25584479,,M,,20250721,,TECFIDERA,Gastrointestinal disorder,,TECFIDERA | Gastrointestinal disorder,NaT
255845001,25584500,52,F,2025-01-01,20250721,,DUPIXENT,Arthralgia,,DUPIXENT | Arthralgia,2024-12-30/2025-01-05
255847141,25584714,36,F,2025-05-27,20250721,,PACLITAXEL,Thrombotic microangiopathy,HO,PACLITAXEL | Thrombotic microangiopathy | HO,2025-05-26/2025-06-01
255847541,25584754,58,M,2011-01-01,20250721,,ENOXAPARIN SODIUM,Palpitations,OT,ENOXAPARIN SODIUM | Palpitations | OT,2010-12-27/2011-01-02
255847671,25584767,66,M,,20250721,,VANCOMYCIN,Encephalopathy,OT,VANCOMYCIN | Encephalopathy | OT,NaT
255848521,25584852,,,,20250721,,METFORMIN,Hypomagnesaemia,HO,METFORMIN | Hypomagnesaemia | HO,NaT
255848841,25584884,,,2025-01-01,20250721,,ISOTRETINOIN,Adverse drug reaction,,ISOTRETINOIN | Adverse drug reaction,2024-12-30/2025-01-05
255849122,25584912,64,M,,20250909,,PADCEV,Diabetes mellitus,OT,PADCEV | Diabetes mellitus | OT,NaT
255849581,25584958,80,F,,20250721,,REVLIMID,Diarrhoea,,REVLIMID | Diarrhoea,NaT
255849612,25584961,,M,,20250805,,HIZENTRA,Infusion site erythema,,HIZENTRA | Infusion site erythema,NaT
255850101,25585010,56,F,,20250721,,RITUXIMAB,Cellulitis,HO,RITUXIMAB | Cellulitis | HO,NaT
255850181,25585018,56,M,2025-07-02,20250721,,DILANTIN,Drug level increased,HO,DILANTIN | Drug level increased | HO,2025-06-30/2025-07-06
255850421,25585042,29,M,,20250721,,QUETIAPINE,Intentional overdose,OT,QUETIAPINE | Intentional overdose | OT,NaT
255850762,25585076,,,,20250908,,POLATUZUMAB VEDOTIN,Cardiomyopathy,OT,POLATUZUMAB VEDOTIN | Cardiomyopathy | OT,NaT
255851151,25585115,,M,2025-07-15,20250721,,CABENUVA,Blood HIV RNA increased,,CABENUVA | Blood HIV RNA increased,2025-07-14/2025-07-20
255851221,25585122,,,,20250721,,DALFAMPRIDINE,Myocardial infarction,OT,DALFAMPRIDINE | Myocardial infarction | OT,NaT
255851761,25585176,64,M,2025-07-18,20250718,,LENALIDOMIDE,Peripheral swelling,OT,LENALIDOMIDE | Peripheral swelling | OT,2025-07-14/2025-07-20
255852551,25585255,45,F,2025-06-01,20250721,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,2025-05-26/2025-06-01
255853021,25585302,,,,20250721,,AMIODARONE,Cardiogenic shock,HO,AMIODARONE | Cardiogenic shock | HO,NaT
255853201,25585320,,,,20250721,,TREMFYA,BRCA1 gene mutation,OT,TREMFYA | BRCA1 gene mutation | OT,NaT
255854721,25585472,,F,,20250721,,ADEMPAS,Decreased activity,OT,ADEMPAS | Decreased activity | OT,NaT
255854881,25585488,4,M,,20250721,,SPRAVATO,Hospitalisation,HO,SPRAVATO | Hospitalisation | HO,NaT
255854971,25585497,,,,20250718,,FLONASE,Drug ineffective,,FLONASE | Drug ineffective,NaT
255855752,25585575,68,F,2025-06-23,20250904,,DUPIXENT,Exposure via skin contact,,DUPIXENT | Exposure via skin contact,2025-06-23/2025-06-29
255856611,25585661,86,M,,20250721,,RUXIENCE,Anaphylactic reaction,HO,RUXIENCE | Anaphylactic reaction | HO,NaT
255857081,25585708,9,F,,20250721,,PACLITAXEL,Polymyalgia rheumatica,OT,PACLITAXEL | Polymyalgia rheumatica | OT,NaT
255858111,25585811,,M,,20250718,,DONEPEZIL HYDROCHLORIDE,Abdominal pain upper,HO,DONEPEZIL HYDROCHLORIDE | Abdominal pain upper | HO,NaT
255858431,25585843,59,M,,20250721,,APIXABAN,Haemorrhage intracranial,OT,APIXABAN | Haemorrhage intracranial | OT,NaT
255859021,25585902,,F,,20250721,,MIRALAX,Product prescribing issue,,MIRALAX | Product prescribing issue,NaT
255859731,25585973,57,M,,20250721,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,NaT
255860461,25586046,,F,,20250721,,MIRENA,Genital haemorrhage,,MIRENA | Genital haemorrhage,NaT
255860971,25586097,,,,20250721,,JAKAFI,Rheumatoid arthritis,OT,JAKAFI | Rheumatoid arthritis | OT,NaT
255860991,25586099,84,F,,20250721,,LEFLUNOMIDE,Hypotension,HO,LEFLUNOMIDE | Hypotension | HO,NaT
255861311,25586131,45,F,,20250721,,DUPIXENT,Injection site reaction,,DUPIXENT | Injection site reaction,NaT
255861361,25586136,,,,20250721,,VALSARTAN,Prostate cancer,OT,VALSARTAN | Prostate cancer | OT,NaT
255861771,25586177,33,M,2024-02-01,20250721,,AMBIEN,Pneumocystis jirovecii infection,HO,AMBIEN | Pneumocystis jirovecii infection | HO,2024-01-29/2024-02-04
255862557,25586255,15,M,,20250911,,GENOTROPIN,Drug dose omission by device,,GENOTROPIN | Drug dose omission by device,NaT
255862903,25586290,,,,20250821,,BICILLIN L-A,Recalled product administered,,BICILLIN L-A | Recalled product administered,NaT
255863696,25586369,,,2025-01-01,20250905,,SELINEXOR,Blood potassium increased,HO,SELINEXOR | Blood potassium increased | HO,2024-12-30/2025-01-05
255863971,25586397,1,M,,20250721,,OLUMIANT,Pneumonia,,OLUMIANT | Pneumonia,NaT
255864031,25586403,76,F,2025-07-17,20250721,,LENALIDOMIDE,Emotional distress,HO,LENALIDOMIDE | Emotional distress | HO,2025-07-14/2025-07-20
255864212,25586421,,F,,20250803,,PEGFILGRASTIM,Febrile neutropenia,OT,PEGFILGRASTIM | Febrile neutropenia | OT,NaT
255864952,25586495,39,F,,20250801,,AZITHROMYCIN,Drug resistance,,AZITHROMYCIN | Drug resistance,NaT
255865141,25586514,63,,,20250721,,TRULICITY,Diarrhoea,HO,TRULICITY | Diarrhoea | HO,NaT
255865391,25586539,68,M,2021-09-10,20250721,,ISATUXIMAB-IRFC,Anaphylactic reaction,LT,ISATUXIMAB-IRFC | Anaphylactic reaction | LT,2021-09-06/2021-09-12
255865711,25586571,55,F,2025-04-24,20250721,,DOXORUBICIN,Anaemia,HO,DOXORUBICIN | Anaemia | HO,2025-04-21/2025-04-27
255866701,25586670,,,,20250721,,VYEPTI,Adverse drug reaction,,VYEPTI | Adverse drug reaction,NaT
255867201,25586720,41,F,,20250721,,RITUXIMAB,Diarrhoea,OT,RITUXIMAB | Diarrhoea | OT,NaT
255867601,25586760,27,F,,20250721,,BICILLIN L-A,Recalled product administered,,BICILLIN L-A | Recalled product administered,NaT
255869261,25586926,60,M,2025-01-01,20250721,,VOQUEZNA,Abdominal discomfort,,VOQUEZNA | Abdominal discomfort,2024-12-30/2025-01-05
255870731,25587073,,F,,20250721,,VOQUEZNA,Constipation,,VOQUEZNA | Constipation,NaT
255871561,25587156,57,F,2025-07-08,20250721,,COSMETICS,Dermatitis contact,OT,COSMETICS | Dermatitis contact | OT,2025-07-07/2025-07-13
255872401,25587240,,,,20250721,,RISPERIDONE,Drug ineffective,,RISPERIDONE | Drug ineffective,NaT
255873631,25587363,34,F,2025-07-14,20250721,,WEGOVY,Pain,DS,WEGOVY | Pain | DS,2025-07-14/2025-07-20
255873821,25587382,72,F,,20250721,,APIXABAN,Cardiac tamponade,HO,APIXABAN | Cardiac tamponade | HO,NaT
255874332,25587433,49,M,,20250728,,FLUCONAZOLE,Drug ineffective,LT,FLUCONAZOLE | Drug ineffective | LT,NaT
255874411,25587441,,,,20250721,,GIVLAARI,Renal disorder,,GIVLAARI | Renal disorder,NaT
255874841,25587484,,,,20250721,,RUCONEST,Weight decreased,,RUCONEST | Weight decreased,NaT
255875391,25587539,,M,,20250721,,LEVETIRACETAM,Decreased appetite,OT,LEVETIRACETAM | Decreased appetite | OT,NaT
255875401,25587540,54,F,2021-01-01,20250721,,KISQALI,Hepatotoxicity,OT,KISQALI | Hepatotoxicity | OT,2020-12-28/2021-01-03
255876431,25587643,46,F,2025-01-01,20250721,,CORTICOTROPIN,Hyperthyroidism,OT,CORTICOTROPIN | Hyperthyroidism | OT,2024-12-30/2025-01-05
255876851,25587685,,,,20250721,,PLUVICTO,General physical health deterioration,,PLUVICTO | General physical health deterioration,NaT
255877081,25587708,53,F,,20250721,,ZEPBOUND,Injection site pain,,ZEPBOUND | Injection site pain,NaT
255877141,25587714,,F,,20250721,,REFRESH OPTIVE MEGA-3,Dry eye,OT,REFRESH OPTIVE MEGA-3 | Dry eye | OT,NaT
255878172,25587817,55,F,2025-06-26,20250806,,ENHERTU,Disease progression,OT,ENHERTU | Disease progression | OT,2025-06-23/2025-06-29
255878651,25587865,,M,2025-01-01,20250721,,LOSARTAN POTASSIUM,Dizziness,OT,LOSARTAN POTASSIUM | Dizziness | OT,2024-12-30/2025-01-05
255879122,25587912,,F,,20250829,,ENTYVIO,Injection site discharge,,ENTYVIO | Injection site discharge,NaT
255879261,25587926,66,,,20250721,,TISLELIZUMAB,Dyspepsia,OT,TISLELIZUMAB | Dyspepsia | OT,NaT
255879382,25587938,53,F,2025-07-01,20250831,,SKYRIZI,Pneumonitis,,SKYRIZI | Pneumonitis,2025-06-30/2025-07-06
255879411,25587941,15,F,,20250721,,TALTZ,Psoriasis,,TALTZ | Psoriasis,NaT
255880011,25588001,,M,,20250721,,RINVOQ,Asthenia,HO,RINVOQ | Asthenia | HO,NaT
255880201,25588020,30,F,,20250721,,AZITHROMYCIN,Drug ineffective,HO,AZITHROMYCIN | Drug ineffective | HO,NaT
255880412,25588041,47,F,2025-01-01,20250725,,CONTRAVE,Product dose omission issue,OT,CONTRAVE | Product dose omission issue | OT,2024-12-30/2025-01-05
255881052,25588105,,F,2025-01-01,20250724,,OFEV,Death,DE,OFEV | Death | DE,2024-12-30/2025-01-05
255881101,25588110,50,,2025-07-09,20250722,,EMGALITY,Underdose,,EMGALITY | Underdose,2025-07-07/2025-07-13
255881251,25588125,60,F,2025-06-25,20250722,,BOTOX,Concussion,HO,BOTOX | Concussion | HO,2025-06-23/2025-06-29
255881301,25588130,,F,,20250722,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
255881481,25588148,65,F,2025-07-18,20250722,,REVLIMID,Rash,,REVLIMID | Rash,2025-07-14/2025-07-20
255881861,25588186,,,,20250722,,INFLIXIMAB,Condition aggravated,OT,INFLIXIMAB | Condition aggravated | OT,NaT
255882261,25588226,,M,,20250722,,VALSARTAN,Blood calcium increased,,VALSARTAN | Blood calcium increased,NaT
255882311,25588231,,F,,20250722,,VALSARTAN,Dust allergy,,VALSARTAN | Dust allergy,NaT
255882381,25588238,,,,20250722,,GLYCOPYRRONIUM,Fatigue,OT,GLYCOPYRRONIUM | Fatigue | OT,NaT
255883102,25588310,56,M,2025-04-16,20250730,,AXITINIB,Diarrhoea,OT,AXITINIB | Diarrhoea | OT,2025-04-14/2025-04-20
255883611,25588361,66,M,2025-06-25,20250722,,AZITHROMYCIN,Hepatic enzyme increased,HO,AZITHROMYCIN | Hepatic enzyme increased | HO,2025-06-23/2025-06-29
255883911,25588391,65,M,2025-07-10,20250722,,PACLITAXEL,Cardiac arrest,LT,PACLITAXEL | Cardiac arrest | LT,2025-07-07/2025-07-13
255885331,25588533,96,M,,20250722,,PREGABALIN,Drug interaction,HO,PREGABALIN | Drug interaction | HO,NaT
255885781,25588578,,M,,20250722,,OPSUMIT,Drug intolerance,HO,OPSUMIT | Drug intolerance | HO,NaT
255886512,25588651,,F,,20250728,,MOUNJARO,No adverse event,,MOUNJARO | No adverse event,NaT
255887501,25588750,,F,,20250722,,TYVASO DPI,Seasonal allergy,,TYVASO DPI | Seasonal allergy,NaT
255887601,25588760,,,,20250722,,ORGOVYX,Dementia,OT,ORGOVYX | Dementia | OT,NaT
255888432,25588843,74,F,2024-10-01,20250811,,CERTOLIZUMAB PEGOL,Fall,HO,CERTOLIZUMAB PEGOL | Fall | HO,2024-09-30/2024-10-06
255889191,25588919,,F,,20250722,,SUMATRIPTAN SUCCINATE,Chest pain,OT,SUMATRIPTAN SUCCINATE | Chest pain | OT,NaT
255889461,25588946,,,,20250722,,ZEPBOUND,Nephrolithiasis,,ZEPBOUND | Nephrolithiasis,NaT
255889881,25588988,38,F,2019-01-01,20250722,,PARAGARD T 380A,Device breakage,OT,PARAGARD T 380A | Device breakage | OT,2018-12-31/2019-01-06
255890082,25589008,26,F,2024-10-01,20250808,,RINVOQ,Stoma site haemorrhage,HO,RINVOQ | Stoma site haemorrhage | HO,2024-09-30/2024-10-06
255890711,25589071,,F,2025-07-01,20250722,,FULVESTRANT,Osteoarthritis,OT,FULVESTRANT | Osteoarthritis | OT,2025-06-30/2025-07-06
255891021,25589102,21,F,2010-01-01,20250722,,PARAGARD T 380A,Foreign body in urogenital tract,OT,PARAGARD T 380A | Foreign body in urogenital tract | OT,2009-12-28/2010-01-03
255891641,25589164,92,M,,20250722,,ZICAM COLD REMEDY NASAL SWABS (HOMEOPATHICS),Pneumonia,DE,ZICAM COLD REMEDY NASAL SWABS (HOMEOPATHICS) | Pneumonia | DE,NaT
255892006,25589200,64,M,2025-07-01,20250927,,REMODULIN,Infusion site erythema,,REMODULIN | Infusion site erythema,2025-06-30/2025-07-06
255893111,25589311,28,F,2025-05-24,20250722,,IBUPROFEN,Haemodynamic instability,LT,IBUPROFEN | Haemodynamic instability | LT,2025-05-19/2025-05-25
255893671,25589367,,,,20250722,,ETANERCEPT,Death,DE,ETANERCEPT | Death | DE,NaT
255893741,25589374,59,F,,20250722,,VANCOMYCIN,Hypotension,HO,VANCOMYCIN | Hypotension | HO,NaT
255894511,25589451,,,,20250722,,TIMOLOL MALEATE,Hallucination,OT,TIMOLOL MALEATE | Hallucination | OT,NaT
255894961,25589496,32,M,2025-07-16,20250722,,COBENFY,Intentional product misuse,,COBENFY | Intentional product misuse,2025-07-14/2025-07-20
255895141,25589514,,,,20250722,,ORGOVYX,Hot flush,,ORGOVYX | Hot flush,NaT
255896801,25589680,,,,20250722,,GEMTESA,Hypoacusis,,GEMTESA | Hypoacusis,NaT
255896971,25589697,51,F,,20250722,,PREDNISONE,Alveolar proteinosis,DE,PREDNISONE | Alveolar proteinosis | DE,NaT
255897043,25589704,68,M,,20250903,,ORGOVYX,Asthenia,,ORGOVYX | Asthenia,NaT
255897081,25589708,72,F,,20250722,,VECURONIUM,Anaphylactic reaction,HO,VECURONIUM | Anaphylactic reaction | HO,NaT
255897492,25589749,67,F,,20250820,,GEMCITABINE,Disease progression,OT,GEMCITABINE | Disease progression | OT,NaT
255897521,25589752,43,F,2025-03-05,20250722,,IBUPROFEN,Necrotising fasciitis,LT,IBUPROFEN | Necrotising fasciitis | LT,2025-03-03/2025-03-09
255897721,25589772,55,M,,20250722,,MYCOPHENOLATE MOFETIL,Herpes simplex,DE,MYCOPHENOLATE MOFETIL | Herpes simplex | DE,NaT
255897871,25589787,74,M,2025-07-11,20250722,,KIMMTRAK,Brain fog,HO,KIMMTRAK | Brain fog | HO,2025-07-07/2025-07-13
255898631,25589863,53,F,,20250722,,LANSOPRAZOLE,Epilepsy,OT,LANSOPRAZOLE | Epilepsy | OT,NaT
255899391,25589939,68,F,,20250722,,PRILOSEC,Pneumonia aspiration,HO,PRILOSEC | Pneumonia aspiration | HO,NaT
255899962,25589996,54,F,2025-06-10,20250910,,TRESIBA,Pneumonia,HO,TRESIBA | Pneumonia | HO,2025-06-09/2025-06-15
255900571,25590057,,F,2025-07-01,20250722,,DILTIAZEM HYDROCHLORIDE,Head discomfort,,DILTIAZEM HYDROCHLORIDE | Head discomfort,2025-06-30/2025-07-06
255901231,25590123,55,F,2025-07-19,20250722,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,2025-07-14/2025-07-20
255901342,25590134,,,,20250813,,VORICONAZOLE,Malignant melanoma,OT,VORICONAZOLE | Malignant melanoma | OT,NaT
255901551,25590155,,M,2025-06-26,20250722,,CABENUVA,Blood HIV RNA increased,,CABENUVA | Blood HIV RNA increased,2025-06-23/2025-06-29
255902262,25590226,,,,20250801,,CHLORDIAZEPOXIDE,Drug ineffective,HO,CHLORDIAZEPOXIDE | Drug ineffective | HO,NaT
255902322,25590232,63,F,2025-04-21,20250827,,TRODELVY,Nausea,OT,TRODELVY | Nausea | OT,2025-04-21/2025-04-27
255902811,25590281,,F,,20250721,,JAKAFI,Therapy change,,JAKAFI | Therapy change,NaT
255903541,25590354,,,2025-06-17,20250722,,NEMLUVIO,Device malfunction,,NEMLUVIO | Device malfunction,2025-06-16/2025-06-22
255903911,25590391,,,2025-01-01,20250722,,NEMLUVIO,Drug ineffective,,NEMLUVIO | Drug ineffective,2024-12-30/2025-01-05
255904461,25590446,,,2025-01-01,20250722,,NEMLUVIO,Headache,,NEMLUVIO | Headache,2024-12-30/2025-01-05
255905301,25590530,60,,,20250722,,MOUNJARO,Cataract,,MOUNJARO | Cataract,NaT
255906001,25590600,72,M,2025-06-25,20250722,,TRELEGY ELLIPTA,Wrong technique in device usage process,,TRELEGY ELLIPTA | Wrong technique in device usage process,2025-06-23/2025-06-29
255906591,25590659,88,F,2025-06-01,20250722,,NUCALA,Off label use,,NUCALA | Off label use,2025-05-26/2025-06-01
255906741,25590674,,,2022-01-01,20250722,,EZETIMIBE\SIMVASTATIN,Constipation,OT,EZETIMIBE\SIMVASTATIN | Constipation | OT,2021-12-27/2022-01-02
255907472,25590747,8,M,,20250807,,ROSUVASTATIN,Drug interaction,HO,ROSUVASTATIN | Drug interaction | HO,NaT
255907561,25590756,80,F,,20250722,,POMALYST,Cough,,POMALYST | Cough,NaT
255908581,25590858,,M,2025-01-01,20250722,,BIMZELX,Product storage error,HO,BIMZELX | Product storage error | HO,2024-12-30/2025-01-05
255908851,25590885,71,M,2025-07-15,20250722,,GLUCOBAY,Chest discomfort,OT,GLUCOBAY | Chest discomfort | OT,2025-07-14/2025-07-20
255909421,25590942,10,F,2025-06-26,20250722,,SOLIRIS,Death,OT,SOLIRIS | Death | OT,2025-06-23/2025-06-29
255909781,25590978,50,M,2025-02-10,20250722,,LORLATINIB,Weight increased,DE,LORLATINIB | Weight increased | DE,2025-02-10/2025-02-16
255909961,25590996,50,M,,20250722,,LORLATINIB,Pleural effusion,OT,LORLATINIB | Pleural effusion | OT,NaT
255910081,25591008,50,M,,20250722,,LORLATINIB,Hypertriglyceridaemia,OT,LORLATINIB | Hypertriglyceridaemia | OT,NaT
255910181,25591018,,F,2025-06-01,20250722,,IBRANCE,Dyspepsia,HO,IBRANCE | Dyspepsia | HO,2025-05-26/2025-06-01
255910461,25591046,28,F,2025-01-01,20250722,,MIRENA,Device dislocation,,MIRENA | Device dislocation,2024-12-30/2025-01-05
255910731,25591073,74,F,2025-06-19,20250722,,PEMETREXED,Hepatitis,DS,PEMETREXED | Hepatitis | DS,2025-06-16/2025-06-22
255911211,25591121,52,M,2025-05-01,20250722,,AMITRIPTYLINE HYDROCHLORIDE,Pain in extremity,OT,AMITRIPTYLINE HYDROCHLORIDE | Pain in extremity | OT,2025-04-28/2025-05-04
255911271,25591127,77,F,2025-01-01,20250722,,CREON,Weight increased,OT,CREON | Weight increased | OT,2024-12-30/2025-01-05
255911452,25591145,19,M,,20250807,,DEXMEDETOMIDINE,Drug withdrawal syndrome,HO,DEXMEDETOMIDINE | Drug withdrawal syndrome | HO,NaT
255911741,25591174,57,M,,20250722,,TALTZ,Hepatitis B,OT,TALTZ | Hepatitis B | OT,NaT
255912111,25591211,,,2025-07-21,20250722,,ZEPBOUND,Drug ineffective,,ZEPBOUND | Drug ineffective,2025-07-21/2025-07-27
255912663,25591266,,,2025-03-26,20250810,,VOWST,Drug ineffective,OT,VOWST | Drug ineffective | OT,2025-03-24/2025-03-30
255913011,25591301,28,F,2025-07-21,20250722,,SPRAVATO,Dissociation,OT,SPRAVATO | Dissociation | OT,2025-07-21/2025-07-27
255913251,25591325,,,,20250722,,ZEPBOUND,Drug ineffective,,ZEPBOUND | Drug ineffective,NaT
255913581,25591358,46,M,,20250722,,ELIQUIS,Product dose omission issue,,ELIQUIS | Product dose omission issue,NaT
255913662,25591366,,,2016-01-01,20250909,,LANREOTIDE ACETATE,Dizziness,OT,LANREOTIDE ACETATE | Dizziness | OT,2015-12-28/2016-01-03
255914421,25591442,73,F,2025-06-09,20250722,,OXALIPLATIN,Agranulocytosis,HO,OXALIPLATIN | Agranulocytosis | HO,2025-06-09/2025-06-15
255914771,25591477,,M,2023-01-01,20250722,,KEYTRUDA,Inappropriate schedule of product administration,HO,KEYTRUDA | Inappropriate schedule of product administration | HO,2022-12-26/2023-01-01
255918081,25591808,,F,,20250722,,HETLIOZ,Sleep deficit,,HETLIOZ | Sleep deficit,NaT
255918781,25591878,,M,,20250722,,FRUZAQLA,Metastases to central nervous system,OT,FRUZAQLA | Metastases to central nervous system | OT,NaT
255918931,25591893,,,,20250722,,ERLEADA,Hyperpyrexia,OT,ERLEADA | Hyperpyrexia | OT,NaT
255921331,25592133,72,M,2025-07-15,20250722,,CORTICOTROPIN,Death,DE,CORTICOTROPIN | Death | DE,2025-07-14/2025-07-20
255921472,25592147,75,F,2025-07-10,20250723,,CARBIDOPA\LEVODOPA,Dyskinesia,DE,CARBIDOPA\LEVODOPA | Dyskinesia | DE,2025-07-07/2025-07-13
255922611,25592261,62,M,,20250722,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Device delivery system issue,HO,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Device delivery system issue | HO,NaT
255923461,25592346,,,,20250722,,SAPHNELO,Dyspnoea,,SAPHNELO | Dyspnoea,NaT
255923591,25592359,69,M,,20250722,,PREDNISONE,Kaposi's sarcoma,OT,PREDNISONE | Kaposi's sarcoma | OT,NaT
255924391,25592439,,F,,20250722,,AZATHIOPRINE,Pneumonia,HO,AZATHIOPRINE | Pneumonia | HO,NaT
255925151,25592515,,,,20250722,,INGREZZA,Dyskinesia,,INGREZZA | Dyskinesia,NaT
255925821,25592582,,,,20250722,,CALQUENCE,White blood cell count abnormal,,CALQUENCE | White blood cell count abnormal,NaT
255926051,25592605,65,M,2025-07-15,20250722,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,2025-07-14/2025-07-20
255926112,25592611,67,M,2025-01-01,20250913,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,2024-12-30/2025-01-05
255926482,25592648,8,F,,20250727,,DUPIXENT,Needle issue,,DUPIXENT | Needle issue,NaT
255926891,25592689,,M,,20250722,,LEMTRADA,Multiple sclerosis,OT,LEMTRADA | Multiple sclerosis | OT,NaT
255926931,25592693,46,F,2025-07-01,20250722,,DUPIXENT,Rebound atopic dermatitis,,DUPIXENT | Rebound atopic dermatitis,2025-06-30/2025-07-06
255927791,25592779,14,F,2025-07-04,20250722,,DUPIXENT,Injection site swelling,,DUPIXENT | Injection site swelling,2025-06-30/2025-07-06
255928451,25592845,17,M,,20250722,,DUPIXENT,Fatigue,,DUPIXENT | Fatigue,NaT
255929281,25592928,,M,,20250722,,XARELTO,General physical health deterioration,,XARELTO | General physical health deterioration,NaT
255929661,25592966,43,F,2025-06-01,20250722,,DUPIXENT,Asthma,,DUPIXENT | Asthma,2025-05-26/2025-06-01
255930122,25593012,53,F,2025-07-18,20250903,,DUPIXENT,Headache,,DUPIXENT | Headache,2025-07-14/2025-07-20
255930221,25593022,30,F,,20250722,,DUPIXENT,Sinus headache,,DUPIXENT | Sinus headache,NaT
255930281,25593028,51,F,,20250722,,KEVZARA,Drug ineffective,,KEVZARA | Drug ineffective,NaT
255930571,25593057,31,M,2025-07-01,20250722,,CORTICOTROPIN,Lethargy,,CORTICOTROPIN | Lethargy,2025-06-30/2025-07-06
255930782,25593078,61,F,,20250821,,ENHERTU,Hepatic cirrhosis,OT,ENHERTU | Hepatic cirrhosis | OT,NaT
255931081,25593108,57,F,2025-07-01,20250722,,ZEPBOUND,Injection site irritation,,ZEPBOUND | Injection site irritation,2025-06-30/2025-07-06
255931921,25593192,,F,,20250722,,CYCLOSPORINE,Multiple use of single-use product,,CYCLOSPORINE | Multiple use of single-use product,NaT
255933221,25593322,,,2025-01-01,20250722,,NEMLUVIO,Heart rate increased,,NEMLUVIO | Heart rate increased,2024-12-30/2025-01-05
255933701,25593370,,,2025-06-23,20250722,,NEMLUVIO,Eczema,,NEMLUVIO | Eczema,2025-06-23/2025-06-29
255933791,25593379,,,,20250722,,NEMLUVIO,Product dose omission issue,,NEMLUVIO | Product dose omission issue,NaT
255933931,25593393,65,M,2017-11-24,20250722,,NEXIUM,Gastric cancer,OT,NEXIUM | Gastric cancer | OT,2017-11-20/2017-11-26
255934691,25593469,72,F,2025-03-28,20250722,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2025-03-24/2025-03-30
255935133,25593513,6,M,2025-06-05,20250908,,DAPAGLIFLOZIN,Drug eruption,HO,DAPAGLIFLOZIN | Drug eruption | HO,2025-06-02/2025-06-08
255935191,25593519,52,F,2025-03-01,20250722,,SKYRIZI,Atrial fibrillation,OT,SKYRIZI | Atrial fibrillation | OT,2025-02-24/2025-03-02
255935841,25593584,42,F,,20250722,,ORENCIA,Joint swelling,,ORENCIA | Joint swelling,NaT
255936112,25593611,,,,20250730,,ROMIPLOSTIM,No adverse event,,ROMIPLOSTIM | No adverse event,NaT
255936517,25593651,65,M,2022-01-01,20250910,,TEPEZZA,Musculoskeletal chest pain,DS,TEPEZZA | Musculoskeletal chest pain | DS,2021-12-27/2022-01-02
255936631,25593663,65,M,2025-02-24,20250722,,NEXIUM,Neuroendocrine carcinoma metastatic,OT,NEXIUM | Neuroendocrine carcinoma metastatic | OT,2025-02-24/2025-03-02
255938281,25593828,36,F,2025-07-07,20250723,,ONIVYDE,Vomiting,HO,ONIVYDE | Vomiting | HO,2025-07-07/2025-07-13
255938401,25593840,,F,2015-01-01,20250723,,AVONEX,Multiple sclerosis relapse,HO,AVONEX | Multiple sclerosis relapse | HO,2014-12-29/2015-01-04
255938872,25593887,,M,,20250904,,NUPLAZID,Hallucination,OT,NUPLAZID | Hallucination | OT,NaT
255939761,25593976,,M,2025-06-30,20250723,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2025-06-30/2025-07-06
255941551,25594155,,F,,20250723,,VEDOLIZUMAB,Colitis ulcerative,OT,VEDOLIZUMAB | Colitis ulcerative | OT,NaT
255942091,25594209,,M,,20250723,,TRELEGY ELLIPTA,Extra dose administered,,TRELEGY ELLIPTA | Extra dose administered,NaT
255943321,25594332,,M,2022-01-01,20250723,,AZITHROMYCIN,Decreased appetite,,AZITHROMYCIN | Decreased appetite,2021-12-27/2022-01-02
255943791,25594379,,F,,20250723,,SKYRIZI,Injection site swelling,,SKYRIZI | Injection site swelling,NaT
255944271,25594427,69,F,,20250723,,DUPIXENT,Myalgia,,DUPIXENT | Myalgia,NaT
255944921,25594492,19,F,2025-02-16,20250723,,PROPOFOL,Type I hypersensitivity,OT,PROPOFOL | Type I hypersensitivity | OT,2025-02-10/2025-02-16
255946281,25594628,,,,20250723,,PREDNISONE,Embolism venous,OT,PREDNISONE | Embolism venous | OT,NaT
255946763,25594676,79,F,2025-01-01,20250807,,FOSCARBIDOPA\FOSLEVODOPA,Gait inability,HO,FOSCARBIDOPA\FOSLEVODOPA | Gait inability | HO,2024-12-30/2025-01-05
255947061,25594706,54,M,2025-06-01,20250723,,KEVZARA,Arthralgia,,KEVZARA | Arthralgia,2025-05-26/2025-06-01
255947081,25594708,9,M,2025-07-10,20250723,,ALPROLIX,Arthralgia,,ALPROLIX | Arthralgia,2025-07-07/2025-07-13
255947371,25594737,30,M,2025-06-28,20250723,,ENDARI,Product dose omission issue,OT,ENDARI | Product dose omission issue | OT,2025-06-23/2025-06-29
255947891,25594789,23,F,2025-06-26,20250723,,CARIPRAZINE,Hepatic cytolysis,OT,CARIPRAZINE | Hepatic cytolysis | OT,2025-06-23/2025-06-29
255948001,25594800,30,M,,20250723,,PREGABALIN,Drug dependence,OT,PREGABALIN | Drug dependence | OT,NaT
255948031,25594803,73,F,,20250723,,ZEPBOUND,Extra dose administered,,ZEPBOUND | Extra dose administered,NaT
255948332,25594833,28,F,,20250814,,METHOTREXATE,Drug intolerance,OT,METHOTREXATE | Drug intolerance | OT,NaT
255948532,25594853,,F,,20250724,,GLATOPA,Incorrect dose administered by device,,GLATOPA | Incorrect dose administered by device,NaT
255948682,25594868,,M,,20250806,,RYSTIGGO,Hospitalisation,HO,RYSTIGGO | Hospitalisation | HO,NaT
255949171,25594917,,,,20250723,,METHOTREXATE,Febrile neutropenia,OT,METHOTREXATE | Febrile neutropenia | OT,NaT
255949561,25594956,69,F,2025-06-19,20250723,,PACLITAXEL,Anaphylactic shock,LT,PACLITAXEL | Anaphylactic shock | LT,2025-06-16/2025-06-22
255949612,25594961,26,F,,20250806,,CABOMETYX,Cardiac failure,OT,CABOMETYX | Cardiac failure | OT,NaT
255950081,25595008,,M,,20250723,,CABOTEGRAVIR\RILPIVIRINE,Product use issue,,CABOTEGRAVIR\RILPIVIRINE | Product use issue,NaT
255950511,25595051,,,,20250723,,MOUNJARO,Injection site hypersensitivity,,MOUNJARO | Injection site hypersensitivity,NaT
255950721,25595072,41,M,,20250723,,ZEPBOUND,Insomnia,,ZEPBOUND | Insomnia,NaT
255951031,25595103,20,F,,20250723,,CEFTRIAXONE,Cerebral infarction,OT,CEFTRIAXONE | Cerebral infarction | OT,NaT
255951081,25595108,,,,20250723,,ORGOVYX,Hot flush,,ORGOVYX | Hot flush,NaT
255952411,25595241,73,F,2025-01-01,20250723,,CHOLESTYRAMINE,Therapeutic response unexpected,OT,CHOLESTYRAMINE | Therapeutic response unexpected | OT,2024-12-30/2025-01-05
255952463,25595246,,,,20250819,,LAMOTRIGINE,Foreign body in throat,OT,LAMOTRIGINE | Foreign body in throat | OT,NaT
255952691,25595269,,,,20250723,,ORGOVYX,Hot flush,,ORGOVYX | Hot flush,NaT
255953261,25595326,83,M,,20250723,,ERLEADA,Metastases to lymph nodes,OT,ERLEADA | Metastases to lymph nodes | OT,NaT
255954841,25595484,,,,20250723,,ORGOVYX,Diarrhoea,,ORGOVYX | Diarrhoea,NaT
255955352,25595535,58,M,2025-07-15,20250729,,FRUQUINTINIB,Malaise,HO,FRUQUINTINIB | Malaise | HO,2025-07-14/2025-07-20
255955461,25595546,71,F,2025-06-27,20250723,,LOSARTAN,Eye pain,OT,LOSARTAN | Eye pain | OT,2025-06-23/2025-06-29
255955981,25595598,,,,20250723,,ELAHERE,Platelet count abnormal,,ELAHERE | Platelet count abnormal,NaT
255957121,25595712,61,,,20250723,,MOUNJARO,Nerve injury,,MOUNJARO | Nerve injury,NaT
255957151,25595715,74,F,,20250723,,TRULICITY,Incorrect dose administered,,TRULICITY | Incorrect dose administered,NaT
255957171,25595717,69,M,,20250723,,TACROLIMUS,Kaposi's sarcoma,DE,TACROLIMUS | Kaposi's sarcoma | DE,NaT
255957481,25595748,,F,,20250722,,OPSUMIT,Gastrointestinal haemorrhage,HO,OPSUMIT | Gastrointestinal haemorrhage | HO,NaT
255958061,25595806,58,F,2025-07-22,20250722,,BIKTARVY,Sepsis,DE,BIKTARVY | Sepsis | DE,2025-07-21/2025-07-27
255958401,25595840,57,M,2025-06-24,20250723,,SODIUM CHLORIDE,Device connection issue,DE,SODIUM CHLORIDE | Device connection issue | DE,2025-06-23/2025-06-29
255958893,25595889,73,F,2025-06-25,20250826,,ERIBULIN,Febrile neutropenia,HO,ERIBULIN | Febrile neutropenia | HO,2025-06-23/2025-06-29
255959132,25595913,87,F,2023-11-23,20250812,,HUMALOG,Hyperinsulinaemic hypoglycaemia,OT,HUMALOG | Hyperinsulinaemic hypoglycaemia | OT,2023-11-20/2023-11-26
255959311,25595931,,,2025-07-01,20250723,,MOUNJARO,Injection site reaction,,MOUNJARO | Injection site reaction,2025-06-30/2025-07-06
255959481,25595948,32,F,2025-01-13,20250723,,ATOMOXETINE HYDROCHLORIDE,Urinary retention,OT,ATOMOXETINE HYDROCHLORIDE | Urinary retention | OT,2025-01-13/2025-01-19
255959501,25595950,,F,,20250723,,MOUNJARO,Malaise,,MOUNJARO | Malaise,NaT
255960261,25596026,51,M,2025-07-17,20250723,,CYCLOPHOSPHAMIDE,Encephalopathy,DE,CYCLOPHOSPHAMIDE | Encephalopathy | DE,2025-07-14/2025-07-20
255960292,25596029,27,F,,20250801,,IBUPROFEN,Aspartate aminotransferase increased,HO,IBUPROFEN | Aspartate aminotransferase increased | HO,NaT
255960751,25596075,11,F,2025-01-01,20250723,,DUPIXENT,Incorrect dose administered,,DUPIXENT | Incorrect dose administered,2024-12-30/2025-01-05
255960961,25596096,50,F,2025-05-23,20250723,,DUPIXENT,Incorrect dose administered,,DUPIXENT | Incorrect dose administered,2025-05-19/2025-05-25
255961541,25596154,32,M,2025-01-01,20250723,,DUPIXENT,Rash,,DUPIXENT | Rash,2024-12-30/2025-01-05
255962571,25596257,28,F,2023-05-20,20250723,,METHIMAZOLE,Anaphylactic reaction,OT,METHIMAZOLE | Anaphylactic reaction | OT,2023-05-15/2023-05-21
255962592,25596259,20,F,2025-06-27,20250729,,PRETOMANID,Abdominal pain,OT,PRETOMANID | Abdominal pain | OT,2025-06-23/2025-06-29
255963061,25596306,,F,,20250723,,CHILDRENS ZYRTEC HIVES RELIEF,Product use in unapproved indication,,CHILDRENS ZYRTEC HIVES RELIEF | Product use in unapproved indication,NaT
255963201,25596320,60,F,2025-05-28,20250723,,DAPTOMYCIN,Eosinophil count increased,HO,DAPTOMYCIN | Eosinophil count increased | HO,2025-05-26/2025-06-01
255963871,25596387,,F,,20250723,,WOMENS ROGAINE UNSCENTED,Drug ineffective,,WOMENS ROGAINE UNSCENTED | Drug ineffective,NaT
255964981,25596498,70,F,,20250723,,ZEPBOUND,Injection site pain,,ZEPBOUND | Injection site pain,NaT
255965151,25596515,,M,,20250723,,DALFAMPRIDINE,Gait disturbance,OT,DALFAMPRIDINE | Gait disturbance | OT,NaT
255966611,25596661,62,F,2025-07-21,20250722,,MOUNJARO,Depression,OT,MOUNJARO | Depression | OT,2025-07-21/2025-07-27
255967591,25596759,57,M,,20250723,,LYUMJEV KWIKPEN,Accidental underdose,,LYUMJEV KWIKPEN | Accidental underdose,NaT
255968121,25596812,,,,20250723,,BEVACIZUMAB,Diabetes mellitus,OT,BEVACIZUMAB | Diabetes mellitus | OT,NaT
255968253,25596825,12,M,2025-07-16,20250822,,GENOTROPIN,Device use error,,GENOTROPIN | Device use error,2025-07-14/2025-07-20
255969491,25596949,,F,,20250723,,XOLAIR,Urticaria,,XOLAIR | Urticaria,NaT
255970761,25597076,64,M,,20250723,,PEMBROLIZUMAB,Oral submucosal fibrosis,HO,PEMBROLIZUMAB | Oral submucosal fibrosis | HO,NaT
255972321,25597232,,,2024-06-14,20250723,,PYLARIFY,Product dispensing error,,PYLARIFY | Product dispensing error,2024-06-10/2024-06-16
255972851,25597285,,M,2025-01-01,20250723,,AZTREONAM LYSINE,Emotional disorder,DS,AZTREONAM LYSINE | Emotional disorder | DS,2024-12-30/2025-01-05
255973263,25597326,,,,20250819,,BICILLIN L-A,Recalled product administered,,BICILLIN L-A | Recalled product administered,NaT
255973305,25597330,,,,20250822,,BICILLIN L-A,Recalled product administered,,BICILLIN L-A | Recalled product administered,NaT
255973324,25597332,,,,20250825,,BICILLIN L-A,Recalled product administered,,BICILLIN L-A | Recalled product administered,NaT
255973743,25597374,,,,20250819,,BICILLIN L-A,Recalled product administered,,BICILLIN L-A | Recalled product administered,NaT
255974121,25597412,,,,20250723,,ZEPBOUND,Therapeutic product effect incomplete,,ZEPBOUND | Therapeutic product effect incomplete,NaT
255974364,25597436,,,,20250820,,BICILLIN L-A,Recalled product administered,,BICILLIN L-A | Recalled product administered,NaT
255976691,25597669,,,,20250723,,SUNOSI,Hospice care,,SUNOSI | Hospice care,NaT
255976911,25597691,71,M,2025-07-15,20250723,,LANREOTIDE,Death,DE,LANREOTIDE | Death | DE,2025-07-14/2025-07-20
255977022,25597702,,F,2025-07-08,20250801,,ACETAMINOPHEN,Depressed mood,OT,ACETAMINOPHEN | Depressed mood | OT,2025-07-07/2025-07-13
255977122,25597712,,F,2025-07-19,20250728,,OPCON-A,Drug ineffective,,OPCON-A | Drug ineffective,2025-07-14/2025-07-20
255977971,25597797,38,F,,20250723,,BUPROPION,Toxic epidermal necrolysis,OT,BUPROPION | Toxic epidermal necrolysis | OT,NaT
255978123,25597812,,,,20250819,,BICILLIN L-A,Recalled product administered,,BICILLIN L-A | Recalled product administered,NaT
255978163,25597816,,,,20250819,,BICILLIN L-A,Recalled product administered,,BICILLIN L-A | Recalled product administered,NaT
255978791,25597879,,,,20250723,,PLUVICTO,General physical health deterioration,,PLUVICTO | General physical health deterioration,NaT
255979491,25597949,39,F,2025-07-09,20250723,,ERIBULIN,Infection,HO,ERIBULIN | Infection | HO,2025-07-07/2025-07-13
255979581,25597958,18,M,,20250723,,PREGABALIN,Substance use disorder,OT,PREGABALIN | Substance use disorder | OT,NaT
255980202,25598020,,F,,20250828,,KRYSTEXXA,Uterine cancer,OT,KRYSTEXXA | Uterine cancer | OT,NaT
255980311,25598031,,F,,20250723,,CIMZIA,Therapy interrupted,OT,CIMZIA | Therapy interrupted | OT,NaT
255981982,25598198,,,,20250724,,WINREVAIR,Telangiectasia,,WINREVAIR | Telangiectasia,NaT
255982181,25598218,,M,,20250723,,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Pneumonia,OT,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN | Pneumonia | OT,NaT
255982652,25598265,61,F,,20250725,,HUMIRA,Hiatus hernia,OT,HUMIRA | Hiatus hernia | OT,NaT
255983362,25598336,88,M,2025-07-05,20250912,,VYNDAMAX,Death,DE,VYNDAMAX | Death | DE,2025-06-30/2025-07-06
255983941,25598394,50,M,2025-07-01,20250723,,POMALYST,Tremor,,POMALYST | Tremor,2025-06-30/2025-07-06
255983981,25598398,59,F,,20250723,,LANTUS SOLOSTAR,Device failure,,LANTUS SOLOSTAR | Device failure,NaT
255984701,25598470,84,F,,20250723,,ENHERTU,Drug intolerance,,ENHERTU | Drug intolerance,NaT
255984882,25598488,57,F,2025-06-01,20250807,,MOUNJARO,Diarrhoea,OT,MOUNJARO | Diarrhoea | OT,2025-05-26/2025-06-01
255984931,25598493,58,F,,20250723,,TEMOZOLOMIDE,Product use in unapproved indication,,TEMOZOLOMIDE | Product use in unapproved indication,NaT
255984991,25598499,49,M,,20250723,,TOFIDENCE,Product use in unapproved indication,DE,TOFIDENCE | Product use in unapproved indication | DE,NaT
255985061,25598506,33,,,20250723,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
255985401,25598540,89,F,2025-07-15,20250723,,JARDIANCE,Oedema,OT,JARDIANCE | Oedema | OT,2025-07-14/2025-07-20
255986181,25598618,75,F,,20250723,,POMALYST,Haemoglobin decreased,,POMALYST | Haemoglobin decreased,NaT
255986261,25598626,,F,,20250723,,UPADACITINIB,White blood cell count decreased,,UPADACITINIB | White blood cell count decreased,NaT
255987161,25598716,,M,,20250724,,RISANKIZUMAB,Product temperature excursion issue,,RISANKIZUMAB | Product temperature excursion issue,NaT
255988621,25598862,,,,20250724,,XOLAIR,Drug ineffective,,XOLAIR | Drug ineffective,NaT
255988691,25598869,,,,20250724,,XOLAIR,Pruritus,,XOLAIR | Pruritus,NaT
255988811,25598881,69,F,2025-03-01,20250724,,TRELEGY ELLIPTA,Gait disturbance,,TRELEGY ELLIPTA | Gait disturbance,2025-02-24/2025-03-02
255988851,25598885,,F,,20250724,,ZURZUVAE,Fatigue,,ZURZUVAE | Fatigue,NaT
255989951,25598995,61,F,2023-01-01,20250724,,TALTZ,Lower limb fracture,,TALTZ | Lower limb fracture,2022-12-26/2023-01-01
255990271,25599027,,M,,20250724,,FINGOLIMOD,Multiple sclerosis relapse,OT,FINGOLIMOD | Multiple sclerosis relapse | OT,NaT
255991322,25599132,,F,,20250910,,REMICADE,Foetal exposure during pregnancy,HO,REMICADE | Foetal exposure during pregnancy | HO,NaT
255991651,25599165,62,M,2023-12-01,20250724,,LEUPROLIDE ACETATE,Bone lesion,OT,LEUPROLIDE ACETATE | Bone lesion | OT,2023-11-27/2023-12-03
255993162,25599316,56,F,2025-07-09,20250903,,ENSPRYNG,Osteonecrosis,OT,ENSPRYNG | Osteonecrosis | OT,2025-07-07/2025-07-13
255994121,25599412,59,F,2025-03-20,20250724,,CARBOPLATIN,Rash vesicular,HO,CARBOPLATIN | Rash vesicular | HO,2025-03-17/2025-03-23
255994241,25599424,49,,,20250724,,OZEMPIC,Hypertension,LT,OZEMPIC | Hypertension | LT,NaT
255995213,25599521,33,F,2025-07-11,20250822,,RHOPHYLAC,Product administration error,OT,RHOPHYLAC | Product administration error | OT,2025-07-07/2025-07-13
255995281,25599528,,,,20250724,,TRASTUZUMAB,Non-cirrhotic portal hypertension,OT,TRASTUZUMAB | Non-cirrhotic portal hypertension | OT,NaT
255996071,25599607,,F,,20250724,,HUMIRA,Osteoarthritis,OT,HUMIRA | Osteoarthritis | OT,NaT
255996171,25599617,,,,20250724,,RISANKIZUMAB,Product storage error,,RISANKIZUMAB | Product storage error,NaT
255997574,25599757,59,M,2025-09-12,20250926,,SOFOSBUVIR\VELPATASVIR,Paracentesis,OT,SOFOSBUVIR\VELPATASVIR | Paracentesis | OT,2025-09-08/2025-09-14
255998111,25599811,46,F,2025-07-03,20250724,,TRASTUZUMAB,Cardio-respiratory arrest,DE,TRASTUZUMAB | Cardio-respiratory arrest | DE,2025-06-30/2025-07-06
255998451,25599845,76,F,,20250724,,PREDNISONE,Pneumonia pseudomonal,HO,PREDNISONE | Pneumonia pseudomonal | HO,NaT
255999171,25599917,,M,,20250724,,BIMEKIZUMAB,Sinusitis,HO,BIMEKIZUMAB | Sinusitis | HO,NaT
255999401,25599940,,,,20250724,,ORGOVYX,Fatigue,,ORGOVYX | Fatigue,NaT
255999961,25599996,,,2025-06-24,20250724,,ISOTRETINOIN,Incorrect dose administered,,ISOTRETINOIN | Incorrect dose administered,2025-06-23/2025-06-29
256000161,25600016,35,F,,20250724,,LAMOTRIGINE,Maternal exposure during breast feeding,,LAMOTRIGINE | Maternal exposure during breast feeding,NaT
256000311,25600031,,,,20250724,,CLOZAPINE,Toxicity to various agents,,CLOZAPINE | Toxicity to various agents,NaT
256000491,25600049,36,F,,20250724,,LAMOTRIGINE,Treatment failure,,LAMOTRIGINE | Treatment failure,NaT
256001281,25600128,71,F,2025-06-27,20250724,,LOSARTAN,Eye pain,OT,LOSARTAN | Eye pain | OT,2025-06-23/2025-06-29
256001472,25600147,30,F,2025-07-09,20250730,,AIMOVIG,Therapy interrupted,,AIMOVIG | Therapy interrupted,2025-07-07/2025-07-13
256001841,25600184,48,M,,20250724,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,NaT
256001881,25600188,31,F,2025-07-10,20250724,,FYCOMPA,Seizure,OT,FYCOMPA | Seizure | OT,2025-07-07/2025-07-13
256001981,25600198,63,F,,20250724,,AUVELITY,Off label use,,AUVELITY | Off label use,NaT
256002201,25600220,6,M,,20250724,,AUVELITY,Contraindicated product administered,OT,AUVELITY | Contraindicated product administered | OT,NaT
256002601,25600260,66,M,,20250724,,VANCOMYCIN HYDROCHLORIDE,Encephalopathy,DE,VANCOMYCIN HYDROCHLORIDE | Encephalopathy | DE,NaT
256002861,25600286,54,F,,20250724,,MYCOPHENOLATE MOFETIL,COVID-19,HO,MYCOPHENOLATE MOFETIL | COVID-19 | HO,NaT
256002961,25600296,30,M,,20250724,,MYCOPHENOLATE MOFETIL,Idiopathic pneumonia syndrome,OT,MYCOPHENOLATE MOFETIL | Idiopathic pneumonia syndrome | OT,NaT
256003912,25600391,67,M,,20250922,,ORGOVYX,Gait disturbance,,ORGOVYX | Gait disturbance,NaT
256003972,25600397,74,F,2025-01-14,20250903,,YIMMUGO,Norovirus infection,OT,YIMMUGO | Norovirus infection | OT,2025-01-13/2025-01-19
256004261,25600426,85,F,2025-06-01,20250724,,LIRAGLUTIDE,Accidental exposure to product,,LIRAGLUTIDE | Accidental exposure to product,2025-05-26/2025-06-01
256004281,25600428,77,F,2025-04-17,20250724,,EYLEA HD,Amaurosis,OT,EYLEA HD | Amaurosis | OT,2025-04-14/2025-04-20
256005122,25600512,,,2025-01-01,20250813,,LEVETIRACETAM,Electrocardiogram QT prolonged,OT,LEVETIRACETAM | Electrocardiogram QT prolonged | OT,2024-12-30/2025-01-05
256005133,25600513,,M,2025-01-01,20250929,,BIMEKIZUMAB,Therapy interrupted,HO,BIMEKIZUMAB | Therapy interrupted | HO,2024-12-30/2025-01-05
256005151,25600515,77,F,,20250723,,HYDROXYCHLOROQUINE SULFATE,Hospitalisation,HO,HYDROXYCHLOROQUINE SULFATE | Hospitalisation | HO,NaT
256005411,25600541,81,F,,20250724,,ADALIMUMAB,Cough,OT,ADALIMUMAB | Cough | OT,NaT
256005532,25600553,79,M,,20250728,,TAXOTERE,Vision blurred,OT,TAXOTERE | Vision blurred | OT,NaT
256005772,25600577,62,M,,20250729,,MOUNJARO,Extra dose administered,,MOUNJARO | Extra dose administered,NaT
256005861,25600586,56,M,2025-07-17,20250724,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,2025-07-14/2025-07-20
256006252,25600625,50,F,,20250814,,DEXAMETHASONE,Deep vein thrombosis,OT,DEXAMETHASONE | Deep vein thrombosis | OT,NaT
256006411,25600641,59,F,,20250724,,METHOTREXATE,Skin maceration,LT,METHOTREXATE | Skin maceration | LT,NaT
256006811,25600681,69,M,2021-01-28,20250724,,RITUXIMAB,Squamous cell carcinoma of skin,,RITUXIMAB | Squamous cell carcinoma of skin,2021-01-25/2021-01-31
256006841,25600684,,,2025-06-16,20250724,,DAPTOMYCIN,Hepatic cytolysis,HO,DAPTOMYCIN | Hepatic cytolysis | HO,2025-06-16/2025-06-22
256006931,25600693,,F,,20250724,,DUPIXENT,Blister,,DUPIXENT | Blister,NaT
256007041,25600704,,,,20250724,,RIBAVIRIN,Suicidal ideation,OT,RIBAVIRIN | Suicidal ideation | OT,NaT
256007522,25600752,43,F,2025-06-01,20250812,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2025-05-26/2025-06-01
256007711,25600771,,F,,20250724,,OLAPARIB,Neoplasm malignant,OT,OLAPARIB | Neoplasm malignant | OT,NaT
256008101,25600810,,M,,20250724,,DUPIXENT,Acne,,DUPIXENT | Acne,NaT
256008241,25600824,70,M,2025-06-01,20250724,,DUPIXENT,Peripheral swelling,,DUPIXENT | Peripheral swelling,2025-05-26/2025-06-01
256008251,25600825,41,F,2025-07-01,20250724,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,2025-06-30/2025-07-06
256008391,25600839,52,M,,20250724,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,NaT
256008512,25600851,46,F,,20250728,,DUPIXENT,Accidental exposure to product,,DUPIXENT | Accidental exposure to product,NaT
256009661,25600966,72,F,2025-06-01,20250724,,ELIQUIS,Pain,,ELIQUIS | Pain,2025-05-26/2025-06-01
256011792,25601179,90,M,2025-04-04,20250805,,TAMSULOSIN,Loss of consciousness,OT,TAMSULOSIN | Loss of consciousness | OT,2025-03-31/2025-04-06
256012131,25601213,,F,,20250724,,CAPIVASERTIB,Diarrhoea,OT,CAPIVASERTIB | Diarrhoea | OT,NaT
256012621,25601262,21,M,,20250724,,PREDNISONE,Candida infection,OT,PREDNISONE | Candida infection | OT,NaT
256012741,25601274,30,F,2023-08-01,20250724,,VANCOMYCIN,Drug ineffective for unapproved indication,DE,VANCOMYCIN | Drug ineffective for unapproved indication | DE,2023-07-31/2023-08-06
256012771,25601277,29,M,,20250724,,OMEPRAZOLE,Drug interaction,HO,OMEPRAZOLE | Drug interaction | HO,NaT
256012931,25601293,,,,20250724,,HYDROXYZINE HYDROCHLORIDE,Hypersomnia,,HYDROXYZINE HYDROCHLORIDE | Hypersomnia,NaT
256015121,25601512,,M,,20250724,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
256015311,25601531,67,M,2025-05-08,20250724,,CARBOPLATIN,Interstitial lung disease,LT,CARBOPLATIN | Interstitial lung disease | LT,2025-05-05/2025-05-11
256015581,25601558,64,F,2025-06-01,20250724,,DUPIXENT,Fibroma,,DUPIXENT | Fibroma,2025-05-26/2025-06-01
256016411,25601641,32,F,2025-04-26,20250724,,VIMPAT,Premature delivery,OT,VIMPAT | Premature delivery | OT,2025-04-21/2025-04-27
256016511,25601651,91,F,2025-05-16,20250724,,RINVOQ,Fall,OT,RINVOQ | Fall | OT,2025-05-12/2025-05-18
256017571,25601757,81,M,2024-01-02,20250724,,RUXIENCE,Sarcoma,OT,RUXIENCE | Sarcoma | OT,2024-01-01/2024-01-07
256017601,25601760,,F,2025-07-01,20250724,,TIVDAK,Infection,HO,TIVDAK | Infection | HO,2025-06-30/2025-07-06
256018343,25601834,10,M,,20250827,,GENOTROPIN,Device leakage,,GENOTROPIN | Device leakage,NaT
256018641,25601864,53,F,,20250724,,VYLEESI,Nausea,,VYLEESI | Nausea,NaT
256018665,25601866,36,M,,20250825,,BICILLIN L-A,Recalled product administered,,BICILLIN L-A | Recalled product administered,NaT
256018871,25601887,91,F,,20250724,,MIRALAX,Drug ineffective,,MIRALAX | Drug ineffective,NaT
256019151,25601915,6,M,2025-01-01,20250724,,DUPIXENT,Loss of personal independence in daily activities,,DUPIXENT | Loss of personal independence in daily activities,2024-12-30/2025-01-05
256019481,25601948,,F,,20250724,,CIBINQO,Hypoaesthesia,,CIBINQO | Hypoaesthesia,NaT
256020111,25602011,,,2022-06-16,20250724,,DOLUTEGRAVIR,Lower respiratory tract infection,OT,DOLUTEGRAVIR | Lower respiratory tract infection | OT,2022-06-13/2022-06-19
256021061,25602106,,,,20250724,,ISTURISA,Pituitary cancer metastatic,OT,ISTURISA | Pituitary cancer metastatic | OT,NaT
256021691,25602169,65,M,2025-03-24,20250724,,DURVALUMAB,Interstitial lung disease,HO,DURVALUMAB | Interstitial lung disease | HO,2025-03-24/2025-03-30
256021961,25602196,49,M,,20250724,,MYCOPHENOLATE MOFETIL,Drug hypersensitivity,OT,MYCOPHENOLATE MOFETIL | Drug hypersensitivity | OT,NaT
256022031,25602203,,F,,20250724,,DUPIXENT,Eosinophilic oesophagitis,,DUPIXENT | Eosinophilic oesophagitis,NaT
256023651,25602365,59,F,2025-01-01,20250724,,IBRANCE,White blood cell count decreased,,IBRANCE | White blood cell count decreased,2024-12-30/2025-01-05
256024511,25602451,21,F,,20250724,,XELJANZ XR,Sensitivity to weather change,,XELJANZ XR | Sensitivity to weather change,NaT
256024781,25602478,20,F,2025-06-01,20250724,,DUPIXENT,Rebound atopic dermatitis,,DUPIXENT | Rebound atopic dermatitis,2025-05-26/2025-06-01
256024821,25602482,,,,20250724,,ZEPBOUND,Treatment failure,,ZEPBOUND | Treatment failure,NaT
256024901,25602490,,,2025-07-17,20250724,,SELINEXOR,Diarrhoea,,SELINEXOR | Diarrhoea,2025-07-14/2025-07-20
256025022,25602502,66,F,,20250814,,LEXAPRO,Diarrhoea,,LEXAPRO | Diarrhoea,NaT
256025132,25602513,64,F,,20250729,,RITUXIMAB,Febrile neutropenia,HO,RITUXIMAB | Febrile neutropenia | HO,NaT
256025401,25602540,49,F,,20250724,,RITUXIMAB,Off label use,OT,RITUXIMAB | Off label use | OT,NaT
256025581,25602558,63,F,,20250724,,COPAXONE,Rectal prolapse,OT,COPAXONE | Rectal prolapse | OT,NaT
256025592,25602559,90,M,,20250813,,DAPAGLIFLOZIN,Anorexia nervosa,OT,DAPAGLIFLOZIN | Anorexia nervosa | OT,NaT
256026581,25602658,,F,,20250724,,ACTEMRA,Herpes zoster,,ACTEMRA | Herpes zoster,NaT
256026861,25602686,27,M,,20250724,,OXYCODONE HYDROCHLORIDE,Drug diversion,,OXYCODONE HYDROCHLORIDE | Drug diversion,NaT
256027161,25602716,71,F,2025-07-18,20250724,,MIRALAX,Illness,,MIRALAX | Illness,2025-07-14/2025-07-20
256027371,25602737,69,F,2025-01-01,20250724,,KEYTRUDA,Aspartate aminotransferase increased,HO,KEYTRUDA | Aspartate aminotransferase increased | HO,2024-12-30/2025-01-05
256028041,25602804,25,F,2025-06-17,20250724,,DUPIXENT,Inappropriate schedule of product administration,,DUPIXENT | Inappropriate schedule of product administration,2025-06-16/2025-06-22
256029411,25602941,86,F,2025-05-23,20250724,,AMLODIPINE,Hypokalaemia,HO,AMLODIPINE | Hypokalaemia | HO,2025-05-19/2025-05-25
256030851,25603085,,F,,20250724,,LORBRENA,Hallucination,OT,LORBRENA | Hallucination | OT,NaT
256031651,25603165,,F,,20250724,,TASIGNA,Dry skin,OT,TASIGNA | Dry skin | OT,NaT
256031882,25603188,,F,,20250805,,PEMBROLIZUMAB,Hodgkin's disease recurrent,OT,PEMBROLIZUMAB | Hodgkin's disease recurrent | OT,NaT
256032293,25603229,4,F,2025-07-11,20250822,,EPINEPHRINE,Product use issue,OT,EPINEPHRINE | Product use issue | OT,2025-07-07/2025-07-13
256032311,25603231,63,M,,20250724,,REVLIMID,Malaise,,REVLIMID | Malaise,NaT
256034051,25603405,54,M,2024-02-03,20250724,,ALIMTA,Colitis,DE,ALIMTA | Colitis | DE,2024-01-29/2024-02-04
256034341,25603434,54,F,2025-04-01,20250724,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,2025-03-31/2025-04-06
256035241,25603524,31,F,,20250724,,TEMOZOLOMIDE,Nausea,OT,TEMOZOLOMIDE | Nausea | OT,NaT
256035791,25603579,,F,,20250725,,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,Dependence,OT,HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Dependence | OT,NaT
256036043,25603604,27,F,2025-06-24,20250807,,RYZNEUTA,Dyspnoea,OT,RYZNEUTA | Dyspnoea | OT,2025-06-23/2025-06-29
256036141,25603614,,,2014-10-01,20250725,,ADALIMUMAB,Therapy cessation,OT,ADALIMUMAB | Therapy cessation | OT,2014-09-29/2014-10-05
256036301,25603630,,M,,20250725,,PENICILLIN G POTASSIUM,Drug hypersensitivity,,PENICILLIN G POTASSIUM | Drug hypersensitivity,NaT
256036862,25603686,,,2024-11-11,20250805,,INFLIXIMAB-DYYB,Lethargy,OT,INFLIXIMAB-DYYB | Lethargy | OT,2024-11-11/2024-11-17
256037492,25603749,,F,,20250811,,OCALIVA,Chronic hepatic failure,DE,OCALIVA | Chronic hepatic failure | DE,NaT
256038261,25603826,4,F,2025-04-01,20250725,,PALFORZIA,Product dose omission issue,,PALFORZIA | Product dose omission issue,2025-03-31/2025-04-06
256038281,25603828,,F,,20250725,,CLINDAMYCIN,Dyspepsia,,CLINDAMYCIN | Dyspepsia,NaT
256038323,25603832,,F,,20250820,,BENLYSTA,Cough,OT,BENLYSTA | Cough | OT,NaT
256038461,25603846,,M,,20250725,,AZITHROMYCIN,Pruritus,,AZITHROMYCIN | Pruritus,NaT
256038501,25603850,80,M,,20250725,,VABYSMO,Oedema,,VABYSMO | Oedema,NaT
256039181,25603918,29,M,,20250725,,NIVOLUMAB,Lower respiratory tract infection,HO,NIVOLUMAB | Lower respiratory tract infection | HO,NaT
256039411,25603941,66,F,2025-06-29,20250725,,ELAHERE,Duodenal perforation,HO,ELAHERE | Duodenal perforation | HO,2025-06-23/2025-06-29
256039592,25603959,,F,,20250806,,INSULIN LISPRO,Hypoacusis,,INSULIN LISPRO | Hypoacusis,NaT
256040221,25604022,,F,,20250725,,WEGOVY,Foot fracture,OT,WEGOVY | Foot fracture | OT,NaT
256040441,25604044,,,,20250725,,ZEPBOUND,Underdose,,ZEPBOUND | Underdose,NaT
256040451,25604045,33,F,2025-07-18,20250725,,ZEPBOUND,Product storage error,,ZEPBOUND | Product storage error,2025-07-14/2025-07-20
256040652,25604065,,F,2024-10-01,20250818,,OZEMPIC,Breast cancer recurrent,OT,OZEMPIC | Breast cancer recurrent | OT,2024-09-30/2024-10-06
256041171,25604117,,F,,20250725,,PARAGARD T 380A,Abortion induced,OT,PARAGARD T 380A | Abortion induced | OT,NaT
256041271,25604127,,M,,20250725,,VENCLEXTA,Lymphadenopathy,HO,VENCLEXTA | Lymphadenopathy | HO,NaT
256041371,25604137,61,F,2025-06-01,20250725,,ATORVASTATIN,Liver injury,DS,ATORVASTATIN | Liver injury | DS,2025-05-26/2025-06-01
256041441,25604144,,,2023-05-18,20250725,,DOLUTEGRAVIR,Lower respiratory tract infection,OT,DOLUTEGRAVIR | Lower respiratory tract infection | OT,2023-05-15/2023-05-21
256042192,25604219,,M,,20250906,,NUCALA,Flushing,,NUCALA | Flushing,NaT
256042391,25604239,,,,20250725,,JARDIANCE,Diarrhoea,,JARDIANCE | Diarrhoea,NaT
256042741,25604274,7,F,,20250725,,AVASTIN,Cytomegalovirus enterocolitis,HO,AVASTIN | Cytomegalovirus enterocolitis | HO,NaT
256042821,25604282,42,M,,20250725,,GABAPENTIN,Completed suicide,HO,GABAPENTIN | Completed suicide | HO,NaT
256043271,25604327,,,,20250725,,ZEPBOUND,Alopecia,,ZEPBOUND | Alopecia,NaT
256043701,25604370,,,,20250725,,TEZSPIRE,Dyspnoea,,TEZSPIRE | Dyspnoea,NaT
256044091,25604409,,,,20250725,,ORGOVYX,Apathy,,ORGOVYX | Apathy,NaT
256044171,25604417,68,M,2025-05-28,20250725,,NUPLAZID,Drug ineffective,OT,NUPLAZID | Drug ineffective | OT,2025-05-26/2025-06-01
256044331,25604433,,,2025-07-22,20250725,,TREMFYA,Hypotension,,TREMFYA | Hypotension,2025-07-21/2025-07-27
256044411,25604441,10,M,2025-01-01,20250725,,HUMATE-P,Dental operation,HO,HUMATE-P | Dental operation | HO,2024-12-30/2025-01-05
256044541,25604454,85,M,2025-06-26,20250725,,COLUMVI,Hepatic cirrhosis,OT,COLUMVI | Hepatic cirrhosis | OT,2025-06-23/2025-06-29
256045551,25604555,,F,,20250725,,FASENRA,Incorrect dose administered by device,,FASENRA | Incorrect dose administered by device,NaT
256045631,25604563,45,F,,20250725,,SOTATERCEPT,Telangiectasia,OT,SOTATERCEPT | Telangiectasia | OT,NaT
256046251,25604625,,F,,20250725,,NUCALA,Weight increased,,NUCALA | Weight increased,NaT
256046301,25604630,58,F,,20250725,,LOSARTAN,Alopecia,OT,LOSARTAN | Alopecia | OT,NaT
256048041,25604804,68,M,2025-03-16,20250725,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2025-03-10/2025-03-16
256048111,25604811,,F,,20250725,,SKYRIZI,Hysterectomy,OT,SKYRIZI | Hysterectomy | OT,NaT
256048212,25604821,,,2025-01-01,20250905,,ESTRADIOL,Circumstance or information capable of leading to medication error,,ESTRADIOL | Circumstance or information capable of leading to medication error,2024-12-30/2025-01-05
256048691,25604869,69,F,,20250725,,SERTRALINE HYDROCHLORIDE,Accidental exposure to product,DE,SERTRALINE HYDROCHLORIDE | Accidental exposure to product | DE,NaT
256049382,25604938,68,M,2025-08-27,20250905,,CINQAIR,Hypertension,OT,CINQAIR | Hypertension | OT,2025-08-25/2025-08-31
256049511,25604951,16,M,2025-07-02,20250725,,METHYLPHENIDATE,Hepatitis,HO,METHYLPHENIDATE | Hepatitis | HO,2025-06-30/2025-07-06
256049981,25604998,16,M,2025-07-15,20250725,,OCTAPLAS LG,Dyspnoea,LT,OCTAPLAS LG | Dyspnoea | LT,2025-07-14/2025-07-20
256050041,25605004,54,M,2017-01-01,20250725,,IMRALDI,Drug ineffective,OT,IMRALDI | Drug ineffective | OT,2016-12-26/2017-01-01
256050081,25605008,,,,20250725,,OCREVUS,Ear infection,,OCREVUS | Ear infection,NaT
256050501,25605050,34,M,2023-05-15,20250725,,STELARA,Drug ineffective,HO,STELARA | Drug ineffective | HO,2023-05-15/2023-05-21
256051391,25605139,39,F,,20250725,,AZACITIDINE,Pleural effusion,OT,AZACITIDINE | Pleural effusion | OT,NaT
256053991,25605399,,F,,20250724,,FORTEO,Hospitalisation,HO,FORTEO | Hospitalisation | HO,NaT
256054251,25605425,81,,2025-07-14,20250725,,HUMALOG,Drug ineffective,,HUMALOG | Drug ineffective,2025-07-14/2025-07-20
256054311,25605431,34,F,,20250725,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
256054531,25605453,17,F,2025-07-20,20250725,,SKYRIZI,Injection site pain,,SKYRIZI | Injection site pain,2025-07-14/2025-07-20
256054661,25605466,,,,20250725,,SILDENAFIL CITRATE,Foreign body in throat,OT,SILDENAFIL CITRATE | Foreign body in throat | OT,NaT
256056271,25605627,66,M,2025-01-01,20250725,,DUPIXENT,Fatigue,,DUPIXENT | Fatigue,2024-12-30/2025-01-05
256057271,25605727,52,F,2025-01-01,20250725,,DUPIXENT,Pain,,DUPIXENT | Pain,2024-12-30/2025-01-05
256058501,25605850,21,M,,20250725,,DUPIXENT,Fatigue,,DUPIXENT | Fatigue,NaT
256058531,25605853,63,M,2025-06-02,20250725,,DOXORUBICIN,Electrolyte depletion,HO,DOXORUBICIN | Electrolyte depletion | HO,2025-06-02/2025-06-08
256058631,25605863,,M,,20250725,,TAKHZYRO,Product dose omission issue,,TAKHZYRO | Product dose omission issue,NaT
256058841,25605884,,M,,20250725,,DUPIXENT,Cough,,DUPIXENT | Cough,NaT
256058931,25605893,71,F,2025-05-25,20250725,,IBUPROFEN,Melaena,OT,IBUPROFEN | Melaena | OT,2025-05-19/2025-05-25
256058982,25605898,18,F,2025-07-01,20250804,,MIRENA,Menstruation delayed,,MIRENA | Menstruation delayed,2025-06-30/2025-07-06
256059021,25605902,25,F,2025-04-28,20250725,,COCAINE,Drug use disorder,OT,COCAINE | Drug use disorder | OT,2025-04-28/2025-05-04
256059271,25605927,43,M,2025-05-23,20250725,,CANNABIS SATIVA SUBSP. INDICA TOP,Coma,HO,CANNABIS SATIVA SUBSP. INDICA TOP | Coma | HO,2025-05-19/2025-05-25
256059971,25605997,75,F,,20250725,,URSODIOL,Liver injury,DE,URSODIOL | Liver injury | DE,NaT
256060692,25606069,74,M,2025-01-10,20250725,,ACETAMINOPHEN,Cytokine release syndrome,OT,ACETAMINOPHEN | Cytokine release syndrome | OT,2025-01-06/2025-01-12
256060831,25606083,,,,20250725,,RISANKIZUMAB,Product storage error,,RISANKIZUMAB | Product storage error,NaT
256060841,25606084,,,,20250725,,ORGOVYX,Neuropathy peripheral,OT,ORGOVYX | Neuropathy peripheral | OT,NaT
256061971,25606197,59,F,,20250725,,IBRANCE,Malaise,,IBRANCE | Malaise,NaT
256062153,25606215,,F,,20250915,,TIVDAK,Ulcerative keratitis,OT,TIVDAK | Ulcerative keratitis | OT,NaT
256063461,25606346,15,M,2025-06-01,20250725,,DUPIXENT,Visual impairment,,DUPIXENT | Visual impairment,2025-05-26/2025-06-01
256063741,25606374,,,,20250725,,SYLVANT,Product dose omission issue,,SYLVANT | Product dose omission issue,NaT
256064433,25606443,65,F,2025-01-01,20250828,,ESTRACE,Inflammation,,ESTRACE | Inflammation,2024-12-30/2025-01-05
256064671,25606467,,,,20250725,,INFLIXIMAB,Chest pain,OT,INFLIXIMAB | Chest pain | OT,NaT
256065401,25606540,72,F,2025-06-01,20250725,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,2025-05-26/2025-06-01
256065851,25606585,,,,20250725,,ADALIMUMAB,Cervix carcinoma,DE,ADALIMUMAB | Cervix carcinoma | DE,NaT
256065952,25606595,44,M,2025-07-01,20250808,,SPRAVATO,Drug ineffective,OT,SPRAVATO | Drug ineffective | OT,2025-06-30/2025-07-06
256066131,25606613,,F,,20250725,,RINVOQ,Back pain,OT,RINVOQ | Back pain | OT,NaT
256066261,25606626,29,M,,20250725,,PREDNISONE,Therapy partial responder,DE,PREDNISONE | Therapy partial responder | DE,NaT
256066341,25606634,46,F,2024-11-01,20250724,,MYRBETRIQ,Dry eye,OT,MYRBETRIQ | Dry eye | OT,2024-10-28/2024-11-03
256067241,25606724,25,M,2024-01-01,20250725,,DUPIXENT,Gallbladder disorder,,DUPIXENT | Gallbladder disorder,2024-01-01/2024-01-07
256067321,25606732,49,M,,20250725,,CASPOFUNGIN,Product use in unapproved indication,,CASPOFUNGIN | Product use in unapproved indication,NaT
256067331,25606733,57,M,,20250725,,PREDNISONE,Hodgkin's disease,HO,PREDNISONE | Hodgkin's disease | HO,NaT
256068523,25606852,54,F,2025-01-01,20250807,,SKYRIZI,Skin exfoliation,HO,SKYRIZI | Skin exfoliation | HO,2024-12-30/2025-01-05
256068531,25606853,60,M,,20250725,,POMALYST,Headache,,POMALYST | Headache,NaT
256068651,25606865,,M,2025-01-01,20250725,,KRYSTEXXA,Dizziness,,KRYSTEXXA | Dizziness,2024-12-30/2025-01-05
256069151,25606915,,,,20250725,,AMBRISENTAN,Rehabilitation therapy,,AMBRISENTAN | Rehabilitation therapy,NaT
256069552,25606955,66,,2025-01-01,20250805,,REPATHA,Device difficult to use,,REPATHA | Device difficult to use,2024-12-30/2025-01-05
256070141,25607014,,F,,20250725,,MOUNJARO,Palpitations,HO,MOUNJARO | Palpitations | HO,NaT
256070251,25607025,49,F,,20250725,,ZEPBOUND,Nausea,,ZEPBOUND | Nausea,NaT
256070491,25607049,,F,,20250725,,MOUNJARO,Vaginal haemorrhage,OT,MOUNJARO | Vaginal haemorrhage | OT,NaT
256071081,25607108,64,,,20250725,,ALBUTEROL SULFATE,Drug dose omission by device,,ALBUTEROL SULFATE | Drug dose omission by device,NaT
256072222,25607222,,F,2025-07-17,20250806,,PROLIA,Device use error,,PROLIA | Device use error,2025-07-14/2025-07-20
256072251,25607225,49,M,,20250725,,MYCOPHENOLATE MOFETIL,Oesophageal stenosis,OT,MYCOPHENOLATE MOFETIL | Oesophageal stenosis | OT,NaT
256072951,25607295,,F,,20250725,,RINVOQ,Clostridium difficile infection,OT,RINVOQ | Clostridium difficile infection | OT,NaT
256073771,25607377,71,F,,20250725,,PRALUENT,Lung neoplasm malignant,OT,PRALUENT | Lung neoplasm malignant | OT,NaT
256074921,25607492,12,M,,20250725,,OMNITROPE,Application site pain,,OMNITROPE | Application site pain,NaT
256075413,25607541,52,F,,20250807,,OMEPRAZOLE,Drug reaction with eosinophilia and systemic symptoms,OT,OMEPRAZOLE | Drug reaction with eosinophilia and systemic symptoms | OT,NaT
256075421,25607542,66,M,2024-06-01,20250725,,AZITHROMYCIN,Off label use,OT,AZITHROMYCIN | Off label use | OT,2024-05-27/2024-06-02
256075692,25607569,66,M,2024-01-01,20250728,,LENVATINIB,Left ventricular hypertrophy,HO,LENVATINIB | Left ventricular hypertrophy | HO,2024-01-01/2024-01-07
256076481,25607648,46,F,2025-07-03,20250725,,SKYRIZI,Product storage error,,SKYRIZI | Product storage error,2025-06-30/2025-07-06
256076581,25607658,,F,,20250725,,PLEGRIDY,Visual impairment,,PLEGRIDY | Visual impairment,NaT
256077111,25607711,52,M,,20250725,,NEXIUM,Intestinal adenocarcinoma,OT,NEXIUM | Intestinal adenocarcinoma | OT,NaT
256077401,25607740,33,F,2025-07-18,20250725,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,2025-07-14/2025-07-20
256077881,25607788,74,F,,20250725,,ATORVASTATIN,Weight decreased,HO,ATORVASTATIN | Weight decreased | HO,NaT
256078201,25607820,,,,20250725,,DOXYCYCLINE,Gastrointestinal disorder,,DOXYCYCLINE | Gastrointestinal disorder,NaT
256078291,25607829,49,F,,20250725,,LENVATINIB,Oropharyngeal fistula,HO,LENVATINIB | Oropharyngeal fistula | HO,NaT
256078511,25607851,,F,,20250725,,VEDOLIZUMAB,Crohn's disease,OT,VEDOLIZUMAB | Crohn's disease | OT,NaT
256078591,25607859,,,,20250725,,PLUVICTO,Illness,,PLUVICTO | Illness,NaT
256079711,25607971,63,F,2025-06-04,20250725,,ABEMACICLIB,Off label use,OT,ABEMACICLIB | Off label use | OT,2025-06-02/2025-06-08
256080071,25608007,67,F,,20250725,,REVLIMID,Dyspnoea,OT,REVLIMID | Dyspnoea | OT,NaT
256080241,25608024,61,F,,20250725,,CORTICOTROPIN,Feeling abnormal,,CORTICOTROPIN | Feeling abnormal,NaT
256080541,25608054,46,M,,20250725,,SPRYCEL,Nausea,,SPRYCEL | Nausea,NaT
256080652,25608065,21,M,2025-06-21,20250930,,ZENATANE,Ear pain,,ZENATANE | Ear pain,2025-06-16/2025-06-22
256080744,25608074,64,M,,20250923,,ADCETRIS,White blood cell count decreased,HO,ADCETRIS | White blood cell count decreased | HO,NaT
256080941,25608094,61,F,2025-04-01,20250725,,IRINOTECAN,Skin toxicity,OT,IRINOTECAN | Skin toxicity | OT,2025-03-31/2025-04-06
256081251,25608125,71,F,2025-01-01,20250725,,AUSTEDO XR,Lethargy,OT,AUSTEDO XR | Lethargy | OT,2024-12-30/2025-01-05
256082291,25608229,,,,20250725,,BOTOX COSMETIC,Drug ineffective,,BOTOX COSMETIC | Drug ineffective,NaT
256082341,25608234,72,M,,20250725,,AMANTADINE,Hypoglycaemia,HO,AMANTADINE | Hypoglycaemia | HO,NaT
256083892,25608389,7,M,2025-06-13,20250730,,TYVASO,Brain injury,HO,TYVASO | Brain injury | HO,2025-06-09/2025-06-15
256084851,25608485,,F,2024-02-01,20250726,,CALQUENCE,Ecchymosis,OT,CALQUENCE | Ecchymosis | OT,2024-01-29/2024-02-04
256085015,25608501,64,F,,20250922,,BISOPROLOL,Pain in extremity,DS,BISOPROLOL | Pain in extremity | DS,NaT
256085141,25608514,55,F,,20250726,,RIFAMPIN,Product use in unapproved indication,,RIFAMPIN | Product use in unapproved indication,NaT
256085591,25608559,70,M,,20250726,,AMLODIPINE,Toxicity to various agents,HO,AMLODIPINE | Toxicity to various agents | HO,NaT
256086151,25608615,,M,,20250726,,DAPAGLIFLOZIN,Dementia Alzheimer's type,OT,DAPAGLIFLOZIN | Dementia Alzheimer's type | OT,NaT
256086161,25608616,69,M,2025-07-01,20250726,,DUPIXENT,Eye pruritus,,DUPIXENT | Eye pruritus,2025-06-30/2025-07-06
256087122,25608712,13,F,,20250909,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,NaT
256088231,25608823,59,M,2022-09-01,20250726,,DAPAGLIFLOZIN,Angioedema,HO,DAPAGLIFLOZIN | Angioedema | HO,2022-08-29/2022-09-04
256088431,25608843,11,F,2025-01-01,20250726,,DUPIXENT,Rash,,DUPIXENT | Rash,2024-12-30/2025-01-05
256088811,25608881,,M,,20250726,,NUCALA,Inappropriate schedule of product administration,,NUCALA | Inappropriate schedule of product administration,NaT
256089271,25608927,33,M,2025-07-19,20250726,,ELOCTATE,Haemorrhage,,ELOCTATE | Haemorrhage,2025-07-14/2025-07-20
256090511,25609051,18,M,2025-01-01,20250726,,DUPIXENT,Rebound eczema,,DUPIXENT | Rebound eczema,2024-12-30/2025-01-05
256090591,25609059,,M,,20250726,,TEMOZOLOMIDE,Product use in unapproved indication,,TEMOZOLOMIDE | Product use in unapproved indication,NaT
256091261,25609126,68,M,,20250727,,LANTUS SOLOSTAR,Nasopharyngitis,,LANTUS SOLOSTAR | Nasopharyngitis,NaT
256091541,25609154,73,,,20250727,,ZEPBOUND,Constipation,,ZEPBOUND | Constipation,NaT
256093591,25609359,,,2025-03-24,20250727,,CLOZARIL,Death,DE,CLOZARIL | Death | DE,2025-03-24/2025-03-30
256093671,25609367,72,F,2025-07-01,20250727,,MOUNJARO,Skin discolouration,,MOUNJARO | Skin discolouration,2025-06-30/2025-07-06
256093881,25609388,65,M,2025-07-01,20250727,,LEQVIO,Arthritis,OT,LEQVIO | Arthritis | OT,2025-06-30/2025-07-06
256094031,25609403,,F,2025-07-11,20250727,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,2025-07-07/2025-07-13
256094051,25609405,78,F,,20250727,,ZEPBOUND,Back pain,,ZEPBOUND | Back pain,NaT
256094741,25609474,,F,,20250727,,VENCLEXTA,Incorrect dose administered,HO,VENCLEXTA | Incorrect dose administered | HO,NaT
256095022,25609502,74,M,,20250817,,IMBRUVICA,Platelet count decreased,OT,IMBRUVICA | Platelet count decreased | OT,NaT
256095311,25609531,,F,,20250727,,IMFINZI,Rheumatoid arthritis,OT,IMFINZI | Rheumatoid arthritis | OT,NaT
256096032,25609603,73,M,2022-11-01,20250822,,LEUPLIN,Death,DE,LEUPLIN | Death | DE,2022-10-31/2022-11-06
256096081,25609608,58,F,2025-01-01,20250728,,KYPROLIS,Oedema peripheral,HO,KYPROLIS | Oedema peripheral | HO,2024-12-30/2025-01-05
256096401,25609640,70,F,2025-07-07,20250728,,ROPINIROLE,Fall,OT,ROPINIROLE | Fall | OT,2025-07-07/2025-07-13
256097331,25609733,,F,,20250728,,STELARA,Off label use,OT,STELARA | Off label use | OT,NaT
256097741,25609774,55,F,2019-02-01,20250728,,VEDOLIZUMAB,Arthralgia,OT,VEDOLIZUMAB | Arthralgia | OT,2019-01-28/2019-02-03
256098451,25609845,,F,,20250728,,TEZEPELUMAB,Wheezing,OT,TEZEPELUMAB | Wheezing | OT,NaT
256099493,25609949,78,M,,20250925,,ORGOVYX,Dizziness,OT,ORGOVYX | Dizziness | OT,NaT
256099901,25609990,,F,,20250728,,AVONEX,Multiple sclerosis,,AVONEX | Multiple sclerosis,NaT
256100583,25610058,65,,,20250923,,TOLVAPTAN,Tooth disorder,,TOLVAPTAN | Tooth disorder,NaT
256100721,25610072,76,M,2025-05-31,20250728,,ACTEMRA ACTPEN,Death,DE,ACTEMRA ACTPEN | Death | DE,2025-05-26/2025-06-01
256101091,25610109,72,F,2025-06-01,20250728,,CIMZIA,Rheumatoid arthritis,OT,CIMZIA | Rheumatoid arthritis | OT,2025-05-26/2025-06-01
256101682,25610168,9,,2025-06-27,20250728,,FRUZAQLA,Malaise,HO,FRUZAQLA | Malaise | HO,2025-06-23/2025-06-29
256101801,25610180,,M,2024-01-01,20250728,,AMONDYS 45,Pyrexia,,AMONDYS 45 | Pyrexia,2024-01-01/2024-01-07
256102481,25610248,,M,,20250728,,AMONDYS 45,Product temperature excursion issue,,AMONDYS 45 | Product temperature excursion issue,NaT
256102653,25610265,74,F,2025-04-23,20250805,,CERTOLIZUMAB PEGOL,Neoplasm malignant,OT,CERTOLIZUMAB PEGOL | Neoplasm malignant | OT,2025-04-21/2025-04-27
256102891,25610289,77,M,2025-01-01,20250728,,DUPIXENT,Dyspnoea,HO,DUPIXENT | Dyspnoea | HO,2024-12-30/2025-01-05
256103001,25610300,,F,,20250728,,BREZTRI,Product dose omission issue,,BREZTRI | Product dose omission issue,NaT
256103321,25610332,,F,,20250728,,TEPEZZA,Symptom recurrence,,TEPEZZA | Symptom recurrence,NaT
256103731,25610373,,,2025-04-13,20250728,,RITUXIMAB,Cardiac failure,HO,RITUXIMAB | Cardiac failure | HO,2025-04-07/2025-04-13
256103791,25610379,,F,,20250728,,KADCYLA,Tongue haemorrhage,OT,KADCYLA | Tongue haemorrhage | OT,NaT
256103882,25610388,60,M,,20250821,,TREMFYA,Arthralgia,,TREMFYA | Arthralgia,NaT
256104051,25610405,19,F,,20250728,,BUPROPION HYDROCHLORIDE,Mydriasis,HO,BUPROPION HYDROCHLORIDE | Mydriasis | HO,NaT
256104971,25610497,39,M,,20250728,,RITUXIMAB,Thrombocytopenia,DE,RITUXIMAB | Thrombocytopenia | DE,NaT
256105233,25610523,62,M,2024-01-01,20250818,,SERTRALINE,Completed suicide,DE,SERTRALINE | Completed suicide | DE,2024-01-01/2024-01-07
256105511,25610551,36,M,,20250728,,METHOTREXATE,Cough,OT,METHOTREXATE | Cough | OT,NaT
256105761,25610576,47,F,2025-06-01,20250728,,ORENCIA,Product prescribing issue,,ORENCIA | Product prescribing issue,2025-05-26/2025-06-01
256105961,25610596,66,F,,20250728,,ZEPBOUND,Gastrooesophageal reflux disease,,ZEPBOUND | Gastrooesophageal reflux disease,NaT
256107022,25610702,,F,,20250903,,VEDOLIZUMAB,Illness,HO,VEDOLIZUMAB | Illness | HO,NaT
256108081,25610808,20,M,,20250728,,RITUXIMAB,Renal impairment,OT,RITUXIMAB | Renal impairment | OT,NaT
256108991,25610899,,,,20250728,,HYDROXYCHLOROQUINE,Sinus tachycardia,HO,HYDROXYCHLOROQUINE | Sinus tachycardia | HO,NaT
256109051,25610905,,,,20250728,,PREDNISONE,Muscle spasms,OT,PREDNISONE | Muscle spasms | OT,NaT
256109131,25610913,84,F,2025-07-25,20250725,,JAKAFI,Muscular weakness,,JAKAFI | Muscular weakness,2025-07-21/2025-07-27
256109543,25610954,,,,20250814,,JAKAFI,Diarrhoea,DE,JAKAFI | Diarrhoea | DE,NaT
256109701,25610970,45,M,2025-06-05,20250728,,HIZENTRA,Sepsis,HO,HIZENTRA | Sepsis | HO,2025-06-02/2025-06-08
256110012,25611001,1,M,,20250804,,MAGNESIUM,Drug ineffective,OT,MAGNESIUM | Drug ineffective | OT,NaT
256110511,25611051,81,M,,20250728,,REVLIMID,Rash,OT,REVLIMID | Rash | OT,NaT
256111591,25611159,,,,20250728,,BUPIVACAINE,Syncope,OT,BUPIVACAINE | Syncope | OT,NaT
256112071,25611207,72,M,2025-07-22,20250725,,MYCOPHENOLIC ACID,Lung transplant rejection,HO,MYCOPHENOLIC ACID | Lung transplant rejection | HO,2025-07-21/2025-07-27
256112691,25611269,21,M,2025-03-07,20250728,,AMONDYS 45,Malaise,,AMONDYS 45 | Malaise,2025-03-03/2025-03-09
256113681,25611368,,M,,20250728,,PLUVICTO,Nausea,,PLUVICTO | Nausea,NaT
256114081,25611408,,F,,20250728,,BOTULINUM TOXIN TYPE A,Death,DE,BOTULINUM TOXIN TYPE A | Death | DE,NaT
256115691,25611569,49,M,2025-05-08,20250728,,YESCARTA,Death,DE,YESCARTA | Death | DE,2025-05-05/2025-05-11
256115953,25611595,69,F,,20250806,,BASAGLAR,Hypersensitivity,,BASAGLAR | Hypersensitivity,NaT
256115961,25611596,54,,,20250728,,MOUNJARO,Vomiting,,MOUNJARO | Vomiting,NaT
256116081,25611608,76,F,2025-07-23,20250728,,HUMALOG,Accidental underdose,,HUMALOG | Accidental underdose,2025-07-21/2025-07-27
256116591,25611659,,F,,20250725,,WINREVAIR,Pericardial effusion,,WINREVAIR | Pericardial effusion,NaT
256117311,25611731,,,,20250728,,BENLYSTA,Off label use,,BENLYSTA | Off label use,NaT
256117421,25611742,,,,20250728,,IMFINZI,Liver disorder,OT,IMFINZI | Liver disorder | OT,NaT
256117731,25611773,,F,,20250728,,DAPAGLIFLOZIN,Myocardial infarction,OT,DAPAGLIFLOZIN | Myocardial infarction | OT,NaT
256118481,25611848,45,F,,20250728,,NURTEC ODT,Drug ineffective,,NURTEC ODT | Drug ineffective,NaT
256119491,25611949,56,F,,20250728,,VERZENIO,Rash,,VERZENIO | Rash,NaT
256120552,25612055,52,F,2025-07-17,20250801,,NEULASTA,Device adhesion issue,,NEULASTA | Device adhesion issue,2025-07-14/2025-07-20
256121401,25612140,,,1995-11-14,20250728,,MINIRIN,Stevens-Johnson syndrome,LT,MINIRIN | Stevens-Johnson syndrome | LT,1995-11-13/1995-11-19
256121591,25612159,2,F,,20250728,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,NaT
256121671,25612167,53,F,2024-11-01,20250728,,LANTHANUM CARBONATE,Death,DE,LANTHANUM CARBONATE | Death | DE,2024-10-28/2024-11-03
256122041,25612204,20,M,,20250728,,DUPIXENT,Skin infection,,DUPIXENT | Skin infection,NaT
256122182,25612218,,M,,20250813,,VEDOLIZUMAB,Drug ineffective,OT,VEDOLIZUMAB | Drug ineffective | OT,NaT
256122351,25612235,49,F,2025-04-01,20250728,,DUPIXENT,Peripheral swelling,,DUPIXENT | Peripheral swelling,2025-03-31/2025-04-06
256122392,25612239,10,M,2025-01-01,20250813,,NEXVIAZYME,Off label use,,NEXVIAZYME | Off label use,2024-12-30/2025-01-05
256123011,25612301,,,,20250725,,PACLITAXEL,Unevaluable event,,PACLITAXEL | Unevaluable event,NaT
256124801,25612480,56,F,,20250728,,VANCOMYCIN,Neutropenia,OT,VANCOMYCIN | Neutropenia | OT,NaT
256125351,25612535,77,M,,20250726,,FONDAPARINUX SODIUM,Thrombosis,HO,FONDAPARINUX SODIUM | Thrombosis | HO,NaT
256125511,25612551,54,M,2025-06-05,20250728,,IRINOTECAN,Skin toxicity,OT,IRINOTECAN | Skin toxicity | OT,2025-06-02/2025-06-08
256125761,25612576,,F,,20250728,,DUPIXENT,Anosmia,,DUPIXENT | Anosmia,NaT
256126391,25612639,33,F,2025-07-24,20250728,,SKYRIZI,Medical procedure,OT,SKYRIZI | Medical procedure | OT,2025-07-21/2025-07-27
256126523,25612652,,M,,20250924,,GENOTROPIN,Device information output issue,,GENOTROPIN | Device information output issue,NaT
256126561,25612656,,F,,20250728,,DEPO-PROVERA,Meningioma benign,OT,DEPO-PROVERA | Meningioma benign | OT,NaT
256127282,25612728,76,M,2025-08-18,20250820,,VEDOLIZUMAB,Haematochezia,OT,VEDOLIZUMAB | Haematochezia | OT,2025-08-18/2025-08-24
256127781,25612778,,F,,20250728,,COSENTYX,Accidental exposure to product,,COSENTYX | Accidental exposure to product,NaT
256128371,25612837,,F,,20250728,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
256128791,25612879,68,F,2025-07-18,20250728,,CANDESARTAN,Suicidal ideation,OT,CANDESARTAN | Suicidal ideation | OT,2025-07-14/2025-07-20
256129071,25612907,,M,,20250728,,ASPIRIN,Dyspnoea,HO,ASPIRIN | Dyspnoea | HO,NaT
256129271,25612927,,F,,20250726,,ABILIFY,Weight increased,OT,ABILIFY | Weight increased | OT,NaT
256129423,25612942,,,2025-06-16,20250812,,DIAZEPAM,Mydriasis,HO,DIAZEPAM | Mydriasis | HO,2025-06-16/2025-06-22
256129481,25612948,19,F,,20250728,,BUPROPION HYDROCHLORIDE,Toxicity to various agents,HO,BUPROPION HYDROCHLORIDE | Toxicity to various agents | HO,NaT
256129731,25612973,,M,,20250728,,VUMERITY,Basal cell carcinoma,OT,VUMERITY | Basal cell carcinoma | OT,NaT
256130032,25613003,70,M,2025-07-15,20250819,,NUPLAZID,Cardiac arrest,DE,NUPLAZID | Cardiac arrest | DE,2025-07-14/2025-07-20
256131172,25613117,54,F,2025-01-01,20250812,,DALTEPARIN SODIUM,Injection site pain,,DALTEPARIN SODIUM | Injection site pain,2024-12-30/2025-01-05
256131221,25613122,33,F,2020-11-30,20250726,,LEXAPRO,Panic disorder,OT,LEXAPRO | Panic disorder | OT,2020-11-30/2020-12-06
256131502,25613150,,F,,20250731,,ASCIMINIB,Hepatic enzyme increased,OT,ASCIMINIB | Hepatic enzyme increased | OT,NaT
256132701,25613270,,,,20250728,,RUXOLITINIB,Renal impairment,OT,RUXOLITINIB | Renal impairment | OT,NaT
256132951,25613295,70,M,,20250728,,REPATHA,Neuropathy peripheral,OT,REPATHA | Neuropathy peripheral | OT,NaT
256133171,25613317,64,M,,20250728,,PREVYMIS,Hospitalisation,HO,PREVYMIS | Hospitalisation | HO,NaT
256133671,25613367,59,F,2025-07-11,20250727,,METHYLPREDNISOLONE,Heart rate increased,OT,METHYLPREDNISOLONE | Heart rate increased | OT,2025-07-07/2025-07-13
256134071,25613407,,M,2025-07-22,20250728,,CLOBETASOL PROPIONATE,Application site irritation,OT,CLOBETASOL PROPIONATE | Application site irritation | OT,2025-07-21/2025-07-27
256134652,25613465,61,F,,20250801,,YESCARTA,Asthenia,OT,YESCARTA | Asthenia | OT,NaT
256134711,25613471,,,,20250728,,OPSUMIT,Rheumatoid arthritis,,OPSUMIT | Rheumatoid arthritis,NaT
256134761,25613476,,,,20250728,,METOPROLOL,Atrioventricular block complete,HO,METOPROLOL | Atrioventricular block complete | HO,NaT
256134811,25613481,,,2025-04-01,20250728,,RIVAROXABAN,Transient ischaemic attack,LT,RIVAROXABAN | Transient ischaemic attack | LT,2025-03-31/2025-04-06
256134821,25613482,,,2025-06-27,20250728,,RIVAROXABAN,Haematoma muscle,HO,RIVAROXABAN | Haematoma muscle | HO,2025-06-23/2025-06-29
256135021,25613502,18,F,,20250728,,VENLAFAXINE HYDROCHLORIDE,Pain in jaw,,VENLAFAXINE HYDROCHLORIDE | Pain in jaw,NaT
256136671,25613667,75,M,2025-07-25,20250728,,ALBUTEROL\IPRATROPIUM,Product appearance confusion,DS,ALBUTEROL\IPRATROPIUM | Product appearance confusion | DS,2025-07-21/2025-07-27
256137151,25613715,78,F,2024-10-10,20250728,,ZOLEDRONIC ACID,Adverse drug reaction,RI,ZOLEDRONIC ACID | Adverse drug reaction | RI,2024-10-07/2024-10-13
256137161,25613716,11,M,2025-01-01,20250728,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,2024-12-30/2025-01-05
256137211,25613721,53,M,2025-07-01,20250728,,METHOTREXATE SODIUM,Fall,DE,METHOTREXATE SODIUM | Fall | DE,2025-06-30/2025-07-06
256137641,25613764,28,M,2022-05-01,20250728,,PONATINIB,Acute lymphocytic leukaemia recurrent,OT,PONATINIB | Acute lymphocytic leukaemia recurrent | OT,2022-04-25/2022-05-01
256137711,25613771,,,,20250728,,LUTATHERA,Haematemesis,OT,LUTATHERA | Haematemesis | OT,NaT
256137981,25613798,93,F,,20250728,,TUMS,Drug ineffective,,TUMS | Drug ineffective,NaT
256138201,25613820,62,,,20250728,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
256138211,25613821,,,,20250728,,MOUNJARO,Glycosylated haemoglobin increased,OT,MOUNJARO | Glycosylated haemoglobin increased | OT,NaT
256138691,25613869,71,F,2025-07-20,20250726,,TERIPARATIDE,Fall,,TERIPARATIDE | Fall,2025-07-14/2025-07-20
256139211,25613921,35,M,2025-05-13,20250728,,BRIGATINIB,Non-small cell lung cancer,OT,BRIGATINIB | Non-small cell lung cancer | OT,2025-05-12/2025-05-18
256139951,25613995,,,,20250728,,SILDENAFIL,Hypoxia,HO,SILDENAFIL | Hypoxia | HO,NaT
256140091,25614009,,,,20250728,,PLUVICTO,General physical health deterioration,,PLUVICTO | General physical health deterioration,NaT
256140192,25614019,43,F,,20250903,,ABEMACICLIB,Feeding disorder,OT,ABEMACICLIB | Feeding disorder | OT,NaT
256140801,25614080,58,M,2021-09-01,20250728,,IPRATROPIUM BROMIDE,Bronchial irritation,OT,IPRATROPIUM BROMIDE | Bronchial irritation | OT,2021-08-30/2021-09-05
256141191,25614119,76,F,,20250728,,TRASTUZUMAB DERUXTECAN,Vomiting,OT,TRASTUZUMAB DERUXTECAN | Vomiting | OT,NaT
256141811,25614181,75,,,20250728,,OXALIPLATIN,Cholecystitis acute,HO,OXALIPLATIN | Cholecystitis acute | HO,NaT
256142111,25614211,67,F,2025-07-17,20250728,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Cardiac arrest,DE,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Cardiac arrest | DE,2025-07-14/2025-07-20
256142901,25614290,73,M,2025-01-01,20250728,,DUPIXENT,Rebound eczema,,DUPIXENT | Rebound eczema,2024-12-30/2025-01-05
256143231,25614323,,F,2025-01-01,20250728,,EVENITY,Arthralgia,,EVENITY | Arthralgia,2024-12-30/2025-01-05
256144711,25614471,,,,20250729,,FASENRA,Injection site pain,OT,FASENRA | Injection site pain | OT,NaT
256144921,25614492,53,F,,20250729,,CIMETIDINE,Serotonin syndrome,HO,CIMETIDINE | Serotonin syndrome | HO,NaT
256145031,25614503,53,F,,20250729,,CIMETIDINE,Serotonin syndrome,HO,CIMETIDINE | Serotonin syndrome | HO,NaT
256145171,25614517,29,M,,20250729,,METHOTREXATE SODIUM,Vision blurred,OT,METHOTREXATE SODIUM | Vision blurred | OT,NaT
256148672,25614867,52,F,,20250826,,GUSELKUMAB,Device leakage,,GUSELKUMAB | Device leakage,NaT
256148851,25614885,,,,20250729,,SODIUM ZIRCONIUM CYCLOSILICATE,Uraemic gastropathy,OT,SODIUM ZIRCONIUM CYCLOSILICATE | Uraemic gastropathy | OT,NaT
256148871,25614887,24,,,20250729,,ESCITALOPRAM,Vomiting,OT,ESCITALOPRAM | Vomiting | OT,NaT
256149611,25614961,,F,,20250729,,SYNTHROID,Thyroid cancer,DE,SYNTHROID | Thyroid cancer | DE,NaT
256149711,25614971,,F,,20250729,,ENTYVIO,Drug ineffective,,ENTYVIO | Drug ineffective,NaT
256149991,25614999,,M,,20250729,,ELIGARD,Death,DE,ELIGARD | Death | DE,NaT
256150501,25615050,76,F,,20250729,,FLUOXETINE HYDROCHLORIDE,Eosinophilic pneumonia chronic,OT,FLUOXETINE HYDROCHLORIDE | Eosinophilic pneumonia chronic | OT,NaT
256151071,25615107,4,M,,20250729,,PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Off label use,OT,PIPERACILLIN SODIUM\TAZOBACTAM SODIUM | Off label use | OT,NaT
256152191,25615219,60,F,2025-03-01,20250729,,WEGOVY,Thyroiditis,OT,WEGOVY | Thyroiditis | OT,2025-02-24/2025-03-02
256153391,25615339,,F,,20250729,,OSIMERTINIB,Death,DE,OSIMERTINIB | Death | DE,NaT
256153691,25615369,,M,,20250729,,FRUQUINTINIB,Asthenia,DE,FRUQUINTINIB | Asthenia | DE,NaT
256154012,25615401,,,2025-07-23,20250731,,ELUXADOLINE,Night sweats,,ELUXADOLINE | Night sweats,2025-07-21/2025-07-27
256154112,25615411,75,M,,20250821,,ORGOVYX,Constipation,,ORGOVYX | Constipation,NaT
256154491,25615449,,,2025-07-02,20250729,,ZEPBOUND,Cholelithiasis,HO,ZEPBOUND | Cholelithiasis | HO,2025-06-30/2025-07-06
256156452,25615645,,M,,20250826,,ULTOMIRIS,Breakthrough haemolysis,OT,ULTOMIRIS | Breakthrough haemolysis | OT,NaT
256156501,25615650,,,,20250729,,LEVETIRACETAM,Psychotic behaviour,OT,LEVETIRACETAM | Psychotic behaviour | OT,NaT
256156651,25615665,71,M,2025-07-18,20250729,,VISIPAQUE,Contrast encephalopathy,OT,VISIPAQUE | Contrast encephalopathy | OT,2025-07-14/2025-07-20
256157071,25615707,69,M,2025-03-18,20250729,,TENAPANOR HYDROCHLORIDE,Hypothyroidism,OT,TENAPANOR HYDROCHLORIDE | Hypothyroidism | OT,2025-03-17/2025-03-23
256158141,25615814,,M,,20250729,,OPDIVO,Death,DE,OPDIVO | Death | DE,NaT
256158241,25615824,65,F,,20250729,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
256158391,25615839,,F,,20250729,,SKYRIZI,Wrist fracture,OT,SKYRIZI | Wrist fracture | OT,NaT
256158435,25615843,70,F,2025-07-17,20250904,,PADCEV,Infusion site extravasation,OT,PADCEV | Infusion site extravasation | OT,2025-07-14/2025-07-20
256158941,25615894,39,M,,20250729,,VANCOMYCIN,Therapeutic product effect incomplete,OT,VANCOMYCIN | Therapeutic product effect incomplete | OT,NaT
256159081,25615908,,M,,20250729,,JARDIANCE,Drug ineffective,,JARDIANCE | Drug ineffective,NaT
256159821,25615982,,,,20250729,,OLAPARIB,Disease progression,OT,OLAPARIB | Disease progression | OT,NaT
256160272,25616027,19,M,,20250820,,SOLIRIS,Renal impairment,HO,SOLIRIS | Renal impairment | HO,NaT
256160661,25616066,,,,20250729,,ORGOVYX,Hot flush,,ORGOVYX | Hot flush,NaT
256160931,25616093,91,F,,20250729,,DAPAGLIFLOZIN,Malaise,OT,DAPAGLIFLOZIN | Malaise | OT,NaT
256161771,25616177,60,M,2023-06-01,20250729,,CLOPIDOGREL,Iron deficiency anaemia,OT,CLOPIDOGREL | Iron deficiency anaemia | OT,2023-05-29/2023-06-04
256162291,25616229,,,2025-06-22,20250729,,LOXAPINE,Choking,LT,LOXAPINE | Choking | LT,2025-06-16/2025-06-22
256162441,25616244,66,M,2025-07-22,20250729,,METFORMIN,Paraesthesia oral,OT,METFORMIN | Paraesthesia oral | OT,2025-07-21/2025-07-27
256162451,25616245,,,,20250729,,GENOSYL,Device malfunction,,GENOSYL | Device malfunction,NaT
256162561,25616256,82,F,,20250729,,ENBREL,Death,DE,ENBREL | Death | DE,NaT
256163071,25616307,37,F,,20250729,,CARBOPLATIN,Therapy partial responder,OT,CARBOPLATIN | Therapy partial responder | OT,NaT
256163251,25616325,,F,,20250729,,MAGNESIUM SULFATE,Jaundice neonatal,HO,MAGNESIUM SULFATE | Jaundice neonatal | HO,NaT
256163551,25616355,43,M,,20250729,,METHYLPREDNISOLONE,Condition aggravated,HO,METHYLPREDNISOLONE | Condition aggravated | HO,NaT
256163611,25616361,60,F,,20250729,,BEVACIZUMAB,Neoplasm progression,OT,BEVACIZUMAB | Neoplasm progression | OT,NaT
256163642,25616364,,,,20250829,,SIMPONI,Device issue,,SIMPONI | Device issue,NaT
256164052,25616405,67,M,2023-09-01,20250814,,METFORMIN,Acute respiratory failure,DE,METFORMIN | Acute respiratory failure | DE,2023-08-28/2023-09-03
256164141,25616414,65,F,2025-07-09,20250729,,PREDNISOLONE,Leukocytosis,OT,PREDNISOLONE | Leukocytosis | OT,2025-07-07/2025-07-13
256164451,25616445,54,F,2025-06-21,20250729,,CARBOPLATIN,Immune-mediated adrenal insufficiency,HO,CARBOPLATIN | Immune-mediated adrenal insufficiency | HO,2025-06-16/2025-06-22
256165071,25616507,68,F,,20250729,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,NaT
256165531,25616553,49,M,2025-02-27,20250725,,OZEMPIC,Allodynia,OT,OZEMPIC | Allodynia | OT,2025-02-24/2025-03-02
256165881,25616588,70,F,2025-06-06,20250725,,VYNDAMAX,Fatigue,,VYNDAMAX | Fatigue,2025-06-02/2025-06-08
256166361,25616636,,F,2025-07-19,20250729,,SYSTANE HYDRATION PF PRESERVATIVE FREE,Poor quality product administered,OT,SYSTANE HYDRATION PF PRESERVATIVE FREE | Poor quality product administered | OT,2025-07-14/2025-07-20
256166992,25616699,34,M,,20250729,,COBENFY,Drooling,,COBENFY | Drooling,NaT
256168801,25616880,70,M,2025-01-01,20250729,,LEQEMBI,Insomnia,,LEQEMBI | Insomnia,2024-12-30/2025-01-05
256169631,25616963,71,M,,20250729,,TIMOLOL MALEATE,Hypotony of eye,OT,TIMOLOL MALEATE | Hypotony of eye | OT,NaT
256170001,25617000,,,,20250729,,QUETIAPINE,Neuropsychological symptoms,OT,QUETIAPINE | Neuropsychological symptoms | OT,NaT
256170181,25617018,82,M,2025-06-26,20250729,,RIMSTAR,Drug-induced liver injury,HO,RIMSTAR | Drug-induced liver injury | HO,2025-06-23/2025-06-29
256170544,25617054,78,F,2025-04-01,20250913,,ZEPBOUND,Myalgia,,ZEPBOUND | Myalgia,2025-03-31/2025-04-06
256170731,25617073,64,F,,20250729,,ROSUVASTATIN,Abdominal distension,OT,ROSUVASTATIN | Abdominal distension | OT,NaT
256171251,25617125,73,F,2025-07-10,20250728,,LENALIDOMIDE,Rash pruritic,,LENALIDOMIDE | Rash pruritic,2025-07-07/2025-07-13
256172041,25617204,56,M,,20250729,,STELARA,Intentional dose omission,OT,STELARA | Intentional dose omission | OT,NaT
256172111,25617211,6,M,2025-07-01,20250729,,CISPLATIN,Renal impairment,OT,CISPLATIN | Renal impairment | OT,2025-06-30/2025-07-06
256172351,25617235,44,F,,20250729,,IBRANCE,Nausea,,IBRANCE | Nausea,NaT
256173241,25617324,81,M,2025-07-14,20250727,,WINREVAIR,Anaemia,HO,WINREVAIR | Anaemia | HO,2025-07-14/2025-07-20
256173671,25617367,27,M,,20250729,,MIRTAZAPINE,Social problem,DS,MIRTAZAPINE | Social problem | DS,NaT
256173811,25617381,,,,20250729,,EVOLOCUMAB,Angina pectoris,OT,EVOLOCUMAB | Angina pectoris | OT,NaT
256173841,25617384,,F,,20250729,,IOPAMIRO,Loss of consciousness,HO,IOPAMIRO | Loss of consciousness | HO,NaT
256173991,25617399,,F,,20250729,,PROLIA,Bone density decreased,,PROLIA | Bone density decreased,NaT
256175091,25617509,,,,20250729,,PREDNISONE,Thrombosis,DE,PREDNISONE | Thrombosis | DE,NaT
256175231,25617523,,,,20250729,,ORGOVYX,Arthralgia,,ORGOVYX | Arthralgia,NaT
256176022,25617602,,,2025-07-01,20250929,,ORSERDU,Intentional dose omission,HO,ORSERDU | Intentional dose omission | HO,2025-06-30/2025-07-06
256176371,25617637,,,,20250729,,ZEPBOUND,Treatment failure,,ZEPBOUND | Treatment failure,NaT
256176401,25617640,,,,20250729,,ZEPBOUND,Therapy non-responder,,ZEPBOUND | Therapy non-responder,NaT
256176651,25617665,76,M,,20250729,,DUPIXENT,Respiratory failure,OT,DUPIXENT | Respiratory failure | OT,NaT
256176901,25617690,,M,2025-07-24,20250729,,BRAFTOVI,Gastrointestinal disorder,OT,BRAFTOVI | Gastrointestinal disorder | OT,2025-07-21/2025-07-27
256177011,25617701,77,M,2025-07-24,20250729,,VYNDAMAX,Dizziness,OT,VYNDAMAX | Dizziness | OT,2025-07-21/2025-07-27
256177821,25617782,59,F,2024-01-01,20250729,,SKYRIZI,Supraventricular tachycardia,OT,SKYRIZI | Supraventricular tachycardia | OT,2024-01-01/2024-01-07
256177861,25617786,,F,2025-01-01,20250729,,SOTATERCEPT,Pleural effusion,,SOTATERCEPT | Pleural effusion,2024-12-30/2025-01-05
256178302,25617830,62,F,2025-05-01,20250903,,KISQALI,Pulmonary oedema,OT,KISQALI | Pulmonary oedema | OT,2025-04-28/2025-05-04
256180661,25618066,,F,,20250729,,XOLAIR PFS,Paraesthesia,,XOLAIR PFS | Paraesthesia,NaT
256181222,25618122,,F,,20250928,,DUPIXENT,Arthralgia,,DUPIXENT | Arthralgia,NaT
256181471,25618147,,F,,20250729,,DUPIXENT,Arthralgia,,DUPIXENT | Arthralgia,NaT
256181542,25618154,61,F,2025-06-01,20250806,,DUPIXENT,Pustule,,DUPIXENT | Pustule,2025-05-26/2025-06-01
256181571,25618157,,F,,20250729,,DUPIXENT,Hospitalisation,HO,DUPIXENT | Hospitalisation | HO,NaT
256181761,25618176,,,,20250729,,ZEPBOUND,Therapeutic response changed,,ZEPBOUND | Therapeutic response changed,NaT
256181781,25618178,68,M,2025-01-01,20250729,,ADMELOG,Drug ineffective,,ADMELOG | Drug ineffective,2024-12-30/2025-01-05
256181981,25618198,,M,,20250729,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,NaT
256182482,25618248,1,F,2025-01-01,20250924,,DUPIXENT,Skin swelling,,DUPIXENT | Skin swelling,2024-12-30/2025-01-05
256182902,25618290,87,M,2025-01-01,20250930,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,2024-12-30/2025-01-05
256183191,25618319,92,F,,20250729,,LANTUS SOLOSTAR,Arthritis,,LANTUS SOLOSTAR | Arthritis,NaT
256183261,25618326,84,F,,20250729,,SOLIQUA 100/33,Product storage error,,SOLIQUA 100/33 | Product storage error,NaT
256183681,25618368,,M,,20250729,,DUPIXENT,Skin exfoliation,,DUPIXENT | Skin exfoliation,NaT
256183771,25618377,54,F,2025-06-12,20250729,,DUPIXENT,Extra dose administered,,DUPIXENT | Extra dose administered,2025-06-09/2025-06-15
256184031,25618403,51,M,,20250729,,DUPIXENT,Injection site erythema,,DUPIXENT | Injection site erythema,NaT
256184331,25618433,75,F,,20250729,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,NaT
256184841,25618484,56,F,,20250729,,ACETAMINOPHEN,Rash,OT,ACETAMINOPHEN | Rash | OT,NaT
256185172,25618517,8,M,2025-06-01,20250904,,SOMATROPIN,Product prescribing error,,SOMATROPIN | Product prescribing error,2025-05-26/2025-06-01
256185743,25618574,,,,20250819,,BICILLIN L-A,Recalled product administered,,BICILLIN L-A | Recalled product administered,NaT
256186167,25618616,58,F,,20250929,,GENOTROPIN,Device power source issue,,GENOTROPIN | Device power source issue,NaT
256186293,25618629,,,,20250819,,BICILLIN L-A,Recalled product administered,,BICILLIN L-A | Recalled product administered,NaT
256187452,25618745,100,F,2025-07-01,20250731,,ZARXIO,Death,DE,ZARXIO | Death | DE,2025-06-30/2025-07-06
256187871,25618787,69,F,2025-03-30,20250729,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,2025-03-24/2025-03-30
256187931,25618793,,M,2025-01-01,20250729,,LUMAKRAS,Drug ineffective,HO,LUMAKRAS | Drug ineffective | HO,2024-12-30/2025-01-05
256188241,25618824,,,,20250729,,SIMPONI ARIA,Product dose omission issue,,SIMPONI ARIA | Product dose omission issue,NaT
256188355,25618835,36,F,2018-01-01,20250902,,TERIFLUNOMIDE,Colitis ulcerative,OT,TERIFLUNOMIDE | Colitis ulcerative | OT,2018-01-01/2018-01-07
256188501,25618850,57,F,2025-07-07,20250729,,REPATHA,Abdominal discomfort,,REPATHA | Abdominal discomfort,2025-07-07/2025-07-13
256189141,25618914,10,M,2025-07-17,20250729,,STRENSIQ,Blood bilirubin decreased,OT,STRENSIQ | Blood bilirubin decreased | OT,2025-07-14/2025-07-20
256189331,25618933,18,F,2025-07-07,20250729,,METHYLPHENIDATE HYDROCHLORIDE,Substance-induced psychotic disorder,HO,METHYLPHENIDATE HYDROCHLORIDE | Substance-induced psychotic disorder | HO,2025-07-07/2025-07-13
256190522,25619052,71,M,2023-01-01,20250801,,METHOTREXATE,B-cell lymphoma,OT,METHOTREXATE | B-cell lymphoma | OT,2022-12-26/2023-01-01
256190861,25619086,76,F,,20250729,,DOXYCYCLINE,Liver injury,OT,DOXYCYCLINE | Liver injury | OT,NaT
256191721,25619172,49,M,2025-06-29,20250729,,SKYRIZI,Intestinal resection,HO,SKYRIZI | Intestinal resection | HO,2025-06-23/2025-06-29
256191981,25619198,,F,,20250729,,HUMIRA,Lethargy,,HUMIRA | Lethargy,NaT
256192071,25619207,,F,,20250729,,VERZENIO,Diarrhoea,,VERZENIO | Diarrhoea,NaT
256192331,25619233,,F,2025-07-24,20250729,,SKYRIZI,Product packaging issue,,SKYRIZI | Product packaging issue,2025-07-21/2025-07-27
256192611,25619261,,,,20250729,,PANITUMUMAB,Vasculitis,OT,PANITUMUMAB | Vasculitis | OT,NaT
256194251,25619425,,M,2025-01-01,20250729,,SKYRIZI,Tooth disorder,,SKYRIZI | Tooth disorder,2024-12-30/2025-01-05
256195211,25619521,53,M,2025-07-24,20250729,,LENVIMA,Cerebral infarction,HO,LENVIMA | Cerebral infarction | HO,2025-07-21/2025-07-27
256197252,25619725,5,,2024-12-01,20250826,,BEYFORTUS,Respiratory syncytial virus infection,,BEYFORTUS | Respiratory syncytial virus infection,2024-11-25/2024-12-01
256197411,25619741,78,F,2025-07-22,20250729,,CAPIVASERTIB,Blood iron decreased,OT,CAPIVASERTIB | Blood iron decreased | OT,2025-07-21/2025-07-27
256197801,25619780,,F,,20250729,,SYNTHROID,Thyroidectomy,OT,SYNTHROID | Thyroidectomy | OT,NaT
256197853,25619785,,F,2025-07-11,20250822,,NEULASTA,Device adhesion issue,,NEULASTA | Device adhesion issue,2025-07-07/2025-07-13
256198191,25619819,45,M,,20250730,,CABENUVA,Neoplasm malignant,OT,CABENUVA | Neoplasm malignant | OT,NaT
256198221,25619822,,,,20250730,,ATRIPLA,Bone density decreased,,ATRIPLA | Bone density decreased,NaT
256199131,25619913,33,M,2025-07-10,20250730,,DUPIXENT,Sarcoidosis,HO,DUPIXENT | Sarcoidosis | HO,2025-07-07/2025-07-13
256199391,25619939,63,F,,20250730,,APIXABAN,Malaise,OT,APIXABAN | Malaise | OT,NaT
256199451,25619945,,,,20250730,,XOLAIR,No adverse event,,XOLAIR | No adverse event,NaT
256200151,25620015,,F,,20250730,,BENRALIZUMAB,Coagulopathy,HO,BENRALIZUMAB | Coagulopathy | HO,NaT
256200381,25620038,,F,,20250730,,UBRELVY,Food allergy,,UBRELVY | Food allergy,NaT
256200471,25620047,,M,,20250730,,DAPAGLIFLOZIN,Pancreatitis,OT,DAPAGLIFLOZIN | Pancreatitis | OT,NaT
256200711,25620071,,F,2025-07-01,20250730,,EVENITY,Acute myocardial infarction,HO,EVENITY | Acute myocardial infarction | HO,2025-06-30/2025-07-06
256201231,25620123,,F,,20250730,,TRIPTODUR,Device issue,,TRIPTODUR | Device issue,NaT
256201451,25620145,,F,,20250730,,TRIPTODUR,Product use complaint,,TRIPTODUR | Product use complaint,NaT
256202271,25620227,,,2025-01-01,20250730,,INFLIXIMAB,Inappropriate schedule of product administration,OT,INFLIXIMAB | Inappropriate schedule of product administration | OT,2024-12-30/2025-01-05
256203082,25620308,58,F,,20250916,,KINERET,Off label use,,KINERET | Off label use,NaT
256203251,25620325,,F,,20250730,,OFEV,Diverticulum intestinal,,OFEV | Diverticulum intestinal,NaT
256203562,25620356,36,M,2025-05-01,20250826,,DELSTRIGO,Product use issue,,DELSTRIGO | Product use issue,2025-04-28/2025-05-04
256203711,25620371,66,M,2024-01-17,20250730,,PEMETREXED,Diarrhoea,OT,PEMETREXED | Diarrhoea | OT,2024-01-15/2024-01-21
256203801,25620380,,F,,20250730,,ACTEMRA,Arthropod bite,,ACTEMRA | Arthropod bite,NaT
256204202,25620420,43,M,2020-01-01,20250828,,FLUOXETINE,Back pain,DS,FLUOXETINE | Back pain | DS,2019-12-30/2020-01-05
256204382,25620438,54,F,2025-07-02,20250901,,PEMETREXED,Pneumonia,HO,PEMETREXED | Pneumonia | HO,2025-06-30/2025-07-06
256204401,25620440,,F,,20250730,,BREZTRI,Visual impairment,,BREZTRI | Visual impairment,NaT
256204701,25620470,,,,20250730,,BENLYSTA,Off label use,,BENLYSTA | Off label use,NaT
256204831,25620483,,M,,20250730,,NUPLAZID,"Hallucination, visual",OT,"NUPLAZID | Hallucination, visual | OT",NaT
256206731,25620673,85,M,2025-04-21,20250730,,APIXABAN,Head injury,DE,APIXABAN | Head injury | DE,2025-04-21/2025-04-27
256207253,25620725,71,F,2025-01-01,20250928,,CREON,Blood glucose decreased,OT,CREON | Blood glucose decreased | OT,2024-12-30/2025-01-05
256207991,25620799,71,M,2025-04-24,20250730,,CARBOPLATIN,Rash pustular,HO,CARBOPLATIN | Rash pustular | HO,2025-04-21/2025-04-27
256208631,25620863,,F,,20250730,,SKYRIZI,Frequent bowel movements,HO,SKYRIZI | Frequent bowel movements | HO,NaT
256208711,25620871,,F,,20250730,,PROLIA,Arthralgia,,PROLIA | Arthralgia,NaT
256209561,25620956,62,F,2024-10-07,20250730,,BACLOFEN,Device dislocation,HO,BACLOFEN | Device dislocation | HO,2024-10-07/2024-10-13
256210601,25621060,,M,,20250730,,ZEPBOUND,Drug ineffective,,ZEPBOUND | Drug ineffective,NaT
256211341,25621134,,F,,20250730,,TRASTUZUMAB,Metastases to lymph nodes,OT,TRASTUZUMAB | Metastases to lymph nodes | OT,NaT
256211571,25621157,,F,,20250730,,ALBUTEROL SULFATE,Product storage error,,ALBUTEROL SULFATE | Product storage error,NaT
256211721,25621172,58,F,2023-05-27,20250730,,RINVOQ,Osteoarthritis,OT,RINVOQ | Osteoarthritis | OT,2023-05-22/2023-05-28
256211992,25621199,57,M,2025-07-21,20250811,,VYALEV,Infusion site abscess,,VYALEV | Infusion site abscess,2025-07-21/2025-07-27
256212252,25621225,50,M,,20250930,,VEDOLIZUMAB,Defaecation urgency,OT,VEDOLIZUMAB | Defaecation urgency | OT,NaT
256212272,25621227,,,,20250801,,COSENTYX,Heart rate increased,,COSENTYX | Heart rate increased,NaT
256212282,25621228,67,F,2025-07-25,20250910,,TREMFYA,Product dose omission issue,,TREMFYA | Product dose omission issue,2025-07-21/2025-07-27
256212401,25621240,46,F,,20250730,,KESIMPTA,Rash macular,OT,KESIMPTA | Rash macular | OT,NaT
256212521,25621252,,,,20250730,,ELIQUIS,Off label use,,ELIQUIS | Off label use,NaT
256213861,25621386,,M,2025-07-01,20250730,,REBLOZYL,Prostate cancer,OT,REBLOZYL | Prostate cancer | OT,2025-06-30/2025-07-06
256214551,25621455,57,F,,20250730,,ISOSORBIDE,Quality of life decreased,HO,ISOSORBIDE | Quality of life decreased | HO,NaT
256214782,25621478,70,M,,20250805,,FLUOROURACIL,Neoplasm progression,OT,FLUOROURACIL | Neoplasm progression | OT,NaT
256214891,25621489,70,M,,20250730,,RIVAROXABAN,Nephropathy,OT,RIVAROXABAN | Nephropathy | OT,NaT
256216611,25621661,54,M,2025-07-26,20250730,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,2025-07-21/2025-07-27
256216671,25621667,66,M,2025-01-01,20250730,,CREON,Pancreatic carcinoma,OT,CREON | Pancreatic carcinoma | OT,2024-12-30/2025-01-05
256216741,25621674,,F,,20250730,,XOLAIR,Peripheral swelling,,XOLAIR | Peripheral swelling,NaT
256217051,25621705,,F,,20250730,,XOLAIR,Idiopathic urticaria,,XOLAIR | Idiopathic urticaria,NaT
256217511,25621751,74,M,2025-07-28,20250730,,HUMIRA,Product storage error,,HUMIRA | Product storage error,2025-07-28/2025-08-03
256218191,25621819,,F,,20250730,,REFRESH OPTIVE MEGA-3,Off label use,OT,REFRESH OPTIVE MEGA-3 | Off label use | OT,NaT
256218501,25621850,81,F,,20250729,,OTEZLA,Vomiting,OT,OTEZLA | Vomiting | OT,NaT
256218551,25621855,,F,,20250730,,NUPLAZID,Patient elopement,OT,NUPLAZID | Patient elopement | OT,NaT
256219281,25621928,84,F,,20250730,,HALOPERIDOL,Thrombocytopenia,OT,HALOPERIDOL | Thrombocytopenia | OT,NaT
256219441,25621944,49,F,2018-12-05,20250730,,ATEZOLIZUMAB,Back pain,HO,ATEZOLIZUMAB | Back pain | HO,2018-12-03/2018-12-09
256219621,25621962,55,M,2021-01-01,20250730,,CREON,Ascites,OT,CREON | Ascites | OT,2020-12-28/2021-01-03
256219821,25621982,,,2025-07-21,20250730,,OMVOH,Arthralgia,,OMVOH | Arthralgia,2025-07-21/2025-07-27
256220772,25622077,,,,20250801,,ETANERCEPT,Pneumonia,OT,ETANERCEPT | Pneumonia | OT,NaT
256221651,25622165,64,F,,20250730,,ZOLEDRONIC ACID,Liver function test abnormal,OT,ZOLEDRONIC ACID | Liver function test abnormal | OT,NaT
256221811,25622181,,,,20250730,,ELAHERE,Pneumonitis,,ELAHERE | Pneumonitis,NaT
256221891,25622189,,,2024-10-25,20250730,,TERLIPRESSIN,Dyspnoea,,TERLIPRESSIN | Dyspnoea,2024-10-21/2024-10-27
256222001,25622200,37,F,2025-05-25,20250729,,DYSPORT,Eyelid ptosis,DS,DYSPORT | Eyelid ptosis | DS,2025-05-19/2025-05-25
256222411,25622241,31,M,,20250730,,CODEINE,Drug diversion,OT,CODEINE | Drug diversion | OT,NaT
256222921,25622292,46,,,20250730,,TRULICITY,Vomiting,HO,TRULICITY | Vomiting | HO,NaT
256223451,25622345,51,,,20250730,,TISLELIZUMAB,Myelosuppression,OT,TISLELIZUMAB | Myelosuppression | OT,NaT
256223893,25622389,42,M,,20250903,,ADALIMUMAB,Psoriasis,OT,ADALIMUMAB | Psoriasis | OT,NaT
256224051,25622405,,F,2025-01-01,20250730,,CERTOLIZUMAB PEGOL,Intentional dose omission,HO,CERTOLIZUMAB PEGOL | Intentional dose omission | HO,2024-12-30/2025-01-05
256224101,25622410,47,,,20250730,,TISLELIZUMAB,Pruritus,OT,TISLELIZUMAB | Pruritus | OT,NaT
256224282,25622428,,F,2025-06-01,20250911,,AZELASTINE HYDROCHLORIDE\FLUTICASONE PROPIONATE,Product label issue,,AZELASTINE HYDROCHLORIDE\FLUTICASONE PROPIONATE | Product label issue,2025-05-26/2025-06-01
256224581,25622458,63,M,,20250730,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
256224601,25622460,,,,20250730,,IMDELLTRA,Off label use,OT,IMDELLTRA | Off label use | OT,NaT
256225261,25622526,25,F,2025-05-01,20250730,,IMPLANON,Unintended pregnancy,OT,IMPLANON | Unintended pregnancy | OT,2025-04-28/2025-05-04
256225442,25622544,70,M,,20250811,,ATORVASTATIN,Immune-mediated myositis,HO,ATORVASTATIN | Immune-mediated myositis | HO,NaT
256225631,25622563,67,M,,20250730,,XELJANZ,Arthralgia,,XELJANZ | Arthralgia,NaT
256226051,25622605,53,,,20250730,,OZEMPIC,Emotional distress,OT,OZEMPIC | Emotional distress | OT,NaT
256226071,25622607,72,F,2023-01-01,20250730,,OZEMPIC,Vomiting,OT,OZEMPIC | Vomiting | OT,2022-12-26/2023-01-01
256226641,25622664,,F,,20250730,,NUCALA,Drug ineffective,,NUCALA | Drug ineffective,NaT
256226801,25622680,65,M,2025-07-26,20250729,,CALQUENCE,Myocardial infarction,DE,CALQUENCE | Myocardial infarction | DE,2025-07-21/2025-07-27
256227841,25622784,,,,20250730,,GANAXOLONE,Seizure,OT,GANAXOLONE | Seizure | OT,NaT
256228341,25622834,,M,,20250730,,VEDOLIZUMAB,Diarrhoea,OT,VEDOLIZUMAB | Diarrhoea | OT,NaT
256228701,25622870,,,2024-07-01,20250730,,LORATADINE,Urticaria,,LORATADINE | Urticaria,2024-07-01/2024-07-07
256229081,25622908,,F,2024-01-01,20250730,,LORATADINE,Drug ineffective,,LORATADINE | Drug ineffective,2024-01-01/2024-01-07
256229571,25622957,81,M,2024-01-01,20250730,,LORATADINE,Drug effective for unapproved indication,,LORATADINE | Drug effective for unapproved indication,2024-01-01/2024-01-07
256229701,25622970,,,2024-01-01,20250730,,LORATADINE,Drug ineffective,,LORATADINE | Drug ineffective,2024-01-01/2024-01-07
256230851,25623085,84,F,2025-05-06,20250730,,INSULIN GLARGINE,Blood albumin decreased,OT,INSULIN GLARGINE | Blood albumin decreased | OT,2025-05-05/2025-05-11
256231401,25623140,44,M,2025-07-14,20250730,,OXCARBAZEPINE,Pruritus,HO,OXCARBAZEPINE | Pruritus | HO,2025-07-14/2025-07-20
256231691,25623169,19,M,,20250730,,XYLOCAINE VISCOUS,Off label use,DE,XYLOCAINE VISCOUS | Off label use | DE,NaT
256232011,25623201,,,2025-07-29,20250730,,ZEPBOUND,Drug ineffective,,ZEPBOUND | Drug ineffective,2025-07-28/2025-08-03
256232531,25623253,,,,20250730,,SLYND,Insomnia,,SLYND | Insomnia,NaT
256233491,25623349,43,F,,20250730,,XYREM,Muscle spasms,,XYREM | Muscle spasms,NaT
256234541,25623454,77,F,,20250730,,MIRALAX,Vomiting,,MIRALAX | Vomiting,NaT
256234671,25623467,23,M,,20250730,,SABRIL,Haemorrhoids,OT,SABRIL | Haemorrhoids | OT,NaT
256235111,25623511,,,2025-07-01,20250730,,RISANKIZUMAB,Product storage error,,RISANKIZUMAB | Product storage error,2025-06-30/2025-07-06
256236741,25623674,69,M,2022-03-01,20250730,,METHOTREXATE,Cardiac failure acute,HO,METHOTREXATE | Cardiac failure acute | HO,2022-02-28/2022-03-06
256237011,25623701,46,,,20250730,,TRULICITY,Impaired gastric emptying,LT,TRULICITY | Impaired gastric emptying | LT,NaT
256237281,25623728,75,M,2025-07-20,20250730,,YESCARTA,Immune effector cell-associated neurotoxicity syndrome,HO,YESCARTA | Immune effector cell-associated neurotoxicity syndrome | HO,2025-07-14/2025-07-20
256237861,25623786,47,M,,20250730,,LORLATINIB,Hypoaesthesia,DE,LORLATINIB | Hypoaesthesia | DE,NaT
256237961,25623796,,,2025-04-01,20250730,,XDEMVY,Condition aggravated,,XDEMVY | Condition aggravated,2025-03-31/2025-04-06
256238141,25623814,41,F,2025-05-01,20250730,,RISANKIZUMAB,Oedema peripheral,,RISANKIZUMAB | Oedema peripheral,2025-04-28/2025-05-04
256238581,25623858,,,,20250730,,PLUVICTO,General physical health deterioration,,PLUVICTO | General physical health deterioration,NaT
256238751,25623875,,,2025-05-08,20250730,,XDEMVY,Wrong technique in product usage process,,XDEMVY | Wrong technique in product usage process,2025-05-05/2025-05-11
256239101,25623910,,F,,20250730,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,NaT
256239461,25623946,35,F,2025-07-25,20250730,,LILETTA,Device placement issue,,LILETTA | Device placement issue,2025-07-21/2025-07-27
256240111,25624011,31,M,,20250730,,DUPIXENT,Injection site swelling,,DUPIXENT | Injection site swelling,NaT
256241231,25624123,,,,20250730,,SORAFENIB,Off label use,OT,SORAFENIB | Off label use | OT,NaT
256241501,25624150,29,F,2025-01-01,20250730,,DUPIXENT,Intentional dose omission,,DUPIXENT | Intentional dose omission,2024-12-30/2025-01-05
256241541,25624154,,M,,20250730,,DUPIXENT,Ocular hyperaemia,,DUPIXENT | Ocular hyperaemia,NaT
256242453,25624245,,M,,20250911,,CORTICOTROPIN,Constipation,HO,CORTICOTROPIN | Constipation | HO,NaT
256243732,25624373,73,M,2025-07-25,20250804,,REPATHA,Device difficult to use,,REPATHA | Device difficult to use,2025-07-21/2025-07-27
256243871,25624387,,M,,20250730,,TRIKAFTA,Infective pulmonary exacerbation of cystic fibrosis,HO,TRIKAFTA | Infective pulmonary exacerbation of cystic fibrosis | HO,NaT
256243901,25624390,,F,,20250730,,TRODELVY,Enterocolitis,DS,TRODELVY | Enterocolitis | DS,NaT
256244011,25624401,,,,20250730,,EVEROLIMUS,Malignant neoplasm progression,OT,EVEROLIMUS | Malignant neoplasm progression | OT,NaT
256244262,25624426,51,M,2025-09-21,20250929,,SARILUMAB,Injection site rash,OT,SARILUMAB | Injection site rash | OT,2025-09-15/2025-09-21
256246111,25624611,,M,2025-07-23,20250730,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2025-07-21/2025-07-27
256246641,25624664,72,M,,20250730,,MIRTAZAPINE,Adverse event,OT,MIRTAZAPINE | Adverse event | OT,NaT
256246761,25624676,66,F,,20250730,,DUPIXENT,Exposure via skin contact,,DUPIXENT | Exposure via skin contact,NaT
256246981,25624698,,,,20250730,,KRYSTEXXA,Therapy interrupted,,KRYSTEXXA | Therapy interrupted,NaT
256249171,25624917,60,F,,20250731,,ZEPBOUND,Wrong technique in product usage process,,ZEPBOUND | Wrong technique in product usage process,NaT
256249271,25624927,44,,2025-07-26,20250731,,MOUNJARO,Product dose omission issue,,MOUNJARO | Product dose omission issue,2025-07-21/2025-07-27
256249391,25624939,38,F,2025-07-01,20250731,,KEVZARA,Dyspepsia,,KEVZARA | Dyspepsia,2025-06-30/2025-07-06
256249452,25624945,85,F,2021-01-01,20250904,,DULOXETINE,Weight decreased,OT,DULOXETINE | Weight decreased | OT,2020-12-28/2021-01-03
256249791,25624979,60,M,2025-06-29,20250731,,DAPAGLIFLOZIN,Rash,OT,DAPAGLIFLOZIN | Rash | OT,2025-06-23/2025-06-29
256249921,25624992,24,M,2025-07-12,20250731,,HEMLIBRA,Peripheral swelling,,HEMLIBRA | Peripheral swelling,2025-07-07/2025-07-13
256250481,25625048,,,,20250731,,LYNPARZA,Haemoglobin decreased,,LYNPARZA | Haemoglobin decreased,NaT
256251551,25625155,54,F,2024-09-03,20250731,,XOLAIR,Arthritis,OT,XOLAIR | Arthritis | OT,2024-09-02/2024-09-08
256251741,25625174,,,,20250731,,RITUXIMAB,Anaphylactic reaction,OT,RITUXIMAB | Anaphylactic reaction | OT,NaT
256252221,25625222,33,F,2024-09-01,20250731,,ORENITRAM,Anxiety,HO,ORENITRAM | Anxiety | HO,2024-08-26/2024-09-01
256252881,25625288,,F,,20250731,,TECFIDERA,Flushing,,TECFIDERA | Flushing,NaT
256252992,25625299,66,M,2025-07-21,20250820,,ORGOVYX,COVID-19,HO,ORGOVYX | COVID-19 | HO,2025-07-21/2025-07-27
256253502,25625350,70,F,2025-04-01,20250830,,TYVASO DPI,Dizziness postural,,TYVASO DPI | Dizziness postural,2025-03-31/2025-04-06
256254391,25625439,71,M,2025-05-14,20250731,,ATEZOLIZUMAB,Furuncle,HO,ATEZOLIZUMAB | Furuncle | HO,2025-05-12/2025-05-18
256254991,25625499,62,F,,20250731,,CLARITHROMYCIN,Arthralgia,OT,CLARITHROMYCIN | Arthralgia | OT,NaT
256255141,25625514,78,M,2025-07-28,20250731,,TRULICITY,Inappropriate schedule of product administration,,TRULICITY | Inappropriate schedule of product administration,2025-07-28/2025-08-03
256255422,25625542,,,,20250815,,HYDROXYZINE,Agitation,HO,HYDROXYZINE | Agitation | HO,NaT
256255681,25625568,52,M,,20250731,,SOLU-CORTEF,Herpes dermatitis,OT,SOLU-CORTEF | Herpes dermatitis | OT,NaT
256256161,25625616,61,F,,20250731,,DEXAMETHASONE,Neutropenia,LT,DEXAMETHASONE | Neutropenia | LT,NaT
256256241,25625624,,,,20250731,,HUMIRA,Injection site swelling,,HUMIRA | Injection site swelling,NaT
256256692,25625669,24,F,,20250901,,SIMPONI,Kidney infection,OT,SIMPONI | Kidney infection | OT,NaT
256256951,25625695,68,F,2025-06-01,20250731,,MOUNJARO,Cataract,,MOUNJARO | Cataract,2025-05-26/2025-06-01
256257031,25625703,27,F,2025-07-28,20250731,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,2025-07-28/2025-08-03
256257271,25625727,5,,,20250731,,IBUPROFEN,Angioedema,OT,IBUPROFEN | Angioedema | OT,NaT
256257771,25625777,56,F,2025-03-01,20250731,,INTERFERON BETA-1A,Fibrosis,OT,INTERFERON BETA-1A | Fibrosis | OT,2025-02-24/2025-03-02
256258551,25625855,81,F,2025-07-01,20250731,,ROMVIMZA,Sinusitis,,ROMVIMZA | Sinusitis,2025-06-30/2025-07-06
256258792,25625879,,F,2025-01-01,20250901,,TYMLOS,Forearm fracture,OT,TYMLOS | Forearm fracture | OT,2024-12-30/2025-01-05
256258861,25625886,71,F,2025-05-12,20250731,,ROSUVASTATIN CALCIUM,Pain in jaw,OT,ROSUVASTATIN CALCIUM | Pain in jaw | OT,2025-05-12/2025-05-18
256258891,25625889,,M,,20250731,,DAPAGLIFLOZIN,Dementia,OT,DAPAGLIFLOZIN | Dementia | OT,NaT
256258952,25625895,,M,2025-05-01,20250811,,OCREVUS,Spinal cord injury,OT,OCREVUS | Spinal cord injury | OT,2025-04-28/2025-05-04
256259151,25625915,32,M,2024-09-01,20250731,,RINVOQ,Rheumatoid arthritis,HO,RINVOQ | Rheumatoid arthritis | HO,2024-08-26/2024-09-01
256260221,25626022,60,M,2025-01-01,20250731,,OZEMPIC,Intestinal obstruction,OT,OZEMPIC | Intestinal obstruction | OT,2024-12-30/2025-01-05
256260391,25626039,19,M,,20250731,,OXYCODONE,Drug diversion,OT,OXYCODONE | Drug diversion | OT,NaT
256260811,25626081,,F,,20250731,,LACOSAMIDE,Maternal exposure during pregnancy,OT,LACOSAMIDE | Maternal exposure during pregnancy | OT,NaT
256260941,25626094,,M,,20250731,,WEGOVY,Death,DE,WEGOVY | Death | DE,NaT
256262011,25626201,55,F,2025-07-14,20250731,,ZEPBOUND,Gastrooesophageal reflux disease,,ZEPBOUND | Gastrooesophageal reflux disease,2025-07-14/2025-07-20
256262391,25626239,,F,,20250731,,NUCALA,Off label use,,NUCALA | Off label use,NaT
256262691,25626269,,,2025-05-01,20250731,,ORGOVYX,Palpitations,,ORGOVYX | Palpitations,2025-04-28/2025-05-04
256263311,25626331,,,,20250731,,ORGOVYX,Headache,,ORGOVYX | Headache,NaT
256263391,25626339,49,F,,20250731,,RISPERIDONE,Thrombocytopenic purpura,OT,RISPERIDONE | Thrombocytopenic purpura | OT,NaT
256263441,25626344,75,F,,20250731,,FLUCONAZOLE,Interstitial lung disease,HO,FLUCONAZOLE | Interstitial lung disease | HO,NaT
256263451,25626345,62,F,,20250731,,HYDRALAZINE,Anti-neutrophil cytoplasmic antibody positive vasculitis,OT,HYDRALAZINE | Anti-neutrophil cytoplasmic antibody positive vasculitis | OT,NaT
256264221,25626422,48,M,2025-01-31,20250731,,QUETIAPINE,Pericardial effusion,OT,QUETIAPINE | Pericardial effusion | OT,2025-01-27/2025-02-02
256264381,25626438,,,,20250731,,BISOPROLOL,Hypotension,OT,BISOPROLOL | Hypotension | OT,NaT
256264421,25626442,56,M,,20250731,,HYDRALAZINE,Anti-neutrophil cytoplasmic antibody positive vasculitis,OT,HYDRALAZINE | Anti-neutrophil cytoplasmic antibody positive vasculitis | OT,NaT
256264671,25626467,80,,,20250731,,VENCLEXTA,Acute myeloid leukaemia,DE,VENCLEXTA | Acute myeloid leukaemia | DE,NaT
256264791,25626479,72,M,2025-05-06,20250731,,ATORVASTATIN,Gout,OT,ATORVASTATIN | Gout | OT,2025-05-05/2025-05-11
256264811,25626481,54,M,2021-01-01,20250731,,RINVOQ,Suicidal ideation,OT,RINVOQ | Suicidal ideation | OT,2020-12-28/2021-01-03
256264831,25626483,78,M,,20250731,,SULFAMETHOXAZOLE\TRIMETHOPRIM,Mixed liver injury,OT,SULFAMETHOXAZOLE\TRIMETHOPRIM | Mixed liver injury | OT,NaT
256265091,25626509,21,M,2025-05-01,20250731,,DIAZEPAM,Toxicity to various agents,HO,DIAZEPAM | Toxicity to various agents | HO,2025-04-28/2025-05-04
256265501,25626550,,,2025-01-01,20250731,,ISOTRETINOIN,Photosensitivity reaction,,ISOTRETINOIN | Photosensitivity reaction,2024-12-30/2025-01-05
256265561,25626556,,F,,20250731,,VENLAFAXINE HYDROCHLORIDE,Product substitution issue,,VENLAFAXINE HYDROCHLORIDE | Product substitution issue,NaT
256265821,25626582,77,M,,20250731,,VALSARTAN,Tongue haemorrhage,HO,VALSARTAN | Tongue haemorrhage | HO,NaT
256266001,25626600,59,M,2024-08-01,20250731,,IRINOTECAN,Prostatic specific antigen increased,OT,IRINOTECAN | Prostatic specific antigen increased | OT,2024-07-29/2024-08-04
256266991,25626699,80,F,2025-07-05,20250731,,ALECENSA,Pulmonary toxicity,HO,ALECENSA | Pulmonary toxicity | HO,2025-06-30/2025-07-06
256267112,25626711,,,,20250804,,TOFIDENCE,Liver function test increased,OT,TOFIDENCE | Liver function test increased | OT,NaT
256267211,25626721,49,M,2025-03-01,20250731,,VEDOLIZUMAB,Colitis ulcerative,OT,VEDOLIZUMAB | Colitis ulcerative | OT,2025-02-24/2025-03-02
256267631,25626763,30,F,,20250731,,ZEPBOUND,Extra dose administered,,ZEPBOUND | Extra dose administered,NaT
256268041,25626804,71,F,,20250730,,ORENCIA,Death,,ORENCIA | Death,NaT
256268631,25626863,,,,20250731,,BIMZELX,Urticaria,OT,BIMZELX | Urticaria | OT,NaT
256268714,25626871,68,F,2025-06-10,20250923,,FOSCARBIDOPA\FOSLEVODOPA,Constipation,HO,FOSCARBIDOPA\FOSLEVODOPA | Constipation | HO,2025-06-09/2025-06-15
256268722,25626872,,F,,20250821,,HUMIRA,Breast cancer,OT,HUMIRA | Breast cancer | OT,NaT
256269951,25626995,68,M,,20250731,,TEPOTINIB,Renal ischaemia,OT,TEPOTINIB | Renal ischaemia | OT,NaT
256270091,25627009,72,M,,20250731,,ROSUVASTATIN,Nephropathy toxic,DE,ROSUVASTATIN | Nephropathy toxic | DE,NaT
256271221,25627122,58,F,,20250731,,DOXORUBICIN,Cardiotoxicity,OT,DOXORUBICIN | Cardiotoxicity | OT,NaT
256271541,25627154,29,M,2025-07-29,20250730,,7-HYDROXYMITRAGYNINE,Muscle spasms,OT,7-HYDROXYMITRAGYNINE | Muscle spasms | OT,2025-07-28/2025-08-03
256271791,25627179,75,,,20250731,,JAKAFI,Pain,HO,JAKAFI | Pain | HO,NaT
256271921,25627192,35,M,2025-06-25,20250731,,ATRACURIUM,Eyelid oedema,OT,ATRACURIUM | Eyelid oedema | OT,2025-06-23/2025-06-29
256272071,25627207,44,F,2025-06-01,20250731,,JANUVIA,Abdominal pain,HO,JANUVIA | Abdominal pain | HO,2025-05-26/2025-06-01
256272681,25627268,20,M,2025-07-26,20250731,,AYVAKIT,Product dose omission issue,,AYVAKIT | Product dose omission issue,2025-07-21/2025-07-27
256273191,25627319,,F,,20250731,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,NaT
256273511,25627351,,,,20250731,,ZOLEDRONIC ACID,Depression,DS,ZOLEDRONIC ACID | Depression | DS,NaT
256273851,25627385,63,F,2025-04-03,20250731,,OXALIPLATIN,Medication error,OT,OXALIPLATIN | Medication error | OT,2025-03-31/2025-04-06
256274285,25627428,9,M,,20250905,,NGENLA,Injection site pain,,NGENLA | Injection site pain,NaT
256274374,25627437,11,F,,20250903,,GENOTROPIN,Device power source issue,,GENOTROPIN | Device power source issue,NaT
256275391,25627539,74,,2025-05-01,20250731,,HIZENTRA,Headache,HO,HIZENTRA | Headache | HO,2025-04-28/2025-05-04
256275871,25627587,59,M,2025-07-14,20250731,,VITRAKVI,Hypertensive crisis,HO,VITRAKVI | Hypertensive crisis | HO,2025-07-14/2025-07-20
256275931,25627593,4,F,,20250731,,BEYFORTUS,Apnoea,OT,BEYFORTUS | Apnoea | OT,NaT
256276191,25627619,62,F,2025-07-17,20250731,,SPRAVATO,Poisoning,OT,SPRAVATO | Poisoning | OT,2025-07-14/2025-07-20
256276543,25627654,22,M,,20250930,,LARONIDASE,Mental disorder,OT,LARONIDASE | Mental disorder | OT,NaT
256276801,25627680,,,,20250731,,TASIGNA,Intentional dose omission,,TASIGNA | Intentional dose omission,NaT
256277191,25627719,,,,20250731,,ORGOVYX,Dry mouth,,ORGOVYX | Dry mouth,NaT
256277272,25627727,74,M,2025-07-20,20250902,,ORGOVYX,Hot flush,,ORGOVYX | Hot flush,2025-07-14/2025-07-20
256278252,25627825,,F,,20250917,,ADEMPAS,General physical health deterioration,LT,ADEMPAS | General physical health deterioration | LT,NaT
256278311,25627831,,F,,20250731,,MAVENCLAD,Breast cancer,OT,MAVENCLAD | Breast cancer | OT,NaT
256278761,25627876,68,F,,20250731,,ZEPBOUND,Injection site reaction,,ZEPBOUND | Injection site reaction,NaT
256279151,25627915,,,2025-07-07,20250731,,EGRIFTA SV,Rash macular,,EGRIFTA SV | Rash macular,2025-07-07/2025-07-13
256279341,25627934,,,2025-07-30,20250731,,ZEPBOUND,Therapeutic response changed,,ZEPBOUND | Therapeutic response changed,2025-07-28/2025-08-03
256281151,25628115,,F,,20250731,,UBRELVY,Fall,HO,UBRELVY | Fall | HO,NaT
256281522,25628152,39,M,,20250811,,EMICIZUMAB,Subdural haemorrhage,LT,EMICIZUMAB | Subdural haemorrhage | LT,NaT
256282362,25628236,75,F,2025-07-15,20250804,,LEQEMBI,Chest pain,OT,LEQEMBI | Chest pain | OT,2025-07-14/2025-07-20
256283381,25628338,45,F,,20250731,,MOUNJARO,Thrombocytosis,,MOUNJARO | Thrombocytosis,NaT
256283621,25628362,74,M,,20250731,,LENALIDOMIDE,Drug intolerance,,LENALIDOMIDE | Drug intolerance,NaT
256284751,25628475,,M,,20250731,,FRUQUINTINIB,Death,DE,FRUQUINTINIB | Death | DE,NaT
256284981,25628498,69,M,2025-07-11,20250731,,EZETIMIBE,Dyspnoea,OT,EZETIMIBE | Dyspnoea | OT,2025-07-07/2025-07-13
256286101,25628610,,,,20250731,,XDEMVY,Condition aggravated,,XDEMVY | Condition aggravated,NaT
256286661,25628666,,,,20250731,,XDEMVY,Visual impairment,,XDEMVY | Visual impairment,NaT
256286701,25628670,,,,20250731,,XDEMVY,Off label use,,XDEMVY | Off label use,NaT
256287051,25628705,,M,2025-01-01,20250731,,XIIDRA,Wrong dose,,XIIDRA | Wrong dose,2024-12-30/2025-01-05
256287531,25628753,,,,20250731,,XDEMVY,Off label use,,XDEMVY | Off label use,NaT
256287611,25628761,,,2025-06-18,20250731,,XDEMVY,Instillation site irritation,,XDEMVY | Instillation site irritation,2025-06-16/2025-06-22
256287781,25628778,82,F,2025-01-01,20250731,,XIIDRA,Eye irritation,,XIIDRA | Eye irritation,2024-12-30/2025-01-05
256288421,25628842,60,F,2025-07-01,20250731,,MOUNJARO,Product dose omission issue,,MOUNJARO | Product dose omission issue,2025-06-30/2025-07-06
256288801,25628880,61,F,2025-04-25,20250731,,CORTICOTROPIN,Drug ineffective,OT,CORTICOTROPIN | Drug ineffective | OT,2025-04-21/2025-04-27
256289031,25628903,48,F,,20250731,,ZEPBOUND,Lymphoedema,,ZEPBOUND | Lymphoedema,NaT
256289931,25628993,,F,,20250731,,DUPIXENT,Product dose omission issue,,DUPIXENT | Product dose omission issue,NaT
256290361,25629036,50,M,2025-01-01,20250731,,SODIUM CHLORIDE,Intentional dose omission,,SODIUM CHLORIDE | Intentional dose omission,2024-12-30/2025-01-05
256290631,25629063,40,F,,20250731,,DUPIXENT,Sinus disorder,,DUPIXENT | Sinus disorder,NaT
256290801,25629080,37,M,2025-07-01,20250731,,DUPIXENT,Eczema,,DUPIXENT | Eczema,2025-06-30/2025-07-06
256291961,25629196,60,M,,20250731,,TOUJEO MAX,Wrong technique in device usage process,OT,TOUJEO MAX | Wrong technique in device usage process | OT,NaT
256291991,25629199,79,M,,20250731,,DUPIXENT,Dry skin,,DUPIXENT | Dry skin,NaT
256292261,25629226,,F,,20250731,,DUPIXENT,Gait disturbance,,DUPIXENT | Gait disturbance,NaT
256292801,25629280,40,F,,20250731,,PREDNISONE,Obesity,CA,PREDNISONE | Obesity | CA,NaT
256293841,25629384,,,,20250731,,ZEPBOUND,Therapeutic response changed,,ZEPBOUND | Therapeutic response changed,NaT
256294301,25629430,39,M,,20250731,,CORTICOTROPIN,COVID-19,OT,CORTICOTROPIN | COVID-19 | OT,NaT
256294661,25629466,,F,,20250731,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,NaT
256294832,25629483,,M,2025-01-01,20250903,,ALYFTREK,Liver disorder,OT,ALYFTREK | Liver disorder | OT,2024-12-30/2025-01-05
256294941,25629494,,,,20250731,,OPZELURA,Skin burning sensation,,OPZELURA | Skin burning sensation,NaT
256295211,25629521,,M,,20250731,,CORTICOTROPIN,Mental disorder,,CORTICOTROPIN | Mental disorder,NaT
256295681,25629568,62,F,2025-06-01,20250731,,WEGOVY,Pancreatic enzymes increased,OT,WEGOVY | Pancreatic enzymes increased | OT,2025-05-26/2025-06-01
256295701,25629570,,F,,20250731,,OZEMPIC,Neoplasm,OT,OZEMPIC | Neoplasm | OT,NaT
256296391,25629639,58,M,2025-07-14,20250731,,DELFLEX WITH DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM,Cardiac arrest,DE,DELFLEX WITH DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM | Cardiac arrest | DE,2025-07-14/2025-07-20
256296762,25629676,,M,2025-01-10,20250807,,BEOVU,Fundoscopy abnormal,OT,BEOVU | Fundoscopy abnormal | OT,2025-01-06/2025-01-12
256297201,25629720,64,F,,20250731,,INSULIN LISPRO,Visual impairment,,INSULIN LISPRO | Visual impairment,NaT
256297451,25629745,,M,2025-01-01,20250731,,VYALEV,Infusion site discomfort,,VYALEV | Infusion site discomfort,2024-12-30/2025-01-05
256297471,25629747,56,M,,20250731,,CARBOPLATIN,Feeling hot,OT,CARBOPLATIN | Feeling hot | OT,NaT
256298514,25629851,45,F,2025-07-01,20250825,,SKYRIZI,Stoma closure,OT,SKYRIZI | Stoma closure | OT,2025-06-30/2025-07-06
256298671,25629867,61,,,20250731,,TISLELIZUMAB,Chills,HO,TISLELIZUMAB | Chills | HO,NaT
256298721,25629872,,F,,20250731,,CUVITRU,Pain,,CUVITRU | Pain,NaT
256299181,25629918,50,M,2025-05-04,20250731,,TREMFYA,Weight increased,OT,TREMFYA | Weight increased | OT,2025-04-28/2025-05-04
256299211,25629921,17,M,2025-01-01,20250731,,DUPIXENT,Product dose omission in error,,DUPIXENT | Product dose omission in error,2024-12-30/2025-01-05
256300001,25630000,44,,,20250801,,TRULICITY,Vomiting,OT,TRULICITY | Vomiting | OT,NaT
256300311,25630031,57,F,,20250801,,SIMPONI,Urosepsis,DE,SIMPONI | Urosepsis | DE,NaT
256301791,25630179,28,M,2022-07-01,20250801,,CISPLATIN,Pneumonia,HO,CISPLATIN | Pneumonia | HO,2022-06-27/2022-07-03
256304091,25630409,,,,20250801,,ORGOVYX,Hot flush,,ORGOVYX | Hot flush,NaT
256304981,25630498,,,,20250801,,CLOPIDOGREL,Procedural haemorrhage,OT,CLOPIDOGREL | Procedural haemorrhage | OT,NaT
256305401,25630540,76,M,,20250801,,MOUNJARO,Injection site pain,,MOUNJARO | Injection site pain,NaT
256305481,25630548,47,F,,20250801,,ETANERCEPT,Illness,HO,ETANERCEPT | Illness | HO,NaT
256305552,25630555,68,F,2025-07-01,20250814,,WEGOVY,Cataract,OT,WEGOVY | Cataract | OT,2025-06-30/2025-07-06
256306451,25630645,,F,2025-01-01,20250801,,BIMEKIZUMAB,Hypersensitivity,HO,BIMEKIZUMAB | Hypersensitivity | HO,2024-12-30/2025-01-05
256307352,25630735,61,F,2025-01-01,20250825,,DUPIXENT,Injection site rash,,DUPIXENT | Injection site rash,2024-12-30/2025-01-05
256307361,25630736,7,M,2025-01-01,20250801,,DUPIXENT,Skin haemorrhage,,DUPIXENT | Skin haemorrhage,2024-12-30/2025-01-05
256307561,25630756,,,,20250801,,ORGOVYX,Incorrect dose administered,,ORGOVYX | Incorrect dose administered,NaT
256307721,25630772,,,,20250801,,UPADACITINIB,Crohn's disease,,UPADACITINIB | Crohn's disease,NaT
256308432,25630843,,M,2024-01-01,20250805,,CIMZIA,Rash,OT,CIMZIA | Rash | OT,2024-01-01/2024-01-07
256308901,25630890,81,F,2025-07-05,20250801,,AIMOVIG,Headache,,AIMOVIG | Headache,2025-06-30/2025-07-06
256308931,25630893,64,F,,20250801,,VERZENIO,Lacrimation increased,,VERZENIO | Lacrimation increased,NaT
256308951,25630895,39,F,,20250801,,CARVEDILOL,Suicide attempt,HO,CARVEDILOL | Suicide attempt | HO,NaT
256309061,25630906,53,M,2023-11-08,20250801,,SYMBICORT,Anaphylactic reaction,OT,SYMBICORT | Anaphylactic reaction | OT,2023-11-06/2023-11-12
256310011,25631001,,,2025-04-08,20250801,,BESREMI,Off label use,,BESREMI | Off label use,2025-04-07/2025-04-13
256310351,25631035,71,F,,20250801,,SILDENAFIL,Skin ulcer,OT,SILDENAFIL | Skin ulcer | OT,NaT
256310621,25631062,69,M,,20250801,,TACROLIMUS,Hyperkalaemia,OT,TACROLIMUS | Hyperkalaemia | OT,NaT
256311251,25631125,64,M,,20250801,,ATORVASTATIN,Treatment noncompliance,,ATORVASTATIN | Treatment noncompliance,NaT
256312001,25631200,,F,,20250801,,RISANKIZUMAB,Wrong technique in product usage process,,RISANKIZUMAB | Wrong technique in product usage process,NaT
256314581,25631458,,F,,20250801,,TAVALISSE,Hospitalisation,HO,TAVALISSE | Hospitalisation | HO,NaT
256314701,25631470,76,M,2025-05-28,20250801,,DAPAGLIFLOZIN,Liver injury,OT,DAPAGLIFLOZIN | Liver injury | OT,2025-05-26/2025-06-01
256317621,25631762,63,,,20250801,,KEYTRUDA,Product use issue,OT,KEYTRUDA | Product use issue | OT,NaT
256317802,25631780,,,,20250805,,ALBUTEROL SULFATE,Device deposit issue,,ALBUTEROL SULFATE | Device deposit issue,NaT
256317972,25631797,51,F,2025-02-28,20250814,,TRIPTORELIN,Gingival bleeding,DS,TRIPTORELIN | Gingival bleeding | DS,2025-02-24/2025-03-02
256318721,25631872,,F,2024-01-01,20250801,,FIRDAPSE,Hospitalisation,HO,FIRDAPSE | Hospitalisation | HO,2024-01-01/2024-01-07
256319171,25631917,86,F,2021-01-01,20250801,,EDOXABAN TOSYLATE,Incorrect dose administered,OT,EDOXABAN TOSYLATE | Incorrect dose administered | OT,2020-12-28/2021-01-03
256320404,25632040,,F,2025-01-01,20250905,,WINREVAIR,Haemoglobin increased,HO,WINREVAIR | Haemoglobin increased | HO,2024-12-30/2025-01-05
256320652,25632065,73,M,,20250815,,KEYTRUDA,Upper gastrointestinal haemorrhage,DE,KEYTRUDA | Upper gastrointestinal haemorrhage | DE,NaT
256320891,25632089,,F,2025-07-25,20250801,,OSIMERTINIB,White blood cell count decreased,OT,OSIMERTINIB | White blood cell count decreased | OT,2025-07-21/2025-07-27
256321411,25632141,,M,,20250731,,TESTOPEL,Death,DE,TESTOPEL | Death | DE,NaT
256321837,25632183,15,M,2025-07-01,20250923,,GENOTROPIN,Incorrect dose administered by device,,GENOTROPIN | Incorrect dose administered by device,2025-06-30/2025-07-06
256321893,25632189,,,,20250811,,GUSELKUMAB,Incorrect dose administered,,GUSELKUMAB | Incorrect dose administered,NaT
256323231,25632323,,M,,20250801,,SCEMBLIX,Death,DE,SCEMBLIX | Death | DE,NaT
256323341,25632334,,,2025-07-21,20250801,,CHILDRENS MOTRIN,Seizure,OT,CHILDRENS MOTRIN | Seizure | OT,2025-07-21/2025-07-27
256323441,25632344,,,2025-06-22,20250801,,XDEMVY,Therapy interrupted,,XDEMVY | Therapy interrupted,2025-06-16/2025-06-22
256323821,25632382,,,2025-06-01,20250801,,XDEMVY,Conjunctival hyperaemia,,XDEMVY | Conjunctival hyperaemia,2025-05-26/2025-06-01
256324001,25632400,,,,20250801,,XDEMVY,Therapeutic response decreased,,XDEMVY | Therapeutic response decreased,NaT
256324111,25632411,76,M,,20250801,,OCTREOTIDE,Drug ineffective,HO,OCTREOTIDE | Drug ineffective | HO,NaT
256324571,25632457,49,F,2025-02-27,20250801,,STRENSIQ,Sinus disorder,HO,STRENSIQ | Sinus disorder | HO,2025-02-24/2025-03-02
256324721,25632472,,M,,20250801,,METHOTREXATE,Diffuse large B-cell lymphoma recurrent,OT,METHOTREXATE | Diffuse large B-cell lymphoma recurrent | OT,NaT
256327382,25632738,,F,2025-07-08,20250806,,TERIPARATIDE,Spinal laminectomy,HO,TERIPARATIDE | Spinal laminectomy | HO,2025-07-07/2025-07-13
256327751,25632775,20,F,2025-01-01,20250801,,GAMUNEX-C,Headache,,GAMUNEX-C | Headache,2024-12-30/2025-01-05
256327881,25632788,59,F,2025-02-08,20250801,,GAMUNEX-C,Blood pressure decreased,,GAMUNEX-C | Blood pressure decreased,2025-02-03/2025-02-09
256327961,25632796,,F,,20250801,,ENTYVIO,Bronchospasm,,ENTYVIO | Bronchospasm,NaT
256329781,25632978,35,F,,20250801,,ADALIMUMAB,Clostridium difficile infection,HO,ADALIMUMAB | Clostridium difficile infection | HO,NaT
256330051,25633005,69,F,,20250801,,LINEZOLID,Drug intolerance,,LINEZOLID | Drug intolerance,NaT
256330291,25633029,,F,,20250801,,THIOTEPA,Staphylococcal infection,OT,THIOTEPA | Staphylococcal infection | OT,NaT
256331671,25633167,68,F,2025-03-09,20250801,,BISOPROLOL,Disturbance in attention,LT,BISOPROLOL | Disturbance in attention | LT,2025-03-03/2025-03-09
256331811,25633181,86,M,,20250801,,COUMADIN,Treatment failure,OT,COUMADIN | Treatment failure | OT,NaT
256331822,25633182,38,F,,20250806,,LEVETIRACETAM,Maternal exposure during pregnancy,HO,LEVETIRACETAM | Maternal exposure during pregnancy | HO,NaT
256331881,25633188,69,M,,20250801,,TESTOSTERONE,Pulmonary embolism,OT,TESTOSTERONE | Pulmonary embolism | OT,NaT
256331891,25633189,,F,,20250801,,ILUMYA,Death,DE,ILUMYA | Death | DE,NaT
256333182,25633318,60,F,2025-07-04,20250905,,ORENITRAM,Headache,,ORENITRAM | Headache,2025-06-30/2025-07-06
256333511,25633351,51,M,,20250801,,PAZOPANIB,Pneumothorax spontaneous,OT,PAZOPANIB | Pneumothorax spontaneous | OT,NaT
256334293,25633429,,F,2025-07-16,20250807,,BRAFTOVI,Visual impairment,,BRAFTOVI | Visual impairment,2025-07-14/2025-07-20
256334361,25633436,34,F,2025-07-06,20250731,,ZURZUVAE,Somnolence,,ZURZUVAE | Somnolence,2025-06-30/2025-07-06
256334371,25633437,37,F,2025-07-09,20250731,,ZURZUVAE,Disturbance in attention,,ZURZUVAE | Disturbance in attention,2025-07-07/2025-07-13
256334602,25633460,13,M,,20250901,,GENOTROPIN,Injection site pain,,GENOTROPIN | Injection site pain,NaT
256334831,25633483,,,,20250801,,GEMTESA,Diarrhoea,,GEMTESA | Diarrhoea,NaT
256334921,25633492,,,,20250801,,ORGOVYX,Arthralgia,,ORGOVYX | Arthralgia,NaT
256335401,25633540,5,F,2025-01-01,20250801,,SPRAVATO,Suicidal ideation,HO,SPRAVATO | Suicidal ideation | HO,2024-12-30/2025-01-05
256335821,25633582,5,M,2023-01-01,20250801,,ELRANATAMAB,Hypogammaglobulinaemia,DE,ELRANATAMAB | Hypogammaglobulinaemia | DE,2022-12-26/2023-01-01
256335941,25633594,86,F,2025-02-25,20250801,,CELECOXIB,Stevens-Johnson syndrome,DE,CELECOXIB | Stevens-Johnson syndrome | DE,2025-02-24/2025-03-02
256336121,25633612,,,,20250801,,ZEPBOUND,Therapeutic response changed,,ZEPBOUND | Therapeutic response changed,NaT
256336541,25633654,39,M,,20250801,,ZEPBOUND,Therapy change,DS,ZEPBOUND | Therapy change | DS,NaT
256336581,25633658,61,F,,20250801,,KRAZATI,Blood creatine increased,,KRAZATI | Blood creatine increased,NaT
256336861,25633686,,,,20250801,,TADALAFIL,Hospitalisation,,TADALAFIL | Hospitalisation,NaT
256337052,25633705,43,F,2025-07-17,20250909,,EPIPEN,Drug dose omission by device,,EPIPEN | Drug dose omission by device,2025-07-14/2025-07-20
256337191,25633719,,F,,20250801,,NUCALA,Product dose omission issue,,NUCALA | Product dose omission issue,NaT
256337952,25633795,80,,2025-07-26,20250828,,ELREXFIO,Uveitis,OT,ELREXFIO | Uveitis | OT,2025-07-21/2025-07-27
256338191,25633819,40,M,2025-07-26,20250801,,ELOCTATE,Swelling,,ELOCTATE | Swelling,2025-07-21/2025-07-27
256338701,25633870,56,M,,20250801,,REZUROCK,Dehydration,,REZUROCK | Dehydration,NaT
256340821,25634082,79,F,2024-01-16,20250801,,ABEMACICLIB,Gastrointestinal toxicity,OT,ABEMACICLIB | Gastrointestinal toxicity | OT,2024-01-15/2024-01-21
256341031,25634103,69,M,2025-05-01,20250801,,GOLIMUMAB,Pulmonary tuberculosis,HO,GOLIMUMAB | Pulmonary tuberculosis | HO,2025-04-28/2025-05-04
256341051,25634105,,,,20250801,,ORGOVYX,Prostatic operation,OT,ORGOVYX | Prostatic operation | OT,NaT
256342041,25634204,,F,,20250801,,BOTOX COSMETIC,Off label use,,BOTOX COSMETIC | Off label use,NaT
256342401,25634240,69,F,,20250801,,MOUNJARO,Injection site bruising,,MOUNJARO | Injection site bruising,NaT
256343021,25634302,26,,,20250801,,RISANKIZUMAB,Product storage error,,RISANKIZUMAB | Product storage error,NaT
256343341,25634334,,F,,20250801,,CORTICOTROPIN,Multiple sclerosis relapse,OT,CORTICOTROPIN | Multiple sclerosis relapse | OT,NaT
256343591,25634359,,F,,20250801,,NUCALA,Illness,,NUCALA | Illness,NaT
256343632,25634363,74,F,,20250821,,XPHOZAH,No adverse event,,XPHOZAH | No adverse event,NaT
256343868,25634386,33,F,2025-03-01,20250819,,DYSPORT,Off label use,OT,DYSPORT | Off label use | OT,2025-02-24/2025-03-02
256345441,25634544,,,,20250801,,XDEMVY,Drug ineffective,,XDEMVY | Drug ineffective,NaT
256345552,25634555,,,,20250814,,XDEMVY,Eye irritation,,XDEMVY | Eye irritation,NaT
256346501,25634650,73,F,,20250801,,NITRIC OXIDE,Multiple organ dysfunction syndrome,DE,NITRIC OXIDE | Multiple organ dysfunction syndrome | DE,NaT
256346701,25634670,76,F,,20250801,,BARICITINIB,Neoplasm malignant,OT,BARICITINIB | Neoplasm malignant | OT,NaT
256348301,25634830,63,M,2025-05-19,20250801,,AMIODARONE,Acute respiratory distress syndrome,LT,AMIODARONE | Acute respiratory distress syndrome | LT,2025-05-19/2025-05-25
256349731,25634973,,F,,20250801,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,NaT
256350191,25635019,5,,,20250801,,VOXZOGO,Injection site pain,,VOXZOGO | Injection site pain,NaT
256350451,25635045,,F,,20250801,,HUMALOG,Renal failure,DE,HUMALOG | Renal failure | DE,NaT
256350851,25635085,73,,,20250802,,TEZSPIRE,Dyspnoea,,TEZSPIRE | Dyspnoea,NaT
256351131,25635113,,,,20250802,,BENLYSTA,Off label use,,BENLYSTA | Off label use,NaT
256353001,25635300,38,F,2025-07-31,20250802,,WAINUA,Abdominal discomfort,,WAINUA | Abdominal discomfort,2025-07-28/2025-08-03
256353701,25635370,78,F,,20250802,,PACLITAXEL,Pneumonitis,DE,PACLITAXEL | Pneumonitis | DE,NaT
256354491,25635449,,,2025-01-01,20250802,,LENALIDOMIDE,Rash,,LENALIDOMIDE | Rash,2024-12-30/2025-01-05
256354551,25635455,,,,20250802,,ISOTRETINOIN,Product use issue,,ISOTRETINOIN | Product use issue,NaT
256354601,25635460,,,2025-07-14,20250802,,ISOTRETINOIN,Product dispensing issue,,ISOTRETINOIN | Product dispensing issue,2025-07-14/2025-07-20
256355091,25635509,,,,20250802,,CLOPIDOGREL,Myocardial infarction,OT,CLOPIDOGREL | Myocardial infarction | OT,NaT
256355561,25635556,52,F,2024-06-01,20250802,,ANASTROZOLE,Impaired healing,OT,ANASTROZOLE | Impaired healing | OT,2024-05-27/2024-06-02
256355641,25635564,28,F,2025-07-28,20250802,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,2025-07-28/2025-08-03
256355712,25635571,74,F,2025-06-01,20250904,,TREPROSTINIL SODIUM,Dyspnoea exertional,OT,TREPROSTINIL SODIUM | Dyspnoea exertional | OT,2025-05-26/2025-06-01
256355731,25635573,20,F,2025-01-01,20250802,,DUPIXENT,Inappropriate schedule of product administration,,DUPIXENT | Inappropriate schedule of product administration,2024-12-30/2025-01-05
256355791,25635579,,M,,20250802,,DOCETAXEL,Prostatic specific antigen increased,OT,DOCETAXEL | Prostatic specific antigen increased | OT,NaT
256355831,25635583,76,F,,20250802,,EMGALITY,Injection site pain,,EMGALITY | Injection site pain,NaT
256356401,25635640,15,,,20250802,,IBUPROFEN,Angioedema,OT,IBUPROFEN | Angioedema | OT,NaT
256356581,25635658,52,F,,20250802,,BELIMUMAB,Systemic lupus erythematosus,OT,BELIMUMAB | Systemic lupus erythematosus | OT,NaT
256358001,25635800,37,F,,20250802,,TRULICITY,Injection site bruising,,TRULICITY | Injection site bruising,NaT
256358091,25635809,,,2025-07-31,20250802,,OMVOH,Inappropriate schedule of product administration,,OMVOH | Inappropriate schedule of product administration,2025-07-28/2025-08-03
256358161,25635816,53,F,,20250802,,ZEPBOUND,Underdose,,ZEPBOUND | Underdose,NaT
256358561,25635856,,M,,20250802,,RAMIPRIL,Tongue injury,OT,RAMIPRIL | Tongue injury | OT,NaT
256359031,25635903,62,F,2025-01-01,20250802,,AZACITIDINE,Off label use,OT,AZACITIDINE | Off label use | OT,2024-12-30/2025-01-05
256359041,25635904,70,M,2025-04-02,20250802,,CARBOPLATIN,Gastroenteritis,HO,CARBOPLATIN | Gastroenteritis | HO,2025-03-31/2025-04-06
256359131,25635913,23,F,2025-05-27,20250802,,CITALOPRAM,Electrocardiogram QT prolonged,HO,CITALOPRAM | Electrocardiogram QT prolonged | HO,2025-05-26/2025-06-01
256359471,25635947,29,M,2025-06-01,20250803,,DUPIXENT,Dry eye,,DUPIXENT | Dry eye,2025-05-26/2025-06-01
256359801,25635980,64,F,2025-05-01,20250803,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,2025-04-28/2025-05-04
256360511,25636051,,,,20250803,,ZEPBOUND,Drug intolerance,,ZEPBOUND | Drug intolerance,NaT
256361421,25636142,,,,20250803,,FINASTERIDE,Arthralgia,OT,FINASTERIDE | Arthralgia | OT,NaT
256361501,25636150,,,,20250803,,DUPIXENT,Exposure via skin contact,,DUPIXENT | Exposure via skin contact,NaT
256362221,25636222,69,F,,20250803,,CYCLOPHOSPHAMIDE,Cardiac failure,OT,CYCLOPHOSPHAMIDE | Cardiac failure | OT,NaT
256362431,25636243,66,M,,20250803,,OMEPRAZOLE,Hypocalcaemia,HO,OMEPRAZOLE | Hypocalcaemia | HO,NaT
256362562,25636256,35,F,,20250829,,MICAFUNGIN,Drug ineffective,LT,MICAFUNGIN | Drug ineffective | LT,NaT
256363202,25636320,32,F,,20250901,,RISPERDAL,Treatment noncompliance,HO,RISPERDAL | Treatment noncompliance | HO,NaT
256363551,25636355,,M,,20250803,,HUMIRA,Road traffic accident,HO,HUMIRA | Road traffic accident | HO,NaT
256364191,25636419,65,M,,20250803,,REVLIMID,Product dose omission issue,,REVLIMID | Product dose omission issue,NaT
256364712,25636471,,M,,20250811,,PLUVICTO,Therapy non-responder,,PLUVICTO | Therapy non-responder,NaT
256365141,25636514,68,F,2025-01-01,20250804,,DUPIXENT,Arthralgia,,DUPIXENT | Arthralgia,2024-12-30/2025-01-05
256365882,25636588,54,F,2024-01-01,20250829,,RINVOQ,Diarrhoea,HO,RINVOQ | Diarrhoea | HO,2024-01-01/2024-01-07
256366071,25636607,,F,,20250804,,RESTASIS,Product storage error,,RESTASIS | Product storage error,NaT
256366081,25636608,,,,20250804,,AVASTIN,Off label use,,AVASTIN | Off label use,NaT
256366541,25636654,55,F,,20250804,,ATORVASTATIN,Brain fog,DS,ATORVASTATIN | Brain fog | DS,NaT
256366592,25636659,49,F,2024-10-01,20250812,,TEZSPIRE,Drug ineffective,,TEZSPIRE | Drug ineffective,2024-09-30/2024-10-06
256367721,25636772,87,M,,20250804,,FINASTERIDE,Depressed mood,OT,FINASTERIDE | Depressed mood | OT,NaT
256368001,25636800,,M,,20250804,,DUPIXENT,Intentional dose omission,,DUPIXENT | Intentional dose omission,NaT
256368061,25636806,,F,,20250804,,DUPIXENT,Rebound atopic dermatitis,,DUPIXENT | Rebound atopic dermatitis,NaT
256368441,25636844,,,2024-08-01,20250804,,TERBINAFINE,Rash,,TERBINAFINE | Rash,2024-07-29/2024-08-04
256368511,25636851,,F,,20250804,,ACTEMRA ACTPEN,Weight decreased,,ACTEMRA ACTPEN | Weight decreased,NaT
256368521,25636852,,M,,20250804,,ACTEMRA ACTPEN,Thrombosis,,ACTEMRA ACTPEN | Thrombosis,NaT
256369012,25636901,67,F,,20250808,,TEZSPIRE,Drug ineffective,,TEZSPIRE | Drug ineffective,NaT
256369241,25636924,70,M,,20250804,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
256369452,25636945,70,F,2024-01-01,20250828,,METFORMIN,Gastrointestinal haemorrhage,OT,METFORMIN | Gastrointestinal haemorrhage | OT,2024-01-01/2024-01-07
256369561,25636956,55,F,2018-06-01,20250804,,DOCETAXEL,Scleral disorder,,DOCETAXEL | Scleral disorder,2018-05-28/2018-06-03
256369631,25636963,,,,20250804,,VIGADRONE,Septic shock,HO,VIGADRONE | Septic shock | HO,NaT
256369993,25636999,82,M,2025-07-29,20250908,,TREMFYA,Product dose omission issue,,TREMFYA | Product dose omission issue,2025-07-28/2025-08-03
256370181,25637018,21,F,2025-07-11,20250804,,PROGRAF,Pneumatosis intestinalis,HO,PROGRAF | Pneumatosis intestinalis | HO,2025-07-07/2025-07-13
256370891,25637089,63,M,,20250804,,DASATINIB,Diarrhoea,,DASATINIB | Diarrhoea,NaT
256371031,25637103,,M,,20250804,,NUPLAZID,Death,OT,NUPLAZID | Death | OT,NaT
256371771,25637177,76,M,2025-05-10,20250804,,AMIODARONE,Eosinophilia,HO,AMIODARONE | Eosinophilia | HO,2025-05-05/2025-05-11
256372251,25637225,63,M,2025-07-18,20250804,,VYALEV,Infusion site rash,,VYALEV | Infusion site rash,2025-07-14/2025-07-20
256373931,25637393,16,,,20250804,,CHILDRENS IBUPROFEN,Urticaria,OT,CHILDRENS IBUPROFEN | Urticaria | OT,NaT
256374032,25637403,61,M,,20250908,,ARIKAYCE,Respiratory failure,DE,ARIKAYCE | Respiratory failure | DE,NaT
256375861,25637586,24,M,2024-05-01,20250804,,FINTEPLA,Hallucination,OT,FINTEPLA | Hallucination | OT,2024-04-29/2024-05-05
256375911,25637591,53,M,,20250804,,LISINOPRIL,Angioedema,HO,LISINOPRIL | Angioedema | HO,NaT
256377031,25637703,61,M,,20250804,,MOUNJARO,Injection site pain,,MOUNJARO | Injection site pain,NaT
256377281,25637728,,,,20250804,,LINZESS,Off label use,,LINZESS | Off label use,NaT
256377391,25637739,,,,20250804,,NICODERM CQ,Product quality issue,,NICODERM CQ | Product quality issue,NaT
256378991,25637899,92,F,,20250804,,LENALIDOMIDE,Dysphagia,,LENALIDOMIDE | Dysphagia,NaT
256379251,25637925,,F,,20250804,,GAMMAGARD LIQUID,Blood pressure increased,,GAMMAGARD LIQUID | Blood pressure increased,NaT
256380501,25638050,,,,20250804,,HUMIRA,Product storage error,,HUMIRA | Product storage error,NaT
256381111,25638111,80,F,,20250804,,REVLIMID,Rash,,REVLIMID | Rash,NaT
256381171,25638117,87,F,,20250804,,ROSUVASTATIN CALCIUM,Tension headache,OT,ROSUVASTATIN CALCIUM | Tension headache | OT,NaT
256381322,25638132,45,M,2025-07-01,20250808,,CABOTEGRAVIR\RILPIVIRINE,Poor quality product administered,,CABOTEGRAVIR\RILPIVIRINE | Poor quality product administered,2025-06-30/2025-07-06
256382051,25638205,,F,,20250804,,NUCALA,Asthma,,NUCALA | Asthma,NaT
256382531,25638253,65,M,,20250804,,DAPTOMYCIN,No adverse event,OT,DAPTOMYCIN | No adverse event | OT,NaT
256383121,25638312,88,M,,20250804,,METHOTREXATE,Myocardial infarction,DE,METHOTREXATE | Myocardial infarction | DE,NaT
256383301,25638330,,F,,20250804,,NUCALA,Injection site bruising,,NUCALA | Injection site bruising,NaT
256383411,25638341,,F,,20250804,,SOTYKTU,Psoriatic arthropathy,,SOTYKTU | Psoriatic arthropathy,NaT
256383421,25638342,26,F,2025-07-11,20250804,,EPIRUBICIN,Drug-induced liver injury,OT,EPIRUBICIN | Drug-induced liver injury | OT,2025-07-07/2025-07-13
256383921,25638392,71,F,2025-07-31,20250801,,LENALIDOMIDE,Vomiting,HO,LENALIDOMIDE | Vomiting | HO,2025-07-28/2025-08-03
256383981,25638398,,F,,20250804,,LUPKYNIS,Illness,,LUPKYNIS | Illness,NaT
256384131,25638413,26,M,2025-04-01,20250804,,LUPKYNIS,Product use issue,,LUPKYNIS | Product use issue,2025-03-31/2025-04-06
256385111,25638511,29,F,2025-06-21,20250804,,ACETAMINOPHEN,Hepatic cytolysis,OT,ACETAMINOPHEN | Hepatic cytolysis | OT,2025-06-16/2025-06-22
256385141,25638514,,F,,20250804,,CLOZARIL,Mental impairment,OT,CLOZARIL | Mental impairment | OT,NaT
256385651,25638565,,F,,20250804,,LUPKYNIS,Product dose omission issue,,LUPKYNIS | Product dose omission issue,NaT
256385911,25638591,,M,,20250804,,LUPKYNIS,Inappropriate schedule of product administration,,LUPKYNIS | Inappropriate schedule of product administration,NaT
256386691,25638669,,F,,20250804,,LUPKYNIS,Off label use,,LUPKYNIS | Off label use,NaT
256387141,25638714,,F,,20250804,,LUPKYNIS,Dizziness,,LUPKYNIS | Dizziness,NaT
256387411,25638741,49,M,,20250804,,ZEPBOUND,Off label use,,ZEPBOUND | Off label use,NaT
256388211,25638821,,M,,20250804,,LUPKYNIS,Pruritus,,LUPKYNIS | Pruritus,NaT
256388391,25638839,,F,,20250804,,LUPKYNIS,Therapy interrupted,,LUPKYNIS | Therapy interrupted,NaT
256388401,25638840,,M,,20250804,,LUPKYNIS,Weight increased,,LUPKYNIS | Weight increased,NaT
256388411,25638841,,F,,20250804,,LUPKYNIS,Nausea,,LUPKYNIS | Nausea,NaT
256388801,25638880,77,F,,20250802,,BRAFTOVI,Death,DE,BRAFTOVI | Death | DE,NaT
256389521,25638952,,F,,20250804,,LUPKYNIS,Illness,,LUPKYNIS | Illness,NaT
256389771,25638977,21,F,2025-02-10,20250804,,LUPKYNIS,Abdominal pain upper,,LUPKYNIS | Abdominal pain upper,2025-02-10/2025-02-16
256389831,25638983,51,M,2025-06-01,20250804,,OPDIVO,Blood thyroid stimulating hormone increased,HO,OPDIVO | Blood thyroid stimulating hormone increased | HO,2025-05-26/2025-06-01
256389861,25638986,,F,,20250804,,LUPKYNIS,Fatigue,,LUPKYNIS | Fatigue,NaT
256390491,25639049,,F,,20250804,,LUPKYNIS,Blood pressure increased,,LUPKYNIS | Blood pressure increased,NaT
256390511,25639051,,M,,20250804,,LUPKYNIS,Product dose omission issue,,LUPKYNIS | Product dose omission issue,NaT
256392131,25639213,42,F,2025-02-20,20250804,,LUPKYNIS,Renal impairment,OT,LUPKYNIS | Renal impairment | OT,2025-02-17/2025-02-23
256392511,25639251,,F,,20250804,,XOLAIR,Idiopathic urticaria,,XOLAIR | Idiopathic urticaria,NaT
256392561,25639256,,F,,20250804,,LUPKYNIS,Abdominal discomfort,,LUPKYNIS | Abdominal discomfort,NaT
256393231,25639323,78,F,2025-05-08,20250804,,RIFAMPIN,Drug reaction with eosinophilia and systemic symptoms,OT,RIFAMPIN | Drug reaction with eosinophilia and systemic symptoms | OT,2025-05-05/2025-05-11
256395111,25639511,,,2025-06-02,20250804,,GADOBUTROL,Throat irritation,,GADOBUTROL | Throat irritation,2025-06-02/2025-06-08
256395331,25639533,65,M,2024-12-26,20250804,,TRULICITY,Pancreatic carcinoma,HO,TRULICITY | Pancreatic carcinoma | HO,2024-12-23/2024-12-29
256396011,25639601,,,,20250804,,ADALIMUMAB,Cystitis,HO,ADALIMUMAB | Cystitis | HO,NaT
256396041,25639604,,F,,20250804,,LUPKYNIS,Product dose omission issue,,LUPKYNIS | Product dose omission issue,NaT
256396821,25639682,,M,2025-01-01,20250804,,XYZAL,Product use issue,,XYZAL | Product use issue,2024-12-30/2025-01-05
256397061,25639706,73,M,2024-12-27,20250804,,SODIUM CHLORIDE,White blood cell count decreased,OT,SODIUM CHLORIDE | White blood cell count decreased | OT,2024-12-23/2024-12-29
256398761,25639876,,F,,20250804,,LUPKYNIS,Urinary tract infection,,LUPKYNIS | Urinary tract infection,NaT
256398832,25639883,10,F,,20250915,,REXULTI,Cardiac failure,OT,REXULTI | Cardiac failure | OT,NaT
256399381,25639938,,M,,20250804,,LUPKYNIS,Vitamin B12 decreased,,LUPKYNIS | Vitamin B12 decreased,NaT
256399861,25639986,61,F,2025-02-01,20250804,,LUPKYNIS,Diarrhoea,,LUPKYNIS | Diarrhoea,2025-01-27/2025-02-02
256400021,25640002,,F,,20250804,,LUPKYNIS,Headache,,LUPKYNIS | Headache,NaT
256400672,25640067,,,,20250923,,GENOTROPIN,Device leakage,,GENOTROPIN | Device leakage,NaT
256400801,25640080,,M,,20250804,,SKYRIZI,Surgery,OT,SKYRIZI | Surgery | OT,NaT
256400921,25640092,89,F,,20250804,,APIXABAN,Product prescribing issue,HO,APIXABAN | Product prescribing issue | HO,NaT
256401131,25640113,,F,,20250804,,MIRENA,Hand dermatitis,,MIRENA | Hand dermatitis,NaT
256401601,25640160,84,F,2025-01-01,20250804,,SKYRIZI,Abdominal pain,HO,SKYRIZI | Abdominal pain | HO,2024-12-30/2025-01-05
256402571,25640257,75,F,,20250804,,ENBREL,Road traffic accident,HO,ENBREL | Road traffic accident | HO,NaT
256402662,25640266,,,,20250807,,SKYRIZI,Blood immunoglobulin A increased,,SKYRIZI | Blood immunoglobulin A increased,NaT
256404441,25640444,,F,,20250804,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,NaT
256404521,25640452,53,M,,20250804,,ALPRAZOLAM,Withdrawal syndrome,HO,ALPRAZOLAM | Withdrawal syndrome | HO,NaT
256404771,25640477,77,M,,20250804,,POMALYST,Mental impairment,OT,POMALYST | Mental impairment | OT,NaT
256405071,25640507,,,,20250804,,RISANKIZUMAB,Product storage error,,RISANKIZUMAB | Product storage error,NaT
256405092,25640509,,,,20250806,,BOTOX COSMETIC,Product quality issue,,BOTOX COSMETIC | Product quality issue,NaT
256405101,25640510,,,,20250804,,ETHINYL ESTRADIOL\NORETHINDRONE ACETATE,Product substitution issue,,ETHINYL ESTRADIOL\NORETHINDRONE ACETATE | Product substitution issue,NaT
256405261,25640526,15,F,2025-01-01,20250804,,VIMIZIM,Cervical radiculopathy,OT,VIMIZIM | Cervical radiculopathy | OT,2024-12-30/2025-01-05
256405461,25640546,,F,2025-06-04,20250804,,ESTRADIOL,Product adhesion issue,,ESTRADIOL | Product adhesion issue,2025-06-02/2025-06-08
256405871,25640587,67,F,,20250804,,NICOTINE,Abnormal dreams,,NICOTINE | Abnormal dreams,NaT
256406141,25640614,,M,,20250804,,LINEZOLID,Upper gastrointestinal haemorrhage,HO,LINEZOLID | Upper gastrointestinal haemorrhage | HO,NaT
256406511,25640651,,F,,20250804,,PREDNISOLONE,Depression,OT,PREDNISOLONE | Depression | OT,NaT
256406591,25640659,68,F,,20250804,,MOUNJARO,Cholecystitis infective,HO,MOUNJARO | Cholecystitis infective | HO,NaT
256407381,25640738,70,,,20250804,,TRULICITY,Dehydration,HO,TRULICITY | Dehydration | HO,NaT
256407681,25640768,,F,,20250804,,BOTOX COSMETIC,Product storage error,,BOTOX COSMETIC | Product storage error,NaT
256407721,25640772,,M,,20250804,,ABILIFY,Blepharitis,OT,ABILIFY | Blepharitis | OT,NaT
256409201,25640920,74,F,,20250804,,BENRALIZUMAB,Hypertension,OT,BENRALIZUMAB | Hypertension | OT,NaT
256409921,25640992,56,,,20250804,,LANTUS SOLOSTAR,Off label use,,LANTUS SOLOSTAR | Off label use,NaT
256410081,25641008,74,M,2025-01-01,20250804,,DUPIXENT,Neurodermatitis,,DUPIXENT | Neurodermatitis,2024-12-30/2025-01-05
256410171,25641017,16,M,2025-01-01,20250804,,DUPIXENT,Dry skin,,DUPIXENT | Dry skin,2024-12-30/2025-01-05
256410231,25641023,,M,,20250804,,DUPIXENT,Psoriasis,,DUPIXENT | Psoriasis,NaT
256410431,25641043,58,M,2025-01-01,20250804,,DUPIXENT,Dry skin,,DUPIXENT | Dry skin,2024-12-30/2025-01-05
256411831,25641183,59,F,2025-01-01,20250804,,DUPIXENT,Asthma,,DUPIXENT | Asthma,2024-12-30/2025-01-05
256411962,25641196,24,M,,20250818,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
256412191,25641219,,M,,20250804,,DUPIXENT,Dermatitis psoriasiform,,DUPIXENT | Dermatitis psoriasiform,NaT
256412331,25641233,62,F,,20250804,,LANTUS SOLOSTAR,Off label use,,LANTUS SOLOSTAR | Off label use,NaT
256414673,25641467,,F,2025-01-01,20250923,,CORTICOTROPIN,Hordeolum,OT,CORTICOTROPIN | Hordeolum | OT,2024-12-30/2025-01-05
256414722,25641472,,F,,20250829,,CORTICOTROPIN,Fluid retention,OT,CORTICOTROPIN | Fluid retention | OT,NaT
256414791,25641479,74,F,2025-07-01,20250804,,CORTICOTROPIN,Skin disorder,,CORTICOTROPIN | Skin disorder,2025-06-30/2025-07-06
256414911,25641491,85,M,,20250804,,VYNDAMAX,Bradycardia,OT,VYNDAMAX | Bradycardia | OT,NaT
256416671,25641667,,F,2025-08-01,20250804,,TRODELVY,Disease progression,OT,TRODELVY | Disease progression | OT,2025-07-28/2025-08-03
256416771,25641677,,,,20250804,,PLUVICTO,General physical health deterioration,,PLUVICTO | General physical health deterioration,NaT
256418941,25641894,,,,20250804,,REPATHA,Pain in jaw,,REPATHA | Pain in jaw,NaT
256419262,25641926,66,F,2025-07-01,20250919,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,2025-06-30/2025-07-06
256419451,25641945,,,,20250804,,DOCETAXEL,Erythema multiforme,OT,DOCETAXEL | Erythema multiforme | OT,NaT
256419571,25641957,,M,,20250804,,LEVOFLOXACIN,Respiratory failure,LT,LEVOFLOXACIN | Respiratory failure | LT,NaT
256419821,25641982,,F,,20250805,,SKYRIZI,Bladder disorder,OT,SKYRIZI | Bladder disorder | OT,NaT
256419941,25641994,,,,20250805,,TREMFYA,Neoplasm malignant,OT,TREMFYA | Neoplasm malignant | OT,NaT
256420015,25642001,,M,2025-01-01,20250917,,REMODULIN,Drug hypersensitivity,,REMODULIN | Drug hypersensitivity,2024-12-30/2025-01-05
256420691,25642069,69,M,2025-07-11,20250805,,EZETIMIBE,Dyspnoea,OT,EZETIMIBE | Dyspnoea | OT,2025-07-07/2025-07-13
256420961,25642096,,M,,20250805,,DURVALUMAB,Disease progression,OT,DURVALUMAB | Disease progression | OT,NaT
256421191,25642119,,M,,20250805,,ZEPBOUND,Melaena,,ZEPBOUND | Melaena,NaT
256422731,25642273,69,F,2025-07-01,20250805,,GABAPENTIN,Accidental exposure to product,,GABAPENTIN | Accidental exposure to product,2025-06-30/2025-07-06
256423211,25642321,63,M,2023-01-01,20250805,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,2022-12-26/2023-01-01
256423631,25642363,,M,,20250805,,HUMATE-P,Basal cell carcinoma,OT,HUMATE-P | Basal cell carcinoma | OT,NaT
256423791,25642379,,F,,20250805,,CLORAZEPATE DIPOTASSIUM,Poor quality product administered,,CLORAZEPATE DIPOTASSIUM | Poor quality product administered,NaT
256425201,25642520,25,F,2025-07-17,20250805,,EMTRICITABINE\TENOFOVIR DISOPROXIL,Maternal exposure during pregnancy,OT,EMTRICITABINE\TENOFOVIR DISOPROXIL | Maternal exposure during pregnancy | OT,2025-07-14/2025-07-20
256425491,25642549,47,F,,20250805,,OMEPRAZOLE,Vomiting,OT,OMEPRAZOLE | Vomiting | OT,NaT
256425791,25642579,89,M,2013-01-01,20250805,,ELIGARD,Off label use,DE,ELIGARD | Off label use | DE,2012-12-31/2013-01-06
256425901,25642590,,M,2025-05-01,20250805,,BRIVIACT,Hypokalaemia,OT,BRIVIACT | Hypokalaemia | OT,2025-04-28/2025-05-04
256426363,25642636,61,F,2025-01-01,20250818,,SKYRIZI,Haemoglobin decreased,HO,SKYRIZI | Haemoglobin decreased | HO,2024-12-30/2025-01-05
256427361,25642736,67,F,,20250805,,CARVEDILOL,Ventricular hypokinesia,HO,CARVEDILOL | Ventricular hypokinesia | HO,NaT
256427392,25642739,73,F,2025-02-05,20250807,,NUPLAZID,Hallucination,OT,NUPLAZID | Hallucination | OT,2025-02-03/2025-02-09
256427531,25642753,74,F,,20250805,,VERZENIO,Illness,,VERZENIO | Illness,NaT
256428271,25642827,,,2023-01-04,20250805,,RITUXIMAB,Lymphadenopathy,OT,RITUXIMAB | Lymphadenopathy | OT,2023-01-02/2023-01-08
256429111,25642911,,,,20250805,,TALIMOGENE LAHERPAREPVEC,Adverse event,OT,TALIMOGENE LAHERPAREPVEC | Adverse event | OT,NaT
256429481,25642948,,F,,20250805,,REVLIMID,Product dispensing error,,REVLIMID | Product dispensing error,NaT
256430011,25643001,,,,20250805,,ZYRTEC,Lethargy,,ZYRTEC | Lethargy,NaT
256431712,25643171,71,F,2025-06-01,20250925,,ZEPBOUND,Fatigue,,ZEPBOUND | Fatigue,2025-05-26/2025-06-01
256433381,25643338,,F,,20250805,,TREMFYA,Adverse event,,TREMFYA | Adverse event,NaT
256433621,25643362,5,,,20250805,,IBUPROFEN,Cross sensitivity reaction,OT,IBUPROFEN | Cross sensitivity reaction | OT,NaT
256433911,25643391,,,,20250805,,ZEPBOUND,Gastritis,,ZEPBOUND | Gastritis,NaT
256433921,25643392,,F,,20250805,,LISINOPRIL,Blood potassium increased,,LISINOPRIL | Blood potassium increased,NaT
256434281,25643428,68,M,2023-01-01,20250805,,SPIRIVA RESPIMAT,Condition aggravated,,SPIRIVA RESPIMAT | Condition aggravated,2022-12-26/2023-01-01
256434421,25643442,47,F,,20250805,,MYCOPHENOLATE MOFETIL,Renal failure,OT,MYCOPHENOLATE MOFETIL | Renal failure | OT,NaT
256434921,25643492,,,,20250805,,ADALIMUMAB,Loss of therapeutic response,OT,ADALIMUMAB | Loss of therapeutic response | OT,NaT
256435161,25643516,,F,,20250805,,DUPIXENT,Faecal vomiting,OT,DUPIXENT | Faecal vomiting | OT,NaT
256435551,25643555,,,2025-06-26,20250805,,DULOXETINE,Drug interaction,HO,DULOXETINE | Drug interaction | HO,2025-06-23/2025-06-29
256436041,25643604,75,F,2025-07-25,20250805,,SERTRALINE,Blood glucose increased,OT,SERTRALINE | Blood glucose increased | OT,2025-07-21/2025-07-27
256437661,25643766,55,F,,20250805,,ZEPBOUND,Injection site pain,,ZEPBOUND | Injection site pain,NaT
256438231,25643823,,F,2025-07-25,20250805,,XOLAIR,Headache,,XOLAIR | Headache,2025-07-21/2025-07-27
256438531,25643853,,F,,20250805,,COSENTYX,Pallor,,COSENTYX | Pallor,NaT
256438811,25643881,,F,,20250805,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
256440661,25644066,,F,,20250805,,ZEJULA,Recurrent cancer,OT,ZEJULA | Recurrent cancer | OT,NaT
256440961,25644096,50,F,2025-04-12,20250803,,WEGOVY,Fournier's gangrene,HO,WEGOVY | Fournier's gangrene | HO,2025-04-07/2025-04-13
256441281,25644128,40,M,,20250805,,NICARDIPINE,Angioedema,OT,NICARDIPINE | Angioedema | OT,NaT
256441301,25644130,40,F,,20250805,,LITHIUM,Toxicity to various agents,OT,LITHIUM | Toxicity to various agents | OT,NaT
256441821,25644182,85,M,2025-04-23,20250805,,HEPARIN SODIUM,Drug interaction,LT,HEPARIN SODIUM | Drug interaction | LT,2025-04-21/2025-04-27
256441971,25644197,,F,,20250805,,BENLYSTA,Drug ineffective,,BENLYSTA | Drug ineffective,NaT
256443201,25644320,,F,,20250805,,SOLIRIS,Off label use,OT,SOLIRIS | Off label use | OT,NaT
256444044,25644404,13,F,,20250917,,GENOTROPIN,Device use issue,,GENOTROPIN | Device use issue,NaT
256444641,25644464,,,,20250805,,MIRALAX,Product prescribing issue,,MIRALAX | Product prescribing issue,NaT
256445401,25644540,50,,,20250805,,TRULICITY,Abdominal distension,OT,TRULICITY | Abdominal distension | OT,NaT
256445662,25644566,,,,20250807,,GAVILYTE G,Circumstance or information capable of leading to medication error,,GAVILYTE G | Circumstance or information capable of leading to medication error,NaT
256445861,25644586,57,M,,20250805,,CARBOPLATIN,Urticaria,OT,CARBOPLATIN | Urticaria | OT,NaT
256446261,25644626,14,F,,20250804,,HUMIRA,Pain,,HUMIRA | Pain,NaT
256446461,25644646,,F,,20250805,,XOLAIR PFS,Muscle twitching,,XOLAIR PFS | Muscle twitching,NaT
256447591,25644759,49,F,,20250805,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,NaT
256447681,25644768,4,F,2025-07-01,20250805,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2025-06-30/2025-07-06
256448191,25644819,40,M,2025-07-01,20250805,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2025-06-30/2025-07-06
256448411,25644841,,F,,20250805,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,NaT
256448531,25644853,71,M,,20250805,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,NaT
256448682,25644868,16,F,,20250919,,DUPIXENT,Eczema,,DUPIXENT | Eczema,NaT
256449231,25644923,86,F,,20250805,,DUPIXENT,Weight increased,,DUPIXENT | Weight increased,NaT
256449731,25644973,78,M,2024-12-06,20250805,,LEQEMBI,Cerebrovascular accident,OT,LEQEMBI | Cerebrovascular accident | OT,2024-12-02/2024-12-08
256450221,25645022,26,F,2025-07-31,20250805,,KYLEENA,Device dislocation,,KYLEENA | Device dislocation,2025-07-28/2025-08-03
256450801,25645080,67,M,2023-04-04,20250805,,LENVIMA,Rash,HO,LENVIMA | Rash | HO,2023-04-03/2023-04-09
256452882,25645288,40,M,2025-07-31,20250806,,RUXIENCE,Blood pressure fluctuation,OT,RUXIENCE | Blood pressure fluctuation | OT,2025-07-28/2025-08-03
256452971,25645297,57,F,2025-01-01,20250805,,SKYRIZI,Salmonellosis,HO,SKYRIZI | Salmonellosis | HO,2024-12-30/2025-01-05
256452981,25645298,88,F,2025-08-01,20250805,,CLARITIN REDITABS,Incorrect product administration duration,,CLARITIN REDITABS | Incorrect product administration duration,2025-07-28/2025-08-03
256453181,25645318,,M,,20250805,,BIMZELX,Death,DE,BIMZELX | Death | DE,NaT
256453331,25645333,,M,,20250804,,LENALIDOMIDE,Pyrexia,HO,LENALIDOMIDE | Pyrexia | HO,NaT
256453561,25645356,,M,,20250805,,COSENTYX,Myocardial infarction,OT,COSENTYX | Myocardial infarction | OT,NaT
256453942,25645394,4,M,,20250815,,PREDNISOLONE,Off label use,OT,PREDNISOLONE | Off label use | OT,NaT
256454381,25645438,,F,,20250805,,MOUNJARO,Pancreatitis,HO,MOUNJARO | Pancreatitis | HO,NaT
256454812,25645481,,F,,20250812,,GLATIRAMER ACETATE,Hospitalisation,HO,GLATIRAMER ACETATE | Hospitalisation | HO,NaT
256455551,25645555,89,M,2025-07-30,20250805,,TYLENOL WITH CODEINE,Product dispensing error,OT,TYLENOL WITH CODEINE | Product dispensing error | OT,2025-07-28/2025-08-03
256457141,25645714,,,,20250805,,PLUVICTO,General physical health deterioration,,PLUVICTO | General physical health deterioration,NaT
256457441,25645744,5,F,2025-07-13,20250805,,CYTARABINE,Rash,DS,CYTARABINE | Rash | DS,2025-07-07/2025-07-13
256459511,25645951,,,,20250805,,HUMIRA,Death,,HUMIRA | Death,NaT
256459551,25645955,68,F,2025-08-05,20250805,,REFRESH PLUS,Eye pruritus,DS,REFRESH PLUS | Eye pruritus | DS,2025-08-04/2025-08-10
256460011,25646001,56,F,,20250805,,ZEPBOUND,Dizziness,,ZEPBOUND | Dizziness,NaT
256460291,25646029,70,F,2025-07-27,20250805,,TOBREX,Eye pain,OT,TOBREX | Eye pain | OT,2025-07-21/2025-07-27
256460421,25646042,,,,20250805,,ZEPBOUND,Treatment failure,,ZEPBOUND | Treatment failure,NaT
256461461,25646146,53,,,20250805,,OZEMPIC,Impaired gastric emptying,OT,OZEMPIC | Impaired gastric emptying | OT,NaT
256461791,25646179,43,M,2025-07-25,20250805,,SKYRIZI,Cerebrovascular accident,OT,SKYRIZI | Cerebrovascular accident | OT,2025-07-21/2025-07-27
256461971,25646197,53,,2022-01-01,20250805,,OZEMPIC,Impaired gastric emptying,LT,OZEMPIC | Impaired gastric emptying | LT,2021-12-27/2022-01-02
256462411,25646241,60,F,2025-06-01,20250805,,SKYRIZI,Foot fracture,OT,SKYRIZI | Foot fracture | OT,2025-05-26/2025-06-01
256462531,25646253,30,F,,20250805,,RINVOQ,Maternal exposure during pregnancy,OT,RINVOQ | Maternal exposure during pregnancy | OT,NaT
256462982,25646298,32,M,,20250808,,ADCETRIS,Constipation,OT,ADCETRIS | Constipation | OT,NaT
256463131,25646313,78,F,2025-07-11,20250805,,FRUQUINTINIB,Protein urine present,OT,FRUQUINTINIB | Protein urine present | OT,2025-07-07/2025-07-13
256463241,25646324,,,2025-07-30,20250805,,SLYND,Dysmenorrhoea,,SLYND | Dysmenorrhoea,2025-07-28/2025-08-03
256463461,25646346,60,F,,20250805,,BUPROPION HYDROCHLORIDE,Toxicity to various agents,HO,BUPROPION HYDROCHLORIDE | Toxicity to various agents | HO,NaT
256463901,25646390,,F,2025-01-20,20250805,,BEOVU,Visual acuity reduced,OT,BEOVU | Visual acuity reduced | OT,2025-01-20/2025-01-26
256464861,25646486,,F,,20250805,,PEMBROLIZUMAB,Malignant neoplasm progression,DE,PEMBROLIZUMAB | Malignant neoplasm progression | DE,NaT
256466501,25646650,,,,20250805,,INVEGA SUSTENNA,Salivary hypersecretion,,INVEGA SUSTENNA | Salivary hypersecretion,NaT
256466561,25646656,60,F,2025-05-20,20250805,,VISIPAQUE,Pruritus,LT,VISIPAQUE | Pruritus | LT,2025-05-19/2025-05-25
256467621,25646762,,,,20250805,,PLUVICTO,General physical health deterioration,,PLUVICTO | General physical health deterioration,NaT
256469052,25646905,49,F,,20250818,,TRETINOIN,Respiratory failure,HO,TRETINOIN | Respiratory failure | HO,NaT
256469521,25646952,,M,2025-01-01,20250805,,TREPROSTINIL,Hypotension,HO,TREPROSTINIL | Hypotension | HO,2024-12-30/2025-01-05
256470391,25647039,30,M,,20250806,,MONTELUKAST,Dyspnoea,DE,MONTELUKAST | Dyspnoea | DE,NaT
256470751,25647075,77,F,2025-07-26,20250806,,ORENCIA,Peripheral swelling,,ORENCIA | Peripheral swelling,2025-07-21/2025-07-27
256471271,25647127,50,F,2024-10-18,20250806,,FILGRASTIM,Deep vein thrombosis,OT,FILGRASTIM | Deep vein thrombosis | OT,2024-10-14/2024-10-20
256471701,25647170,,F,,20250806,,BORTEZOMIB,Neuropathy peripheral,OT,BORTEZOMIB | Neuropathy peripheral | OT,NaT
256473021,25647302,66,,,20250806,,TRULICITY,Impaired gastric emptying,OT,TRULICITY | Impaired gastric emptying | OT,NaT
256473261,25647326,59,M,2025-07-28,20250806,,ATEZOLIZUMAB,Anaemia,HO,ATEZOLIZUMAB | Anaemia | HO,2025-07-28/2025-08-03
256474012,25647401,49,M,2025-06-17,20250818,,VEDOLIZUMAB,Anxiety,HO,VEDOLIZUMAB | Anxiety | HO,2025-06-16/2025-06-22
256474061,25647406,64,F,2024-01-01,20250806,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2024-01-01/2024-01-07
256474111,25647411,10,F,2025-01-01,20250806,,DUPIXENT,Inappropriate schedule of product administration,,DUPIXENT | Inappropriate schedule of product administration,2024-12-30/2025-01-05
256474931,25647493,,,2025-07-25,20250806,,VOWST,Gastrointestinal sounds abnormal,,VOWST | Gastrointestinal sounds abnormal,2025-07-21/2025-07-27
256475221,25647522,,F,2025-07-01,20250806,,SKYRIZI,Injection site bruising,,SKYRIZI | Injection site bruising,2025-06-30/2025-07-06
256475861,25647586,35,F,2025-07-23,20250806,,FINTEPLA,Mitral valve incompetence,OT,FINTEPLA | Mitral valve incompetence | OT,2025-07-21/2025-07-27
256476281,25647628,76,F,2025-07-29,20250806,,BREZTRI,Dysgeusia,,BREZTRI | Dysgeusia,2025-07-28/2025-08-03
256476991,25647699,50,F,,20250806,,MOUNJARO,Injection site haemorrhage,,MOUNJARO | Injection site haemorrhage,NaT
256477591,25647759,33,F,,20250806,,DICLOFENAC,Intentional product use issue,HO,DICLOFENAC | Intentional product use issue | HO,NaT
256477691,25647769,4,F,,20250806,,BUSULFAN,Febrile neutropenia,OT,BUSULFAN | Febrile neutropenia | OT,NaT
256479521,25647952,,,,20250806,,BOTOX COSMETIC,Off label use,,BOTOX COSMETIC | Off label use,NaT
256480481,25648048,33,F,,20250806,,PREDNISOLONE,Drug resistance,HO,PREDNISOLONE | Drug resistance | HO,NaT
256480951,25648095,25,M,,20250806,,ADBRY,Lacrimation increased,,ADBRY | Lacrimation increased,NaT
256481011,25648101,55,,,20250806,,MOUNJARO,Impaired gastric emptying,OT,MOUNJARO | Impaired gastric emptying | OT,NaT
256481481,25648148,,F,,20250806,,FASENRA,Muscular weakness,,FASENRA | Muscular weakness,NaT
256482282,25648228,50,M,,20250825,,DUPIXENT,Dysarthria,,DUPIXENT | Dysarthria,NaT
256482542,25648254,,,,20250918,,ELIGARD,Wrong technique in product usage process,,ELIGARD | Wrong technique in product usage process,NaT
256482641,25648264,,,,20250806,,BEVACIZUMAB,Colorectal cancer metastatic,OT,BEVACIZUMAB | Colorectal cancer metastatic | OT,NaT
256483081,25648308,,M,2024-10-15,20250806,,MUCINEX,Throat tightness,,MUCINEX | Throat tightness,2024-10-14/2024-10-20
256483691,25648369,61,F,2025-04-30,20250806,,ATORVASTATIN,Musculoskeletal chest pain,HO,ATORVASTATIN | Musculoskeletal chest pain | HO,2025-04-28/2025-05-04
256483731,25648373,,M,,20250806,,ERIVEDGE,Muscle spasms,,ERIVEDGE | Muscle spasms,NaT
256484911,25648491,,F,2025-08-01,20250806,,IMJUDO,Dysphagia,OT,IMJUDO | Dysphagia | OT,2025-07-28/2025-08-03
256485491,25648549,57,F,2025-03-25,20250806,,LENACAPAVIR,Death,DE,LENACAPAVIR | Death | DE,2025-03-24/2025-03-30
256485692,25648569,44,M,2025-04-27,20250822,,SKYRIZI,Appendicitis,HO,SKYRIZI | Appendicitis | HO,2025-04-21/2025-04-27
256485751,25648575,78,M,,20250806,,GEMCITABINE,Pneumocystis jirovecii pneumonia,OT,GEMCITABINE | Pneumocystis jirovecii pneumonia | OT,NaT
256485921,25648592,73,F,2025-07-09,20250806,,SKYRIZI,Death,DE,SKYRIZI | Death | DE,2025-07-07/2025-07-13
256486451,25648645,,F,2025-01-01,20250806,,LANTUS SOLOSTAR,Blood glucose increased,,LANTUS SOLOSTAR | Blood glucose increased,2024-12-30/2025-01-05
256488181,25648818,,,,20250806,,CLOPIDOGREL,Procedural haemorrhage,OT,CLOPIDOGREL | Procedural haemorrhage | OT,NaT
256489561,25648956,38,,,20250806,,TOLVAPTAN,No adverse event,,TOLVAPTAN | No adverse event,NaT
256489991,25648999,,,,20250806,,ZEPBOUND,Constipation,,ZEPBOUND | Constipation,NaT
256491231,25649123,32,F,2025-08-05,20250805,,CORTICOTROPIN,Weight increased,OT,CORTICOTROPIN | Weight increased | OT,2025-08-04/2025-08-10
256492191,25649219,,,,20250806,,FILGRASTIM,Acute myeloid leukaemia refractory,OT,FILGRASTIM | Acute myeloid leukaemia refractory | OT,NaT
256492972,25649297,63,,,20250901,,DESVENLAFAXINE SUCCINATE,Impaired quality of life,OT,DESVENLAFAXINE SUCCINATE | Impaired quality of life | OT,NaT
256493321,25649332,39,M,,20250806,,ERTAPENEM,Product use in unapproved indication,,ERTAPENEM | Product use in unapproved indication,NaT
256493791,25649379,81,F,2025-06-26,20250806,,AMLODIPINE,Headache,OT,AMLODIPINE | Headache | OT,2025-06-23/2025-06-29
256494271,25649427,5,,,20250806,,IBUPROFEN,Angioedema,OT,IBUPROFEN | Angioedema | OT,NaT
256494311,25649431,,F,,20250806,,ETANERCEPT,Deep vein thrombosis,OT,ETANERCEPT | Deep vein thrombosis | OT,NaT
256494501,25649450,,M,2025-04-15,20250806,,CABOTEGRAVIR,Drug ineffective,OT,CABOTEGRAVIR | Drug ineffective | OT,2025-04-14/2025-04-20
256494605,25649460,38,M,2025-02-13,20250904,,BICILLIN L-A,Recalled product administered,,BICILLIN L-A | Recalled product administered,2025-02-10/2025-02-16
256494952,25649495,77,F,,20250930,,OXALIPLATIN,Dysaesthesia pharynx,OT,OXALIPLATIN | Dysaesthesia pharynx | OT,NaT
256495021,25649502,57,F,,20250806,,CARBOPLATIN,Acute kidney injury,OT,CARBOPLATIN | Acute kidney injury | OT,NaT
256495221,25649522,,,,20250806,,CARVYKTI,Pyrexia,HO,CARVYKTI | Pyrexia | HO,NaT
256495751,25649575,48,F,,20250806,,CARBOPLATIN,Hypotension,OT,CARBOPLATIN | Hypotension | OT,NaT
256496461,25649646,,F,,20250806,,ACTEMRA,Infection,,ACTEMRA | Infection,NaT
256496831,25649683,,F,2025-07-15,20250806,,KEYTRUDA,General physical health deterioration,,KEYTRUDA | General physical health deterioration,2025-07-14/2025-07-20
256496991,25649699,70,M,2025-01-01,20250806,,SKYRIZI,Blood creatinine increased,HO,SKYRIZI | Blood creatinine increased | HO,2024-12-30/2025-01-05
256497341,25649734,,,,20250806,,LEVOFLOXACIN,Drug resistance,OT,LEVOFLOXACIN | Drug resistance | OT,NaT
256498161,25649816,86,,,20250806,,ELIQUIS,Cardiac disorder,,ELIQUIS | Cardiac disorder,NaT
256498471,25649847,81,,2025-08-01,20250806,,MOUNJARO,Accidental overdose,,MOUNJARO | Accidental overdose,2025-07-28/2025-08-03
256498561,25649856,26,F,,20250806,,BLINCYTO,Leukaemic infiltration extramedullary,OT,BLINCYTO | Leukaemic infiltration extramedullary | OT,NaT
256499421,25649942,81,F,,20250806,,MIRALAX,Product prescribing issue,,MIRALAX | Product prescribing issue,NaT
256499881,25649988,51,F,2025-05-29,20250806,,MAVENCLAD,Death,DE,MAVENCLAD | Death | DE,2025-05-26/2025-06-01
256500571,25650057,56,F,,20250806,,ORENCIA,Adverse event,,ORENCIA | Adverse event,NaT
256501021,25650102,,M,,20250806,,VELTASSA,Hypersensitivity,,VELTASSA | Hypersensitivity,NaT
256501141,25650114,53,M,,20250806,,OTEZLA,Insurance issue,,OTEZLA | Insurance issue,NaT
256502041,25650204,86,,,20250806,,OZEMPIC,Intestinal obstruction,OT,OZEMPIC | Intestinal obstruction | OT,NaT
256502441,25650244,57,F,2022-01-01,20250806,,SKYRIZI,Intestinal obstruction,HO,SKYRIZI | Intestinal obstruction | HO,2021-12-27/2022-01-02
256503011,25650301,75,M,2025-05-28,20250806,,OXALIPLATIN,Somnolence,OT,OXALIPLATIN | Somnolence | OT,2025-05-26/2025-06-01
256503081,25650308,,,,20250805,,SILDENAFIL CITRATE,Drug ineffective,,SILDENAFIL CITRATE | Drug ineffective,NaT
256503133,25650313,57,M,2025-08-04,20250902,,SPRAVATO,Drug ineffective,,SPRAVATO | Drug ineffective,2025-08-04/2025-08-10
256503341,25650334,79,,,20250806,,MOUNJARO,Constipation,HO,MOUNJARO | Constipation | HO,NaT
256503791,25650379,59,,,20250806,,TRULICITY,Ileus,HO,TRULICITY | Ileus | HO,NaT
256504022,25650402,16,F,,20250828,,DEXAMETHASONE,Respiratory failure,HO,DEXAMETHASONE | Respiratory failure | HO,NaT
256504291,25650429,,M,,20250806,,RILPIVIRINE,Viral load increased,OT,RILPIVIRINE | Viral load increased | OT,NaT
256504321,25650432,35,F,2025-07-22,20250806,,KETOROLAC,Anaphylactic reaction,LT,KETOROLAC | Anaphylactic reaction | LT,2025-07-21/2025-07-27
256505601,25650560,,,2025-07-06,20250806,,ALENDRONIC ACID,Oropharyngeal pain,OT,ALENDRONIC ACID | Oropharyngeal pain | OT,2025-06-30/2025-07-06
256505851,25650585,,M,,20250806,,CALCIUM CL\DEXTROSE\MAGNESIUM CL\SODIUM BICAR\SODIUM CL\SODIUM LACT,Malaise,OT,CALCIUM CL\DEXTROSE\MAGNESIUM CL\SODIUM BICAR\SODIUM CL\SODIUM LACT | Malaise | OT,NaT
256506772,25650677,63,F,2025-07-01,20250901,,CABLIVI,Product use in unapproved indication,,CABLIVI | Product use in unapproved indication,2025-06-30/2025-07-06
256508711,25650871,13,F,2025-01-01,20250806,,DUPIXENT,Alopecia,,DUPIXENT | Alopecia,2024-12-30/2025-01-05
256508811,25650881,39,M,2022-01-01,20250806,,DUPIXENT,Rhinitis,,DUPIXENT | Rhinitis,2021-12-27/2022-01-02
256509061,25650906,61,F,2025-07-19,20250806,,CARFILZOMIB,Myelosuppression,OT,CARFILZOMIB | Myelosuppression | OT,2025-07-14/2025-07-20
256509111,25650911,,F,,20250806,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
256509981,25650998,88,F,2024-10-01,20250806,,LANTUS,Spinal operation,OT,LANTUS | Spinal operation | OT,2024-09-30/2024-10-06
256510131,25651013,,F,,20250806,,ZITHROMAX,Off label use,,ZITHROMAX | Off label use,NaT
256510581,25651058,36,F,2025-04-15,20250806,,JUNEL FE 24,Product use in unapproved indication,HO,JUNEL FE 24 | Product use in unapproved indication | HO,2025-04-14/2025-04-20
256510871,25651087,42,M,2023-08-13,20250806,,MOXIFLOXACIN,Drug intolerance,OT,MOXIFLOXACIN | Drug intolerance | OT,2023-08-07/2023-08-13
256516321,25651632,5,,,20250806,,IBUPROFEN,Cross sensitivity reaction,OT,IBUPROFEN | Cross sensitivity reaction | OT,NaT
256517551,25651755,,F,,20250806,,METOCLOPRAMIDE HYDROCHLORIDE,Tremor,OT,METOCLOPRAMIDE HYDROCHLORIDE | Tremor | OT,NaT
256517761,25651776,,,2025-01-01,20250806,,GIMOTI,Fatigue,,GIMOTI | Fatigue,2024-12-30/2025-01-05
256518121,25651812,42,M,,20250806,,HYDROMORPHONE HYDROCHLORIDE,Chest discomfort,OT,HYDROMORPHONE HYDROCHLORIDE | Chest discomfort | OT,NaT
256519961,25651996,65,M,,20250806,,ORGOVYX,Decreased appetite,,ORGOVYX | Decreased appetite,NaT
256520011,25652001,,M,2025-07-01,20250806,,APALUTAMIDE,Nephrostomy,OT,APALUTAMIDE | Nephrostomy | OT,2025-06-30/2025-07-06
256520111,25652011,,F,2022-07-12,20250806,,CARVYKTI,Cytopenia,DE,CARVYKTI | Cytopenia | DE,2022-07-11/2022-07-17
256520891,25652089,73,M,,20250806,,IBRUTINIB,Haematoma,OT,IBRUTINIB | Haematoma | OT,NaT
256522001,25652200,44,F,,20250807,,DUPIXENT,Dry eye,,DUPIXENT | Dry eye,NaT
256522331,25652233,,M,,20250807,,HUMIRA,Product storage error,,HUMIRA | Product storage error,NaT
256522861,25652286,,F,,20250807,,RYBELSUS,Pulmonary embolism,HO,RYBELSUS | Pulmonary embolism | HO,NaT
256523871,25652387,,F,,20250807,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
256524101,25652410,48,M,,20250807,,CARBIDOPA\LEVODOPA,Overdose,HO,CARBIDOPA\LEVODOPA | Overdose | HO,NaT
256525332,25652533,50,F,,20250822,,IXEKIZUMAB,Bronchitis,OT,IXEKIZUMAB | Bronchitis | OT,NaT
256525492,25652549,82,M,,20250821,,DAPTOMYCIN,Eosinophilic pneumonia acute,HO,DAPTOMYCIN | Eosinophilic pneumonia acute | HO,NaT
256525551,25652555,85,M,,20250807,,ORGOVYX,Product dose omission issue,,ORGOVYX | Product dose omission issue,NaT
256525621,25652562,59,M,2024-03-16,20250807,,EZETIMIBE,Anxiety,DS,EZETIMIBE | Anxiety | DS,2024-03-11/2024-03-17
256525802,25652580,63,M,,20250818,,ORGOVYX,Hot flush,,ORGOVYX | Hot flush,NaT
256526331,25652633,,,,20250807,,LEVOTHYROXINE SODIUM,Drug ineffective,,LEVOTHYROXINE SODIUM | Drug ineffective,NaT
256526652,25652665,56,M,2024-10-02,20250828,,QINLOCK,Underdose,,QINLOCK | Underdose,2024-09-30/2024-10-06
256526751,25652675,32,,,20250807,,MOUNJARO,Product dose omission issue,,MOUNJARO | Product dose omission issue,NaT
256527051,25652705,,F,,20250807,,NUPLAZID,Nausea,,NUPLAZID | Nausea,NaT
256527202,25652720,82,M,,20250910,,ORGOVYX,Nasopharyngitis,HO,ORGOVYX | Nasopharyngitis | HO,NaT
256527301,25652730,,,,20250807,,CABOTEGRAVIR,Drug ineffective,OT,CABOTEGRAVIR | Drug ineffective | OT,NaT
256528001,25652800,,,,20250807,,SKYRIZI,Product storage error,,SKYRIZI | Product storage error,NaT
256528071,25652807,23,F,2025-07-28,20250807,,ZURZUVAE,Somnolence,,ZURZUVAE | Somnolence,2025-07-28/2025-08-03
256528114,25652811,,F,,20250820,,ZEJULA,Epistaxis,HO,ZEJULA | Epistaxis | HO,NaT
256528851,25652885,,F,2025-07-10,20250807,,EZETIMIBE,Hyperglycaemia,LT,EZETIMIBE | Hyperglycaemia | LT,2025-07-07/2025-07-13
256531112,25653111,,F,,20250926,,DAYBUE,Rhinovirus infection,HO,DAYBUE | Rhinovirus infection | HO,NaT
256532151,25653215,,,,20250807,,ACETAMINOPHEN,Restlessness,HO,ACETAMINOPHEN | Restlessness | HO,NaT
256532293,25653229,,F,,20250929,,DAYBUE,Diarrhoea,,DAYBUE | Diarrhoea,NaT
256532661,25653266,,,,20250807,,ZEPBOUND,Pain,,ZEPBOUND | Pain,NaT
256532781,25653278,24,F,,20250807,,DRONABINOL,Drug abuse,OT,DRONABINOL | Drug abuse | OT,NaT
256533041,25653304,,F,,20250807,,NUCALA,Multiple allergies,,NUCALA | Multiple allergies,NaT
256533941,25653394,,,,20250807,,LITHIUM CARBONATE,Mania,OT,LITHIUM CARBONATE | Mania | OT,NaT
256534631,25653463,53,F,2025-07-28,20250807,,ACETAMINOPHEN,Palpitations,OT,ACETAMINOPHEN | Palpitations | OT,2025-07-28/2025-08-03
256535721,25653572,64,,2025-01-09,20250807,,HEPARIN SODIUM,Therapeutic response decreased,,HEPARIN SODIUM | Therapeutic response decreased,2025-01-06/2025-01-12
256535941,25653594,,,,20250807,,SCEMBLIX,Rash,,SCEMBLIX | Rash,NaT
256536352,25653635,92,M,2025-05-19,20250919,,METHOTREXATE,Purpura,HO,METHOTREXATE | Purpura | HO,2025-05-19/2025-05-25
256536881,25653688,,F,,20250807,,CLOZAPINE,Death,DE,CLOZAPINE | Death | DE,NaT
256536991,25653699,59,M,2025-07-09,20250807,,FRUQUINTINIB,Myelosuppression,OT,FRUQUINTINIB | Myelosuppression | OT,2025-07-07/2025-07-13
256537482,25653748,,M,,20250922,,KESIMPTA,Hypoaesthesia,,KESIMPTA | Hypoaesthesia,NaT
256537602,25653760,73,M,2025-07-17,20250922,,DAPAGLIFLOZIN,Cholelithiasis,HO,DAPAGLIFLOZIN | Cholelithiasis | HO,2025-07-14/2025-07-20
256537711,25653771,38,M,,20250807,,INGREZZA,Somnolence,,INGREZZA | Somnolence,NaT
256538121,25653812,,F,,20250807,,DUPIXENT,Rebound atopic dermatitis,,DUPIXENT | Rebound atopic dermatitis,NaT
256538921,25653892,,,,20250807,,ALLEGRA,Drug effect less than expected,,ALLEGRA | Drug effect less than expected,NaT
256538991,25653899,60,F,,20250807,,TADALAFIL,Drug ineffective,OT,TADALAFIL | Drug ineffective | OT,NaT
256539521,25653952,60,F,,20250807,,LANTUS,Drug ineffective,,LANTUS | Drug ineffective,NaT
256540271,25654027,50,M,,20250807,,METHOTREXATE,Off label use,OT,METHOTREXATE | Off label use | OT,NaT
256541021,25654102,9,,,20250807,,IBUPROFEN,Cross sensitivity reaction,OT,IBUPROFEN | Cross sensitivity reaction | OT,NaT
256541541,25654154,,F,,20250807,,CLOZARIL,Fall,OT,CLOZARIL | Fall | OT,NaT
256541881,25654188,38,F,2025-01-01,20250807,,DUPIXENT,Rash,,DUPIXENT | Rash,2024-12-30/2025-01-05
256542791,25654279,,,,20250807,,NEMLUVIO,Drug ineffective,,NEMLUVIO | Drug ineffective,NaT
256542832,25654283,12,M,2025-07-31,20250811,,SCOPOLAMINE,Anticholinergic syndrome,HO,SCOPOLAMINE | Anticholinergic syndrome | HO,2025-07-28/2025-08-03
256543271,25654327,77,M,2025-06-01,20250807,,TREMFYA,Flatulence,,TREMFYA | Flatulence,2025-05-26/2025-06-01
256543661,25654366,,,,20250807,,CARVYKTI,Eating disorder,,CARVYKTI | Eating disorder,NaT
256543911,25654391,1,F,2025-08-01,20250807,,DUPIXENT,Product dose omission issue,,DUPIXENT | Product dose omission issue,2025-07-28/2025-08-03
256545201,25654520,,M,,20250806,,VYNDAQEL,Death,DE,VYNDAQEL | Death | DE,NaT
256545351,25654535,98,F,,20250806,,CAPECITABINE,Death,DE,CAPECITABINE | Death | DE,NaT
256546401,25654640,,M,2024-12-01,20250807,,BRIVARACETAM,Product dispensing issue,OT,BRIVARACETAM | Product dispensing issue | OT,2024-11-25/2024-12-01
256547491,25654749,52,F,,20250807,,VINCRISTINE,Inflammatory marker increased,DE,VINCRISTINE | Inflammatory marker increased | DE,NaT
256547641,25654764,,,,20250807,,SERTRALINE,Newborn persistent pulmonary hypertension,OT,SERTRALINE | Newborn persistent pulmonary hypertension | OT,NaT
256547671,25654767,75,M,,20250807,,LEVETIRACETAM,Condition aggravated,OT,LEVETIRACETAM | Condition aggravated | OT,NaT
256547721,25654772,59,F,2023-04-11,20250807,,ZOPICLONE,Multiple organ dysfunction syndrome,OT,ZOPICLONE | Multiple organ dysfunction syndrome | OT,2023-04-10/2023-04-16
256548171,25654817,29,F,2023-06-13,20250807,,PREDNISOLONE,Maternal exposure during pregnancy,HO,PREDNISOLONE | Maternal exposure during pregnancy | HO,2023-06-12/2023-06-18
256548561,25654856,58,F,,20250807,,GEMCITABINE,Neoplasm progression,OT,GEMCITABINE | Neoplasm progression | OT,NaT
256548781,25654878,75,F,,20250807,,LANTUS SOLOSTAR,Off label use,,LANTUS SOLOSTAR | Off label use,NaT
256549221,25654922,67,F,2024-11-01,20250807,,ATORVASTATIN,Non-high-density lipoprotein cholesterol decreased,OT,ATORVASTATIN | Non-high-density lipoprotein cholesterol decreased | OT,2024-10-28/2024-11-03
256549371,25654937,50,M,,20250807,,AMIODARONE HYDROCHLORIDE,Drug ineffective,OT,AMIODARONE HYDROCHLORIDE | Drug ineffective | OT,NaT
256549592,25654959,67,,,20250821,,LEFLUNOMIDE,Pulmonary mass,HO,LEFLUNOMIDE | Pulmonary mass | HO,NaT
256549711,25654971,53,F,2025-04-17,20250807,,CYCLOPHOSPHAMIDE,Heart failure with reduced ejection fraction,HO,CYCLOPHOSPHAMIDE | Heart failure with reduced ejection fraction | HO,2025-04-14/2025-04-20
256549721,25654972,32,F,2025-06-01,20250807,,DUPIXENT,Acne,,DUPIXENT | Acne,2025-05-26/2025-06-01
256550161,25655016,,,2025-01-01,20250807,,NEMLUVIO,Device malfunction,,NEMLUVIO | Device malfunction,2024-12-30/2025-01-05
256550431,25655043,,M,2025-01-01,20250807,,DOXYCYCLINE,Swelling face,OT,DOXYCYCLINE | Swelling face | OT,2024-12-30/2025-01-05
256550662,25655066,10,M,,20250905,,DUPIXENT,Asthma,,DUPIXENT | Asthma,NaT
256551201,25655120,69,M,,20250807,,FRAGMIN,Upper gastrointestinal haemorrhage,HO,FRAGMIN | Upper gastrointestinal haemorrhage | HO,NaT
256551391,25655139,87,M,2025-07-04,20250807,,CLOPIDOGREL,Anaemia,HO,CLOPIDOGREL | Anaemia | HO,2025-06-30/2025-07-06
256551442,25655144,,,2025-07-25,20250819,,DAXIBOTULINUMTOXIN A-LANM,Product preparation error,OT,DAXIBOTULINUMTOXIN A-LANM | Product preparation error | OT,2025-07-21/2025-07-27
256551841,25655184,,,,20250806,,PAXIL,Asthenia,,PAXIL | Asthenia,NaT
256551941,25655194,68,M,2025-08-06,20250806,,JEVTANA,Cough,OT,JEVTANA | Cough | OT,2025-08-04/2025-08-10
256553551,25655355,28,M,2025-01-01,20250807,,SPRYCEL,Iron deficiency anaemia,,SPRYCEL | Iron deficiency anaemia,2024-12-30/2025-01-05
256553681,25655368,60,M,,20250807,,TAGRISSO,Malignant neoplasm progression,OT,TAGRISSO | Malignant neoplasm progression | OT,NaT
256554571,25655457,67,F,2025-07-07,20250807,,MITAPIVAT,Central venous catheter removal,OT,MITAPIVAT | Central venous catheter removal | OT,2025-07-07/2025-07-13
256555143,25655514,62,F,2025-07-30,20250930,,EPIPEN,Needle issue,LT,EPIPEN | Needle issue | LT,2025-07-28/2025-08-03
256555181,25655518,87,F,,20250807,,KISQALI,Death,DE,KISQALI | Death | DE,NaT
256555542,25655554,,,,20250828,,SIMPONI,Device defective,,SIMPONI | Device defective,NaT
256558392,25655839,10,,,20250829,,REXULTI,Pneumonia aspiration,DE,REXULTI | Pneumonia aspiration | DE,NaT
256559331,25655933,65,,,20250807,,MOUNJARO,Constipation,HO,MOUNJARO | Constipation | HO,NaT
256559481,25655948,47,,,20250807,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
256559711,25655971,,M,,20250807,,DUPIXENT,Accidental exposure to product,,DUPIXENT | Accidental exposure to product,NaT
256559931,25655993,,,,20250807,,INQOVI,Death,DE,INQOVI | Death | DE,NaT
256560213,25656021,48,M,2020-01-01,20250826,,CAPECITABINE,Neutropenia,OT,CAPECITABINE | Neutropenia | OT,2019-12-30/2020-01-05
256560241,25656024,,M,,20250807,,ACALABRUTINIB,Hip fracture,OT,ACALABRUTINIB | Hip fracture | OT,NaT
256560521,25656052,60,F,,20250807,,MUCINEX,Burning sensation,,MUCINEX | Burning sensation,NaT
256560592,25656059,,F,,20250822,,GENOTROPIN,Device material issue,,GENOTROPIN | Device material issue,NaT
256560621,25656062,,F,2022-11-12,20250807,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,2022-11-07/2022-11-13
256560751,25656075,,M,,20250807,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Death,DE,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Death | DE,NaT
256561651,25656165,74,M,2025-07-21,20250807,,OFEV,Death,DE,OFEV | Death | DE,2025-07-21/2025-07-27
256562111,25656211,,M,,20250807,,FILSPARI,Product administration error,,FILSPARI | Product administration error,NaT
256562311,25656231,40,F,2025-06-04,20250807,,CYCLOSPORINE,Headache,OT,CYCLOSPORINE | Headache | OT,2025-06-02/2025-06-08
256562941,25656294,,M,2025-06-27,20250807,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Death,DE,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Death | DE,2025-06-23/2025-06-29
256562991,25656299,,F,,20250807,,GLATOPA,Circumstance or information capable of leading to medication error,,GLATOPA | Circumstance or information capable of leading to medication error,NaT
256563501,25656350,72,M,,20250807,,LENALIDOMIDE,Tooth disorder,OT,LENALIDOMIDE | Tooth disorder | OT,NaT
256564831,25656483,54,,,20250807,,MOUNJARO,Nausea,LT,MOUNJARO | Nausea | LT,NaT
256565231,25656523,,F,,20250807,,HIZENTRA,Urinary tract infection,,HIZENTRA | Urinary tract infection,NaT
256566011,25656601,73,M,2025-07-23,20250807,,DURVALUMAB,Lung disorder,LT,DURVALUMAB | Lung disorder | LT,2025-07-21/2025-07-27
256567801,25656780,24,F,2025-04-25,20250807,,CORTICOTROPIN,Injection site erythema,,CORTICOTROPIN | Injection site erythema,2025-04-21/2025-04-27
256567811,25656781,54,M,,20250807,,CORTICOTROPIN,Illness,,CORTICOTROPIN | Illness,NaT
256568011,25656801,59,M,,20250807,,JARDIANCE,Urine ketone body present,LT,JARDIANCE | Urine ketone body present | LT,NaT
256568531,25656853,66,F,2025-08-04,20250807,,XIIDRA,Blindness transient,OT,XIIDRA | Blindness transient | OT,2025-08-04/2025-08-10
256569301,25656930,,F,,20250807,,FILSPARI,Fatigue,OT,FILSPARI | Fatigue | OT,NaT
256569961,25656996,,F,2025-01-01,20250807,,OZEMPIC,Postmenopausal haemorrhage,OT,OZEMPIC | Postmenopausal haemorrhage | OT,2024-12-30/2025-01-05
256570061,25657006,45,F,2025-07-17,20250807,,DAPAGLIFLOZIN,Eructation,HO,DAPAGLIFLOZIN | Eructation | HO,2025-07-14/2025-07-20
256570631,25657063,73,F,,20250807,,REVLIMID,Colitis,OT,REVLIMID | Colitis | OT,NaT
256571961,25657196,16,F,,20250808,,LACOSAMIDE,Multiple-drug resistance,,LACOSAMIDE | Multiple-drug resistance,NaT
256572161,25657216,,F,,20250808,,BENLYSTA,Gastric ulcer,OT,BENLYSTA | Gastric ulcer | OT,NaT
256572801,25657280,75,F,,20250808,,POMALYST,Adverse event,HO,POMALYST | Adverse event | HO,NaT
256573101,25657310,76,F,,20250808,,FLUOROURACIL,Febrile neutropenia,OT,FLUOROURACIL | Febrile neutropenia | OT,NaT
256573291,25657329,64,F,,20250808,,AMLODIPINE,Joint swelling,OT,AMLODIPINE | Joint swelling | OT,NaT
256574221,25657422,56,M,2022-03-02,20250808,,PREDNISOLONE,Tumour lysis syndrome,OT,PREDNISOLONE | Tumour lysis syndrome | OT,2022-02-28/2022-03-06
256574983,25657498,,F,,20250814,,ELIQUIS,Metastases to bone,OT,ELIQUIS | Metastases to bone | OT,NaT
256575371,25657537,81,M,2025-07-30,20250808,,CARBIDOPA LEVODOPA,Death,DE,CARBIDOPA LEVODOPA | Death | DE,2025-07-28/2025-08-03
256575761,25657576,71,F,2025-06-16,20250808,,LOSARTAN,Gout,OT,LOSARTAN | Gout | OT,2025-06-16/2025-06-22
256575771,25657577,68,F,2025-06-17,20250808,,PACLITAXEL,Cardiac failure,LT,PACLITAXEL | Cardiac failure | LT,2025-06-16/2025-06-22
256575841,25657584,57,M,2024-01-01,20250808,,PREDNISONE,Neuroendocrine carcinoma of the skin,HO,PREDNISONE | Neuroendocrine carcinoma of the skin | HO,2024-01-01/2024-01-07
256576741,25657674,69,M,2025-01-01,20250808,,ODOMZO,Product use issue,,ODOMZO | Product use issue,2024-12-30/2025-01-05
256576891,25657689,,F,,20250808,,ODOMZO,Stress,,ODOMZO | Stress,NaT
256576981,25657698,,M,,20250808,,ODOMZO,Muscle spasms,,ODOMZO | Muscle spasms,NaT
256577001,25657700,82,M,2024-11-18,20250808,,ODOMZO,Product use issue,,ODOMZO | Product use issue,2024-11-18/2024-11-24
256577101,25657710,,F,,20250808,,ODOMZO,Taste disorder,,ODOMZO | Taste disorder,NaT
256577331,25657733,,M,,20250808,,ODOMZO,Alopecia,,ODOMZO | Alopecia,NaT
256579011,25657901,,,2025-01-01,20250808,,ISOTRETINOIN,Adverse drug reaction,,ISOTRETINOIN | Adverse drug reaction,2024-12-30/2025-01-05
256579231,25657923,46,,,20250808,,MOUNJARO,Impaired gastric emptying,HO,MOUNJARO | Impaired gastric emptying | HO,NaT
256579471,25657947,70,F,,20250808,,BILASTINE,Treatment failure,OT,BILASTINE | Treatment failure | OT,NaT
256579651,25657965,79,F,2024-07-01,20250808,,ROSUVASTATIN CALCIUM,Chronic kidney disease,OT,ROSUVASTATIN CALCIUM | Chronic kidney disease | OT,2024-07-01/2024-07-07
256580082,25658008,82,F,2025-01-01,20250902,,BOTOX,Illness,HO,BOTOX | Illness | HO,2024-12-30/2025-01-05
256580181,25658018,69,M,2025-07-22,20250808,,ETANERCEPT,Intrusive thoughts,OT,ETANERCEPT | Intrusive thoughts | OT,2025-07-21/2025-07-27
256580201,25658020,39,F,2025-07-01,20250808,,AUSTEDO XR,Feeling of despair,HO,AUSTEDO XR | Feeling of despair | HO,2025-06-30/2025-07-06
256580721,25658072,,F,2025-07-01,20250808,,ADALIMUMAB,Rash,OT,ADALIMUMAB | Rash | OT,2025-06-30/2025-07-06
256580741,25658074,,F,2024-01-01,20250808,,TYMLOS,Back pain,OT,TYMLOS | Back pain | OT,2024-01-01/2024-01-07
256580772,25658077,53,M,2024-10-31,20250814,,DRONABINOL,Ischaemic stroke,OT,DRONABINOL | Ischaemic stroke | OT,2024-10-28/2024-11-03
256580912,25658091,85,M,2025-01-01,20250901,,DUPIXENT,Craniofacial fracture,OT,DUPIXENT | Craniofacial fracture | OT,2024-12-30/2025-01-05
256581121,25658112,60,M,,20250808,,MOUNJARO,Extra dose administered,,MOUNJARO | Extra dose administered,NaT
256581691,25658169,13,F,2025-01-01,20250808,,DUPIXENT,Rebound atopic dermatitis,,DUPIXENT | Rebound atopic dermatitis,2024-12-30/2025-01-05
256582172,25658217,71,M,,20250825,,OXALIPLATIN,Gait disturbance,OT,OXALIPLATIN | Gait disturbance | OT,NaT
256583151,25658315,49,M,,20250808,,ARIPIPRAZOLE,Megacolon,OT,ARIPIPRAZOLE | Megacolon | OT,NaT
256583931,25658393,64,F,2025-06-03,20250808,,ROSUVASTATIN,Cholestasis,HO,ROSUVASTATIN | Cholestasis | HO,2025-06-02/2025-06-08
256583951,25658395,64,M,,20250808,,TICAGRELOR,Drug interaction,OT,TICAGRELOR | Drug interaction | OT,NaT
256584072,25658407,77,M,2025-08-03,20250923,,MAVYRET,Urinary tract infection,HO,MAVYRET | Urinary tract infection | HO,2025-07-28/2025-08-03
256584861,25658486,59,F,2025-01-01,20250808,,SKYRIZI,Diverticulitis,HO,SKYRIZI | Diverticulitis | HO,2024-12-30/2025-01-05
256585111,25658511,,M,,20250808,,BRILINTA,Neoplasm progression,OT,BRILINTA | Neoplasm progression | OT,NaT
256585712,25658571,75,F,2025-05-08,20250909,,LIVDELZI,Glomerular filtration rate decreased,,LIVDELZI | Glomerular filtration rate decreased,2025-05-05/2025-05-11
256587031,25658703,,F,,20250808,,TRAMADOL,Rash,OT,TRAMADOL | Rash | OT,NaT
256587041,25658704,76,M,,20250808,,PREGABALIN,Memory impairment,OT,PREGABALIN | Memory impairment | OT,NaT
256587392,25658739,10,F,2025-08-01,20250828,,QUVIVIQ,Malaise,OT,QUVIVIQ | Malaise | OT,2025-07-28/2025-08-03
256587431,25658743,43,M,2024-11-18,20250808,,IMATINIB,Pulmonary arterial hypertension,LT,IMATINIB | Pulmonary arterial hypertension | LT,2024-11-18/2024-11-24
256587451,25658745,,M,,20250808,,VEDOLIZUMAB,Weight decreased,OT,VEDOLIZUMAB | Weight decreased | OT,NaT
256587651,25658765,38,M,2025-04-15,20250808,,VEDOLIZUMAB,Diabetes mellitus,OT,VEDOLIZUMAB | Diabetes mellitus | OT,2025-04-14/2025-04-20
256588301,25658830,,F,,20250808,,VUMERITY,Mobility decreased,,VUMERITY | Mobility decreased,NaT
256588651,25658865,51,M,2025-01-01,20250808,,DUPIXENT,Nasal congestion,,DUPIXENT | Nasal congestion,2024-12-30/2025-01-05
256588851,25658885,51,F,2025-01-01,20250808,,DUPIXENT,Malaise,,DUPIXENT | Malaise,2024-12-30/2025-01-05
256589431,25658943,,F,,20250808,,VENTOLIN HFA,Wrong technique in product usage process,,VENTOLIN HFA | Wrong technique in product usage process,NaT
256590991,25659099,43,F,,20250808,,VERZENIO,Diarrhoea,,VERZENIO | Diarrhoea,NaT
256591381,25659138,76,M,,20250808,,SODIUM BICARBONATE,Off label use,HO,SODIUM BICARBONATE | Off label use | HO,NaT
256591731,25659173,50,M,,20250808,,BRILINTA,Chest pain,HO,BRILINTA | Chest pain | HO,NaT
256591801,25659180,,M,,20250808,,BAVENCIO,Interstitial lung disease,OT,BAVENCIO | Interstitial lung disease | OT,NaT
256592591,25659259,43,M,2025-07-19,20250808,,FINASTERIDE,Completed suicide,DE,FINASTERIDE | Completed suicide | DE,2025-07-14/2025-07-20
256592801,25659280,16,M,,20250808,,DUPIXENT,Oropharyngeal pain,,DUPIXENT | Oropharyngeal pain,NaT
256593531,25659353,66,F,2025-03-21,20250807,,LENALIDOMIDE,Energy increased,,LENALIDOMIDE | Energy increased,2025-03-17/2025-03-23
256593961,25659396,63,M,2025-07-10,20250808,,DUPIXENT,Insomnia,,DUPIXENT | Insomnia,2025-07-07/2025-07-13
256594111,25659411,,F,,20250808,,VEDOLIZUMAB,Fatigue,OT,VEDOLIZUMAB | Fatigue | OT,NaT
256594121,25659412,74,F,,20250808,,TOUJEO MAX,Product storage error,,TOUJEO MAX | Product storage error,NaT
256594871,25659487,,F,,20250808,,IZERVAY,Pain,,IZERVAY | Pain,NaT
256595931,25659593,,F,,20250808,,JAYPIRCA,Malaise,,JAYPIRCA | Malaise,NaT
256596101,25659610,66,F,2025-01-01,20250808,,BIMZELX,Upper limb fracture,OT,BIMZELX | Upper limb fracture | OT,2024-12-30/2025-01-05
256597071,25659707,,M,,20250807,,AMBRISENTAN,Pulmonary arterial hypertension,HO,AMBRISENTAN | Pulmonary arterial hypertension | HO,NaT
256599142,25659914,,F,,20250827,,PALYNZIQ,Swelling,,PALYNZIQ | Swelling,NaT
256599341,25659934,,,,20250807,,KESIMPTA,Muscle strain,,KESIMPTA | Muscle strain,NaT
256599581,25659958,56,F,2025-07-28,20250808,,MOUNJARO,Diabetic ketoacidosis,LT,MOUNJARO | Diabetic ketoacidosis | LT,2025-07-28/2025-08-03
256600141,25660014,51,M,2025-01-01,20250808,,DUPIXENT,Alopecia,,DUPIXENT | Alopecia,2024-12-30/2025-01-05
256600801,25660080,76,F,2025-07-16,20250808,,RITUXIMAB,Nausea,OT,RITUXIMAB | Nausea | OT,2025-07-14/2025-07-20
256601711,25660171,,F,,20250808,,MIRENA,Intermenstrual bleeding,,MIRENA | Intermenstrual bleeding,NaT
256601761,25660176,,F,,20250808,,BENLYSTA,Drug ineffective,,BENLYSTA | Drug ineffective,NaT
256602561,25660256,27,M,,20250808,,ZEPBOUND,Headache,,ZEPBOUND | Headache,NaT
256603291,25660329,37,M,,20250808,,DUPIXENT,Product prescribing issue,,DUPIXENT | Product prescribing issue,NaT
256603661,25660366,,,,20250808,,TRUXIMA,Diffuse large B-cell lymphoma recurrent,OT,TRUXIMA | Diffuse large B-cell lymphoma recurrent | OT,NaT
256604591,25660459,31,M,2025-07-28,20250808,,FINTEPLA,Tricuspid valve incompetence,OT,FINTEPLA | Tricuspid valve incompetence | OT,2025-07-28/2025-08-03
256604881,25660488,,,,20250808,,MIRALAX,Product use issue,,MIRALAX | Product use issue,NaT
256607961,25660796,78,F,2025-03-18,20250808,,METFORMIN,Lactic acidosis,DE,METFORMIN | Lactic acidosis | DE,2025-03-17/2025-03-23
256607992,25660799,,,,20250826,,EPIPEN,Product quality issue,,EPIPEN | Product quality issue,NaT
256608541,25660854,,,2023-01-01,20250808,,BEVACIZUMAB,Pneumonia,HO,BEVACIZUMAB | Pneumonia | HO,2022-12-26/2023-01-01
256609102,25660910,,F,,20250911,,KRYSTEXXA,Death,DE,KRYSTEXXA | Death | DE,NaT
256610011,25661001,,M,2024-05-09,20250808,,BEYFORTUS,Pyrexia,OT,BEYFORTUS | Pyrexia | OT,2024-05-06/2024-05-12
256610772,25661077,,,2025-04-01,20250818,,TIBSOVO,Cerebrovascular accident,OT,TIBSOVO | Cerebrovascular accident | OT,2025-03-31/2025-04-06
256611201,25661120,40,,,20250808,,TRULICITY,Diarrhoea,HO,TRULICITY | Diarrhoea | HO,NaT
256612091,25661209,,M,,20250808,,CORTICOTROPIN,Lymphocyte count increased,,CORTICOTROPIN | Lymphocyte count increased,NaT
256612581,25661258,87,M,2025-07-05,20250808,,SPIRONOLACTONE,Acute kidney injury,HO,SPIRONOLACTONE | Acute kidney injury | HO,2025-06-30/2025-07-06
256612972,25661297,36,F,2019-04-01,20250822,,HUMIRA,Abortion spontaneous,OT,HUMIRA | Abortion spontaneous | OT,2019-04-01/2019-04-07
256614911,25661491,70,M,2025-01-01,20250808,,COBENFY,Cerebrovascular accident,HO,COBENFY | Cerebrovascular accident | HO,2024-12-30/2025-01-05
256614922,25661492,6,M,,20250902,,BICILLIN L-A,Recalled product administered,,BICILLIN L-A | Recalled product administered,NaT
256615761,25661576,69,M,2025-07-13,20250808,,DELFLEX WITH DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM,Myocardial necrosis marker increased,HO,DELFLEX WITH DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM | Myocardial necrosis marker increased | HO,2025-07-07/2025-07-13
256616251,25661625,32,,,20250808,,OXYCODONE HYDROCHLORIDE,Product counterfeit,,OXYCODONE HYDROCHLORIDE | Product counterfeit,NaT
256616531,25661653,53,F,2023-07-06,20250808,,CIMETIDINE HYDROCHLORIDE,Serotonin syndrome,OT,CIMETIDINE HYDROCHLORIDE | Serotonin syndrome | OT,2023-07-03/2023-07-09
256616592,25661659,72,F,2018-04-01,20250918,,DAPAGLIFLOZIN,Myopathy,OT,DAPAGLIFLOZIN | Myopathy | OT,2018-03-26/2018-04-01
256616742,25661674,,F,,20250815,,SOTATERCEPT,Feeling abnormal,,SOTATERCEPT | Feeling abnormal,NaT
256617381,25661738,,F,,20250808,,CLOZAPINE,Respiratory failure,DE,CLOZAPINE | Respiratory failure | DE,NaT
256618341,25661834,,,2022-03-30,20250809,,TRASTUZUMAB,General physical health deterioration,OT,TRASTUZUMAB | General physical health deterioration | OT,2022-03-28/2022-04-03
256618542,25661854,,,2023-01-01,20250813,,RINVOQ,Colitis,OT,RINVOQ | Colitis | OT,2022-12-26/2023-01-01
256618851,25661885,,F,,20250809,,BENRALIZUMAB,Rib fracture,OT,BENRALIZUMAB | Rib fracture | OT,NaT
256619141,25661914,71,M,,20250809,,ENTYVIO,Off label use,HO,ENTYVIO | Off label use | HO,NaT
256619611,25661961,,,,20250809,,LIDOCAINE,Embolia cutis medicamentosa,OT,LIDOCAINE | Embolia cutis medicamentosa | OT,NaT
256621611,25662161,66,M,2025-06-05,20250810,,FLUOROURACIL,Nausea,OT,FLUOROURACIL | Nausea | OT,2025-06-02/2025-06-08
256621682,25662168,12,F,2025-08-05,20250812,,HIZENTRA,Infusion site discharge,,HIZENTRA | Infusion site discharge,2025-08-04/2025-08-10
256623551,25662355,47,F,,20250810,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,NaT
256624521,25662452,54,M,2025-07-07,20250810,,RINVOQ,Hip arthroplasty,OT,RINVOQ | Hip arthroplasty | OT,2025-07-07/2025-07-13
256625711,25662571,71,M,,20250810,,PREDNISONE,Dry eye,OT,PREDNISONE | Dry eye | OT,NaT
256625751,25662575,,,,20250810,,AUVELITY,Withdrawal syndrome,,AUVELITY | Withdrawal syndrome,NaT
256626241,25662624,,,,20250811,,RITUXIMAB,Neurosarcoidosis,OT,RITUXIMAB | Neurosarcoidosis | OT,NaT
256626611,25662661,,M,,20250811,,MUCINEX,Incorrect product administration duration,,MUCINEX | Incorrect product administration duration,NaT
256626791,25662679,59,F,,20250811,,MOUNJARO,Injection site paraesthesia,,MOUNJARO | Injection site paraesthesia,NaT
256627062,25662706,11,,,20250903,,OXCARBAZEPINE,Product colour issue,,OXCARBAZEPINE | Product colour issue,NaT
256628291,25662829,,M,,20250811,,SKYCLARYS,Drug-induced liver injury,OT,SKYCLARYS | Drug-induced liver injury | OT,NaT
256628383,25662838,,,2025-07-18,20250825,,ANAKINRA,Haemophagocytic lymphohistiocytosis,OT,ANAKINRA | Haemophagocytic lymphohistiocytosis | OT,2025-07-14/2025-07-20
256628831,25662883,7,F,2025-08-04,20250811,,PALIVIZUMAB,Urinary tract infection,HO,PALIVIZUMAB | Urinary tract infection | HO,2025-08-04/2025-08-10
256629501,25662950,,F,,20250811,,MUCINEX,Drug ineffective,,MUCINEX | Drug ineffective,NaT
256630001,25663000,46,M,,20250811,,ZEPBOUND,Underdose,,ZEPBOUND | Underdose,NaT
256630081,25663008,77,F,,20250811,,NITROFURANTOIN,Interstitial lung disease,HO,NITROFURANTOIN | Interstitial lung disease | HO,NaT
256630161,25663016,,,,20250811,,RITUXIMAB,Dermatitis exfoliative generalised,OT,RITUXIMAB | Dermatitis exfoliative generalised | OT,NaT
256630831,25663083,67,F,2025-04-01,20250811,,ATORVASTATIN,Weight decreased,OT,ATORVASTATIN | Weight decreased | OT,2025-03-31/2025-04-06
256630941,25663094,76,M,2025-05-30,20250811,,ESCITALOPRAM,Rash maculo-papular,HO,ESCITALOPRAM | Rash maculo-papular | HO,2025-05-26/2025-06-01
256631051,25663105,,,,20250811,,LEVETIRACETAM,Renal fusion anomaly,OT,LEVETIRACETAM | Renal fusion anomaly | OT,NaT
256631102,25663110,50,F,,20250828,,ESTRADIOL,Intermenstrual bleeding,,ESTRADIOL | Intermenstrual bleeding,NaT
256631471,25663147,84,F,2025-07-01,20250811,,POMALYST,Transient ischaemic attack,OT,POMALYST | Transient ischaemic attack | OT,2025-06-30/2025-07-06
256632681,25663268,,,,20250811,,AMYVID,False negative investigation result,,AMYVID | False negative investigation result,NaT
256633291,25663329,,F,,20250811,,FORTEO,Nervousness,,FORTEO | Nervousness,NaT
256634361,25663436,70,M,,20250811,,LIDOCAINE HYDROCHLORIDE,Hypochromic anaemia,OT,LIDOCAINE HYDROCHLORIDE | Hypochromic anaemia | OT,NaT
256634661,25663466,,,2021-01-01,20250811,,DIAZEPAM,Substance use disorder,HO,DIAZEPAM | Substance use disorder | HO,2020-12-28/2021-01-03
256634981,25663498,,,,20250811,,IMBRUVICA,Death,DE,IMBRUVICA | Death | DE,NaT
256636051,25663605,,F,,20250811,,ZEPBOUND,Alopecia,,ZEPBOUND | Alopecia,NaT
256636281,25663628,25,F,2025-01-16,20250811,,VYVANSE,Mood swings,OT,VYVANSE | Mood swings | OT,2025-01-13/2025-01-19
256636881,25663688,,,,20250811,,VOLTAREN,Application site papules,,VOLTAREN | Application site papules,NaT
256637321,25663732,70,F,,20250811,,VYALEV,Cellulitis,,VYALEV | Cellulitis,NaT
256637801,25663780,54,,,20250811,,WEGOVY,Emotional distress,OT,WEGOVY | Emotional distress | OT,NaT
256638272,25663827,64,F,,20250827,,AVASTIN,Neuropathy peripheral,OT,AVASTIN | Neuropathy peripheral | OT,NaT
256638811,25663881,,F,,20250811,,CISPLATIN,Disease progression,OT,CISPLATIN | Disease progression | OT,NaT
256639261,25663926,67,F,,20250811,,MOUNJARO,Food craving,,MOUNJARO | Food craving,NaT
256639321,25663932,72,M,2025-08-05,20250811,,ZEPBOUND,Intercepted product dispensing error,,ZEPBOUND | Intercepted product dispensing error,2025-08-04/2025-08-10
256639631,25663963,17,,,20250811,,INVEGA SUSTENNA,Off label use,,INVEGA SUSTENNA | Off label use,NaT
256640331,25664033,70,F,2025-07-01,20250811,,REVLIMID,Bone pain,,REVLIMID | Bone pain,2025-06-30/2025-07-06
256640551,25664055,,F,,20250811,,MUCINEX,Drug ineffective,,MUCINEX | Drug ineffective,NaT
256640681,25664068,78,F,,20250811,,MINOCYCLINE,Condition aggravated,DE,MINOCYCLINE | Condition aggravated | DE,NaT
256641021,25664102,,F,,20250811,,AMLODIPINE,Bladder irritation,OT,AMLODIPINE | Bladder irritation | OT,NaT
256641241,25664124,52,F,,20250811,,ZEPBOUND,Inappropriate schedule of product administration,,ZEPBOUND | Inappropriate schedule of product administration,NaT
256641261,25664126,,,,20250811,,MOUNJARO,Rheumatoid arthritis,,MOUNJARO | Rheumatoid arthritis,NaT
256643831,25664383,49,F,,20250811,,METHOTREXATE,Extrapulmonary tuberculosis,DE,METHOTREXATE | Extrapulmonary tuberculosis | DE,NaT
256644471,25664447,,F,,20250811,,ARMOUR THYROID,Therapeutic product effect decreased,,ARMOUR THYROID | Therapeutic product effect decreased,NaT
256644501,25664450,48,F,,20250811,,MYCOPHENOLATE MOFETIL,Smooth muscle cell neoplasm,OT,MYCOPHENOLATE MOFETIL | Smooth muscle cell neoplasm | OT,NaT
256644841,25664484,,,,20250811,,OCREVUS,Febrile neutropenia,OT,OCREVUS | Febrile neutropenia | OT,NaT
256644882,25664488,68,M,,20250815,,DOVATO,Blindness,OT,DOVATO | Blindness | OT,NaT
256645301,25664530,,M,,20250811,,JUXTAPID,Therapy interrupted,,JUXTAPID | Therapy interrupted,NaT
256645631,25664563,55,M,,20250811,,FLUDARABINE,Off label use,OT,FLUDARABINE | Off label use | OT,NaT
256646221,25664622,77,M,,20250811,,KORSUVA,Pulmonary oedema,DE,KORSUVA | Pulmonary oedema | DE,NaT
256646261,25664626,57,F,2023-01-01,20250811,,CARBOPLATIN,Thrombocytopenia,HO,CARBOPLATIN | Thrombocytopenia | HO,2022-12-26/2023-01-01
256646322,25664632,,,2025-07-01,20250827,,MEROPENEM,No adverse event,,MEROPENEM | No adverse event,2025-06-30/2025-07-06
256648081,25664808,49,M,2025-07-21,20250811,,SODIUM CHLORIDE,Myelosuppression,HO,SODIUM CHLORIDE | Myelosuppression | HO,2025-07-21/2025-07-27
256648171,25664817,,F,2025-07-15,20250811,,TREMFYA,Headache,,TREMFYA | Headache,2025-07-14/2025-07-20
256648271,25664827,72,F,,20250808,,OTEZLA,Gastrointestinal disorder,OT,OTEZLA | Gastrointestinal disorder | OT,NaT
256648321,25664832,,M,,20250811,,LACOSAMIDE,Product substitution issue,,LACOSAMIDE | Product substitution issue,NaT
256649681,25664968,,,,20250811,,TACROLIMUS,Off label use,OT,TACROLIMUS | Off label use | OT,NaT
256650111,25665011,24,F,,20250811,,ADALIMUMAB,Drug-induced liver injury,OT,ADALIMUMAB | Drug-induced liver injury | OT,NaT
256650761,25665076,64,M,2025-07-28,20250811,,POMALYST,Death,DE,POMALYST | Death | DE,2025-07-28/2025-08-03
256650981,25665098,71,M,2024-12-01,20250811,,CERTOLIZUMAB PEGOL,Intentional dose omission,HO,CERTOLIZUMAB PEGOL | Intentional dose omission | HO,2024-11-25/2024-12-01
256651061,25665106,52,M,2024-03-01,20250811,,AMPHOTERICIN B,Gastrointestinal toxicity,HO,AMPHOTERICIN B | Gastrointestinal toxicity | HO,2024-02-26/2024-03-03
256651091,25665109,28,F,,20250811,,OCREVUS ZUNOVO,Injection site reaction,,OCREVUS ZUNOVO | Injection site reaction,NaT
256651293,25665129,54,F,2025-07-29,20250828,,NEULASTA,Device adhesion issue,,NEULASTA | Device adhesion issue,2025-07-28/2025-08-03
256651862,25665186,48,F,2025-07-23,20250813,,ENHERTU,Dyspnoea,DE,ENHERTU | Dyspnoea | DE,2025-07-21/2025-07-27
256653051,25665305,,,,20250811,,TREMFYA,Rash pruritic,,TREMFYA | Rash pruritic,NaT
256653611,25665361,39,F,,20250811,,ZEPBOUND,Injection site pain,,ZEPBOUND | Injection site pain,NaT
256653911,25665391,,F,,20250811,,MIRENA,Genital haemorrhage,,MIRENA | Genital haemorrhage,NaT
256654831,25665483,68,M,,20250811,,TACROLIMUS,Demyelinating polyneuropathy,OT,TACROLIMUS | Demyelinating polyneuropathy | OT,NaT
256654901,25665490,,,2025-07-19,20250811,,CHILDRENS MOTRIN,Cytopenia,OT,CHILDRENS MOTRIN | Cytopenia | OT,2025-07-14/2025-07-20
256654951,25665495,75,M,,20250811,,REVLIMID,Off label use,,REVLIMID | Off label use,NaT
256655401,25665540,30,F,,20250811,,MYCOPHENOLATE MOFETIL,Abdominal pain,OT,MYCOPHENOLATE MOFETIL | Abdominal pain | OT,NaT
256655742,25665574,36,F,,20250828,,CYCLOSPORINE,Drug ineffective,DE,CYCLOSPORINE | Drug ineffective | DE,NaT
256655941,25665594,,,,20250811,,BREXPIPRAZOLE,Death,DE,BREXPIPRAZOLE | Death | DE,NaT
256656012,25665601,16,F,,20250818,,TOCILIZUMAB,Malaise,HO,TOCILIZUMAB | Malaise | HO,NaT
256656921,25665692,26,F,2025-01-01,20250811,,ETONOGESTREL,Unintended pregnancy,OT,ETONOGESTREL | Unintended pregnancy | OT,2024-12-30/2025-01-05
256657011,25665701,,M,,20250811,,INVEGA,Gynaecomastia,,INVEGA | Gynaecomastia,NaT
256657112,25665711,22,F,,20250812,,DEPO-PROVERA,Pruritus,,DEPO-PROVERA | Pruritus,NaT
256657281,25665728,,M,,20250811,,ADEMPAS,Gastrointestinal disorder,HO,ADEMPAS | Gastrointestinal disorder | HO,NaT
256657692,25665769,38,F,,20250818,,DIANEAL PD-2 PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE,Bloody peritoneal effluent,OT,DIANEAL PD-2 PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE | Bloody peritoneal effluent | OT,NaT
256657871,25665787,40,M,,20250811,,CIPROFLOXACIN,Drug ineffective for unapproved indication,LT,CIPROFLOXACIN | Drug ineffective for unapproved indication | LT,NaT
256657951,25665795,80,M,2025-07-30,20250811,,ERBITUX,Anaphylactic shock,OT,ERBITUX | Anaphylactic shock | OT,2025-07-28/2025-08-03
256658481,25665848,53,F,2023-01-01,20250811,,RINVOQ,Pain,HO,RINVOQ | Pain | HO,2022-12-26/2023-01-01
256658561,25665856,62,F,2025-01-01,20250811,,HUMIRA,Procedural pain,OT,HUMIRA | Procedural pain | OT,2024-12-30/2025-01-05
256658881,25665888,70,F,2025-06-28,20250811,,ZEPBOUND,Fatigue,,ZEPBOUND | Fatigue,2025-06-23/2025-06-29
256659031,25665903,,F,,20250811,,RITUXIMAB,Papilloedema,OT,RITUXIMAB | Papilloedema | OT,NaT
256660941,25666094,,,,20250811,,PHENTERMINE,Right ventricular failure,DE,PHENTERMINE | Right ventricular failure | DE,NaT
256661461,25666146,,M,,20250811,,LEQVIO,Pneumonia,OT,LEQVIO | Pneumonia | OT,NaT
256661961,25666196,18,F,2025-01-01,20250811,,MESALAMINE,Chest pain,HO,MESALAMINE | Chest pain | HO,2024-12-30/2025-01-05
256662342,25666234,54,F,,20250813,,CORTICOTROPIN,Diarrhoea,,CORTICOTROPIN | Diarrhoea,NaT
256662381,25666238,,,,20250811,,VYNDAMAX,Surgery,,VYNDAMAX | Surgery,NaT
256663532,25666353,51,F,2025-01-01,20250813,,CORTICOTROPIN,Injection site pain,,CORTICOTROPIN | Injection site pain,2024-12-30/2025-01-05
256663811,25666381,,M,2025-01-01,20250811,,BIMEKIZUMAB,Weight decreased,OT,BIMEKIZUMAB | Weight decreased | OT,2024-12-30/2025-01-05
256664021,25666402,15,F,,20250811,,APREMILAST,Therapy interrupted,HO,APREMILAST | Therapy interrupted | HO,NaT
256664271,25666427,,M,2025-01-01,20250811,,BIMEKIZUMAB,Incorrect dose administered,HO,BIMEKIZUMAB | Incorrect dose administered | HO,2024-12-30/2025-01-05
256664581,25666458,,F,,20250811,,DUPIXENT,Maternal exposure during pregnancy,,DUPIXENT | Maternal exposure during pregnancy,NaT
256665331,25666533,79,M,,20250811,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
256665381,25666538,57,F,2025-01-01,20250811,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2024-12-30/2025-01-05
256667121,25666712,,M,,20250811,,DUPIXENT,Rash,,DUPIXENT | Rash,NaT
256667881,25666788,64,F,2025-01-01,20250811,,LANTUS SOLOSTAR,Device dispensing error,,LANTUS SOLOSTAR | Device dispensing error,2024-12-30/2025-01-05
256668371,25666837,33,F,,20250811,,DUPIXENT,Maternal exposure during pregnancy,,DUPIXENT | Maternal exposure during pregnancy,NaT
256668561,25666856,67,F,,20250811,,DUPIXENT,Dyspnoea,,DUPIXENT | Dyspnoea,NaT
256668802,25666880,74,F,2025-01-01,20250818,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,2024-12-30/2025-01-05
256668811,25666881,,F,,20250811,,DUPIXENT,Erythema,,DUPIXENT | Erythema,NaT
256669691,25666969,,F,,20250811,,DUPIXENT,Eye pruritus,,DUPIXENT | Eye pruritus,NaT
256670401,25667040,,M,,20250809,,VYNDAMAX,Atrial fibrillation,HO,VYNDAMAX | Atrial fibrillation | HO,NaT
256670921,25667092,,,2025-01-01,20250811,,NEMLUVIO,Inappropriate schedule of product administration,,NEMLUVIO | Inappropriate schedule of product administration,2024-12-30/2025-01-05
256670981,25667098,,,2025-07-09,20250811,,NEMLUVIO,Product dose omission issue,,NEMLUVIO | Product dose omission issue,2025-07-07/2025-07-13
256671291,25667129,,,2025-01-01,20250811,,NEMLUVIO,Product dose omission issue,,NEMLUVIO | Product dose omission issue,2024-12-30/2025-01-05
256671331,25667133,,,2025-07-01,20250811,,NEMLUVIO,Skin fissures,,NEMLUVIO | Skin fissures,2025-06-30/2025-07-06
256671821,25667182,,,,20250811,,OPZELURA,Vitiligo,,OPZELURA | Vitiligo,NaT
256672511,25667251,,,2025-07-03,20250811,,NEMLUVIO,Somnolence,,NEMLUVIO | Somnolence,2025-06-30/2025-07-06
256672911,25667291,,,2025-03-01,20250811,,NEMLUVIO,Injection site papule,,NEMLUVIO | Injection site papule,2025-02-24/2025-03-02
256673383,25667338,39,M,2025-07-28,20250928,,VIVITROL,Needle issue,,VIVITROL | Needle issue,2025-07-28/2025-08-03
256673472,25667347,63,M,2025-01-01,20250929,,DUPIXENT,Asthma,,DUPIXENT | Asthma,2024-12-30/2025-01-05
256673481,25667348,50,F,2025-07-22,20250811,,RIBOCICLIB,Myelosuppression,LT,RIBOCICLIB | Myelosuppression | LT,2025-07-21/2025-07-27
256674281,25667428,,M,,20250811,,NOVORAPID,Pneumonia,OT,NOVORAPID | Pneumonia | OT,NaT
256674501,25667450,20,M,2025-08-06,20250811,,ZEPBOUND,Alopecia,,ZEPBOUND | Alopecia,2025-08-04/2025-08-10
256674601,25667460,46,M,2025-08-05,20250811,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,2025-08-04/2025-08-10
256674821,25667482,,,,20250811,,OPSUMIT,Cardiac ventricular disorder,,OPSUMIT | Cardiac ventricular disorder,NaT
256675281,25667528,16,F,2025-08-04,20250811,,LILETTA,Device expulsion,,LILETTA | Device expulsion,2025-08-04/2025-08-10
256675571,25667557,63,F,,20250811,,REVLIMID,Fall,HO,REVLIMID | Fall | HO,NaT
256675762,25667576,85,M,,20250929,,LENALIDOMIDE,Product quality issue,,LENALIDOMIDE | Product quality issue,NaT
256676131,25667613,73,M,2025-01-01,20250811,,CREON,Neoplasm malignant,OT,CREON | Neoplasm malignant | OT,2024-12-30/2025-01-05
256676801,25667680,29,M,2025-07-04,20250811,,OMEPRAZOLE,Paraesthesia,OT,OMEPRAZOLE | Paraesthesia | OT,2025-06-30/2025-07-06
256677011,25667701,,,,20250811,,AUSTEDO XR,Balance disorder,,AUSTEDO XR | Balance disorder,NaT
256678021,25667802,,M,,20250812,,RINVOQ,Intervertebral disc protrusion,OT,RINVOQ | Intervertebral disc protrusion | OT,NaT
256678091,25667809,14,F,2025-07-30,20250812,,LAMOTRIGINE,Dizziness,OT,LAMOTRIGINE | Dizziness | OT,2025-07-28/2025-08-03
256678321,25667832,,,2025-01-01,20250812,,KRYSTEXXA,Back pain,,KRYSTEXXA | Back pain,2024-12-30/2025-01-05
256678481,25667848,16,M,,20250812,,EMGALITY,Injection site swelling,,EMGALITY | Injection site swelling,NaT
256679471,25667947,16,F,2025-07-18,20250812,,LISDEXAMFETAMINE DIMESYLATE,Raynaud's phenomenon,OT,LISDEXAMFETAMINE DIMESYLATE | Raynaud's phenomenon | OT,2025-07-14/2025-07-20
256680321,25668032,63,,2025-08-04,20250812,,MOUNJARO,Nausea,,MOUNJARO | Nausea,2025-08-04/2025-08-10
256680811,25668081,48,M,2025-04-25,20250812,,TESTOSTERONE CYPIONATE,Liquid product physical issue,,TESTOSTERONE CYPIONATE | Liquid product physical issue,2025-04-21/2025-04-27
256680882,25668088,,M,2025-01-01,20250904,,BIMEKIZUMAB,Product availability issue,DS,BIMEKIZUMAB | Product availability issue | DS,2024-12-30/2025-01-05
256681062,25668106,7,M,,20250812,,VIDAZA,Staphylococcal bacteraemia,OT,VIDAZA | Staphylococcal bacteraemia | OT,NaT
256681091,25668109,,F,,20250812,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
256681211,25668121,,,,20250812,,ADALIMUMAB,Antinuclear antibody positive,OT,ADALIMUMAB | Antinuclear antibody positive | OT,NaT
256683061,25668306,,F,,20250812,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
256683502,25668350,13,M,2025-07-01,20250923,,TOPIRAMATE,Medication error,OT,TOPIRAMATE | Medication error | OT,2025-06-30/2025-07-06
256684371,25668437,52,F,2025-08-01,20250812,,AYVAKIT,Death,DE,AYVAKIT | Death | DE,2025-07-28/2025-08-03
256684623,25668462,,F,2025-08-04,20250922,,KISQALI,Neutropenia,OT,KISQALI | Neutropenia | OT,2025-08-04/2025-08-10
256684661,25668466,64,F,2025-07-01,20250812,,CIMZIA,Aspiration,HO,CIMZIA | Aspiration | HO,2025-06-30/2025-07-06
256684681,25668468,,,2025-06-04,20250812,,INFLIXIMAB,Crohn's disease,OT,INFLIXIMAB | Crohn's disease | OT,2025-06-02/2025-06-08
256685112,25668511,65,M,2025-08-08,20250819,,POMALYST,Asthenia,,POMALYST | Asthenia,2025-08-04/2025-08-10
256685301,25668530,62,M,,20250812,,TESTOSTERONE CYPIONATE,Recalled product administered,,TESTOSTERONE CYPIONATE | Recalled product administered,NaT
256685383,25668538,56,M,,20250926,,ORGOVYX,Incorrect dose administered,,ORGOVYX | Incorrect dose administered,NaT
256685611,25668561,,F,,20250812,,VABYSMO,Spinal operation,OT,VABYSMO | Spinal operation | OT,NaT
256685721,25668572,,F,2025-06-11,20250812,,FUROSEMIDE,Deafness neurosensory,OT,FUROSEMIDE | Deafness neurosensory | OT,2025-06-09/2025-06-15
256686181,25668618,65,F,,20250812,,AMOXICILLIN AND CLAVULANATE POTASSIUM,Clostridium difficile colitis,HO,AMOXICILLIN AND CLAVULANATE POTASSIUM | Clostridium difficile colitis | HO,NaT
256686941,25668694,35,F,2020-08-01,20250812,,TEPEZZA,Blood pressure abnormal,,TEPEZZA | Blood pressure abnormal,2020-07-27/2020-08-02
256687751,25668775,63,F,,20250812,,MOUNJARO,Product dose omission issue,,MOUNJARO | Product dose omission issue,NaT
256688481,25668848,3,F,,20250812,,TACROLIMUS,Hypogammaglobulinaemia,OT,TACROLIMUS | Hypogammaglobulinaemia | OT,NaT
256688541,25668854,,,,20250812,,USTEKINUMAB,Tracheal stenosis,OT,USTEKINUMAB | Tracheal stenosis | OT,NaT
256688911,25668891,,F,2025-01-01,20250812,,OHTUVAYRE,Hypertension,,OHTUVAYRE | Hypertension,2024-12-30/2025-01-05
256690322,25669032,77,F,2025-08-11,20250813,,ORENCIA,Device use error,,ORENCIA | Device use error,2025-08-11/2025-08-17
256691471,25669147,,,,20250812,,CEFAZOLIN,Tongue oedema,OT,CEFAZOLIN | Tongue oedema | OT,NaT
256691801,25669180,,F,,20250812,,COSENTYX,Pulmonary calcification,OT,COSENTYX | Pulmonary calcification | OT,NaT
256692523,25669252,83,M,,20250918,,OFEV,Dyspnoea,HO,OFEV | Dyspnoea | HO,NaT
256692843,25669284,40,F,,20250924,,ANIFROLUMAB,Osteonecrosis,OT,ANIFROLUMAB | Osteonecrosis | OT,NaT
256692962,25669296,,F,,20250821,,VEDOLIZUMAB,Pneumonia,OT,VEDOLIZUMAB | Pneumonia | OT,NaT
256693391,25669339,63,F,,20250812,,NEXIUM 24HR,Blood creatinine increased,OT,NEXIUM 24HR | Blood creatinine increased | OT,NaT
256693741,25669374,66,M,,20250812,,ORGOVYX,Hot flush,,ORGOVYX | Hot flush,NaT
256693861,25669386,85,F,2025-06-16,20250812,,DAPTOMYCIN,Rhabdomyolysis,HO,DAPTOMYCIN | Rhabdomyolysis | HO,2025-06-16/2025-06-22
256694341,25669434,20,F,2025-05-01,20250812,,ENSPRYNG,Therapeutic response decreased,OT,ENSPRYNG | Therapeutic response decreased | OT,2025-04-28/2025-05-04
256694521,25669452,51,F,,20250812,,LENALIDOMIDE,Pain,,LENALIDOMIDE | Pain,NaT
256694921,25669492,66,M,,20250812,,RIFAMPIN,Drug ineffective,OT,RIFAMPIN | Drug ineffective | OT,NaT
256695801,25669580,,M,,20250812,,BRIMONIDINE TARTRATE,Cyst,OT,BRIMONIDINE TARTRATE | Cyst | OT,NaT
256696001,25669600,64,F,,20250812,,ZEPOSIA,Abdominal discomfort,,ZEPOSIA | Abdominal discomfort,NaT
256696571,25669657,,,2025-01-01,20250812,,NEMLUVIO,Erythema,,NEMLUVIO | Erythema,2024-12-30/2025-01-05
256696881,25669688,58,M,2024-06-12,20250812,,EPIRUBICIN,Blood lactate dehydrogenase increased,OT,EPIRUBICIN | Blood lactate dehydrogenase increased | OT,2024-06-10/2024-06-16
256696891,25669689,,,,20250812,,ALBUREX,Lung disorder,OT,ALBUREX | Lung disorder | OT,NaT
256697141,25669714,38,F,,20250812,,ZEPBOUND,Diarrhoea,,ZEPBOUND | Diarrhoea,NaT
256697261,25669726,66,F,,20250812,,HUMALOG,Blood glucose increased,,HUMALOG | Blood glucose increased,NaT
256697472,25669747,76,M,2025-07-30,20250922,,DONEPEZIL,Drug ineffective,,DONEPEZIL | Drug ineffective,2025-07-28/2025-08-03
256698641,25669864,,F,,20250810,,VUMERITY,Sepsis,HO,VUMERITY | Sepsis | HO,NaT
256699913,25669991,88,M,,20250818,,METHOTREXATE SODIUM,Angiocentric lymphoma,OT,METHOTREXATE SODIUM | Angiocentric lymphoma | OT,NaT
256700081,25670008,,M,,20250811,,LENALIDOMIDE,Gastrointestinal viral infection,HO,LENALIDOMIDE | Gastrointestinal viral infection | HO,NaT
256700461,25670046,,M,,20250812,,XOLAIR PFS,Drug ineffective,,XOLAIR PFS | Drug ineffective,NaT
256701881,25670188,53,F,,20250811,,TYENNE,Femur fracture,,TYENNE | Femur fracture,NaT
256702161,25670216,49,F,2025-08-02,20250812,,OZEMPIC,Small intestinal obstruction,HO,OZEMPIC | Small intestinal obstruction | HO,2025-07-28/2025-08-03
256702341,25670234,,,,20250812,,MIRALAX,Drug effect less than expected,,MIRALAX | Drug effect less than expected,NaT
256703211,25670321,36,M,2025-08-06,20250812,,MOUNJARO,Accidental overdose,,MOUNJARO | Accidental overdose,2025-08-04/2025-08-10
256704291,25670429,,,,20250812,,KESIMPTA,Peripheral swelling,,KESIMPTA | Peripheral swelling,NaT
256704381,25670438,,,2025-08-08,20250812,,OPDIVO,Product storage error,,OPDIVO | Product storage error,2025-08-04/2025-08-10
256704411,25670441,72,F,,20250812,,POMALYST,White blood cell count decreased,HO,POMALYST | White blood cell count decreased | HO,NaT
256704971,25670497,38,F,2025-06-09,20250812,,MOUNJARO,Incorrect dose administered,OT,MOUNJARO | Incorrect dose administered | OT,2025-06-09/2025-06-15
256705321,25670532,35,M,2025-01-01,20250812,,AYVAKIT,Irritability,,AYVAKIT | Irritability,2024-12-30/2025-01-05
256705361,25670536,58,M,,20250812,,CLOZAPINE,Arrhythmia,HO,CLOZAPINE | Arrhythmia | HO,NaT
256705483,25670548,,M,2025-01-01,20250918,,BIMZELX,Blister,OT,BIMZELX | Blister | OT,2024-12-30/2025-01-05
256705611,25670561,,F,,20250812,,REVLIMID,Death,DE,REVLIMID | Death | DE,NaT
256705691,25670569,85,F,2025-07-12,20250812,,DARATUMUMAB\HYALURONIDASE-FIHJ,Colitis ischaemic,HO,DARATUMUMAB\HYALURONIDASE-FIHJ | Colitis ischaemic | HO,2025-07-07/2025-07-13
256706681,25670668,35,F,2024-08-27,20250812,,GABAPENTIN,Rhabdomyolysis,HO,GABAPENTIN | Rhabdomyolysis | HO,2024-08-26/2024-09-01
256706731,25670673,34,M,2009-10-20,20250812,,COLCHICINE,Rhabdomyolysis,HO,COLCHICINE | Rhabdomyolysis | HO,2009-10-19/2009-10-25
256707151,25670715,,,,20250812,,LATUDA,Treatment failure,,LATUDA | Treatment failure,NaT
256707231,25670723,84,M,,20250812,,LUPRON DEPOT,Death,DE,LUPRON DEPOT | Death | DE,NaT
256708141,25670814,88,F,,20250812,,VYNDAMAX,Transient ischaemic attack,OT,VYNDAMAX | Transient ischaemic attack | OT,NaT
256709831,25670983,55,M,,20250812,,MOUNJARO,Abdominal pain upper,,MOUNJARO | Abdominal pain upper,NaT
256710971,25671097,60,M,2025-06-03,20250812,,CLOZAPINE,Drug ineffective,OT,CLOZAPINE | Drug ineffective | OT,2025-06-02/2025-06-08
256711141,25671114,,,,20250812,,AMLODIPINE,Acute kidney injury,OT,AMLODIPINE | Acute kidney injury | OT,NaT
256711341,25671134,,F,,20250812,,ACCUTANE,Pain,,ACCUTANE | Pain,NaT
256711781,25671178,55,F,,20250812,,ZEPBOUND,Extra dose administered,,ZEPBOUND | Extra dose administered,NaT
256712171,25671217,,F,,20250812,,KEVZARA,Rheumatoid arthritis,OT,KEVZARA | Rheumatoid arthritis | OT,NaT
256712421,25671242,,,,20250812,,EDURANT,Dysphagia,OT,EDURANT | Dysphagia | OT,NaT
256712731,25671273,,F,,20250812,,VENTOLIN,Drug ineffective,,VENTOLIN | Drug ineffective,NaT
256714151,25671415,,F,,20250812,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,NaT
256714482,25671448,,F,,20250814,,GLATOPA,Circumstance or information capable of leading to medication error,,GLATOPA | Circumstance or information capable of leading to medication error,NaT
256714834,25671483,72,M,2025-08-01,20250909,,CARBIDOPA\LEVODOPA,Pain,DE,CARBIDOPA\LEVODOPA | Pain | DE,2025-07-28/2025-08-03
256715031,25671503,42,F,2024-07-01,20250812,,XYWAV,Surgery,OT,XYWAV | Surgery | OT,2024-07-01/2024-07-07
256715081,25671508,49,M,2024-04-05,20250812,,DOXAZOSIN,Male sexual dysfunction,OT,DOXAZOSIN | Male sexual dysfunction | OT,2024-04-01/2024-04-07
256715441,25671544,70,F,2025-01-01,20250812,,HUMIRA,Intestinal operation,OT,HUMIRA | Intestinal operation | OT,2024-12-30/2025-01-05
256715781,25671578,72,F,,20250812,,IBRANCE,Feeling cold,OT,IBRANCE | Feeling cold | OT,NaT
256716841,25671684,,F,,20250812,,ACETAMINOPHEN,Muscle spasms,DE,ACETAMINOPHEN | Muscle spasms | DE,NaT
256717021,25671702,2,M,2025-04-26,20250812,,ADVATE,Seizure,HO,ADVATE | Seizure | HO,2025-04-21/2025-04-27
256717271,25671727,38,M,,20250812,,POMALYST,Hospitalisation,HO,POMALYST | Hospitalisation | HO,NaT
256717652,25671765,49,F,2025-01-01,20250904,,BACTERIOSTATIC SODIUM CHLORIDE,Injection site pain,,BACTERIOSTATIC SODIUM CHLORIDE | Injection site pain,2024-12-30/2025-01-05
256717851,25671785,40,F,2025-01-01,20250812,,AUSTEDO,Mental disorder,HO,AUSTEDO | Mental disorder | HO,2024-12-30/2025-01-05
256719052,25671905,89,F,,20250821,,XELJANZ,Death,DE,XELJANZ | Death | DE,NaT
256720951,25672095,59,F,2025-01-07,20250812,,COSENTYX,Hepatic cytolysis,OT,COSENTYX | Hepatic cytolysis | OT,2025-01-06/2025-01-12
256721291,25672129,,,2025-06-30,20250812,,NEMLUVIO,Inappropriate schedule of product administration,,NEMLUVIO | Inappropriate schedule of product administration,2025-06-30/2025-07-06
256721301,25672130,,,,20250812,,NEMLUVIO,Rash,,NEMLUVIO | Rash,NaT
256721351,25672135,,,2025-01-01,20250812,,NEMLUVIO,Skin weeping,,NEMLUVIO | Skin weeping,2024-12-30/2025-01-05
256721401,25672140,,,2025-07-03,20250812,,NEMLUVIO,Device leakage,,NEMLUVIO | Device leakage,2025-06-30/2025-07-06
256721641,25672164,,,2025-01-01,20250812,,NEMLUVIO,Blister,,NEMLUVIO | Blister,2024-12-30/2025-01-05
256722181,25672218,,,,20250812,,NEMLUVIO,Intentional underdose,,NEMLUVIO | Intentional underdose,NaT
256722551,25672255,,,2025-01-01,20250812,,NEMLUVIO,Product dose omission issue,,NEMLUVIO | Product dose omission issue,2024-12-30/2025-01-05
256722871,25672287,,,2025-06-17,20250812,,NEMLUVIO,Inappropriate schedule of product administration,,NEMLUVIO | Inappropriate schedule of product administration,2025-06-16/2025-06-22
256723151,25672315,39,F,2024-01-01,20250812,,DUPIXENT,Maternal exposure during pregnancy,,DUPIXENT | Maternal exposure during pregnancy,2024-01-01/2024-01-07
256723982,25672398,13,F,2025-05-01,20250916,,DUPIXENT,No adverse event,,DUPIXENT | No adverse event,2025-04-28/2025-05-04
256724391,25672439,66,F,,20250812,,KEVZARA,Therapeutic response unexpected,,KEVZARA | Therapeutic response unexpected,NaT
256724511,25672451,46,F,2025-01-01,20250812,,DUPIXENT,Rash,,DUPIXENT | Rash,2024-12-30/2025-01-05
256725531,25672553,,,,20250812,,DUPIXENT,Arthritis,,DUPIXENT | Arthritis,NaT
256726211,25672621,68,F,2025-08-07,20250812,,DUPIXENT,Rash pruritic,,DUPIXENT | Rash pruritic,2025-08-04/2025-08-10
256726251,25672625,,F,,20250812,,DUPIXENT,Neurodermatitis,,DUPIXENT | Neurodermatitis,NaT
256726301,25672630,61,M,,20250812,,DUPIXENT,Dyspnoea,,DUPIXENT | Dyspnoea,NaT
256726752,25672675,33,F,2025-01-01,20250823,,DUPIXENT,Skin irritation,,DUPIXENT | Skin irritation,2024-12-30/2025-01-05
256727251,25672725,15,F,,20250812,,DUPIXENT,Ocular hyperaemia,,DUPIXENT | Ocular hyperaemia,NaT
256728071,25672807,83,F,2025-01-01,20250812,,UPADACITINIB,Off label use,OT,UPADACITINIB | Off label use | OT,2024-12-30/2025-01-05
256728191,25672819,77,F,2025-01-01,20250812,,CORTICOTROPIN,Dysuria,,CORTICOTROPIN | Dysuria,2024-12-30/2025-01-05
256728951,25672895,36,F,2025-07-01,20250812,,SKYRIZI,Pancreatitis chronic,HO,SKYRIZI | Pancreatitis chronic | HO,2025-06-30/2025-07-06
256729051,25672905,,,2025-07-21,20250812,,NEMLUVIO,Inappropriate schedule of product administration,,NEMLUVIO | Inappropriate schedule of product administration,2025-07-21/2025-07-27
256729241,25672924,17,F,2025-07-01,20250812,,DUPIXENT,Rash,,DUPIXENT | Rash,2025-06-30/2025-07-06
256729821,25672982,65,,2025-07-24,20250812,,DARZALEX FASPRO,Multiple organ dysfunction syndrome,DE,DARZALEX FASPRO | Multiple organ dysfunction syndrome | DE,2025-07-21/2025-07-27
256731171,25673117,,M,,20250813,,DUPIXENT,Off label use,,DUPIXENT | Off label use,NaT
256731261,25673126,14,F,2025-01-01,20250813,,DUPIXENT,Loss of consciousness,OT,DUPIXENT | Loss of consciousness | OT,2024-12-30/2025-01-05
256731702,25673170,55,M,2025-07-28,20250823,,VENCLEXTA,Gait disturbance,HO,VENCLEXTA | Gait disturbance | HO,2025-07-28/2025-08-03
256734081,25673408,70,M,,20250813,,PREDNISONE,Acute myeloid leukaemia,OT,PREDNISONE | Acute myeloid leukaemia | OT,NaT
256735091,25673509,62,M,,20250813,,OSIMERTINIB,MET gene amplification,OT,OSIMERTINIB | MET gene amplification | OT,NaT
256735351,25673535,,F,,20250813,,DUPIXENT,Condition aggravated,,DUPIXENT | Condition aggravated,NaT
256735511,25673551,,,,20250813,,ELIQUIS,Diarrhoea,,ELIQUIS | Diarrhoea,NaT
256736201,25673620,,F,,20250813,,MUCINEX MAXIMUM STRENGTH,Incorrect product administration duration,,MUCINEX MAXIMUM STRENGTH | Incorrect product administration duration,NaT
256736721,25673672,73,M,2023-03-01,20250813,,DRONEDARONE,Pneumonitis chemical,OT,DRONEDARONE | Pneumonitis chemical | OT,2023-02-27/2023-03-05
256736801,25673680,55,F,2025-07-01,20250813,,REVLIMID,Product dose omission issue,,REVLIMID | Product dose omission issue,2025-06-30/2025-07-06
256736851,25673685,72,F,2025-07-11,20250813,,HYALURONIDASE-ZZXF\PERTUZUMAB\TRASTUZUMAB,Myelosuppression,OT,HYALURONIDASE-ZZXF\PERTUZUMAB\TRASTUZUMAB | Myelosuppression | OT,2025-07-07/2025-07-13
256737342,25673734,15,F,2025-08-06,20250813,,XOLAIR,Product dose omission issue,,XOLAIR | Product dose omission issue,2025-08-04/2025-08-10
256738311,25673831,72,F,2025-07-26,20250813,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,2025-07-21/2025-07-27
256739261,25673926,78,M,,20250813,,ELIGARD,Death,DE,ELIGARD | Death | DE,NaT
256739293,25673929,48,M,,20250910,,ORGOVYX,Hypersensitivity,,ORGOVYX | Hypersensitivity,NaT
256739311,25673931,,M,,20250813,,SIMPONI,Crohn's disease,OT,SIMPONI | Crohn's disease | OT,NaT
256739381,25673938,39,F,,20250813,,RITUXIMAB,Haemophilus infection,HO,RITUXIMAB | Haemophilus infection | HO,NaT
256739661,25673966,,,,20250813,,VENLAFAXINE,Intentional overdose,HO,VENLAFAXINE | Intentional overdose | HO,NaT
256739781,25673978,65,M,2020-12-18,20250813,,CAPECITABINE,Hyperglycaemia,HO,CAPECITABINE | Hyperglycaemia | HO,2020-12-14/2020-12-20
256740271,25674027,78,F,,20250813,,POMALYST,Product distribution issue,,POMALYST | Product distribution issue,NaT
256740731,25674073,66,F,2025-05-25,20250813,,PACLITAXEL,Colitis,DE,PACLITAXEL | Colitis | DE,2025-05-19/2025-05-25
256740841,25674084,57,M,,20250813,,MOUNJARO,Injection site haemorrhage,,MOUNJARO | Injection site haemorrhage,NaT
256741821,25674182,42,,,20250813,,OCRELIZUMAB,Colon cancer stage III,OT,OCRELIZUMAB | Colon cancer stage III | OT,NaT
256742041,25674204,54,F,,20250813,,ORENCIA,Joint swelling,,ORENCIA | Joint swelling,NaT
256742072,25674207,,F,,20250925,,ZYRTEC,Therapeutic product effect incomplete,,ZYRTEC | Therapeutic product effect incomplete,NaT
256742381,25674238,62,F,,20250813,,CYMBALTA,Fatigue,,CYMBALTA | Fatigue,NaT
256742391,25674239,32,M,2025-05-20,20250813,,PEPCID AC,Dizziness,,PEPCID AC | Dizziness,2025-05-19/2025-05-25
256742731,25674273,43,F,,20250813,,HYDROXYCHLOROQUINE,Vomiting,LT,HYDROXYCHLOROQUINE | Vomiting | LT,NaT
256743571,25674357,43,M,2025-06-01,20250813,,MIRCERA,Serum ferritin increased,DE,MIRCERA | Serum ferritin increased | DE,2025-05-26/2025-06-01
256743641,25674364,,F,2024-07-18,20250813,,METOPROLOL SUCCINATE,Drug intolerance,OT,METOPROLOL SUCCINATE | Drug intolerance | OT,2024-07-15/2024-07-21
256743941,25674394,27,F,2025-07-18,20250813,,PERTUZUMAB,Liver injury,OT,PERTUZUMAB | Liver injury | OT,2025-07-14/2025-07-20
256744471,25674447,,,,20250813,,BENZONATATE,Toxicity to various agents,HO,BENZONATATE | Toxicity to various agents | HO,NaT
256745351,25674535,52,,,20250813,,MOUNJARO,Impaired gastric emptying,OT,MOUNJARO | Impaired gastric emptying | OT,NaT
256745551,25674555,,F,2025-08-06,20250813,,TREMFYA,Device deployment issue,,TREMFYA | Device deployment issue,2025-08-04/2025-08-10
256746611,25674661,46,M,2025-04-24,20250813,,SERTRALINE,Reversible cerebral vasoconstriction syndrome,HO,SERTRALINE | Reversible cerebral vasoconstriction syndrome | HO,2025-04-21/2025-04-27
256747491,25674749,,F,2025-08-12,20250813,,DIANEAL,Death,DE,DIANEAL | Death | DE,2025-08-11/2025-08-17
256747511,25674751,66,F,,20250813,,CISPLATIN,Pulmonary embolism,HO,CISPLATIN | Pulmonary embolism | HO,NaT
256747811,25674781,67,F,2025-07-24,20250813,,NEULASTA,Device use error,,NEULASTA | Device use error,2025-07-21/2025-07-27
256748521,25674852,77,F,,20250813,,OFEV,Death,DE,OFEV | Death | DE,NaT
256749801,25674980,,F,,20250813,,TICAGRELOR,Death,DE,TICAGRELOR | Death | DE,NaT
256750151,25675015,72,M,2025-06-19,20250813,,TALQUETAMAB,Skin exfoliation,,TALQUETAMAB | Skin exfoliation,2025-06-16/2025-06-22
256750321,25675032,,F,,20250812,,MACITENTAN\TADALAFIL,Right ventricular failure,HO,MACITENTAN\TADALAFIL | Right ventricular failure | HO,NaT
256750711,25675071,85,F,,20250813,,REVLIMID,Urinary tract infection,,REVLIMID | Urinary tract infection,NaT
256750801,25675080,57,M,2025-01-01,20250813,,UPADACITINIB,Inflammation,OT,UPADACITINIB | Inflammation | OT,2024-12-30/2025-01-05
256750861,25675086,61,M,2017-03-01,20250813,,TACROLIMUS,Kaposi sarcoma inflammatory cytokine syndrome,LT,TACROLIMUS | Kaposi sarcoma inflammatory cytokine syndrome | LT,2017-02-27/2017-03-05
256751131,25675113,10,M,2025-07-24,20250813,,FLUVOXAMINE MALEATE,Agitation,HO,FLUVOXAMINE MALEATE | Agitation | HO,2025-07-21/2025-07-27
256752161,25675216,56,M,,20250813,,MOUNJARO,Drug ineffective,,MOUNJARO | Drug ineffective,NaT
256753231,25675323,25,F,,20250813,,CETIRIZINE,Drug ineffective,OT,CETIRIZINE | Drug ineffective | OT,NaT
256754361,25675436,76,F,2025-07-19,20250812,,LENALIDOMIDE,COVID-19,HO,LENALIDOMIDE | COVID-19 | HO,2025-07-14/2025-07-20
256755262,25675526,52,F,2025-08-03,20250822,,MULTIHANCE,Shock,OT,MULTIHANCE | Shock | OT,2025-07-28/2025-08-03
256755661,25675566,44,M,2025-05-01,20250813,,TRUVADA,Device expulsion,OT,TRUVADA | Device expulsion | OT,2025-04-28/2025-05-04
256758361,25675836,,F,2025-05-29,20250813,,SKYLA,Device expulsion,,SKYLA | Device expulsion,2025-05-26/2025-06-01
256758681,25675868,46,M,2025-07-05,20250813,,CLONAZEPAM,Acute kidney injury,HO,CLONAZEPAM | Acute kidney injury | HO,2025-06-30/2025-07-06
256758801,25675880,,F,,20250813,,RITUXAN,Myasthenia gravis,OT,RITUXAN | Myasthenia gravis | OT,NaT
256759892,25675989,68,M,,20250829,,ERBITUX,Cholecystitis,OT,ERBITUX | Cholecystitis | OT,NaT
256760051,25676005,49,F,,20250813,,ZEPBOUND,Gastrooesophageal reflux disease,,ZEPBOUND | Gastrooesophageal reflux disease,NaT
256760101,25676010,,,,20250813,,MOUNJARO,Dyspepsia,,MOUNJARO | Dyspepsia,NaT
256760341,25676034,,,,20250813,,ZEPBOUND,Treatment failure,,ZEPBOUND | Treatment failure,NaT
256761041,25676104,59,,,20250813,,JAKAFI,Night sweats,,JAKAFI | Night sweats,NaT
256761521,25676152,70,F,2024-07-01,20250813,,ARIMIDEX,Vomiting,,ARIMIDEX | Vomiting,2024-07-01/2024-07-07
256763221,25676322,,,2025-07-01,20250813,,TOLVAPTAN,Death,DE,TOLVAPTAN | Death | DE,2025-06-30/2025-07-06
256763351,25676335,,,2025-08-12,20250813,,PHENTERMINE,Contraindicated product prescribed,,PHENTERMINE | Contraindicated product prescribed,2025-08-11/2025-08-17
256763521,25676352,64,F,2025-01-01,20250813,,RINVOQ,Coeliac disease,OT,RINVOQ | Coeliac disease | OT,2024-12-30/2025-01-05
256763601,25676360,8,F,,20250813,,METRONIDAZOLE,Drug reaction with eosinophilia and systemic symptoms,OT,METRONIDAZOLE | Drug reaction with eosinophilia and systemic symptoms | OT,NaT
256763661,25676366,,,2025-01-01,20250813,,NEMLUVIO,Inappropriate schedule of product administration,,NEMLUVIO | Inappropriate schedule of product administration,2024-12-30/2025-01-05
256763911,25676391,,,,20250813,,NEMLUVIO,Rash,,NEMLUVIO | Rash,NaT
256764081,25676408,,,,20250813,,NEMLUVIO,Product dose omission issue,,NEMLUVIO | Product dose omission issue,NaT
256764341,25676434,,,2025-01-01,20250813,,NEMLUVIO,Myalgia,,NEMLUVIO | Myalgia,2024-12-30/2025-01-05
256765111,25676511,84,M,2025-01-01,20250813,,VENCLEXTA,Platelet count decreased,OT,VENCLEXTA | Platelet count decreased | OT,2024-12-30/2025-01-05
256765411,25676541,,F,,20250813,,BROMFENAC\MOXIFLOXACIN\PREDNISONE,Lip swelling,OT,BROMFENAC\MOXIFLOXACIN\PREDNISONE | Lip swelling | OT,NaT
256765511,25676551,55,M,,20250813,,FENTANYL,Drug withdrawal syndrome,HO,FENTANYL | Drug withdrawal syndrome | HO,NaT
256765701,25676570,,F,,20250813,,OZEMPIC,Cataract,OT,OZEMPIC | Cataract | OT,NaT
256765861,25676586,60,,,20250813,,OZEMPIC,Intestinal obstruction,OT,OZEMPIC | Intestinal obstruction | OT,NaT
256768071,25676807,28,F,2023-05-01,20250813,,SPRYCEL,Chronic kidney disease,OT,SPRYCEL | Chronic kidney disease | OT,2023-05-01/2023-05-07
256768431,25676843,87,M,,20250813,,GABAPENTIN,Dysgeusia,,GABAPENTIN | Dysgeusia,NaT
256769421,25676942,,F,,20250813,,XYWAV,Hernia,OT,XYWAV | Hernia | OT,NaT
256769771,25676977,,,2024-01-01,20250813,,FERRIC CARBOXYMALTOSE,Blood phosphorus decreased,OT,FERRIC CARBOXYMALTOSE | Blood phosphorus decreased | OT,2024-01-01/2024-01-07
256769781,25676978,,,2024-01-01,20250813,,FERRIC CARBOXYMALTOSE,Blood phosphorus decreased,OT,FERRIC CARBOXYMALTOSE | Blood phosphorus decreased | OT,2024-01-01/2024-01-07
256769861,25676986,,,2024-01-01,20250813,,FERRIC CARBOXYMALTOSE,Blood phosphorus decreased,OT,FERRIC CARBOXYMALTOSE | Blood phosphorus decreased | OT,2024-01-01/2024-01-07
256770541,25677054,73,F,,20250813,,DUPIXENT,Rash,,DUPIXENT | Rash,NaT
256770772,25677077,,F,,20250912,,VYVANSE,Drug hypersensitivity,HO,VYVANSE | Drug hypersensitivity | HO,NaT
256771501,25677150,57,M,2025-01-01,20250813,,DUPIXENT,Upper-airway cough syndrome,,DUPIXENT | Upper-airway cough syndrome,2024-12-30/2025-01-05
256771511,25677151,93,M,2025-01-01,20250813,,DUPIXENT,Rash,,DUPIXENT | Rash,2024-12-30/2025-01-05
256771621,25677162,,F,,20250813,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,NaT
256772591,25677259,5,M,,20250813,,DUPIXENT,Off label use,,DUPIXENT | Off label use,NaT
256772711,25677271,9,M,,20250813,,DUPIXENT,Off label use,,DUPIXENT | Off label use,NaT
256773091,25677309,,M,,20250813,,DUPIXENT,Cough,,DUPIXENT | Cough,NaT
256773151,25677315,,F,2025-04-01,20250813,,DUPIXENT,SARS-CoV-2 test positive,,DUPIXENT | SARS-CoV-2 test positive,2025-03-31/2025-04-06
256773981,25677398,,F,,20250813,,OXYCODONE HYDROCHLORIDE,Impaired quality of life,OT,OXYCODONE HYDROCHLORIDE | Impaired quality of life | OT,NaT
256774031,25677403,,F,2025-01-01,20250813,,ZURZUVAE,Off label use,,ZURZUVAE | Off label use,2024-12-30/2025-01-05
256774081,25677408,,F,,20250813,,DUPIXENT,Pyrexia,HO,DUPIXENT | Pyrexia | HO,NaT
256774121,25677412,54,F,,20250813,,DUPIXENT,Weight increased,,DUPIXENT | Weight increased,NaT
256775141,25677514,60,M,2025-02-01,20250813,,DUPIXENT,Nasal obstruction,,DUPIXENT | Nasal obstruction,2025-01-27/2025-02-02
256775281,25677528,,M,,20250813,,DESCOVY,Extradural haematoma,HO,DESCOVY | Extradural haematoma | HO,NaT
256776941,25677694,31,M,,20250813,,BUPROPION,Suicide attempt,OT,BUPROPION | Suicide attempt | OT,NaT
256777141,25677714,,F,2025-01-01,20250813,,HIZENTRA,Pain,,HIZENTRA | Pain,2024-12-30/2025-01-05
256777321,25677732,,F,,20250813,,TRASTUZUMAB DERUXTECAN,Pneumocystis jirovecii pneumonia,DE,TRASTUZUMAB DERUXTECAN | Pneumocystis jirovecii pneumonia | DE,NaT
256777931,25677793,83,M,2025-07-03,20250813,,TRAMADOL,Poisoning deliberate,HO,TRAMADOL | Poisoning deliberate | HO,2025-06-30/2025-07-06
256778411,25677841,9,M,,20250813,,DUPIXENT,Incorrect dose administered,,DUPIXENT | Incorrect dose administered,NaT
256778521,25677852,68,F,2025-06-04,20250813,,BIMEKIZUMAB,Drug ineffective,OT,BIMEKIZUMAB | Drug ineffective | OT,2025-06-02/2025-06-08
256779061,25677906,,,2025-01-01,20250813,,NEMLUVIO,Inappropriate schedule of product administration,,NEMLUVIO | Inappropriate schedule of product administration,2024-12-30/2025-01-05
256779311,25677931,,,2025-01-01,20250813,,NEMLUVIO,Inappropriate schedule of product administration,,NEMLUVIO | Inappropriate schedule of product administration,2024-12-30/2025-01-05
256779671,25677967,,,2025-01-01,20250813,,NEMLUVIO,Pruritus,,NEMLUVIO | Pruritus,2024-12-30/2025-01-05
256779821,25677982,,F,2025-08-03,20250813,,RIVAROXABAN,Pulmonary embolism,OT,RIVAROXABAN | Pulmonary embolism | OT,2025-07-28/2025-08-03
256779961,25677996,,M,,20250813,,DUPIXENT,Malaise,,DUPIXENT | Malaise,NaT
256780251,25678025,71,F,2025-07-01,20250813,,METHOTREXATE SODIUM,Pyrexia,HO,METHOTREXATE SODIUM | Pyrexia | HO,2025-06-30/2025-07-06
256780431,25678043,21,F,,20250813,,DUPIXENT,Off label use,,DUPIXENT | Off label use,NaT
256781051,25678105,,,,20250813,,NEMLUVIO,Eye irritation,,NEMLUVIO | Eye irritation,NaT
256781061,25678106,,,2025-01-01,20250813,,NEMLUVIO,Condition aggravated,,NEMLUVIO | Condition aggravated,2024-12-30/2025-01-05
256781741,25678174,,,,20250813,,NEMLUVIO,Product dose omission issue,,NEMLUVIO | Product dose omission issue,NaT
256781931,25678193,,,,20250813,,NEMLUVIO,Fungal infection,,NEMLUVIO | Fungal infection,NaT
256782171,25678217,73,F,2012-01-01,20250813,,CYCLOSPORINE,Anal squamous cell carcinoma,HO,CYCLOSPORINE | Anal squamous cell carcinoma | HO,2011-12-26/2012-01-01
256783221,25678322,,F,2025-06-01,20250813,,INSULIN LISPRO,Off label use,OT,INSULIN LISPRO | Off label use | OT,2025-05-26/2025-06-01
256783621,25678362,,F,,20250813,,LISINOPRIL,Illness,,LISINOPRIL | Illness,NaT
256784022,25678402,82,F,,20250821,,PEMBROLIZUMAB,Interstitial lung disease,HO,PEMBROLIZUMAB | Interstitial lung disease | HO,NaT
256784771,25678477,72,,,20250813,,TISLELIZUMAB,Hypersensitivity,OT,TISLELIZUMAB | Hypersensitivity | OT,NaT
256786801,25678680,57,M,2025-03-29,20250814,,VENETOCLAX,Abdominal pain upper,HO,VENETOCLAX | Abdominal pain upper | HO,2025-03-24/2025-03-30
256786891,25678689,,F,2025-01-01,20250814,,XIIDRA,Foreign body sensation in eyes,,XIIDRA | Foreign body sensation in eyes,2024-12-30/2025-01-05
256787232,25678723,45,M,2025-08-01,20250828,,METHYLPHENIDATE HYDROCHLORIDE,Myelodysplastic syndrome,HO,METHYLPHENIDATE HYDROCHLORIDE | Myelodysplastic syndrome | HO,2025-07-28/2025-08-03
256787702,25678770,27,M,2020-01-01,20250819,,DUPIXENT,Rash erythematous,,DUPIXENT | Rash erythematous,2019-12-30/2020-01-05
256787801,25678780,56,F,,20250814,,LANTUS SOLOSTAR,Product storage error,,LANTUS SOLOSTAR | Product storage error,NaT
256788891,25678889,,F,,20250814,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,NaT
256790401,25679040,68,F,,20250814,,ZEPBOUND,Balance disorder,,ZEPBOUND | Balance disorder,NaT
256790641,25679064,,F,,20250814,,ERIVEDGE,Weight decreased,,ERIVEDGE | Weight decreased,NaT
256791791,25679179,,,,20250814,,MUCINEX MAXIMUM STRENGTH,Incorrect product administration duration,,MUCINEX MAXIMUM STRENGTH | Incorrect product administration duration,NaT
256791811,25679181,75,F,,20250814,,COVID-19 VACCINE NOS,Lymphadenopathy,DE,COVID-19 VACCINE NOS | Lymphadenopathy | DE,NaT
256791841,25679184,59,M,,20250814,,POMALYST,Dyspnoea,,POMALYST | Dyspnoea,NaT
256793041,25679304,,,,20250814,,TRELEGY ELLIPTA,Drug ineffective,,TRELEGY ELLIPTA | Drug ineffective,NaT
256793421,25679342,54,F,2025-07-26,20250814,,CYCLOPHOSPHAMIDE,Vomiting,OT,CYCLOPHOSPHAMIDE | Vomiting | OT,2025-07-21/2025-07-27
256794061,25679406,,,,20250814,,LEFLUNOMIDE,Hepatic fibrosis,OT,LEFLUNOMIDE | Hepatic fibrosis | OT,NaT
256794731,25679473,65,F,,20250814,,HEPARIN,Drug ineffective,OT,HEPARIN | Drug ineffective | OT,NaT
256794951,25679495,,F,,20250814,,SYNTHROID,Product dispensing error,,SYNTHROID | Product dispensing error,NaT
256795191,25679519,,M,,20250814,,RISANKIZUMAB,Product temperature excursion issue,,RISANKIZUMAB | Product temperature excursion issue,NaT
256795282,25679528,71,M,2025-08-07,20250915,,TREMFYA,Product dose omission issue,,TREMFYA | Product dose omission issue,2025-08-04/2025-08-10
256795451,25679545,,F,,20250814,,DAYBUE,Cystitis,,DAYBUE | Cystitis,NaT
256796211,25679621,,F,,20250814,,MUCINEX MAXIMUM STRENGTH,Drug ineffective,,MUCINEX MAXIMUM STRENGTH | Drug ineffective,NaT
256796221,25679622,,F,,20250814,,DIFICID,Disease recurrence,,DIFICID | Disease recurrence,NaT
256796471,25679647,70,M,,20250814,,LIDOCAINE,Local anaesthetic systemic toxicity,LT,LIDOCAINE | Local anaesthetic systemic toxicity | LT,NaT
256796651,25679665,,,,20250814,,INFLIXIMAB,Vomiting,OT,INFLIXIMAB | Vomiting | OT,NaT
256796721,25679672,63,M,,20250814,,ORGOVYX,Hot flush,,ORGOVYX | Hot flush,NaT
256797401,25679740,,M,,20250814,,CREON,Death,DE,CREON | Death | DE,NaT
256798261,25679826,,,,20250814,,MUCINEX,Product use in unapproved indication,,MUCINEX | Product use in unapproved indication,NaT
256799601,25679960,,F,,20250814,,SYNDROS,Product use in unapproved indication,,SYNDROS | Product use in unapproved indication,NaT
256800341,25680034,,,,20250814,,FENTANYL,Peripheral ischaemia,HO,FENTANYL | Peripheral ischaemia | HO,NaT
256800551,25680055,71,F,2025-07-21,20250814,,NICOTINE POLACRILEX,Wrong technique in product usage process,,NICOTINE POLACRILEX | Wrong technique in product usage process,2025-07-21/2025-07-27
256801411,25680141,90,F,2025-05-12,20250814,,LANSOPRAZOLE,Colitis microscopic,HO,LANSOPRAZOLE | Colitis microscopic | HO,2025-05-12/2025-05-18
256801451,25680145,,F,,20250814,,HUMIRA,Breast cellulitis,HO,HUMIRA | Breast cellulitis | HO,NaT
256802341,25680234,63,M,,20250814,,ORGOVYX,Hot flush,OT,ORGOVYX | Hot flush | OT,NaT
256802711,25680271,46,F,2025-08-11,20250814,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,2025-08-11/2025-08-17
256803141,25680314,51,F,,20250814,,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Rash papular,,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN | Rash papular,NaT
256803311,25680331,,F,,20250814,,JANUVIA,End stage renal disease,OT,JANUVIA | End stage renal disease | OT,NaT
256804561,25680456,,F,,20250814,,MUCINEX,Drug ineffective,,MUCINEX | Drug ineffective,NaT
256804641,25680464,,M,,20250814,,NUPLAZID,Macular degeneration,OT,NUPLAZID | Macular degeneration | OT,NaT
256804712,25680471,57,F,2025-06-07,20250916,,GEMCITABINE HYDROCHLORIDE,Vomiting,OT,GEMCITABINE HYDROCHLORIDE | Vomiting | OT,2025-06-02/2025-06-08
256805191,25680519,61,M,,20250814,,VELSIPITY,Condition aggravated,OT,VELSIPITY | Condition aggravated | OT,NaT
256805243,25680524,55,M,2025-01-01,20250827,,CRIZOTINIB,Cardiopulmonary failure,DE,CRIZOTINIB | Cardiopulmonary failure | DE,2024-12-30/2025-01-05
256806151,25680615,,M,,20250813,,BCG LIVE,Therapy non-responder,,BCG LIVE | Therapy non-responder,NaT
256806441,25680644,,M,,20250814,,RISANKIZUMAB,Product storage error,,RISANKIZUMAB | Product storage error,NaT
256806921,25680692,43,F,,20250814,,SIMLANDI,Pustular psoriasis,,SIMLANDI | Pustular psoriasis,NaT
256807721,25680772,59,F,,20250814,,WINREVAIR,Pericardial effusion,LT,WINREVAIR | Pericardial effusion | LT,NaT
256808191,25680819,44,F,,20250814,,MYCOPHENOLATE MOFETIL,Drug ineffective,HO,MYCOPHENOLATE MOFETIL | Drug ineffective | HO,NaT
256808331,25680833,5,M,,20250814,,PROPOFOL,Vernal keratoconjunctivitis,OT,PROPOFOL | Vernal keratoconjunctivitis | OT,NaT
256808361,25680836,48,M,2025-05-01,20250814,,AVELOX,Anxiety,OT,AVELOX | Anxiety | OT,2025-04-28/2025-05-04
256808571,25680857,,,,20250814,,ALPELISIB,Sarcomatoid carcinoma,DE,ALPELISIB | Sarcomatoid carcinoma | DE,NaT
256808811,25680881,25,M,,20250814,,LAMOTRIGINE,Drug ineffective,OT,LAMOTRIGINE | Drug ineffective | OT,NaT
256809761,25680976,16,,,20250814,,CITALOPRAM,Intentional overdose,HO,CITALOPRAM | Intentional overdose | HO,NaT
256810201,25681020,21,F,2025-07-31,20250814,,HUMATE-P,Epistaxis,,HUMATE-P | Epistaxis,2025-07-28/2025-08-03
256810721,25681072,,F,,20250814,,DALFAMPRIDINE,Fall,OT,DALFAMPRIDINE | Fall | OT,NaT
256810851,25681085,,,2025-01-01,20250814,,TASCENSO ODT,Cerebrovascular accident,HO,TASCENSO ODT | Cerebrovascular accident | HO,2024-12-30/2025-01-05
256811131,25681113,31,F,,20250814,,AMPICILLIN,Bladder obstruction,HO,AMPICILLIN | Bladder obstruction | HO,NaT
256811432,25681143,73,,,20250929,,ALBUTEROL SULFATE,Circumstance or information capable of leading to device use error,,ALBUTEROL SULFATE | Circumstance or information capable of leading to device use error,NaT
256811541,25681154,,,,20250814,,ETOPOSIDE,Drug ineffective,,ETOPOSIDE | Drug ineffective,NaT
256811991,25681199,79,M,,20250814,,ESCITALOPRAM,Serotonin syndrome,HO,ESCITALOPRAM | Serotonin syndrome | HO,NaT
256812791,25681279,,,,20250814,,VANCOMYCIN,Renal injury,OT,VANCOMYCIN | Renal injury | OT,NaT
256813121,25681312,,F,,20250814,,FORTEO,Rash macular,,FORTEO | Rash macular,NaT
256814071,25681407,,F,,20250814,,LAMISIL,Drug ineffective,,LAMISIL | Drug ineffective,NaT
256814301,25681430,,,,20250814,,DICLOFENAC SODIUM,Lupus vulgaris,LT,DICLOFENAC SODIUM | Lupus vulgaris | LT,NaT
256814311,25681431,79,M,2024-06-01,20250814,,LENVATINIB,Gingival bleeding,HO,LENVATINIB | Gingival bleeding | HO,2024-05-27/2024-06-02
256815261,25681526,69,M,,20250814,,LACTULOSE,Therapeutic response decreased,HO,LACTULOSE | Therapeutic response decreased | HO,NaT
256815701,25681570,,F,,20250814,,CARBIDOPA AND LEVODOPA,Therapeutic product effect decreased,OT,CARBIDOPA AND LEVODOPA | Therapeutic product effect decreased | OT,NaT
256816071,25681607,58,M,,20250814,,AMLODIPINE,Acute kidney injury,HO,AMLODIPINE | Acute kidney injury | HO,NaT
256816121,25681612,31,F,2025-07-05,20250814,,MIRENA,Unintentional medical device removal,,MIRENA | Unintentional medical device removal,2025-06-30/2025-07-06
256816371,25681637,,,,20250814,,SUBLOCADE,Seizure,OT,SUBLOCADE | Seizure | OT,NaT
256816971,25681697,,F,,20250814,,HIZENTRA,Decreased appetite,,HIZENTRA | Decreased appetite,NaT
256817751,25681775,25,M,,20250814,,LORAZEPAM,Intentional product misuse,LT,LORAZEPAM | Intentional product misuse | LT,NaT
256818141,25681814,,F,,20250814,,ZURZUVAE,Dizziness,,ZURZUVAE | Dizziness,NaT
256819012,25681901,,,,20250902,,YONDELIS,Electrolyte imbalance,OT,YONDELIS | Electrolyte imbalance | OT,NaT
256819591,25681959,76,M,2025-01-01,20250814,,VENCLEXTA,Death,DE,VENCLEXTA | Death | DE,2024-12-30/2025-01-05
256819911,25681991,,F,2023-10-04,20250814,,OZEMPIC,Thyroid neoplasm,OT,OZEMPIC | Thyroid neoplasm | OT,2023-10-02/2023-10-08
256820681,25682068,66,M,,20250814,,ANAKINRA,Amyloidosis,OT,ANAKINRA | Amyloidosis | OT,NaT
256821371,25682137,15,F,,20250814,,HYDROCHLOROTHIAZIDE,Sudden death,HO,HYDROCHLOROTHIAZIDE | Sudden death | HO,NaT
256821503,25682150,,,,20250918,,PREGABALIN,Drug dependence,DE,PREGABALIN | Drug dependence | DE,NaT
256821731,25682173,,F,,20250814,,CRENESSITY,Fatigue,,CRENESSITY | Fatigue,NaT
256824151,25682415,,,,20250814,,KISUNLA,Amyloid related imaging abnormality-oedema/effusion,HO,KISUNLA | Amyloid related imaging abnormality-oedema/effusion | HO,NaT
256824911,25682491,49,F,,20250814,,HUMIRA,Intestinal obstruction,,HUMIRA | Intestinal obstruction,NaT
256825401,25682540,19,M,2025-01-01,20250814,,RINVOQ,Cardiac failure,OT,RINVOQ | Cardiac failure | OT,2024-12-30/2025-01-05
256826491,25682649,58,F,2024-01-01,20250814,,FORTEO,Tooth disorder,HO,FORTEO | Tooth disorder | HO,2024-01-01/2024-01-07
256827262,25682726,43,F,2025-07-15,20250819,,CARBOPLATIN,Rash morbilliform,HO,CARBOPLATIN | Rash morbilliform | HO,2025-07-14/2025-07-20
256827481,25682748,,F,,20250814,,ADALIMUMAB,Pneumonia,HO,ADALIMUMAB | Pneumonia | HO,NaT
256828151,25682815,,,,20250814,,ZENATANE,Illness,,ZENATANE | Illness,NaT
256828482,25682848,75,F,2025-08-01,20250815,,PAXLOVID,Arthralgia,,PAXLOVID | Arthralgia,2025-07-28/2025-08-03
256828511,25682851,,,,20250814,,PLUVICTO,Neoplasm malignant,DE,PLUVICTO | Neoplasm malignant | DE,NaT
256829452,25682945,63,M,2025-07-31,20250820,,CREON,Pancreaticoduodenectomy,OT,CREON | Pancreaticoduodenectomy | OT,2025-07-28/2025-08-03
256829761,25682976,,F,2025-07-27,20250814,,MOUNJARO,Haematemesis,OT,MOUNJARO | Haematemesis | OT,2025-07-21/2025-07-27
256830601,25683060,59,M,,20250814,,MOUNJARO,Abdominal pain,OT,MOUNJARO | Abdominal pain | OT,NaT
256831071,25683107,46,M,2025-08-01,20250814,,LYBALVI,Weight increased,,LYBALVI | Weight increased,2025-07-28/2025-08-03
256831441,25683144,69,M,2025-06-01,20250814,,ZEPBOUND,Blood pressure decreased,OT,ZEPBOUND | Blood pressure decreased | OT,2025-05-26/2025-06-01
256831503,25683150,,F,,20250923,,BUDESONIDE\FORMOTEROL FUMARATE,Wrong technique in product usage process,,BUDESONIDE\FORMOTEROL FUMARATE | Wrong technique in product usage process,NaT
256831751,25683175,80,F,,20250814,,ZEPBOUND,Brain fog,OT,ZEPBOUND | Brain fog | OT,NaT
256831951,25683195,67,F,,20250814,,GLEEVEC,Haemorrhage,HO,GLEEVEC | Haemorrhage | HO,NaT
256831961,25683196,52,M,2025-07-30,20250814,,RINVOQ,Blood glucose increased,OT,RINVOQ | Blood glucose increased | OT,2025-07-28/2025-08-03
256832332,25683233,70,M,,20250917,,BUDESONIDE,Cholestasis,OT,BUDESONIDE | Cholestasis | OT,NaT
256832481,25683248,80,F,,20250814,,ELREXFIO,Cytokine release syndrome,OT,ELREXFIO | Cytokine release syndrome | OT,NaT
256832781,25683278,,M,2025-01-01,20250814,,SOTATERCEPT,Haemoglobin increased,,SOTATERCEPT | Haemoglobin increased,2024-12-30/2025-01-05
256833381,25683338,,F,,20250814,,CLOZAPINE,Death,DE,CLOZAPINE | Death | DE,NaT
256834851,25683485,28,F,2025-01-01,20250814,,DUPIXENT,Sleep disorder,,DUPIXENT | Sleep disorder,2024-12-30/2025-01-05
256834961,25683496,60,F,2025-01-01,20250814,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,2024-12-30/2025-01-05
256835951,25683595,,F,,20250814,,DUPIXENT,Weight increased,,DUPIXENT | Weight increased,NaT
256836101,25683610,46,F,2025-07-01,20250814,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2025-06-30/2025-07-06
256836732,25683673,12,F,2025-08-01,20250929,,DUPIXENT,Myalgia,,DUPIXENT | Myalgia,2025-07-28/2025-08-03
256836832,25683683,47,F,2025-01-01,20250923,,DUPIXENT,Dry eye,,DUPIXENT | Dry eye,2024-12-30/2025-01-05
256837201,25683720,43,F,,20250814,,DUPIXENT,Therapeutic response shortened,,DUPIXENT | Therapeutic response shortened,NaT
256837411,25683741,57,F,2022-01-01,20250814,,DUPIXENT,Rebound effect,,DUPIXENT | Rebound effect,2021-12-27/2022-01-02
256837821,25683782,,,2025-01-01,20250814,,ASPARLAS,Pancreatitis haemorrhagic,OT,ASPARLAS | Pancreatitis haemorrhagic | OT,2024-12-30/2025-01-05
256838401,25683840,63,F,2025-08-05,20250814,,SYNTHROID,Death,DE,SYNTHROID | Death | DE,2025-08-04/2025-08-10
256838881,25683888,,,2025-01-01,20250814,,SLYND,Menstruation irregular,,SLYND | Menstruation irregular,2024-12-30/2025-01-05
256839611,25683961,,,,20250815,,YUFLYMA,Surgery,OT,YUFLYMA | Surgery | OT,NaT
256840511,25684051,42,F,2025-08-12,20250815,,NEXVIAZYME,Off label use,,NEXVIAZYME | Off label use,2025-08-11/2025-08-17
256841671,25684167,67,M,2025-07-22,20250815,,SODIUM CHLORIDE,Pruritus,OT,SODIUM CHLORIDE | Pruritus | OT,2025-07-21/2025-07-27
256842201,25684220,,,2021-01-01,20250815,,USTEKINUMAB,Sarcoid-like reaction,OT,USTEKINUMAB | Sarcoid-like reaction | OT,2020-12-28/2021-01-03
256842352,25684235,57,F,2025-08-01,20250910,,LENALIDOMIDE,Platelet count decreased,HO,LENALIDOMIDE | Platelet count decreased | HO,2025-07-28/2025-08-03
256842361,25684236,,,,20250815,,INFLIXIMAB,Headache,OT,INFLIXIMAB | Headache | OT,NaT
256843191,25684319,48,F,2021-12-06,20250815,,USTEKINUMAB,Invasive ductal breast carcinoma,OT,USTEKINUMAB | Invasive ductal breast carcinoma | OT,2021-12-06/2021-12-12
256846171,25684617,66,F,,20250815,,TRASTUZUMAB,Off label use,OT,TRASTUZUMAB | Off label use | OT,NaT
256846321,25684632,38,F,2025-07-16,20250815,,BENLYSTA,Malaise,,BENLYSTA | Malaise,2025-07-14/2025-07-20
256846671,25684667,33,M,2025-08-09,20250815,,YEZTUGO,Injection site swelling,,YEZTUGO | Injection site swelling,2025-08-04/2025-08-10
256847151,25684715,76,M,2024-08-23,20250815,,OBINUTUZUMAB,Urinary fistula,OT,OBINUTUZUMAB | Urinary fistula | OT,2024-08-19/2024-08-25
256847241,25684724,,F,2025-06-01,20250815,,LETROZOLE,Fatigue,LT,LETROZOLE | Fatigue | LT,2025-05-26/2025-06-01
256847591,25684759,23,F,2025-07-01,20250815,,DUPIXENT,Product dose omission in error,,DUPIXENT | Product dose omission in error,2025-06-30/2025-07-06
256847851,25684785,23,M,2025-07-24,20250815,,GABAPENTIN,Suicide attempt,HO,GABAPENTIN | Suicide attempt | HO,2025-07-21/2025-07-27
256848301,25684830,83,F,2025-08-04,20250815,,ACTEMRA,Deafness,OT,ACTEMRA | Deafness | OT,2025-08-04/2025-08-10
256848961,25684896,,F,,20250815,,CAPIVASERTIB,Disease progression,OT,CAPIVASERTIB | Disease progression | OT,NaT
256848971,25684897,,F,,20250815,,OLAPARIB,Hepatitis,OT,OLAPARIB | Hepatitis | OT,NaT
256849271,25684927,,F,2025-01-01,20250815,,DIENOGEST\ESTRADIOL VALERATE,Dyspnoea,OT,DIENOGEST\ESTRADIOL VALERATE | Dyspnoea | OT,2024-12-30/2025-01-05
256851351,25685135,60,F,2025-06-19,20250814,,BREYANZI,Cytokine release syndrome,HO,BREYANZI | Cytokine release syndrome | HO,2025-06-16/2025-06-22
256852181,25685218,48,F,2025-08-05,20250815,,ZEPBOUND,Accidental underdose,,ZEPBOUND | Accidental underdose,2025-08-04/2025-08-10
256852241,25685224,59,F,,20250815,,VERZENIO,Abdominal pain upper,,VERZENIO | Abdominal pain upper,NaT
256852562,25685256,42,M,2025-08-01,20250926,,CORTICOTROPIN,Headache,,CORTICOTROPIN | Headache,2025-07-28/2025-08-03
256852691,25685269,,,,20250814,,BREYNA,Chest pain,,BREYNA | Chest pain,NaT
256853031,25685303,,,,20250815,,ESOMEPRAZOLE,Hypomagnesaemia,HO,ESOMEPRAZOLE | Hypomagnesaemia | HO,NaT
256854042,25685404,,M,,20250828,,ACALABRUTINIB,Renal impairment,OT,ACALABRUTINIB | Renal impairment | OT,NaT
256854281,25685428,69,F,,20250815,,XELJANZ,Pelvic fracture,OT,XELJANZ | Pelvic fracture | OT,NaT
256854301,25685430,74,F,2025-05-22,20250815,,RITUXIMAB,Immune thrombocytopenia,HO,RITUXIMAB | Immune thrombocytopenia | HO,2025-05-19/2025-05-25
256854321,25685432,37,F,,20250815,,ADALIMUMAB,Intentional product use issue,OT,ADALIMUMAB | Intentional product use issue | OT,NaT
256854751,25685475,85,M,,20250815,,VENCLEXTA,Death,DE,VENCLEXTA | Death | DE,NaT
256855231,25685523,,F,,20250815,,XOLAIR PFS,No adverse event,,XOLAIR PFS | No adverse event,NaT
256855711,25685571,68,M,2025-08-01,20250815,,NUBEQA,Nephrolithiasis,,NUBEQA | Nephrolithiasis,2025-07-28/2025-08-03
256856211,25685621,68,F,2025-08-01,20250815,,ABEMACICLIB,Myopericarditis,HO,ABEMACICLIB | Myopericarditis | HO,2025-07-28/2025-08-03
256857501,25685750,,,,20250815,,NURTEC ODT,Paraesthesia,,NURTEC ODT | Paraesthesia,NaT
256857971,25685797,,,,20250811,,METHENAMINE,Treatment failure,,METHENAMINE | Treatment failure,NaT
256858261,25685826,66,M,,20250815,,QINLOCK,Liver disorder,OT,QINLOCK | Liver disorder | OT,NaT
256858921,25685892,,M,,20250815,,OZEMPIC,Abdominal pain,HO,OZEMPIC | Abdominal pain | HO,NaT
256859441,25685944,45,M,,20250815,,INGREZZA,Restlessness,,INGREZZA | Restlessness,NaT
256859901,25685990,48,F,2022-02-02,20250815,,RIBOCICLIB,Neutropenia,OT,RIBOCICLIB | Neutropenia | OT,2022-01-31/2022-02-06
256860881,25686088,,F,,20250815,,LONSURF,Disease progression,DE,LONSURF | Disease progression | DE,NaT
256861031,25686103,,F,,20250815,,IXAZOMIB,Inflammation,HO,IXAZOMIB | Inflammation | HO,NaT
256861093,25686109,,F,2025-01-01,20250828,,WINREVAIR,Contusion,OT,WINREVAIR | Contusion | OT,2024-12-30/2025-01-05
256861681,25686168,72,M,2025-07-31,20250815,,VIZAMYL,Nausea,,VIZAMYL | Nausea,2025-07-28/2025-08-03
256861722,25686172,38,M,,20250905,,VIMIZIM,Seizure,OT,VIMIZIM | Seizure | OT,NaT
256862141,25686214,69,M,,20250815,,NOVOLOG,Memory impairment,OT,NOVOLOG | Memory impairment | OT,NaT
256862571,25686257,,,,20250815,,OZEMPIC,Intestinal obstruction,OT,OZEMPIC | Intestinal obstruction | OT,NaT
256862792,25686279,,F,2025-01-01,20250913,,ROZANOLIXIZUMAB,Haematuria,OT,ROZANOLIXIZUMAB | Haematuria | OT,2024-12-30/2025-01-05
256864021,25686402,31,,,20250815,,OXYCODONE HYDROCHLORIDE,Child abuse,,OXYCODONE HYDROCHLORIDE | Child abuse,NaT
256864121,25686412,25,,,20250815,,OXYCODONE HYDROCHLORIDE,Drug diversion,,OXYCODONE HYDROCHLORIDE | Drug diversion,NaT
256864571,25686457,,F,,20250815,,MOUNJARO,Colitis,OT,MOUNJARO | Colitis | OT,NaT
256864891,25686489,61,F,2025-07-07,20250815,,BASAGLAR,Cyst,OT,BASAGLAR | Cyst | OT,2025-07-07/2025-07-13
256865241,25686524,,F,2025-02-01,20250815,,REPATHA,Pain,,REPATHA | Pain,2025-01-27/2025-02-02
256865371,25686537,,F,2009-01-01,20250816,,DUPIXENT,Shoulder fracture,,DUPIXENT | Shoulder fracture,2008-12-29/2009-01-04
256865381,25686538,,F,,20250816,,REMODULIN,Infusion site infection,,REMODULIN | Infusion site infection,NaT
256865831,25686583,,F,,20250816,,DUPIXENT,Rebound atopic dermatitis,,DUPIXENT | Rebound atopic dermatitis,NaT
256866791,25686679,44,M,,20250816,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,NaT
256867052,25686705,39,F,2025-01-01,20250823,,AIMOVIG,Device difficult to use,,AIMOVIG | Device difficult to use,2024-12-30/2025-01-05
256867141,25686714,,F,,20250816,,MYCOPHENOLIC ACID,Papilloedema,OT,MYCOPHENOLIC ACID | Papilloedema | OT,NaT
256867411,25686741,,F,,20250816,,DUPIXENT,Drug ineffective for unapproved indication,,DUPIXENT | Drug ineffective for unapproved indication,NaT
256868091,25686809,94,F,2025-07-27,20250816,,SERTRALINE,Hepatitis cholestatic,HO,SERTRALINE | Hepatitis cholestatic | HO,2025-07-21/2025-07-27
256868572,25686857,22,F,2025-08-13,20250818,,DUPIXENT,Headache,,DUPIXENT | Headache,2025-08-11/2025-08-17
256868761,25686876,51,F,,20250816,,LAMOTRIGINE,Alopecia,,LAMOTRIGINE | Alopecia,NaT
256869311,25686931,71,F,,20250816,,VANCOMYCIN,Anaphylactic reaction,LT,VANCOMYCIN | Anaphylactic reaction | LT,NaT
256869341,25686934,27,F,2025-04-01,20250816,,QUETIAPINE,Product availability issue,HO,QUETIAPINE | Product availability issue | HO,2025-03-31/2025-04-06
256869511,25686951,13,M,,20250816,,NADOLOL,Drug ineffective,OT,NADOLOL | Drug ineffective | OT,NaT
256870202,25687020,77,F,,20250818,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,NaT
256870941,25687094,,F,,20250816,,WELLBUTRIN SR,Pruritus,,WELLBUTRIN SR | Pruritus,NaT
256871161,25687116,,,,20250816,,VIGABATRIN,Retinal toxicity,OT,VIGABATRIN | Retinal toxicity | OT,NaT
256871201,25687120,34,M,2025-02-01,20250816,,DUPIXENT,Incorrect dose administered,,DUPIXENT | Incorrect dose administered,2025-01-27/2025-02-02
256871251,25687125,,,,20250816,,VIGABATRIN,Retinal toxicity,OT,VIGABATRIN | Retinal toxicity | OT,NaT
256871831,25687183,53,M,2025-07-30,20250816,,CARFILZOMIB,Myelosuppression,OT,CARFILZOMIB | Myelosuppression | OT,2025-07-28/2025-08-03
256871911,25687191,,F,,20250816,,VEDOLIZUMAB,Intestinal perforation,OT,VEDOLIZUMAB | Intestinal perforation | OT,NaT
256872441,25687244,84,M,2025-07-11,20250816,,GLIVEC,Death,DE,GLIVEC | Death | DE,2025-07-07/2025-07-13
256873661,25687366,,M,,20250816,,DUPIXENT,Confusional state,,DUPIXENT | Confusional state,NaT
256873841,25687384,45,M,,20250816,,DUPIXENT,Exposure via skin contact,,DUPIXENT | Exposure via skin contact,NaT
256874742,25687474,72,F,2024-01-01,20250912,,LENALIDOMIDE,Pain in jaw,,LENALIDOMIDE | Pain in jaw,2024-01-01/2024-01-07
256875881,25687588,73,F,,20250817,,TOUJEO MAX,Off label use,,TOUJEO MAX | Off label use,NaT
256876411,25687641,74,M,2025-07-04,20250817,,BREO ELLIPTA,Oral fungal infection,,BREO ELLIPTA | Oral fungal infection,2025-06-30/2025-07-06
256877481,25687748,53,F,,20250817,,DUPIXENT,Urinary tract infection,,DUPIXENT | Urinary tract infection,NaT
256877571,25687757,,,,20250817,,ZEPBOUND,Visual impairment,,ZEPBOUND | Visual impairment,NaT
256877593,25687759,45,F,2025-01-01,20250923,,DUPIXENT,Condition aggravated,,DUPIXENT | Condition aggravated,2024-12-30/2025-01-05
256877621,25687762,,,,20250817,,CAPECITABINE,Liver injury,OT,CAPECITABINE | Liver injury | OT,NaT
256877841,25687784,84,M,2025-08-08,20250817,,ZEPBOUND,Increased appetite,,ZEPBOUND | Increased appetite,2025-08-04/2025-08-10
256877971,25687797,45,,,20250817,,CLOZAPINE,Death,DE,CLOZAPINE | Death | DE,NaT
256878071,25687807,70,F,,20250817,,ARTEMETHER\LUMEFANTRINE,Haemolytic anaemia,HO,ARTEMETHER\LUMEFANTRINE | Haemolytic anaemia | HO,NaT
256878081,25687808,27,,,20250817,,CLOZAPINE,Myocarditis,OT,CLOZAPINE | Myocarditis | OT,NaT
256878751,25687875,64,M,2025-07-21,20250817,,VENCLEXTA,Death,DE,VENCLEXTA | Death | DE,2025-07-21/2025-07-27
256879251,25687925,39,F,2025-01-01,20250817,,LUPRON,Scar,OT,LUPRON | Scar | OT,2024-12-30/2025-01-05
256880861,25688086,36,M,2025-08-01,20250818,,DUPIXENT,Dysphagia,,DUPIXENT | Dysphagia,2025-07-28/2025-08-03
256881311,25688131,54,F,,20250818,,REVLIMID,Pain,,REVLIMID | Pain,NaT
256881371,25688137,62,M,2025-01-01,20250818,,DUPIXENT,Pain,,DUPIXENT | Pain,2024-12-30/2025-01-05
256881791,25688179,53,M,,20250818,,EBGLYSS,Testicular pain,,EBGLYSS | Testicular pain,NaT
256882313,25688231,65,M,2025-08-11,20250821,,ENZALUTAMIDE,Blood pressure increased,HO,ENZALUTAMIDE | Blood pressure increased | HO,2025-08-11/2025-08-17
256882491,25688249,,,2025-05-28,20250818,,INFLIXIMAB,Cough,HO,INFLIXIMAB | Cough | HO,2025-05-26/2025-06-01
256884182,25688418,76,M,2024-09-11,20250930,,IXAZOMIB,Squamous cell carcinoma,OT,IXAZOMIB | Squamous cell carcinoma | OT,2024-09-09/2024-09-15
256884361,25688436,,,2025-01-01,20250818,,PAXLOVID,Hypotension,,PAXLOVID | Hypotension,2024-12-30/2025-01-05
256884771,25688477,42,M,2025-07-05,20250818,,DEGREE (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY),Blister,OT,DEGREE (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) | Blister | OT,2025-06-30/2025-07-06
256884832,25688483,,F,,20250919,,ELMIRON,Dry age-related macular degeneration,OT,ELMIRON | Dry age-related macular degeneration | OT,NaT
256885091,25688509,,F,,20250818,,OCALIVA,Nephrolithiasis,OT,OCALIVA | Nephrolithiasis | OT,NaT
256885961,25688596,57,M,2025-01-01,20250818,,SKYRIZI,Abdominal pain,HO,SKYRIZI | Abdominal pain | HO,2024-12-30/2025-01-05
256886481,25688648,,,,20250818,,LISINOPRIL AND HYDROCHLOROTHIAZIDE,Recalled product administered,,LISINOPRIL AND HYDROCHLOROTHIAZIDE | Recalled product administered,NaT
256886541,25688654,,M,2025-08-05,20250818,,ROSUVASTATIN,Wheezing,,ROSUVASTATIN | Wheezing,2025-08-04/2025-08-10
256886601,25688660,51,M,,20250818,,PREDNISOLONE,Nocardiosis,DE,PREDNISOLONE | Nocardiosis | DE,NaT
256887502,25688750,65,F,,20250830,,BOSENTAN,Drug ineffective,HO,BOSENTAN | Drug ineffective | HO,NaT
256887612,25688761,79,F,2025-07-01,20250912,,TYMLOS,Thrombosis,OT,TYMLOS | Thrombosis | OT,2025-06-30/2025-07-06
256887941,25688794,18,F,,20250818,,LACTULOSE,Drug ineffective,OT,LACTULOSE | Drug ineffective | OT,NaT
256888391,25688839,,F,,20250818,,OLAPARIB,Neuropathy peripheral,OT,OLAPARIB | Neuropathy peripheral | OT,NaT
256889901,25688990,75,M,2025-01-25,20250818,,FRUZAQLA,Hypothyroidism,HO,FRUZAQLA | Hypothyroidism | HO,2025-01-20/2025-01-26
256890013,25689001,36,M,,20250922,,INFLIXIMAB,Testicular swelling,HO,INFLIXIMAB | Testicular swelling | HO,NaT
256890051,25689005,,,2025-02-03,20250818,,YUFLYMA,Loss of therapeutic response,OT,YUFLYMA | Loss of therapeutic response | OT,2025-02-03/2025-02-09
256890132,25689013,50,F,2024-01-01,20250821,,ACTEMRA,Product dose omission issue,,ACTEMRA | Product dose omission issue,2024-01-01/2024-01-07
256890482,25689048,56,M,,20250825,,TACROLIMUS,Bile duct stenosis,OT,TACROLIMUS | Bile duct stenosis | OT,NaT
256890551,25689055,6,F,,20250818,,LEVETIRACETAM,Drug ineffective,OT,LEVETIRACETAM | Drug ineffective | OT,NaT
256890731,25689073,,F,,20250818,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
256890761,25689076,18,M,,20250818,,FLECAINIDE,Cardiac arrest,LT,FLECAINIDE | Cardiac arrest | LT,NaT
256891051,25689105,74,F,2025-05-22,20250818,,RITUXIMAB,Immune thrombocytopenia,HO,RITUXIMAB | Immune thrombocytopenia | HO,2025-05-19/2025-05-25
256892051,25689205,34,M,2025-01-01,20250818,,CREON,Dehydration,HO,CREON | Dehydration | HO,2024-12-30/2025-01-05
256892281,25689228,83,F,2025-06-26,20250818,,KISUNLA,Muscular weakness,,KISUNLA | Muscular weakness,2025-06-23/2025-06-29
256893121,25689312,,F,,20250818,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
256893321,25689332,81,M,2025-01-01,20250818,,VENCLEXTA,Death,DE,VENCLEXTA | Death | DE,2024-12-30/2025-01-05
256893361,25689336,24,M,,20250818,,UPADACITINIB,Syncope,OT,UPADACITINIB | Syncope | OT,NaT
256893951,25689395,80,F,2025-01-01,20250818,,VEDOLIZUMAB,Alopecia,OT,VEDOLIZUMAB | Alopecia | OT,2024-12-30/2025-01-05
256894391,25689439,25,M,2025-06-01,20250818,,ACETAMINOPHEN\OPIUM,Drug use disorder,OT,ACETAMINOPHEN\OPIUM | Drug use disorder | OT,2025-05-26/2025-06-01
256894531,25689453,,,,20250818,,ATORVASTATIN,Drug-induced liver injury,DE,ATORVASTATIN | Drug-induced liver injury | DE,NaT
256894681,25689468,,M,2025-06-03,20250818,,PANTOPRAZOLE,Eosinophilia,HO,PANTOPRAZOLE | Eosinophilia | HO,2025-06-02/2025-06-08
256894881,25689488,75,M,,20250818,,SEVELAMER CARBONATE,Foreign body aspiration,HO,SEVELAMER CARBONATE | Foreign body aspiration | HO,NaT
256894922,25689492,75,M,2024-10-31,20250929,,SODIUM CHLORIDE,Adrenal insufficiency,DS,SODIUM CHLORIDE | Adrenal insufficiency | DS,2024-10-28/2024-11-03
256894931,25689493,57,M,,20250818,,POSACONAZOLE,Eye infection fungal,OT,POSACONAZOLE | Eye infection fungal | OT,NaT
256895041,25689504,,F,,20250818,,MONOFERRIC,Nasal congestion,,MONOFERRIC | Nasal congestion,NaT
256895081,25689508,59,F,,20250818,,PREDNISONE,Rash,OT,PREDNISONE | Rash | OT,NaT
256895691,25689569,68,M,2025-05-27,20250818,,ALPRAZOLAM,Tonic convulsion,OT,ALPRAZOLAM | Tonic convulsion | OT,2025-05-26/2025-06-01
256895911,25689591,15,M,2025-06-28,20250818,,ARIPIPRAZOLE,Dyskinesia,HO,ARIPIPRAZOLE | Dyskinesia | HO,2025-06-23/2025-06-29
256896121,25689612,,F,,20250818,,ENHERTU,Haematemesis,OT,ENHERTU | Haematemesis | OT,NaT
256896321,25689632,68,F,,20250818,,ZEPBOUND,Wrong technique in product usage process,,ZEPBOUND | Wrong technique in product usage process,NaT
256896931,25689693,,F,,20250818,,NUPLAZID,Death,DE,NUPLAZID | Death | DE,NaT
256896991,25689699,19,M,2025-03-11,20250818,,PENTASA,Warm autoimmune haemolytic anaemia,OT,PENTASA | Warm autoimmune haemolytic anaemia | OT,2025-03-10/2025-03-16
256897051,25689705,33,M,,20250818,,LACOSAMIDE,Fluid imbalance,OT,LACOSAMIDE | Fluid imbalance | OT,NaT
256898261,25689826,,M,,20250818,,IXAZOMIB,Pyrexia,HO,IXAZOMIB | Pyrexia | HO,NaT
256898881,25689888,,,,20250818,,MINOXIDIL,Palpitations,OT,MINOXIDIL | Palpitations | OT,NaT
256899462,25689946,,F,2025-01-27,20250910,,STELARA,Incorrect dose administered by device,,STELARA | Incorrect dose administered by device,2025-01-27/2025-02-02
256899541,25689954,42,F,,20250818,,RITUXIMAB,Off label use,OT,RITUXIMAB | Off label use | OT,NaT
256899772,25689977,,,,20250911,,PREDNISONE,Toxicity to various agents,DE,PREDNISONE | Toxicity to various agents | DE,NaT
256899811,25689981,67,F,2025-07-17,20250818,,LEQVIO,Drug hypersensitivity,,LEQVIO | Drug hypersensitivity,2025-07-14/2025-07-20
256900641,25690064,47,F,,20250818,,PAXLOVID,Dysgeusia,,PAXLOVID | Dysgeusia,NaT
256901341,25690134,77,F,,20250818,,IBRANCE,Neutrophil count decreased,,IBRANCE | Neutrophil count decreased,NaT
256901351,25690135,42,F,,20250818,,LITFULO,Condition aggravated,,LITFULO | Condition aggravated,NaT
256901472,25690147,76,M,,20250828,,VYNDAMAX,Peripheral swelling,,VYNDAMAX | Peripheral swelling,NaT
256901621,25690162,59,,,20250818,,TRULICITY,Abdominal pain,HO,TRULICITY | Abdominal pain | HO,NaT
256902391,25690239,,,,20250818,,VANCOMYCIN,Renal failure,DE,VANCOMYCIN | Renal failure | DE,NaT
256902601,25690260,72,F,2013-01-01,20250818,,CLARITIN-D 24 HOUR,Drug ineffective,,CLARITIN-D 24 HOUR | Drug ineffective,2012-12-31/2013-01-06
256903091,25690309,84,M,,20250815,,ORENCIA,Hemiplegia,,ORENCIA | Hemiplegia,NaT
256903511,25690351,62,F,2025-08-01,20250816,,KISQALI,Alopecia,OT,KISQALI | Alopecia | OT,2025-07-28/2025-08-03
256903561,25690356,76,M,2025-08-03,20250815,,TACROLIMUS,Herpes zoster,HO,TACROLIMUS | Herpes zoster | HO,2025-07-28/2025-08-03
256905712,25690571,,F,2025-01-01,20250825,,CORTICOTROPIN,Back pain,OT,CORTICOTROPIN | Back pain | OT,2024-12-30/2025-01-05
256905911,25690591,,F,2025-01-01,20250818,,ESTRADIOL TRANSDERMAL SYSTEM,Product administered at inappropriate site,,ESTRADIOL TRANSDERMAL SYSTEM | Product administered at inappropriate site,2024-12-30/2025-01-05
256906101,25690610,,M,,20250818,,HUMIRA,Product dispensing error,,HUMIRA | Product dispensing error,NaT
256906502,25690650,,,2025-05-01,20250904,,BICILLIN L-A,Injection site pain,,BICILLIN L-A | Injection site pain,2025-04-28/2025-05-04
256907671,25690767,34,M,2025-08-08,20250817,,ZEPBOUND,Depression,DS,ZEPBOUND | Depression | DS,2025-08-04/2025-08-10
256908061,25690806,30,F,,20250818,,HYDROCORTISONE,Diabetes insipidus,OT,HYDROCORTISONE | Diabetes insipidus | OT,NaT
256908521,25690852,50,M,2025-06-18,20250818,,IMFINZI,Pulmonary artery thrombosis,OT,IMFINZI | Pulmonary artery thrombosis | OT,2025-06-16/2025-06-22
256908561,25690856,39,M,,20250818,,VELSIPITY,Psoriasis,OT,VELSIPITY | Psoriasis | OT,NaT
256908901,25690890,36,M,2025-07-22,20250817,,SEMAGLUTIDE,Anxiety,,SEMAGLUTIDE | Anxiety,2025-07-21/2025-07-27
256909351,25690935,83,F,,20250818,,ADALIMUMAB,Urinary tract infection,HO,ADALIMUMAB | Urinary tract infection | HO,NaT
256909951,25690995,,,,20250818,,LEVOFLOXACIN,Substance-induced psychotic disorder,HO,LEVOFLOXACIN | Substance-induced psychotic disorder | HO,NaT
256910011,25691001,,,,20250818,,METFORMIN HYDROCHLORIDE,Hypomagnesaemia,OT,METFORMIN HYDROCHLORIDE | Hypomagnesaemia | OT,NaT
256910021,25691002,,,,20250818,,SILDENAFIL,Central serous chorioretinopathy,OT,SILDENAFIL | Central serous chorioretinopathy | OT,NaT
256910301,25691030,,,,20250818,,ADVIL,Drug ineffective,,ADVIL | Drug ineffective,NaT
256910851,25691085,,F,2023-12-01,20250818,,ALENDRONATE SODIUM,Depression,OT,ALENDRONATE SODIUM | Depression | OT,2023-11-27/2023-12-03
256911972,25691197,16,M,2025-07-01,20250909,,AGAMREE,Fall,HO,AGAMREE | Fall | HO,2025-06-30/2025-07-06
256912212,25691221,58,M,,20250925,,PALYNZIQ,Prostate cancer metastatic,OT,PALYNZIQ | Prostate cancer metastatic | OT,NaT
256912722,25691272,55,M,,20250822,,XELJANZ,Arthralgia,,XELJANZ | Arthralgia,NaT
256912741,25691274,,F,,20250818,,OPSUMIT,Intestinal obstruction,HO,OPSUMIT | Intestinal obstruction | HO,NaT
256912971,25691297,56,M,,20250818,,ELTROMBOPAG OLAMINE,Nausea,OT,ELTROMBOPAG OLAMINE | Nausea | OT,NaT
256913531,25691353,46,F,,20250818,,TRUDHESA,Malaise,,TRUDHESA | Malaise,NaT
256913621,25691362,88,F,2024-03-01,20250818,,APIXABAN,Respiratory distress,DE,APIXABAN | Respiratory distress | DE,2024-02-26/2024-03-03
256916191,25691619,,M,,20250818,,MENS ROGAINE EXTRA STRENGTH,Application site pruritus,,MENS ROGAINE EXTRA STRENGTH | Application site pruritus,NaT
256916501,25691650,74,M,,20250818,,GLIMEPIRIDE,Product contamination chemical,OT,GLIMEPIRIDE | Product contamination chemical | OT,NaT
256916871,25691687,60,F,2024-08-08,20250818,,OLAPARIB,Loss of consciousness,OT,OLAPARIB | Loss of consciousness | OT,2024-08-05/2024-08-11
256917011,25691701,,M,,20250818,,LEVEMIR,Seizure,OT,LEVEMIR | Seizure | OT,NaT
256917151,25691715,66,F,2025-07-29,20250818,,KEYTRUDA,Myelosuppression,HO,KEYTRUDA | Myelosuppression | HO,2025-07-28/2025-08-03
256917261,25691726,75,F,2025-06-19,20250818,,METFORMIN,Metabolic acidosis,HO,METFORMIN | Metabolic acidosis | HO,2025-06-16/2025-06-22
256917381,25691738,,F,2022-08-01,20250818,,LISDEXAMFETAMINE DIMESYLATE,Foetal exposure during pregnancy,OT,LISDEXAMFETAMINE DIMESYLATE | Foetal exposure during pregnancy | OT,2022-08-01/2022-08-07
256917902,25691790,14,M,,20250819,,GENOTROPIN,Drug dose omission by device,,GENOTROPIN | Drug dose omission by device,NaT
256918551,25691855,51,F,2025-04-13,20250818,,TRUDHESA,Eye pain,,TRUDHESA | Eye pain,2025-04-07/2025-04-13
256918781,25691878,81,M,,20250818,,DEFERASIROX,Glomerular filtration rate decreased,OT,DEFERASIROX | Glomerular filtration rate decreased | OT,NaT
256918911,25691891,71,,,20250818,,INGREZZA,Rash,,INGREZZA | Rash,NaT
256921481,25692148,72,M,2025-01-01,20250818,,DUPIXENT,Urticaria,,DUPIXENT | Urticaria,2024-12-30/2025-01-05
256921971,25692197,,M,,20250818,,DUPIXENT,Rash,,DUPIXENT | Rash,NaT
256923681,25692368,,F,,20250818,,DUPIXENT,Injection site haematoma,,DUPIXENT | Injection site haematoma,NaT
256924231,25692423,,F,,20250818,,DUPIXENT,Injury associated with device,,DUPIXENT | Injury associated with device,NaT
256925002,25692500,72,F,2025-01-01,20250917,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,2024-12-30/2025-01-05
256925061,25692506,,F,,20250818,,DUPIXENT,Rash,,DUPIXENT | Rash,NaT
256925381,25692538,53,M,,20250818,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
256925741,25692574,31,M,,20250818,,DUPIXENT,Injection site urticaria,,DUPIXENT | Injection site urticaria,NaT
256926801,25692680,46,M,,20250818,,CEFIDEROCOL,Osteomyelitis,,CEFIDEROCOL | Osteomyelitis,NaT
256926961,25692696,64,M,,20250818,,CEFIDEROCOL,Drug resistance,,CEFIDEROCOL | Drug resistance,NaT
256936981,25693698,,,,20250818,,TARLATAMAB,Immune effector cell-associated neurotoxicity syndrome,OT,TARLATAMAB | Immune effector cell-associated neurotoxicity syndrome | OT,NaT
256974141,25697414,,,,20250818,,ZEPBOUND,Lung disorder,OT,ZEPBOUND | Lung disorder | OT,NaT
256974291,25697429,,,,20250818,,NEMLUVIO,Product dose omission issue,,NEMLUVIO | Product dose omission issue,NaT
256974831,25697483,,F,,20250818,,MOUNJARO,Neoplasm malignant,OT,MOUNJARO | Neoplasm malignant | OT,NaT
256976151,25697615,27,M,,20250819,,SCEMBLIX,Malignant neoplasm progression,LT,SCEMBLIX | Malignant neoplasm progression | LT,NaT
256976311,25697631,68,F,2025-08-12,20250819,,SKYRIZI,Abdominal pain,OT,SKYRIZI | Abdominal pain | OT,2025-08-11/2025-08-17
256977011,25697701,,M,,20250819,,DESCOVY,Product storage error,,DESCOVY | Product storage error,NaT
256977543,25697754,,F,2025-01-01,20250910,,TYVASO DPI,Throat irritation,,TYVASO DPI | Throat irritation,2024-12-30/2025-01-05
256977582,25697758,69,M,2025-07-01,20250825,,FASENRA,Wrong technique in device usage process,,FASENRA | Wrong technique in device usage process,2025-06-30/2025-07-06
256978071,25697807,,,,20250819,,TRELEGY ELLIPTA,Product storage error,,TRELEGY ELLIPTA | Product storage error,NaT
256978251,25697825,,,,20250819,,TRASTUZUMAB,Radiation necrosis,OT,TRASTUZUMAB | Radiation necrosis | OT,NaT
256978911,25697891,56,F,,20250819,,GLATIRAMER,Heart rate increased,OT,GLATIRAMER | Heart rate increased | OT,NaT
256979141,25697914,39,M,2025-04-16,20250819,,BREVITAL SODIUM,Drug effect less than expected,,BREVITAL SODIUM | Drug effect less than expected,2025-04-14/2025-04-20
256979601,25697960,70,F,,20250819,,RIZATRIPTAN BENZOATE,Product taste abnormal,,RIZATRIPTAN BENZOATE | Product taste abnormal,NaT
256979621,25697962,48,M,2025-01-01,20250819,,DUPIXENT,Rebound effect,,DUPIXENT | Rebound effect,2024-12-30/2025-01-05
256980321,25698032,55,F,2025-06-06,20250819,,CYCLOPHOSPHAMIDE,Febrile neutropenia,OT,CYCLOPHOSPHAMIDE | Febrile neutropenia | OT,2025-06-02/2025-06-08
256980741,25698074,,F,,20250819,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
256981581,25698158,58,M,,20250819,,TALTZ,Treatment failure,,TALTZ | Treatment failure,NaT
256981611,25698161,49,,,20250819,,TRULICITY,Nausea,HO,TRULICITY | Nausea | HO,NaT
256981662,25698166,76,F,2025-08-01,20250905,,ZEPBOUND,Abdominal discomfort,,ZEPBOUND | Abdominal discomfort,2025-07-28/2025-08-03
256982161,25698216,52,M,2025-07-01,20250819,,SKYRIZI,Crohn's disease,OT,SKYRIZI | Crohn's disease | OT,2025-06-30/2025-07-06
256984451,25698445,,F,2025-06-13,20250819,,CETRORELIX ACETATE,Accidental exposure to product,,CETRORELIX ACETATE | Accidental exposure to product,2025-06-09/2025-06-15
256984671,25698467,44,F,,20250819,,GEMTUZUMAB OZOGAMICIN,Drug ineffective for unapproved indication,DE,GEMTUZUMAB OZOGAMICIN | Drug ineffective for unapproved indication | DE,NaT
256984701,25698470,76,M,,20250819,,ETOPOSIDE,Off label use,HO,ETOPOSIDE | Off label use | HO,NaT
256985051,25698505,,,,20250819,,IMATINIB,Toxicity to various agents,,IMATINIB | Toxicity to various agents,NaT
256985651,25698565,81,M,,20250819,,ORGOVYX,Nocturia,,ORGOVYX | Nocturia,NaT
256986171,25698617,42,F,2025-07-10,20250819,,ALPRAZOLAM,Trismus,OT,ALPRAZOLAM | Trismus | OT,2025-07-07/2025-07-13
256986451,25698645,,,,20250819,,AFATINIB,Malaise,OT,AFATINIB | Malaise | OT,NaT
256986691,25698669,,,,20250819,,CLINDAMYCIN,Product quality issue,,CLINDAMYCIN | Product quality issue,NaT
256986711,25698671,,F,,20250819,,SKYRIZI,Injection site pain,OT,SKYRIZI | Injection site pain | OT,NaT
256987111,25698711,,M,,20250819,,KISUNLA,Dyspnoea,,KISUNLA | Dyspnoea,NaT
256987761,25698776,,,2025-01-01,20250819,,GANAXOLONE,Respiratory tract infection,HO,GANAXOLONE | Respiratory tract infection | HO,2024-12-30/2025-01-05
256989881,25698988,,,,20250819,,XYZAL ALLERGY 24HR,Drug effect less than expected,,XYZAL ALLERGY 24HR | Drug effect less than expected,NaT
256990291,25699029,,M,,20250819,,ELIGARD,Death,DE,ELIGARD | Death | DE,NaT
256990434,25699043,,F,,20250930,,DAYBUE,Diarrhoea,,DAYBUE | Diarrhoea,NaT
256991021,25699102,89,F,,20250819,,POMALYST,Hospitalisation,HO,POMALYST | Hospitalisation | HO,NaT
256991711,25699171,50,M,2025-07-21,20250819,,ISOTRETINOIN,Drug ineffective,,ISOTRETINOIN | Drug ineffective,2025-07-21/2025-07-27
256992741,25699274,,,,20250819,,INFLIXIMAB,Arthralgia,OT,INFLIXIMAB | Arthralgia | OT,NaT
256992912,25699291,42,M,2025-08-01,20250825,,CLOZAPINE,Haematological neoplasm,OT,CLOZAPINE | Haematological neoplasm | OT,2025-07-28/2025-08-03
256993491,25699349,,F,,20250819,,NUPLAZID,Pancreatic failure,OT,NUPLAZID | Pancreatic failure | OT,NaT
256993522,25699352,74,F,2022-01-01,20250911,,OXALIPLATIN,Haematotoxicity,OT,OXALIPLATIN | Haematotoxicity | OT,2021-12-27/2022-01-02
256993941,25699394,71,,,20250819,,AMPHOTERICIN B,Condition aggravated,DE,AMPHOTERICIN B | Condition aggravated | DE,NaT
256994451,25699445,41,M,,20250819,,LENALIDOMIDE,Febrile neutropenia,HO,LENALIDOMIDE | Febrile neutropenia | HO,NaT
256994721,25699472,52,M,2023-11-01,20250819,,ROSUVASTATIN CALCIUM,Fatigue,OT,ROSUVASTATIN CALCIUM | Fatigue | OT,2023-10-30/2023-11-05
256994901,25699490,,,,20250819,,ADEMPAS,Death,DE,ADEMPAS | Death | DE,NaT
256995051,25699505,,M,,20250819,,DIANEAL,Death,OT,DIANEAL | Death | OT,NaT
256995311,25699531,57,F,2025-07-01,20250819,,HYRIMOZ,Condition aggravated,OT,HYRIMOZ | Condition aggravated | OT,2025-06-30/2025-07-06
256995451,25699545,17,F,,20250819,,WYNZORA,Product use issue,,WYNZORA | Product use issue,NaT
256995591,25699559,32,F,2025-06-28,20250819,,CYCLOPHOSPHAMIDE,Guillain-Barre syndrome,DE,CYCLOPHOSPHAMIDE | Guillain-Barre syndrome | DE,2025-06-23/2025-06-29
256996211,25699621,,M,2023-01-01,20250819,,VUMERITY,Leukaemia,DE,VUMERITY | Leukaemia | DE,2022-12-26/2023-01-01
256996711,25699671,,,,20250819,,DONEPEZIL,Dementia Alzheimer's type,OT,DONEPEZIL | Dementia Alzheimer's type | OT,NaT
256997001,25699700,,,2024-07-01,20250819,,ORLADEYO,Drug interaction,,ORLADEYO | Drug interaction,2024-07-01/2024-07-07
256997321,25699732,51,M,2025-04-23,20250819,,ROSUVASTATIN,Pneumonia,OT,ROSUVASTATIN | Pneumonia | OT,2025-04-21/2025-04-27
256997552,25699755,,M,,20250915,,SOLIRIS,Infection,DE,SOLIRIS | Infection | DE,NaT
256998072,25699807,59,,2025-07-06,20250821,,TRODELVY,Neutropenia,HO,TRODELVY | Neutropenia | HO,2025-06-30/2025-07-06
256998751,25699875,,F,,20250819,,BENLYSTA,Contusion,,BENLYSTA | Contusion,NaT
256999531,25699953,60,F,2025-08-13,20250818,,AMBRISENTAN,Haemoglobin decreased,HO,AMBRISENTAN | Haemoglobin decreased | HO,2025-08-11/2025-08-17
256999673,25699967,66,M,,20250918,,ORGOVYX,Increased appetite,,ORGOVYX | Increased appetite,NaT
257000921,25700092,61,F,,20250819,,VERZENIO,Diarrhoea,,VERZENIO | Diarrhoea,NaT
257000971,25700097,60,F,,20250819,,MOUNJARO,Skin reaction,,MOUNJARO | Skin reaction,NaT
257001651,25700165,71,F,2025-08-08,20250819,,CERTOLIZUMAB PEGOL,Pulmonary thrombosis,HO,CERTOLIZUMAB PEGOL | Pulmonary thrombosis | HO,2025-08-04/2025-08-10
257002101,25700210,60,F,2022-09-30,20250819,,DOXORUBICIN HYDROCHLORIDE,Dermatomyositis,OT,DOXORUBICIN HYDROCHLORIDE | Dermatomyositis | OT,2022-09-26/2022-10-02
257002181,25700218,72,M,,20250819,,WELIREG,Diarrhoea,,WELIREG | Diarrhoea,NaT
257002251,25700225,,,2025-07-01,20250819,,ZORYVE,Rash,,ZORYVE | Rash,2025-06-30/2025-07-06
257002531,25700253,,,,20250819,,ZORYVE,Pain of skin,,ZORYVE | Pain of skin,NaT
257002901,25700290,78,M,2025-07-30,20250819,,FERINJECT,Bronchospasm,OT,FERINJECT | Bronchospasm | OT,2025-07-28/2025-08-03
257003392,25700339,,F,,20250915,,DAYBUE,Vomiting,HO,DAYBUE | Vomiting | HO,NaT
257003711,25700371,74,F,2025-08-10,20250818,,MYCOPHENOLIC ACID,Infection,DE,MYCOPHENOLIC ACID | Infection | DE,2025-08-04/2025-08-10
257003741,25700374,14,M,,20250818,,RINVOQ,Gastrointestinal inflammation,HO,RINVOQ | Gastrointestinal inflammation | HO,NaT
257003902,25700390,55,M,2024-02-01,20250903,,CLOZAPINE,Atrioventricular block complete,LT,CLOZAPINE | Atrioventricular block complete | LT,2024-01-29/2024-02-04
257004171,25700417,,,,20250819,,INFLIXIMAB,Atrial fibrillation,HO,INFLIXIMAB | Atrial fibrillation | HO,NaT
257005531,25700553,82,F,2025-02-21,20250819,,ABEMACICLIB,Pain in extremity,DE,ABEMACICLIB | Pain in extremity | DE,2025-02-17/2025-02-23
257005731,25700573,,F,,20250819,,MIRENA,Vaginal haemorrhage,,MIRENA | Vaginal haemorrhage,NaT
257005931,25700593,1,F,2025-08-09,20250819,,ELTROMBOPAG OLAMINE,Off label use,HO,ELTROMBOPAG OLAMINE | Off label use | HO,2025-08-04/2025-08-10
257005961,25700596,64,M,,20250819,,LISINOPRIL,Angioedema,HO,LISINOPRIL | Angioedema | HO,NaT
257006741,25700674,27,M,2025-07-01,20250819,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2025-06-30/2025-07-06
257007731,25700773,,F,2025-01-01,20250819,,DUPIXENT,Blister,,DUPIXENT | Blister,2024-12-30/2025-01-05
257007891,25700789,44,F,2025-08-13,20250819,,KEVZARA,Pain,,KEVZARA | Pain,2025-08-11/2025-08-17
257008092,25700809,,F,,20250911,,DUPIXENT,Eye disorder,,DUPIXENT | Eye disorder,NaT
257008371,25700837,70,F,,20250819,,DUPIXENT,Asthma,,DUPIXENT | Asthma,NaT
257008871,25700887,,F,,20250819,,DUPIXENT,Inappropriate schedule of product administration,,DUPIXENT | Inappropriate schedule of product administration,NaT
257009291,25700929,62,F,2025-01-01,20250819,,DUPIXENT,Condition aggravated,,DUPIXENT | Condition aggravated,2024-12-30/2025-01-05
257010601,25701060,,M,,20250818,,BOTOX,Chronic lymphocytic leukaemia,OT,BOTOX | Chronic lymphocytic leukaemia | OT,NaT
257010811,25701081,70,M,,20250819,,PAXLOVID,Diarrhoea,,PAXLOVID | Diarrhoea,NaT
257011141,25701114,37,F,,20250819,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,NaT
257011251,25701125,70,M,,20250819,,PAXLOVID,Dysgeusia,,PAXLOVID | Dysgeusia,NaT
257011631,25701163,75,F,,20250819,,REVLIMID,Product dispensing error,,REVLIMID | Product dispensing error,NaT
257012361,25701236,65,F,2024-11-01,20250819,,GAZYVA,Agitation,OT,GAZYVA | Agitation | OT,2024-10-28/2024-11-03
257012431,25701243,65,F,2025-08-18,20250819,,NUCALA,Disease complication,DE,NUCALA | Disease complication | DE,2025-08-18/2025-08-24
257013451,25701345,,,,20250819,,RILPIVIRINE,Gait disturbance,,RILPIVIRINE | Gait disturbance,NaT
257013482,25701348,,,,20250901,,TYLENOL 8 HR ARTHRITIS PAIN,Arthralgia,,TYLENOL 8 HR ARTHRITIS PAIN | Arthralgia,NaT
257014031,25701403,38,F,,20250819,,EPINEPHRINE,Septic shock,OT,EPINEPHRINE | Septic shock | OT,NaT
257015252,25701525,81,M,,20250821,,RIVAROXABAN,Diverticulum intestinal,OT,RIVAROXABAN | Diverticulum intestinal | OT,NaT
257015681,25701568,,F,,20250819,,MOUNJARO,Renal pain,HO,MOUNJARO | Renal pain | HO,NaT
257016231,25701623,,F,2024-08-01,20250819,,PRALUENT,Fatigue,,PRALUENT | Fatigue,2024-07-29/2024-08-04
257016371,25701637,,F,2024-08-22,20250819,,PRALUENT,Injection site bruising,,PRALUENT | Injection site bruising,2024-08-19/2024-08-25
257016721,25701672,,F,2024-09-30,20250819,,PRALUENT,Injection site pain,,PRALUENT | Injection site pain,2024-09-30/2024-10-06
257016801,25701680,,F,,20250819,,PRALUENT,Injection site pain,,PRALUENT | Injection site pain,NaT
257017301,25701730,65,M,2025-07-02,20250819,,TALTZ,Cerebrovascular accident,HO,TALTZ | Cerebrovascular accident | HO,2025-06-30/2025-07-06
257017601,25701760,,,,20250819,,NINTEDANIB,Aneurysm,OT,NINTEDANIB | Aneurysm | OT,NaT
257017751,25701775,,F,,20250819,,PRALUENT,Drug ineffective,,PRALUENT | Drug ineffective,NaT
257018081,25701808,,M,2024-08-27,20250819,,PRALUENT,Product delivery mechanism issue,,PRALUENT | Product delivery mechanism issue,2024-08-26/2024-09-01
257018101,25701810,73,F,2025-07-15,20250819,,CLOZAPINE,Respiratory distress,HO,CLOZAPINE | Respiratory distress | HO,2025-07-14/2025-07-20
257018271,25701827,,F,,20250819,,MINOXIDIL,Hair texture abnormal,,MINOXIDIL | Hair texture abnormal,NaT
257018851,25701885,,F,,20250819,,OPILL,Crying,OT,OPILL | Crying | OT,NaT
257019151,25701915,,,,20250819,,MINOXIDIL,Incorrect dose administered,,MINOXIDIL | Incorrect dose administered,NaT
257019401,25701940,,,,20250819,,MINOXIDIL,Application site irritation,,MINOXIDIL | Application site irritation,NaT
257019591,25701959,,,,20250819,,MINOXIDIL,Alopecia,,MINOXIDIL | Alopecia,NaT
257019601,25701960,,,,20250819,,MINOXIDIL,Application site paraesthesia,,MINOXIDIL | Application site paraesthesia,NaT
257020011,25702001,,,,20250819,,MINOXIDIL,Product administered at inappropriate site,,MINOXIDIL | Product administered at inappropriate site,NaT
257020531,25702053,25,F,2025-08-13,20250819,,HUMIRA,Wrong technique in product usage process,,HUMIRA | Wrong technique in product usage process,2025-08-11/2025-08-17
257021791,25702179,,F,2024-11-14,20250819,,PRALUENT,Injection site pain,,PRALUENT | Injection site pain,2024-11-11/2024-11-17
257022201,25702220,,F,,20250819,,PRALUENT,Injection site reaction,,PRALUENT | Injection site reaction,NaT
257022341,25702234,,F,2024-01-01,20250819,,PRALUENT,Myalgia,,PRALUENT | Myalgia,2024-01-01/2024-01-07
257022451,25702245,85,M,2022-10-21,20250819,,PEMBROLIZUMAB,Proteinuria,OT,PEMBROLIZUMAB | Proteinuria | OT,2022-10-17/2022-10-23
257022551,25702255,,F,2025-01-02,20250819,,PRALUENT,Product preparation error,,PRALUENT | Product preparation error,2024-12-30/2025-01-05
257022781,25702278,68,M,,20250819,,POMALYST,Death,OT,POMALYST | Death | OT,NaT
257022921,25702292,,M,,20250819,,DUPIXENT,Dry eye,,DUPIXENT | Dry eye,NaT
257024631,25702463,,,2025-01-01,20250819,,NEMLUVIO,Fatigue,,NEMLUVIO | Fatigue,2024-12-30/2025-01-05
257024641,25702464,,F,2025-04-07,20250819,,PRALUENT,Injection site swelling,,PRALUENT | Injection site swelling,2025-04-07/2025-04-13
257024901,25702490,,F,,20250819,,RADICAVA,Muscular weakness,,RADICAVA | Muscular weakness,NaT
257025241,25702524,63,M,2025-08-01,20250819,,LENALIDOMIDE,Joint swelling,,LENALIDOMIDE | Joint swelling,2025-07-28/2025-08-03
257025311,25702531,,M,2025-04-14,20250819,,PRALUENT,Injection site haemorrhage,,PRALUENT | Injection site haemorrhage,2025-04-14/2025-04-20
257025381,25702538,,F,,20250819,,PRALUENT,Product preparation error,,PRALUENT | Product preparation error,NaT
257026092,25702609,,,,20250915,,PEGFILGRASTIM,Device issue,,PEGFILGRASTIM | Device issue,NaT
257026101,25702610,,,2025-07-24,20250819,,NEMLUVIO,Device leakage,,NEMLUVIO | Device leakage,2025-07-21/2025-07-27
257026351,25702635,,F,,20250819,,PRALUENT,Eye disorder,,PRALUENT | Eye disorder,NaT
257027151,25702715,,M,2025-06-17,20250819,,PRALUENT,Product preparation error,,PRALUENT | Product preparation error,2025-06-16/2025-06-22
257027871,25702787,,F,2025-01-01,20250819,,PRALUENT,Muscular weakness,,PRALUENT | Muscular weakness,2024-12-30/2025-01-05
257027921,25702792,43,M,2025-06-26,20250819,,XYWAV,Surgery,OT,XYWAV | Surgery | OT,2025-06-23/2025-06-29
257028111,25702811,23,M,,20250819,,OXYCODONE HYDROCHLORIDE,Drug diversion,,OXYCODONE HYDROCHLORIDE | Drug diversion,NaT
257029252,25702925,77,F,2024-01-01,20250908,,ADEMPAS,Abdominal hernia,OT,ADEMPAS | Abdominal hernia | OT,2024-01-01/2024-01-07
257030031,25703003,,,,20250819,,NEMLUVIO,Rash pruritic,,NEMLUVIO | Rash pruritic,NaT
257030801,25703080,,,,20250819,,CARVYKTI,Neurological symptom,OT,CARVYKTI | Neurological symptom | OT,NaT
257031791,25703179,47,F,2025-08-01,20250820,,BOTOX,Product quality issue,,BOTOX | Product quality issue,2025-07-28/2025-08-03
257032825,25703282,,M,2025-06-07,20250916,,NEULASTA,Device adhesion issue,,NEULASTA | Device adhesion issue,2025-06-02/2025-06-08
257033121,25703312,,M,,20250820,,XOLAIR PFS,Drug hypersensitivity,,XOLAIR PFS | Drug hypersensitivity,NaT
257033461,25703346,62,F,2025-01-01,20250820,,ESBRIET,Dysphonia,,ESBRIET | Dysphonia,2024-12-30/2025-01-05
257033531,25703353,,,,20250820,,INFLIXIMAB,Fatigue,OT,INFLIXIMAB | Fatigue | OT,NaT
257034011,25703401,50,M,,20250820,,PREGABALIN,Drug interaction,OT,PREGABALIN | Drug interaction | OT,NaT
257034601,25703460,,F,2025-01-01,20250820,,BIMEKIZUMAB,Injection site pain,OT,BIMEKIZUMAB | Injection site pain | OT,2024-12-30/2025-01-05
257034741,25703474,,F,,20250820,,BENLYSTA,Drug hypersensitivity,,BENLYSTA | Drug hypersensitivity,NaT
257035631,25703563,44,F,,20250820,,TACROLIMUS,Off label use,HO,TACROLIMUS | Off label use | HO,NaT
257035811,25703581,,,,20250820,,AVMAPKI FAKZYNJA CO-PACK,Vision blurred,,AVMAPKI FAKZYNJA CO-PACK | Vision blurred,NaT
257036821,25703682,,,,20250820,,AVMAPKI FAKZYNJA CO-PACK,Product dose omission issue,,AVMAPKI FAKZYNJA CO-PACK | Product dose omission issue,NaT
257040541,25704054,,,,20250820,,INFLIXIMAB,Intentional product use issue,OT,INFLIXIMAB | Intentional product use issue | OT,NaT
257041341,25704134,,F,,20250820,,BACLOFEN,Lower limb fracture,OT,BACLOFEN | Lower limb fracture | OT,NaT
257042081,25704208,,,,20250820,,PREDNISOLONE ACETATE,Instillation site irritation,,PREDNISOLONE ACETATE | Instillation site irritation,NaT
257042511,25704251,61,M,,20250820,,TACROLIMUS,Headache,OT,TACROLIMUS | Headache | OT,NaT
257042911,25704291,68,M,,20250820,,KEVZARA,Renal mass,OT,KEVZARA | Renal mass | OT,NaT
257043191,25704319,,,,20250820,,LENALIDOMIDE,Follicular lymphoma,OT,LENALIDOMIDE | Follicular lymphoma | OT,NaT
257043391,25704339,,F,,20250820,,MOUNJARO,Nausea,,MOUNJARO | Nausea,NaT
257043461,25704346,56,F,,20250820,,TACROLIMUS,Calcineurin inhibitor induced pain syndrome,OT,TACROLIMUS | Calcineurin inhibitor induced pain syndrome | OT,NaT
257043551,25704355,25,F,,20250820,,USTEKINUMAB,Maternal exposure during pregnancy,CA,USTEKINUMAB | Maternal exposure during pregnancy | CA,NaT
257043832,25704383,,M,,20250822,,EMTRICITABINE\TENOFOVIR DISOPROXIL,Renal disorder,OT,EMTRICITABINE\TENOFOVIR DISOPROXIL | Renal disorder | OT,NaT
257043981,25704398,67,F,2025-08-03,20250820,,RECLAST,Pruritus,DS,RECLAST | Pruritus | DS,2025-07-28/2025-08-03
257046321,25704632,65,F,,20250820,,METHOTREXATE,Hypersensitivity pneumonitis,HO,METHOTREXATE | Hypersensitivity pneumonitis | HO,NaT
257046671,25704667,7,M,,20250820,,TACROLIMUS,Liver transplant rejection,HO,TACROLIMUS | Liver transplant rejection | HO,NaT
257046934,25704693,70,M,2025-07-08,20250901,,XELODA,Urethritis,HO,XELODA | Urethritis | HO,2025-07-07/2025-07-13
257047921,25704792,,,,20250820,,PREDNISOLONE,Fatigue,HO,PREDNISOLONE | Fatigue | HO,NaT
257049251,25704925,,F,,20250820,,REMICADE,Herpes zoster,OT,REMICADE | Herpes zoster | OT,NaT
257049351,25704935,,F,2025-01-01,20250820,,CORTICOTROPIN,Weight increased,,CORTICOTROPIN | Weight increased,2024-12-30/2025-01-05
257049671,25704967,,,,20250820,,ZEPBOUND,Drug ineffective,,ZEPBOUND | Drug ineffective,NaT
257049811,25704981,78,F,,20250820,,ZEPBOUND,Diarrhoea,,ZEPBOUND | Diarrhoea,NaT
257050651,25705065,,F,,20250820,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
257050672,25705067,,F,,20250908,,XOLAIR,Angioedema,OT,XOLAIR | Angioedema | OT,NaT
257050781,25705078,,F,,20250820,,DAYBUE,Diarrhoea,,DAYBUE | Diarrhoea,NaT
257051101,25705110,62,M,2025-08-11,20250820,,TECENTRIQ,Gastric infection,HO,TECENTRIQ | Gastric infection | HO,2025-08-11/2025-08-17
257051202,25705120,62,F,2025-08-06,20250916,,PEMETREXED,Lip pain,OT,PEMETREXED | Lip pain | OT,2025-08-04/2025-08-10
257051601,25705160,81,F,2025-08-16,20250819,,XOLAIR,Asthma,HO,XOLAIR | Asthma | HO,2025-08-11/2025-08-17
257051721,25705172,,,2025-01-01,20250820,,URSODIOL,Diarrhoea,,URSODIOL | Diarrhoea,2024-12-30/2025-01-05
257051961,25705196,,,,20250820,,CARVYKTI,Immune-mediated enterocolitis,OT,CARVYKTI | Immune-mediated enterocolitis | OT,NaT
257052092,25705209,69,M,2024-03-22,20250926,,METFORMIN,Overdose,LT,METFORMIN | Overdose | LT,2024-03-18/2024-03-24
257052261,25705226,,M,,20250820,,NUCALA,Asthma,,NUCALA | Asthma,NaT
257052481,25705248,,,,20250819,,JARDIANCE,Chest pain,,JARDIANCE | Chest pain,NaT
257053751,25705375,,F,,20250820,,ZEPBOUND,Intercepted product dispensing error,,ZEPBOUND | Intercepted product dispensing error,NaT
257054101,25705410,,,,20250819,,PAROXETINE,Anxiety,,PAROXETINE | Anxiety,NaT
257054361,25705436,41,M,2025-08-11,20250820,,FINASTERIDE,Anhedonia,OT,FINASTERIDE | Anhedonia | OT,2025-08-11/2025-08-17
257054851,25705485,72,M,2024-03-01,20250819,,RIVAROXABAN,Transfusion,HO,RIVAROXABAN | Transfusion | HO,2024-02-26/2024-03-03
257055031,25705503,4,M,,20250820,,SILDENAFIL CITRATE,Intentional overdose,OT,SILDENAFIL CITRATE | Intentional overdose | OT,NaT
257055081,25705508,,,,20250820,,AVMAPKI FAKZYNJA CO-PACK,Off label use,,AVMAPKI FAKZYNJA CO-PACK | Off label use,NaT
257056021,25705602,,F,,20250820,,BLINCYTO,Cytokine release syndrome,OT,BLINCYTO | Cytokine release syndrome | OT,NaT
257056041,25705604,52,M,2025-08-08,20250820,,SERTRALINE,Abnormal dreams,HO,SERTRALINE | Abnormal dreams | HO,2025-08-04/2025-08-10
257056551,25705655,37,F,,20250820,,TRASTUZUMAB,Drug ineffective,DS,TRASTUZUMAB | Drug ineffective | DS,NaT
257058031,25705803,12,M,,20250820,,IRINOTECAN,Deafness neurosensory,OT,IRINOTECAN | Deafness neurosensory | OT,NaT
257058111,25705811,43,F,2025-08-11,20250819,,VYVGART HYTRULO,Infusion site pain,OT,VYVGART HYTRULO | Infusion site pain | OT,2025-08-11/2025-08-17
257058871,25705887,,F,,20250820,,BENLYSTA,Hospitalisation,HO,BENLYSTA | Hospitalisation | HO,NaT
257058931,25705893,34,M,2025-08-19,20250820,,DIANEAL FOR PERITONEAL DIALYSIS,Electrolyte imbalance,,DIANEAL FOR PERITONEAL DIALYSIS | Electrolyte imbalance,2025-08-18/2025-08-24
257058961,25705896,35,F,,20250820,,MIRENA,Product use in unapproved indication,,MIRENA | Product use in unapproved indication,NaT
257058991,25705899,34,F,2023-12-05,20250819,,SERTRALINE,Drug withdrawal syndrome,RI,SERTRALINE | Drug withdrawal syndrome | RI,2023-12-04/2023-12-10
257059471,25705947,,F,,20250820,,CERTOLIZUMAB PEGOL,Rheumatoid arthritis,OT,CERTOLIZUMAB PEGOL | Rheumatoid arthritis | OT,NaT
257060681,25706068,61,M,,20250820,,PHENYLEPHRINE HYDROCHLORIDE,Arteriospasm coronary,OT,PHENYLEPHRINE HYDROCHLORIDE | Arteriospasm coronary | OT,NaT
257061951,25706195,,M,,20250820,,GOMEKLI,Neoplasm progression,,GOMEKLI | Neoplasm progression,NaT
257062561,25706256,59,F,2025-06-01,20250820,,XELJANZ XR,Condition aggravated,OT,XELJANZ XR | Condition aggravated | OT,2025-05-26/2025-06-01
257063261,25706326,,,,20250820,,REMODULIN,Pulmonary arterial hypertension,OT,REMODULIN | Pulmonary arterial hypertension | OT,NaT
257063501,25706350,5,M,2025-04-09,20250820,,VITAMIN D3,Pain in extremity,,VITAMIN D3 | Pain in extremity,2025-04-07/2025-04-13
257063671,25706367,70,M,2025-08-14,20250820,,DARATUMUMAB\HYALURONIDASE-FIHJ,Lung opacity,HO,DARATUMUMAB\HYALURONIDASE-FIHJ | Lung opacity | HO,2025-08-11/2025-08-17
257064511,25706451,74,M,2025-01-01,20250820,,VENCLEXTA,Infectious pleural effusion,DE,VENCLEXTA | Infectious pleural effusion | DE,2024-12-30/2025-01-05
257064561,25706456,,,,20250820,,GAMMAGARD,Dyspnoea,,GAMMAGARD | Dyspnoea,NaT
257065531,25706553,8,M,2025-06-19,20250820,,AGAMREE,Hypersensitivity,,AGAMREE | Hypersensitivity,2025-06-16/2025-06-22
257066032,25706603,,,,20250905,,SIPONIMOD,Muscle spasms,OT,SIPONIMOD | Muscle spasms | OT,NaT
257066381,25706638,,,,20250820,,SAJAZIR,Vomiting,,SAJAZIR | Vomiting,NaT
257067281,25706728,51,F,2025-01-01,20250820,,DUPIXENT,Symptom recurrence,,DUPIXENT | Symptom recurrence,2024-12-30/2025-01-05
257067511,25706751,66,M,2025-08-01,20250820,,DUPIXENT,Skin disorder,,DUPIXENT | Skin disorder,2025-07-28/2025-08-03
257067612,25706761,75,F,,20250903,,DUPIXENT,Accidental exposure to product,,DUPIXENT | Accidental exposure to product,NaT
257067801,25706780,46,M,,20250820,,DUPIXENT,Asthma,,DUPIXENT | Asthma,NaT
257068201,25706820,88,M,,20250820,,LANTUS,Off label use,,LANTUS | Off label use,NaT
257069931,25706993,89,M,2025-08-15,20250820,,INLYTA,Death,DE,INLYTA | Death | DE,2025-08-11/2025-08-17
257070021,25707002,70,M,2025-06-16,20250820,,LINEZOLID,Condition aggravated,HO,LINEZOLID | Condition aggravated | HO,2025-06-16/2025-06-22
257070481,25707048,,,2024-01-01,20250820,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,2024-01-01/2024-01-07
257070681,25707068,50,M,2024-01-01,20250820,,LANTUS SOLOSTAR,Monoplegia,OT,LANTUS SOLOSTAR | Monoplegia | OT,2024-01-01/2024-01-07
257071571,25707157,29,M,2022-08-01,20250820,,"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",Toxicity to various agents,DE,"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE | Toxicity to various agents | DE",2022-08-01/2022-08-07
257071781,25707178,,M,,20250820,,METHOTREXATE SODIUM,Haematochezia,OT,METHOTREXATE SODIUM | Haematochezia | OT,NaT
257071792,25707179,78,M,,20250910,,CIPROFLOXACIN,Torsade de pointes,HO,CIPROFLOXACIN | Torsade de pointes | HO,NaT
257072132,25707213,34,F,2022-01-26,20250916,,ARIPIPRAZOLE LAUROXIL,Off label use,OT,ARIPIPRAZOLE LAUROXIL | Off label use | OT,2022-01-24/2022-01-30
257072292,25707229,,M,,20250904,,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Infusion site erythema,,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN | Infusion site erythema,NaT
257072991,25707299,,,,20250820,,VOLTAREN ARTHRITIS PAIN,Cough,,VOLTAREN ARTHRITIS PAIN | Cough,NaT
257073281,25707328,36,F,2025-08-20,20250820,,SUBOXONE,Nausea,OT,SUBOXONE | Nausea | OT,2025-08-18/2025-08-24
257073411,25707341,,,,20250820,,AUVELITY,Neoplasm malignant,OT,AUVELITY | Neoplasm malignant | OT,NaT
257073791,25707379,,M,,20250820,,ALBUTEROL SULFATE,Incorrect dose administered,,ALBUTEROL SULFATE | Incorrect dose administered,NaT
257074911,25707491,78,M,,20250820,,XTANDI,Weight decreased,,XTANDI | Weight decreased,NaT
257074971,25707497,,M,,20250820,,XTANDI,Ageusia,,XTANDI | Ageusia,NaT
257075351,25707535,,M,,20250820,,DUPIXENT,Chest pain,,DUPIXENT | Chest pain,NaT
257075442,25707544,80,F,2025-08-01,20250911,,RINVOQ,Cataract,,RINVOQ | Cataract,2025-07-28/2025-08-03
257075761,25707576,50,F,,20250820,,MOUNJARO,Nausea,,MOUNJARO | Nausea,NaT
257075981,25707598,,,,20250820,,PREDNISONE,Prostatic obstruction,OT,PREDNISONE | Prostatic obstruction | OT,NaT
257076291,25707629,,F,,20250820,,OSIMERTINIB,Death,DE,OSIMERTINIB | Death | DE,NaT
257076583,25707658,61,M,,20250917,,VENETOCLAX,Pancreatitis,LT,VENETOCLAX | Pancreatitis | LT,NaT
257077671,25707767,,,,20250820,,MOUNJARO,Abdominal discomfort,,MOUNJARO | Abdominal discomfort,NaT
257078771,25707877,,F,,20250820,,TYSABRI,Mycobacterium tuberculosis complex test positive,,TYSABRI | Mycobacterium tuberculosis complex test positive,NaT
257079371,25707937,65,M,,20250820,,POMALYST,Tooth infection,,POMALYST | Tooth infection,NaT
257079582,25707958,,M,2025-08-01,20250912,,VIMIZIM,Infection,HO,VIMIZIM | Infection | HO,2025-07-28/2025-08-03
257079742,25707974,8,F,2025-01-01,20250930,,DUPIXENT,Mental status changes,,DUPIXENT | Mental status changes,2024-12-30/2025-01-05
257079852,25707985,78,F,2025-08-01,20250915,,OFEV,Dry mouth,,OFEV | Dry mouth,2025-07-28/2025-08-03
257080081,25708008,,F,,20250820,,FASLODEX,Treatment noncompliance,OT,FASLODEX | Treatment noncompliance | OT,NaT
257080101,25708010,,F,,20250820,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
257081224,25708122,71,M,2025-07-01,20250930,,LEQVIO,Metastases to liver,HO,LEQVIO | Metastases to liver | HO,2025-06-30/2025-07-06
257081332,25708133,59,F,2023-01-01,20250930,,KEYTRUDA,Immune-mediated myocarditis,DE,KEYTRUDA | Immune-mediated myocarditis | DE,2022-12-26/2023-01-01
257081741,25708174,,,,20250820,,CLOZARIL,Dementia,HO,CLOZARIL | Dementia | HO,NaT
257081931,25708193,,F,,20250820,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Death,DE,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Death | DE,NaT
257082221,25708222,52,M,,20250821,,TACROLIMUS,Pneumocystis jirovecii pneumonia,LT,TACROLIMUS | Pneumocystis jirovecii pneumonia | LT,NaT
257082291,25708229,67,M,2025-08-17,20250821,,VYALEV,Depressed level of consciousness,HO,VYALEV | Depressed level of consciousness | HO,2025-08-11/2025-08-17
257082841,25708284,73,F,2023-07-27,20250821,,AZITHROMYCIN,Drug intolerance,,AZITHROMYCIN | Drug intolerance,2023-07-24/2023-07-30
257083471,25708347,47,F,,20250821,,CEFACLOR,Hypersensitivity,,CEFACLOR | Hypersensitivity,NaT
257084511,25708451,,F,,20250821,,SPIRIVA RESPIMAT,Wrist fracture,,SPIRIVA RESPIMAT | Wrist fracture,NaT
257084791,25708479,85,F,,20250821,,PALBOCICLIB,Leukopenia,OT,PALBOCICLIB | Leukopenia | OT,NaT
257085541,25708554,40,M,,20250821,,FLUOXETINE,Metabolic acidosis,HO,FLUOXETINE | Metabolic acidosis | HO,NaT
257085861,25708586,70,M,2025-08-07,20250821,,TECENTRIQ,Death,DE,TECENTRIQ | Death | DE,2025-08-04/2025-08-10
257085921,25708592,60,,,20250821,,TISLELIZUMAB,Myelosuppression,HO,TISLELIZUMAB | Myelosuppression | HO,NaT
257086671,25708667,23,F,,20250821,,ADBRY,Dizziness,,ADBRY | Dizziness,NaT
257086982,25708698,64,M,,20250924,,ORGOVYX,Thrombosis,HO,ORGOVYX | Thrombosis | HO,NaT
257087461,25708746,,,,20250821,,TECHNETIUM TC-99M PYROPHOSPHATE,Product dose omission issue,,TECHNETIUM TC-99M PYROPHOSPHATE | Product dose omission issue,NaT
257089762,25708976,,,,20250905,,SIPONIMOD,Atrial fibrillation,OT,SIPONIMOD | Atrial fibrillation | OT,NaT
257090991,25709099,28,F,,20250821,,CYCLOSPORINE,Off label use,,CYCLOSPORINE | Off label use,NaT
257091581,25709158,,,,20250821,,GENOSYL,Underdose,,GENOSYL | Underdose,NaT
257092201,25709220,,,,20250821,,TAMSULOSIN HYDROCHLORIDE,Product substitution issue,,TAMSULOSIN HYDROCHLORIDE | Product substitution issue,NaT
257092301,25709230,61,F,2023-08-23,20250821,,ICATIBANT,Fall,HO,ICATIBANT | Fall | HO,2023-08-21/2023-08-27
257092321,25709232,,M,2015-03-01,20250821,,MYCOPHENOLATE MOFETIL,Pneumonia,DE,MYCOPHENOLATE MOFETIL | Pneumonia | DE,2015-02-23/2015-03-01
257092501,25709250,38,F,,20250821,,TALTZ,Maternal exposure during pregnancy,,TALTZ | Maternal exposure during pregnancy,NaT
257092601,25709260,51,M,2025-06-21,20250821,,EPCLUSA,Diarrhoea,OT,EPCLUSA | Diarrhoea | OT,2025-06-16/2025-06-22
257092832,25709283,59,M,,20250901,,TRUVADA,Chronic kidney disease,OT,TRUVADA | Chronic kidney disease | OT,NaT
257093431,25709343,54,F,,20250821,,SOFOSBUVIR\VELPATASVIR,Product dose omission issue,,SOFOSBUVIR\VELPATASVIR | Product dose omission issue,NaT
257093611,25709361,23,F,,20250821,,APREMILAST,Pustule,OT,APREMILAST | Pustule | OT,NaT
257093622,25709362,31,,,20250826,,TOLVAPTAN,Flank pain,,TOLVAPTAN | Flank pain,NaT
257094702,25709470,69,M,,20250926,,ORGOVYX,Myalgia,,ORGOVYX | Myalgia,NaT
257096681,25709668,71,,,20250821,,ADDERALL XR,Insurance issue,,ADDERALL XR | Insurance issue,NaT
257096721,25709672,48,F,,20250821,,METHOTREXATE,Drug ineffective,OT,METHOTREXATE | Drug ineffective | OT,NaT
257097621,25709762,,M,,20250821,,NUCALA,Rash,,NUCALA | Rash,NaT
257097991,25709799,,,,20250821,,LEVETIRACETAM,Autism spectrum disorder,OT,LEVETIRACETAM | Autism spectrum disorder | OT,NaT
257098101,25709810,,,,20250821,,CYCLOBENZAPRINE HYDROCHLORIDE,Genital paraesthesia,,CYCLOBENZAPRINE HYDROCHLORIDE | Genital paraesthesia,NaT
257098331,25709833,66,M,,20250821,,ORGOVYX,Blood pressure abnormal,,ORGOVYX | Blood pressure abnormal,NaT
257098691,25709869,,,,20250821,,MUCINEX,Drug ineffective,,MUCINEX | Drug ineffective,NaT
257099742,25709974,73,M,,20250904,,PREDNISONE,Pneumomediastinum,HO,PREDNISONE | Pneumomediastinum | HO,NaT
257099921,25709992,89,M,2025-08-18,20250821,,NUPLAZID,Death,DE,NUPLAZID | Death | DE,2025-08-18/2025-08-24
257101112,25710111,43,M,2025-02-12,20250911,,PREGABALIN,Confusional state,HO,PREGABALIN | Confusional state | HO,2025-02-10/2025-02-16
257101571,25710157,,,,20250821,,OXALIPLATIN,Death,DE,OXALIPLATIN | Death | DE,NaT
257101671,25710167,68,M,2025-02-24,20250821,,OMEPRAZOLE,Rash pruritic,HO,OMEPRAZOLE | Rash pruritic | HO,2025-02-24/2025-03-02
257102531,25710253,55,F,,20250821,,ZEPBOUND,Heart rate increased,,ZEPBOUND | Heart rate increased,NaT
257102761,25710276,48,M,,20250821,,CORTICOTROPIN,Contraindicated product administered,HO,CORTICOTROPIN | Contraindicated product administered | HO,NaT
257102891,25710289,,,,20250821,,PLUVICTO,General physical health deterioration,,PLUVICTO | General physical health deterioration,NaT
257103322,25710332,67,M,,20250918,,LENALIDOMIDE,Off label use,OT,LENALIDOMIDE | Off label use | OT,NaT
257103741,25710374,47,,,20250821,,ZEPBOUND,Hunger,,ZEPBOUND | Hunger,NaT
257104221,25710422,,,2025-08-19,20250820,,ZEPBOUND,Therapeutic response changed,,ZEPBOUND | Therapeutic response changed,2025-08-18/2025-08-24
257104361,25710436,71,M,2025-07-23,20250821,,ONDANSETRON,Altered state of consciousness,OT,ONDANSETRON | Altered state of consciousness | OT,2025-07-21/2025-07-27
257105061,25710506,,,,20250821,,DICLOFENAC,Foetal exposure during pregnancy,CA,DICLOFENAC | Foetal exposure during pregnancy | CA,NaT
257105321,25710532,53,F,2025-01-02,20250821,,PACLITAXEL,Anaphylactic reaction,LT,PACLITAXEL | Anaphylactic reaction | LT,2024-12-30/2025-01-05
257105401,25710540,,M,,20250821,,ACALABRUTINIB,Pericarditis,HO,ACALABRUTINIB | Pericarditis | HO,NaT
257105491,25710549,,,,20250821,,DABIGATRAN ETEXILATE,Product substitution issue,,DABIGATRAN ETEXILATE | Product substitution issue,NaT
257105901,25710590,,F,,20250821,,KISQALI,Product temperature excursion issue,,KISQALI | Product temperature excursion issue,NaT
257106121,25710612,28,M,2025-06-20,20250821,,BIMZELX,Colitis,OT,BIMZELX | Colitis | OT,2025-06-16/2025-06-22
257106471,25710647,,,,20250821,,OPSUMIT,Pneumonia,,OPSUMIT | Pneumonia,NaT
257107171,25710717,61,F,2025-01-01,20250821,,DUPIXENT,Asthma,,DUPIXENT | Asthma,2024-12-30/2025-01-05
257107622,25710762,57,F,2025-01-01,20250827,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,2024-12-30/2025-01-05
257107951,25710795,,F,2025-01-01,20250821,,DUPIXENT,Eye irritation,,DUPIXENT | Eye irritation,2024-12-30/2025-01-05
257109321,25710932,6,F,2025-01-01,20250821,,DUPIXENT,Injection site bruising,,DUPIXENT | Injection site bruising,2024-12-30/2025-01-05
257109571,25710957,83,F,2025-01-01,20250821,,DUPIXENT,Wheezing,,DUPIXENT | Wheezing,2024-12-30/2025-01-05
257109672,25710967,77,F,,20250826,,DUPIXENT,Arthralgia,,DUPIXENT | Arthralgia,NaT
257109681,25710968,65,F,,20250821,,LANTUS SOLOSTAR,Off label use,,LANTUS SOLOSTAR | Off label use,NaT
257110311,25711031,37,F,,20250821,,DUPIXENT,Alopecia,,DUPIXENT | Alopecia,NaT
257110371,25711037,70,M,,20250821,,LANTUS SOLOSTAR,Off label use,,LANTUS SOLOSTAR | Off label use,NaT
257110502,25711050,92,F,2025-08-15,20250911,,DUPIXENT,Rash pruritic,,DUPIXENT | Rash pruritic,2025-08-11/2025-08-17
257111471,25711147,,M,,20250821,,DUPIXENT,Cough,,DUPIXENT | Cough,NaT
257112481,25711248,,M,,20250821,,NUCALA,Asthma,,NUCALA | Asthma,NaT
257112591,25711259,,F,,20250821,,LAMOTRIGINE,Pruritus,,LAMOTRIGINE | Pruritus,NaT
257113001,25711300,,F,,20250821,,MUCINEX,Product use in unapproved indication,,MUCINEX | Product use in unapproved indication,NaT
257113841,25711384,,,,20250821,,MOUNJARO,Hypoglycaemia,OT,MOUNJARO | Hypoglycaemia | OT,NaT
257114851,25711485,55,,,20250821,,TRULICITY,Blindness,HO,TRULICITY | Blindness | HO,NaT
257114871,25711487,35,M,,20250821,,MOUNJARO,Cardiac failure,HO,MOUNJARO | Cardiac failure | HO,NaT
257117501,25711750,54,,,20250821,,MOUNJARO,Abdominal pain,OT,MOUNJARO | Abdominal pain | OT,NaT
257118491,25711849,,M,,20250821,,VEDOLIZUMAB,Road traffic accident,HO,VEDOLIZUMAB | Road traffic accident | HO,NaT
257119101,25711910,,F,,20250821,,HUMAN IMMUNOGLOBULIN G,Malaise,OT,HUMAN IMMUNOGLOBULIN G | Malaise | OT,NaT
257119911,25711991,53,F,2025-05-27,20250821,,CARBOPLATIN,Drug eruption,HO,CARBOPLATIN | Drug eruption | HO,2025-05-26/2025-06-01
257120821,25712082,,F,,20250821,,ZEJULA,Ovarian cancer recurrent,OT,ZEJULA | Ovarian cancer recurrent | OT,NaT
257121061,25712106,,F,,20250821,,ILARIS,Maternal exposure timing unspecified,OT,ILARIS | Maternal exposure timing unspecified | OT,NaT
257122321,25712232,,,,20250821,,PREVACID SOLUTAB,Inappropriate schedule of product administration,,PREVACID SOLUTAB | Inappropriate schedule of product administration,NaT
257122391,25712239,80,F,2025-07-01,20250821,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2025-06-30/2025-07-06
257122561,25712256,24,M,,20250821,,DUPIXENT,Abdominal discomfort,,DUPIXENT | Abdominal discomfort,NaT
257122831,25712283,32,F,2025-08-01,20250821,,ZURZUVAE,Mood swings,HO,ZURZUVAE | Mood swings | HO,2025-07-28/2025-08-03
257123502,25712350,24,F,2009-01-01,20250912,,VENLAFAXINE HCL,Restlessness,OT,VENLAFAXINE HCL | Restlessness | OT,2008-12-29/2009-01-04
257123682,25712368,42,M,2025-08-13,20250903,,ULTRAVIST,Ocular hyperaemia,OT,ULTRAVIST | Ocular hyperaemia | OT,2025-08-11/2025-08-17
257123872,25712387,,,,20250916,,COMBIGAN,No adverse event,,COMBIGAN | No adverse event,NaT
257124551,25712455,,F,,20250821,,KESIMPTA,Hypersensitivity,,KESIMPTA | Hypersensitivity,NaT
257125031,25712503,43,F,,20250821,,METRONIDAZOLE,Cerebellar syndrome,OT,METRONIDAZOLE | Cerebellar syndrome | OT,NaT
257125631,25712563,35,F,2025-07-18,20250821,,DEPO-MEDROL,Off label use,HO,DEPO-MEDROL | Off label use | HO,2025-07-14/2025-07-20
257127452,25712745,80,M,2025-02-07,20250827,,FARXIGA,Death,DE,FARXIGA | Death | DE,2025-02-03/2025-02-09
257128041,25712804,,F,,20250821,,SAXENDA,Haematochezia,OT,SAXENDA | Haematochezia | OT,NaT
257128281,25712828,,M,,20250821,,PALYNZIQ,Arthralgia,,PALYNZIQ | Arthralgia,NaT
257128292,25712829,35,F,2025-08-13,20250910,,PALYNZIQ,Dizziness,,PALYNZIQ | Dizziness,2025-08-11/2025-08-17
257128331,25712833,,,2025-01-01,20250821,,KEYTRUDA,Pain in extremity,,KEYTRUDA | Pain in extremity,2024-12-30/2025-01-05
257128451,25712845,23,M,,20250821,,FLUOXETINE HYDROCHLORIDE,Mucosal prolapse syndrome,HO,FLUOXETINE HYDROCHLORIDE | Mucosal prolapse syndrome | HO,NaT
257129261,25712926,17,M,2025-08-12,20250821,,HUMIRA,Injection site haemorrhage,,HUMIRA | Injection site haemorrhage,2025-08-11/2025-08-17
257130641,25713064,,,,20250822,,OCREVUS,Immunosuppression,,OCREVUS | Immunosuppression,NaT
257131051,25713105,80,F,2025-08-01,20250822,,IMBRUVICA,Ophthalmic vascular thrombosis,HO,IMBRUVICA | Ophthalmic vascular thrombosis | HO,2025-07-28/2025-08-03
257131341,25713134,,F,,20250822,,SODIUM CHLORIDE,Product dose omission issue,OT,SODIUM CHLORIDE | Product dose omission issue | OT,NaT
257132241,25713224,,M,,20250822,,HUMIRA,Cardiac failure congestive,HO,HUMIRA | Cardiac failure congestive | HO,NaT
257132531,25713253,72,M,2025-08-11,20250822,,DAPAGLIFLOZIN,Dry mouth,OT,DAPAGLIFLOZIN | Dry mouth | OT,2025-08-11/2025-08-17
257132561,25713256,,F,,20250822,,SKYRIZI,Renal transplant,OT,SKYRIZI | Renal transplant | OT,NaT
257133581,25713358,,,,20250822,,ZEPBOUND,Wrong technique in product usage process,,ZEPBOUND | Wrong technique in product usage process,NaT
257134941,25713494,,,,20250822,,NEMLUVIO,Chest pain,HO,NEMLUVIO | Chest pain | HO,NaT
257135212,25713521,82,M,2025-06-19,20250823,,VIDAZA,Pyrexia,DE,VIDAZA | Pyrexia | DE,2025-06-16/2025-06-22
257135502,25713550,57,F,2025-08-09,20250829,,NEULASTA,Device leakage,,NEULASTA | Device leakage,2025-08-04/2025-08-10
257135542,25713554,81,M,,20250915,,CARBIDOPA\LEVODOPA,Adverse drug reaction,HO,CARBIDOPA\LEVODOPA | Adverse drug reaction | HO,NaT
257136203,25713620,68,M,,20250924,,GUSELKUMAB,Product dose omission issue,,GUSELKUMAB | Product dose omission issue,NaT
257136421,25713642,,,2025-08-12,20250822,,PROQUAD,No adverse event,,PROQUAD | No adverse event,2025-08-11/2025-08-17
257136881,25713688,,M,2025-08-11,20250822,,XOLAIR PFS,Accidental exposure to product,,XOLAIR PFS | Accidental exposure to product,2025-08-11/2025-08-17
257137521,25713752,80,F,2024-12-14,20250822,,METHOTREXATE SODIUM,Cytomegalovirus chorioretinitis,HO,METHOTREXATE SODIUM | Cytomegalovirus chorioretinitis | HO,2024-12-09/2024-12-15
257137841,25713784,57,M,2025-08-01,20250822,,MOUNJARO,Injection site haemorrhage,,MOUNJARO | Injection site haemorrhage,2025-07-28/2025-08-03
257138541,25713854,34,M,2025-08-04,20250822,,OLANZAPINE,Hepatic function abnormal,OT,OLANZAPINE | Hepatic function abnormal | OT,2025-08-04/2025-08-10
257138662,25713866,,F,,20250902,,CERTOLIZUMAB PEGOL,Cellulitis,OT,CERTOLIZUMAB PEGOL | Cellulitis | OT,NaT
257138771,25713877,23,F,2025-08-01,20250822,,XOLAIR,Off label use,OT,XOLAIR | Off label use | OT,2025-07-28/2025-08-03
257139021,25713902,82,M,2025-08-07,20250822,,RYTELO,Thrombocytopenia,OT,RYTELO | Thrombocytopenia | OT,2025-08-04/2025-08-10
257139101,25713910,42,F,2021-04-15,20250822,,TACROLIMUS,Visceral leishmaniasis,HO,TACROLIMUS | Visceral leishmaniasis | HO,2021-04-12/2021-04-18
257139562,25713956,,M,2025-01-01,20250903,,NUPLAZID,Sciatica,HO,NUPLAZID | Sciatica | HO,2024-12-30/2025-01-05
257140491,25714049,,,2024-02-01,20250822,,INFLIXIMAB,Rectal tenesmus,OT,INFLIXIMAB | Rectal tenesmus | OT,2024-01-29/2024-02-04
257141401,25714140,58,F,,20250822,,CARBOPLATIN,Febrile neutropenia,HO,CARBOPLATIN | Febrile neutropenia | HO,NaT
257141441,25714144,,F,,20250822,,XEMBIFY,Meningitis aseptic,OT,XEMBIFY | Meningitis aseptic | OT,NaT
257142201,25714220,41,F,2025-04-13,20250822,,XEMBIFY,Headache,,XEMBIFY | Headache,2025-04-07/2025-04-13
257142211,25714221,,F,,20250822,,XEMBIFY,Arthralgia,,XEMBIFY | Arthralgia,NaT
257143011,25714301,73,M,,20250822,,ORGOVYX,Death,OT,ORGOVYX | Death | OT,NaT
257143741,25714374,49,F,2025-07-08,20250822,,POLATUZUMAB VEDOTIN,Neutrophil count decreased,OT,POLATUZUMAB VEDOTIN | Neutrophil count decreased | OT,2025-07-07/2025-07-13
257144812,25714481,50,F,,20250918,,ZOSYN,Acute kidney injury,HO,ZOSYN | Acute kidney injury | HO,NaT
257144901,25714490,58,F,,20250822,,HYDROCHLOROTHIAZIDE,Drug ineffective,OT,HYDROCHLOROTHIAZIDE | Drug ineffective | OT,NaT
257144931,25714493,7,F,,20250822,,CYPROHEPTADINE,Drug ineffective for unapproved indication,,CYPROHEPTADINE | Drug ineffective for unapproved indication,NaT
257145081,25714508,67,F,2025-08-11,20250822,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,2025-08-11/2025-08-17
257145731,25714573,,F,,20250822,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
257145961,25714596,,,,20250822,,SIMPONI,Device defective,,SIMPONI | Device defective,NaT
257146631,25714663,,,2025-08-06,20250822,,FOLIC ACID,Flushing,,FOLIC ACID | Flushing,2025-08-04/2025-08-10
257146691,25714669,45,F,,20250822,,METOPROLOL,Off label use,HO,METOPROLOL | Off label use | HO,NaT
257148412,25714841,27,M,2025-01-01,20250902,,SKYRIZI,Paronychia,OT,SKYRIZI | Paronychia | OT,2024-12-30/2025-01-05
257148691,25714869,56,F,2025-07-10,20250822,,MONTELUKAST,Abnormal behaviour,OT,MONTELUKAST | Abnormal behaviour | OT,2025-07-07/2025-07-13
257151651,25715165,,,,20250822,,ADALIMUMAB,Retinal vein occlusion,OT,ADALIMUMAB | Retinal vein occlusion | OT,NaT
257152221,25715222,59,M,2025-08-19,20250822,,TECENTRIQ,Death,DE,TECENTRIQ | Death | DE,2025-08-18/2025-08-24
257152491,25715249,,,2025-07-01,20250822,,ATORVASTATIN,Neuralgia,OT,ATORVASTATIN | Neuralgia | OT,2025-06-30/2025-07-06
257153311,25715331,84,F,2025-07-11,20250822,,DULOXETINE HYDROCHLORIDE,Inappropriate antidiuretic hormone secretion,HO,DULOXETINE HYDROCHLORIDE | Inappropriate antidiuretic hormone secretion | HO,2025-07-07/2025-07-13
257153531,25715353,49,F,2025-08-19,20250822,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,2025-08-18/2025-08-24
257154061,25715406,55,M,2025-07-10,20250822,,GABAPENTIN,Urinary incontinence,HO,GABAPENTIN | Urinary incontinence | HO,2025-07-07/2025-07-13
257154081,25715408,75,M,2025-08-15,20250822,,NUPLAZID,Death,DE,NUPLAZID | Death | DE,2025-08-11/2025-08-17
257154331,25715433,55,,,20250822,,SYNTHROID,Death,DE,SYNTHROID | Death | DE,NaT
257154701,25715470,,,,20250822,,ROSUVASTATIN,Drug interaction,HO,ROSUVASTATIN | Drug interaction | HO,NaT
257155141,25715514,36,F,2025-08-01,20250822,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,2025-07-28/2025-08-03
257155581,25715558,82,M,2025-07-24,20250822,,BENLYSTA,Injection site pain,,BENLYSTA | Injection site pain,2025-07-21/2025-07-27
257156532,25715653,71,F,2025-06-27,20250909,,METHOTREXATE,Platelet count decreased,HO,METHOTREXATE | Platelet count decreased | HO,2025-06-23/2025-06-29
257156941,25715694,65,,,20250822,,TOLVAPTAN,Product dose omission issue,,TOLVAPTAN | Product dose omission issue,NaT
257156991,25715699,70,M,2025-03-25,20250822,,PANTOPRAZOLE,Agranulocytosis,HO,PANTOPRAZOLE | Agranulocytosis | HO,2025-03-24/2025-03-30
257157511,25715751,,,,20250822,,CILTACABTAGENE AUTOLEUCEL,Colitis ulcerative,DE,CILTACABTAGENE AUTOLEUCEL | Colitis ulcerative | DE,NaT
257157621,25715762,,,,20250822,,HUMIRA,Off label use,,HUMIRA | Off label use,NaT
257157961,25715796,,,,20250821,,ADDERALL,Therapy change,,ADDERALL | Therapy change,NaT
257159061,25715906,72,M,2025-01-01,20250822,,OCTREOTIDE,Malaise,OT,OCTREOTIDE | Malaise | OT,2024-12-30/2025-01-05
257159891,25715989,28,F,2024-07-08,20250822,,ETHINYL ESTRADIOL\LEVONORGESTREL,Cerebral venous sinus thrombosis,HO,ETHINYL ESTRADIOL\LEVONORGESTREL | Cerebral venous sinus thrombosis | HO,2024-07-08/2024-07-14
257160841,25716084,,F,,20250822,,KYLEENA,Endometriosis,,KYLEENA | Endometriosis,NaT
257161231,25716123,76,,,20250822,,ZEPBOUND,Diarrhoea,,ZEPBOUND | Diarrhoea,NaT
257161471,25716147,66,F,2025-07-01,20250822,,ZEPBOUND,Rash,,ZEPBOUND | Rash,2025-06-30/2025-07-06
257162161,25716216,57,F,2022-01-01,20250822,,DUPIXENT,Dyspnoea,HO,DUPIXENT | Dyspnoea | HO,2021-12-27/2022-01-02
257162561,25716256,71,M,2020-01-15,20250822,,OZEMPIC,Pancreatitis necrotising,HO,OZEMPIC | Pancreatitis necrotising | HO,2020-01-13/2020-01-19
257162581,25716258,76,M,,20250822,,RYBELSUS,Blood potassium decreased,HO,RYBELSUS | Blood potassium decreased | HO,NaT
257162771,25716277,,F,,20250822,,WEGOVY,Euphoric mood,OT,WEGOVY | Euphoric mood | OT,NaT
257163432,25716343,36,F,,20250827,,METHYLPREDNISOLONE ACETATE,Osteopenia,OT,METHYLPREDNISOLONE ACETATE | Osteopenia | OT,NaT
257163461,25716346,,F,,20250822,,INBRIJA,Hospitalisation,HO,INBRIJA | Hospitalisation | HO,NaT
257163541,25716354,21,F,2025-08-08,20250822,,XOLAIR PFS,Incorrect dose administered,,XOLAIR PFS | Incorrect dose administered,2025-08-04/2025-08-10
257163591,25716359,32,F,,20250822,,OPSUMIT,Pneumonia,HO,OPSUMIT | Pneumonia | HO,NaT
257163901,25716390,52,F,2021-08-08,20250822,,FIRAZYR,Abdominal distension,OT,FIRAZYR | Abdominal distension | OT,2021-08-02/2021-08-08
257164601,25716460,52,M,2025-08-20,20250822,,SPRAVATO,Sedation,OT,SPRAVATO | Sedation | OT,2025-08-18/2025-08-24
257166241,25716624,,F,,20250822,,BENLYSTA,Pruritus,,BENLYSTA | Pruritus,NaT
257167031,25716703,56,M,,20250822,,XIFAXAN,Death,DE,XIFAXAN | Death | DE,NaT
257167121,25716712,87,F,,20250822,,ARANESP,Death,DE,ARANESP | Death | DE,NaT
257167511,25716751,87,M,2025-08-17,20250822,,INVANZ,Loss of consciousness,OT,INVANZ | Loss of consciousness | OT,2025-08-11/2025-08-17
257167761,25716776,82,M,2024-07-31,20250822,,CARBOPLATIN,Anaphylactic reaction,HO,CARBOPLATIN | Anaphylactic reaction | HO,2024-07-29/2024-08-04
257167911,25716791,,,2025-08-12,20250822,,MOTRIN INFANTS,Incorrect dose administered,OT,MOTRIN INFANTS | Incorrect dose administered | OT,2025-08-11/2025-08-17
257167931,25716793,62,F,,20250822,,METHOTREXATE SODIUM,Neoplasm malignant,OT,METHOTREXATE SODIUM | Neoplasm malignant | OT,NaT
257168062,25716806,,F,,20250826,,BUTRANS,Product packaging quantity issue,,BUTRANS | Product packaging quantity issue,NaT
257169351,25716935,,M,,20250822,,DELFLEX WITH DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM,Dehydration,,DELFLEX WITH DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM | Dehydration,NaT
257170091,25717009,50,F,2025-01-01,20250822,,DUPIXENT,Condition aggravated,,DUPIXENT | Condition aggravated,2024-12-30/2025-01-05
257171451,25717145,,M,,20250822,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,NaT
257171531,25717153,2,F,,20250822,,DUPIXENT,Dry skin,,DUPIXENT | Dry skin,NaT
257172531,25717253,59,M,2025-05-01,20250822,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,2025-04-28/2025-05-04
257172691,25717269,,M,,20250822,,DUPIXENT,Renal disorder,,DUPIXENT | Renal disorder,NaT
257173491,25717349,22,M,,20250822,,DUPIXENT,Injection site erythema,,DUPIXENT | Injection site erythema,NaT
257173631,25717363,66,M,2025-01-01,20250822,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,2024-12-30/2025-01-05
257173701,25717370,34,M,,20250822,,TACROLIMUS,Renal artery thrombosis,OT,TACROLIMUS | Renal artery thrombosis | OT,NaT
257173871,25717387,,,,20250822,,CYCLOPHOSPHAMIDE,Muscle spasms,OT,CYCLOPHOSPHAMIDE | Muscle spasms | OT,NaT
257174271,25717427,91,F,2025-07-01,20250822,,DUPIXENT,Rebound effect,,DUPIXENT | Rebound effect,2025-06-30/2025-07-06
257174571,25717457,26,F,,20250822,,DUPIXENT,Dyspnoea,,DUPIXENT | Dyspnoea,NaT
257175211,25717521,,F,,20250822,,ZEJULA,Ovarian cancer recurrent,OT,ZEJULA | Ovarian cancer recurrent | OT,NaT
257175692,25717569,,F,2025-08-11,20250909,,LENVIMA,Gastrointestinal perforation,HO,LENVIMA | Gastrointestinal perforation | HO,2025-08-11/2025-08-17
257175821,25717582,,F,2022-01-01,20250822,,EDOXABAN TOSYLATE,Blood alkaline phosphatase increased,OT,EDOXABAN TOSYLATE | Blood alkaline phosphatase increased | OT,2021-12-27/2022-01-02
257175861,25717586,,F,2025-07-28,20250822,,TRASTUZUMAB DERUXTECAN,Death,DE,TRASTUZUMAB DERUXTECAN | Death | DE,2025-07-28/2025-08-03
257175971,25717597,,,,20250822,,MIRALAX,Product prescribing issue,,MIRALAX | Product prescribing issue,NaT
257176162,25717616,,M,2025-01-01,20250908,,CEMIPLIMAB,Dyspnoea,OT,CEMIPLIMAB | Dyspnoea | OT,2024-12-30/2025-01-05
257176781,25717678,,,,20250822,,SIMPONI,Influenza,HO,SIMPONI | Influenza | HO,NaT
257177631,25717763,,F,,20250822,,XOLAIR PFS,Arthralgia,,XOLAIR PFS | Arthralgia,NaT
257177871,25717787,,F,,20250822,,BEVACIZUMAB,Anaemia,OT,BEVACIZUMAB | Anaemia | OT,NaT
257179301,25717930,62,M,2024-04-17,20250822,,FENTANYL CITRATE,Subdural haematoma,HO,FENTANYL CITRATE | Subdural haematoma | HO,2024-04-15/2024-04-21
257179481,25717948,3,M,2025-03-31,20250822,,"MEASLES-MUMPS-RUBELLA-VARICELLA VIRUS VACCINE, LIVE",No adverse event,,"MEASLES-MUMPS-RUBELLA-VARICELLA VIRUS VACCINE, LIVE | No adverse event",2025-03-31/2025-04-06
257179502,25717950,59,M,2024-05-21,20250929,,TENAPANOR HYDROCHLORIDE,Diarrhoea,DE,TENAPANOR HYDROCHLORIDE | Diarrhoea | DE,2024-05-20/2024-05-26
257180701,25718070,,,,20250823,,APIXABAN,Haemorrhage,OT,APIXABAN | Haemorrhage | OT,NaT
257180891,25718089,75,M,2025-05-28,20250823,,FLUOROURACIL,Chills,OT,FLUOROURACIL | Chills | OT,2025-05-26/2025-06-01
257181752,25718175,76,F,,20250829,,LANTUS SOLOSTAR,Off label use,,LANTUS SOLOSTAR | Off label use,NaT
257182032,25718203,33,F,2025-03-01,20250825,,EPIDIOLEX,Seizure,OT,EPIDIOLEX | Seizure | OT,2025-02-24/2025-03-02
257182071,25718207,55,M,,20250823,,MOUNJARO,Product dose omission issue,,MOUNJARO | Product dose omission issue,NaT
257182092,25718209,76,F,2025-01-01,20250901,,DUPIXENT,Injection site bruising,,DUPIXENT | Injection site bruising,2024-12-30/2025-01-05
257182571,25718257,63,M,2023-10-09,20250823,,CAPECITABINE,Diarrhoea,HO,CAPECITABINE | Diarrhoea | HO,2023-10-09/2023-10-15
257182761,25718276,63,F,2025-08-01,20250824,,DUPIXENT,Dyspnoea,,DUPIXENT | Dyspnoea,2025-07-28/2025-08-03
257183611,25718361,29,M,,20250823,,LEVOFLOXACIN,Drug ineffective,DE,LEVOFLOXACIN | Drug ineffective | DE,NaT
257183781,25718378,48,F,2025-08-18,20250823,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,2025-08-18/2025-08-24
257183791,25718379,72,,,20250823,,MOUNJARO,Product dose omission issue,,MOUNJARO | Product dose omission issue,NaT
257183961,25718396,,M,,20250822,,MOUNJARO,Skin odour abnormal,OT,MOUNJARO | Skin odour abnormal | OT,NaT
257185391,25718539,,,,20250823,,BEVACIZUMAB,Ovarian cancer,OT,BEVACIZUMAB | Ovarian cancer | OT,NaT
257186402,25718640,,F,2025-07-01,20250923,,ENJAYMO,Pain,OT,ENJAYMO | Pain | OT,2025-06-30/2025-07-06
257186961,25718696,59,F,,20250823,,CERTOLIZUMAB PEGOL,Off label use,OT,CERTOLIZUMAB PEGOL | Off label use | OT,NaT
257187041,25718704,64,F,,20250822,,TAGRISSO,Pancreatitis acute,HO,TAGRISSO | Pancreatitis acute | HO,NaT
257187531,25718753,68,F,2025-01-01,20250823,,OTEZLA,Fatigue,,OTEZLA | Fatigue,2024-12-30/2025-01-05
257188491,25718849,68,M,,20250823,,ZEPBOUND,Intercepted product dispensing error,,ZEPBOUND | Intercepted product dispensing error,NaT
257189121,25718912,72,F,,20250822,,FOSCARBIDOPA\FOSLEVODOPA,Hip surgery,OT,FOSCARBIDOPA\FOSLEVODOPA | Hip surgery | OT,NaT
257189691,25718969,,F,,20250823,,DUPIXENT,Asthenia,,DUPIXENT | Asthenia,NaT
257189721,25718972,,,,20250823,,CABENUVA,Diabetes mellitus,OT,CABENUVA | Diabetes mellitus | OT,NaT
257189991,25718999,,F,,20250823,,ENHERTU,Alopecia,,ENHERTU | Alopecia,NaT
257190031,25719003,72,M,2022-03-16,20250823,,LENALIDOMIDE,Hyperglycaemia,HO,LENALIDOMIDE | Hyperglycaemia | HO,2022-03-14/2022-03-20
257190371,25719037,,,,20250823,,BOTOX COSMETIC,Drug ineffective,,BOTOX COSMETIC | Drug ineffective,NaT
257191601,25719160,,F,,20250823,,ZEPBOUND,Abortion spontaneous,OT,ZEPBOUND | Abortion spontaneous | OT,NaT
257192072,25719207,51,M,2025-08-01,20250915,,CERDELGA,Weight decreased,,CERDELGA | Weight decreased,2025-07-28/2025-08-03
257192241,25719224,,F,2025-01-01,20250824,,NEXPLANON,Product use issue,OT,NEXPLANON | Product use issue | OT,2024-12-30/2025-01-05
257192531,25719253,72,F,2025-01-08,20250824,,OXALIPLATIN,Fracture,HO,OXALIPLATIN | Fracture | HO,2025-01-06/2025-01-12
257192601,25719260,,F,,20250824,,BENLYSTA,Hypoaesthesia,,BENLYSTA | Hypoaesthesia,NaT
257192924,25719292,31,M,2025-01-01,20250910,,TZIELD,Pyrexia,,TZIELD | Pyrexia,2024-12-30/2025-01-05
257194341,25719434,66,F,2025-08-18,20250824,,TREMFYA,Nail disorder,,TREMFYA | Nail disorder,2025-08-18/2025-08-24
257195912,25719591,,F,,20250825,,KEYTRUDA,Wernicke's encephalopathy,OT,KEYTRUDA | Wernicke's encephalopathy | OT,NaT
257196051,25719605,53,F,2025-06-01,20250825,,TRULICITY,Incorrect dose administered,,TRULICITY | Incorrect dose administered,2025-05-26/2025-06-01
257197241,25719724,,M,,20250825,,MAXITROL,Therapeutic product effect delayed,OT,MAXITROL | Therapeutic product effect delayed | OT,NaT
257198131,25719813,,F,2025-01-01,20250825,,FENFLURAMINE HYDROCHLORIDE,Product use in unapproved indication,HO,FENFLURAMINE HYDROCHLORIDE | Product use in unapproved indication | HO,2024-12-30/2025-01-05
257199061,25719906,64,M,2025-07-14,20250825,,GUSELKUMAB,Hypersensitivity pneumonitis,HO,GUSELKUMAB | Hypersensitivity pneumonitis | HO,2025-07-14/2025-07-20
257199501,25719950,70,M,,20250825,,LENALIDOMIDE,Prostate cancer,OT,LENALIDOMIDE | Prostate cancer | OT,NaT
257199811,25719981,44,F,2025-01-01,20250825,,DUPIXENT,Injection site swelling,,DUPIXENT | Injection site swelling,2024-12-30/2025-01-05
257199881,25719988,13,F,,20250825,,DUPIXENT,Incorrect dose administered,,DUPIXENT | Incorrect dose administered,NaT
257200001,25720000,85,M,,20250825,,GOSERELIN,Blood phosphorus decreased,HO,GOSERELIN | Blood phosphorus decreased | HO,NaT
257200061,25720006,,M,,20250825,,OMNITROPE,Device breakage,,OMNITROPE | Device breakage,NaT
257200621,25720062,74,F,,20250825,,ZEPBOUND,Abdominal pain upper,,ZEPBOUND | Abdominal pain upper,NaT
257201121,25720112,87,,,20250825,,ELIQUIS,Treatment noncompliance,,ELIQUIS | Treatment noncompliance,NaT
257201351,25720135,68,F,2024-11-13,20250825,,IMDELLTRA,Neutropenia,OT,IMDELLTRA | Neutropenia | OT,2024-11-11/2024-11-17
257201601,25720160,83,F,,20250825,,CAYSTON,Product use in unapproved indication,,CAYSTON | Product use in unapproved indication,NaT
257201891,25720189,,F,2025-08-12,20250825,,DIANEAL,Death,OT,DIANEAL | Death | OT,2025-08-11/2025-08-17
257201901,25720190,8,M,,20250825,,DIANEAL PD-2 WITH DEXTROSE,Infection,HO,DIANEAL PD-2 WITH DEXTROSE | Infection | HO,NaT
257202091,25720209,38,M,2025-08-19,20250825,,HYRIMOZ,Device malfunction,,HYRIMOZ | Device malfunction,2025-08-18/2025-08-24
257202412,25720241,,F,,20250904,,NUPLAZID,Dementia with Lewy bodies,OT,NUPLAZID | Dementia with Lewy bodies | OT,NaT
257203141,25720314,64,M,2022-01-01,20250825,,POLYMYXIN B,Condition aggravated,DE,POLYMYXIN B | Condition aggravated | DE,2021-12-27/2022-01-02
257203221,25720322,92,F,2025-01-01,20250825,,ABALOPARATIDE,Fall,HO,ABALOPARATIDE | Fall | HO,2024-12-30/2025-01-05
257203661,25720366,,F,,20250825,,SKYRIZI,General symptom,HO,SKYRIZI | General symptom | HO,NaT
257204011,25720401,85,M,,20250825,,ORGOVYX,Constipation,,ORGOVYX | Constipation,NaT
257204171,25720417,68,F,2025-07-01,20250825,,ORENCIA,Pain in extremity,,ORENCIA | Pain in extremity,2025-06-30/2025-07-06
257204271,25720427,58,F,2025-08-04,20250825,,CAPECITABINE,Muscle spasms,OT,CAPECITABINE | Muscle spasms | OT,2025-08-04/2025-08-10
257204311,25720431,,M,,20250825,,MYCOPHENOLATE MOFETIL,Dialysis,OT,MYCOPHENOLATE MOFETIL | Dialysis | OT,NaT
257204521,25720452,,F,,20250825,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
257204901,25720490,37,F,,20250825,,TECENTRIQ,Death,DE,TECENTRIQ | Death | DE,NaT
257206703,25720670,53,M,2025-07-11,20250906,,ERELZI,Feeling abnormal,OT,ERELZI | Feeling abnormal | OT,2025-07-07/2025-07-13
257207392,25720739,34,F,,20250829,,VERZENIO,Abdominal pain,,VERZENIO | Abdominal pain,NaT
257207591,25720759,,,,20250825,,OPSUMIT,Hospitalisation,HO,OPSUMIT | Hospitalisation | HO,NaT
257208751,25720875,44,M,,20250825,,AZATHIOPRINE,Abdominal abscess,OT,AZATHIOPRINE | Abdominal abscess | OT,NaT
257208972,25720897,79,M,,20250912,,ORGOVYX,Pain in extremity,,ORGOVYX | Pain in extremity,NaT
257209191,25720919,,F,,20250825,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
257211151,25721115,11,M,2025-08-22,20250822,,ENDARI,Bone marrow transplant,,ENDARI | Bone marrow transplant,2025-08-18/2025-08-24
257212081,25721208,73,F,,20250825,,EYLEA,Intraocular pressure increased,OT,EYLEA | Intraocular pressure increased | OT,NaT
257212521,25721252,48,F,2025-08-22,20250822,,BUPRENORPHINE\NALOXONE,Nausea,OT,BUPRENORPHINE\NALOXONE | Nausea | OT,2025-08-18/2025-08-24
257212771,25721277,,M,,20250825,,CLOZARIL,Hospitalisation,HO,CLOZARIL | Hospitalisation | HO,NaT
257213871,25721387,,M,,20250825,,TREMFYA,Confusional state,OT,TREMFYA | Confusional state | OT,NaT
257214032,25721403,86,F,,20250830,,SIMPONI,Herpes zoster,HO,SIMPONI | Herpes zoster | HO,NaT
257214141,25721414,70,M,,20250825,,POMALYST,Diarrhoea,,POMALYST | Diarrhoea,NaT
257216101,25721610,,F,,20250825,,CARBAMAZEPINE,Thyroid function test abnormal,,CARBAMAZEPINE | Thyroid function test abnormal,NaT
257218341,25721834,76,F,2025-07-14,20250825,,LINZESS,Gastrointestinal disorder,OT,LINZESS | Gastrointestinal disorder | OT,2025-07-14/2025-07-20
257218721,25721872,61,M,,20250825,,SILDENAFIL,Aneurysm ruptured,DE,SILDENAFIL | Aneurysm ruptured | DE,NaT
257218911,25721891,,,,20250825,,INFLIXIMAB,Gastrointestinal lymphoma,OT,INFLIXIMAB | Gastrointestinal lymphoma | OT,NaT
257219131,25721913,86,M,,20250823,,VENCLEXTA,Death,DE,VENCLEXTA | Death | DE,NaT
257219691,25721969,,,,20250825,,INFLIXIMAB,Intentional product use issue,OT,INFLIXIMAB | Intentional product use issue | OT,NaT
257220601,25722060,68,F,2025-08-13,20250825,,UPADACITINIB,Cerebrovascular accident,OT,UPADACITINIB | Cerebrovascular accident | OT,2025-08-11/2025-08-17
257221121,25722112,,,2018-02-20,20250825,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,2018-02-19/2018-02-25
257222762,25722276,57,F,,20250902,,OPDIVO,Pneumonia aspiration,OT,OPDIVO | Pneumonia aspiration | OT,NaT
257222791,25722279,69,F,2025-08-07,20250825,,REVLIMID,White blood cell count decreased,,REVLIMID | White blood cell count decreased,2025-08-04/2025-08-10
257223131,25722313,57,F,2025-07-17,20250825,,MOUNJARO,Cholangitis,OT,MOUNJARO | Cholangitis | OT,2025-07-14/2025-07-20
257223401,25722340,,,,20250825,,INSULIN LISPRO,Visual impairment,,INSULIN LISPRO | Visual impairment,NaT
257223842,25722384,,,,20250916,,BICILLIN L-A,Recalled product administered,,BICILLIN L-A | Recalled product administered,NaT
257224211,25722421,31,F,2024-02-07,20250825,,SIROLIMUS,Lipid metabolism disorder,OT,SIROLIMUS | Lipid metabolism disorder | OT,2024-02-05/2024-02-11
257224431,25722443,,F,,20250825,,INVEGA TRINZA,Product dose omission issue,,INVEGA TRINZA | Product dose omission issue,NaT
257224871,25722487,,F,,20250825,,DIANEAL,Chronic kidney disease,DE,DIANEAL | Chronic kidney disease | DE,NaT
257225331,25722533,62,F,2025-01-01,20250825,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2024-12-30/2025-01-05
257226164,25722616,42,F,2025-08-12,20250911,,PAXLOVID,Electrocardiogram QT prolonged,OT,PAXLOVID | Electrocardiogram QT prolonged | OT,2025-08-11/2025-08-17
257226202,25722620,63,M,,20250903,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,NaT
257226471,25722647,66,M,2025-08-18,20250825,,SACITUZUMAB GOVITECAN-HZIY,Death,DE,SACITUZUMAB GOVITECAN-HZIY | Death | DE,2025-08-18/2025-08-24
257226831,25722683,29,F,2025-07-29,20250825,,FLUOXETINE,Muscle twitching,OT,FLUOXETINE | Muscle twitching | OT,2025-07-28/2025-08-03
257227091,25722709,,M,,20250825,,DISOPYRAMIDE PHOSPHATE,Product use issue,,DISOPYRAMIDE PHOSPHATE | Product use issue,NaT
257227652,25722765,81,,,20250911,,TAGRISSO,Cardiac failure acute,LT,TAGRISSO | Cardiac failure acute | LT,NaT
257229101,25722910,68,F,2025-08-11,20250825,,RINVOQ,COVID-19,HO,RINVOQ | COVID-19 | HO,2025-08-11/2025-08-17
257229111,25722911,,F,,20250825,,HUMAN IMMUNOGLOBULIN G,Psychomotor skills impaired,HO,HUMAN IMMUNOGLOBULIN G | Psychomotor skills impaired | HO,NaT
257229201,25722920,40,M,,20250825,,BIMZELX,Sepsis,OT,BIMZELX | Sepsis | OT,NaT
257229501,25722950,,F,,20250825,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
257230181,25723018,65,M,2025-06-15,20250825,,LORLATINIB,Psychotic disorder,OT,LORLATINIB | Psychotic disorder | OT,2025-06-09/2025-06-15
257231071,25723107,,F,,20250825,,METHOTREXATE SODIUM,Chronic obstructive pulmonary disease,OT,METHOTREXATE SODIUM | Chronic obstructive pulmonary disease | OT,NaT
257231352,25723135,20,M,,20250828,,COBENFY,Blood alkaline phosphatase increased,,COBENFY | Blood alkaline phosphatase increased,NaT
257231431,25723143,50,M,2025-07-28,20250825,,TALTZ,Myalgia,,TALTZ | Myalgia,2025-07-28/2025-08-03
257231541,25723154,,,2025-07-10,20250825,,NEMLUVIO,Inappropriate schedule of product administration,,NEMLUVIO | Inappropriate schedule of product administration,2025-07-07/2025-07-13
257232151,25723215,,F,,20250822,,TEZSPIRE,Dizziness,HO,TEZSPIRE | Dizziness | HO,NaT
257232371,25723237,,F,,20250823,,TADALAFIL,Haemorrhagic stroke,HO,TADALAFIL | Haemorrhagic stroke | HO,NaT
257232381,25723238,,F,,20250823,,WINREVAIR,Haemorrhagic stroke,HO,WINREVAIR | Haemorrhagic stroke | HO,NaT
257232971,25723297,,,,20250825,,DOXORUBICIN HYDROCHLORIDE,Death,OT,DOXORUBICIN HYDROCHLORIDE | Death | OT,NaT
257233301,25723330,,M,2025-03-01,20250825,,VOCABRIA,Staphylococcal infection,OT,VOCABRIA | Staphylococcal infection | OT,2025-02-24/2025-03-02
257233371,25723337,32,F,2025-07-20,20250825,,ACETAMINOPHEN,Prothrombin time ratio decreased,HO,ACETAMINOPHEN | Prothrombin time ratio decreased | HO,2025-07-14/2025-07-20
257234231,25723423,,,,20250825,,GLIPIZIDE,Laboratory test abnormal,,GLIPIZIDE | Laboratory test abnormal,NaT
257234271,25723427,81,M,,20250825,,ELIQUIS,Impaired healing,,ELIQUIS | Impaired healing,NaT
257236501,25723650,74,F,,20250825,,ACYCLOVIR,Ophthalmic herpes zoster,OT,ACYCLOVIR | Ophthalmic herpes zoster | OT,NaT
257236552,25723655,78,F,2025-01-28,20250911,,BIVIGAM,Anaphylactic shock,OT,BIVIGAM | Anaphylactic shock | OT,2025-01-27/2025-02-02
257237591,25723759,,F,2025-08-08,20250825,,RIBOCICLIB,Rash,HO,RIBOCICLIB | Rash | HO,2025-08-04/2025-08-10
257237752,25723775,,F,2025-03-28,20250911,,KISQALI,Pruritus,OT,KISQALI | Pruritus | OT,2025-03-24/2025-03-30
257237911,25723791,40,F,,20250825,,WELIREG,Drug ineffective,,WELIREG | Drug ineffective,NaT
257238141,25723814,66,M,,20250825,,CYCLOSPORINE,Hypoaesthesia,HO,CYCLOSPORINE | Hypoaesthesia | HO,NaT
257238601,25723860,,F,,20250825,,CREON,Therapeutic product effect incomplete,OT,CREON | Therapeutic product effect incomplete | OT,NaT
257238842,25723884,83,M,2025-08-06,20250929,,ENTRESTO,Laryngeal oedema,HO,ENTRESTO | Laryngeal oedema | HO,2025-08-04/2025-08-10
257239401,25723940,53,F,,20250825,,SODIUM ZIRCONIUM CYCLOSILICATE,Cardiac failure,OT,SODIUM ZIRCONIUM CYCLOSILICATE | Cardiac failure | OT,NaT
257239541,25723954,,,2025-08-01,20250825,,LENALIDOMIDE,Rash,,LENALIDOMIDE | Rash,2025-07-28/2025-08-03
257240401,25724040,15,M,2025-08-19,20250826,,SOLIRIS,Cardiac arrest,OT,SOLIRIS | Cardiac arrest | OT,2025-08-18/2025-08-24
257241591,25724159,,M,,20250826,,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Product dose omission issue,OT,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN | Product dose omission issue | OT,NaT
257242991,25724299,58,F,,20250826,,HIZENTRA,Hospitalisation,HO,HIZENTRA | Hospitalisation | HO,NaT
257243701,25724370,,,,20250826,,EVENITY,Cardiac failure,OT,EVENITY | Cardiac failure | OT,NaT
257244291,25724429,75,F,,20250826,,TRULICITY,Product storage error,,TRULICITY | Product storage error,NaT
257244721,25724472,,M,,20250826,,ACTEMRA ACTPEN,Needle issue,,ACTEMRA ACTPEN | Needle issue,NaT
257244971,25724497,,F,,20250826,,SIMPONI ARIA,Drug ineffective,HO,SIMPONI ARIA | Drug ineffective | HO,NaT
257245041,25724504,,,,20250826,,ADALIMUMAB,Headache,OT,ADALIMUMAB | Headache | OT,NaT
257246981,25724698,,,,20250826,,TEPEZZA,Graves' disease,OT,TEPEZZA | Graves' disease | OT,NaT
257247331,25724733,,M,,20250826,,REPATHA,Low density lipoprotein increased,DE,REPATHA | Low density lipoprotein increased | DE,NaT
257247701,25724770,59,M,2022-01-01,20250826,,MYCOPHENOLIC ACID,COVID-19,OT,MYCOPHENOLIC ACID | COVID-19 | OT,2021-12-27/2022-01-02
257249581,25724958,,F,,20250826,,CREXONT,Product substitution issue,,CREXONT | Product substitution issue,NaT
257249601,25724960,67,F,2025-06-01,20250826,,CREXONT,Product use issue,,CREXONT | Product use issue,2025-05-26/2025-06-01
257249661,25724966,81,F,2025-01-01,20250826,,MYRBETRIQ,Blood pressure systolic increased,,MYRBETRIQ | Blood pressure systolic increased,2024-12-30/2025-01-05
257249881,25724988,,,2025-08-01,20250826,,CATHFLO ACTIVASE,No adverse event,,CATHFLO ACTIVASE | No adverse event,2025-07-28/2025-08-03
257250031,25725003,,F,,20250826,,LOSARTAN,Medication error,OT,LOSARTAN | Medication error | OT,NaT
257250521,25725052,23,M,,20250826,,PREGABALIN,Substance abuse,OT,PREGABALIN | Substance abuse | OT,NaT
257250561,25725056,67,,2025-03-01,20250826,,CREXONT,Psychomotor hyperactivity,,CREXONT | Psychomotor hyperactivity,2025-02-24/2025-03-02
257251401,25725140,,M,,20250826,,OCREVUS,Herpes zoster,,OCREVUS | Herpes zoster,NaT
257252281,25725228,50,F,2025-08-01,20250826,,BORTEZOMIB,Hyperlipasaemia,HO,BORTEZOMIB | Hyperlipasaemia | HO,2025-07-28/2025-08-03
257253131,25725313,,,,20250826,,ZEPBOUND,Diarrhoea,HO,ZEPBOUND | Diarrhoea | HO,NaT
257253692,25725369,63,M,2025-08-08,20250912,,LENALIDOMIDE,Plasma cell myeloma,OT,LENALIDOMIDE | Plasma cell myeloma | OT,2025-08-04/2025-08-10
257254381,25725438,73,F,2025-08-15,20250826,,FLUORESCITE,Cough,OT,FLUORESCITE | Cough | OT,2025-08-11/2025-08-17
257254901,25725490,60,F,2022-02-24,20250826,,LETROZOLE,Malignant neoplasm progression,DE,LETROZOLE | Malignant neoplasm progression | DE,2022-02-21/2022-02-27
257255122,25725512,,F,2025-01-01,20250905,,ARIKAYCE,Mental disorder,HO,ARIKAYCE | Mental disorder | HO,2024-12-30/2025-01-05
257255891,25725589,,M,2024-08-07,20250826,,ATORVASTATIN,Diabetes mellitus,OT,ATORVASTATIN | Diabetes mellitus | OT,2024-08-05/2024-08-11
257255941,25725594,68,M,2025-08-22,20250826,,SPRAVATO,Dissociation,OT,SPRAVATO | Dissociation | OT,2025-08-18/2025-08-24
257256591,25725659,79,F,2024-10-03,20250826,,RITUXIMAB,Hypokalaemia,OT,RITUXIMAB | Hypokalaemia | OT,2024-09-30/2024-10-06
257257451,25725745,70,F,2025-06-01,20250826,,DUPIXENT,Psoriatic arthropathy,OT,DUPIXENT | Psoriatic arthropathy | OT,2025-05-26/2025-06-01
257258383,25725838,45,F,2025-08-19,20250922,,MIRENA,Complication of device insertion,OT,MIRENA | Complication of device insertion | OT,2025-08-18/2025-08-24
257258591,25725859,14,F,,20250826,,SERTRALINE,Nausea,OT,SERTRALINE | Nausea | OT,NaT
257258862,25725886,,M,,20250911,,ILUMYA,Tuberculosis,OT,ILUMYA | Tuberculosis | OT,NaT
257259041,25725904,35,M,,20250826,,CLINDAMYCIN,Condition aggravated,OT,CLINDAMYCIN | Condition aggravated | OT,NaT
257259302,25725930,20,F,2025-01-01,20250929,,RINVOQ,Mania,HO,RINVOQ | Mania | HO,2024-12-30/2025-01-05
257261251,25726125,6,M,,20250826,,METHYLPREDNISOLONE SODIUM SUCCINATE,Drug ineffective,HO,METHYLPREDNISOLONE SODIUM SUCCINATE | Drug ineffective | HO,NaT
257261441,25726144,,,,20250826,,BESREMI,Product use complaint,,BESREMI | Product use complaint,NaT
257261561,25726156,70,M,,20250826,,LENVATINIB,Urinary tract infection,HO,LENVATINIB | Urinary tract infection | HO,NaT
257262371,25726237,62,M,,20250826,,DUPIXENT,Exposure via skin contact,,DUPIXENT | Exposure via skin contact,NaT
257262491,25726249,47,F,2025-01-01,20250826,,DUPIXENT,Vision blurred,,DUPIXENT | Vision blurred,2024-12-30/2025-01-05
257262511,25726251,79,F,,20250826,,DUPIXENT,Cough,,DUPIXENT | Cough,NaT
257262711,25726271,71,M,2025-01-01,20250826,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,2024-12-30/2025-01-05
257262802,25726280,42,M,2025-01-01,20250915,,DUPIXENT,Dermatitis allergic,,DUPIXENT | Dermatitis allergic,2024-12-30/2025-01-05
257263011,25726301,,F,,20250826,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,NaT
257263681,25726368,,F,2025-08-01,20250826,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,2025-07-28/2025-08-03
257263741,25726374,,F,2025-01-01,20250826,,DUPIXENT,Arthralgia,,DUPIXENT | Arthralgia,2024-12-30/2025-01-05
257265001,25726500,83,M,,20250826,,ELIQUIS,Post procedural haematoma,,ELIQUIS | Post procedural haematoma,NaT
257265121,25726512,65,F,,20250826,,ARIKAYCE,Mycobacterium avium complex infection,OT,ARIKAYCE | Mycobacterium avium complex infection | OT,NaT
257265421,25726542,,M,,20250826,,RISPERIDONE,Drug ineffective,,RISPERIDONE | Drug ineffective,NaT
257266082,25726608,77,F,,20250828,,PAXLOVID,Dysgeusia,,PAXLOVID | Dysgeusia,NaT
257268001,25726800,96,M,2022-01-22,20250825,,WARFARIN,Asthenia,HO,WARFARIN | Asthenia | HO,2022-01-17/2022-01-23
257268031,25726803,,,2022-02-14,20250825,,APIXABAN,Cerebrovascular accident,HO,APIXABAN | Cerebrovascular accident | HO,2022-02-14/2022-02-20
257268331,25726833,58,F,,20250826,,METHOTREXATE SODIUM,Crohn's disease,OT,METHOTREXATE SODIUM | Crohn's disease | OT,NaT
257268451,25726845,62,M,2025-02-11,20250826,,HEPARIN SODIUM,Drug ineffective,,HEPARIN SODIUM | Drug ineffective,2025-02-10/2025-02-16
257269281,25726928,54,F,,20250826,,PAXLOVID,COVID-19,,PAXLOVID | COVID-19,NaT
257269291,25726929,81,M,2022-05-21,20250825,,WARFARIN,Contusion,HO,WARFARIN | Contusion | HO,2022-05-16/2022-05-22
257269851,25726985,87,F,,20250826,,DUPIXENT,Fall,,DUPIXENT | Fall,NaT
257270571,25727057,62,M,,20250825,,UDENYCA,Death,DE,UDENYCA | Death | DE,NaT
257272032,25727203,,,2025-07-10,20250828,,ENBREL,Needle issue,,ENBREL | Needle issue,2025-07-07/2025-07-13
257272591,25727259,70,M,2025-03-07,20250826,,DAPTOMYCIN,Pancreatitis,HO,DAPTOMYCIN | Pancreatitis | HO,2025-03-03/2025-03-09
257272821,25727282,76,M,2025-08-17,20250826,,SODIUM ZIRCONIUM CYCLOSILICATE,Chills,HO,SODIUM ZIRCONIUM CYCLOSILICATE | Chills | HO,2025-08-11/2025-08-17
257273042,25727304,67,F,2025-08-01,20250918,,PROLASTIN-C LIQUID,Herpes zoster,,PROLASTIN-C LIQUID | Herpes zoster,2025-07-28/2025-08-03
257273321,25727332,,F,,20250826,,DUPIXENT,Accidental exposure to product,,DUPIXENT | Accidental exposure to product,NaT
257273541,25727354,70,M,2025-08-10,20250826,,MOUNJARO,Extra dose administered,,MOUNJARO | Extra dose administered,2025-08-04/2025-08-10
257273761,25727376,53,F,2025-06-03,20250826,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,2025-06-02/2025-06-08
257273811,25727381,65,F,,20250826,,KEYTRUDA,Discomfort,OT,KEYTRUDA | Discomfort | OT,NaT
257276445,25727644,,M,2025-01-01,20250927,,TYVASO DPI,Rhinorrhoea,OT,TYVASO DPI | Rhinorrhoea | OT,2024-12-30/2025-01-05
257276941,25727694,,M,,20250826,,HUMALOG MIX75/25,Dementia Alzheimer's type,OT,HUMALOG MIX75/25 | Dementia Alzheimer's type | OT,NaT
257277042,25727704,,F,,20250908,,FLUOXETINE,Depression,OT,FLUOXETINE | Depression | OT,NaT
257277352,25727735,,F,,20250915,,CREON,Craniofacial fracture,OT,CREON | Craniofacial fracture | OT,NaT
257278131,25727813,65,F,2025-08-15,20250826,,FLUOROURACIL,Dysuria,HO,FLUOROURACIL | Dysuria | HO,2025-08-11/2025-08-17
257278531,25727853,,,2025-08-25,20250826,,KEPPRA,Treatment failure,,KEPPRA | Treatment failure,2025-08-25/2025-08-31
257278711,25727871,36,,,20250826,,JAKAFI,Pneumonia,HO,JAKAFI | Pneumonia | HO,NaT
257279221,25727922,8,,2025-08-21,20250826,,DUPIXENT,Accidental exposure to product,,DUPIXENT | Accidental exposure to product,2025-08-18/2025-08-24
257279631,25727963,50,M,,20250826,,POMALYST,Product dose omission issue,,POMALYST | Product dose omission issue,NaT
257279711,25727971,76,F,2025-01-01,20250826,,XIIDRA,Circumstance or information capable of leading to medication error,,XIIDRA | Circumstance or information capable of leading to medication error,2024-12-30/2025-01-05
257279811,25727981,48,F,2025-08-16,20250826,,MOUNJARO,Malaise,OT,MOUNJARO | Malaise | OT,2025-08-11/2025-08-17
257279991,25727999,,,,20250826,,OMEPRAZOLE AND SODIUM BICARBONATE,Drug effect less than expected,,OMEPRAZOLE AND SODIUM BICARBONATE | Drug effect less than expected,NaT
257280591,25728059,10,F,,20250826,,GEMCITABINE,Thrombocytopenia,OT,GEMCITABINE | Thrombocytopenia | OT,NaT
257281671,25728167,,,,20250826,,PREDNISONE,Renal failure,OT,PREDNISONE | Renal failure | OT,NaT
257283411,25728341,77,M,2025-06-27,20250826,,CYCLOPHOSPHAMIDE,Cytokine release syndrome,HO,CYCLOPHOSPHAMIDE | Cytokine release syndrome | HO,2025-06-23/2025-06-29
257283801,25728380,,,,20250826,,ELREXFIO,Headache,,ELREXFIO | Headache,NaT
257283851,25728385,86,,,20250826,,PALBOCICLIB,Toxicity to various agents,OT,PALBOCICLIB | Toxicity to various agents | OT,NaT
257284991,25728499,,F,,20250826,,METHOTREXATE,Syncope,OT,METHOTREXATE | Syncope | OT,NaT
257285491,25728549,,F,,20250826,,HUMIRA,Drug ineffective,,HUMIRA | Drug ineffective,NaT
257287611,25728761,48,M,,20250826,,MIDOMAFETAMINE,Drug diversion,OT,MIDOMAFETAMINE | Drug diversion | OT,NaT
257287731,25728773,,,,20250826,,CALCIUM,Wrong technique in device usage process,,CALCIUM | Wrong technique in device usage process,NaT
257287831,25728783,,,,20250826,,YORVIPATH,Injection site reaction,,YORVIPATH | Injection site reaction,NaT
257287841,25728784,,,,20250826,,YORVIPATH,Dyspnoea,,YORVIPATH | Dyspnoea,NaT
257288751,25728875,,,,20250826,,ICATIBANT,Therapeutic product effect incomplete,HO,ICATIBANT | Therapeutic product effect incomplete | HO,NaT
257289401,25728940,73,F,2024-09-16,20250826,,VENETOCLAX,Death,DE,VENETOCLAX | Death | DE,2024-09-16/2024-09-22
257289761,25728976,,,,20250826,,SYNTHROID,Abnormal behaviour,,SYNTHROID | Abnormal behaviour,NaT
257290331,25729033,,,,20250827,,VENETOCLAX,Myelosuppression,OT,VENETOCLAX | Myelosuppression | OT,NaT
257291571,25729157,,F,,20250827,,SKYRIZI,Hernia,OT,SKYRIZI | Hernia | OT,NaT
257291651,25729165,,F,,20250827,,REFRESH CLASSIC,Cataract,OT,REFRESH CLASSIC | Cataract | OT,NaT
257292221,25729222,16,F,2025-08-06,20250827,,IBUPROFEN,Peritonsillar abscess,OT,IBUPROFEN | Peritonsillar abscess | OT,2025-08-04/2025-08-10
257292761,25729276,60,,,20250827,,ZEPBOUND,Wrong technique in product usage process,,ZEPBOUND | Wrong technique in product usage process,NaT
257293001,25729300,,F,,20250827,,PENICILLIN G SODIUM,Hypersensitivity,,PENICILLIN G SODIUM | Hypersensitivity,NaT
257293361,25729336,,,,20250827,,CARVYKTI,Fear,,CARVYKTI | Fear,NaT
257293532,25729353,,F,2025-01-01,20250926,,EYLEA HD,Polymyositis,OT,EYLEA HD | Polymyositis | OT,2024-12-30/2025-01-05
257294301,25729430,,F,2025-05-01,20250827,,VIVITROL,Drug ineffective,,VIVITROL | Drug ineffective,2025-04-28/2025-05-04
257294801,25729480,,,,20250827,,VABYSMO,Blindness,OT,VABYSMO | Blindness | OT,NaT
257295101,25729510,52,F,2025-08-22,20250827,,ZEPBOUND,Accidental underdose,,ZEPBOUND | Accidental underdose,2025-08-18/2025-08-24
257295821,25729582,78,F,2024-11-01,20250827,,RINVOQ,Hypoaesthesia,OT,RINVOQ | Hypoaesthesia | OT,2024-10-28/2024-11-03
257296031,25729603,,F,,20250827,,OCREVUS,Liver disorder,DE,OCREVUS | Liver disorder | DE,NaT
257296672,25729667,,,,20250909,,EVRYSDI,Pancreatitis acute,OT,EVRYSDI | Pancreatitis acute | OT,NaT
257296741,25729674,,,2025-06-22,20250827,,BEVACIZUMAB,Colitis ulcerative,HO,BEVACIZUMAB | Colitis ulcerative | HO,2025-06-16/2025-06-22
257297171,25729717,39,F,2025-05-01,20250827,,TRASTUZUMAB,Ejection fraction decreased,OT,TRASTUZUMAB | Ejection fraction decreased | OT,2025-04-28/2025-05-04
257297291,25729729,72,M,2025-07-29,20250826,,LENALIDOMIDE,Deep vein thrombosis,HO,LENALIDOMIDE | Deep vein thrombosis | HO,2025-07-28/2025-08-03
257298601,25729860,68,M,2025-07-07,20250827,,IZERVAY,Retinal haemorrhage,OT,IZERVAY | Retinal haemorrhage | OT,2025-07-07/2025-07-13
257298921,25729892,70,F,2024-12-01,20250827,,XYREM,Blood pressure increased,OT,XYREM | Blood pressure increased | OT,2024-11-25/2024-12-01
257299111,25729911,,M,,20250827,,MYCOPHENOLATE MOFETIL,Tuberculosis,HO,MYCOPHENOLATE MOFETIL | Tuberculosis | HO,NaT
257299301,25729930,60,M,,20250827,,LANTUS SOLOSTAR,Product dispensing error,,LANTUS SOLOSTAR | Product dispensing error,NaT
257299701,25729970,29,M,2025-01-01,20250827,,DUPIXENT,Eczema,,DUPIXENT | Eczema,2024-12-30/2025-01-05
257300341,25730034,64,M,,20250827,,LANTUS SOLOSTAR,Off label use,,LANTUS SOLOSTAR | Off label use,NaT
257300461,25730046,82,F,2025-01-01,20250827,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2024-12-30/2025-01-05
257300611,25730061,32,M,2025-01-01,20250827,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2024-12-30/2025-01-05
257300621,25730062,,M,,20250827,,DUPIXENT,Peripheral swelling,,DUPIXENT | Peripheral swelling,NaT
257301401,25730140,,,2025-06-18,20250827,,ACETAMINOPHEN,Hepatitis fulminant,LT,ACETAMINOPHEN | Hepatitis fulminant | LT,2025-06-16/2025-06-22
257301501,25730150,,F,,20250827,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Death,DE,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Death | DE,NaT
257301941,25730194,61,M,2025-07-01,20250827,,ORENCIA,Joint swelling,,ORENCIA | Joint swelling,2025-06-30/2025-07-06
257302041,25730204,54,M,2025-08-08,20250827,,TECENTRIQ,Death,DE,TECENTRIQ | Death | DE,2025-08-04/2025-08-10
257302701,25730270,,F,,20250827,,RYSTIGGO,Abdominal distension,,RYSTIGGO | Abdominal distension,NaT
257303151,25730315,43,M,2025-01-01,20250827,,DUPIXENT,Arthralgia,,DUPIXENT | Arthralgia,2024-12-30/2025-01-05
257305621,25730562,,M,,20250827,,DUPIXENT,Injection site reaction,,DUPIXENT | Injection site reaction,NaT
257305762,25730576,77,F,,20250831,,LENALIDOMIDE,Laboratory test abnormal,,LENALIDOMIDE | Laboratory test abnormal,NaT
257305821,25730582,50,F,,20250827,,ESOMEPRAZOLE,Respiratory disorder,OT,ESOMEPRAZOLE | Respiratory disorder | OT,NaT
257306221,25730622,41,F,2025-08-22,20250825,,LACTATED RINGERS SOLUTION,Epistaxis,,LACTATED RINGERS SOLUTION | Epistaxis,2025-08-18/2025-08-24
257306231,25730623,,M,,20250827,,OMNITROPE,Circumstance or information capable of leading to device use error,,OMNITROPE | Circumstance or information capable of leading to device use error,NaT
257307421,25730742,48,F,2025-08-08,20250827,,MOUNJARO,Diarrhoea,OT,MOUNJARO | Diarrhoea | OT,2025-08-04/2025-08-10
257308041,25730804,36,M,2025-08-01,20250827,,DUPIXENT,Injection site haemorrhage,,DUPIXENT | Injection site haemorrhage,2025-07-28/2025-08-03
257308751,25730875,,M,,20250827,,TOLVAPTAN,Muscle spasms,HO,TOLVAPTAN | Muscle spasms | HO,NaT
257308911,25730891,63,F,,20250827,,VABYSMO,Emotional distress,OT,VABYSMO | Emotional distress | OT,NaT
257309331,25730933,58,F,2025-07-20,20250827,,CLOZAPINE,Hypoxia,HO,CLOZAPINE | Hypoxia | HO,2025-07-14/2025-07-20
257309511,25730951,56,F,2025-08-01,20250826,,VERZENIO,Hypoglycaemia,,VERZENIO | Hypoglycaemia,2025-07-28/2025-08-03
257310011,25731001,73,F,,20250827,,CORTICOTROPIN,Rash,,CORTICOTROPIN | Rash,NaT
257310461,25731046,67,M,2025-03-01,20250827,,RUBRACA,Fluid imbalance,HO,RUBRACA | Fluid imbalance | HO,2025-02-24/2025-03-02
257310792,25731079,54,F,,20250925,,CORTICOTROPIN,Fatigue,,CORTICOTROPIN | Fatigue,NaT
257310851,25731085,,M,,20250827,,CORTICOTROPIN,Swelling,,CORTICOTROPIN | Swelling,NaT
257311081,25731108,,,,20250827,,FINTEPLA,Epilepsy,OT,FINTEPLA | Epilepsy | OT,NaT
257311941,25731194,,,,20250827,,YORVIPATH,Bone density decreased,,YORVIPATH | Bone density decreased,NaT
257312191,25731219,45,F,,20250827,,MOUNJARO,Metabolic alkalosis,HO,MOUNJARO | Metabolic alkalosis | HO,NaT
257312731,25731273,69,F,,20250827,,LENVIMA,Pancreatitis,OT,LENVIMA | Pancreatitis | OT,NaT
257313162,25731316,43,F,2025-08-05,20250829,,IBRANCE,Pyelonephritis,HO,IBRANCE | Pyelonephritis | HO,2025-08-04/2025-08-10
257313901,25731390,,,,20250827,,ADDERALL,Fatigue,,ADDERALL | Fatigue,NaT
257314461,25731446,70,M,2025-08-15,20250827,,METHOTREXATE SODIUM,Acute kidney injury,HO,METHOTREXATE SODIUM | Acute kidney injury | HO,2025-08-11/2025-08-17
257314683,25731468,54,F,2025-08-01,20250908,,DUPIXENT,Myalgia,,DUPIXENT | Myalgia,2025-07-28/2025-08-03
257314911,25731491,,,2025-08-27,20250827,,CINACALCET,Death,,CINACALCET | Death,2025-08-25/2025-08-31
257315411,25731541,74,M,2025-08-15,20250827,,JANUVIA,Musculoskeletal chest pain,OT,JANUVIA | Musculoskeletal chest pain | OT,2025-08-11/2025-08-17
257315531,25731553,87,F,2024-07-20,20250827,,UPNEEQ,Eye pain,,UPNEEQ | Eye pain,2024-07-15/2024-07-21
257315571,25731557,,F,2024-01-01,20250827,,UPNEEQ,Device physical property issue,,UPNEEQ | Device physical property issue,2024-01-01/2024-01-07
257315731,25731573,63,F,2024-08-11,20250827,,UPNEEQ,Conjunctivitis,,UPNEEQ | Conjunctivitis,2024-08-05/2024-08-11
257316061,25731606,78,F,2024-09-25,20250827,,UPNEEQ,Vision blurred,,UPNEEQ | Vision blurred,2024-09-23/2024-09-29
257316741,25731674,,F,2025-01-01,20250827,,UPNEEQ,Vision blurred,,UPNEEQ | Vision blurred,2024-12-30/2025-01-05
257316781,25731678,74,F,2025-01-01,20250827,,UPNEEQ,Intentional product misuse,,UPNEEQ | Intentional product misuse,2024-12-30/2025-01-05
257316861,25731686,60,F,2025-02-04,20250827,,UPNEEQ,Eyelid oedema,,UPNEEQ | Eyelid oedema,2025-02-03/2025-02-09
257317131,25731713,36,M,2025-03-18,20250827,,UPNEEQ,Eye pruritus,,UPNEEQ | Eye pruritus,2025-03-17/2025-03-23
257317291,25731729,,F,2025-04-01,20250827,,UPNEEQ,Expired product administered,,UPNEEQ | Expired product administered,2025-03-31/2025-04-06
257317301,25731730,64,F,2025-04-01,20250827,,UPNEEQ,Eye infection,,UPNEEQ | Eye infection,2025-03-31/2025-04-06
257317341,25731734,,M,,20250827,,UPNEEQ,Multiple use of single-use product,,UPNEEQ | Multiple use of single-use product,NaT
257318661,25731866,60,F,2025-06-24,20250827,,TRASTUZUMAB DERUXTECAN,Myelosuppression,OT,TRASTUZUMAB DERUXTECAN | Myelosuppression | OT,2025-06-23/2025-06-29
257318691,25731869,75,F,2025-04-01,20250827,,RINVOQ,Headache,,RINVOQ | Headache,2025-03-31/2025-04-06
257319041,25731904,80,M,2021-03-25,20250827,,CAPECITABINE,Neutropenia,OT,CAPECITABINE | Neutropenia | OT,2021-03-22/2021-03-28
257320161,25732016,,M,,20250827,,ELOCTATE,Haemorrhage,,ELOCTATE | Haemorrhage,NaT
257320523,25732052,75,F,,20250902,,CAMZYOS,Dyspnoea,,CAMZYOS | Dyspnoea,NaT
257320891,25732089,,F,2025-01-01,20250827,,INGREZZA,Rash,,INGREZZA | Rash,2024-12-30/2025-01-05
257321091,25732109,67,F,2025-01-01,20250827,,PEMBROLIZUMAB,Pneumonitis,HO,PEMBROLIZUMAB | Pneumonitis | HO,2024-12-30/2025-01-05
257321411,25732141,,,,20250827,,TERIFLUNOMIDE,Malabsorption,,TERIFLUNOMIDE | Malabsorption,NaT
257321491,25732149,35,F,2025-08-27,20250827,,DUPIXENT,Paradoxical drug reaction,,DUPIXENT | Paradoxical drug reaction,2025-08-25/2025-08-31
257321871,25732187,,F,,20250827,,WEGOVY,Thrombosis,OT,WEGOVY | Thrombosis | OT,NaT
257322664,25732266,,F,,20250929,,GENOTROPIN,Viral infection,,GENOTROPIN | Viral infection,NaT
257324271,25732427,62,M,2024-07-11,20250827,,LENVIMA,Haematemesis,HO,LENVIMA | Haematemesis | HO,2024-07-08/2024-07-14
257324721,25732472,55,F,2025-05-01,20250827,,JARDIANCE,Dry mouth,HO,JARDIANCE | Dry mouth | HO,2025-04-28/2025-05-04
257325081,25732508,19,,2025-07-01,20250827,,DRONABINOL,Drug screen positive,OT,DRONABINOL | Drug screen positive | OT,2025-06-30/2025-07-06
257325591,25732559,72,,,20250827,,JAKAFI,Off label use,,JAKAFI | Off label use,NaT
257326931,25732693,,,2025-08-15,20250827,,OPCON-A,Vision blurred,,OPCON-A | Vision blurred,2025-08-11/2025-08-17
257327362,25732736,,F,2025-08-20,20250930,,FOLLITROPIN ALFA,Ligament sprain,OT,FOLLITROPIN ALFA | Ligament sprain | OT,2025-08-18/2025-08-24
257329991,25732999,64,F,2025-07-15,20250828,,TENOFOVIR,Renal tubular acidosis,HO,TENOFOVIR | Renal tubular acidosis | HO,2025-07-14/2025-07-20
257332751,25733275,14,M,2025-08-22,20250828,,OMNITROPE,Injection site haemorrhage,,OMNITROPE | Injection site haemorrhage,2025-08-18/2025-08-24
257333081,25733308,,F,,20250828,,RIBOCICLIB,Off label use,OT,RIBOCICLIB | Off label use | OT,NaT
257334101,25733410,,F,,20250828,,HUMIRA,Anal ulcer,OT,HUMIRA | Anal ulcer | OT,NaT
257334191,25733419,72,F,,20250828,,HUMIRA,Herpes zoster,,HUMIRA | Herpes zoster,NaT
257334871,25733487,44,M,,20250828,,CEFAZOLIN,Product use in unapproved indication,HO,CEFAZOLIN | Product use in unapproved indication | HO,NaT
257336001,25733600,28,F,2025-07-01,20250828,,GABAPENTIN,Polymenorrhoea,OT,GABAPENTIN | Polymenorrhoea | OT,2025-06-30/2025-07-06
257336021,25733602,,F,,20250828,,SPRAVATO,Impaired gastric emptying,OT,SPRAVATO | Impaired gastric emptying | OT,NaT
257336111,25733611,,,,20250828,,CARVYKTI,General physical health deterioration,HO,CARVYKTI | General physical health deterioration | HO,NaT
257337361,25733736,65,M,,20250828,,LYTGOBI,Intestinal obstruction,HO,LYTGOBI | Intestinal obstruction | HO,NaT
257337561,25733756,73,M,,20250828,,MOUNJARO,Product dose omission issue,,MOUNJARO | Product dose omission issue,NaT
257339351,25733935,58,F,,20250828,,TACROLIMUS,Iron deficiency anaemia,HO,TACROLIMUS | Iron deficiency anaemia | HO,NaT
257339431,25733943,60,,2025-08-01,20250828,,ZEPBOUND,Gastrooesophageal reflux disease,,ZEPBOUND | Gastrooesophageal reflux disease,2025-07-28/2025-08-03
257339461,25733946,,,,20250828,,MOUNJARO,Pancreatitis,OT,MOUNJARO | Pancreatitis | OT,NaT
257339681,25733968,,M,,20250828,,TYLENOL,Drug ineffective,,TYLENOL | Drug ineffective,NaT
257340831,25734083,,F,2025-05-01,20250828,,ATORVASTATIN,Medication error,OT,ATORVASTATIN | Medication error | OT,2025-04-28/2025-05-04
257340921,25734092,77,M,2024-11-06,20250828,,POMALYST,Death,DE,POMALYST | Death | DE,2024-11-04/2024-11-10
257340991,25734099,,,,20250828,,CHLORAPREP,Device defective,,CHLORAPREP | Device defective,NaT
257341521,25734152,,F,,20250828,,WOMENS ROGAINE,Alopecia,,WOMENS ROGAINE | Alopecia,NaT
257342081,25734208,,,2025-01-01,20250828,,INFLECTRA,Hyperthyroidism,OT,INFLECTRA | Hyperthyroidism | OT,2024-12-30/2025-01-05
257342841,25734284,,,,20250828,,YORVIPATH,Cardiac failure congestive,OT,YORVIPATH | Cardiac failure congestive | OT,NaT
257343691,25734369,,M,,20250828,,Oral Treprostinil (TREPROSTINIL DIETHANOLAMINE),Product administered to patient of inappropriate age,,Oral Treprostinil (TREPROSTINIL DIETHANOLAMINE) | Product administered to patient of inappropriate age,NaT
257344321,25734432,60,F,,20250828,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
257344981,25734498,60,M,,20250828,,AMIODARONE,Treatment failure,HO,AMIODARONE | Treatment failure | HO,NaT
257345381,25734538,34,M,,20250828,,BUPRENORPHINE,Substance use disorder,LT,BUPRENORPHINE | Substance use disorder | LT,NaT
257346821,25734682,58,F,,20250827,,TALTZ,Vomiting,,TALTZ | Vomiting,NaT
257347191,25734719,,F,,20250828,,IMBRUVICA,Ventricular fibrillation,HO,IMBRUVICA | Ventricular fibrillation | HO,NaT
257347321,25734732,,F,2025-01-01,20250828,,NEXPLANON,Implant site pain,OT,NEXPLANON | Implant site pain | OT,2024-12-30/2025-01-05
257347341,25734734,40,F,2024-08-09,20250828,,PEMBROLIZUMAB,Stomatitis,HO,PEMBROLIZUMAB | Stomatitis | HO,2024-08-05/2024-08-11
257347592,25734759,,,,20250828,,BENLYSTA,Off label use,,BENLYSTA | Off label use,NaT
257349811,25734981,67,M,2025-07-18,20250828,,GABAPENTIN,Fatigue,OT,GABAPENTIN | Fatigue | OT,2025-07-14/2025-07-20
257350171,25735017,,M,,20250828,,XOLAIR,Headache,,XOLAIR | Headache,NaT
257350642,25735064,,M,,20250910,,CORTICOTROPIN,Insomnia,,CORTICOTROPIN | Insomnia,NaT
257351641,25735164,,M,2025-08-01,20250828,,ADEMPAS,Pulmonary embolism,HO,ADEMPAS | Pulmonary embolism | HO,2025-07-28/2025-08-03
257351891,25735189,65,M,2025-07-01,20250828,,VENCLEXTA,Death,DE,VENCLEXTA | Death | DE,2025-06-30/2025-07-06
257351981,25735198,39,F,,20250828,,ORENCIA,General physical health deterioration,,ORENCIA | General physical health deterioration,NaT
257352631,25735263,54,,,20250828,,JAKAFI,Off label use,DE,JAKAFI | Off label use | DE,NaT
257353001,25735300,,,,20250828,,IMDELLTRA,Ill-defined disorder,OT,IMDELLTRA | Ill-defined disorder | OT,NaT
257353301,25735330,,,,20250828,,REMICADE,Off label use,,REMICADE | Off label use,NaT
257353701,25735370,,,,20250828,,HYDROCHLOROTHIAZIDE\LISINOPRIL,No adverse event,,HYDROCHLOROTHIAZIDE\LISINOPRIL | No adverse event,NaT
257354231,25735423,30,M,2025-08-27,20250827,,CORTICOTROPIN,Weight increased,OT,CORTICOTROPIN | Weight increased | OT,2025-08-25/2025-08-31
257355052,25735505,63,F,,20250922,,PERINDOPRIL,Epistaxis,HO,PERINDOPRIL | Epistaxis | HO,NaT
257355201,25735520,,,,20250828,,OMNITROPE,Product knowledge deficit,,OMNITROPE | Product knowledge deficit,NaT
257355751,25735575,51,F,,20250828,,RINVOQ,Hysterectomy,,RINVOQ | Hysterectomy,NaT
257356021,25735602,,,2025-07-01,20250828,,EGRIFTA SV,Product dose omission issue,,EGRIFTA SV | Product dose omission issue,2025-06-30/2025-07-06
257356031,25735603,,,2025-06-01,20250828,,EGRIFTA SV,Product dose omission issue,,EGRIFTA SV | Product dose omission issue,2025-05-26/2025-06-01
257356301,25735630,,,2025-08-27,20250828,,ZEPBOUND,Therapeutic response changed,,ZEPBOUND | Therapeutic response changed,2025-08-25/2025-08-31
257356331,25735633,,,2025-08-16,20250828,,EGRIFTA SV,Frequent bowel movements,,EGRIFTA SV | Frequent bowel movements,2025-08-11/2025-08-17
257356911,25735691,64,F,2025-08-19,20250828,,ALECENSA,Disease progression,OT,ALECENSA | Disease progression | OT,2025-08-18/2025-08-24
257357111,25735711,,,,20250828,,ZEPBOUND,Therapeutic response changed,,ZEPBOUND | Therapeutic response changed,NaT
257357361,25735736,52,F,2025-07-02,20250828,,CARBOPLATIN,Rash erythematous,RI,CARBOPLATIN | Rash erythematous | RI,2025-06-30/2025-07-06
257357411,25735741,,F,2025-07-01,20250828,,BELSOMRA,Product dose omission issue,,BELSOMRA | Product dose omission issue,2025-06-30/2025-07-06
257357991,25735799,39,F,2025-01-01,20250828,,XELJANZ XR,Rheumatoid arthritis,OT,XELJANZ XR | Rheumatoid arthritis | OT,2024-12-30/2025-01-05
257358751,25735875,25,M,2025-02-25,20250828,,ARIPIPRAZOLE,Aphantasia,OT,ARIPIPRAZOLE | Aphantasia | OT,2025-02-24/2025-03-02
257359292,25735929,40,F,,20250915,,BUPROPION,Fatigue,OT,BUPROPION | Fatigue | OT,NaT
257359732,25735973,,F,,20250915,,DAYBUE,Intentional dose omission,,DAYBUE | Intentional dose omission,NaT
257360341,25736034,,,2023-11-14,20250828,,TROGARZO,Flushing,,TROGARZO | Flushing,2023-11-13/2023-11-19
257361041,25736104,,M,,20250828,,DUPIXENT,Nasal congestion,,DUPIXENT | Nasal congestion,NaT
257361581,25736158,69,M,2025-08-01,20250828,,DUPIXENT,Eczema,,DUPIXENT | Eczema,2025-07-28/2025-08-03
257362211,25736221,56,F,2025-01-01,20250828,,DUPIXENT,Arthralgia,,DUPIXENT | Arthralgia,2024-12-30/2025-01-05
257362491,25736249,73,M,,20250828,,DUPIXENT,Sputum increased,,DUPIXENT | Sputum increased,NaT
257362621,25736262,82,M,2025-01-01,20250828,,DUPIXENT,Asthma,,DUPIXENT | Asthma,2024-12-30/2025-01-05
257362731,25736273,,F,2025-01-01,20250828,,DUPIXENT,Conjunctivitis,,DUPIXENT | Conjunctivitis,2024-12-30/2025-01-05
257363411,25736341,2,M,,20250828,,DUPIXENT,Eczema,,DUPIXENT | Eczema,NaT
257363541,25736354,62,M,2025-01-01,20250828,,REZUROCK,Inappropriate schedule of product administration,,REZUROCK | Inappropriate schedule of product administration,2024-12-30/2025-01-05
257364061,25736406,6,F,2025-01-01,20250828,,DUPIXENT,Rebound eczema,,DUPIXENT | Rebound eczema,2024-12-30/2025-01-05
257365141,25736514,36,F,,20250828,,HUMIRA,Nasopharyngitis,,HUMIRA | Nasopharyngitis,NaT
257366141,25736614,63,F,2024-08-15,20250828,,LANTUS,Abdominal distension,HO,LANTUS | Abdominal distension | HO,2024-08-12/2024-08-18
257366321,25736632,,F,,20250828,,LENVIMA,Adrenal insufficiency,HO,LENVIMA | Adrenal insufficiency | HO,NaT
257368221,25736822,40,F,,20250828,,RITUXIMAB,Rash,DE,RITUXIMAB | Rash | DE,NaT
257368302,25736830,,M,,20250829,,SPRAVATO,Cardiac disorder,DE,SPRAVATO | Cardiac disorder | DE,NaT
257368832,25736883,77,F,2025-02-13,20250923,,QINLOCK,Bradycardia,,QINLOCK | Bradycardia,2025-02-10/2025-02-16
257370062,25737006,,F,,20250912,,GENOTROPIN,Device mechanical issue,,GENOTROPIN | Device mechanical issue,NaT
257371952,25737195,,F,2025-01-01,20250904,,BIMZELX,Pneumonia,OT,BIMZELX | Pneumonia | OT,2024-12-30/2025-01-05
257372241,25737224,,F,,20250828,,MAVENCLAD,White blood cell count decreased,OT,MAVENCLAD | White blood cell count decreased | OT,NaT
257373181,25737318,52,F,,20250828,,ORENCIA,Drug interaction,,ORENCIA | Drug interaction,NaT
257375111,25737511,9,F,,20250828,,FRUZAQLA,Colorectal cancer,OT,FRUZAQLA | Colorectal cancer | OT,NaT
257376711,25737671,,M,,20250828,,HUMIRA,Cough,,HUMIRA | Cough,NaT
257376931,25737693,,,2024-01-01,20250828,,JORNAY PM EXTENDED-RELEASE,Drug ineffective,,JORNAY PM EXTENDED-RELEASE | Drug ineffective,2024-01-01/2024-01-07
257377731,25737773,,M,,20250828,,JORNAY PM EXTENDED-RELEASE,Therapeutic product effect incomplete,,JORNAY PM EXTENDED-RELEASE | Therapeutic product effect incomplete,NaT
257378001,25737800,,M,,20250828,,JORNAY PM EXTENDED-RELEASE,Feeling jittery,,JORNAY PM EXTENDED-RELEASE | Feeling jittery,NaT
257378021,25737802,6,M,2025-05-01,20250828,,JORNAY PM EXTENDED-RELEASE,Accidental overdose,,JORNAY PM EXTENDED-RELEASE | Accidental overdose,2025-04-28/2025-05-04
257378571,25737857,,,,20250828,,JORNAY PM EXTENDED-RELEASE,Decreased appetite,,JORNAY PM EXTENDED-RELEASE | Decreased appetite,NaT
257379731,25737973,66,F,2025-02-28,20250829,,REMICADE,Neoplasm malignant,OT,REMICADE | Neoplasm malignant | OT,2025-02-24/2025-03-02
257379832,25737983,,,,20250923,,STELARA,Accidental exposure to product,,STELARA | Accidental exposure to product,NaT
257380661,25738066,,,2025-01-01,20250829,,NEMLUVIO,Inappropriate schedule of product administration,HO,NEMLUVIO | Inappropriate schedule of product administration | HO,2024-12-30/2025-01-05
257380811,25738081,,M,,20250829,,OMNITROPE,Incorrect dose administered by device,,OMNITROPE | Incorrect dose administered by device,NaT
257380872,25738087,90,F,,20250922,,DARBEPOETIN ALFA,Hospitalisation,HO,DARBEPOETIN ALFA | Hospitalisation | HO,NaT
257381831,25738183,75,M,,20250829,,ESBRIET,Death,DE,ESBRIET | Death | DE,NaT
257382631,25738263,,F,,20250829,,PREGABALIN,Transferrin decreased,,PREGABALIN | Transferrin decreased,NaT
257383002,25738300,,F,,20250901,,ANASTROZOLE,Confusional state,,ANASTROZOLE | Confusional state,NaT
257384271,25738427,39,F,2025-07-31,20250829,,VALACYCLOVIR HYDROCHLORIDE,Agranulocytosis,HO,VALACYCLOVIR HYDROCHLORIDE | Agranulocytosis | HO,2025-07-28/2025-08-03
257384281,25738428,,,2025-07-01,20250829,,YUFLYMA,Maternal exposure timing unspecified,OT,YUFLYMA | Maternal exposure timing unspecified | OT,2025-06-30/2025-07-06
257384341,25738434,19,M,2025-06-15,20250829,,ISOTRETINOIN,Hepatic cytolysis,OT,ISOTRETINOIN | Hepatic cytolysis | OT,2025-06-09/2025-06-15
257384511,25738451,,F,,20250829,,ROSUVASTATIN,Muscle spasms,OT,ROSUVASTATIN | Muscle spasms | OT,NaT
257384681,25738468,76,M,2025-06-01,20250829,,HUMIRA,Spinal fracture,OT,HUMIRA | Spinal fracture | OT,2025-05-26/2025-06-01
257384781,25738478,67,F,2025-07-01,20250829,,ONAPGO,Infusion site haemorrhage,,ONAPGO | Infusion site haemorrhage,2025-06-30/2025-07-06
257385301,25738530,,F,,20250829,,TREMFYA,Dizziness,,TREMFYA | Dizziness,NaT
257385372,25738537,62,M,2025-08-01,20250911,,DUPIXENT,Chest discomfort,HO,DUPIXENT | Chest discomfort | HO,2025-07-28/2025-08-03
257385991,25738599,64,F,,20250829,,OMALIZUMAB,Poor quality sleep,OT,OMALIZUMAB | Poor quality sleep | OT,NaT
257387361,25738736,54,M,2025-02-01,20250829,,COLGATE TOTAL SF WHITENING,Stomatitis,,COLGATE TOTAL SF WHITENING | Stomatitis,2025-01-27/2025-02-02
257388292,25738829,,F,,20250901,,SKYRIZI,Mental disorder,,SKYRIZI | Mental disorder,NaT
257388791,25738879,66,F,,20250829,,TRULICITY,Incorrect dose administered,,TRULICITY | Incorrect dose administered,NaT
257389231,25738923,55,F,2025-08-19,20250829,,FLUTICASONE PROPIONATE,Rhinalgia,,FLUTICASONE PROPIONATE | Rhinalgia,2025-08-18/2025-08-24
257389361,25738936,60,F,2025-08-01,20250829,,VYALEV,Product storage error,,VYALEV | Product storage error,2025-07-28/2025-08-03
257389891,25738989,,M,,20250829,,VEDOLIZUMAB,Death,DE,VEDOLIZUMAB | Death | DE,NaT
257389901,25738990,32,F,2025-07-01,20250829,,SKYRIZI,Intestinal ulcer,OT,SKYRIZI | Intestinal ulcer | OT,2025-06-30/2025-07-06
257389951,25738995,,,2025-06-19,20250829,,TEZSPIRE,Accidental exposure to product,,TEZSPIRE | Accidental exposure to product,2025-06-16/2025-06-22
257390231,25739023,,M,,20250829,,SKYRIZI,Craniofacial fracture,OT,SKYRIZI | Craniofacial fracture | OT,NaT
257390261,25739026,48,M,,20250829,,PREGABALIN,Hypoaesthesia,OT,PREGABALIN | Hypoaesthesia | OT,NaT
257390761,25739076,,,,20250829,,NEMLUVIO,Incorrect dose administered,,NEMLUVIO | Incorrect dose administered,NaT
257390861,25739086,,F,,20250829,,RINVOQ,Atrial fibrillation,HO,RINVOQ | Atrial fibrillation | HO,NaT
257391051,25739105,58,F,2025-01-01,20250829,,SPRAVATO,Osteomyelitis,HO,SPRAVATO | Osteomyelitis | HO,2024-12-30/2025-01-05
257392801,25739280,,M,,20250829,,NUPLAZID,Product distribution issue,,NUPLAZID | Product distribution issue,NaT
257393481,25739348,,M,,20250829,,KOSELUGO,Dermatitis acneiform,OT,KOSELUGO | Dermatitis acneiform | OT,NaT
257393761,25739376,,,,20250829,,INFLECTRA,Nephrolithiasis,OT,INFLECTRA | Nephrolithiasis | OT,NaT
257393921,25739392,54,F,,20250829,,MESALAMINE,Posterior reversible encephalopathy syndrome,OT,MESALAMINE | Posterior reversible encephalopathy syndrome | OT,NaT
257394261,25739426,57,F,2023-11-19,20250829,,VENLAFAXINE,Reversible cerebral vasoconstriction syndrome,HO,VENLAFAXINE | Reversible cerebral vasoconstriction syndrome | HO,2023-11-13/2023-11-19
257394431,25739443,59,F,2025-08-15,20250829,,ATORVASTATIN,Chromaturia,OT,ATORVASTATIN | Chromaturia | OT,2025-08-11/2025-08-17
257394731,25739473,,,2025-08-10,20250829,,MENS ROGAINE EXTRA STRENGTH,Application site rash,,MENS ROGAINE EXTRA STRENGTH | Application site rash,2025-08-04/2025-08-10
257394831,25739483,,F,,20250829,,NUPLAZID,Behaviour disorder,,NUPLAZID | Behaviour disorder,NaT
257394981,25739498,88,F,2025-08-01,20250829,,GEMTESA,Urinary retention,,GEMTESA | Urinary retention,2025-07-28/2025-08-03
257395321,25739532,,M,,20250829,,VEDOLIZUMAB,Blood pressure increased,OT,VEDOLIZUMAB | Blood pressure increased | OT,NaT
257396631,25739663,,,2025-06-01,20250829,,LEQEMBI,Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits,,LEQEMBI | Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits,2025-05-26/2025-06-01
257397341,25739734,84,M,2025-08-08,20250829,,KORSUVA,Loss of consciousness,HO,KORSUVA | Loss of consciousness | HO,2025-08-04/2025-08-10
257397971,25739797,56,F,,20250829,,TECARTUS,Malaise,,TECARTUS | Malaise,NaT
257398111,25739811,73,M,2025-08-25,20250828,,LENALIDOMIDE,Loss of consciousness,HO,LENALIDOMIDE | Loss of consciousness | HO,2025-08-25/2025-08-31
257398461,25739846,,,,20250829,,MOUNJARO,Vomiting,,MOUNJARO | Vomiting,NaT
257398511,25739851,81,,,20250829,,MOUNJARO,Accidental overdose,,MOUNJARO | Accidental overdose,NaT
257399651,25739965,39,M,2025-01-01,20250829,,SKYRIZI,Appendicectomy,OT,SKYRIZI | Appendicectomy | OT,2024-12-30/2025-01-05
257400511,25740051,19,F,,20250829,,PREDNISONE,Drug ineffective,OT,PREDNISONE | Drug ineffective | OT,NaT
257400551,25740055,20,F,,20250829,,SERTRALINE,Drug ineffective,OT,SERTRALINE | Drug ineffective | OT,NaT
257400821,25740082,,F,,20250829,,PROMETHAZINE HYDROCHLORIDE,Fatigue,,PROMETHAZINE HYDROCHLORIDE | Fatigue,NaT
257401131,25740113,,F,,20250829,,ACTEMRA,No adverse event,,ACTEMRA | No adverse event,NaT
257401741,25740174,,,,20250829,,TYLENOL,Drug abuse,OT,TYLENOL | Drug abuse | OT,NaT
257401891,25740189,65,F,2025-08-07,20250829,,IRBESARTAN,Blood pressure decreased,OT,IRBESARTAN | Blood pressure decreased | OT,2025-08-04/2025-08-10
257401901,25740190,,,,20250829,,OCREVUS,Fatigue,,OCREVUS | Fatigue,NaT
257402832,25740283,,M,,20250909,,SYNTHROID,Hospitalisation,HO,SYNTHROID | Hospitalisation | HO,NaT
257402941,25740294,61,M,2025-06-28,20250828,,PROMACTA,Death,DE,PROMACTA | Death | DE,2025-06-23/2025-06-29
257405171,25740517,24,M,,20250829,,DEXMEDETOMIDINE HYDROCHLORIDE,Drug ineffective,LT,DEXMEDETOMIDINE HYDROCHLORIDE | Drug ineffective | LT,NaT
257406691,25740669,76,F,2025-07-01,20250829,,DUPIXENT,Cough,,DUPIXENT | Cough,2025-06-30/2025-07-06
257407101,25740710,44,F,,20250829,,DUPIXENT,Asthma,,DUPIXENT | Asthma,NaT
257407241,25740724,,F,,20250829,,CYCLOSPORINE,Rash morbilliform,OT,CYCLOSPORINE | Rash morbilliform | OT,NaT
257408061,25740806,39,F,2025-08-21,20250829,,DUPIXENT,Injection site mass,,DUPIXENT | Injection site mass,2025-08-18/2025-08-24
257408142,25740814,6,M,2025-05-01,20250903,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,2025-04-28/2025-05-04
257409131,25740913,61,M,2025-08-01,20250829,,DUPIXENT,Nasopharyngitis,,DUPIXENT | Nasopharyngitis,2025-07-28/2025-08-03
257410621,25741062,26,F,2025-07-30,20250829,,IBSRELA,Hospitalisation,HO,IBSRELA | Hospitalisation | HO,2025-07-28/2025-08-03
257410701,25741070,,,2024-10-05,20250829,,ALENDRONATE,Incorrect product administration duration,,ALENDRONATE | Incorrect product administration duration,2024-09-30/2024-10-06
257411361,25741136,64,F,2025-04-01,20250829,,HYRIMOZ,Product substitution issue,OT,HYRIMOZ | Product substitution issue | OT,2025-03-31/2025-04-06
257411981,25741198,,M,,20250829,,DUPIXENT,Dizziness postural,,DUPIXENT | Dizziness postural,NaT
257412241,25741224,74,M,2024-08-12,20250829,,ERLEADA,Atrial fibrillation,OT,ERLEADA | Atrial fibrillation | OT,2024-08-12/2024-08-18
257412501,25741250,66,F,,20250829,,FORTEO,COVID-19,OT,FORTEO | COVID-19 | OT,NaT
257412611,25741261,,,,20250829,,OZEMPIC,Nausea,OT,OZEMPIC | Nausea | OT,NaT
257413251,25741325,74,F,2025-07-23,20250829,,OZEMPIC,Macular degeneration,OT,OZEMPIC | Macular degeneration | OT,2025-07-21/2025-07-27
257413801,25741380,64,M,2025-08-21,20250829,,LUMASON,Vomiting,DE,LUMASON | Vomiting | DE,2025-08-18/2025-08-24
257414572,25741457,,M,2025-01-01,20250926,,CORTICOTROPIN,Injection site pruritus,OT,CORTICOTROPIN | Injection site pruritus | OT,2024-12-30/2025-01-05
257414681,25741468,44,F,2025-08-18,20250829,,AYVAKIT,Colitis ulcerative,OT,AYVAKIT | Colitis ulcerative | OT,2025-08-18/2025-08-24
257415401,25741540,,,,20250829,,TERIFLUNOMIDE,Mental disorder,,TERIFLUNOMIDE | Mental disorder,NaT
257415481,25741548,,M,,20250829,,RYBREVANT,Infusion related reaction,,RYBREVANT | Infusion related reaction,NaT
257415841,25741584,56,F,2020-01-01,20250829,,JAKAFI,Lip exfoliation,,JAKAFI | Lip exfoliation,2019-12-30/2020-01-05
257416641,25741664,65,M,,20250829,,METOPROLOL SUCCINATE,BRASH syndrome,HO,METOPROLOL SUCCINATE | BRASH syndrome | HO,NaT
257416752,25741675,,F,,20250909,,OTEZLA,Rash,,OTEZLA | Rash,NaT
257417641,25741764,83,F,,20250829,,FEMARA,Balance disorder,OT,FEMARA | Balance disorder | OT,NaT
257417791,25741779,,F,,20250829,,ORENITRAM,Feeling abnormal,,ORENITRAM | Feeling abnormal,NaT
257418281,25741828,50,M,,20250829,,LENALIDOMIDE,Follicular lymphoma,HO,LENALIDOMIDE | Follicular lymphoma | HO,NaT
257419142,25741914,64,M,2023-11-16,20250901,,CABOMETYX,Cerebrovascular accident,HO,CABOMETYX | Cerebrovascular accident | HO,2023-11-13/2023-11-19
257419371,25741937,76,F,2025-08-25,20250829,,RINVOQ,Eye operation,OT,RINVOQ | Eye operation | OT,2025-08-25/2025-08-31
257420821,25742082,79,M,2025-07-28,20250829,,ZOLEDRONIC ACID,Liver injury,OT,ZOLEDRONIC ACID | Liver injury | OT,2025-07-28/2025-08-03
257421771,25742177,73,M,2025-08-26,20250829,,CARBIDOPA\LEVODOPA,Device implantation error,HO,CARBIDOPA\LEVODOPA | Device implantation error | HO,2025-08-25/2025-08-31
257422261,25742226,59,M,2025-08-03,20250829,,GABAPENTIN,Pancreatitis necrotising,HO,GABAPENTIN | Pancreatitis necrotising | HO,2025-07-28/2025-08-03
257422651,25742265,62,,,20250829,,BORTEZOMIB,Secondary immunodeficiency,OT,BORTEZOMIB | Secondary immunodeficiency | OT,NaT
257422811,25742281,,,,20250829,,LUTATHERA,General physical health deterioration,,LUTATHERA | General physical health deterioration,NaT
257423583,25742358,13,M,2025-08-19,20250908,,NGENLA,Injection site pruritus,,NGENLA | Injection site pruritus,2025-08-18/2025-08-24
257423711,25742371,82,F,,20250829,,REVLIMID,Alopecia,,REVLIMID | Alopecia,NaT
257423731,25742373,,,,20250829,,PROQUAD,Product storage error,,PROQUAD | Product storage error,NaT
257423891,25742389,73,F,2025-07-06,20250829,,PEMBROLIZUMAB,Mixed liver injury,HO,PEMBROLIZUMAB | Mixed liver injury | HO,2025-06-30/2025-07-06
257424351,25742435,76,F,2025-01-01,20250829,,DOXYCYCLINE,Yellow skin,HO,DOXYCYCLINE | Yellow skin | HO,2024-12-30/2025-01-05
257425412,25742541,62,F,,20250924,,FARXIGA,Glycosylated haemoglobin increased,OT,FARXIGA | Glycosylated haemoglobin increased | OT,NaT
257425452,25742545,,M,,20250926,,IMFINZI,Malignant neoplasm progression,OT,IMFINZI | Malignant neoplasm progression | OT,NaT
257425821,25742582,58,M,2025-06-28,20250829,,NPLATE,Unevaluable event,HO,NPLATE | Unevaluable event | HO,2025-06-23/2025-06-29
257425842,25742584,42,M,,20250903,,METFORMIN,Dry skin,,METFORMIN | Dry skin,NaT
257426441,25742644,,F,,20250830,,SKYRIZI,Breast cancer female,OT,SKYRIZI | Breast cancer female | OT,NaT
257427631,25742763,34,M,,20250830,,TACROLIMUS,Cognitive disorder,OT,TACROLIMUS | Cognitive disorder | OT,NaT
257428181,25742818,,F,2024-12-06,20250830,,GUAIFENESIN,Condition aggravated,,GUAIFENESIN | Condition aggravated,2024-12-02/2024-12-08
257429081,25742908,,,2025-07-22,20250830,,INFLIXIMAB,Chest pain,LT,INFLIXIMAB | Chest pain | LT,2025-07-21/2025-07-27
257429181,25742918,73,F,,20250830,,ZEPBOUND,Accidental underdose,,ZEPBOUND | Accidental underdose,NaT
257430851,25743085,68,M,2025-06-18,20250830,,OXALIPLATIN,Diarrhoea,OT,OXALIPLATIN | Diarrhoea | OT,2025-06-16/2025-06-22
257431051,25743105,,,2025-08-03,20250830,,GABAPENTIN,Pancreatitis necrotising,LT,GABAPENTIN | Pancreatitis necrotising | LT,2025-07-28/2025-08-03
257431251,25743125,,,,20250830,,AZATHIOPRINE,Myelosuppression,DE,AZATHIOPRINE | Myelosuppression | DE,NaT
257431331,25743133,53,F,,20250830,,ZEPBOUND,Accidental overdose,,ZEPBOUND | Accidental overdose,NaT
257432441,25743244,10,M,,20250830,,PREDNISONE,Psychomotor hyperactivity,OT,PREDNISONE | Psychomotor hyperactivity | OT,NaT
257433291,25743329,,,,20250830,,OPSUMIT,Product packaging difficult to open,,OPSUMIT | Product packaging difficult to open,NaT
257433541,25743354,5,M,2025-07-01,20250830,,DUPIXENT,Skin burning sensation,,DUPIXENT | Skin burning sensation,2025-06-30/2025-07-06
257433781,25743378,,M,,20250830,,DUPIXENT,Skin wound,,DUPIXENT | Skin wound,NaT
257434551,25743455,52,M,,20250831,,BORTEZOMIB,Histoplasmosis,OT,BORTEZOMIB | Histoplasmosis | OT,NaT
257436201,25743620,,F,,20250831,,DUPIXENT,Productive cough,,DUPIXENT | Productive cough,NaT
257437131,25743713,,,,20250831,,MOUNJARO,Illness,,MOUNJARO | Illness,NaT
257437501,25743750,9,F,2025-07-01,20250831,,DUPIXENT,Rebound effect,,DUPIXENT | Rebound effect,2025-06-30/2025-07-06
257437751,25743775,,F,2025-08-01,20250831,,LENVIMA,White blood cell count decreased,HO,LENVIMA | White blood cell count decreased | HO,2025-07-28/2025-08-03
257439931,25743993,74,F,,20250831,,DUPIXENT,Therapeutic response decreased,,DUPIXENT | Therapeutic response decreased,NaT
257441141,25744114,,F,,20250831,,DUPIXENT,Fall,,DUPIXENT | Fall,NaT
257441911,25744191,,F,,20250901,,XOLAIR,Idiopathic urticaria,,XOLAIR | Idiopathic urticaria,NaT
257442621,25744262,78,M,2024-01-01,20250901,,VECTIBIX,Therapy interrupted,OT,VECTIBIX | Therapy interrupted | OT,2024-01-01/2024-01-07
257442673,25744267,74,M,,20250929,,ADMELOG,Renal disorder,OT,ADMELOG | Renal disorder | OT,NaT
257442691,25744269,,,,20250901,,INFLECTRA,Premature baby,OT,INFLECTRA | Premature baby | OT,NaT
257443391,25744339,,F,,20250901,,ACTEMRA,Drug hypersensitivity,,ACTEMRA | Drug hypersensitivity,NaT
257443722,25744372,58,F,2025-07-25,20250919,,PACLITAXEL,Hot flush,OT,PACLITAXEL | Hot flush | OT,2025-07-21/2025-07-27
257444471,25744447,,,,20250901,,PREDNISONE,Osteoarthritis,,PREDNISONE | Osteoarthritis,NaT
257444611,25744461,,F,2024-08-01,20250901,,PREDNISONE,Diarrhoea haemorrhagic,,PREDNISONE | Diarrhoea haemorrhagic,2024-07-29/2024-08-04
257445752,25744575,,,,20250922,,STELARA,Device issue,,STELARA | Device issue,NaT
257447231,25744723,,,2025-08-04,20250901,,NEMLUVIO,Inappropriate schedule of product administration,,NEMLUVIO | Inappropriate schedule of product administration,2025-08-04/2025-08-10
257448711,25744871,,M,,20250901,,TREMFYA,Hepatic enzyme increased,,TREMFYA | Hepatic enzyme increased,NaT
257449311,25744931,,,,20250901,,NEMOLIZUMAB,Erythema,HO,NEMOLIZUMAB | Erythema | HO,NaT
257449401,25744940,57,F,2025-07-04,20250901,,"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",Self-injurious ideation,OT,"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE | Self-injurious ideation | OT",2025-06-30/2025-07-06
257449591,25744959,76,F,,20250901,,REVLIMID,Palpitations,,REVLIMID | Palpitations,NaT
257449651,25744965,54,F,2025-07-01,20250901,,MAVENCLAD,Back pain,OT,MAVENCLAD | Back pain | OT,2025-06-30/2025-07-06
257449741,25744974,,F,,20250901,,CIPROFLOXACIN,Drug ineffective for unapproved indication,,CIPROFLOXACIN | Drug ineffective for unapproved indication,NaT
257450291,25745029,83,M,2025-08-01,20250901,,XARELTO,Distributive shock,LT,XARELTO | Distributive shock | LT,2025-07-28/2025-08-03
257450831,25745083,,F,2025-01-01,20250901,,RECLAST,Joint stiffness,,RECLAST | Joint stiffness,2024-12-30/2025-01-05
257451022,25745102,,,2025-08-22,20250903,,TRIMETHOPRIM,Back pain,HO,TRIMETHOPRIM | Back pain | HO,2025-08-18/2025-08-24
257451031,25745103,46,M,,20250901,,HALOPERIDOL,Drug ineffective,HO,HALOPERIDOL | Drug ineffective | HO,NaT
257451071,25745107,69,M,2025-05-09,20250901,,ZANIDATAMAB,Bile duct cancer stage IV,OT,ZANIDATAMAB | Bile duct cancer stage IV | OT,2025-05-05/2025-05-11
257451481,25745148,75,F,,20250901,,EYLEA HD,Dry age-related macular degeneration,OT,EYLEA HD | Dry age-related macular degeneration | OT,NaT
257451711,25745171,70,F,,20250901,,PANTOPRAZOLE SODIUM,Product use in unapproved indication,OT,PANTOPRAZOLE SODIUM | Product use in unapproved indication | OT,NaT
257452691,25745269,,M,,20250901,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Death,DE,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Death | DE,NaT
257452801,25745280,,,,20250901,,CABENUVA,Product dose omission issue,,CABENUVA | Product dose omission issue,NaT
257453621,25745362,49,F,2025-07-20,20250901,,TYLENOL,Headache,,TYLENOL | Headache,2025-07-14/2025-07-20
257453941,25745394,74,F,,20250901,,ATORVASTATIN,Myopathy,LT,ATORVASTATIN | Myopathy | LT,NaT
257454581,25745458,25,M,2025-02-25,20250901,,ARIPIPRAZOLE,Aphantasia,OT,ARIPIPRAZOLE | Aphantasia | OT,2025-02-24/2025-03-02
257454691,25745469,73,M,2025-04-26,20250901,,CARBOPLATIN,Anaemia,HO,CARBOPLATIN | Anaemia | HO,2025-04-21/2025-04-27
257455331,25745533,57,F,,20250901,,FUROSEMIDE,Condition aggravated,HO,FUROSEMIDE | Condition aggravated | HO,NaT
257456251,25745625,,,2025-08-01,20250901,,BISOPROLOL,Distributive shock,LT,BISOPROLOL | Distributive shock | LT,2025-07-28/2025-08-03
257456681,25745668,,F,,20250901,,TETRACYCLINE HYDROCHLORIDE,Drug hypersensitivity,,TETRACYCLINE HYDROCHLORIDE | Drug hypersensitivity,NaT
257457361,25745736,,,,20250901,,INVEGA SUSTENNA,Incorrect dose administered,,INVEGA SUSTENNA | Incorrect dose administered,NaT
257458101,25745810,,M,2025-07-30,20250901,,GAZYVA,Disease progression,DE,GAZYVA | Disease progression | DE,2025-07-28/2025-08-03
257458201,25745820,,F,,20250901,,TECFIDERA,Drug ineffective,,TECFIDERA | Drug ineffective,NaT
257458331,25745833,4,F,,20250901,,OMNITROPE,Circumstance or information capable of leading to medication error,,OMNITROPE | Circumstance or information capable of leading to medication error,NaT
257458571,25745857,73,M,,20250901,,AVASTIN,Hepatic mass,DE,AVASTIN | Hepatic mass | DE,NaT
257459261,25745926,,F,,20250901,,BEVACIZUMAB,Embolism venous,OT,BEVACIZUMAB | Embolism venous | OT,NaT
257459661,25745966,76,M,,20250901,,MOUNJARO,Weight decreased,,MOUNJARO | Weight decreased,NaT
257460261,25746026,55,F,,20250901,,PREDNISONE,Osteopenia,OT,PREDNISONE | Osteopenia | OT,NaT
257460921,25746092,51,F,,20250901,,CYCLOSPORINE,Product use in unapproved indication,LT,CYCLOSPORINE | Product use in unapproved indication | LT,NaT
257461101,25746110,67,F,,20250901,,GEMTESA,Drug effect less than expected,,GEMTESA | Drug effect less than expected,NaT
257461711,25746171,,F,2025-01-01,20250901,,BIMEKIZUMAB,Product prescribing issue,OT,BIMEKIZUMAB | Product prescribing issue | OT,2024-12-30/2025-01-05
257462461,25746246,,F,,20250901,,MAVENCLAD,Abortion spontaneous,OT,MAVENCLAD | Abortion spontaneous | OT,NaT
257463091,25746309,16,F,2025-08-06,20250901,,IBUPROFEN,Peritonsillar abscess,OT,IBUPROFEN | Peritonsillar abscess | OT,2025-08-04/2025-08-10
257465011,25746501,56,F,,20250901,,MOUNJARO,Injection site bruising,,MOUNJARO | Injection site bruising,NaT
257465341,25746534,,,,20250901,,PEGASYS,Injection site pain,,PEGASYS | Injection site pain,NaT
257465501,25746550,,,2025-08-13,20250901,,MVASI,Laboratory test abnormal,,MVASI | Laboratory test abnormal,2025-08-11/2025-08-17
257465613,25746561,50,F,2024-06-01,20250926,,KISQALI,Urinary tract infection,OT,KISQALI | Urinary tract infection | OT,2024-05-27/2024-06-02
257465871,25746587,65,M,,20250901,,BENDAMUSTINE HYDROCHLORIDE,Multiple organ dysfunction syndrome,LT,BENDAMUSTINE HYDROCHLORIDE | Multiple organ dysfunction syndrome | LT,NaT
257466381,25746638,3,M,,20250901,,PALFORZIA,Oral contusion,,PALFORZIA | Oral contusion,NaT
257466652,25746665,20,M,,20250915,,CLOZAPINE,Tachycardia,OT,CLOZAPINE | Tachycardia | OT,NaT
257467141,25746714,,F,,20250901,,SKYRIZI,Nasal polyps,OT,SKYRIZI | Nasal polyps | OT,NaT
257467453,25746745,72,F,,20250926,,METFORMIN,Lactic acidosis,OT,METFORMIN | Lactic acidosis | OT,NaT
257467521,25746752,75,F,2022-12-21,20250901,,ISATUXIMAB,Rash,DE,ISATUXIMAB | Rash | DE,2022-12-19/2022-12-25
257468011,25746801,72,F,,20250901,,ZEPBOUND,Overdose,,ZEPBOUND | Overdose,NaT
257468471,25746847,71,M,,20250901,,MOUNJARO,Extra dose administered,,MOUNJARO | Extra dose administered,NaT
257468741,25746874,42,M,2025-08-01,20250901,,DUPIXENT,Dyspnoea,,DUPIXENT | Dyspnoea,2025-07-28/2025-08-03
257469081,25746908,77,M,,20250901,,DUPIXENT,Dry skin,,DUPIXENT | Dry skin,NaT
257469531,25746953,5,M,2025-08-01,20250901,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2025-07-28/2025-08-03
257469741,25746974,16,F,2025-01-01,20250901,,DUPIXENT,Cyst,,DUPIXENT | Cyst,2024-12-30/2025-01-05
257469963,25746996,48,F,2025-06-01,20250911,,DUPIXENT,Injection site swelling,,DUPIXENT | Injection site swelling,2025-05-26/2025-06-01
257470062,25747006,66,M,2025-01-01,20250927,,DUPIXENT,Injection site erythema,,DUPIXENT | Injection site erythema,2024-12-30/2025-01-05
257470551,25747055,63,F,2025-06-01,20250901,,TRODELVY,Hypophagia,HO,TRODELVY | Hypophagia | HO,2025-05-26/2025-06-01
257471031,25747103,4,F,2025-01-01,20250901,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2024-12-30/2025-01-05
257471771,25747177,55,F,,20250901,,TACROLIMUS,Pneumocystis jirovecii pneumonia,HO,TACROLIMUS | Pneumocystis jirovecii pneumonia | HO,NaT
257471831,25747183,,M,,20250901,,DUPIXENT,Conjunctivitis,,DUPIXENT | Conjunctivitis,NaT
257472491,25747249,54,M,2025-07-01,20250901,,DUPIXENT,Ocular hyperaemia,,DUPIXENT | Ocular hyperaemia,2025-06-30/2025-07-06
257472722,25747272,,M,,20250917,,CORTICOTROPIN,Headache,OT,CORTICOTROPIN | Headache | OT,NaT
257473381,25747338,45,,,20250901,,MOUNJARO,Extra dose administered,,MOUNJARO | Extra dose administered,NaT
257474281,25747428,69,F,2025-08-16,20250901,,OBINUTUZUMAB,Chills,OT,OBINUTUZUMAB | Chills | OT,2025-08-11/2025-08-17
257474522,25747452,,F,,20250906,,REPATHA,Device difficult to use,,REPATHA | Device difficult to use,NaT
257474531,25747453,,M,,20250901,,CELLCEPT,Hepatic enzyme increased,,CELLCEPT | Hepatic enzyme increased,NaT
257474991,25747499,45,F,,20250901,,SOTATERCEPT,Pericardial effusion,OT,SOTATERCEPT | Pericardial effusion | OT,NaT
257475001,25747500,,,,20250901,,ORSERDU,Constipation,,ORSERDU | Constipation,NaT
257475661,25747566,67,F,,20250901,,SOTATERCEPT,Pericardial effusion,OT,SOTATERCEPT | Pericardial effusion | OT,NaT
257477071,25747707,78,F,,20250901,,VERZENIO,Malignant neoplasm progression,OT,VERZENIO | Malignant neoplasm progression | OT,NaT
257477982,25747798,,F,,20250901,,ALBUTEROL SULFATE,Device breakage,,ALBUTEROL SULFATE | Device breakage,NaT
257478201,25747820,,F,2025-01-01,20250901,,HUMIRA,Injection site erythema,,HUMIRA | Injection site erythema,2024-12-30/2025-01-05
257478561,25747856,2,M,,20250901,,DUPIXENT,Off label use,,DUPIXENT | Off label use,NaT
257478961,25747896,,M,2025-01-06,20250901,,MARIBAVIR,Pneumonia bacterial,HO,MARIBAVIR | Pneumonia bacterial | HO,2025-01-06/2025-01-12
257479941,25747994,48,F,,20250901,,ACETAMINOPHEN,Coma,OT,ACETAMINOPHEN | Coma | OT,NaT
257481271,25748127,,F,,20250901,,HUMIRA,Death,DE,HUMIRA | Death | DE,NaT
257482081,25748208,16,M,,20250902,,XOLAIR,Abdominal pain,OT,XOLAIR | Abdominal pain | OT,NaT
257482401,25748240,,F,,20250902,,NUCALA,Arthritis,RI,NUCALA | Arthritis | RI,NaT
257482951,25748295,55,F,2018-11-01,20250902,,CREON,Pancreatectomy,OT,CREON | Pancreatectomy | OT,2018-10-29/2018-11-04
257483331,25748333,,F,,20250902,,COSENTYX,Needle issue,,COSENTYX | Needle issue,NaT
257483741,25748374,70,M,,20250902,,PADCEV,Malignant neoplasm progression,OT,PADCEV | Malignant neoplasm progression | OT,NaT
257485291,25748529,30,M,2022-12-01,20250902,,AMLODIPINE BESYLATE,Hypotension,HO,AMLODIPINE BESYLATE | Hypotension | HO,2022-11-28/2022-12-04
257486171,25748617,77,F,,20250902,,CRESTOR,Palpitations,OT,CRESTOR | Palpitations | OT,NaT
257486391,25748639,,M,,20250902,,HUMIRA,Rhinorrhoea,,HUMIRA | Rhinorrhoea,NaT
257486791,25748679,61,F,2025-05-23,20250902,,SKYRIZI,Glaucoma,HO,SKYRIZI | Glaucoma | HO,2025-05-19/2025-05-25
257487511,25748751,49,M,,20250902,,AMLODIPINE,Weight increased,HO,AMLODIPINE | Weight increased | HO,NaT
257488301,25748830,73,M,,20250902,,DUPIXENT,Vomiting,,DUPIXENT | Vomiting,NaT
257490092,25749009,,,2025-08-13,20250926,,KIMMTRAK,Incorrect dose administered,OT,KIMMTRAK | Incorrect dose administered | OT,2025-08-11/2025-08-17
257491221,25749122,,,,20250902,,REVUFORJ,Off label use,,REVUFORJ | Off label use,NaT
257491502,25749150,77,M,2025-01-01,20250903,,VYALEV,Loss of consciousness,OT,VYALEV | Loss of consciousness | OT,2024-12-30/2025-01-05
257492071,25749207,,F,2025-08-10,20250902,,MONTELUKAST,Epistaxis,OT,MONTELUKAST | Epistaxis | OT,2025-08-04/2025-08-10
257492251,25749225,2,M,2025-08-07,20250902,,HEMLIBRA,Anaphylactic reaction,HO,HEMLIBRA | Anaphylactic reaction | HO,2025-08-04/2025-08-10
257492661,25749266,63,F,,20250902,,COMBIVENT RESPIMAT,Dysphonia,,COMBIVENT RESPIMAT | Dysphonia,NaT
257493541,25749354,66,M,2025-02-06,20250902,,CARBOPLATIN,Immune-mediated enterocolitis,OT,CARBOPLATIN | Immune-mediated enterocolitis | OT,2025-02-03/2025-02-09
257493841,25749384,82,F,,20250902,,ZYRTEC,Product use in unapproved indication,,ZYRTEC | Product use in unapproved indication,NaT
257493981,25749398,,F,,20250902,,VEDOLIZUMAB,Loss of personal independence in daily activities,OT,VEDOLIZUMAB | Loss of personal independence in daily activities | OT,NaT
257494061,25749406,,F,,20250902,,TYMLOS,Dementia,OT,TYMLOS | Dementia | OT,NaT
257494841,25749484,45,F,,20250902,,PREDNISONE,Cerebrovascular accident,OT,PREDNISONE | Cerebrovascular accident | OT,NaT
257495061,25749506,61,F,,20250902,,PREDNISONE,Transplant rejection,OT,PREDNISONE | Transplant rejection | OT,NaT
257495631,25749563,9,F,2025-07-22,20250902,,HUMALOG,Haemorrhage,,HUMALOG | Haemorrhage,2025-07-21/2025-07-27
257495671,25749567,75,F,2025-08-06,20250902,,KISUNLA,Hypertension,,KISUNLA | Hypertension,2025-08-04/2025-08-10
257495851,25749585,94,M,,20250902,,LEVOTHYROXINE,Delirium,HO,LEVOTHYROXINE | Delirium | HO,NaT
257495981,25749598,,,,20250902,,TRELEGY ELLIPTA,Off label use,,TRELEGY ELLIPTA | Off label use,NaT
257496771,25749677,,F,,20250902,,OTEZLA,Pruritus,,OTEZLA | Pruritus,NaT
257497361,25749736,64,M,2025-08-23,20250902,,VENCLEXTA,Urinary tract infection,HO,VENCLEXTA | Urinary tract infection | HO,2025-08-18/2025-08-24
257497421,25749742,75,F,2025-08-25,20250902,,RINVOQ,Musculoskeletal stiffness,OT,RINVOQ | Musculoskeletal stiffness | OT,2025-08-25/2025-08-31
257497601,25749760,76,F,,20250902,,ELIQUIS,Epistaxis,,ELIQUIS | Epistaxis,NaT
257498501,25749850,62,F,2025-03-12,20250902,,CYCLOPHOSPHAMIDE,Drug ineffective,HO,CYCLOPHOSPHAMIDE | Drug ineffective | HO,2025-03-10/2025-03-16
257500051,25750005,61,F,2025-01-01,20250902,,CIPRO,Chest pain,LT,CIPRO | Chest pain | LT,2024-12-30/2025-01-05
257501501,25750150,44,M,2025-01-01,20250902,,DUPIXENT,Skin irritation,,DUPIXENT | Skin irritation,2024-12-30/2025-01-05
257501611,25750161,64,M,,20250902,,DUPIXENT,Dyspnoea,,DUPIXENT | Dyspnoea,NaT
257501762,25750176,44,F,2025-01-01,20250915,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2024-12-30/2025-01-05
257502151,25750215,,F,2025-01-01,20250902,,DUPIXENT,Rash,,DUPIXENT | Rash,2024-12-30/2025-01-05
257503881,25750388,69,M,,20250902,,BEVACIZUMAB,Off label use,HO,BEVACIZUMAB | Off label use | HO,NaT
257506161,25750616,57,F,,20250902,,TACROLIMUS,COVID-19,OT,TACROLIMUS | COVID-19 | OT,NaT
257506721,25750672,,F,,20250902,,DUPIXENT,Rebound effect,,DUPIXENT | Rebound effect,NaT
257507042,25750704,55,F,2020-01-01,20250918,,BRENTUXIMAB VEDOTIN,Haematotoxicity,HO,BRENTUXIMAB VEDOTIN | Haematotoxicity | HO,2019-12-30/2020-01-05
257508091,25750809,,,2025-01-01,20250902,,LENVIMA,Nausea,,LENVIMA | Nausea,2024-12-30/2025-01-05
257508191,25750819,66,M,,20250902,,LANTUS SOLOSTAR,Off label use,,LANTUS SOLOSTAR | Off label use,NaT
257508221,25750822,3,F,,20250902,,ZOLEDRONIC ACID,Status epilepticus,HO,ZOLEDRONIC ACID | Status epilepticus | HO,NaT
257509401,25750940,80,F,,20250902,,MEROPENEM,Status epilepticus,OT,MEROPENEM | Status epilepticus | OT,NaT
257509971,25750997,67,F,2025-08-16,20250902,,AJOVY,Injection site pain,,AJOVY | Injection site pain,2025-08-11/2025-08-17
257510121,25751012,50,F,2022-09-15,20250830,,VENLAFAXINE HCL,Insomnia,DS,VENLAFAXINE HCL | Insomnia | DS,2022-09-12/2022-09-18
257510361,25751036,52,F,,20250902,,DIAZEPAM,Nasal polyps,HO,DIAZEPAM | Nasal polyps | HO,NaT
257510551,25751055,,F,,20250902,,NUCALA,Anxiety,,NUCALA | Anxiety,NaT
257512491,25751249,52,F,2025-08-12,20250831,,FLUOROURACIL,Nausea,HO,FLUOROURACIL | Nausea | HO,2025-08-11/2025-08-17
257513061,25751306,66,F,,20250902,,ISONIAZID,Orbital myositis,OT,ISONIAZID | Orbital myositis | OT,NaT
257513251,25751325,,F,,20250901,,CAPECITABINE,Complication associated with device,HO,CAPECITABINE | Complication associated with device | HO,NaT
257513561,25751356,29,M,2025-06-13,20250902,,DOTAREM,Urticaria,,DOTAREM | Urticaria,2025-06-09/2025-06-15
257513931,25751393,6,M,2025-04-01,20250902,,AGAMREE,Irritability,,AGAMREE | Irritability,2025-03-31/2025-04-06
257514411,25751441,71,M,2025-08-18,20250902,,MIRALAX,Diarrhoea,,MIRALAX | Diarrhoea,2025-08-18/2025-08-24
257514471,25751447,65,M,,20250902,,KEYTRUDA,Malignant neoplasm progression,OT,KEYTRUDA | Malignant neoplasm progression | OT,NaT
257514931,25751493,69,M,2020-04-01,20250902,,ALECTINIB,Fluid retention,,ALECTINIB | Fluid retention,2020-03-30/2020-04-05
257516782,25751678,19,M,,20250905,,METHOTREXATE SODIUM,Hepatic cytolysis,OT,METHOTREXATE SODIUM | Hepatic cytolysis | OT,NaT
257517631,25751763,59,M,2015-05-06,20250902,,PREDNISONE,Immunosuppression,OT,PREDNISONE | Immunosuppression | OT,2015-05-04/2015-05-10
257517671,25751767,34,M,2025-08-25,20250902,,RINVOQ,Haematochezia,OT,RINVOQ | Haematochezia | OT,2025-08-25/2025-08-31
257517702,25751770,76,M,2025-08-01,20250929,,SKYRIZI,Cervical vertebral fracture,OT,SKYRIZI | Cervical vertebral fracture | OT,2025-07-28/2025-08-03
257518841,25751884,40,F,2025-08-30,20250901,,LAMICTAL,Nervousness,DS,LAMICTAL | Nervousness | DS,2025-08-25/2025-08-31
257520431,25752043,74,M,2022-01-01,20250902,,NOVOLOG,Neoplasm malignant,HO,NOVOLOG | Neoplasm malignant | HO,2021-12-27/2022-01-02
257520641,25752064,96,F,,20250902,,PAXLOVID,Drug ineffective,LT,PAXLOVID | Drug ineffective | LT,NaT
257521181,25752118,57,F,2025-06-26,20250902,,INGREZZA,Urinary tract infection,HO,INGREZZA | Urinary tract infection | HO,2025-06-23/2025-06-29
257521291,25752129,55,M,,20250902,,HYDROCODONE BITARTRATE,Drug abuse,OT,HYDROCODONE BITARTRATE | Drug abuse | OT,NaT
257521741,25752174,,,,20250902,,TRAVOPROST,Therapeutic product effect decreased,,TRAVOPROST | Therapeutic product effect decreased,NaT
257521871,25752187,,F,,20250902,,CIPROFLOXACIN,Dermatitis allergic,,CIPROFLOXACIN | Dermatitis allergic,NaT
257522051,25752205,,,,20250902,,IBUPROFEN,Drug ineffective,,IBUPROFEN | Drug ineffective,NaT
257522541,25752254,51,M,,20250902,,TRAZODONE HYDROCHLORIDE,Intentional overdose,OT,TRAZODONE HYDROCHLORIDE | Intentional overdose | OT,NaT
257522771,25752277,45,M,2024-01-18,20250902,,TOLVAPTAN,Underdose,HO,TOLVAPTAN | Underdose | HO,2024-01-15/2024-01-21
257522792,25752279,,M,,20250905,,OMNITROPE,Incorrect dose administered,,OMNITROPE | Incorrect dose administered,NaT
257523121,25752312,,F,,20250902,,ACALABRUTINIB,Myocardial infarction,OT,ACALABRUTINIB | Myocardial infarction | OT,NaT
257523401,25752340,68,M,,20250902,,KEYTRUDA,Malignant neoplasm progression,DE,KEYTRUDA | Malignant neoplasm progression | DE,NaT
257523791,25752379,,F,,20250902,,OLAPARIB,Disease progression,OT,OLAPARIB | Disease progression | OT,NaT
257524031,25752403,,,,20250902,,BLINATUMOMAB,Acute lymphocytic leukaemia recurrent,DE,BLINATUMOMAB | Acute lymphocytic leukaemia recurrent | DE,NaT
257524701,25752470,,,,20250902,,BLINATUMOMAB,Death,DE,BLINATUMOMAB | Death | DE,NaT
257525591,25752559,60,F,,20250902,,SOTATERCEPT,Pericardial effusion,OT,SOTATERCEPT | Pericardial effusion | OT,NaT
257525871,25752587,61,M,2025-08-19,20250902,,MOUNJARO,Vomiting,OT,MOUNJARO | Vomiting | OT,2025-08-18/2025-08-24
257526453,25752645,40,F,,20250911,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
257526521,25752652,41,M,,20250902,,LORBRENA,Dehydration,,LORBRENA | Dehydration,NaT
257526591,25752659,70,M,2025-07-15,20250902,,OXALIPLATIN,Toxic skin eruption,HO,OXALIPLATIN | Toxic skin eruption | HO,2025-07-14/2025-07-20
257527371,25752737,81,M,,20250902,,VYNDAMAX,Death,DE,VYNDAMAX | Death | DE,NaT
257528031,25752803,61,M,,20250902,,KEYTRUDA,Polyarthritis,OT,KEYTRUDA | Polyarthritis | OT,NaT
257528581,25752858,38,F,,20250902,,MOUNJARO,Maternal exposure during pregnancy,OT,MOUNJARO | Maternal exposure during pregnancy | OT,NaT
257528681,25752868,57,F,,20250902,,MAVYRET,Nausea,,MAVYRET | Nausea,NaT
257528761,25752876,,F,,20250902,,SYNTHROID,Food allergy,,SYNTHROID | Food allergy,NaT
257529211,25752921,21,F,,20250902,,MOUNJARO,Polymenorrhoea,OT,MOUNJARO | Polymenorrhoea | OT,NaT
257529231,25752923,80,M,,20250902,,HUMALOG,Diabetic complication,HO,HUMALOG | Diabetic complication | HO,NaT
257529401,25752940,76,F,2025-08-14,20250902,,DULAGLUTIDE,Vomiting,OT,DULAGLUTIDE | Vomiting | OT,2025-08-11/2025-08-17
257529481,25752948,58,F,,20250902,,INSULIN LISPRO,Loss of consciousness,OT,INSULIN LISPRO | Loss of consciousness | OT,NaT
257529691,25752969,,F,2025-07-16,20250902,,HUMALOG,Hypoglycaemia,OT,HUMALOG | Hypoglycaemia | OT,2025-07-14/2025-07-20
257530221,25753022,45,M,,20250902,,ORENCIA,Arthralgia,OT,ORENCIA | Arthralgia | OT,NaT
257531182,25753118,80,M,2025-08-28,20250909,,CARBIDOPA\LEVODOPA,Influenza,HO,CARBIDOPA\LEVODOPA | Influenza | HO,2025-08-25/2025-08-31
257532281,25753228,28,M,2024-06-26,20250903,,BEVACIZUMAB,Disease progression,DE,BEVACIZUMAB | Disease progression | DE,2024-06-24/2024-06-30
257533101,25753310,62,,,20250903,,OZEMPIC,Intestinal obstruction,OT,OZEMPIC | Intestinal obstruction | OT,NaT
257533311,25753331,46,M,2025-08-25,20250903,,TALVEY,Product prescribing error,,TALVEY | Product prescribing error,2025-08-25/2025-08-31
257533611,25753361,,F,,20250903,,DUPIXENT,Gastric infection,,DUPIXENT | Gastric infection,NaT
257534872,25753487,49,,,20250909,,TISLELIZUMAB,Radiation pneumonitis,HO,TISLELIZUMAB | Radiation pneumonitis | HO,NaT
257536121,25753612,69,M,,20250903,,PAXLOVID,Product prescribing error,,PAXLOVID | Product prescribing error,NaT
257536722,25753672,,F,,20250908,,BRAFTOVI,Nausea,,BRAFTOVI | Nausea,NaT
257536741,25753674,,M,,20250903,,ELREXFIO,Tremor,,ELREXFIO | Tremor,NaT
257536952,25753695,,,2025-05-01,20250911,,OPSUMIT,Hospitalisation,HO,OPSUMIT | Hospitalisation | HO,2025-04-28/2025-05-04
257537161,25753716,,F,,20250903,,METHOTREXATE,Somnolence,OT,METHOTREXATE | Somnolence | OT,NaT
257537451,25753745,,M,,20250903,,GUAIFENESIN,Expired product administered,,GUAIFENESIN | Expired product administered,NaT
257538201,25753820,59,F,2022-08-01,20250903,,SOLIFENACIN,Dyspnoea,HO,SOLIFENACIN | Dyspnoea | HO,2022-08-01/2022-08-07
257539561,25753956,13,,,20250903,,ASPIRIN,Product administered to patient of inappropriate age,OT,ASPIRIN | Product administered to patient of inappropriate age | OT,NaT
257539691,25753969,,F,,20250903,,ESTRADIOL,Influenza,,ESTRADIOL | Influenza,NaT
257540531,25754053,79,M,2025-07-28,20250903,,ZOLEDRONIC ACID,Liver injury,OT,ZOLEDRONIC ACID | Liver injury | OT,2025-07-28/2025-08-03
257541271,25754127,,,,20250903,,METHOTREXATE,Memory impairment,DE,METHOTREXATE | Memory impairment | DE,NaT
257541641,25754164,75,M,2025-01-01,20250903,,GEMCITABINE,Immune effector cell-associated neurotoxicity syndrome,DE,GEMCITABINE | Immune effector cell-associated neurotoxicity syndrome | DE,2024-12-30/2025-01-05
257543341,25754334,3,F,,20250903,,DEXTROSE,Drug ineffective for unapproved indication,HO,DEXTROSE | Drug ineffective for unapproved indication | HO,NaT
257543581,25754358,31,M,,20250903,,AZACITIDINE,Product use in unapproved indication,OT,AZACITIDINE | Product use in unapproved indication | OT,NaT
257543712,25754371,53,F,,20250904,,ORENCIA,Product storage error,,ORENCIA | Product storage error,NaT
257544051,25754405,51,M,2025-08-29,20250903,,DAPAGLIFLOZIN,Dermatitis bullous,OT,DAPAGLIFLOZIN | Dermatitis bullous | OT,2025-08-25/2025-08-31
257544691,25754469,76,M,2025-07-24,20250903,,VONOPRAZAN FUMARATE,Pleural effusion,HO,VONOPRAZAN FUMARATE | Pleural effusion | HO,2025-07-21/2025-07-27
257545091,25754509,5,F,,20250903,,ANDEMBRY,Hereditary angioedema,OT,ANDEMBRY | Hereditary angioedema | OT,NaT
257545111,25754511,59,M,2025-08-21,20250903,,CIPROFLOXACIN,Disturbance in attention,OT,CIPROFLOXACIN | Disturbance in attention | OT,2025-08-18/2025-08-24
257545551,25754555,40,M,,20250903,,PREGABALIN,Toxicity to various agents,DE,PREGABALIN | Toxicity to various agents | DE,NaT
257545971,25754597,,M,,20250903,,PREGABALIN,Urticaria,,PREGABALIN | Urticaria,NaT
257546061,25754606,,M,,20250903,,PREGABALIN,Headache,,PREGABALIN | Headache,NaT
257546471,25754647,16,F,,20250903,,GABAPENTIN,Treatment failure,,GABAPENTIN | Treatment failure,NaT
257547071,25754707,62,M,2025-08-25,20250903,,METGLUCO,Weight decreased,OT,METGLUCO | Weight decreased | OT,2025-08-25/2025-08-31
257547161,25754716,81,F,,20250903,,INPEFA,Surgery,HO,INPEFA | Surgery | HO,NaT
257549081,25754908,77,F,,20250903,,PEMETREXED,Disease progression,OT,PEMETREXED | Disease progression | OT,NaT
257550821,25755082,35,M,2025-08-25,20250903,,DIPROSPAN,Hypotension,OT,DIPROSPAN | Hypotension | OT,2025-08-25/2025-08-31
257551001,25755100,65,M,,20250903,,METOPROLOL,BRASH syndrome,HO,METOPROLOL | BRASH syndrome | HO,NaT
257551161,25755116,83,M,,20250903,,ORGOVYX,Hot flush,,ORGOVYX | Hot flush,NaT
257551261,25755126,,F,,20250903,,DUPIXENT,COVID-19 pneumonia,OT,DUPIXENT | COVID-19 pneumonia | OT,NaT
257551451,25755145,67,M,2025-08-27,20250903,,ZEPBOUND,Chills,,ZEPBOUND | Chills,2025-08-25/2025-08-31
257552771,25755277,63,F,2025-07-21,20250903,,HUMALOG,Fatigue,,HUMALOG | Fatigue,2025-07-21/2025-07-27
257554061,25755406,,M,,20250903,,NUPLAZID,Adverse drug reaction,OT,NUPLAZID | Adverse drug reaction | OT,NaT
257554361,25755436,,F,,20250903,,DAYBUE,Diarrhoea,,DAYBUE | Diarrhoea,NaT
257554511,25755451,47,F,2025-08-08,20250903,,INFLIXIMAB,Malaise,HO,INFLIXIMAB | Malaise | HO,2025-08-04/2025-08-10
257554701,25755470,77,F,2025-08-25,20250903,,NUPLAZID,Condition aggravated,OT,NUPLAZID | Condition aggravated | OT,2025-08-25/2025-08-31
257555061,25755506,45,M,2025-01-01,20250903,,SPRAVATO,Drug abuse,OT,SPRAVATO | Drug abuse | OT,2024-12-30/2025-01-05
257555941,25755594,69,F,,20250903,,MOUNJARO,Accidental underdose,,MOUNJARO | Accidental underdose,NaT
257556943,25755694,,F,2024-01-01,20250918,,KISQALI,Cataract,OT,KISQALI | Cataract | OT,2024-01-01/2024-01-07
257558321,25755832,26,F,,20250903,,DULOXETINE,Constipation,OT,DULOXETINE | Constipation | OT,NaT
257560051,25756005,,M,,20250903,,TECENTRIQ,Hypersensitivity,HO,TECENTRIQ | Hypersensitivity | HO,NaT
257560941,25756094,68,M,2025-08-11,20250903,,SODIUM CHLORIDE,Myelosuppression,OT,SODIUM CHLORIDE | Myelosuppression | OT,2025-08-11/2025-08-17
257561291,25756129,59,F,2025-08-02,20250902,,HADLIMA,Rash,HO,HADLIMA | Rash | HO,2025-07-28/2025-08-03
257561781,25756178,60,M,2024-07-01,20250903,,CLARITHROMYCIN,Deafness bilateral,DS,CLARITHROMYCIN | Deafness bilateral | DS,2024-07-01/2024-07-07
257561941,25756194,67,M,2025-08-28,20250903,,TECVAYLI,Urosepsis,HO,TECVAYLI | Urosepsis | HO,2025-08-25/2025-08-31
257562041,25756204,55,F,2024-01-01,20250903,,OZEMPIC,Vitamin D decreased,OT,OZEMPIC | Vitamin D decreased | OT,2024-01-01/2024-01-07
257562101,25756210,,F,,20250903,,LENVIMA,Hypothyroidism,HO,LENVIMA | Hypothyroidism | HO,NaT
257562221,25756222,49,,,20250903,,OZEMPIC,Dehydration,OT,OZEMPIC | Dehydration | OT,NaT
257562231,25756223,,F,,20250903,,SAXENDA,Abnormal uterine bleeding,OT,SAXENDA | Abnormal uterine bleeding | OT,NaT
257562351,25756235,74,M,2024-10-01,20250903,,OZEMPIC,Urinary tract infection,OT,OZEMPIC | Urinary tract infection | OT,2024-09-30/2024-10-06
257562681,25756268,,,,20250902,,OPSUMIT,Ill-defined disorder,,OPSUMIT | Ill-defined disorder,NaT
257562971,25756297,4,F,2025-01-01,20250903,,ACETAMINOPHEN\BUTALBITAL\CAFFEINE,Intentional overdose,HO,ACETAMINOPHEN\BUTALBITAL\CAFFEINE | Intentional overdose | HO,2024-12-30/2025-01-05
257563141,25756314,75,F,2025-07-31,20250903,,AMLODIPINE,Asthenia,OT,AMLODIPINE | Asthenia | OT,2025-07-28/2025-08-03
257564131,25756413,,M,,20250902,,TRACLEER,Respiratory disorder,HO,TRACLEER | Respiratory disorder | HO,NaT
257564761,25756476,68,F,,20250903,,LINEZOLID,Papillitis,OT,LINEZOLID | Papillitis | OT,NaT
257565501,25756550,65,F,2025-01-01,20250903,,DUPIXENT,Mental status changes,,DUPIXENT | Mental status changes,2024-12-30/2025-01-05
257565852,25756585,9,M,2025-01-01,20250923,,DUPIXENT,Wheezing,,DUPIXENT | Wheezing,2024-12-30/2025-01-05
257566121,25756612,,F,,20250903,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,NaT
257566161,25756616,59,F,2025-08-01,20250903,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2025-07-28/2025-08-03
257566191,25756619,33,F,2025-01-01,20250903,,DUPIXENT,Dry skin,,DUPIXENT | Dry skin,2024-12-30/2025-01-05
257566451,25756645,34,M,2025-08-08,20250903,,FABRAZYME,Drug specific antibody present,,FABRAZYME | Drug specific antibody present,2025-08-04/2025-08-10
257566551,25756655,,F,,20250903,,DUPIXENT,Injection site swelling,,DUPIXENT | Injection site swelling,NaT
257567781,25756778,71,F,2025-07-01,20250903,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2025-06-30/2025-07-06
257568072,25756807,24,M,,20250908,,ACETAMINOPHEN,Angioedema,OT,ACETAMINOPHEN | Angioedema | OT,NaT
257569531,25756953,,M,,20250903,,HUMIRA,Product storage error,,HUMIRA | Product storage error,NaT
257569541,25756954,61,F,2021-10-04,20250903,,DUPIXENT,Eosinophilic pneumonia,HO,DUPIXENT | Eosinophilic pneumonia | HO,2021-10-04/2021-10-10
257570121,25757012,75,,,20250903,,ELIQUIS,Embolic stroke,OT,ELIQUIS | Embolic stroke | OT,NaT
257570271,25757027,,,2025-08-15,20250903,,AZATHIOPRINE,Pancreatitis,HO,AZATHIOPRINE | Pancreatitis | HO,2025-08-11/2025-08-17
257570311,25757031,,,,20250903,,PHESGO,Fatigue,,PHESGO | Fatigue,NaT
257570711,25757071,55,,,20250903,,LANTUS SOLOSTAR,Off label use,,LANTUS SOLOSTAR | Off label use,NaT
257573341,25757334,33,F,2025-08-14,20250903,,FERINJECT,Hypoaesthesia,OT,FERINJECT | Hypoaesthesia | OT,2025-08-11/2025-08-17
257574751,25757475,,F,,20250903,,LEVOXYL,Hormone level abnormal,,LEVOXYL | Hormone level abnormal,NaT
257574892,25757489,36,F,2025-08-17,20250909,,METHOTREXATE SODIUM,Off label use,HO,METHOTREXATE SODIUM | Off label use | HO,2025-08-11/2025-08-17
257575702,25757570,56,F,,20250904,,LORLATINIB,Gait inability,HO,LORLATINIB | Gait inability | HO,NaT
257577091,25757709,,,,20250903,,RINVOQ,Off label use,,RINVOQ | Off label use,NaT
257577141,25757714,65,M,,20250903,,OZEMPIC,Gastroenteritis,OT,OZEMPIC | Gastroenteritis | OT,NaT
257577251,25757725,20,F,2023-03-01,20250903,,AMLODIPINE BESYLATE,Overdose,OT,AMLODIPINE BESYLATE | Overdose | OT,2023-02-27/2023-03-05
257577761,25757776,78,F,,20250903,,KEYTRUDA,Malignant neoplasm progression,DE,KEYTRUDA | Malignant neoplasm progression | DE,NaT
257578841,25757884,,F,,20250903,,ZURZUVAE,Neurological symptom,,ZURZUVAE | Neurological symptom,NaT
257579091,25757909,,F,,20250903,,COSENTYX,Drug hypersensitivity,,COSENTYX | Drug hypersensitivity,NaT
257579221,25757922,72,M,,20250903,,GLIVEC,Second primary malignancy,OT,GLIVEC | Second primary malignancy | OT,NaT
257579451,25757945,,M,2025-08-29,20250903,,DUPIXENT,Wrong patient received product,,DUPIXENT | Wrong patient received product,2025-08-25/2025-08-31
257579911,25757991,59,,,20250903,,TISLELIZUMAB,Myelosuppression,OT,TISLELIZUMAB | Myelosuppression | OT,NaT
257581241,25758124,81,M,2025-07-27,20250903,,HUMALOG,Dyspnoea,OT,HUMALOG | Dyspnoea | OT,2025-07-21/2025-07-27
257582961,25758296,,F,,20250904,,IBUPROFEN,Cyanosis,OT,IBUPROFEN | Cyanosis | OT,NaT
257583111,25758311,,M,,20250904,,DICLOFENAC SODIUM,Drug ineffective,,DICLOFENAC SODIUM | Drug ineffective,NaT
257583391,25758339,70,M,,20250904,,AMBRISENTAN,Death,OT,AMBRISENTAN | Death | OT,NaT
257584612,25758461,52,F,2019-01-09,20250918,,KADCYLA,Rash,HO,KADCYLA | Rash | HO,2019-01-07/2019-01-13
257584671,25758467,40,F,,20250904,,PREDNISONE,Histoplasmosis disseminated,HO,PREDNISONE | Histoplasmosis disseminated | HO,NaT
257585201,25758520,52,F,,20250904,,DIAZEPAM,Vomiting,HO,DIAZEPAM | Vomiting | HO,NaT
257585361,25758536,17,F,,20250904,,CARBOPLATIN,Second primary malignancy,OT,CARBOPLATIN | Second primary malignancy | OT,NaT
257585481,25758548,83,F,2025-08-30,20250904,,CARBIDOPA\LEVODOPA,Transient ischaemic attack,HO,CARBIDOPA\LEVODOPA | Transient ischaemic attack | HO,2025-08-25/2025-08-31
257585621,25758562,,M,,20250904,,SPORANOX,Autism spectrum disorder,OT,SPORANOX | Autism spectrum disorder | OT,NaT
257585691,25758569,,F,2024-11-18,20250904,,FINGOLIMOD,Central nervous system lesion,LT,FINGOLIMOD | Central nervous system lesion | LT,2024-11-18/2024-11-24
257586601,25758660,,F,,20250904,,DUPIXENT,Inappropriate schedule of product administration,,DUPIXENT | Inappropriate schedule of product administration,NaT
257586851,25758685,24,F,,20250904,,DUPIXENT,Discomfort,,DUPIXENT | Discomfort,NaT
257586982,25758698,32,F,2025-08-01,20250927,,DUPIXENT,Rhinorrhoea,,DUPIXENT | Rhinorrhoea,2025-07-28/2025-08-03
257588281,25758828,63,M,,20250904,,MYCOPHENOLATE MOFETIL,Acute respiratory failure,HO,MYCOPHENOLATE MOFETIL | Acute respiratory failure | HO,NaT
257588691,25758869,,,,20250904,,METRONIDAZOLE,Drug ineffective,HO,METRONIDAZOLE | Drug ineffective | HO,NaT
257589581,25758958,62,F,2025-08-01,20250904,,AYVAKIT,Ear canal erythema,,AYVAKIT | Ear canal erythema,2025-07-28/2025-08-03
257589821,25758982,59,M,2025-08-01,20250904,,DUPIXENT,Nausea,,DUPIXENT | Nausea,2025-07-28/2025-08-03
257589851,25758985,32,,,20250904,,DUPIXENT,Neutrophil count decreased,,DUPIXENT | Neutrophil count decreased,NaT
257590711,25759071,77,F,,20250904,,REVLIMID,Product dose omission issue,,REVLIMID | Product dose omission issue,NaT
257592361,25759236,,,,20250904,,SIMPONI,Product storage error,,SIMPONI | Product storage error,NaT
257592641,25759264,18,M,2025-08-18,20250904,,GLUCOPHAGE XR,Hepatic function abnormal,OT,GLUCOPHAGE XR | Hepatic function abnormal | OT,2025-08-18/2025-08-24
257592681,25759268,70,F,,20250904,,METFORMIN HYDROCHLORIDE,Lactic acidosis,OT,METFORMIN HYDROCHLORIDE | Lactic acidosis | OT,NaT
257593621,25759362,,,,20250904,,ADALIMUMAB,Pneumonia,OT,ADALIMUMAB | Pneumonia | OT,NaT
257593841,25759384,,M,,20250904,,ACETAMINOPHEN\OXYCODONE HYDROCHLORIDE,Blood pressure abnormal,,ACETAMINOPHEN\OXYCODONE HYDROCHLORIDE | Blood pressure abnormal,NaT
257594291,25759429,6,F,2020-07-21,20250904,,FERRIPROX,Red blood cell count decreased,,FERRIPROX | Red blood cell count decreased,2020-07-20/2020-07-26
257594801,25759480,32,F,,20250904,,VARITHENA,Thrombosis,,VARITHENA | Thrombosis,NaT
257595091,25759509,61,F,2025-08-05,20250904,,PREGABALIN,Hyponatraemia,HO,PREGABALIN | Hyponatraemia | HO,2025-08-04/2025-08-10
257595892,25759589,63,F,2025-08-01,20250917,,TYVASO DPI,Dyspnoea,,TYVASO DPI | Dyspnoea,2025-07-28/2025-08-03
257596521,25759652,,F,,20250904,,ELIGARD,Intercepted product preparation error,,ELIGARD | Intercepted product preparation error,NaT
257596741,25759674,48,M,2025-08-15,20250904,,SODIUM CHLORIDE,Myelosuppression,LT,SODIUM CHLORIDE | Myelosuppression | LT,2025-08-11/2025-08-17
257597561,25759756,,M,,20250904,,DUPIXENT,Eyelid margin crusting,,DUPIXENT | Eyelid margin crusting,NaT
257597961,25759796,,,2025-08-12,20250904,,NEMLUVIO,Device use issue,,NEMLUVIO | Device use issue,2025-08-11/2025-08-17
257598391,25759839,,,,20250904,,LAMOTRIGINE,Electrocardiogram abnormal,OT,LAMOTRIGINE | Electrocardiogram abnormal | OT,NaT
257598881,25759888,,M,2021-06-04,20250904,,ARIPIPRAZOLE,Premature baby,HO,ARIPIPRAZOLE | Premature baby | HO,2021-05-31/2021-06-06
257599901,25759990,63,M,,20250904,,METHOTREXATE,Arthralgia,OT,METHOTREXATE | Arthralgia | OT,NaT
257600221,25760022,,F,2025-01-01,20250904,,CIMZIA,Psoriasis,OT,CIMZIA | Psoriasis | OT,2024-12-30/2025-01-05
257600272,25760027,48,F,2025-01-01,20250927,,DUPIXENT,Arthralgia,,DUPIXENT | Arthralgia,2024-12-30/2025-01-05
257600331,25760033,55,M,,20250904,,LANTUS,Off label use,,LANTUS | Off label use,NaT
257600421,25760042,48,M,,20250904,,LOSARTAN POTASSIUM,Hypertensive crisis,OT,LOSARTAN POTASSIUM | Hypertensive crisis | OT,NaT
257601561,25760156,68,M,2025-08-06,20250904,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,2025-08-04/2025-08-10
257601601,25760160,,,,20250904,,TREMFYA,Swollen tongue,,TREMFYA | Swollen tongue,NaT
257601621,25760162,53,,,20250904,,MODAFINIL,Drug interaction,,MODAFINIL | Drug interaction,NaT
257601891,25760189,59,F,,20250904,,ENTYVIO,Oral discomfort,,ENTYVIO | Oral discomfort,NaT
257602221,25760222,,F,,20250904,,LUCENTIS,Vision blurred,,LUCENTIS | Vision blurred,NaT
257602491,25760249,67,M,2025-08-01,20250903,,DOVATO,Pneumonia aspiration,HO,DOVATO | Pneumonia aspiration | HO,2025-07-28/2025-08-03
257602571,25760257,48,F,2025-08-27,20250904,,CYCLOPHOSPHAMIDE,Myelosuppression,OT,CYCLOPHOSPHAMIDE | Myelosuppression | OT,2025-08-25/2025-08-31
257603171,25760317,,M,,20250903,,INVEGA SUSTENNA,Hospitalisation,HO,INVEGA SUSTENNA | Hospitalisation | HO,NaT
257603831,25760383,79,M,2024-12-23,20250904,,PREDNISONE,Acute respiratory failure,OT,PREDNISONE | Acute respiratory failure | OT,2024-12-23/2024-12-29
257604021,25760402,50,M,,20250904,,METHOTREXATE,Rebound effect,OT,METHOTREXATE | Rebound effect | OT,NaT
257604311,25760431,,F,,20250904,,TYVASO DPI,Arthropathy,OT,TYVASO DPI | Arthropathy | OT,NaT
257604751,25760475,69,M,2025-01-01,20250904,,KEVZARA,Injection site pain,,KEVZARA | Injection site pain,2024-12-30/2025-01-05
257605271,25760527,36,F,2015-08-17,20250904,,AVONEX,Caesarean section,OT,AVONEX | Caesarean section | OT,2015-08-17/2015-08-23
257606261,25760626,66,F,,20250904,,PENICILLIN G SODIUM,Drug hypersensitivity,,PENICILLIN G SODIUM | Drug hypersensitivity,NaT
257606441,25760644,,M,,20250904,,PLUVICTO,Laboratory test abnormal,HO,PLUVICTO | Laboratory test abnormal | HO,NaT
257606691,25760669,43,M,,20250904,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,NaT
257607171,25760717,53,M,,20250904,,MOUNJARO,Injection site haemorrhage,,MOUNJARO | Injection site haemorrhage,NaT
257608351,25760835,,,,20250904,,IRESSA,Death,DE,IRESSA | Death | DE,NaT
257609871,25760987,7,M,,20250904,,EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL FUMARATE,Osteoporosis,OT,EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL FUMARATE | Osteoporosis | OT,NaT
257610511,25761051,,M,2025-01-01,20250904,,ELEXACAFTOR\IVACAFTOR\TEZACAFTOR,Influenza,HO,ELEXACAFTOR\IVACAFTOR\TEZACAFTOR | Influenza | HO,2024-12-30/2025-01-05
257611341,25761134,73,M,2025-08-18,20250904,,BAVENCIO,Hypoxia,OT,BAVENCIO | Hypoxia | OT,2025-08-18/2025-08-24
257611361,25761136,,,,20250904,,SIMPONI ARIA,Incorrect dose administered,,SIMPONI ARIA | Incorrect dose administered,NaT
257611861,25761186,49,F,2025-07-18,20250904,,DUPILUMAB,Lichenoid keratosis,HO,DUPILUMAB | Lichenoid keratosis | HO,2025-07-14/2025-07-20
257611941,25761194,72,F,2024-09-01,20250904,,IBRANCE,Death,DE,IBRANCE | Death | DE,2024-08-26/2024-09-01
257612281,25761228,,F,,20250904,,EVENITY,Bone disorder,OT,EVENITY | Bone disorder | OT,NaT
257612621,25761262,,F,,20250904,,GOLYTELY,Drug ineffective,,GOLYTELY | Drug ineffective,NaT
257612701,25761270,,M,2024-09-01,20250904,,GOLYTELY,Constipation,,GOLYTELY | Constipation,2024-08-26/2024-09-01
257612771,25761277,70,M,2024-11-01,20250904,,PEG-3350 AND ELECTROLYTES,Pollakiuria,,PEG-3350 AND ELECTROLYTES | Pollakiuria,2024-10-28/2024-11-03
257612832,25761283,,,2025-01-01,20250910,,HYDROXYCHLOROQUINE,Myopathy toxic,OT,HYDROXYCHLOROQUINE | Myopathy toxic | OT,2024-12-30/2025-01-05
257613381,25761338,60,M,2025-04-02,20250904,,PALEXIA,Rectal haemorrhage,DE,PALEXIA | Rectal haemorrhage | DE,2025-03-31/2025-04-06
257613811,25761381,42,F,2023-01-01,20250904,,PACLITAXEL,Gastrointestinal disorder,OT,PACLITAXEL | Gastrointestinal disorder | OT,2022-12-26/2023-01-01
257613872,25761387,48,M,2025-08-11,20250908,,CYTARABINE,Toxic epidermal necrolysis,DE,CYTARABINE | Toxic epidermal necrolysis | DE,2025-08-11/2025-08-17
257613921,25761392,53,F,2023-04-19,20250904,,COSENTYX,Pruritus,OT,COSENTYX | Pruritus | OT,2023-04-17/2023-04-23
257614352,25761435,12,F,2025-08-24,20250910,,GENOTROPIN,Device leakage,,GENOTROPIN | Device leakage,2025-08-18/2025-08-24
257614981,25761498,90,F,2024-12-09,20250904,,RASUVO,Product dose omission issue,,RASUVO | Product dose omission issue,2024-12-09/2024-12-15
257615121,25761512,,F,2024-01-01,20250904,,RASUVO,Injection site bruising,,RASUVO | Injection site bruising,2024-01-01/2024-01-07
257615131,25761513,,F,2023-01-01,20250904,,RASUVO,Duodenal polyp,,RASUVO | Duodenal polyp,2022-12-26/2023-01-01
257615451,25761545,48,F,2025-08-18,20250903,,SULFAMETHOXAZOLE AND TRIMETHOPRIM,Pain in extremity,,SULFAMETHOXAZOLE AND TRIMETHOPRIM | Pain in extremity,2025-08-18/2025-08-24
257616431,25761643,,M,,20250904,,BRENTUXIMAB VEDOTIN,Leukopenia,OT,BRENTUXIMAB VEDOTIN | Leukopenia | OT,NaT
257616711,25761671,,,,20250904,,MOUNJARO,Appendicitis,OT,MOUNJARO | Appendicitis | OT,NaT
257616871,25761687,31,M,2024-01-01,20250904,,CABOMETYX,Gastrointestinal toxicity,OT,CABOMETYX | Gastrointestinal toxicity | OT,2024-01-01/2024-01-07
257617341,25761734,,F,,20250904,,HABITROL,Product adhesion issue,,HABITROL | Product adhesion issue,NaT
257618291,25761829,,,,20250904,,NEMLUVIO,Product dose omission issue,,NEMLUVIO | Product dose omission issue,NaT
257619042,25761904,,,,20250916,,VYEPTI,Impaired quality of life,,VYEPTI | Impaired quality of life,NaT
257619111,25761911,,,,20250904,,TRAMADOL,Adverse event,,TRAMADOL | Adverse event,NaT
257619611,25761961,56,F,2023-01-01,20250904,,PACLITAXEL,Cell death,OT,PACLITAXEL | Cell death | OT,2022-12-26/2023-01-01
257621391,25762139,57,F,2025-04-02,20250904,,CLIMARA PRO,Application site rash,,CLIMARA PRO | Application site rash,2025-03-31/2025-04-06
257622273,25762227,,,,20250911,,KESIMPTA,General physical health deterioration,,KESIMPTA | General physical health deterioration,NaT
257622801,25762280,,M,,20250904,,SUTENT,Death,DE,SUTENT | Death | DE,NaT
257624331,25762433,14,F,2025-08-08,20250904,,HUMALOG JUNIOR KWIKPEN,Haemorrhage,,HUMALOG JUNIOR KWIKPEN | Haemorrhage,2025-08-04/2025-08-10
257624581,25762458,73,F,2025-08-18,20250904,,LENALIDOMIDE,Fatigue,,LENALIDOMIDE | Fatigue,2025-08-18/2025-08-24
257625242,25762524,73,M,,20250916,,ABIRATERONE,Cerebral infarction,HO,ABIRATERONE | Cerebral infarction | HO,NaT
257625391,25762539,,,2025-08-19,20250904,,BRAFTOVI,Abdominal pain upper,OT,BRAFTOVI | Abdominal pain upper | OT,2025-08-18/2025-08-24
257625921,25762592,3,F,,20250904,,DUPIXENT,Eye irritation,,DUPIXENT | Eye irritation,NaT
257626001,25762600,,F,2025-08-27,20250904,,LEQVIO,Arthralgia,,LEQVIO | Arthralgia,2025-08-25/2025-08-31
257626191,25762619,,,2025-08-19,20250904,,JOENJA,Food poisoning,,JOENJA | Food poisoning,2025-08-18/2025-08-24
257626531,25762653,51,M,,20250904,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,NaT
257627991,25762799,,,,20250904,,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,Adverse event,,HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Adverse event,NaT
257629261,25762926,77,M,2024-10-10,20250904,,BISOPROLOL,Confusional state,OT,BISOPROLOL | Confusional state | OT,2024-10-07/2024-10-13
257629591,25762959,77,M,,20250904,,POMALYST,Therapy interrupted,,POMALYST | Therapy interrupted,NaT
257630141,25763014,,,,20250904,,TAGRISSO,Metastasis,OT,TAGRISSO | Metastasis | OT,NaT
257630341,25763034,70,M,2025-08-25,20250904,,GLECAPREVIR\PIBRENTASVIR,Cardio-respiratory arrest,DE,GLECAPREVIR\PIBRENTASVIR | Cardio-respiratory arrest | DE,2025-08-25/2025-08-31
257630842,25763084,87,M,,20250915,,DARZALEX,Blood glucose increased,OT,DARZALEX | Blood glucose increased | OT,NaT
257632101,25763210,,M,,20250905,,DUPIXENT,Dyspnoea,,DUPIXENT | Dyspnoea,NaT
257632641,25763264,67,M,,20250905,,APIXABAN,Hepatic haematoma,LT,APIXABAN | Hepatic haematoma | LT,NaT
257632712,25763271,66,M,,20250930,,ACETAZOLAMIDE,Somnolence,HO,ACETAZOLAMIDE | Somnolence | HO,NaT
257632871,25763287,,F,,20250905,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
257634401,25763440,55,M,,20250905,,TRULICITY,Dyspepsia,,TRULICITY | Dyspepsia,NaT
257634681,25763468,72,M,2025-07-01,20250905,,SIRTURO,Electrocardiogram QT prolonged,OT,SIRTURO | Electrocardiogram QT prolonged | OT,2025-06-30/2025-07-06
257635121,25763512,53,F,,20250905,,PREDNISOLONE,Mouth ulceration,OT,PREDNISOLONE | Mouth ulceration | OT,NaT
257635761,25763576,,F,,20250905,,OXERVATE,Eye irritation,,OXERVATE | Eye irritation,NaT
257635771,25763577,,F,,20250905,,OXERVATE,Vitreous floaters,,OXERVATE | Vitreous floaters,NaT
257636261,25763626,,M,,20250905,,OXERVATE,Eye pain,,OXERVATE | Eye pain,NaT
257636341,25763634,,F,,20250905,,OXERVATE,Wrong technique in product usage process,,OXERVATE | Wrong technique in product usage process,NaT
257636451,25763645,,M,,20250905,,OXERVATE,Product dose omission issue,,OXERVATE | Product dose omission issue,NaT
257636731,25763673,,F,,20250905,,OXERVATE,Eye pain,,OXERVATE | Eye pain,NaT
257637001,25763700,,F,,20250905,,OXERVATE,Eyelid pain,,OXERVATE | Eyelid pain,NaT
257637491,25763749,,F,,20250905,,OXERVATE,Eyelid pain,,OXERVATE | Eyelid pain,NaT
257637671,25763767,,M,,20250905,,DULOXETINE HYDROCHLORIDE,Accidental overdose,,DULOXETINE HYDROCHLORIDE | Accidental overdose,NaT
257637701,25763770,51,F,2024-11-17,20250905,,OXERVATE,Lacrimation increased,,OXERVATE | Lacrimation increased,2024-11-11/2024-11-17
257637921,25763792,80,F,2024-12-06,20250905,,OXERVATE,Eye swelling,,OXERVATE | Eye swelling,2024-12-02/2024-12-08
257638071,25763807,,F,,20250905,,OXERVATE,Eye pain,,OXERVATE | Eye pain,NaT
257638111,25763811,,F,,20250905,,OXERVATE,Periorbital pain,,OXERVATE | Periorbital pain,NaT
257638391,25763839,78,F,2024-11-14,20250905,,OXERVATE,Headache,,OXERVATE | Headache,2024-11-11/2024-11-17
257639511,25763951,45,F,2024-11-19,20250905,,OXERVATE,Eye pain,,OXERVATE | Eye pain,2024-11-18/2024-11-24
257639561,25763956,,F,,20250905,,OXERVATE,Ocular discomfort,,OXERVATE | Ocular discomfort,NaT
257639821,25763982,,M,2021-01-01,20250905,,VALCHLOR,Eczema,HO,VALCHLOR | Eczema | HO,2020-12-28/2021-01-03
257641321,25764132,,,,20250905,,RITUXIMAB,Oropharyngeal pain,OT,RITUXIMAB | Oropharyngeal pain | OT,NaT
257641761,25764176,36,F,,20250905,,TALTZ,Inappropriate schedule of product administration,,TALTZ | Inappropriate schedule of product administration,NaT
257641781,25764178,41,M,2025-08-21,20250905,,MOUNJARO,Flatulence,,MOUNJARO | Flatulence,2025-08-18/2025-08-24
257641981,25764198,32,F,2024-12-11,20250905,,OXERVATE,Ocular hyperaemia,,OXERVATE | Ocular hyperaemia,2024-12-09/2024-12-15
257642221,25764222,65,M,2024-12-18,20250905,,OXERVATE,Periorbital pain,,OXERVATE | Periorbital pain,2024-12-16/2024-12-22
257642311,25764231,72,F,2024-12-16,20250905,,OXERVATE,Eye pain,,OXERVATE | Eye pain,2024-12-16/2024-12-22
257642441,25764244,,M,,20250905,,OXERVATE,Dry eye,,OXERVATE | Dry eye,NaT
257642551,25764255,62,F,2025-01-05,20250905,,OXERVATE,Eye pain,,OXERVATE | Eye pain,2024-12-30/2025-01-05
257642611,25764261,86,F,2024-12-19,20250905,,OXERVATE,Product dose omission issue,,OXERVATE | Product dose omission issue,2024-12-16/2024-12-22
257642621,25764262,,F,,20250905,,OXERVATE,Dyspnoea,,OXERVATE | Dyspnoea,NaT
257643271,25764327,,F,,20250905,,OXERVATE,Eyelid pain,,OXERVATE | Eyelid pain,NaT
257643821,25764382,,F,,20250905,,OXERVATE,Ocular hyperaemia,,OXERVATE | Ocular hyperaemia,NaT
257644151,25764415,,F,,20250905,,ACETAMINOPHEN,Eye pain,,ACETAMINOPHEN | Eye pain,NaT
257644411,25764441,78,F,2025-01-29,20250905,,OXERVATE,Product dose omission issue,,OXERVATE | Product dose omission issue,2025-01-27/2025-02-02
257644871,25764487,80,F,2025-01-02,20250905,,OXERVATE,Therapy interrupted,,OXERVATE | Therapy interrupted,2024-12-30/2025-01-05
257645641,25764564,71,M,2025-01-16,20250905,,OXERVATE,Wrong technique in product usage process,,OXERVATE | Wrong technique in product usage process,2025-01-13/2025-01-19
257645821,25764582,53,F,,20250905,,BUPRENORPHINE\NALOXONE,Squamous cell carcinoma of the oral cavity,OT,BUPRENORPHINE\NALOXONE | Squamous cell carcinoma of the oral cavity | OT,NaT
257646311,25764631,,F,,20250905,,HUMIRA,Thalassaemia,OT,HUMIRA | Thalassaemia | OT,NaT
257646441,25764644,6,M,2024-10-08,20250905,,ALBUTEROL,Product odour abnormal,,ALBUTEROL | Product odour abnormal,2024-10-07/2024-10-13
257647601,25764760,,M,2024-01-01,20250905,,DOJOLVI,Decreased appetite,,DOJOLVI | Decreased appetite,2024-01-01/2024-01-07
257648451,25764845,,,,20250905,,OMALIZUMAB,Skin plaque,OT,OMALIZUMAB | Skin plaque | OT,NaT
257649161,25764916,,,,20250905,,METRONIDAZOLE,Cough,,METRONIDAZOLE | Cough,NaT
257649871,25764987,72,M,2025-01-01,20250905,,SKYRIZI,Heart valve replacement,OT,SKYRIZI | Heart valve replacement | OT,2024-12-30/2025-01-05
257650041,25765004,,,2025-08-29,20250905,,INVEGA SUSTENNA,Injection site nodule,,INVEGA SUSTENNA | Injection site nodule,2025-08-25/2025-08-31
257650301,25765030,,F,,20250905,,VEDOLIZUMAB,Crohn's disease,OT,VEDOLIZUMAB | Crohn's disease | OT,NaT
257650871,25765087,,M,,20250905,,COLCHICINE,Cardiac function test abnormal,DE,COLCHICINE | Cardiac function test abnormal | DE,NaT
257651112,25765111,89,F,2025-01-01,20250917,,MIRCERA,Fracture,HO,MIRCERA | Fracture | HO,2024-12-30/2025-01-05
257651311,25765131,,,,20250905,,TRUXIMA,Systemic lupus erythematosus,DE,TRUXIMA | Systemic lupus erythematosus | DE,NaT
257651582,25765158,,,2025-08-01,20250929,,ELTROMBOPAG OLAMINE,Thrombosis,CA,ELTROMBOPAG OLAMINE | Thrombosis | CA,2025-07-28/2025-08-03
257652501,25765250,,F,2022-06-05,20250905,,CITALOPRAM,Suicide attempt,LT,CITALOPRAM | Suicide attempt | LT,2022-05-30/2022-06-05
257653312,25765331,29,F,2025-01-01,20250911,,HUMIRA,Haematochezia,HO,HUMIRA | Haematochezia | HO,2024-12-30/2025-01-05
257653401,25765340,16,F,,20250905,,LISDEXAMFETAMINE DIMESYLATE,Raynaud's phenomenon,OT,LISDEXAMFETAMINE DIMESYLATE | Raynaud's phenomenon | OT,NaT
257654511,25765451,,,2025-02-01,20250905,,IMATINIB MESYLATE,Nausea,,IMATINIB MESYLATE | Nausea,2025-01-27/2025-02-02
257654662,25765466,,,,20250927,,FENSOLVI,Incorrect dose administered,,FENSOLVI | Incorrect dose administered,NaT
257654721,25765472,,F,2025-06-01,20250905,,JARDIANCE,Cystitis,,JARDIANCE | Cystitis,2025-05-26/2025-06-01
257655261,25765526,,,,20250905,,HUMAN IMMUNOGLOBULIN G,Foetal exposure during pregnancy,DE,HUMAN IMMUNOGLOBULIN G | Foetal exposure during pregnancy | DE,NaT
257656101,25765610,,F,2025-01-01,20250905,,OMEPRAZOLE MAGNESIUM,Dysgeusia,,OMEPRAZOLE MAGNESIUM | Dysgeusia,2024-12-30/2025-01-05
257656811,25765681,,,,20250905,,HUMAN IMMUNOGLOBULIN G,Foetal chromosome abnormality,DE,HUMAN IMMUNOGLOBULIN G | Foetal chromosome abnormality | DE,NaT
257657131,25765713,82,M,2025-09-03,20250905,,TECENTRIQ,Death,DE,TECENTRIQ | Death | DE,2025-09-01/2025-09-07
257657171,25765717,,F,,20250905,,DEXAMETHASONE,Foetal exposure during pregnancy,OT,DEXAMETHASONE | Foetal exposure during pregnancy | OT,NaT
257657381,25765738,36,F,2025-07-01,20250905,,AVONEX,Multiple sclerosis relapse,HO,AVONEX | Multiple sclerosis relapse | HO,2025-06-30/2025-07-06
257659001,25765900,,F,,20250905,,OXERVATE,Overdose,,OXERVATE | Overdose,NaT
257659191,25765919,66,F,2024-07-16,20250905,,OXERVATE,Ocular hyperaemia,,OXERVATE | Ocular hyperaemia,2024-07-15/2024-07-21
257659671,25765967,45,F,2024-07-18,20250905,,OXERVATE,Therapy interrupted,,OXERVATE | Therapy interrupted,2024-07-15/2024-07-21
257659681,25765968,,M,,20250905,,OXERVATE,Vision blurred,,OXERVATE | Vision blurred,NaT
257659741,25765974,,F,,20250905,,OXERVATE,Therapy interrupted,,OXERVATE | Therapy interrupted,NaT
257660061,25766006,,F,,20250905,,OXERVATE,Treatment noncompliance,,OXERVATE | Treatment noncompliance,NaT
257660271,25766027,,F,,20250905,,HUMAN IMMUNOGLOBULIN G,Foetal death,OT,HUMAN IMMUNOGLOBULIN G | Foetal death | OT,NaT
257660591,25766059,89,M,2025-08-01,20250905,,BREYNA,Product use complaint,,BREYNA | Product use complaint,2025-07-28/2025-08-03
257660631,25766063,58,M,2025-03-01,20250905,,SKYRIZI,Blood glucose decreased,OT,SKYRIZI | Blood glucose decreased | OT,2025-02-24/2025-03-02
257660971,25766097,63,M,,20250905,,ORGOVYX,Nausea,,ORGOVYX | Nausea,NaT
257660981,25766098,73,M,,20250905,,ORGOVYX,Testosterone deficiency syndrome,,ORGOVYX | Testosterone deficiency syndrome,NaT
257661371,25766137,,M,,20250905,,OXERVATE,Ocular hyperaemia,,OXERVATE | Ocular hyperaemia,NaT
257661971,25766197,70,M,,20250905,,ORGOVYX,Sinusitis,,ORGOVYX | Sinusitis,NaT
257662841,25766284,,,,20250905,,BOSUTINIB,Autoimmune haemolytic anaemia,OT,BOSUTINIB | Autoimmune haemolytic anaemia | OT,NaT
257663062,25766306,38,M,2023-03-01,20250915,,HYDRALAZINE,Monoclonal immunoglobulin increased,HO,HYDRALAZINE | Monoclonal immunoglobulin increased | HO,2023-02-27/2023-03-05
257663661,25766366,67,F,,20250905,,REVLIMID,Constipation,,REVLIMID | Constipation,NaT
257663871,25766387,73,F,2025-01-01,20250905,,RENFLEXIS,Therapeutic response shortened,OT,RENFLEXIS | Therapeutic response shortened | OT,2024-12-30/2025-01-05
257663931,25766393,,F,,20250905,,TADALAFIL,Limb injury,HO,TADALAFIL | Limb injury | HO,NaT
257665601,25766560,,,,20250903,,AMBRISENTAN,Hospitalisation,,AMBRISENTAN | Hospitalisation,NaT
257666121,25766612,60,F,,20250905,,AMBRISENTAN,Pneumonia,HO,AMBRISENTAN | Pneumonia | HO,NaT
257666661,25766666,,F,,20250905,,HUMIRA,Product storage error,,HUMIRA | Product storage error,NaT
257666921,25766692,,,,20250905,,PADCEV,Product label confusion,,PADCEV | Product label confusion,NaT
257667071,25766707,56,F,2025-08-24,20250905,,MOUNJARO,Injection site erythema,,MOUNJARO | Injection site erythema,2025-08-18/2025-08-24
257667171,25766717,,F,,20250905,,NIVOLUMAB,Renal failure,OT,NIVOLUMAB | Renal failure | OT,NaT
257667811,25766781,80,F,2025-08-14,20250905,,NUPLAZID,Death,DE,NUPLAZID | Death | DE,2025-08-11/2025-08-17
257667891,25766789,63,,,20250905,,PEMBROLIZUMAB,Hypothyroidism,OT,PEMBROLIZUMAB | Hypothyroidism | OT,NaT
257668311,25766831,66,F,2025-08-22,20250905,,LENALIDOMIDE,Urinary tract infection,,LENALIDOMIDE | Urinary tract infection,2025-08-18/2025-08-24
257668791,25766879,76,F,,20250905,,POMALIDOMIDE,Plasma cell myeloma,OT,POMALIDOMIDE | Plasma cell myeloma | OT,NaT
257669551,25766955,,,,20250905,,JAKAFI,Exostosis of jaw,,JAKAFI | Exostosis of jaw,NaT
257670291,25767029,,,,20250905,,OPDIVO,Cerebrovascular accident,HO,OPDIVO | Cerebrovascular accident | HO,NaT
257670781,25767078,17,F,,20250905,,DUPIXENT,Off label use,,DUPIXENT | Off label use,NaT
257671001,25767100,62,F,2025-08-01,20250905,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2025-07-28/2025-08-03
257671251,25767125,18,F,,20250905,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,NaT
257672281,25767228,28,M,2025-08-01,20250905,,DUPIXENT,Dermatitis allergic,,DUPIXENT | Dermatitis allergic,2025-07-28/2025-08-03
257672571,25767257,,,2025-09-04,20250904,,ZEPBOUND,Therapeutic response changed,,ZEPBOUND | Therapeutic response changed,2025-09-01/2025-09-07
257673521,25767352,,,,20250904,,VYVANSE,Bruxism,,VYVANSE | Bruxism,NaT
257673571,25767357,77,F,2025-09-04,20250904,,TAVNEOS,Hospitalisation,HO,TAVNEOS | Hospitalisation | HO,2025-09-01/2025-09-07
257674441,25767444,48,F,2023-08-10,20250905,,OZEMPIC,Fatigue,DS,OZEMPIC | Fatigue | DS,2023-08-07/2023-08-13
257674471,25767447,66,F,2025-08-13,20250905,,OZEMPIC,Constipation,HO,OZEMPIC | Constipation | HO,2025-08-11/2025-08-17
257674801,25767480,47,M,2025-06-28,20250905,,NOVALGIN (METAMIZOLE SODIUM),Pyrexia,OT,NOVALGIN (METAMIZOLE SODIUM) | Pyrexia | OT,2025-06-23/2025-06-29
257675831,25767583,,F,2025-06-01,20250905,,NEXPLANON,Heavy menstrual bleeding,OT,NEXPLANON | Heavy menstrual bleeding | OT,2025-05-26/2025-06-01
257675941,25767594,75,F,2025-08-27,20250905,,MOUNJARO,Wrong technique in product usage process,,MOUNJARO | Wrong technique in product usage process,2025-08-25/2025-08-31
257677151,25767715,,F,,20250905,,SCEMBLIX,Hospitalisation,,SCEMBLIX | Hospitalisation,NaT
257678341,25767834,,M,2024-08-20,20250905,,EPIPEN,Circumstance or information capable of leading to medication error,,EPIPEN | Circumstance or information capable of leading to medication error,2024-08-19/2024-08-25
257679581,25767958,,F,,20250905,,OXERVATE,Eye irritation,,OXERVATE | Eye irritation,NaT
257679602,25767960,,,2025-06-26,20250912,,ELZONRIS,Transaminases increased,HO,ELZONRIS | Transaminases increased | HO,2025-06-23/2025-06-29
257679761,25767976,,,,20250905,,OXERVATE,Off label use,,OXERVATE | Off label use,NaT
257679941,25767994,,F,,20250905,,MOUNJARO,Syncope,OT,MOUNJARO | Syncope | OT,NaT
257679981,25767998,,M,,20250905,,OXERVATE,Dry eye,,OXERVATE | Dry eye,NaT
257680001,25768000,,F,,20250905,,OXERVATE,Eye irritation,,OXERVATE | Eye irritation,NaT
257680471,25768047,,F,,20250905,,OXERVATE,Eyelid pain,,OXERVATE | Eyelid pain,NaT
257680621,25768062,,F,,20250905,,OXERVATE,Dacryocanaliculitis,,OXERVATE | Dacryocanaliculitis,NaT
257680831,25768083,,,,20250905,,AZITHROMYCIN,Drug ineffective,,AZITHROMYCIN | Drug ineffective,NaT
257681581,25768158,,,,20250905,,OXERVATE,Therapy interrupted,,OXERVATE | Therapy interrupted,NaT
257682791,25768279,,F,,20250905,,OXERVATE,Nausea,,OXERVATE | Nausea,NaT
257683141,25768314,,F,,20250905,,OXERVATE,Eye infection,,OXERVATE | Eye infection,NaT
257683191,25768319,,F,,20250905,,BENLYSTA,Cutaneous T-cell lymphoma,OT,BENLYSTA | Cutaneous T-cell lymphoma | OT,NaT
257683241,25768324,,F,,20250905,,OXERVATE,Eye pain,,OXERVATE | Eye pain,NaT
257683931,25768393,,M,,20250905,,EVEKEO,Irritability,,EVEKEO | Irritability,NaT
257684591,25768459,,F,,20250905,,CIBINQO,Tachycardia,,CIBINQO | Tachycardia,NaT
257685022,25768502,,F,,20250916,,BIMZELX,Blood urine present,OT,BIMZELX | Blood urine present | OT,NaT
257685781,25768578,62,F,,20250905,,FINGOLIMOD,Pneumonitis,OT,FINGOLIMOD | Pneumonitis | OT,NaT
257686341,25768634,67,M,2025-08-29,20250905,,CERTOLIZUMAB PEGOL,Thrombosis,OT,CERTOLIZUMAB PEGOL | Thrombosis | OT,2025-08-25/2025-08-31
257686391,25768639,,F,2025-01-01,20250905,,NUPLAZID,Drug intolerance,,NUPLAZID | Drug intolerance,2024-12-30/2025-01-05
257686402,25768640,59,M,,20250930,,EYLEA,Vitreous disorder,OT,EYLEA | Vitreous disorder | OT,NaT
257686921,25768692,,M,,20250905,,BENLYSTA,Product dose omission issue,,BENLYSTA | Product dose omission issue,NaT
257687051,25768705,,F,,20250905,,NUCALA,Asthma,,NUCALA | Asthma,NaT
257687451,25768745,,F,,20250905,,XPHOZAH,Hospitalisation,HO,XPHOZAH | Hospitalisation | HO,NaT
257687691,25768769,,F,,20250905,,IBRANCE,Liver function test increased,OT,IBRANCE | Liver function test increased | OT,NaT
257688111,25768811,44,M,2025-08-21,20250905,,BIMEKIZUMAB,Pain,HO,BIMEKIZUMAB | Pain | HO,2025-08-18/2025-08-24
257688172,25768817,52,F,2025-07-01,20250909,,YERVOY,Off label use,HO,YERVOY | Off label use | HO,2025-06-30/2025-07-06
257688941,25768894,,,,20250905,,TEMAZEPAM,Treatment failure,,TEMAZEPAM | Treatment failure,NaT
257689301,25768930,4,F,,20250905,,ZOLGENSMA,Dysphagia,HO,ZOLGENSMA | Dysphagia | HO,NaT
257689371,25768937,54,F,2024-06-01,20250905,,WINREVAIR,Inappropriate schedule of product administration,,WINREVAIR | Inappropriate schedule of product administration,2024-05-27/2024-06-02
257690461,25769046,51,M,,20250905,,TRULICITY,Injection site haemorrhage,,TRULICITY | Injection site haemorrhage,NaT
257691123,25769112,50,M,2025-09-01,20250922,,REPATHA,Injection site pain,,REPATHA | Injection site pain,2025-09-01/2025-09-07
257691421,25769142,,M,2025-08-01,20250905,,OTEZLA,Abdominal pain upper,,OTEZLA | Abdominal pain upper,2025-07-28/2025-08-03
257694721,25769472,,F,,20250906,,BREZTRI,Insomnia,,BREZTRI | Insomnia,NaT
257695061,25769506,34,M,,20250906,,TRELEGY ELLIPTA,Skin irritation,,TRELEGY ELLIPTA | Skin irritation,NaT
257695882,25769588,,F,2025-01-01,20250926,,TYVASO DPI,Device malfunction,,TYVASO DPI | Device malfunction,2024-12-30/2025-01-05
257696081,25769608,,F,,20250906,,ITRACONAZOLE,Myelitis transverse,OT,ITRACONAZOLE | Myelitis transverse | OT,NaT
257696302,25769630,,F,2025-01-01,20250907,,TREPROSTINIL SODIUM,Asthenia,OT,TREPROSTINIL SODIUM | Asthenia | OT,2024-12-30/2025-01-05
257696561,25769656,62,M,,20250906,,INSULIN LISPRO,Mobility decreased,,INSULIN LISPRO | Mobility decreased,NaT
257696611,25769661,26,M,,20250906,,JAVYGTOR,Suicidal ideation,OT,JAVYGTOR | Suicidal ideation | OT,NaT
257697451,25769745,64,F,,20250907,,VENLAFAXINE,Dry mouth,OT,VENLAFAXINE | Dry mouth | OT,NaT
257697831,25769783,57,F,,20250907,,ZEPBOUND,Constipation,,ZEPBOUND | Constipation,NaT
257698041,25769804,7,M,,20250907,,KEYTRUDA,Altered state of consciousness,DE,KEYTRUDA | Altered state of consciousness | DE,NaT
257698521,25769852,,,,20250907,,STELARA,Neutropenia,OT,STELARA | Neutropenia | OT,NaT
257698941,25769894,61,F,,20250907,,VERZENIO,Dizziness,,VERZENIO | Dizziness,NaT
257699471,25769947,53,F,,20250907,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,NaT
257699861,25769986,,,,20250907,,NEMLUVIO,Product dose omission issue,,NEMLUVIO | Product dose omission issue,NaT
257700391,25770039,58,F,2025-01-01,20250907,,DUPIXENT,Dyspnoea,,DUPIXENT | Dyspnoea,2024-12-30/2025-01-05
257701291,25770129,,M,,20250907,,SKYRIZI,Sciatica,HO,SKYRIZI | Sciatica | HO,NaT
257701371,25770137,38,F,,20250907,,COPAXONE,Skin striae,,COPAXONE | Skin striae,NaT
257701391,25770139,46,M,,20250907,,USTEKINUMAB,Off label use,HO,USTEKINUMAB | Off label use | HO,NaT
257701841,25770184,20,F,2025-01-01,20250907,,DUPIXENT,Product preparation error,,DUPIXENT | Product preparation error,2024-12-30/2025-01-05
257702441,25770244,,F,,20250907,,DAPAGLIFLOZIN,Renal disorder,OT,DAPAGLIFLOZIN | Renal disorder | OT,NaT
257702721,25770272,70,F,2025-08-21,20250907,,APOKYN,Death,DE,APOKYN | Death | DE,2025-08-18/2025-08-24
257702801,25770280,,,,20250907,,SEVOFLURANE,Hyperthermia malignant,OT,SEVOFLURANE | Hyperthermia malignant | OT,NaT
257702902,25770290,68,F,2025-07-24,20250911,,YONDELIS,Sepsis,LT,YONDELIS | Sepsis | LT,2025-07-21/2025-07-27
257703641,25770364,50,M,2025-08-28,20250908,,HYRIMOZ,Circumstance or information capable of leading to device use error,,HYRIMOZ | Circumstance or information capable of leading to device use error,2025-08-25/2025-08-31
257704491,25770449,28,F,,20250908,,COSENTYX,Ankylosing spondylitis,OT,COSENTYX | Ankylosing spondylitis | OT,NaT
257705741,25770574,,,,20250908,,IMFINZI,Cortisol increased,OT,IMFINZI | Cortisol increased | OT,NaT
257706031,25770603,51,M,2025-08-13,20250908,,OZAGREL,Dyspnoea,OT,OZAGREL | Dyspnoea | OT,2025-08-11/2025-08-17
257706181,25770618,22,F,2023-12-21,20250908,,FERRIPROX,Off label use,,FERRIPROX | Off label use,2023-12-18/2023-12-24
257706211,25770621,,F,2024-01-01,20250908,,FERRIPROX,Dyspnoea,,FERRIPROX | Dyspnoea,2024-01-01/2024-01-07
257706371,25770637,,,,20250908,,ACYCLOVIR,Malaise,,ACYCLOVIR | Malaise,NaT
257706471,25770647,,F,,20250908,,CLOTRIMAZOLE CREAM 1%,Accidental exposure to product,,CLOTRIMAZOLE CREAM 1% | Accidental exposure to product,NaT
257706651,25770665,56,F,2025-08-21,20250908,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,2025-08-18/2025-08-24
257707541,25770754,,,,20250908,,ZENPEP,Malaise,,ZENPEP | Malaise,NaT
257707741,25770774,,,,20250908,,OMALIZUMAB,Blood immunoglobulin E increased,OT,OMALIZUMAB | Blood immunoglobulin E increased | OT,NaT
257708621,25770862,,,,20250908,,ZENPEP,Product communication issue,,ZENPEP | Product communication issue,NaT
257708641,25770864,,,,20250908,,ZENPEP,Pruritus,,ZENPEP | Pruritus,NaT
257708831,25770883,,,2025-06-17,20250908,,ZENPEP,Weight decreased,,ZENPEP | Weight decreased,2025-06-16/2025-06-22
257708931,25770893,,,,20250908,,ZEPBOUND,Nasopharyngitis,,ZEPBOUND | Nasopharyngitis,NaT
257709491,25770949,,,,20250908,,THIOTEPA,Inappropriate antidiuretic hormone secretion,OT,THIOTEPA | Inappropriate antidiuretic hormone secretion | OT,NaT
257709891,25770989,39,F,2025-08-31,20250908,,EMGALITY,Nausea,,EMGALITY | Nausea,2025-08-25/2025-08-31
257712021,25771202,,F,,20250908,,OXERVATE,Therapy interrupted,,OXERVATE | Therapy interrupted,NaT
257712051,25771205,,F,,20250908,,OXERVATE,Dry eye,,OXERVATE | Dry eye,NaT
257712071,25771207,,F,,20250908,,OXERVATE,Anxiety,,OXERVATE | Anxiety,NaT
257712961,25771296,,F,,20250908,,OXERVATE,Eye pain,,OXERVATE | Eye pain,NaT
257713141,25771314,,F,,20250908,,OXERVATE,Eye pain,,OXERVATE | Eye pain,NaT
257713781,25771378,77,F,2025-04-11,20250908,,OXERVATE,Ocular hyperaemia,,OXERVATE | Ocular hyperaemia,2025-04-07/2025-04-13
257714171,25771417,,M,,20250908,,OXERVATE,Dry eye,,OXERVATE | Dry eye,NaT
257714381,25771438,,F,,20250908,,OXERVATE,Product administration error,,OXERVATE | Product administration error,NaT
257715441,25771544,,M,,20250908,,OXERVATE,Eye pain,,OXERVATE | Eye pain,NaT
257715861,25771586,,F,,20250908,,OXERVATE,Ocular discomfort,,OXERVATE | Ocular discomfort,NaT
257716221,25771622,,M,,20250908,,OXERVATE,Eye irritation,,OXERVATE | Eye irritation,NaT
257717081,25771708,,F,,20250908,,OXERVATE,Eye pain,,OXERVATE | Eye pain,NaT
257717501,25771750,,,,20250908,,GEMCITABINE,Therapy partial responder,OT,GEMCITABINE | Therapy partial responder | OT,NaT
257718311,25771831,,M,,20250908,,PREDNISONE,Drug ineffective,OT,PREDNISONE | Drug ineffective | OT,NaT
257718721,25771872,62,M,,20250908,,ORGOVYX,Fatigue,OT,ORGOVYX | Fatigue | OT,NaT
257718731,25771873,71,M,,20250908,,ORGOVYX,Drug hypersensitivity,HO,ORGOVYX | Drug hypersensitivity | HO,NaT
257719511,25771951,,M,,20250908,,IPRATROPIUM BROMIDE,Product delivery mechanism issue,,IPRATROPIUM BROMIDE | Product delivery mechanism issue,NaT
257720091,25772009,75,F,,20250908,,POMALYST,Influenza,HO,POMALYST | Influenza | HO,NaT
257720742,25772074,61,F,,20250923,,MYCOPHENOLATE MOFETIL,Therapy non-responder,OT,MYCOPHENOLATE MOFETIL | Therapy non-responder | OT,NaT
257720831,25772083,64,F,2025-08-31,20250908,,DUPIXENT,Sinusitis,,DUPIXENT | Sinusitis,2025-08-25/2025-08-31
257721221,25772122,,F,,20250908,,MAVENCLAD,Diarrhoea,OT,MAVENCLAD | Diarrhoea | OT,NaT
257721701,25772170,20,F,2025-08-20,20250908,,CABLIVI,Catheter site haemorrhage,,CABLIVI | Catheter site haemorrhage,2025-08-18/2025-08-24
257721851,25772185,36,F,,20250908,,REZUROCK,Drug ineffective,,REZUROCK | Drug ineffective,NaT
257722461,25772246,77,M,,20250908,,PEMBROLIZUMAB,Drug intolerance,,PEMBROLIZUMAB | Drug intolerance,NaT
257722872,25772287,74,M,,20250930,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,NaT
257723372,25772337,7,F,,20250920,,TACROLIMUS,Drug ineffective for unapproved indication,OT,TACROLIMUS | Drug ineffective for unapproved indication | OT,NaT
257724321,25772432,69,,,20250908,,LANTUS SOLOSTAR,Off label use,OT,LANTUS SOLOSTAR | Off label use | OT,NaT
257725631,25772563,,,,20250908,,GEMCITABINE,Myositis,,GEMCITABINE | Myositis,NaT
257726741,25772674,,,,20250908,,SERTRALINE,Multiple acyl-coenzyme A dehydrogenase deficiency,OT,SERTRALINE | Multiple acyl-coenzyme A dehydrogenase deficiency | OT,NaT
257727021,25772702,,,,20250908,,DICLOFENAC,Off label use,,DICLOFENAC | Off label use,NaT
257727271,25772727,73,F,2025-08-16,20250908,,RITUXIMAB,Oxygen saturation decreased,OT,RITUXIMAB | Oxygen saturation decreased | OT,2025-08-11/2025-08-17
257727691,25772769,73,M,,20250908,,MOUNJARO,Extra dose administered,,MOUNJARO | Extra dose administered,NaT
257728411,25772841,32,M,2025-07-01,20250906,,REXULTI,Paraphilia,RI,REXULTI | Paraphilia | RI,2025-06-30/2025-07-06
257729561,25772956,84,F,2025-08-24,20250908,,CLOZAPINE,Death,DE,CLOZAPINE | Death | DE,2025-08-18/2025-08-24
257729991,25772999,,M,,20250908,,NUPLAZID,Product dose omission issue,,NUPLAZID | Product dose omission issue,NaT
257730481,25773048,61,F,,20250908,,SKYRIZI,Brain neoplasm,OT,SKYRIZI | Brain neoplasm | OT,NaT
257730571,25773057,34,F,2016-01-01,20250908,,VALPROATE SODIUM,Hypokinesia,HO,VALPROATE SODIUM | Hypokinesia | HO,2015-12-28/2016-01-03
257730941,25773094,,F,,20250908,,JARDIANCE,Stevens-Johnson syndrome,OT,JARDIANCE | Stevens-Johnson syndrome | OT,NaT
257731171,25773117,80,F,,20250908,,LANTUS SOLOSTAR,Hypersensitivity,OT,LANTUS SOLOSTAR | Hypersensitivity | OT,NaT
257732061,25773206,,F,,20250908,,XOLAIR,Idiopathic urticaria,,XOLAIR | Idiopathic urticaria,NaT
257732381,25773238,69,F,2025-06-26,20250905,,NITROFURANTOIN MONOHYDRATE MACROCRYSTALS,Pain in extremity,,NITROFURANTOIN MONOHYDRATE MACROCRYSTALS | Pain in extremity,2025-06-23/2025-06-29
257732511,25773251,41,M,2025-08-28,20250908,,XOLAIR,Off label use,,XOLAIR | Off label use,2025-08-25/2025-08-31
257732701,25773270,77,F,,20250908,,MOUNJARO,Eye disorder,,MOUNJARO | Eye disorder,NaT
257733001,25773300,44,F,,20250908,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
257733971,25773397,,M,,20250908,,SKYRIZI,Death,DE,SKYRIZI | Death | DE,NaT
257734811,25773481,69,M,2024-12-21,20250908,,DOXORUBICIN,Diarrhoea,HO,DOXORUBICIN | Diarrhoea | HO,2024-12-16/2024-12-22
257735731,25773573,70,F,,20250908,,LENALIDOMIDE,Blindness,HO,LENALIDOMIDE | Blindness | HO,NaT
257735961,25773596,,,,20250908,,TRIMETHOPRIM,Depressed mood,OT,TRIMETHOPRIM | Depressed mood | OT,NaT
257736431,25773643,80,,,20250908,,REXULTI,Hepatic encephalopathy,DE,REXULTI | Hepatic encephalopathy | DE,NaT
257736471,25773647,57,F,2025-06-10,20250908,,PHESGO,Somnolence,OT,PHESGO | Somnolence | OT,2025-06-09/2025-06-15
257736781,25773678,,F,2025-01-01,20250908,,FERRIPROX,Off label use,,FERRIPROX | Off label use,2024-12-30/2025-01-05
257737141,25773714,,,,20250908,,TAFAMIDIS,Aortic dissection,DE,TAFAMIDIS | Aortic dissection | DE,NaT
257737351,25773735,,F,2025-07-07,20250908,,MOUNJARO,Blood pressure fluctuation,OT,MOUNJARO | Blood pressure fluctuation | OT,2025-07-07/2025-07-13
257737431,25773743,30,M,2025-03-01,20250908,,HUMALOG,Prostate cancer,HO,HUMALOG | Prostate cancer | HO,2025-02-24/2025-03-02
257738141,25773814,12,M,,20250908,,LITFULO,Rash,,LITFULO | Rash,NaT
257739271,25773927,71,M,,20250908,,OMVOH,Pulmonary embolism,OT,OMVOH | Pulmonary embolism | OT,NaT
257739751,25773975,,M,,20250908,,ULTOMIRIS,Candida infection,HO,ULTOMIRIS | Candida infection | HO,NaT
257740011,25774001,72,M,2024-01-01,20250908,,RYBELSUS,Decreased appetite,OT,RYBELSUS | Decreased appetite | OT,2024-01-01/2024-01-07
257740121,25774012,,M,,20250908,,LACTULOSE,Constipation,OT,LACTULOSE | Constipation | OT,NaT
257740221,25774022,19,F,2025-04-03,20250905,,GAMMAGARD S/D,Headache,OT,GAMMAGARD S/D | Headache | OT,2025-03-31/2025-04-06
257740551,25774055,74,M,2025-01-01,20250908,,DUPIXENT,Eczema,,DUPIXENT | Eczema,2024-12-30/2025-01-05
257740961,25774096,67,F,2020-01-01,20250908,,HUMIRA,Keratomileusis,OT,HUMIRA | Keratomileusis | OT,2019-12-30/2020-01-05
257741091,25774109,68,F,2023-01-01,20250908,,KEYTRUDA,Neuropathy peripheral,OT,KEYTRUDA | Neuropathy peripheral | OT,2022-12-26/2023-01-01
257741371,25774137,,F,,20250908,,ORMALVI,Drug ineffective,,ORMALVI | Drug ineffective,NaT
257741851,25774185,,F,2024-09-02,20250908,,WEGOVY,Dizziness,OT,WEGOVY | Dizziness | OT,2024-09-02/2024-09-08
257743121,25774312,,,,20250908,,CARVYKTI,Stenotrophomonas infection,HO,CARVYKTI | Stenotrophomonas infection | HO,NaT
257743431,25774343,67,F,2025-07-11,20250908,,EDOXABAN,Ophthalmic migraine,OT,EDOXABAN | Ophthalmic migraine | OT,2025-07-07/2025-07-13
257743761,25774376,36,M,,20250908,,TIRZEPATIDE,Diarrhoea,,TIRZEPATIDE | Diarrhoea,NaT
257743992,25774399,64,,,20250912,,JAKAFI,Fatigue,HO,JAKAFI | Fatigue | HO,NaT
257744071,25774407,58,M,,20250908,,OTEZLA,Nephrolithiasis,HO,OTEZLA | Nephrolithiasis | HO,NaT
257744482,25774448,6,F,2025-08-24,20250923,,PALIVIZUMAB,Dyspnoea,HO,PALIVIZUMAB | Dyspnoea | HO,2025-08-18/2025-08-24
257745051,25774505,,F,,20250908,,DAPAGLIFLOZIN,Death,OT,DAPAGLIFLOZIN | Death | OT,NaT
257745171,25774517,,F,,20250908,,SCEMBLIX,Anaemia,,SCEMBLIX | Anaemia,NaT
257745341,25774534,9,M,2024-07-31,20250908,,STELARA,Enteritis,OT,STELARA | Enteritis | OT,2024-07-29/2024-08-04
257745471,25774547,,,,20250908,,ACCUTANE,Mental disorder,,ACCUTANE | Mental disorder,NaT
257746071,25774607,,F,,20250908,,LANTUS SOLOSTAR,Injury associated with device,,LANTUS SOLOSTAR | Injury associated with device,NaT
257746181,25774618,88,M,2025-08-27,20250908,,NUBEQA,Cerebrovascular accident,HO,NUBEQA | Cerebrovascular accident | HO,2025-08-25/2025-08-31
257748001,25774800,,,,20250908,,DICLOFENAC,Wrong technique in product usage process,,DICLOFENAC | Wrong technique in product usage process,NaT
257748111,25774811,,M,,20250908,,AMLODIPINE BESYLATE,Wound,HO,AMLODIPINE BESYLATE | Wound | HO,NaT
257748281,25774828,53,F,2025-08-25,20250908,,ESTRADIOL TRANSDERMAL SYSTEM,Product adhesion issue,,ESTRADIOL TRANSDERMAL SYSTEM | Product adhesion issue,2025-08-25/2025-08-31
257748391,25774839,,,,20250908,,CLARITIN,Drug ineffective,,CLARITIN | Drug ineffective,NaT
257748741,25774874,73,M,2023-02-14,20250908,,GALLIUM GA-68 GOZETOTIDE,Death,DE,GALLIUM GA-68 GOZETOTIDE | Death | DE,2023-02-13/2023-02-19
257749231,25774923,61,F,2025-07-01,20250908,,LENALIDOMIDE,Thrombosis,,LENALIDOMIDE | Thrombosis,2025-06-30/2025-07-06
257749791,25774979,45,F,2025-08-01,20250908,,VICTOZA,Discomfort,HO,VICTOZA | Discomfort | HO,2025-07-28/2025-08-03
257750101,25775010,5,F,,20250908,,ARIPIPRAZOLE,Adverse reaction,OT,ARIPIPRAZOLE | Adverse reaction | OT,NaT
257750261,25775026,,,2025-01-01,20250909,,UPADACITINIB,Anal abscess,OT,UPADACITINIB | Anal abscess | OT,2024-12-30/2025-01-05
257750591,25775059,,F,,20250909,,TIRZEPATIDE,Diabetes mellitus,HO,TIRZEPATIDE | Diabetes mellitus | HO,NaT
257750951,25775095,63,M,2023-06-01,20250909,,VENCLEXTA,Acute myeloid leukaemia recurrent,OT,VENCLEXTA | Acute myeloid leukaemia recurrent | OT,2023-05-29/2023-06-04
257751473,25775147,,F,,20250926,,STELARA,Device defective,,STELARA | Device defective,NaT
257752311,25775231,73,M,2025-01-01,20250909,,CREON,Autonomic nervous system imbalance,OT,CREON | Autonomic nervous system imbalance | OT,2024-12-30/2025-01-05
257752362,25775236,67,M,2025-07-11,20250910,,OZURDEX,Type 2 diabetes mellitus,HO,OZURDEX | Type 2 diabetes mellitus | HO,2025-07-07/2025-07-13
257752621,25775262,16,F,2025-01-01,20250909,,OTEZLA,Diarrhoea,,OTEZLA | Diarrhoea,2024-12-30/2025-01-05
257752901,25775290,53,F,2025-08-29,20250909,,DUPIXENT,Dyspnoea,,DUPIXENT | Dyspnoea,2025-08-25/2025-08-31
257753011,25775301,40,M,2025-09-04,20250909,,SKYRIZI,Surgery,OT,SKYRIZI | Surgery | OT,2025-09-01/2025-09-07
257753341,25775334,,,,20250909,,VOCABRIA,Hepatitis B,OT,VOCABRIA | Hepatitis B | OT,NaT
257753481,25775348,60,F,2025-07-01,20250909,,ZEPBOUND,Injection site reaction,,ZEPBOUND | Injection site reaction,2025-06-30/2025-07-06
257753931,25775393,49,M,2023-11-24,20250909,,NIFEDIPINE,Pneumonia,HO,NIFEDIPINE | Pneumonia | HO,2023-11-20/2023-11-26
257754641,25775464,31,F,,20250909,,ACETAMINOPHEN\TRAMADOL HYDROCHLORIDE,Psychomotor skills impaired,HO,ACETAMINOPHEN\TRAMADOL HYDROCHLORIDE | Psychomotor skills impaired | HO,NaT
257755171,25775517,90,M,,20250909,,RAMIPRIL,Orthostatic hypotension,HO,RAMIPRIL | Orthostatic hypotension | HO,NaT
257756771,25775677,,,2025-08-01,20250909,,LANREOTIDE ACETATE,Drug dose omission by device,,LANREOTIDE ACETATE | Drug dose omission by device,2025-07-28/2025-08-03
257757051,25775705,,F,,20250909,,NUPLAZID,Tremor,,NUPLAZID | Tremor,NaT
257757481,25775748,62,M,,20250909,,RITUXIMAB,Muscular weakness,OT,RITUXIMAB | Muscular weakness | OT,NaT
257757682,25775768,65,F,2025-09-03,20250911,,MOUNJARO,Injection site bruising,,MOUNJARO | Injection site bruising,2025-09-01/2025-09-07
257759841,25775984,63,M,2025-01-06,20250909,,VYLOY,Platelet count decreased,OT,VYLOY | Platelet count decreased | OT,2025-01-06/2025-01-12
257760102,25776010,,M,,20250912,,YERVOY,Rash,OT,YERVOY | Rash | OT,NaT
257760261,25776026,,,,20250909,,VANCOMYCIN,Linear IgA disease,OT,VANCOMYCIN | Linear IgA disease | OT,NaT
257760491,25776049,54,F,,20250909,,TRULICITY,Hunger,,TRULICITY | Hunger,NaT
257761191,25776119,,M,,20250909,,OXERVATE,Dry eye,,OXERVATE | Dry eye,NaT
257762451,25776245,,F,,20250909,,OXERVATE,Photophobia,,OXERVATE | Photophobia,NaT
257762991,25776299,,,,20250909,,OXERVATE,Off label use,,OXERVATE | Off label use,NaT
257763001,25776300,1,M,2025-02-08,20250909,,OXERVATE,Swelling of eyelid,,OXERVATE | Swelling of eyelid,2025-02-03/2025-02-09
257763761,25776376,41,F,2024-08-20,20250909,,OXERVATE,Eye irritation,,OXERVATE | Eye irritation,2024-08-19/2024-08-25
257763841,25776384,81,F,2024-08-22,20250909,,OXERVATE,Disease progression,,OXERVATE | Disease progression,2024-08-19/2024-08-25
257763981,25776398,,F,,20250909,,OXERVATE,Urinary tract infection,,OXERVATE | Urinary tract infection,NaT
257764501,25776450,,M,,20250909,,OXERVATE,Ocular discomfort,,OXERVATE | Ocular discomfort,NaT
257765332,25776533,,F,,20250909,,OXERVATE,Eye pruritus,,OXERVATE | Eye pruritus,NaT
257765631,25776563,,M,,20250909,,OXERVATE,Adverse event,,OXERVATE | Adverse event,NaT
257765881,25776588,,F,,20250909,,OXERVATE,Treatment noncompliance,,OXERVATE | Treatment noncompliance,NaT
257765961,25776596,,M,,20250909,,OXERVATE,Eye swelling,,OXERVATE | Eye swelling,NaT
257766541,25776654,85,F,2025-03-09,20250909,,OXERVATE,Nasal congestion,,OXERVATE | Nasal congestion,2025-03-03/2025-03-09
257768221,25776822,36,F,2025-03-17,20250909,,OXERVATE,Eye irritation,,OXERVATE | Eye irritation,2025-03-17/2025-03-23
257769281,25776928,,F,,20250909,,OXERVATE,Eye pain,,OXERVATE | Eye pain,NaT
257769411,25776941,,F,,20250909,,OXERVATE,Ocular discomfort,,OXERVATE | Ocular discomfort,NaT
257769872,25776987,79,F,,20250917,,BUDESONIDE\FORMOTEROL,Blood viscosity increased,HO,BUDESONIDE\FORMOTEROL | Blood viscosity increased | HO,NaT
257769891,25776989,86,F,2024-09-17,20250909,,OXERVATE,Eye infection,,OXERVATE | Eye infection,2024-09-16/2024-09-22
257769912,25776991,81,F,2025-01-01,20250916,,EVENITY,Urticaria,,EVENITY | Urticaria,2024-12-30/2025-01-05
257770391,25777039,45,F,2021-01-01,20250909,,CAMRELIZUMAB,Gastrointestinal toxicity,OT,CAMRELIZUMAB | Gastrointestinal toxicity | OT,2020-12-28/2021-01-03
257770681,25777068,,F,,20250909,,OXERVATE,Eyelid pain,,OXERVATE | Eyelid pain,NaT
257770961,25777096,48,M,,20250909,,GENTAMICIN,Nausea,OT,GENTAMICIN | Nausea | OT,NaT
257771241,25777124,69,F,2023-01-01,20250909,,SKYRIZI,Sciatic nerve neuropathy,HO,SKYRIZI | Sciatic nerve neuropathy | HO,2022-12-26/2023-01-01
257771261,25777126,,F,,20250909,,OXERVATE,Ocular hyperaemia,,OXERVATE | Ocular hyperaemia,NaT
257775461,25777546,,F,,20250909,,POTASSIUM CHLORIDE,Product taste abnormal,,POTASSIUM CHLORIDE | Product taste abnormal,NaT
257776531,25777653,,F,,20250909,,DEPAKOTE,Medical induction of coma,HO,DEPAKOTE | Medical induction of coma | HO,NaT
257777031,25777703,95,M,,20250909,,TENECTEPLASE,Aneurysm ruptured,OT,TENECTEPLASE | Aneurysm ruptured | OT,NaT
257778331,25777833,,,,20250909,,SYMBICORT,Asthma,,SYMBICORT | Asthma,NaT
257778351,25777835,,,,20250909,,MUCINEX MAXIMUM STRENGTH,Drug effective for unapproved indication,,MUCINEX MAXIMUM STRENGTH | Drug effective for unapproved indication,NaT
257779661,25777966,45,M,2025-08-23,20250906,,LEVOFLOXACIN,Activities of daily living decreased,,LEVOFLOXACIN | Activities of daily living decreased,2025-08-18/2025-08-24
257779881,25777988,58,F,,20250909,,PREDNISONE,Therapy non-responder,HO,PREDNISONE | Therapy non-responder | HO,NaT
257780311,25778031,80,M,,20250909,,PREDNISOLONE,Joint swelling,OT,PREDNISOLONE | Joint swelling | OT,NaT
257781041,25778104,57,F,,20250909,,TACROLIMUS,Drug ineffective,OT,TACROLIMUS | Drug ineffective | OT,NaT
257781511,25778151,,F,,20250909,,DAYBUE,Constipation,,DAYBUE | Constipation,NaT
257782041,25778204,,M,,20250909,,VABYSMO,Eye haemorrhage,OT,VABYSMO | Eye haemorrhage | OT,NaT
257784281,25778428,,,,20250909,,LAMIVUDINE\ZIDOVUDINE,Drug interaction,HO,LAMIVUDINE\ZIDOVUDINE | Drug interaction | HO,NaT
257784301,25778430,,F,,20250909,,COMBIPATCH,Abdominal distension,,COMBIPATCH | Abdominal distension,NaT
257784321,25778432,,F,2025-01-01,20250909,,COMBIPATCH,Application site erosion,,COMBIPATCH | Application site erosion,2024-12-30/2025-01-05
257785061,25778506,64,M,,20250909,,VORICONAZOLE,Drug ineffective,DE,VORICONAZOLE | Drug ineffective | DE,NaT
257785302,25778530,51,M,2025-08-14,20250918,,DOCETAXEL,Hepatitis,HO,DOCETAXEL | Hepatitis | HO,2025-08-11/2025-08-17
257785411,25778541,67,,,20250909,,JAKAFI,Dizziness,,JAKAFI | Dizziness,NaT
257785731,25778573,96,M,,20250909,,UPTRAVI,Death,DE,UPTRAVI | Death | DE,NaT
257786411,25778641,72,M,,20250908,,TYMLOS,Peroneal nerve palsy,HO,TYMLOS | Peroneal nerve palsy | HO,NaT
257787251,25778725,56,M,,20250909,,AMBRISENTAN,Hypotension,OT,AMBRISENTAN | Hypotension | OT,NaT
257787691,25778769,43,F,2025-05-15,20250905,,ZICAM COLD REMEDY NASAL SWABS (HOMEOPATHICS),Nasal pruritus,DS,ZICAM COLD REMEDY NASAL SWABS (HOMEOPATHICS) | Nasal pruritus | DS,2025-05-12/2025-05-18
257788361,25778836,64,F,2025-07-22,20250909,,ADCETRIS,Staphylococcal infection,HO,ADCETRIS | Staphylococcal infection | HO,2025-07-21/2025-07-27
257788601,25778860,,F,,20250909,,ZEPBOUND,Nausea,,ZEPBOUND | Nausea,NaT
257788911,25778891,,,2025-01-01,20250909,,UPADACITINIB,Blood cholesterol increased,,UPADACITINIB | Blood cholesterol increased,2024-12-30/2025-01-05
257789311,25778931,57,M,2025-08-25,20250908,,OZEMPIC,Muscle atrophy,OT,OZEMPIC | Muscle atrophy | OT,2025-08-25/2025-08-31
257789561,25778956,63,F,2025-08-27,20250909,,INSULIN GLARGINE,Oxygen saturation decreased,LT,INSULIN GLARGINE | Oxygen saturation decreased | LT,2025-08-25/2025-08-31
257790201,25779020,,M,,20250909,,CLADRIBINE,Multiple sclerosis relapse,OT,CLADRIBINE | Multiple sclerosis relapse | OT,NaT
257790671,25779067,49,F,2025-08-01,20250909,,XELJANZ,Hand fracture,HO,XELJANZ | Hand fracture | HO,2025-07-28/2025-08-03
257791051,25779105,31,F,2025-09-08,20250908,,TRIAMCINOLONE,Burning sensation,,TRIAMCINOLONE | Burning sensation,2025-09-08/2025-09-14
257791781,25779178,,,,20250908,,TRIAMCINOLONE,Drug ineffective,,TRIAMCINOLONE | Drug ineffective,NaT
257791961,25779196,71,F,2025-09-01,20250909,,DESMOPRESSIN,Blood sodium decreased,DS,DESMOPRESSIN | Blood sodium decreased | DS,2025-09-01/2025-09-07
257792761,25779276,82,F,,20250909,,VERZENIO,Diarrhoea,OT,VERZENIO | Diarrhoea | OT,NaT
257793001,25779300,73,M,2025-09-03,20250909,,HYRIMOZ,Fall,HO,HYRIMOZ | Fall | HO,2025-09-01/2025-09-07
257794181,25779418,,M,,20250909,,IMBRUVICA,Off label use,,IMBRUVICA | Off label use,NaT
257794421,25779442,62,M,2025-08-29,20250909,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,2025-08-25/2025-08-31
257795171,25779517,22,M,,20250909,,MONTELUKAST,Yellow skin,OT,MONTELUKAST | Yellow skin | OT,NaT
257795301,25779530,65,,,20250909,,RUXOLITINIB,Tuberculosis,OT,RUXOLITINIB | Tuberculosis | OT,NaT
257795571,25779557,58,F,2025-08-14,20250909,,PACLITAXEL,Anaphylactic reaction,OT,PACLITAXEL | Anaphylactic reaction | OT,2025-08-11/2025-08-17
257795651,25779565,86,F,2021-09-13,20250909,,BORTEZOMIB,Toxic skin eruption,OT,BORTEZOMIB | Toxic skin eruption | OT,2021-09-13/2021-09-19
257796391,25779639,73,F,,20250909,,POMALYST,Fatigue,,POMALYST | Fatigue,NaT
257796632,25779663,65,M,2025-01-01,20250930,,SKYRIZI,Eczema,OT,SKYRIZI | Eczema | OT,2024-12-30/2025-01-05
257796831,25779683,,,,20250908,,ABIRATERONE,Hospice care,,ABIRATERONE | Hospice care,NaT
257796981,25779698,,F,,20250909,,"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",Drug abuse,OT,"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE | Drug abuse | OT",NaT
257797631,25779763,,,,20250909,,MOUNJARO,Paraesthesia,,MOUNJARO | Paraesthesia,NaT
257797971,25779797,78,M,2025-01-01,20250909,,POMALYST,Rash,,POMALYST | Rash,2024-12-30/2025-01-05
257798391,25779839,,F,,20250909,,UPADACITINIB,Product residue present,,UPADACITINIB | Product residue present,NaT
257798491,25779849,55,M,,20250909,,MOUNJARO,Renal cancer,OT,MOUNJARO | Renal cancer | OT,NaT
257798811,25779881,75,F,2021-09-17,20250909,,BORTEZOMIB,Cytopenia,OT,BORTEZOMIB | Cytopenia | OT,2021-09-13/2021-09-19
257799281,25779928,22,F,2023-07-07,20250908,,ESCITALOPRAM,Suicidal ideation,OT,ESCITALOPRAM | Suicidal ideation | OT,2023-07-03/2023-07-09
257800971,25780097,85,M,,20250909,,FINASTERIDE,Depressed mood,OT,FINASTERIDE | Depressed mood | OT,NaT
257801022,25780102,33,M,2025-08-18,20250915,,WEGOVY,Blood glucose increased,HO,WEGOVY | Blood glucose increased | HO,2025-08-18/2025-08-24
257802272,25780227,,,,20250923,,DUPIXENT,Exposure via skin contact,,DUPIXENT | Exposure via skin contact,NaT
257802841,25780284,67,M,,20250909,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,NaT
257803401,25780340,55,F,2025-08-01,20250909,,DUPIXENT,Injection site erythema,,DUPIXENT | Injection site erythema,2025-07-28/2025-08-03
257803511,25780351,56,M,,20250909,,DUPIXENT,Muscle spasms,,DUPIXENT | Muscle spasms,NaT
257803601,25780360,29,F,2025-08-01,20250909,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2025-07-28/2025-08-03
257804011,25780401,,F,,20250909,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,NaT
257804511,25780451,,,,20250909,,RITUXIMAB,Febrile neutropenia,DE,RITUXIMAB | Febrile neutropenia | DE,NaT
257804751,25780475,79,F,2025-01-01,20250909,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,2024-12-30/2025-01-05
257804851,25780485,60,M,,20250909,,DUPIXENT,Accidental exposure to product,,DUPIXENT | Accidental exposure to product,NaT
257805811,25780581,,F,,20250909,,DUPIXENT,Rash,,DUPIXENT | Rash,NaT
257806681,25780668,,,,20250909,,KESIMPTA,Alopecia,,KESIMPTA | Alopecia,NaT
257807351,25780735,,,,20250909,,ELIQUIS,Headache,,ELIQUIS | Headache,NaT
257807821,25780782,,,,20250909,,AZATHIOPRINE,Foetal distress syndrome,OT,AZATHIOPRINE | Foetal distress syndrome | OT,NaT
257808181,25780818,74,M,,20250909,,TALZENNA,Malignant neoplasm progression,OT,TALZENNA | Malignant neoplasm progression | OT,NaT
257809821,25780982,,F,,20250909,,BASAGLAR,Wrong product administered,,BASAGLAR | Wrong product administered,NaT
257813131,25781313,,F,,20250909,,CLOZAPINE,Death,DE,CLOZAPINE | Death | DE,NaT
257823832,25782383,36,F,2025-08-01,20250919,,AVONEX,Multiple sclerosis relapse,HO,AVONEX | Multiple sclerosis relapse | HO,2025-07-28/2025-08-03
257825111,25782511,48,F,2020-01-01,20250909,,DUPIXENT,Dry skin,,DUPIXENT | Dry skin,2019-12-30/2020-01-05
257828683,25782868,66,F,,20250919,,IMFINZI,Neuropathy peripheral,OT,IMFINZI | Neuropathy peripheral | OT,NaT
257828701,25782870,64,,,20250909,,SODIUM CHLORIDE,Myelosuppression,HO,SODIUM CHLORIDE | Myelosuppression | HO,NaT
257829431,25782943,,M,,20250909,,DUPIXENT,Erythema,,DUPIXENT | Erythema,NaT
257830151,25783015,,F,2025-09-01,20250910,,ALBUTEROL SULFATE,Device delivery system issue,,ALBUTEROL SULFATE | Device delivery system issue,2025-09-01/2025-09-07
257832281,25783228,,,,20250910,,DICLOFENAC,Product packaging issue,,DICLOFENAC | Product packaging issue,NaT
257835141,25783514,,F,,20250910,,NUCALA,Off label use,,NUCALA | Off label use,NaT
257837021,25783702,67,M,2025-08-25,20250910,,HUMALOG,Blood glucose decreased,,HUMALOG | Blood glucose decreased,2025-08-25/2025-08-31
257838021,25783802,,M,,20250910,,MUCINEX,Off label use,,MUCINEX | Off label use,NaT
257840601,25784060,57,F,2025-08-01,20250910,,DUPIXENT,Asthma,,DUPIXENT | Asthma,2025-07-28/2025-08-03
257842441,25784244,,,,20250910,,DARZALEX FASPRO,Colostomy,OT,DARZALEX FASPRO | Colostomy | OT,NaT
257842751,25784275,,,,20250910,,NEMLUVIO,Injection site haemorrhage,,NEMLUVIO | Injection site haemorrhage,NaT
257843792,25784379,,F,2025-07-31,20250914,,LETROZOLE,Neutropenia,OT,LETROZOLE | Neutropenia | OT,2025-07-28/2025-08-03
257844731,25784473,10,F,,20250910,,ALBUTEROL,Hyperthermia malignant,OT,ALBUTEROL | Hyperthermia malignant | OT,NaT
257845991,25784599,,M,,20250910,,IMFINZI,Ascites,OT,IMFINZI | Ascites | OT,NaT
257846231,25784623,76,F,,20250910,,CANDESARTAN,Headache,OT,CANDESARTAN | Headache | OT,NaT
257847181,25784718,61,F,,20250910,,BASAGLAR,Accidental underdose,,BASAGLAR | Accidental underdose,NaT
257848041,25784804,59,M,,20250910,,ATEZOLIZUMAB,Immune-mediated hepatic disorder,OT,ATEZOLIZUMAB | Immune-mediated hepatic disorder | OT,NaT
257848331,25784833,73,F,2022-01-01,20250910,,RINVOQ,Mobility decreased,HO,RINVOQ | Mobility decreased | HO,2021-12-27/2022-01-02
257848451,25784845,,F,,20250910,,HYDROCORTISONE VALERATE,Therapy partial responder,,HYDROCORTISONE VALERATE | Therapy partial responder,NaT
257848461,25784846,72,M,,20250910,,MOUNJARO,Accidental overdose,,MOUNJARO | Accidental overdose,NaT
257848882,25784888,71,F,2025-06-30,20250911,,ENBREL,Device difficult to use,,ENBREL | Device difficult to use,2025-06-30/2025-07-06
257850351,25785035,,F,,20250910,,AZTREONAM LYSINE,Cystic fibrosis,OT,AZTREONAM LYSINE | Cystic fibrosis | OT,NaT
257852531,25785253,,F,,20250910,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
257853011,25785301,7,M,2024-03-14,20250910,,FERRIPROX,Acne,,FERRIPROX | Acne,2024-03-11/2024-03-17
257853331,25785333,87,F,,20250910,,LENALIDOMIDE,Stress cardiomyopathy,OT,LENALIDOMIDE | Stress cardiomyopathy | OT,NaT
257854771,25785477,,,,20250910,,ESTRADIOL,Off label use,,ESTRADIOL | Off label use,NaT
257855121,25785512,40,M,,20250910,,PREGABALIN,Depressed level of consciousness,LT,PREGABALIN | Depressed level of consciousness | LT,NaT
257855971,25785597,66,F,,20250910,,ZEPBOUND,Nausea,,ZEPBOUND | Nausea,NaT
257857111,25785711,84,M,,20250910,,ENFORTUMAB VEDOTIN,Rash,OT,ENFORTUMAB VEDOTIN | Rash | OT,NaT
257857391,25785739,33,F,2025-09-05,20250909,,AMBRISENTAN,Loss of consciousness,,AMBRISENTAN | Loss of consciousness,2025-09-01/2025-09-07
257858241,25785824,,F,,20250909,,WINREVAIR,Interstitial lung disease,HO,WINREVAIR | Interstitial lung disease | HO,NaT
257859261,25785926,78,F,,20250910,,AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN,Ear neoplasm malignant,OT,AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN | Ear neoplasm malignant | OT,NaT
257859331,25785933,62,M,,20250910,,POMALYST,Emotional disorder,,POMALYST | Emotional disorder,NaT
257861001,25786100,,M,,20250910,,XYNTHA,Myocardial infarction,DE,XYNTHA | Myocardial infarction | DE,NaT
257861311,25786131,25,F,,20250910,,Immune globulin,Off label use,OT,Immune globulin | Off label use | OT,NaT
257864281,25786428,60,F,,20250910,,DUPIXENT,Condition aggravated,,DUPIXENT | Condition aggravated,NaT
257865071,25786507,39,F,2025-01-01,20250910,,DUPIXENT,Asthma,,DUPIXENT | Asthma,2024-12-30/2025-01-05
257865431,25786543,42,F,,20250910,,DUPIXENT,Dermatitis contact,,DUPIXENT | Dermatitis contact,NaT
257865801,25786580,54,F,2025-01-01,20250910,,RUXIENCE,Cystitis,HO,RUXIENCE | Cystitis | HO,2024-12-30/2025-01-05
257866211,25786621,65,M,,20250910,,LANTUS SOLOSTAR,Off label use,,LANTUS SOLOSTAR | Off label use,NaT
257867881,25786788,,F,,20250910,,RINVOQ,Surgery,OT,RINVOQ | Surgery | OT,NaT
257868131,25786813,14,M,,20250910,,PREDNISOLONE,Off label use,HO,PREDNISOLONE | Off label use | HO,NaT
257868342,25786834,,,2025-08-25,20250929,,NEMOLIZUMAB,Pemphigoid,OT,NEMOLIZUMAB | Pemphigoid | OT,2025-08-25/2025-08-31
257868371,25786837,9,F,,20250910,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,NaT
257868611,25786861,79,M,,20250910,,VYNDAMAX,Tinnitus,,VYNDAMAX | Tinnitus,NaT
257869021,25786902,69,F,2025-03-06,20250910,,CORTICOTROPIN,Pain in extremity,,CORTICOTROPIN | Pain in extremity,2025-03-03/2025-03-09
257870021,25787002,,,,20250910,,XEOMIN,Drug ineffective,,XEOMIN | Drug ineffective,NaT
257870281,25787028,54,F,2025-09-01,20250910,,DUPIXENT,Mental status changes,,DUPIXENT | Mental status changes,2025-09-01/2025-09-07
257871921,25787192,24,M,2025-09-03,20250910,,EBGLYSS,Eczema,HO,EBGLYSS | Eczema | HO,2025-09-01/2025-09-07
257872491,25787249,,,,20250910,,COBENFY,COVID-19,,COBENFY | COVID-19,NaT
257872761,25787276,40,F,,20250910,,DIENOGEST\ESTRADIOL VALERATE,Cervical polyp,OT,DIENOGEST\ESTRADIOL VALERATE | Cervical polyp | OT,NaT
257872881,25787288,74,M,,20250910,,GEMCITABINE HYDROCHLORIDE,Cholangitis,OT,GEMCITABINE HYDROCHLORIDE | Cholangitis | OT,NaT
257874151,25787415,49,F,2025-07-01,20250910,,OZEMPIC,Vomiting,HO,OZEMPIC | Vomiting | HO,2025-06-30/2025-07-06
257875061,25787506,,M,2025-08-27,20250910,,FERRLECIT,Tremor,,FERRLECIT | Tremor,2025-08-25/2025-08-31
257875491,25787549,,M,,20250910,,LUPRON,Device issue,,LUPRON | Device issue,NaT
257875771,25787577,,F,,20250910,,OXERVATE,Off label use,,OXERVATE | Off label use,NaT
257877641,25787764,,F,,20250910,,SKYRIZI,Surgery,OT,SKYRIZI | Surgery | OT,NaT
257877831,25787783,70,M,2025-07-01,20250910,,SKYRIZI,Arteriosclerosis,OT,SKYRIZI | Arteriosclerosis | OT,2025-06-30/2025-07-06
257879821,25787982,,,,20250910,,STEGLATRO,Product dose omission issue,,STEGLATRO | Product dose omission issue,NaT
257880561,25788056,91,F,,20250910,,CLOZAPINE,Death,DE,CLOZAPINE | Death | DE,NaT
257880611,25788061,56,F,,20250910,,TRULICITY,Vision blurred,,TRULICITY | Vision blurred,NaT
257881311,25788131,,M,,20250910,,LANTUS SOLOSTAR,Hypoacusis,,LANTUS SOLOSTAR | Hypoacusis,NaT
257881411,25788141,43,M,,20250910,,INGREZZA,Dyskinesia,,INGREZZA | Dyskinesia,NaT
257881711,25788171,70,M,,20250910,,POLIVY,Ill-defined disorder,HO,POLIVY | Ill-defined disorder | HO,NaT
257881841,25788184,79,M,2025-07-09,20250910,,TRESIBA,Post procedural fever,HO,TRESIBA | Post procedural fever | HO,2025-07-07/2025-07-13
257882121,25788212,,,,20250910,,MOUNJARO,Retinal haemorrhage,OT,MOUNJARO | Retinal haemorrhage | OT,NaT
257883011,25788301,72,F,2023-01-01,20250910,,KEYTRUDA,Hepatic cytolysis,HO,KEYTRUDA | Hepatic cytolysis | HO,2022-12-26/2023-01-01
257883051,25788305,,F,,20250910,,XOLAIR PFS,Urticaria,,XOLAIR PFS | Urticaria,NaT
257883191,25788319,51,,2025-08-30,20250910,,TALTZ,Arthropod bite,,TALTZ | Arthropod bite,2025-08-25/2025-08-31
257883251,25788325,71,M,,20250910,,ZEPBOUND,Extra dose administered,,ZEPBOUND | Extra dose administered,NaT
257883881,25788388,,F,,20250910,,DOXORUBICIN,Small intestinal obstruction,OT,DOXORUBICIN | Small intestinal obstruction | OT,NaT
257884282,25788428,36,F,2025-08-29,20250915,,INVEGA TRINZA,Product dose omission issue,,INVEGA TRINZA | Product dose omission issue,2025-08-25/2025-08-31
257885302,25788530,68,M,2025-08-29,20250918,,HEPZATO,Embolism,HO,HEPZATO | Embolism | HO,2025-08-25/2025-08-31
257885661,25788566,61,M,2025-05-01,20250910,,RINVOQ,Surgery,OT,RINVOQ | Surgery | OT,2025-04-28/2025-05-04
257886461,25788646,,M,,20250910,,VYVANSE,Insurance issue,,VYVANSE | Insurance issue,NaT
257886491,25788649,70,M,2025-01-01,20250910,,RINVOQ,Chest pain,HO,RINVOQ | Chest pain | HO,2024-12-30/2025-01-05
257887281,25788728,,,,20250910,,ACETAMINOPHEN,No adverse event,,ACETAMINOPHEN | No adverse event,NaT
257887461,25788746,66,,,20250910,,TISLELIZUMAB,White blood cell count abnormal,OT,TISLELIZUMAB | White blood cell count abnormal | OT,NaT
257887631,25788763,,F,,20250910,,CREON,Vomiting,OT,CREON | Vomiting | OT,NaT
257887731,25788773,,,,20250911,,LEVETIRACETAM,Psychotic symptom,HO,LEVETIRACETAM | Psychotic symptom | HO,NaT
257888041,25788804,35,M,2025-08-18,20250911,,CABENUVA,Blood HIV RNA increased,,CABENUVA | Blood HIV RNA increased,2025-08-18/2025-08-24
257888381,25788838,,M,2021-12-05,20250911,,WELLBUTRIN,Obsessive thoughts,OT,WELLBUTRIN | Obsessive thoughts | OT,2021-11-29/2021-12-05
257888741,25788874,87,M,2025-07-01,20250911,,BORTEZOMIB,Neoplasm malignant,OT,BORTEZOMIB | Neoplasm malignant | OT,2025-06-30/2025-07-06
257889691,25788969,78,F,,20250911,,NUCALA,Fatigue,HO,NUCALA | Fatigue | HO,NaT
257891101,25789110,,,,20250911,,PLUVICTO,General physical health deterioration,,PLUVICTO | General physical health deterioration,NaT
257892541,25789254,,F,,20250911,,RIBOCICLIB,Neutropenia,OT,RIBOCICLIB | Neutropenia | OT,NaT
257892621,25789262,,,2025-01-01,20250911,,NEMLUVIO,Dry skin,,NEMLUVIO | Dry skin,2024-12-30/2025-01-05
257893631,25789363,49,M,2025-08-01,20250911,,MOUNJARO,Product dose omission issue,,MOUNJARO | Product dose omission issue,2025-07-28/2025-08-03
257893651,25789365,65,F,,20250911,,MOUNJARO,Injection site inflammation,,MOUNJARO | Injection site inflammation,NaT
257893671,25789367,78,F,,20250911,,FORTEO,Oropharyngeal pain,,FORTEO | Oropharyngeal pain,NaT
257893792,25789379,66,M,2025-08-30,20250918,,LUCENTIS,Diabetic complication,DE,LUCENTIS | Diabetic complication | DE,2025-08-25/2025-08-31
257893823,25789382,78,F,,20250926,,PANTOPRAZOLE,Acute hepatic failure,HO,PANTOPRAZOLE | Acute hepatic failure | HO,NaT
257894001,25789400,77,M,2025-03-12,20250911,,VENETOCLAX,Acute kidney injury,HO,VENETOCLAX | Acute kidney injury | HO,2025-03-10/2025-03-16
257896151,25789615,33,F,,20250911,,TACROLIMUS,Diabetic ketoacidosis,OT,TACROLIMUS | Diabetic ketoacidosis | OT,NaT
257896471,25789647,,,,20250911,,BREZTRI,Asthma,,BREZTRI | Asthma,NaT
257897421,25789742,57,F,,20250911,,VERZENIO,Arthralgia,OT,VERZENIO | Arthralgia | OT,NaT
257897781,25789778,55,M,2025-09-01,20250911,,SIMPONI,Device defective,,SIMPONI | Device defective,2025-09-01/2025-09-07
257899421,25789942,,,,20250911,,MOUNJARO,Constipation,,MOUNJARO | Constipation,NaT
257900882,25790088,27,M,2025-01-14,20250929,,FENFLURAMINE HYDROCHLORIDE,Myoclonic epilepsy,OT,FENFLURAMINE HYDROCHLORIDE | Myoclonic epilepsy | OT,2025-01-13/2025-01-19
257902311,25790231,62,M,2025-09-03,20250911,,OLAPARIB,Pyrexia,HO,OLAPARIB | Pyrexia | HO,2025-09-01/2025-09-07
257902581,25790258,42,M,2025-08-03,20250911,,AMBIEN,Speech disorder,OT,AMBIEN | Speech disorder | OT,2025-07-28/2025-08-03
257903281,25790328,82,F,2025-05-02,20250911,,QUETIAPINE,Choking,DE,QUETIAPINE | Choking | DE,2025-04-28/2025-05-04
257903361,25790336,41,M,2025-04-12,20250911,,ACETAMINOPHEN,Intentional overdose,HO,ACETAMINOPHEN | Intentional overdose | HO,2025-04-07/2025-04-13
257903451,25790345,69,F,2025-05-09,20250911,,LANSOPRAZOLE,Drug interaction,LT,LANSOPRAZOLE | Drug interaction | LT,2025-05-05/2025-05-11
257903461,25790346,50,F,2025-06-12,20250911,,ATORVASTATIN,Prophylaxis of nausea and vomiting,DS,ATORVASTATIN | Prophylaxis of nausea and vomiting | DS,2025-06-09/2025-06-15
257903981,25790398,31,M,2025-04-24,20250911,,BUTYROLACTONE,Persecutory delusion,HO,BUTYROLACTONE | Persecutory delusion | HO,2025-04-21/2025-04-27
257904931,25790493,,,,20250911,,KERENDIA,Death,DE,KERENDIA | Death | DE,NaT
257905011,25790501,,F,,20250911,,AZITHROMYCIN,Drug ineffective,OT,AZITHROMYCIN | Drug ineffective | OT,NaT
257905021,25790502,74,F,,20250911,,ATORVASTATIN CALCIUM,Drug reaction with eosinophilia and systemic symptoms,HO,ATORVASTATIN CALCIUM | Drug reaction with eosinophilia and systemic symptoms | HO,NaT
257905231,25790523,76,F,2025-07-24,20250910,,AMBRISENTAN,Subdural haematoma,DE,AMBRISENTAN | Subdural haematoma | DE,2025-07-21/2025-07-27
257905462,25790546,14,F,,20250925,,VINCRISTINE,Ocular toxicity,OT,VINCRISTINE | Ocular toxicity | OT,NaT
257905531,25790553,60,F,2025-08-31,20250911,,HUMALOG,Haemorrhage,,HUMALOG | Haemorrhage,2025-08-25/2025-08-31
257905881,25790588,,M,,20250910,,AMBRISENTAN,Disease complication,HO,AMBRISENTAN | Disease complication | HO,NaT
257906041,25790604,,,,20250911,,RENFLEXIS,Colitis ulcerative,OT,RENFLEXIS | Colitis ulcerative | OT,NaT
257907511,25790751,,F,,20250911,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
257907581,25790758,65,F,,20250911,,XELJANZ XR,Pain in extremity,,XELJANZ XR | Pain in extremity,NaT
257907841,25790784,72,F,,20250911,,IBRANCE,Vomiting,,IBRANCE | Vomiting,NaT
257907871,25790787,71,F,,20250911,,SCOPOLAMINE,Adverse event,OT,SCOPOLAMINE | Adverse event | OT,NaT
257908071,25790807,74,F,2025-09-05,20250910,,PIRFENIDONE,Rash,,PIRFENIDONE | Rash,2025-09-01/2025-09-07
257908272,25790827,69,M,2025-08-28,20250918,,BIVIGAM,Rash,,BIVIGAM | Rash,2025-08-25/2025-08-31
257908641,25790864,74,M,2018-01-01,20250911,,DOCETAXEL,Haematotoxicity,OT,DOCETAXEL | Haematotoxicity | OT,2018-01-01/2018-01-07
257909071,25790907,,F,,20250911,,GENOTROPIN,Device information output issue,,GENOTROPIN | Device information output issue,NaT
257910281,25791028,52,M,2025-08-16,20250911,,CLOZAPINE,Death,DE,CLOZAPINE | Death | DE,2025-08-11/2025-08-17
257910681,25791068,,,,20250911,,REBLOZYL,Product storage error,,REBLOZYL | Product storage error,NaT
257910972,25791097,,,2025-01-25,20250930,,DOXAZOSIN MESYLATE,Pain,HO,DOXAZOSIN MESYLATE | Pain | HO,2025-01-20/2025-01-26
257911011,25791101,55,M,2025-09-09,20250911,,EMPAGLIFLOZIN,Fournier's gangrene,LT,EMPAGLIFLOZIN | Fournier's gangrene | LT,2025-09-08/2025-09-14
257911361,25791136,51,F,2025-09-05,20250911,,LANREOTIDE ACETATE,Death,DE,LANREOTIDE ACETATE | Death | DE,2025-09-01/2025-09-07
257912681,25791268,,,,20250911,,PRAVASTATIN,Drug ineffective,,PRAVASTATIN | Drug ineffective,NaT
257913231,25791323,,M,,20250911,,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,Urethritis,OT,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE | Urethritis | OT,NaT
257913251,25791325,,F,,20250911,,ACETAMINOPHEN,Inappropriate schedule of product administration,,ACETAMINOPHEN | Inappropriate schedule of product administration,NaT
257914001,25791400,34,M,,20250911,,AMPHETAMINE,Ocular hyperaemia,OT,AMPHETAMINE | Ocular hyperaemia | OT,NaT
257914131,25791413,,,2025-08-18,20250911,,NEMLUVIO,Device malfunction,,NEMLUVIO | Device malfunction,2025-08-18/2025-08-24
257914441,25791444,45,,,20250911,,OZEMPIC,Ileus,OT,OZEMPIC | Ileus | OT,NaT
257914871,25791487,43,M,2025-08-27,20250911,,MYCOPHENOLIC ACID,International normalised ratio abnormal,HO,MYCOPHENOLIC ACID | International normalised ratio abnormal | HO,2025-08-25/2025-08-31
257915271,25791527,,F,2025-03-01,20250911,,APIXABAN,Mixed dementia,OT,APIXABAN | Mixed dementia | OT,2025-02-24/2025-03-02
257916471,25791647,54,M,2025-01-01,20250911,,SKYRIZI,Inflammation,OT,SKYRIZI | Inflammation | OT,2024-12-30/2025-01-05
257916821,25791682,76,M,2025-06-01,20250911,,BREXUCABTAGENE AUTOLEUCEL,Death,DE,BREXUCABTAGENE AUTOLEUCEL | Death | DE,2025-05-26/2025-06-01
257918971,25791897,,M,,20250911,,DUPIXENT,Sleep disorder due to a general medical condition,,DUPIXENT | Sleep disorder due to a general medical condition,NaT
257919831,25791983,3,F,2025-01-01,20250911,,DUPIXENT,Skin exfoliation,,DUPIXENT | Skin exfoliation,2024-12-30/2025-01-05
257920381,25792038,61,F,2025-08-01,20250911,,DUPIXENT,Neurodermatitis,,DUPIXENT | Neurodermatitis,2025-07-28/2025-08-03
257920642,25792064,34,F,2025-01-01,20250915,,DUPIXENT,Visual impairment,,DUPIXENT | Visual impairment,2024-12-30/2025-01-05
257921011,25792101,52,M,,20250911,,MOUNJARO,Intercepted product dispensing error,,MOUNJARO | Intercepted product dispensing error,NaT
257921571,25792157,51,F,2025-08-01,20250911,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2025-07-28/2025-08-03
257921601,25792160,65,M,,20250911,,TOUJEO,Gait disturbance,,TOUJEO | Gait disturbance,NaT
257922181,25792218,55,M,2025-08-01,20250911,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2025-07-28/2025-08-03
257922431,25792243,,M,,20250911,,LANTUS,Intentional product misuse,,LANTUS | Intentional product misuse,NaT
257922501,25792250,52,M,,20250911,,LANTUS,Product storage error,,LANTUS | Product storage error,NaT
257922671,25792267,18,M,,20250911,,DUPIXENT,Injection site warmth,,DUPIXENT | Injection site warmth,NaT
257922911,25792291,65,F,2025-08-23,20250911,,EPIRUBICIN HYDROCHLORIDE,Transaminases increased,OT,EPIRUBICIN HYDROCHLORIDE | Transaminases increased | OT,2025-08-18/2025-08-24
257923281,25792328,77,M,,20250911,,FILGRASTIM,Cytokine release syndrome,HO,FILGRASTIM | Cytokine release syndrome | HO,NaT
257923431,25792343,,F,,20250911,,VEDOLIZUMAB,Drug level decreased,OT,VEDOLIZUMAB | Drug level decreased | OT,NaT
257923522,25792352,,M,,20250916,,CLOZARIL,Malaise,HO,CLOZARIL | Malaise | HO,NaT
257923851,25792385,,,2025-01-01,20250911,,EVENITY,Fatigue,,EVENITY | Fatigue,2024-12-30/2025-01-05
257924581,25792458,72,F,2025-08-31,20250911,,ZEPBOUND,Acne,,ZEPBOUND | Acne,2025-08-25/2025-08-31
257925701,25792570,,F,,20250911,,REPATHA,Nausea,,REPATHA | Nausea,NaT
257925911,25792591,72,F,2025-09-03,20250911,,KEVZARA,Therapeutic response shortened,OT,KEVZARA | Therapeutic response shortened | OT,2025-09-01/2025-09-07
257925951,25792595,62,M,,20250911,,SODIUM CHLORIDE,Fatigue,,SODIUM CHLORIDE | Fatigue,NaT
257926071,25792607,85,M,,20250911,,DOPTELET,Product use issue,,DOPTELET | Product use issue,NaT
257926081,25792608,,,,20250911,,VOLTAREN ARTHRITIS PAIN,Drug ineffective,,VOLTAREN ARTHRITIS PAIN | Drug ineffective,NaT
257926621,25792662,69,M,,20250911,,POMALYST,Muscular weakness,,POMALYST | Muscular weakness,NaT
257926951,25792695,68,M,2025-01-01,20250911,,CORTICOTROPIN,Arthralgia,,CORTICOTROPIN | Arthralgia,2024-12-30/2025-01-05
257927701,25792770,65,M,2023-11-09,20250911,,INSULIN ASPART,Insulin autoimmune syndrome,HO,INSULIN ASPART | Insulin autoimmune syndrome | HO,2023-11-06/2023-11-12
257927781,25792778,,,,20250911,,OPZELURA,Application site swelling,,OPZELURA | Application site swelling,NaT
257927821,25792782,62,,,20250911,,MOUNJARO,Extra dose administered,,MOUNJARO | Extra dose administered,NaT
257928121,25792812,72,M,2025-01-01,20250911,,DUPIXENT,Dizziness,,DUPIXENT | Dizziness,2024-12-30/2025-01-05
257928201,25792820,87,F,2025-08-01,20250911,,REVLIMID,Loss of consciousness,OT,REVLIMID | Loss of consciousness | OT,2025-07-28/2025-08-03
257928801,25792880,68,M,2025-01-01,20250911,,BREYNA,Off label use,,BREYNA | Off label use,2024-12-30/2025-01-05
257929751,25792975,,,,20250911,,DIAZEPAM,Drug withdrawal syndrome,,DIAZEPAM | Drug withdrawal syndrome,NaT
257930011,25793001,77,M,,20250911,,PREDNISONE,Septic shock,LT,PREDNISONE | Septic shock | LT,NaT
257930221,25793022,,M,,20250911,,SKYRIZI,Basal cell carcinoma,OT,SKYRIZI | Basal cell carcinoma | OT,NaT
257930321,25793032,51,,2024-09-01,20250911,,ZEPBOUND,Postprandial hypoglycaemia,,ZEPBOUND | Postprandial hypoglycaemia,2024-08-26/2024-09-01
257930731,25793073,89,F,2025-09-07,20250911,,TREPROSTINIL,Death,DE,TREPROSTINIL | Death | DE,2025-09-01/2025-09-07
257932981,25793298,,,,20250911,,DAPAGLIFLOZIN,Fatigue,OT,DAPAGLIFLOZIN | Fatigue | OT,NaT
257933101,25793310,84,F,,20250911,,ZEPBOUND,Drug ineffective,,ZEPBOUND | Drug ineffective,NaT
257933361,25793336,45,M,,20250911,,TALTZ,Therapy partial responder,,TALTZ | Therapy partial responder,NaT
257933701,25793370,,,2025-01-01,20250911,,NEMLUVIO,Product dose omission issue,,NEMLUVIO | Product dose omission issue,2024-12-30/2025-01-05
257934531,25793453,69,F,2025-07-17,20250911,,SKYRIZI,Lower limb fracture,HO,SKYRIZI | Lower limb fracture | HO,2025-07-14/2025-07-20
257934921,25793492,,F,,20250911,,DUPIXENT,Memory impairment,,DUPIXENT | Memory impairment,NaT
257935371,25793537,71,F,2025-08-01,20250911,,DUPIXENT,COVID-19,,DUPIXENT | COVID-19,2025-07-28/2025-08-03
257936441,25793644,,F,,20250912,,HYDROCORTISONE,Drug ineffective,,HYDROCORTISONE | Drug ineffective,NaT
257936592,25793659,74,M,,20250919,,IMFINZI,Eczema,DE,IMFINZI | Eczema | DE,NaT
257939531,25793953,,,,20250912,,CRYSVITA,Therapy interrupted,,CRYSVITA | Therapy interrupted,NaT
257939651,25793965,,,,20250912,,DUPIXENT,Blindness,DS,DUPIXENT | Blindness | DS,NaT
257939802,25793980,78,M,,20250926,,POMALYST,White blood cell count decreased,,POMALYST | White blood cell count decreased,NaT
257940261,25794026,76,M,2025-01-01,20250912,,SKYRIZI,Feeling abnormal,OT,SKYRIZI | Feeling abnormal | OT,2024-12-30/2025-01-05
257940531,25794053,18,M,2025-08-01,20250912,,SKYRIZI,Device issue,HO,SKYRIZI | Device issue | HO,2025-07-28/2025-08-03
257940741,25794074,,F,,20250912,,ZURZUVAE,General physical health deterioration,,ZURZUVAE | General physical health deterioration,NaT
257941761,25794176,56,F,2025-05-19,20250912,,ATORVASTATIN,Mixed liver injury,HO,ATORVASTATIN | Mixed liver injury | HO,2025-05-19/2025-05-25
257942831,25794283,,F,,20250912,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
257942911,25794291,,F,2025-05-01,20250912,,HYDROCHLOROTHIAZIDE,Rash,,HYDROCHLOROTHIAZIDE | Rash,2025-04-28/2025-05-04
257943591,25794359,86,M,,20250912,,ORGOVYX,Laryngeal injury,HO,ORGOVYX | Laryngeal injury | HO,NaT
257943831,25794383,,,,20250912,,ATEZOLIZUMAB,Adrenal insufficiency,OT,ATEZOLIZUMAB | Adrenal insufficiency | OT,NaT
257944481,25794448,75,M,,20250912,,ORGOVYX,Incorrect dose administered,,ORGOVYX | Incorrect dose administered,NaT
257946081,25794608,24,M,,20250912,,RILPIVIRINE,Product administered at inappropriate site,,RILPIVIRINE | Product administered at inappropriate site,NaT
257947321,25794732,,,,20250912,,SEMGLEE (INSULIN GLARGINE-YFGN),Drug ineffective,,SEMGLEE (INSULIN GLARGINE-YFGN) | Drug ineffective,NaT
257948051,25794805,85,F,,20250912,,LENALIDOMIDE,Peripheral swelling,,LENALIDOMIDE | Peripheral swelling,NaT
257949981,25794998,78,M,,20250912,,ORGOVYX,Hyperhidrosis,,ORGOVYX | Hyperhidrosis,NaT
257950531,25795053,,,,20250912,,KEYTRUDA,Lichen sclerosus,,KEYTRUDA | Lichen sclerosus,NaT
257951601,25795160,,F,,20250912,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
257951851,25795185,63,F,2025-08-06,20250912,,VARENICLINE,Diarrhoea,,VARENICLINE | Diarrhoea,2025-08-04/2025-08-10
257955311,25795531,,,,20250912,,NEMLUVIO,Drug ineffective,,NEMLUVIO | Drug ineffective,NaT
257956141,25795614,66,F,,20250912,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
257956611,25795661,,,,20250912,,SEMGLEE (INSULIN GLARGINE-YFGN),Glycosylated haemoglobin increased,,SEMGLEE (INSULIN GLARGINE-YFGN) | Glycosylated haemoglobin increased,NaT
257958132,25795813,38,F,2025-09-01,20250920,,BOTOX,Injection site pain,,BOTOX | Injection site pain,2025-09-01/2025-09-07
257958801,25795880,23,F,,20250912,,TACROLIMUS,Drug ineffective for unapproved indication,HO,TACROLIMUS | Drug ineffective for unapproved indication | HO,NaT
257958831,25795883,,,2025-01-01,20250912,,BEMPEDOIC ACID\EZETIMIBE,Incorrect dose administered,OT,BEMPEDOIC ACID\EZETIMIBE | Incorrect dose administered | OT,2024-12-30/2025-01-05
257959261,25795926,54,F,,20250912,,DOCETAXEL,Myelosuppression,OT,DOCETAXEL | Myelosuppression | OT,NaT
257960291,25796029,,M,,20250912,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Respiratory failure,OT,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Respiratory failure | OT,NaT
257960691,25796069,,F,,20250912,,LANREOTIDE ACETATE,Injection site pain,OT,LANREOTIDE ACETATE | Injection site pain | OT,NaT
257960751,25796075,66,M,2025-06-05,20250912,,CYCLOPHOSPHAMIDE,Immune effector cell-associated neurotoxicity syndrome,OT,CYCLOPHOSPHAMIDE | Immune effector cell-associated neurotoxicity syndrome | OT,2025-06-02/2025-06-08
257960891,25796089,,M,,20250912,,IMFINZI,Myocardial infarction,DE,IMFINZI | Myocardial infarction | DE,NaT
257963101,25796310,,,,20250912,,RITUXIMAB,Adrenal insufficiency,OT,RITUXIMAB | Adrenal insufficiency | OT,NaT
257963611,25796361,80,F,,20250912,,ELIQUIS,Epistaxis,,ELIQUIS | Epistaxis,NaT
257964702,25796470,30,M,2025-08-01,20250930,,DUPIXENT,Condition aggravated,,DUPIXENT | Condition aggravated,2025-07-28/2025-08-03
257965531,25796553,82,F,,20250912,,DUPIXENT,Productive cough,,DUPIXENT | Productive cough,NaT
257965801,25796580,13,F,,20250912,,DUPIXENT,Inappropriate schedule of product administration,,DUPIXENT | Inappropriate schedule of product administration,NaT
257966781,25796678,33,M,2025-01-01,20250912,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2024-12-30/2025-01-05
257968131,25796813,,,,20250912,,QUETIAPINE,"Hallucination, auditory",OT,"QUETIAPINE | Hallucination, auditory | OT",NaT
257968421,25796842,,F,,20250912,,DUPIXENT,Diarrhoea,,DUPIXENT | Diarrhoea,NaT
257968641,25796864,,F,,20250912,,DUPIXENT,Thyroid cyst,,DUPIXENT | Thyroid cyst,NaT
257968871,25796887,40,M,,20250912,,IMDELLTRA,Off label use,,IMDELLTRA | Off label use,NaT
257968881,25796888,31,,2025-09-09,20250912,,VECTIBIX,Rash,,VECTIBIX | Rash,2025-09-08/2025-09-14
257968941,25796894,62,F,2025-08-05,20250912,,RUXIENCE,Agranulocytosis,LT,RUXIENCE | Agranulocytosis | LT,2025-08-04/2025-08-10
257969811,25796981,,F,2022-01-01,20250912,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,2021-12-27/2022-01-02
257969991,25796999,,F,,20250912,,TYMLOS,Pneumonia bacterial,OT,TYMLOS | Pneumonia bacterial | OT,NaT
257970581,25797058,,M,2025-09-04,20250912,,METOPROLOL SUCCINATE,Heart rate increased,,METOPROLOL SUCCINATE | Heart rate increased,2025-09-01/2025-09-07
257970821,25797082,,,,20250912,,CARBOPLATIN,Neuropathy peripheral,OT,CARBOPLATIN | Neuropathy peripheral | OT,NaT
257972001,25797200,,,,20250912,,ZEPBOUND,Extra dose administered,,ZEPBOUND | Extra dose administered,NaT
257973361,25797336,69,F,2025-08-01,20250912,,INPEFA,Vomiting,,INPEFA | Vomiting,2025-07-28/2025-08-03
257974251,25797425,,F,,20250912,,MOUNJARO,Hypothermia,OT,MOUNJARO | Hypothermia | OT,NaT
257974561,25797456,36,F,2021-06-01,20250912,,LEXAPRO,Heart rate increased,HO,LEXAPRO | Heart rate increased | HO,2021-05-31/2021-06-06
257975171,25797517,,F,,20250912,,TYENNE,Abdominal pain upper,OT,TYENNE | Abdominal pain upper | OT,NaT
257975291,25797529,,M,,20250912,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,NaT
257975381,25797538,61,F,2025-07-01,20250912,,DUPIXENT,Osteoarthritis,HO,DUPIXENT | Osteoarthritis | HO,2025-06-30/2025-07-06
257976001,25797600,65,M,2025-08-28,20250912,,DOXAZOSIN,Fatigue,OT,DOXAZOSIN | Fatigue | OT,2025-08-25/2025-08-31
257976371,25797637,,F,2025-09-01,20250912,,XPHOZAH,Nausea,HO,XPHOZAH | Nausea | HO,2025-09-01/2025-09-07
257976731,25797673,,,2025-06-10,20250912,,EYLEA HD,Incorrect dose administered,,EYLEA HD | Incorrect dose administered,2025-06-09/2025-06-15
257976821,25797682,,M,,20250912,,EYLEA HD,Product dose omission issue,,EYLEA HD | Product dose omission issue,NaT
257977031,25797703,,F,2025-01-01,20250912,,EYLEA HD,Maternal exposure during pregnancy,,EYLEA HD | Maternal exposure during pregnancy,2024-12-30/2025-01-05
257977081,25797708,,F,,20250912,,OMNITROPE,Circumstance or information capable of leading to device use error,,OMNITROPE | Circumstance or information capable of leading to device use error,NaT
257977962,25797796,,M,2025-09-09,20250923,,FASENRA,Off label use,HO,FASENRA | Off label use | HO,2025-09-08/2025-09-14
257978061,25797806,,M,,20250912,,VENCLEXTA,Death,DE,VENCLEXTA | Death | DE,NaT
257978081,25797808,77,M,,20250912,,TAGRISSO,Weight decreased,OT,TAGRISSO | Weight decreased | OT,NaT
257978871,25797887,,,,20250910,,SKYRIZI,Adenosquamous cell carcinoma,,SKYRIZI | Adenosquamous cell carcinoma,NaT
257978981,25797898,,,,20250912,,ZEPBOUND,Therapeutic response changed,,ZEPBOUND | Therapeutic response changed,NaT
257980161,25798016,,F,2025-09-10,20250912,,IMFINZI,Anaphylactic shock,OT,IMFINZI | Anaphylactic shock | OT,2025-09-08/2025-09-14
257981101,25798110,61,F,,20250912,,XELJANZ XR,Headache,,XELJANZ XR | Headache,NaT
257981861,25798186,,F,,20250912,,TAVALISSE,White blood cell count decreased,OT,TAVALISSE | White blood cell count decreased | OT,NaT
257982041,25798204,41,F,2025-09-09,20250912,,ZEPBOUND,Injection site pain,,ZEPBOUND | Injection site pain,2025-09-08/2025-09-14
257982951,25798295,88,,,20250912,,BASAGLAR,Accidental underdose,,BASAGLAR | Accidental underdose,NaT
257983021,25798302,61,M,2024-01-01,20250912,,SKYRIZI,Hypoaesthesia,OT,SKYRIZI | Hypoaesthesia | OT,2024-01-01/2024-01-07
257983051,25798305,,F,,20250912,,FASENRA,Dyspnoea,,FASENRA | Dyspnoea,NaT
257984241,25798424,52,F,2025-01-01,20250913,,DUPIXENT,Neurodermatitis,,DUPIXENT | Neurodermatitis,2024-12-30/2025-01-05
257985111,25798511,,M,,20250913,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
257985471,25798547,,,2022-01-26,20250913,,INFLECTRA,Off label use,OT,INFLECTRA | Off label use | OT,2022-01-24/2022-01-30
257986142,25798614,35,F,,20250917,,DUPIXENT,Exposure via skin contact,,DUPIXENT | Exposure via skin contact,NaT
257986483,25798648,58,F,2025-08-14,20250918,,BENRALIZUMAB,Cerebrovascular accident,LT,BENRALIZUMAB | Cerebrovascular accident | LT,2025-08-11/2025-08-17
257987291,25798729,,,,20250913,,ACETAMINOPHEN,Off label use,,ACETAMINOPHEN | Off label use,NaT
257988211,25798821,69,F,2025-03-07,20250913,,PREDNISOLONE,Condition aggravated,OT,PREDNISOLONE | Condition aggravated | OT,2025-03-03/2025-03-09
257988261,25798826,,M,,20250913,,SYMBICORT,Lymphadenopathy,,SYMBICORT | Lymphadenopathy,NaT
257988451,25798845,46,F,2025-03-01,20250913,,HUMIRA,Device issue,,HUMIRA | Device issue,2025-02-24/2025-03-02
257988531,25798853,,,,20250913,,ZEPBOUND,Bronchitis,,ZEPBOUND | Bronchitis,NaT
257988821,25798882,75,F,2025-08-27,20250913,,MIRTAZAPINE,Leukopenia,OT,MIRTAZAPINE | Leukopenia | OT,2025-08-25/2025-08-31
257990351,25799035,85,F,2025-06-01,20250913,,SKYRIZI,Surgery,OT,SKYRIZI | Surgery | OT,2025-05-26/2025-06-01
257990621,25799062,68,F,2025-02-01,20250913,,XYWAV,Drug ineffective,HO,XYWAV | Drug ineffective | HO,2025-01-27/2025-02-02
257991821,25799182,,F,2025-01-01,20250913,,REMODULIN,Infusion site infection,,REMODULIN | Infusion site infection,2024-12-30/2025-01-05
257992261,25799226,,F,,20250913,,REMODULIN,Exposure via ingestion,,REMODULIN | Exposure via ingestion,NaT
257992441,25799244,1,M,2024-08-01,20250913,,DUPIXENT,Seasonal allergy,,DUPIXENT | Seasonal allergy,2024-07-29/2024-08-04
257993141,25799314,,F,,20250913,,DUPIXENT,Nasopharyngitis,,DUPIXENT | Nasopharyngitis,NaT
257993241,25799324,39,F,,20250913,,DUPIXENT,Injection site irritation,,DUPIXENT | Injection site irritation,NaT
257993341,25799334,,,,20250913,,BIMEKIZUMAB,Adverse drug reaction,OT,BIMEKIZUMAB | Adverse drug reaction | OT,NaT
257993831,25799383,,M,,20250913,,METOPROLOL,Cardiac arrest,OT,METOPROLOL | Cardiac arrest | OT,NaT
257993841,25799384,54,M,,20250913,,SILDENAFIL,Toxicity to various agents,DE,SILDENAFIL | Toxicity to various agents | DE,NaT
257994911,25799491,,F,,20250914,,LEQVIO,Alopecia,,LEQVIO | Alopecia,NaT
257995021,25799502,,,,20250914,,DUPIXENT,Dizziness,,DUPIXENT | Dizziness,NaT
257995051,25799505,,M,2025-08-01,20250914,,DUPIXENT,Injury associated with device,,DUPIXENT | Injury associated with device,2025-07-28/2025-08-03
257995232,25799523,,F,,20250916,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
257995611,25799561,,M,,20250914,,LENALIDOMIDE,Cholecystectomy,HO,LENALIDOMIDE | Cholecystectomy | HO,NaT
257996201,25799620,30,F,2025-01-01,20250914,,DUPIXENT,Eczema,,DUPIXENT | Eczema,2024-12-30/2025-01-05
257996291,25799629,57,F,,20250914,,TOPIRAMATE,Off label use,OT,TOPIRAMATE | Off label use | OT,NaT
257996351,25799635,69,F,,20250914,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
257997521,25799752,,F,,20250914,,DUPIXENT,Drug hypersensitivity,,DUPIXENT | Drug hypersensitivity,NaT
257997591,25799759,64,M,2025-09-10,20250914,,MOUNJARO,Extra dose administered,,MOUNJARO | Extra dose administered,2025-09-08/2025-09-14
257997661,25799766,76,F,,20250914,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
257997771,25799777,,,,20250914,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
257998161,25799816,82,F,,20250914,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
257998271,25799827,62,M,2025-09-11,20250914,,DUPIXENT,Off label use,,DUPIXENT | Off label use,2025-09-08/2025-09-14
257998431,25799843,28,F,2025-01-01,20250914,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,2024-12-30/2025-01-05
257999722,25799972,,M,,20250914,,ALBUTEROL SULFATE,Drug ineffective,,ALBUTEROL SULFATE | Drug ineffective,NaT
257999921,25799992,60,F,2025-09-03,20250914,,BOTOX COSMETIC,Rash papular,,BOTOX COSMETIC | Rash papular,2025-09-01/2025-09-07
258000081,25800008,62,F,2025-01-01,20250914,,LINZESS,Knee arthroplasty,OT,LINZESS | Knee arthroplasty | OT,2024-12-30/2025-01-05
258000431,25800043,71,F,2024-08-01,20250914,,BOTOX COSMETIC,Ocular hyperaemia,,BOTOX COSMETIC | Ocular hyperaemia,2024-07-29/2024-08-04
258000811,25800081,,F,,20250914,,RINVOQ,Surgery,OT,RINVOQ | Surgery | OT,NaT
258000981,25800098,49,F,2025-09-01,20250915,,EBGLYSS,Urticaria,,EBGLYSS | Urticaria,2025-09-01/2025-09-07
258001491,25800149,64,F,2025-01-01,20250915,,CREON,Fluid retention,HO,CREON | Fluid retention | HO,2024-12-30/2025-01-05
258002681,25800268,,M,2025-07-29,20250915,,CABENUVA,Injection site pain,,CABENUVA | Injection site pain,2025-07-28/2025-08-03
258003241,25800324,76,M,,20250915,,XTAMPZA ER,Constipation,HO,XTAMPZA ER | Constipation | HO,NaT
258003301,25800330,3,F,2025-01-01,20250915,,DUPIXENT,Cough,,DUPIXENT | Cough,2024-12-30/2025-01-05
258003861,25800386,,,,20250915,,BENLYSTA,Off label use,,BENLYSTA | Off label use,NaT
258004801,25800480,,F,,20250915,,CAPLYTA,Loss of consciousness,OT,CAPLYTA | Loss of consciousness | OT,NaT
258005951,25800595,52,M,,20250915,,FLUOXETINE,Musculoskeletal stiffness,OT,FLUOXETINE | Musculoskeletal stiffness | OT,NaT
258006171,25800617,,F,,20250915,,ACALABRUTINIB,Contusion,HO,ACALABRUTINIB | Contusion | HO,NaT
258007081,25800708,,,2025-08-01,20250915,,ARANESP,Death,DE,ARANESP | Death | DE,2025-07-28/2025-08-03
258008141,25800814,47,F,,20250915,,AVASTIN,Cardiac failure,HO,AVASTIN | Cardiac failure | HO,NaT
258008841,25800884,31,M,,20250915,,DUPIXENT,Anaphylactic reaction,OT,DUPIXENT | Anaphylactic reaction | OT,NaT
258009021,25800902,,F,2024-01-01,20250915,,VEOZAH,Nausea,,VEOZAH | Nausea,2024-01-01/2024-01-07
258009341,25800934,74,F,2025-01-22,20250915,,OFEV,Diarrhoea,HO,OFEV | Diarrhoea | HO,2025-01-20/2025-01-26
258009761,25800976,,M,,20250915,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,NaT
258010381,25801038,,M,,20250915,,NUPLAZID,Memory impairment,,NUPLAZID | Memory impairment,NaT
258011881,25801188,,,2025-02-02,20250915,,SEMGLEE (INSULIN GLARGINE-YFGN),Blood glucose increased,,SEMGLEE (INSULIN GLARGINE-YFGN) | Blood glucose increased,2025-01-27/2025-02-02
258012181,25801218,49,F,,20250915,,XOLAIR,Superficial vein thrombosis,LT,XOLAIR | Superficial vein thrombosis | LT,NaT
258013551,25801355,,M,,20250915,,AFATINIB,Human epidermal growth factor receptor increased,OT,AFATINIB | Human epidermal growth factor receptor increased | OT,NaT
258013901,25801390,27,M,,20250915,,LEVETIRACETAM,Drug-induced liver injury,OT,LEVETIRACETAM | Drug-induced liver injury | OT,NaT
258014541,25801454,,,,20250915,,LISDEXAMFETAMINE DIMESYLATE,Brain fog,,LISDEXAMFETAMINE DIMESYLATE | Brain fog,NaT
258014631,25801463,23,M,2025-08-30,20250915,,ZEPBOUND,Injection site irritation,,ZEPBOUND | Injection site irritation,2025-08-25/2025-08-31
258015291,25801529,,F,2025-01-01,20250915,,REMODULIN,Dermatitis contact,,REMODULIN | Dermatitis contact,2024-12-30/2025-01-05
258015751,25801575,,,,20250915,,BENLYSTA,Off label use,,BENLYSTA | Off label use,NaT
258015901,25801590,49,F,2025-02-15,20250915,,USTEKINUMAB,Colitis,OT,USTEKINUMAB | Colitis | OT,2025-02-10/2025-02-16
258016051,25801605,55,F,2025-08-26,20250915,,OBINUTUZUMAB,Sinus tachycardia,OT,OBINUTUZUMAB | Sinus tachycardia | OT,2025-08-25/2025-08-31
258016411,25801641,,M,2024-01-01,20250915,,OXYCODONE AND ACETAMINOPHEN,Drug effect less than expected,,OXYCODONE AND ACETAMINOPHEN | Drug effect less than expected,2024-01-01/2024-01-07
258016591,25801659,4,M,2025-08-25,20250912,,EPIDIOLEX,Brain operation,HO,EPIDIOLEX | Brain operation | HO,2025-08-25/2025-08-31
258016781,25801678,61,M,2025-09-11,20250912,,DOBUTAMINE,Dizziness,LT,DOBUTAMINE | Dizziness | LT,2025-09-08/2025-09-14
258016801,25801680,75,M,2025-09-12,20250912,,XTANDI,Rash macular,,XTANDI | Rash macular,2025-09-08/2025-09-14
258017181,25801718,97,M,2025-08-08,20250915,,MIRTAZAPINE,Somnolence,HO,MIRTAZAPINE | Somnolence | HO,2025-08-04/2025-08-10
258017201,25801720,,F,,20250915,,DUPIXENT,Rebound effect,,DUPIXENT | Rebound effect,NaT
258017301,25801730,39,F,2025-01-01,20250915,,ROMVIMZA,Hepatic enzyme increased,,ROMVIMZA | Hepatic enzyme increased,2024-12-30/2025-01-05
258019191,25801919,33,F,,20250915,,DICLOFENAC,Intentional product misuse,HO,DICLOFENAC | Intentional product misuse | HO,NaT
258019611,25801961,72,M,,20250915,,TECENTRIQ,Death,DE,TECENTRIQ | Death | DE,NaT
258020441,25802044,74,M,,20250915,,FONDAPARINUX,Retroperitoneal haematoma,DE,FONDAPARINUX | Retroperitoneal haematoma | DE,NaT
258020481,25802048,1,F,2025-08-09,20250915,,PACLITAXEL,Maternal exposure timing unspecified,LT,PACLITAXEL | Maternal exposure timing unspecified | LT,2025-08-04/2025-08-10
258021111,25802111,,,,20250915,,NEMLUVIO,Back pain,,NEMLUVIO | Back pain,NaT
258021871,25802187,,F,,20250915,,BENLYSTA,Drug ineffective,,BENLYSTA | Drug ineffective,NaT
258022311,25802231,,,,20250915,,CLOZAPINE,Aspiration,OT,CLOZAPINE | Aspiration | OT,NaT
258023651,25802365,39,F,,20250915,,HYDROXYCHLOROQUINE,Porphyria non-acute,DS,HYDROXYCHLOROQUINE | Porphyria non-acute | DS,NaT
258024111,25802411,45,M,2023-01-01,20250915,,TACROLIMUS,Product use in unapproved indication,OT,TACROLIMUS | Product use in unapproved indication | OT,2022-12-26/2023-01-01
258024331,25802433,,F,2025-01-01,20250915,,SOTATERCEPT,Musculoskeletal stiffness,,SOTATERCEPT | Musculoskeletal stiffness,2024-12-30/2025-01-05
258024701,25802470,72,F,,20250912,,EVEROLIMUS,Pneumonia,HO,EVEROLIMUS | Pneumonia | HO,NaT
258025441,25802544,,,2025-08-01,20250915,,FERRLECIT,Nausea,OT,FERRLECIT | Nausea | OT,2025-07-28/2025-08-03
258025932,25802593,,M,2025-01-01,20250922,,VICTOZA,Localised infection,HO,VICTOZA | Localised infection | HO,2024-12-30/2025-01-05
258026221,25802622,33,M,,20250915,,TREMFYA,Colitis ulcerative,OT,TREMFYA | Colitis ulcerative | OT,NaT
258028351,25802835,58,F,2025-01-01,20250915,,OTEZLA,Nausea,,OTEZLA | Nausea,2024-12-30/2025-01-05
258029861,25802986,34,F,,20250915,,MOUNJARO,Vaginal haemorrhage,OT,MOUNJARO | Vaginal haemorrhage | OT,NaT
258029871,25802987,40,F,2025-08-28,20250915,,MOUNJARO,Syncope,OT,MOUNJARO | Syncope | OT,2025-08-25/2025-08-31
258030151,25803015,14,M,2024-12-06,20250915,,VYONDYS 53,Product dispensing error,,VYONDYS 53 | Product dispensing error,2024-12-02/2024-12-08
258030281,25803028,16,M,2024-12-20,20250915,,VYONDYS 53,Influenza like illness,,VYONDYS 53 | Influenza like illness,2024-12-16/2024-12-22
258031081,25803108,50,F,2025-06-01,20250915,,DUPIXENT,Condition aggravated,,DUPIXENT | Condition aggravated,2025-05-26/2025-06-01
258033271,25803327,73,M,2025-08-18,20250915,,XULTOPHY 100/3.6,Pruritus,OT,XULTOPHY 100/3.6 | Pruritus | OT,2025-08-18/2025-08-24
258033671,25803367,23,F,2020-01-01,20250915,,FLUOROURACIL,Product use in unapproved indication,OT,FLUOROURACIL | Product use in unapproved indication | OT,2019-12-30/2020-01-05
258033791,25803379,69,F,2025-08-01,20250915,,OZEMPIC,Decreased appetite,HO,OZEMPIC | Decreased appetite | HO,2025-07-28/2025-08-03
258033811,25803381,60,M,,20250915,,RYBELSUS,Suicidal ideation,OT,RYBELSUS | Suicidal ideation | OT,NaT
258034321,25803432,68,M,,20250915,,TRIAMCINOLONE ACETONIDE,Condition aggravated,DE,TRIAMCINOLONE ACETONIDE | Condition aggravated | DE,NaT
258034741,25803474,,,2025-03-10,20250915,,ESOMEPRAZOLE MAGNESIUM,Dysgeusia,,ESOMEPRAZOLE MAGNESIUM | Dysgeusia,2025-03-10/2025-03-16
258035061,25803506,74,F,2025-09-07,20250915,,MOUNJARO,Extra dose administered,,MOUNJARO | Extra dose administered,2025-09-01/2025-09-07
258037031,25803703,6,M,,20250915,,ARIPIPRAZOLE,Seizure,OT,ARIPIPRAZOLE | Seizure | OT,NaT
258038482,25803848,44,F,,20250923,,IBRANCE,Fatigue,HO,IBRANCE | Fatigue | HO,NaT
258038751,25803875,69,M,,20250915,,NURTEC ODT,Drug ineffective,,NURTEC ODT | Drug ineffective,NaT
258038891,25803889,81,M,,20250915,,PAXLOVID,Product prescribing error,,PAXLOVID | Product prescribing error,NaT
258038961,25803896,26,F,,20250915,,XELJANZ,Drug ineffective,,XELJANZ | Drug ineffective,NaT
258039731,25803973,8,M,2025-09-04,20250915,,VIMIZIM,Malaise,,VIMIZIM | Malaise,2025-09-01/2025-09-07
258040511,25804051,65,M,2025-09-10,20250915,,TECVAYLI,Pneumonia,HO,TECVAYLI | Pneumonia | HO,2025-09-08/2025-09-14
258041911,25804191,668,F,,20250915,,METHYLCOBALAMIN,Hyperglycaemia,HO,METHYLCOBALAMIN | Hyperglycaemia | HO,NaT
258041951,25804195,,M,,20250915,,SUNOSI,Drug ineffective,,SUNOSI | Drug ineffective,NaT
258042772,25804277,54,F,2025-01-01,20250925,,CORTICOTROPIN,Confusional state,,CORTICOTROPIN | Confusional state,2024-12-30/2025-01-05
258042871,25804287,63,M,2025-09-10,20250915,,CORTICOTROPIN,Injection site pruritus,,CORTICOTROPIN | Injection site pruritus,2025-09-08/2025-09-14
258043801,25804380,37,F,,20250915,,ZIRABEV,Haemoglobin decreased,OT,ZIRABEV | Haemoglobin decreased | OT,NaT
258043981,25804398,37,F,2025-08-15,20250915,,EPIRUBICIN,Hepatic function abnormal,OT,EPIRUBICIN | Hepatic function abnormal | OT,2025-08-11/2025-08-17
258044381,25804438,,,,20250915,,UPADACITINIB,Colectomy,OT,UPADACITINIB | Colectomy | OT,NaT
258044391,25804439,34,F,,20250915,,KESIMPTA,Pneumonia,OT,KESIMPTA | Pneumonia | OT,NaT
258044741,25804474,59,F,,20250915,,ZEPBOUND,Injection site pain,,ZEPBOUND | Injection site pain,NaT
258045061,25804506,,F,,20250915,,POMALYST,Neutropenia,OT,POMALYST | Neutropenia | OT,NaT
258045301,25804530,54,,2016-01-01,20250915,,NILOTINIB,Diabetes mellitus,OT,NILOTINIB | Diabetes mellitus | OT,2015-12-28/2016-01-03
258046641,25804664,,,,20250915,,EPKINLY,Diffuse large B-cell lymphoma refractory,OT,EPKINLY | Diffuse large B-cell lymphoma refractory | OT,NaT
258047631,25804763,64,F,2025-04-08,20250915,,RINVOQ,Joint dislocation,OT,RINVOQ | Joint dislocation | OT,2025-04-07/2025-04-13
258048141,25804814,,F,,20250915,,SKYRIZI,Impaired gastric emptying,OT,SKYRIZI | Impaired gastric emptying | OT,NaT
258048361,25804836,73,M,2025-09-01,20250915,,IMBRUVICA,Food poisoning,HO,IMBRUVICA | Food poisoning | HO,2025-09-01/2025-09-07
258048621,25804862,81,F,,20250916,,INFLIXIMAB,Sepsis,DE,INFLIXIMAB | Sepsis | DE,NaT
258050261,25805026,,F,2025-03-01,20250916,,PADCEV,Fatigue,,PADCEV | Fatigue,2025-02-24/2025-03-02
258055971,25805597,58,M,2025-07-01,20250916,,TREMFYA,Intervertebral disc protrusion,,TREMFYA | Intervertebral disc protrusion,2025-06-30/2025-07-06
258057161,25805716,,M,,20250916,,DAYBUE,Fine motor skill dysfunction,,DAYBUE | Fine motor skill dysfunction,NaT
258058021,25805802,,,,20250916,,NEMLUVIO,Device malfunction,,NEMLUVIO | Device malfunction,NaT
258058141,25805814,74,F,,20250916,,METHOTREXATE,Granuloma,HO,METHOTREXATE | Granuloma | HO,NaT
258058421,25805842,8,M,2025-09-01,20250916,,TECENTRIQ,Cytokine release syndrome,HO,TECENTRIQ | Cytokine release syndrome | HO,2025-09-01/2025-09-07
258058661,25805866,68,F,,20250916,,RIBOCICLIB,White blood cell count decreased,OT,RIBOCICLIB | White blood cell count decreased | OT,NaT
258059141,25805914,,M,,20250916,,TAVALISSE,Hip fracture,HO,TAVALISSE | Hip fracture | HO,NaT
258059431,25805943,,,2025-03-01,20250916,,DYANAVEL XR,Off label use,,DYANAVEL XR | Off label use,2025-02-24/2025-03-02
258059821,25805982,,,,20250916,,PREGABALIN,Somnolence,OT,PREGABALIN | Somnolence | OT,NaT
258059871,25805987,44,F,2025-05-22,20250916,,METRONIDAZOLE,Substance-induced psychotic disorder,OT,METRONIDAZOLE | Substance-induced psychotic disorder | OT,2025-05-19/2025-05-25
258060051,25806005,54,F,2025-09-04,20250916,,LENALIDOMIDE,Rash pruritic,,LENALIDOMIDE | Rash pruritic,2025-09-01/2025-09-07
258060081,25806008,45,F,2025-01-01,20250916,,SKYRIZI,Crohn's disease,HO,SKYRIZI | Crohn's disease | HO,2024-12-30/2025-01-05
258060701,25806070,64,F,2025-09-08,20250916,,SAPHNELO,Cough,,SAPHNELO | Cough,2025-09-08/2025-09-14
258061131,25806113,68,F,,20250916,,VENLAFAXINE,Toothache,OT,VENLAFAXINE | Toothache | OT,NaT
258061801,25806180,,F,,20250916,,CAPIVASERTIB,Pain in extremity,HO,CAPIVASERTIB | Pain in extremity | HO,NaT
258062151,25806215,66,M,,20250916,,ORGOVYX,Decreased appetite,,ORGOVYX | Decreased appetite,NaT
258064461,25806446,81,M,2025-01-01,20250916,,SKYRIZI,Increased tendency to bruise,OT,SKYRIZI | Increased tendency to bruise | OT,2024-12-30/2025-01-05
258064701,25806470,,F,,20250916,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258065242,25806524,61,M,2025-09-02,20250926,,BAVENCIO,Chills,HO,BAVENCIO | Chills | HO,2025-09-01/2025-09-07
258066261,25806626,56,,,20250916,,ENHERTU,Death,OT,ENHERTU | Death | OT,NaT
258066511,25806651,,F,,20250916,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258067011,25806701,69,F,2025-06-30,20250916,,MESALAMINE,Cardiac failure congestive,OT,MESALAMINE | Cardiac failure congestive | OT,2025-06-30/2025-07-06
258067331,25806733,91,M,2025-09-10,20250915,,NIVOLUMAB,Throat irritation,OT,NIVOLUMAB | Throat irritation | OT,2025-09-08/2025-09-14
258067571,25806757,9,F,,20250916,,TADALAFIL,Product ineffective,OT,TADALAFIL | Product ineffective | OT,NaT
258068712,25806871,57,F,2025-08-28,20250923,,NEULASTA,Wrong technique in product usage process,,NEULASTA | Wrong technique in product usage process,2025-08-25/2025-08-31
258068731,25806873,33,F,2025-09-12,20250916,,ZEPBOUND,Accidental underdose,,ZEPBOUND | Accidental underdose,2025-09-08/2025-09-14
258069231,25806923,,M,2025-05-01,20250916,,BRIXADI,Somnolence,,BRIXADI | Somnolence,2025-04-28/2025-05-04
258070681,25807068,44,M,2025-09-01,20250916,,IDELVION,Renal haemorrhage,OT,IDELVION | Renal haemorrhage | OT,2025-09-01/2025-09-07
258071081,25807108,,F,,20250916,,FINGOLIMOD,Drug intolerance,OT,FINGOLIMOD | Drug intolerance | OT,NaT
258071431,25807143,,F,,20250916,,BENLYSTA,White blood cell count increased,OT,BENLYSTA | White blood cell count increased | OT,NaT
258071491,25807149,,F,,20250916,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
258072351,25807235,45,F,,20250916,,MOUNJARO,Myalgia,,MOUNJARO | Myalgia,NaT
258073401,25807340,81,M,2025-09-01,20250915,,POMALYST,Intentional dose omission,HO,POMALYST | Intentional dose omission | HO,2025-09-01/2025-09-07
258073701,25807370,6,F,2017-01-01,20250916,,IBUPROFEN,Pyrexia,HO,IBUPROFEN | Pyrexia | HO,2016-12-26/2017-01-01
258073822,25807382,58,F,,20250922,,CARBIDOPA\LEVODOPA,Neck surgery,HO,CARBIDOPA\LEVODOPA | Neck surgery | HO,NaT
258073981,25807398,39,M,2025-09-07,20250916,,CYCLOPHOSPHAMIDE,Pneumonia,HO,CYCLOPHOSPHAMIDE | Pneumonia | HO,2025-09-01/2025-09-07
258074061,25807406,42,F,,20250916,,TEZSPIRE,Seizure,HO,TEZSPIRE | Seizure | HO,NaT
258075051,25807505,77,F,2025-01-01,20250916,,ATROVENT HFA,Influenza,,ATROVENT HFA | Influenza,2024-12-30/2025-01-05
258075291,25807529,,F,,20250916,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,NaT
258076571,25807657,37,M,2024-01-01,20250916,,XELJANZ XR,Blood triglycerides increased,,XELJANZ XR | Blood triglycerides increased,2024-01-01/2024-01-07
258076771,25807677,67,F,2025-01-01,20250916,,XELJANZ,COVID-19,,XELJANZ | COVID-19,2024-12-30/2025-01-05
258077301,25807730,55,,2025-08-15,20250916,,REPATHA,Drug dose omission by device,,REPATHA | Drug dose omission by device,2025-08-11/2025-08-17
258077361,25807736,50,F,2023-06-01,20250916,,VICTOZA,Asthenia,HO,VICTOZA | Asthenia | HO,2023-05-29/2023-06-04
258077591,25807759,81,F,2025-06-07,20250916,,OLUMIANT,Pneumonia aspiration,LT,OLUMIANT | Pneumonia aspiration | LT,2025-06-02/2025-06-08
258080143,25808014,34,F,2025-08-25,20250923,,XYWAV,Restless legs syndrome,OT,XYWAV | Restless legs syndrome | OT,2025-08-25/2025-08-31
258080321,25808032,,M,,20250916,,WEGOVY,Optic ischaemic neuropathy,HO,WEGOVY | Optic ischaemic neuropathy | HO,NaT
258081621,25808162,46,F,,20250916,,TRODELVY,Disease progression,OT,TRODELVY | Disease progression | OT,NaT
258081962,25808196,60,F,,20250922,,LORLATINIB,Death,DE,LORLATINIB | Death | DE,NaT
258082101,25808210,70,M,2024-01-01,20250916,,OZEMPIC,Depression,OT,OZEMPIC | Depression | OT,2024-01-01/2024-01-07
258082532,25808253,43,F,2025-09-01,20250930,,KYLEENA,Device dislocation,,KYLEENA | Device dislocation,2025-09-01/2025-09-07
258083551,25808355,76,M,,20250916,,LENALIDOMIDE,Contusion,HO,LENALIDOMIDE | Contusion | HO,NaT
258083731,25808373,89,M,2025-09-01,20250916,,CREON,Death,DE,CREON | Death | DE,2025-09-01/2025-09-07
258084251,25808425,73,,,20250916,,LAMOTRIGINE,Toxicity to various agents,HO,LAMOTRIGINE | Toxicity to various agents | HO,NaT
258084341,25808434,,F,,20250916,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258085191,25808519,53,F,2025-08-01,20250916,,AYVAKIT,Condition aggravated,HO,AYVAKIT | Condition aggravated | HO,2025-07-28/2025-08-03
258086271,25808627,80,F,2025-05-15,20250916,,SKYRIZI,COVID-19 pneumonia,HO,SKYRIZI | COVID-19 pneumonia | HO,2025-05-12/2025-05-18
258087811,25808781,,F,,20250916,,LYNPARZA,Underdose,OT,LYNPARZA | Underdose | OT,NaT
258087841,25808784,53,F,2025-04-01,20250916,,ESCITALOPRAM,Liver function test increased,HO,ESCITALOPRAM | Liver function test increased | HO,2025-03-31/2025-04-06
258087961,25808796,37,F,,20250916,,DOXORUBICIN,Drug ineffective,OT,DOXORUBICIN | Drug ineffective | OT,NaT
258088311,25808831,4,M,,20250916,,DUPIXENT,Lung disorder,HO,DUPIXENT | Lung disorder | HO,NaT
258089041,25808904,27,F,,20250916,,LEVETIRACETAM,Irritability,OT,LEVETIRACETAM | Irritability | OT,NaT
258089331,25808933,,,,20250916,,RUCONEST,Abdominal pain,,RUCONEST | Abdominal pain,NaT
258089401,25808940,70,F,2025-01-01,20250916,,CORTICOTROPIN,Hypoacusis,,CORTICOTROPIN | Hypoacusis,2024-12-30/2025-01-05
258089721,25808972,34,M,,20250916,,TAVNEOS,COVID-19,HO,TAVNEOS | COVID-19 | HO,NaT
258090741,25809074,53,F,2025-08-01,20250916,,BIMZELX,Psoriatic arthropathy,OT,BIMZELX | Psoriatic arthropathy | OT,2025-07-28/2025-08-03
258091201,25809120,48,F,2025-09-03,20250916,,VYEPTI,Therapeutic response shortened,OT,VYEPTI | Therapeutic response shortened | OT,2025-09-01/2025-09-07
258091421,25809142,68,,2025-09-16,20250916,,TACROLIMUS,Pneumonia,HO,TACROLIMUS | Pneumonia | HO,2025-09-15/2025-09-21
258091582,25809158,28,F,2025-07-11,20250930,,BIMZELX,Colitis ulcerative,HO,BIMZELX | Colitis ulcerative | HO,2025-07-07/2025-07-13
258091721,25809172,60,F,,20250916,,ISENTRESS,Death,DE,ISENTRESS | Death | DE,NaT
258092581,25809258,83,M,2025-01-01,20250916,,REVLIMID,Thrombosis,LT,REVLIMID | Thrombosis | LT,2024-12-30/2025-01-05
258094141,25809414,,F,,20250916,,DUPIXENT,Mood swings,,DUPIXENT | Mood swings,NaT
258094221,25809422,3,F,2025-01-01,20250916,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,2024-12-30/2025-01-05
258094241,25809424,36,M,2025-01-01,20250916,,DUPIXENT,COVID-19,,DUPIXENT | COVID-19,2024-12-30/2025-01-05
258094601,25809460,20,F,2025-08-01,20250916,,DUPIXENT,Abdominal pain,,DUPIXENT | Abdominal pain,2025-07-28/2025-08-03
258095041,25809504,44,F,,20250916,,DUPIXENT,Restless legs syndrome,,DUPIXENT | Restless legs syndrome,NaT
258095441,25809544,63,F,2025-08-01,20250916,,DUPIXENT,Sleep disorder due to a general medical condition,,DUPIXENT | Sleep disorder due to a general medical condition,2025-07-28/2025-08-03
258095481,25809548,,F,,20250916,,DUPIXENT,Exposure via skin contact,,DUPIXENT | Exposure via skin contact,NaT
258095681,25809568,47,F,2025-09-11,20250916,,DUPIXENT,Product prescribing issue,,DUPIXENT | Product prescribing issue,2025-09-08/2025-09-14
258096801,25809680,13,F,2025-07-01,20250916,,METHYLPHENIDATE HYDROCHLORIDE,Impulsive behaviour,,METHYLPHENIDATE HYDROCHLORIDE | Impulsive behaviour,2025-06-30/2025-07-06
258096831,25809683,43,F,,20250916,,BREO ELLIPTA,Oedema peripheral,OT,BREO ELLIPTA | Oedema peripheral | OT,NaT
258097411,25809741,67,M,,20250916,,TECLISTAMAB,Hemiparesis,HO,TECLISTAMAB | Hemiparesis | HO,NaT
258098001,25809800,53,F,2025-09-10,20250916,,RINVOQ,Gut derived infection,OT,RINVOQ | Gut derived infection | OT,2025-09-08/2025-09-14
258098381,25809838,69,F,2025-07-01,20250916,,XOSPATA,Cytopenia,HO,XOSPATA | Cytopenia | HO,2025-06-30/2025-07-06
258098572,25809857,18,M,,20250925,,TREMFYA,Product dose omission issue,,TREMFYA | Product dose omission issue,NaT
258099091,25809909,65,F,2025-08-27,20250917,,VALTREX,Diarrhoea,OT,VALTREX | Diarrhoea | OT,2025-08-25/2025-08-31
258099841,25809984,,M,,20250917,,OPDIVO,Death,DE,OPDIVO | Death | DE,NaT
258100121,25810012,83,F,2020-12-01,20250917,,DENOSUMAB,Abscess jaw,OT,DENOSUMAB | Abscess jaw | OT,2020-11-30/2020-12-06
258101301,25810130,52,M,,20250917,,FLUOXETINE,Gingival bleeding,OT,FLUOXETINE | Gingival bleeding | OT,NaT
258101611,25810161,69,M,2025-06-01,20250917,,NUPLAZID,Product use in unapproved indication,HO,NUPLAZID | Product use in unapproved indication | HO,2025-05-26/2025-06-01
258101881,25810188,,,,20250917,,SELINEXOR,Nausea,,SELINEXOR | Nausea,NaT
258101961,25810196,4,F,,20250917,,DOXORUBICIN,Acute kidney injury,OT,DOXORUBICIN | Acute kidney injury | OT,NaT
258102241,25810224,,,,20250917,,ACETAZOLAMIDE,Weight loss poor,OT,ACETAZOLAMIDE | Weight loss poor | OT,NaT
258102811,25810281,66,F,2021-05-11,20250917,,CARBOPLATIN,Neutropenia,HO,CARBOPLATIN | Neutropenia | HO,2021-05-10/2021-05-16
258102982,25810298,,F,,20250925,,HERCEPTIN,Memory impairment,OT,HERCEPTIN | Memory impairment | OT,NaT
258103401,25810340,,,,20250917,,ELIQUIS,Gastrointestinal haemorrhage,OT,ELIQUIS | Gastrointestinal haemorrhage | OT,NaT
258104612,25810461,72,F,2025-05-30,20250919,,SUGAMMADEX SODIUM,Anaphylactic reaction,LT,SUGAMMADEX SODIUM | Anaphylactic reaction | LT,2025-05-26/2025-06-01
258104961,25810496,57,F,2023-01-01,20250917,,AIMOVIG,Constipation,OT,AIMOVIG | Constipation | OT,2022-12-26/2023-01-01
258105561,25810556,85,F,2025-08-08,20250917,,HERCEPTIN,Breast cancer metastatic,OT,HERCEPTIN | Breast cancer metastatic | OT,2025-08-04/2025-08-10
258106102,25810610,65,,,20250924,,ALBUTEROL SULFATE,Off label use,,ALBUTEROL SULFATE | Off label use,NaT
258106821,25810682,14,M,2025-08-18,20250917,,HYDROCORTISONE,Systemic inflammatory response syndrome,HO,HYDROCORTISONE | Systemic inflammatory response syndrome | HO,2025-08-18/2025-08-24
258107321,25810732,,,,20250917,,INFLECTRA,Dementia,OT,INFLECTRA | Dementia | OT,NaT
258107521,25810752,75,F,2025-06-27,20250917,,ROSUVASTATIN CALCIUM,Myoglobin blood increased,OT,ROSUVASTATIN CALCIUM | Myoglobin blood increased | OT,2025-06-23/2025-06-29
258107611,25810761,58,M,,20250917,,SILDENAFIL CITRATE,Cerebral haemorrhage,OT,SILDENAFIL CITRATE | Cerebral haemorrhage | OT,NaT
258108441,25810844,84,F,2025-06-30,20250917,,SORAFENIB,Rash maculo-papular,HO,SORAFENIB | Rash maculo-papular | HO,2025-06-30/2025-07-06
258108591,25810859,52,M,2025-09-12,20250917,,OSIMERTINIB,Death,DE,OSIMERTINIB | Death | DE,2025-09-08/2025-09-14
258109511,25810951,76,M,2025-09-01,20250917,,CARBIDOPA\LEVODOPA,General physical health deterioration,DE,CARBIDOPA\LEVODOPA | General physical health deterioration | DE,2025-09-01/2025-09-07
258109611,25810961,,,,20250917,,NEMLUVIO,Product dose omission issue,,NEMLUVIO | Product dose omission issue,NaT
258109662,25810966,60,M,2025-01-01,20250925,,SPRAVATO,Balance disorder,OT,SPRAVATO | Balance disorder | OT,2024-12-30/2025-01-05
258109731,25810973,76,M,2025-02-23,20250917,,IRBESARTAN,Hyperkalaemia,HO,IRBESARTAN | Hyperkalaemia | HO,2025-02-17/2025-02-23
258110091,25811009,,,,20250917,,BEVACIZUMAB,Hypertension,OT,BEVACIZUMAB | Hypertension | OT,NaT
258110291,25811029,,F,,20250917,,PRALUENT,Cardiac disorder,HO,PRALUENT | Cardiac disorder | HO,NaT
258110681,25811068,30,M,2025-08-08,20250917,,CLOZAPINE,Coma,HO,CLOZAPINE | Coma | HO,2025-08-04/2025-08-10
258111331,25811133,,,,20250917,,SPRAVATO,Intentional product misuse,,SPRAVATO | Intentional product misuse,NaT
258111841,25811184,,F,2025-03-01,20250917,,COSENTYX,Renal disorder,DS,COSENTYX | Renal disorder | DS,2025-02-24/2025-03-02
258111871,25811187,73,M,2025-08-27,20250917,,TAMSULOSIN,Nightmare,OT,TAMSULOSIN | Nightmare | OT,2025-08-25/2025-08-31
258111971,25811197,40,M,2025-09-07,20250917,,HUMIRA,Brain neoplasm,HO,HUMIRA | Brain neoplasm | HO,2025-09-01/2025-09-07
258112031,25811203,,F,,20250917,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258112511,25811251,35,M,2025-02-25,20250917,,BLEOMYCIN,Abdominal pain,OT,BLEOMYCIN | Abdominal pain | OT,2025-02-24/2025-03-02
258113421,25811342,,M,,20250917,,BRIXADI,Therapeutic response shortened,,BRIXADI | Therapeutic response shortened,NaT
258113751,25811375,,M,2025-08-01,20250917,,BRIXADI,Injection site mass,,BRIXADI | Injection site mass,2025-07-28/2025-08-03
258113941,25811394,55,M,,20250917,,ORGOVYX,Fatigue,,ORGOVYX | Fatigue,NaT
258115051,25811505,,F,,20250917,,PRAVASTATIN SODIUM,Pain,OT,PRAVASTATIN SODIUM | Pain | OT,NaT
258115281,25811528,54,F,,20250917,,PACLITAXEL,Unresponsive to stimuli,HO,PACLITAXEL | Unresponsive to stimuli | HO,NaT
258116611,25811661,61,M,2025-09-10,20250917,,CINQAIR,Incorrect dose administered,OT,CINQAIR | Incorrect dose administered | OT,2025-09-08/2025-09-14
258116841,25811684,,,,20250917,,ISOTRETINOIN,Depression,OT,ISOTRETINOIN | Depression | OT,NaT
258117211,25811721,,F,,20250917,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
258119711,25811971,48,M,2025-09-13,20250917,,PAXLOVID,Disease recurrence,,PAXLOVID | Disease recurrence,2025-09-08/2025-09-14
258119942,25811994,47,F,2025-01-01,20250923,,IXIFI,Noninfective gingivitis,OT,IXIFI | Noninfective gingivitis | OT,2024-12-30/2025-01-05
258121231,25812123,61,M,,20250916,,LENVIMA,Fatigue,,LENVIMA | Fatigue,NaT
258121331,25812133,82,F,2025-09-06,20250917,,OLAPARIB,Hyponatraemia,HO,OLAPARIB | Hyponatraemia | HO,2025-09-01/2025-09-07
258121501,25812150,81,M,2025-09-16,20250916,,TAVNEOS,Hospitalisation,HO,TAVNEOS | Hospitalisation | HO,2025-09-15/2025-09-21
258121601,25812160,94,F,2025-03-27,20250917,,MIRTAZAPINE,Blood loss anaemia,OT,MIRTAZAPINE | Blood loss anaemia | OT,2025-03-24/2025-03-30
258122001,25812200,67,F,,20250917,,XELJANZ XR,Hip surgery,HO,XELJANZ XR | Hip surgery | HO,NaT
258122021,25812202,,,,20250917,,RITUXIMAB,Richter's syndrome,OT,RITUXIMAB | Richter's syndrome | OT,NaT
258122071,25812207,,F,,20250917,,INDOMETHACIN SODIUM,Fibromyalgia,OT,INDOMETHACIN SODIUM | Fibromyalgia | OT,NaT
258122171,25812217,,,2025-04-01,20250917,,DIMETHYL FUMARATE,Medication error,DS,DIMETHYL FUMARATE | Medication error | DS,2025-03-31/2025-04-06
258122611,25812261,,F,2022-06-20,20250917,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,2022-06-20/2022-06-26
258123531,25812353,85,M,2025-01-01,20250917,,FOSCARBIDOPA\FOSLEVODOPA,Dysphagia,DE,FOSCARBIDOPA\FOSLEVODOPA | Dysphagia | DE,2024-12-30/2025-01-05
258123761,25812376,,,,20250917,,ENTYVIO,Infusion related reaction,,ENTYVIO | Infusion related reaction,NaT
258123901,25812390,80,F,2025-09-01,20250917,,DUPIXENT,Condition aggravated,OT,DUPIXENT | Condition aggravated | OT,2025-09-01/2025-09-07
258123941,25812394,,,,20250917,,METRONIDAZOLE,Adverse drug reaction,,METRONIDAZOLE | Adverse drug reaction,NaT
258124331,25812433,,M,,20250917,,GEMCITABINE,Asthenia,,GEMCITABINE | Asthenia,NaT
258125061,25812506,51,F,,20250917,,ZEPBOUND,Product dose omission issue,,ZEPBOUND | Product dose omission issue,NaT
258125601,25812560,,,,20250917,,KETOROLAC TROMETHAMINE,Injection site pain,,KETOROLAC TROMETHAMINE | Injection site pain,NaT
258125621,25812562,62,F,2025-09-04,20250917,,SIMPONI,Cellulitis,HO,SIMPONI | Cellulitis | HO,2025-09-01/2025-09-07
258125791,25812579,87,F,,20250917,,CAPECITABINE,Death,DE,CAPECITABINE | Death | DE,NaT
258126001,25812600,,,2000-01-01,20250917,,VALIUM,Memory impairment,OT,VALIUM | Memory impairment | OT,1999-12-27/2000-01-02
258126371,25812637,,F,,20250917,,BOTOX COSMETIC,Drug ineffective,,BOTOX COSMETIC | Drug ineffective,NaT
258127281,25812728,74,F,,20250917,,DUPIXENT,Infection,,DUPIXENT | Infection,NaT
258127411,25812741,53,M,2025-09-01,20250917,,DUPIXENT,Discomfort,,DUPIXENT | Discomfort,2025-09-01/2025-09-07
258128211,25812821,,F,,20250917,,DUPIXENT,Rash macular,,DUPIXENT | Rash macular,NaT
258128591,25812859,64,M,2025-01-01,20250917,,DUPIXENT,Conjunctivitis,,DUPIXENT | Conjunctivitis,2024-12-30/2025-01-05
258128881,25812888,,M,,20250917,,SODIUM CHLORIDE,Pain in extremity,,SODIUM CHLORIDE | Pain in extremity,NaT
258129601,25812960,47,F,2025-09-12,20250917,,DUPIXENT,Accidental exposure to product,,DUPIXENT | Accidental exposure to product,2025-09-08/2025-09-14
258130381,25813038,,,,20250917,,PROZAC,Jaundice neonatal,OT,PROZAC | Jaundice neonatal | OT,NaT
258130441,25813044,,,,20250917,,ZEPBOUND,Diarrhoea,,ZEPBOUND | Diarrhoea,NaT
258130771,25813077,33,F,2025-05-29,20250917,,REBYOTA,Vomiting,,REBYOTA | Vomiting,2025-05-26/2025-06-01
258131511,25813151,40,M,,20250917,,TARPEYO,Nasopharyngitis,,TARPEYO | Nasopharyngitis,NaT
258131611,25813161,,M,,20250917,,RINVOQ,Neoplasm malignant,OT,RINVOQ | Neoplasm malignant | OT,NaT
258132551,25813255,,F,2017-01-11,20250917,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,2017-01-09/2017-01-15
258133071,25813307,,M,,20250917,,NUCALA,Asthma,,NUCALA | Asthma,NaT
258135221,25813522,33,M,,20250917,,DEXAMETHASONE,Uveitis,OT,DEXAMETHASONE | Uveitis | OT,NaT
258135401,25813540,70,,,20250917,,LITHIUM,End stage renal disease,OT,LITHIUM | End stage renal disease | OT,NaT
258135501,25813550,71,M,2025-01-01,20250917,,DUPIXENT,Inappropriate schedule of product administration,,DUPIXENT | Inappropriate schedule of product administration,2024-12-30/2025-01-05
258135552,25813555,,F,,20250919,,ODOMZO,Dysgeusia,LT,ODOMZO | Dysgeusia | LT,NaT
258135652,25813565,52,F,2025-09-10,20250920,,ORENCIA,Needle issue,OT,ORENCIA | Needle issue | OT,2025-09-08/2025-09-14
258135661,25813566,,M,,20250917,,NUBEQA,Drug ineffective,,NUBEQA | Drug ineffective,NaT
258136261,25813626,,,,20250917,,BUPRENORPHINE HYDROCHLORIDE,Dizziness,,BUPRENORPHINE HYDROCHLORIDE | Dizziness,NaT
258136501,25813650,,,,20250917,,NEXIUM,Drug ineffective,,NEXIUM | Drug ineffective,NaT
258137401,25813740,,M,,20250917,,MIDAZOLAM,Hypotension,OT,MIDAZOLAM | Hypotension | OT,NaT
258139201,25813920,,M,,20250917,,XPHOZAH,Diarrhoea,,XPHOZAH | Diarrhoea,NaT
258139311,25813931,29,F,,20250917,,XPHOZAH,Wrong technique in product usage process,,XPHOZAH | Wrong technique in product usage process,NaT
258139511,25813951,,F,2025-01-01,20250917,,XPHOZAH,Diarrhoea,,XPHOZAH | Diarrhoea,2024-12-30/2025-01-05
258140821,25814082,17,F,2025-08-31,20250917,,SPRYCEL,Death,DE,SPRYCEL | Death | DE,2025-08-25/2025-08-31
258141781,25814178,58,,,20250917,,KERENDIA,Urine albumin/creatinine ratio increased,OT,KERENDIA | Urine albumin/creatinine ratio increased | OT,NaT
258142681,25814268,58,M,,20250917,,REVLIMID,Oedema peripheral,,REVLIMID | Oedema peripheral,NaT
258143071,25814307,45,F,2025-08-29,20250917,,ERIBULIN,Agranulocytosis,HO,ERIBULIN | Agranulocytosis | HO,2025-08-25/2025-08-31
258143161,25814316,,F,2025-09-05,20250917,,ZEPBOUND,Gastrointestinal disorder,,ZEPBOUND | Gastrointestinal disorder,2025-09-01/2025-09-07
258143661,25814366,70,F,2025-08-19,20250917,,LEVOFLOXACIN,Dizziness,RI,LEVOFLOXACIN | Dizziness | RI,2025-08-18/2025-08-24
258143771,25814377,,,,20250917,,OTEZLA,Hospitalisation,,OTEZLA | Hospitalisation,NaT
258143951,25814395,51,F,2025-09-02,20250917,,OZEMPIC,Decreased appetite,OT,OZEMPIC | Decreased appetite | OT,2025-09-01/2025-09-07
258143961,25814396,,M,,20250917,,NOVOLOG,Pancreatic carcinoma recurrent,OT,NOVOLOG | Pancreatic carcinoma recurrent | OT,NaT
258144701,25814470,46,F,,20250917,,MOUNJARO,Oropharyngeal cancer,OT,MOUNJARO | Oropharyngeal cancer | OT,NaT
258146241,25814624,72,M,,20250917,,ADALIMUMAB,Cardiac failure congestive,OT,ADALIMUMAB | Cardiac failure congestive | OT,NaT
258146411,25814641,73,,,20250917,,SODIUM CHLORIDE,Myelosuppression,HO,SODIUM CHLORIDE | Myelosuppression | HO,NaT
258146541,25814654,,M,,20250917,,DUPIXENT,Back pain,,DUPIXENT | Back pain,NaT
258146631,25814663,49,F,2025-08-22,20250917,,CRESTOR,Skin ulcer,OT,CRESTOR | Skin ulcer | OT,2025-08-18/2025-08-24
258147391,25814739,59,,,20250917,,BRUKINSA,Posterior reversible encephalopathy syndrome,OT,BRUKINSA | Posterior reversible encephalopathy syndrome | OT,NaT
258147441,25814744,,F,2025-01-01,20250917,,ORENITRAM,Off label use,,ORENITRAM | Off label use,2024-12-30/2025-01-05
258147631,25814763,52,F,,20250917,,EMGALITY,Therapeutic response decreased,,EMGALITY | Therapeutic response decreased,NaT
258149821,25814982,66,,2025-09-07,20250918,,REPATHA,Rash,,REPATHA | Rash,2025-09-01/2025-09-07
258150041,25815004,,F,2025-09-10,20250918,,ESTRADIOL,Device adhesion issue,,ESTRADIOL | Device adhesion issue,2025-09-08/2025-09-14
258150241,25815024,38,F,2025-01-01,20250918,,XOLAIR,Device defective,,XOLAIR | Device defective,2024-12-30/2025-01-05
258150491,25815049,,F,,20250918,,ALENDRONATE SODIUM,Abdominal discomfort,,ALENDRONATE SODIUM | Abdominal discomfort,NaT
258150581,25815058,85,F,2024-08-26,20250918,,ALENDRONATE SODIUM,Diarrhoea,,ALENDRONATE SODIUM | Diarrhoea,2024-08-26/2024-09-01
258151341,25815134,,F,,20250918,,ALENDRONATE SODIUM,Product packaging difficult to open,,ALENDRONATE SODIUM | Product packaging difficult to open,NaT
258151501,25815150,75,M,2025-05-28,20250918,,DEXAMETHASONE,Polyneuropathy,OT,DEXAMETHASONE | Polyneuropathy | OT,2025-05-26/2025-06-01
258152021,25815202,74,F,,20250918,,VALSARTAN,Blood pressure increased,OT,VALSARTAN | Blood pressure increased | OT,NaT
258153311,25815331,,M,,20250918,,CARBOPLATIN,Penile erosion,HO,CARBOPLATIN | Penile erosion | HO,NaT
258154951,25815495,,F,,20250918,,TAGRISSO,Metastases to central nervous system,OT,TAGRISSO | Metastases to central nervous system | OT,NaT
258156871,25815687,,,2025-01-01,20250918,,ISOTRETINOIN,Product dispensing error,,ISOTRETINOIN | Product dispensing error,2024-12-30/2025-01-05
258158111,25815811,,M,,20250918,,FYCOMPA,Pain,,FYCOMPA | Pain,NaT
258159321,25815932,,,,20250918,,FYCOMPA,Weight decreased,,FYCOMPA | Weight decreased,NaT
258159781,25815978,63,F,2025-07-01,20250918,,OMNIPAQUE,Limb discomfort,,OMNIPAQUE | Limb discomfort,2025-06-30/2025-07-06
258160141,25816014,,,2025-09-01,20250918,,ALBUTEROL,Device delivery system issue,,ALBUTEROL | Device delivery system issue,2025-09-01/2025-09-07
258160491,25816049,67,M,2025-08-19,20250918,,ARNUITY ELLIPTA,Wrong technique in device usage process,,ARNUITY ELLIPTA | Wrong technique in device usage process,2025-08-18/2025-08-24
258160571,25816057,,,,20250918,,POLYETHYLENE GLYCOL 3350,Drug effect less than expected,,POLYETHYLENE GLYCOL 3350 | Drug effect less than expected,NaT
258161081,25816108,67,F,2025-01-01,20250918,,REPATHA,Drug dose omission by device,,REPATHA | Drug dose omission by device,2024-12-30/2025-01-05
258161311,25816131,,M,,20250918,,LOPERAMIDE HYDROCHLORIDE,Intentional product misuse,,LOPERAMIDE HYDROCHLORIDE | Intentional product misuse,NaT
258161501,25816150,,M,,20250918,,BENRALIZUMAB,Drug ineffective,OT,BENRALIZUMAB | Drug ineffective | OT,NaT
258161541,25816154,,,,20250918,,POLYETHYLENE GLYCOL 3350,Drug ineffective,,POLYETHYLENE GLYCOL 3350 | Drug ineffective,NaT
258161551,25816155,86,M,,20250918,,OXYCODONE HYDROCHLORIDE,Balance disorder,DS,OXYCODONE HYDROCHLORIDE | Balance disorder | DS,NaT
258161711,25816171,,,,20250918,,POLYETHYLENE GLYCOL 3350,Drug effective for unapproved indication,,POLYETHYLENE GLYCOL 3350 | Drug effective for unapproved indication,NaT
258162531,25816253,54,M,,20250918,,CILTACABTAGENE AUTOLEUCEL,Myelodysplastic syndrome,OT,CILTACABTAGENE AUTOLEUCEL | Myelodysplastic syndrome | OT,NaT
258165191,25816519,66,F,2025-09-09,20250918,,CRESEMBA,Off label use,,CRESEMBA | Off label use,2025-09-08/2025-09-14
258165501,25816550,67,M,2025-01-01,20250918,,SKYRIZI,Swelling,OT,SKYRIZI | Swelling | OT,2024-12-30/2025-01-05
258167341,25816734,,F,,20250918,,BREO ELLIPTA,Underdose,,BREO ELLIPTA | Underdose,NaT
258167801,25816780,69,F,,20250918,,MELPHALAN,Drug ineffective,OT,MELPHALAN | Drug ineffective | OT,NaT
258167891,25816789,70,M,,20250918,,LEVOTHYROXINE,Intentional overdose,HO,LEVOTHYROXINE | Intentional overdose | HO,NaT
258169741,25816974,85,F,,20250918,,HUMALOG,Blood glucose increased,,HUMALOG | Blood glucose increased,NaT
258171111,25817111,54,M,,20250918,,OMEPRAZOLE,Cerebellar syndrome,OT,OMEPRAZOLE | Cerebellar syndrome | OT,NaT
258171381,25817138,71,M,2025-08-18,20250917,,PIRFENIDONE,Abdominal discomfort,,PIRFENIDONE | Abdominal discomfort,2025-08-18/2025-08-24
258171471,25817147,15,F,2025-09-10,20250918,,XOLAIR,Drug delivery system malfunction,,XOLAIR | Drug delivery system malfunction,2025-09-08/2025-09-14
258171751,25817175,49,F,,20250918,,PREGABALIN,Toxicity to various agents,LT,PREGABALIN | Toxicity to various agents | LT,NaT
258172081,25817208,,F,,20250918,,TRODELVY,Neutropenia,OT,TRODELVY | Neutropenia | OT,NaT
258172231,25817223,,,2025-09-12,20250917,,GAMUNEX-C,Urticaria,,GAMUNEX-C | Urticaria,2025-09-08/2025-09-14
258172291,25817229,69,F,,20250917,,RINVOQ,Dizziness,OT,RINVOQ | Dizziness | OT,NaT
258172811,25817281,29,F,2025-09-04,20250918,,METHOTREXATE SODIUM,Face oedema,OT,METHOTREXATE SODIUM | Face oedema | OT,2025-09-01/2025-09-07
258173661,25817366,,,,20250918,,PROPRANOLOL HYDROCHLORIDE,Headache,,PROPRANOLOL HYDROCHLORIDE | Headache,NaT
258173771,25817377,65,F,,20250918,,PACLITAXEL,Off label use,OT,PACLITAXEL | Off label use | OT,NaT
258173791,25817379,,,2025-01-01,20250918,,RUCONEST,Stress,,RUCONEST | Stress,2024-12-30/2025-01-05
258174091,25817409,,,,20250918,,JAKAFI,Arthropathy,OT,JAKAFI | Arthropathy | OT,NaT
258174751,25817475,61,M,,20250918,,METFORMIN HYDROCHLORIDE,Basal cell carcinoma,OT,METFORMIN HYDROCHLORIDE | Basal cell carcinoma | OT,NaT
258174821,25817482,,,,20250918,,DASATINIB,Pleural effusion,DE,DASATINIB | Pleural effusion | DE,NaT
258175671,25817567,59,,,20250918,,FLUOROURACIL,Abdominal pain,HO,FLUOROURACIL | Abdominal pain | HO,NaT
258175991,25817599,61,M,,20250918,,USTEKINUMAB,Intentional dose omission,OT,USTEKINUMAB | Intentional dose omission | OT,NaT
258176131,25817613,52,,,20250918,,FILSPARI,Burning sensation,,FILSPARI | Burning sensation,NaT
258176171,25817617,38,F,,20250918,,FILSPARI,Swelling,,FILSPARI | Swelling,NaT
258176411,25817641,86,M,2025-01-01,20250918,,VYNDAMAX,Left atrial appendage closure implant,OT,VYNDAMAX | Left atrial appendage closure implant | OT,2024-12-30/2025-01-05
258177111,25817711,61,F,2025-09-15,20250918,,RINVOQ,Knee operation,OT,RINVOQ | Knee operation | OT,2025-09-15/2025-09-21
258177301,25817730,,,,20250918,,CINACALCET HYDROCHLORIDE,Computerised tomogram heart abnormal,OT,CINACALCET HYDROCHLORIDE | Computerised tomogram heart abnormal | OT,NaT
258177941,25817794,,F,,20250918,,IMDELLTRA,Pneumonitis,OT,IMDELLTRA | Pneumonitis | OT,NaT
258178721,25817872,,F,,20250918,,ELEXACAFTOR\IVACAFTOR\TEZACAFTOR,Paraesthesia,,ELEXACAFTOR\IVACAFTOR\TEZACAFTOR | Paraesthesia,NaT
258178771,25817877,,F,,20250918,,JOURNAVX,Rash,,JOURNAVX | Rash,NaT
258178931,25817893,,,,20250918,,ZEPBOUND,Product dispensing error,,ZEPBOUND | Product dispensing error,NaT
258179741,25817974,,M,,20250918,,CLOZARIL,Death,DE,CLOZARIL | Death | DE,NaT
258181681,25818168,,F,,20250918,,EGATEN,Drug ineffective,,EGATEN | Drug ineffective,NaT
258181691,25818169,68,F,,20250918,,KISQALI,Arrhythmia,OT,KISQALI | Arrhythmia | OT,NaT
258181781,25818178,73,M,,20250918,,SOLIFENACIN,Somnolence,,SOLIFENACIN | Somnolence,NaT
258182211,25818221,73,F,2023-12-28,20250918,,OSIMERTINIB,Gastrointestinal toxicity,OT,OSIMERTINIB | Gastrointestinal toxicity | OT,2023-12-25/2023-12-31
258182311,25818231,59,F,2025-09-07,20250918,,OZEMPIC,Depressed mood,OT,OZEMPIC | Depressed mood | OT,2025-09-01/2025-09-07
258182591,25818259,,F,,20250918,,MOUNJARO,Visual impairment,,MOUNJARO | Visual impairment,NaT
258182991,25818299,58,F,,20250918,,MAYZENT,Acute cholecystitis necrotic,HO,MAYZENT | Acute cholecystitis necrotic | HO,NaT
258184831,25818483,,,,20250918,,JAKAFI,Wrong technique in product usage process,,JAKAFI | Wrong technique in product usage process,NaT
258185371,25818537,,M,2024-02-01,20250918,,LEVETIRACETAM,Developmental coordination disorder,OT,LEVETIRACETAM | Developmental coordination disorder | OT,2024-01-29/2024-02-04
258186572,25818657,64,M,,20250920,,IBRUTINIB,Cerebellar stroke,DE,IBRUTINIB | Cerebellar stroke | DE,NaT
258186931,25818693,,,,20250918,,OMNITROPE,Circumstance or information capable of leading to device use error,,OMNITROPE | Circumstance or information capable of leading to device use error,NaT
258187101,25818710,64,F,2025-08-21,20250918,,TAVNEOS,Neutropenia,LT,TAVNEOS | Neutropenia | LT,2025-08-18/2025-08-24
258187181,25818718,59,M,,20250918,,RITUXIMAB,Tachycardia,OT,RITUXIMAB | Tachycardia | OT,NaT
258187641,25818764,20,M,2025-08-08,20250918,,MIRDAMETINIB,Electrocardiogram T wave abnormal,HO,MIRDAMETINIB | Electrocardiogram T wave abnormal | HO,2025-08-04/2025-08-10
258188071,25818807,7,F,2025-01-01,20250918,,KEYTRUDA,Femoral neck fracture,OT,KEYTRUDA | Femoral neck fracture | OT,2024-12-30/2025-01-05
258188301,25818830,,F,,20250918,,COSENTYX,Accidental exposure to product,,COSENTYX | Accidental exposure to product,NaT
258188961,25818896,,F,,20250918,,LEQVIO,Injection site pruritus,,LEQVIO | Injection site pruritus,NaT
258189081,25818908,83,,2025-09-16,20250918,,ELIQUIS,Treatment noncompliance,,ELIQUIS | Treatment noncompliance,2025-09-15/2025-09-21
258190071,25819007,63,F,2025-07-03,20250918,,LANTUS SOLOSTAR,Product dispensing error,,LANTUS SOLOSTAR | Product dispensing error,2025-06-30/2025-07-06
258191161,25819116,49,M,2025-01-01,20250918,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,2024-12-30/2025-01-05
258191411,25819141,60,F,2025-01-01,20250918,,DUPIXENT,Rhinorrhoea,,DUPIXENT | Rhinorrhoea,2024-12-30/2025-01-05
258192661,25819266,,F,2023-01-01,20250918,,DUPIXENT,Incorrect dose administered,,DUPIXENT | Incorrect dose administered,2022-12-26/2023-01-01
258193772,25819377,28,F,,20250927,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
258193781,25819378,,F,,20250918,,DUPIXENT,Product dose omission issue,,DUPIXENT | Product dose omission issue,NaT
258194371,25819437,17,F,2025-07-01,20250918,,DUPIXENT,Inappropriate schedule of product administration,,DUPIXENT | Inappropriate schedule of product administration,2025-06-30/2025-07-06
258194922,25819492,25,F,2025-01-01,20250925,,DUPIXENT,Injection site swelling,,DUPIXENT | Injection site swelling,2024-12-30/2025-01-05
258195061,25819506,,F,,20250918,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,NaT
258195281,25819528,24,M,2025-08-01,20250918,,DUPIXENT,Rebound effect,,DUPIXENT | Rebound effect,2025-07-28/2025-08-03
258196151,25819615,80,F,2025-09-06,20250918,,BREXPIPRAZOLE,Product use in unapproved indication,DE,BREXPIPRAZOLE | Product use in unapproved indication | DE,2025-09-01/2025-09-07
258196962,25819696,65,M,2025-02-08,20250922,,CERTOLIZUMAB PEGOL,Rash,OT,CERTOLIZUMAB PEGOL | Rash | OT,2025-02-03/2025-02-09
258197081,25819708,,,,20250918,,CYRAMZA,Thrombosis,OT,CYRAMZA | Thrombosis | OT,NaT
258197171,25819717,86,F,2025-08-19,20250918,,CETUXIMAB,Cardiac failure,HO,CETUXIMAB | Cardiac failure | HO,2025-08-18/2025-08-24
258197571,25819757,65,,,20250918,,ELIQUIS,Haemorrhage,,ELIQUIS | Haemorrhage,NaT
258198331,25819833,,F,,20250918,,LYNPARZA,Blood disorder,OT,LYNPARZA | Blood disorder | OT,NaT
258198601,25819860,,,,20250918,,OXYCODONE HYDROCHLORIDE,Product taste abnormal,,OXYCODONE HYDROCHLORIDE | Product taste abnormal,NaT
258198911,25819891,,,2024-09-05,20250918,,OXYCODONE HYDROCHLORIDE,Drug ineffective,,OXYCODONE HYDROCHLORIDE | Drug ineffective,2024-09-02/2024-09-08
258199301,25819930,46,F,2025-09-11,20250918,,DUPIXENT,Arthralgia,,DUPIXENT | Arthralgia,2025-09-08/2025-09-14
258199621,25819962,75,M,2025-01-01,20250918,,CREON,Blood potassium increased,HO,CREON | Blood potassium increased | HO,2024-12-30/2025-01-05
258199701,25819970,6,F,2025-07-31,20250918,,PEGFILGRASTIM,Aortic wall hypertrophy,HO,PEGFILGRASTIM | Aortic wall hypertrophy | HO,2025-07-28/2025-08-03
258200601,25820060,,F,,20250918,,SKYRIZI,Mobility decreased,HO,SKYRIZI | Mobility decreased | HO,NaT
258201251,25820125,,F,,20250919,,BOTOX,Cerebrovascular accident,OT,BOTOX | Cerebrovascular accident | OT,NaT
258203331,25820333,,M,,20250919,,HIZENTRA,Injection site haemorrhage,,HIZENTRA | Injection site haemorrhage,NaT
258203621,25820362,35,F,,20250919,,VANCOMYCIN,Drug ineffective,HO,VANCOMYCIN | Drug ineffective | HO,NaT
258203901,25820390,50,M,2025-09-08,20250919,,CETUXIMAB,Dizziness,OT,CETUXIMAB | Dizziness | OT,2025-09-08/2025-09-14
258204141,25820414,,M,,20250919,,NUCALA,Insomnia,,NUCALA | Insomnia,NaT
258205521,25820552,62,F,,20250919,,AUSTEDO XR,Huntington's disease,OT,AUSTEDO XR | Huntington's disease | OT,NaT
258205831,25820583,,F,,20250919,,DAPAGLIFLOZIN,Cerebrovascular accident,OT,DAPAGLIFLOZIN | Cerebrovascular accident | OT,NaT
258206501,25820650,67,M,2025-01-01,20250919,,REPATHA,Wrong technique in product usage process,,REPATHA | Wrong technique in product usage process,2024-12-30/2025-01-05
258206511,25820651,71,M,,20250919,,ORGOVYX,Dyspepsia,,ORGOVYX | Dyspepsia,NaT
258207701,25820770,,F,,20250919,,DUPIXENT,Sleep disorder due to a general medical condition,,DUPIXENT | Sleep disorder due to a general medical condition,NaT
258208311,25820831,38,M,,20250919,,ACYCLOVIR,Endotracheal intubation,HO,ACYCLOVIR | Endotracheal intubation | HO,NaT
258210481,25821048,86,M,,20250919,,APIXABAN,Diverticulum intestinal haemorrhagic,HO,APIXABAN | Diverticulum intestinal haemorrhagic | HO,NaT
258211171,25821117,52,F,2025-01-11,20250919,,DULOXETINE HYDROCHLORIDE,Drug ineffective,OT,DULOXETINE HYDROCHLORIDE | Drug ineffective | OT,2025-01-06/2025-01-12
258211381,25821138,41,M,,20250919,,DULOXETINE HYDROCHLORIDE,Parkinsonism,,DULOXETINE HYDROCHLORIDE | Parkinsonism,NaT
258211421,25821142,45,M,,20250919,,TRAZODONE,Treatment failure,,TRAZODONE | Treatment failure,NaT
258213241,25821324,53,F,2025-08-19,20250919,,ZOLEDRONIC ACID,Hyperpyrexia,OT,ZOLEDRONIC ACID | Hyperpyrexia | OT,2025-08-18/2025-08-24
258213541,25821354,,F,,20250919,,HUMIRA,Injection site discharge,,HUMIRA | Injection site discharge,NaT
258213711,25821371,68,M,,20250919,,ORGOVYX,Hot flush,,ORGOVYX | Hot flush,NaT
258214141,25821414,,F,,20250919,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
258214411,25821441,,F,,20250919,,FRUQUINTINIB,Malignant ascites,OT,FRUQUINTINIB | Malignant ascites | OT,NaT
258214921,25821492,,F,,20250919,,BUSULFAN,Inappropriate antidiuretic hormone secretion,OT,BUSULFAN | Inappropriate antidiuretic hormone secretion | OT,NaT
258215551,25821555,41,F,2025-09-15,20250919,,GONAL-F,Blood glucose increased,,GONAL-F | Blood glucose increased,2025-09-15/2025-09-21
258215631,25821563,,F,2025-04-14,20250919,,FLUOCINONIDE,Rash,,FLUOCINONIDE | Rash,2025-04-14/2025-04-20
258216271,25821627,62,F,,20250919,,MIDAZOLAM,Transient global amnesia,HO,MIDAZOLAM | Transient global amnesia | HO,NaT
258216311,25821631,,F,,20250919,,TYLENOL,Foetal exposure during pregnancy,OT,TYLENOL | Foetal exposure during pregnancy | OT,NaT
258217181,25821718,79,M,2025-07-01,20250919,,NUPLAZID,Hallucination,OT,NUPLAZID | Hallucination | OT,2025-06-30/2025-07-06
258218261,25821826,,F,,20250919,,DAYBUE,Diarrhoea,,DAYBUE | Diarrhoea,NaT
258218351,25821835,77,M,,20250919,,REVLIMID,Fatigue,,REVLIMID | Fatigue,NaT
258218501,25821850,74,M,,20250919,,ORGOVYX,Fatigue,,ORGOVYX | Fatigue,NaT
258218671,25821867,67,M,,20250919,,VABYSMO,Malaise,HO,VABYSMO | Malaise | HO,NaT
258219531,25821953,,,2025-01-01,20250919,,BOSENTAN,Hospitalisation,HO,BOSENTAN | Hospitalisation | HO,2024-12-30/2025-01-05
258219911,25821991,38,F,,20250919,,HYDROXYCHLOROQUINE SULFATE,Neurosyphilis,OT,HYDROXYCHLOROQUINE SULFATE | Neurosyphilis | OT,NaT
258220601,25822060,,,,20250919,,QSYMIA,Feeling abnormal,,QSYMIA | Feeling abnormal,NaT
258220821,25822082,,,2024-09-01,20250919,,QSYMIA,Headache,,QSYMIA | Headache,2024-08-26/2024-09-01
258221121,25822112,,,,20250919,,QSYMIA,Weight increased,,QSYMIA | Weight increased,NaT
258221352,25822135,,,2024-10-11,20250919,,QSYMIA,Temperature intolerance,,QSYMIA | Temperature intolerance,2024-10-07/2024-10-13
258221471,25822147,,,,20250919,,QSYMIA,Anxiety,,QSYMIA | Anxiety,NaT
258222381,25822238,,,,20250919,,QSYMIA,Feeling abnormal,,QSYMIA | Feeling abnormal,NaT
258223281,25822328,,,,20250919,,QSYMIA,Anger,,QSYMIA | Anger,NaT
258223991,25822399,,,2025-07-01,20250919,,ZEPBOUND,Injection site reaction,,ZEPBOUND | Injection site reaction,2025-06-30/2025-07-06
258224621,25822462,,,2025-09-10,20250919,,EC-NAPROSYN,Diarrhoea,OT,EC-NAPROSYN | Diarrhoea | OT,2025-09-08/2025-09-14
258225131,25822513,33,M,,20250919,,GEMCITABINE,Pseudomembranous colitis,OT,GEMCITABINE | Pseudomembranous colitis | OT,NaT
258225221,25822522,74,F,,20250919,,AMIODARONE,Treatment failure,OT,AMIODARONE | Treatment failure | OT,NaT
258225271,25822527,,,,20250919,,QSYMIA,Constipation,,QSYMIA | Constipation,NaT
258225441,25822544,,,,20250919,,QSYMIA,Parosmia,,QSYMIA | Parosmia,NaT
258226141,25822614,,,,20250919,,QSYMIA,Nasopharyngitis,,QSYMIA | Nasopharyngitis,NaT
258226451,25822645,,,,20250919,,QSYMIA,Lethargy,,QSYMIA | Lethargy,NaT
258226471,25822647,,,,20250919,,QSYMIA,Product prescribing issue,,QSYMIA | Product prescribing issue,NaT
258226731,25822673,,,,20250919,,QSYMIA,Inappropriate schedule of product administration,,QSYMIA | Inappropriate schedule of product administration,NaT
258228271,25822827,,,,20250919,,QSYMIA,Drug titration error,,QSYMIA | Drug titration error,NaT
258228981,25822898,,,,20250919,,QSYMIA,Adverse event,,QSYMIA | Adverse event,NaT
258229181,25822918,83,F,,20250919,,METHOTREXATE SODIUM,Off label use,OT,METHOTREXATE SODIUM | Off label use | OT,NaT
258229671,25822967,,,,20250919,,TYLENOL,Foetal exposure during pregnancy,OT,TYLENOL | Foetal exposure during pregnancy | OT,NaT
258229761,25822976,72,F,2025-06-09,20250919,,TICAGRELOR,Death,DE,TICAGRELOR | Death | DE,2025-06-09/2025-06-15
258230591,25823059,11,F,2025-09-07,20250919,,CUVITRU,Hypersensitivity,,CUVITRU | Hypersensitivity,2025-09-01/2025-09-07
258230951,25823095,76,F,,20250919,,CAPECITABINE,Venoocclusive liver disease,OT,CAPECITABINE | Venoocclusive liver disease | OT,NaT
258231111,25823111,,F,,20250919,,CLOZARIL,Pneumonia,HO,CLOZARIL | Pneumonia | HO,NaT
258231811,25823181,,,,20250919,,IMDELLTRA,Tumour lysis syndrome,OT,IMDELLTRA | Tumour lysis syndrome | OT,NaT
258232081,25823208,,F,,20250919,,AVASTIN,No adverse event,,AVASTIN | No adverse event,NaT
258232321,25823232,,,,20250919,,QSYMIA,Urinary tract infection,,QSYMIA | Urinary tract infection,NaT
258232421,25823242,,,,20250919,,QSYMIA,Urine odour abnormal,,QSYMIA | Urine odour abnormal,NaT
258232731,25823273,,,,20250919,,TYLENOL,Foetal exposure during pregnancy,OT,TYLENOL | Foetal exposure during pregnancy | OT,NaT
258233641,25823364,,F,,20250919,,QSYMIA,Illness,,QSYMIA | Illness,NaT
258233711,25823371,,F,,20250919,,QSYMIA,Fatigue,,QSYMIA | Fatigue,NaT
258233801,25823380,,F,,20250919,,QSYMIA,Dizziness,,QSYMIA | Dizziness,NaT
258234071,25823407,,,,20250919,,QSYMIA,Malaise,,QSYMIA | Malaise,NaT
258234231,25823423,,,,20250919,,QSYMIA,Dizziness,,QSYMIA | Dizziness,NaT
258234571,25823457,,F,,20250919,,CARFILZOMIB,Drug ineffective,OT,CARFILZOMIB | Drug ineffective | OT,NaT
258234751,25823475,82,F,,20250919,,REVLIMID,Faecaloma,OT,REVLIMID | Faecaloma | OT,NaT
258234991,25823499,83,M,2025-09-15,20250918,,NUPLAZID,Death,DE,NUPLAZID | Death | DE,2025-09-15/2025-09-21
258235431,25823543,60,F,2021-07-15,20250919,,STELARA,Off label use,OT,STELARA | Off label use | OT,2021-07-12/2021-07-18
258236161,25823616,81,M,2025-08-15,20250919,,REQUIP,Dizziness,OT,REQUIP | Dizziness | OT,2025-08-11/2025-08-17
258236451,25823645,,M,,20250919,,NUPLAZID,Poor quality sleep,OT,NUPLAZID | Poor quality sleep | OT,NaT
258237191,25823719,,F,,20250919,,MIRENA,Device dislocation,,MIRENA | Device dislocation,NaT
258237481,25823748,92,F,2025-09-05,20250919,,CARBIDOPA\LEVODOPA,Death,DE,CARBIDOPA\LEVODOPA | Death | DE,2025-09-01/2025-09-07
258237621,25823762,37,F,2023-11-19,20250918,,KETOROLAC,Product prescribing issue,OT,KETOROLAC | Product prescribing issue | OT,2023-11-13/2023-11-19
258237861,25823786,24,M,2019-06-14,20250919,,CITALOPRAM,Medication error,DS,CITALOPRAM | Medication error | DS,2019-06-10/2019-06-16
258238072,25823807,52,M,,20250922,,OPSUMIT,Cardiac failure chronic,HO,OPSUMIT | Cardiac failure chronic | HO,NaT
258238101,25823810,,,,20250919,,ALLEGRA ALLERGY,No adverse event,,ALLEGRA ALLERGY | No adverse event,NaT
258238891,25823889,,F,,20250919,,ESTRADIOL TRANSDERMAL SYSTEM,Vulvovaginal dryness,,ESTRADIOL TRANSDERMAL SYSTEM | Vulvovaginal dryness,NaT
258239091,25823909,,,,20250919,,ESTRADIOL,Drug ineffective,OT,ESTRADIOL | Drug ineffective | OT,NaT
258239591,25823959,,F,,20250919,,MARIBAVIR,Death,DE,MARIBAVIR | Death | DE,NaT
258239631,25823963,51,F,2025-01-01,20250919,,SKYRIZI,Haemorrhoids,OT,SKYRIZI | Haemorrhoids | OT,2024-12-30/2025-01-05
258240291,25824029,,M,,20250919,,ARISTADA,Off label use,,ARISTADA | Off label use,NaT
258241061,25824106,68,F,2025-09-14,20250919,,ZEPBOUND,Pancreatitis,HO,ZEPBOUND | Pancreatitis | HO,2025-09-08/2025-09-14
258241341,25824134,69,F,2025-08-28,20250919,,CIPROFLOXACIN,Product dispensing error,,CIPROFLOXACIN | Product dispensing error,2025-08-25/2025-08-31
258241461,25824146,,F,2024-11-01,20250919,,NOVOLOG MIX 70/30,Hospitalisation,HO,NOVOLOG MIX 70/30 | Hospitalisation | HO,2024-10-28/2024-11-03
258243551,25824355,64,F,2025-01-01,20250919,,DUPIXENT,Oral herpes,,DUPIXENT | Oral herpes,2024-12-30/2025-01-05
258243661,25824366,66,M,2025-01-01,20250919,,DUPIXENT,SARS-CoV-2 test positive,,DUPIXENT | SARS-CoV-2 test positive,2024-12-30/2025-01-05
258244112,25824411,55,M,,20250923,,LANTUS SOLOSTAR,Off label use,,LANTUS SOLOSTAR | Off label use,NaT
258245631,25824563,80,F,2025-01-01,20250919,,DUPIXENT,Nasopharyngitis,,DUPIXENT | Nasopharyngitis,2024-12-30/2025-01-05
258246451,25824645,50,M,2025-01-01,20250919,,DUPIXENT,Product use in unapproved indication,,DUPIXENT | Product use in unapproved indication,2024-12-30/2025-01-05
258246811,25824681,,,,20250919,,GANAXOLONE,Seizure,OT,GANAXOLONE | Seizure | OT,NaT
258247181,25824718,54,M,,20250919,,ONDANSETRON,Neoplasm malignant,OT,ONDANSETRON | Neoplasm malignant | OT,NaT
258247301,25824730,,M,,20250919,,FILSPARI,Visual impairment,,FILSPARI | Visual impairment,NaT
258247901,25824790,20,F,2025-09-12,20250919,,MONOFERRIC,Syncope,OT,MONOFERRIC | Syncope | OT,2025-09-08/2025-09-14
258248431,25824843,,M,,20250919,,AMBRISENTAN,Pneumonia,HO,AMBRISENTAN | Pneumonia | HO,NaT
258249811,25824981,,F,,20250919,,PROLIA,Atypical femur fracture,OT,PROLIA | Atypical femur fracture | OT,NaT
258251031,25825103,,F,,20250919,,FIORICET,Flat affect,,FIORICET | Flat affect,NaT
258251851,25825185,,M,,20250919,,AUSTEDO XR,Drug ineffective,,AUSTEDO XR | Drug ineffective,NaT
258252391,25825239,57,M,,20250919,,COSENTYX,Death,DE,COSENTYX | Death | DE,NaT
258252541,25825254,54,M,2025-09-01,20250919,,LONSURF,Intestinal obstruction,HO,LONSURF | Intestinal obstruction | HO,2025-09-01/2025-09-07
258252951,25825295,69,M,2025-04-01,20250919,,REMICADE,Dermatitis psoriasiform,OT,REMICADE | Dermatitis psoriasiform | OT,2025-03-31/2025-04-06
258253291,25825329,,F,,20250919,,LENVIMA,Chronic kidney disease,OT,LENVIMA | Chronic kidney disease | OT,NaT
258253351,25825335,19,F,2025-09-01,20250919,,CIMZIA,Product dose omission issue,OT,CIMZIA | Product dose omission issue | OT,2025-09-01/2025-09-07
258254611,25825461,70,F,2025-09-09,20250919,,PALBOCICLIB,Myelosuppression,OT,PALBOCICLIB | Myelosuppression | OT,2025-09-08/2025-09-14
258255111,25825511,44,F,2025-07-01,20250919,,DUPIXENT,Urticaria,,DUPIXENT | Urticaria,2025-06-30/2025-07-06
258255151,25825515,,,,20250919,,TYLENOL,Foetal exposure during pregnancy,OT,TYLENOL | Foetal exposure during pregnancy | OT,NaT
258255361,25825536,30,M,,20250919,,CITALOPRAM,Drug interaction,OT,CITALOPRAM | Drug interaction | OT,NaT
258255621,25825562,,F,,20250919,,MOUNJARO,Nephrolithiasis,HO,MOUNJARO | Nephrolithiasis | HO,NaT
258256121,25825612,72,F,2025-08-01,20250919,,SKYRIZI,Leukaemia,OT,SKYRIZI | Leukaemia | OT,2025-07-28/2025-08-03
258257451,25825745,77,F,2024-07-01,20250919,,DIMETHICONE\LOPERAMIDE HYDROCHLORIDE,Intentional product use issue,,DIMETHICONE\LOPERAMIDE HYDROCHLORIDE | Intentional product use issue,2024-07-01/2024-07-07
258257801,25825780,69,,,20250919,,RITUXIMAB,Pneumonia,DE,RITUXIMAB | Pneumonia | DE,NaT
258258191,25825819,,M,2008-01-01,20250919,,PROSCAR,Cognitive disorder,OT,PROSCAR | Cognitive disorder | OT,2007-12-31/2008-01-06
258258631,25825863,,M,,20250919,,WAINUA,Vision blurred,,WAINUA | Vision blurred,NaT
258258831,25825883,,F,,20250919,,CORTICOTROPIN,Headache,,CORTICOTROPIN | Headache,NaT
258258881,25825888,,,2024-05-10,20250919,,TERLIPRESSIN,Pulmonary oedema,OT,TERLIPRESSIN | Pulmonary oedema | OT,2024-05-06/2024-05-12
258258961,25825896,,M,2025-09-11,20250919,,NITRIC OXIDE,Condition aggravated,OT,NITRIC OXIDE | Condition aggravated | OT,2025-09-08/2025-09-14
258259061,25825906,55,F,2025-08-01,20250919,,CIMZIA,Axial spondyloarthritis,OT,CIMZIA | Axial spondyloarthritis | OT,2025-07-28/2025-08-03
258259441,25825944,54,F,,20250919,,LIBTAYO,Off label use,HO,LIBTAYO | Off label use | HO,NaT
258260181,25826018,,F,2025-07-29,20250919,,ALBUTEROL SULFATE,Drug ineffective,,ALBUTEROL SULFATE | Drug ineffective,2025-07-28/2025-08-03
258260821,25826082,72,M,2024-08-01,20250919,,VEVYE,Eye irritation,,VEVYE | Eye irritation,2024-07-29/2024-08-04
258261001,25826100,,,2025-01-01,20250919,,ASPARLAS,Hepatotoxicity,,ASPARLAS | Hepatotoxicity,2024-12-30/2025-01-05
258261671,25826167,,M,,20250919,,CREON,Illness,OT,CREON | Illness | OT,NaT
258262441,25826244,64,F,,20250919,,SKYRIZI,Colitis ulcerative,OT,SKYRIZI | Colitis ulcerative | OT,NaT
258263121,25826312,,,,20250919,,TYLENOL,Foetal exposure during pregnancy,OT,TYLENOL | Foetal exposure during pregnancy | OT,NaT
258263291,25826329,12,M,,20250919,,DUPIXENT,Vitiligo,,DUPIXENT | Vitiligo,NaT
258263521,25826352,,F,,20250920,,TYLENOL,Foetal exposure during pregnancy,OT,TYLENOL | Foetal exposure during pregnancy | OT,NaT
258263781,25826378,,F,,20250920,,MIRVETUXIMAB SORAVTANSINE,Neoplasm progression,OT,MIRVETUXIMAB SORAVTANSINE | Neoplasm progression | OT,NaT
258264131,25826413,49,M,2025-01-01,20250920,,FOSCARBIDOPA\FOSLEVODOPA,Drug ineffective,DE,FOSCARBIDOPA\FOSLEVODOPA | Drug ineffective | DE,2024-12-30/2025-01-05
258264391,25826439,,,,20250920,,TYLENOL,Autism spectrum disorder,OT,TYLENOL | Autism spectrum disorder | OT,NaT
258265351,25826535,86,M,2025-08-01,20250920,,ENJAYMO,Haemolysis,DE,ENJAYMO | Haemolysis | DE,2025-07-28/2025-08-03
258265391,25826539,,M,,20250920,,CALQUENCE,Diarrhoea,,CALQUENCE | Diarrhoea,NaT
258265551,25826555,,,,20250920,,LINACLOTIDE,Drug ineffective,,LINACLOTIDE | Drug ineffective,NaT
258266771,25826677,59,M,2025-01-01,20250920,,SKYRIZI,Cerebrovascular accident,OT,SKYRIZI | Cerebrovascular accident | OT,2024-12-30/2025-01-05
258267021,25826702,70,F,2024-10-01,20250920,,VYALEV,Incorrect dose administered,HO,VYALEV | Incorrect dose administered | HO,2024-09-30/2024-10-06
258267182,25826718,,,,20250926,,OMALIZUMAB,Oral pain,OT,OMALIZUMAB | Oral pain | OT,NaT
258267711,25826771,57,M,2025-06-13,20250920,,SKYRIZI,Haematochezia,OT,SKYRIZI | Haematochezia | OT,2025-06-09/2025-06-15
258268351,25826835,44,M,,20250920,,CYCLOPHOSPHAMIDE,Drug ineffective,DE,CYCLOPHOSPHAMIDE | Drug ineffective | DE,NaT
258268481,25826848,,M,,20250920,,FOSCARBIDOPA\FOSLEVODOPA,Cardiac failure,HO,FOSCARBIDOPA\FOSLEVODOPA | Cardiac failure | HO,NaT
258269491,25826949,80,F,2025-08-31,20250920,,CARBIDOPA\LEVODOPA,Death,DE,CARBIDOPA\LEVODOPA | Death | DE,2025-08-25/2025-08-31
258270131,25827013,,,2022-03-01,20250920,,BUTYLSCOPOLAMINE BROMIDE,Haemorrhagic cholecystitis,OT,BUTYLSCOPOLAMINE BROMIDE | Haemorrhagic cholecystitis | OT,2022-02-28/2022-03-06
258270761,25827076,,M,,20250920,,BIMZELX,Gastric infection,HO,BIMZELX | Gastric infection | HO,NaT
258270981,25827098,,,,20250920,,TASIGNA,Myocardial ischaemia,OT,TASIGNA | Myocardial ischaemia | OT,NaT
258271262,25827126,,M,,20250930,,ELIGARD,Death,OT,ELIGARD | Death | OT,NaT
258271381,25827138,33,M,2025-01-01,20250920,,LANTUS SOLOSTAR,Product storage error,,LANTUS SOLOSTAR | Product storage error,2024-12-30/2025-01-05
258272431,25827243,,F,,20250920,,VEVYE,Eye pain,,VEVYE | Eye pain,NaT
258272981,25827298,74,F,2025-05-30,20250920,,VEVYE,Eye pain,,VEVYE | Eye pain,2025-05-26/2025-06-01
258273011,25827301,76,F,2025-06-01,20250920,,VEVYE,Drug ineffective,,VEVYE | Drug ineffective,2025-05-26/2025-06-01
258273292,25827329,,M,,20250926,,VOYDEYA,Intellectual disability,OT,VOYDEYA | Intellectual disability | OT,NaT
258273501,25827350,68,F,2025-01-01,20250920,,SKYRIZI,Scar,OT,SKYRIZI | Scar | OT,2024-12-30/2025-01-05
258274031,25827403,,F,,20250920,,FILSPARI,Product use in unapproved indication,,FILSPARI | Product use in unapproved indication,NaT
258274661,25827466,75,F,,20250920,,VEVYE,Drug ineffective,,VEVYE | Drug ineffective,NaT
258274781,25827478,71,M,,20250920,,ABACAVIR SULFATE\LAMIVUDINE,Diabetes mellitus,OT,ABACAVIR SULFATE\LAMIVUDINE | Diabetes mellitus | OT,NaT
258275311,25827531,80,F,2025-07-23,20250920,,VEVYE,Eye irritation,,VEVYE | Eye irritation,2025-07-21/2025-07-27
258275381,25827538,,F,,20250920,,VEVYE,Drug ineffective,,VEVYE | Drug ineffective,NaT
258275691,25827569,81,F,2025-05-25,20250920,,VEVYE,Drug hypersensitivity,,VEVYE | Drug hypersensitivity,2025-05-19/2025-05-25
258276171,25827617,,F,,20250921,,DUPIXENT,Cough,,DUPIXENT | Cough,NaT
258276321,25827632,,F,,20250921,,VEVYE,Fatigue,,VEVYE | Fatigue,NaT
258276681,25827668,,,,20250921,,MOUNJARO,Abdominal pain upper,,MOUNJARO | Abdominal pain upper,NaT
258277641,25827764,35,F,,20250921,,BREO ELLIPTA,Asthma,OT,BREO ELLIPTA | Asthma | OT,NaT
258277731,25827773,16,M,2025-08-07,20250921,,STERILE DILUENT (WATER),Product administered to patient of inappropriate age,,STERILE DILUENT (WATER) | Product administered to patient of inappropriate age,2025-08-04/2025-08-10
258278061,25827806,12,M,,20250921,,DUPIXENT,Rebound eczema,,DUPIXENT | Rebound eczema,NaT
258279091,25827909,,F,,20250921,,FILSPARI,Hypotension,,FILSPARI | Hypotension,NaT
258279111,25827911,15,F,,20250921,,TALTZ,Psoriasis,,TALTZ | Psoriasis,NaT
258279211,25827921,,F,,20250921,,VEVYE,Eye irritation,,VEVYE | Eye irritation,NaT
258279271,25827927,73,F,2025-08-09,20250921,,VEVYE,Eye pain,,VEVYE | Eye pain,2025-08-04/2025-08-10
258279381,25827938,,F,,20250921,,FILSPARI,Menstruation delayed,,FILSPARI | Menstruation delayed,NaT
258279961,25827996,28,M,2022-01-01,20250921,,KEYTRUDA,Immune-mediated mucositis,DE,KEYTRUDA | Immune-mediated mucositis | DE,2021-12-27/2022-01-02
258281461,25828146,,,2025-01-01,20250921,,NEMLUVIO,Neurodermatitis,,NEMLUVIO | Neurodermatitis,2024-12-30/2025-01-05
258281761,25828176,66,F,2025-03-03,20250921,,VEVYE,Eye irritation,,VEVYE | Eye irritation,2025-03-03/2025-03-09
258282191,25828219,,F,,20250921,,VEVYE,Drug ineffective,,VEVYE | Drug ineffective,NaT
258282881,25828288,53,F,2024-07-01,20250921,,SKYRIZI,Blood test abnormal,OT,SKYRIZI | Blood test abnormal | OT,2024-07-01/2024-07-07
258285641,25828564,,F,,20250922,,XOLAIR,Anaphylactic reaction,OT,XOLAIR | Anaphylactic reaction | OT,NaT
258285991,25828599,,F,,20250922,,JEMPERLI,Autoimmune disorder,HO,JEMPERLI | Autoimmune disorder | HO,NaT
258286631,25828663,21,F,,20250922,,DUPIXENT,Therapeutic response decreased,,DUPIXENT | Therapeutic response decreased,NaT
258286871,25828687,50,F,2025-09-01,20250922,,LEVOTHYROXINE,Paraesthesia,HO,LEVOTHYROXINE | Paraesthesia | HO,2025-09-01/2025-09-07
258287511,25828751,61,F,,20250922,,UPTRAVI,Peripheral swelling,,UPTRAVI | Peripheral swelling,NaT
258287711,25828771,54,F,,20250922,,LANTUS,Myalgia,DS,LANTUS | Myalgia | DS,NaT
258289021,25828902,71,M,,20250922,,POMALYST,Laboratory test abnormal,,POMALYST | Laboratory test abnormal,NaT
258290291,25829029,,M,,20250922,,FILSPARI,Dizziness,,FILSPARI | Dizziness,NaT
258290941,25829094,,F,,20250922,,NUPLAZID,Procedural complication,OT,NUPLAZID | Procedural complication | OT,NaT
258291211,25829121,,M,,20250922,,CARBIDOPA\LEVODOPA,Death,DE,CARBIDOPA\LEVODOPA | Death | DE,NaT
258291901,25829190,66,F,,20250922,,EMGALITY,Illness,,EMGALITY | Illness,NaT
258292721,25829272,52,M,2025-01-01,20250922,,OCTREOTIDE,Lower respiratory tract infection,OT,OCTREOTIDE | Lower respiratory tract infection | OT,2024-12-30/2025-01-05
258292831,25829283,65,M,,20250922,,POMALYST,Breast tenderness,,POMALYST | Breast tenderness,NaT
258293841,25829384,,,,20250922,,METFORMIN,Toxicity to various agents,OT,METFORMIN | Toxicity to various agents | OT,NaT
258293951,25829395,,,,20250922,,OCREVUS,Immunodeficiency,,OCREVUS | Immunodeficiency,NaT
258295301,25829530,76,M,2025-06-03,20250922,,FILSPARI,White blood cells urine positive,,FILSPARI | White blood cells urine positive,2025-06-02/2025-06-08
258296471,25829647,78,F,2025-06-20,20250922,,POLIVY,Abdominal pain,DE,POLIVY | Abdominal pain | DE,2025-06-16/2025-06-22
258297241,25829724,68,M,2024-03-01,20250922,,XTANDI,Osteonecrosis of jaw,OT,XTANDI | Osteonecrosis of jaw | OT,2024-02-26/2024-03-03
258297801,25829780,,F,,20250922,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
258298661,25829866,16,F,,20250922,,DUPIXENT,Eyelash thickening,,DUPIXENT | Eyelash thickening,NaT
258299731,25829973,,M,,20250922,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Death,DE,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Death | DE,NaT
258300801,25830080,50,M,,20250922,,AMPHOTERICIN B,Drug ineffective for unapproved indication,DE,AMPHOTERICIN B | Drug ineffective for unapproved indication | DE,NaT
258301362,25830136,,F,,20250930,,NUCALA,Product dose omission issue,HO,NUCALA | Product dose omission issue | HO,NaT
258301951,25830195,,M,,20250922,,VEDOLIZUMAB,Anastomotic ulcer,OT,VEDOLIZUMAB | Anastomotic ulcer | OT,NaT
258302711,25830271,75,F,2021-09-17,20250922,,BORTEZOMIB,Off label use,OT,BORTEZOMIB | Off label use | OT,2021-09-13/2021-09-19
258305181,25830518,39,F,,20250922,,GANCICLOVIR,Gait disturbance,OT,GANCICLOVIR | Gait disturbance | OT,NaT
258305981,25830598,,M,,20250922,,DUPIXENT,Pyrexia,,DUPIXENT | Pyrexia,NaT
258306221,25830622,70,F,2025-09-10,20250922,,ADEMPAS,Hypotension,OT,ADEMPAS | Hypotension | OT,2025-09-08/2025-09-14
258306721,25830672,44,F,2025-09-08,20250922,,PERTUZUMAB\TRASTUZUMAB,Drug eruption,HO,PERTUZUMAB\TRASTUZUMAB | Drug eruption | HO,2025-09-08/2025-09-14
258307871,25830787,,M,2025-09-01,20250922,,CLOZARIL,Schizoaffective disorder,HO,CLOZARIL | Schizoaffective disorder | HO,2025-09-01/2025-09-07
258308121,25830812,,M,,20250922,,TOUJEO,Off label use,,TOUJEO | Off label use,NaT
258308661,25830866,,,,20250922,,TYLENOL,Autism spectrum disorder,OT,TYLENOL | Autism spectrum disorder | OT,NaT
258308881,25830888,74,F,2025-01-01,20250922,,DUPIXENT,Ligament sprain,,DUPIXENT | Ligament sprain,2024-12-30/2025-01-05
258309181,25830918,,F,,20250922,,TYLENOL,Foetal exposure during pregnancy,OT,TYLENOL | Foetal exposure during pregnancy | OT,NaT
258309311,25830931,,,,20250922,,NEXVIAZYME,Infusion related reaction,,NEXVIAZYME | Infusion related reaction,NaT
258309531,25830953,,M,,20250922,,TYLENOL,Autism spectrum disorder,OT,TYLENOL | Autism spectrum disorder | OT,NaT
258310032,25831003,63,F,,20250929,,VEDOLIZUMAB,Anal stenosis,OT,VEDOLIZUMAB | Anal stenosis | OT,NaT
258310581,25831058,51,F,,20250919,,STELARA,Surgery,HO,STELARA | Surgery | HO,NaT
258310651,25831065,57,F,,20250919,,SKYRIZI,Haemorrhoids,,SKYRIZI | Haemorrhoids,NaT
258310831,25831083,,,,20250922,,BETAMETHASONE DIPROPIONATE,Dermatoporosis,OT,BETAMETHASONE DIPROPIONATE | Dermatoporosis | OT,NaT
258311001,25831100,,,2025-07-01,20250922,,DAPSONE,No adverse event,,DAPSONE | No adverse event,2025-06-30/2025-07-06
258311731,25831173,73,F,,20250919,,PIRFENIDONE,Confusional state,HO,PIRFENIDONE | Confusional state | HO,NaT
258312391,25831239,72,M,2025-08-28,20250922,,PANTOPRAZOLE,Hypochloraemia,HO,PANTOPRAZOLE | Hypochloraemia | HO,2025-08-25/2025-08-31
258313031,25831303,26,F,2024-04-01,20250922,,MAVENCLAD,Optic neuritis,OT,MAVENCLAD | Optic neuritis | OT,2024-04-01/2024-04-07
258313231,25831323,52,M,,20250922,,REZUROCK,Nausea,,REZUROCK | Nausea,NaT
258314861,25831486,,M,,20250922,,OZEMPIC,Haematemesis,OT,OZEMPIC | Haematemesis | OT,NaT
258316411,25831641,,M,,20250919,,AMBRISENTAN,Seizure,HO,AMBRISENTAN | Seizure | HO,NaT
258316671,25831667,63,F,2025-08-08,20250922,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2025-08-04/2025-08-10
258317062,25831706,25,M,,20250922,,BENEFIX,Haemorrhage,OT,BENEFIX | Haemorrhage | OT,NaT
258317081,25831708,,F,,20250922,,NURTEC ODT,Therapeutic product effect decreased,,NURTEC ODT | Therapeutic product effect decreased,NaT
258317341,25831734,72,M,2025-08-21,20250922,,SIVEXTRO,Hyponatraemia,HO,SIVEXTRO | Hyponatraemia | HO,2025-08-18/2025-08-24
258317361,25831736,46,F,2025-09-03,20250922,,TRESIBA,Uterine dilation and curettage,HO,TRESIBA | Uterine dilation and curettage | HO,2025-09-01/2025-09-07
258317601,25831760,56,M,2025-07-01,20250922,,PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Drug reaction with eosinophilia and systemic symptoms,OT,PIPERACILLIN SODIUM\TAZOBACTAM SODIUM | Drug reaction with eosinophilia and systemic symptoms | OT,2025-06-30/2025-07-06
258318451,25831845,58,M,2025-09-02,20250921,,FABHALTA,General physical health deterioration,DE,FABHALTA | General physical health deterioration | DE,2025-09-01/2025-09-07
258319791,25831979,,F,,20250922,,DUPIXENT,Meningitis,HO,DUPIXENT | Meningitis | HO,NaT
258320101,25832010,,F,2025-01-01,20250922,,CIMZIA,Rheumatoid arthritis,OT,CIMZIA | Rheumatoid arthritis | OT,2024-12-30/2025-01-05
258320561,25832056,,F,,20250919,,MACITENTAN\TADALAFIL,Illness,HO,MACITENTAN\TADALAFIL | Illness | HO,NaT
258320621,25832062,47,F,2025-09-02,20250919,,OPSUMIT,Anaemia,HO,OPSUMIT | Anaemia | HO,2025-09-01/2025-09-07
258321341,25832134,53,F,,20250922,,XELJANZ XR,Oropharyngeal candidiasis,HO,XELJANZ XR | Oropharyngeal candidiasis | HO,NaT
258322221,25832222,,F,,20250919,,LENALIDOMIDE,Loss of personal independence in daily activities,HO,LENALIDOMIDE | Loss of personal independence in daily activities | HO,NaT
258322251,25832225,,,,20250922,,FERAHEME,Vomiting,,FERAHEME | Vomiting,NaT
258323821,25832382,27,M,,20250922,,PREDNISOLONE,Cushing's syndrome,OT,PREDNISOLONE | Cushing's syndrome | OT,NaT
258324092,25832409,70,F,,20250925,,LORAZEPAM,Drug ineffective,LT,LORAZEPAM | Drug ineffective | LT,NaT
258324921,25832492,,F,,20250921,,LENALIDOMIDE,Stem cell transplant,,LENALIDOMIDE | Stem cell transplant,NaT
258324931,25832493,,F,,20250921,,STELARA,Intestinal obstruction,HO,STELARA | Intestinal obstruction | HO,NaT
258325201,25832520,,,,20250922,,RISANKIZUMAB,Hernia,,RISANKIZUMAB | Hernia,NaT
258325541,25832554,77,F,,20250922,,OPSUMIT,Death,DE,OPSUMIT | Death | DE,NaT
258325771,25832577,,,,20250922,,CRYSVITA,Cholelithiasis,OT,CRYSVITA | Cholelithiasis | OT,NaT
258326141,25832614,74,F,2025-09-04,20250922,,HUMIRA,Hip surgery,HO,HUMIRA | Hip surgery | HO,2025-09-01/2025-09-07
258328281,25832828,,,,20250922,,ELAPRASE,Drug ineffective,,ELAPRASE | Drug ineffective,NaT
258328531,25832853,47,M,2025-04-09,20250922,,DEXAMETHASONE ACETATE,Hypertension,OT,DEXAMETHASONE ACETATE | Hypertension | OT,2025-04-07/2025-04-13
258328801,25832880,,,,20250922,,TERIFLUNOMIDE,Stress,,TERIFLUNOMIDE | Stress,NaT
258329341,25832934,,M,2025-06-15,20250922,,SUPREP BOWEL PREP,Nausea,,SUPREP BOWEL PREP | Nausea,2025-06-09/2025-06-15
258329481,25832948,56,M,2024-09-29,20250922,,"SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE",Nausea,,"SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | Nausea",2024-09-23/2024-09-29
258329901,25832990,50,M,2019-07-01,20250922,,LENALIDOMIDE,Intentional product use issue,OT,LENALIDOMIDE | Intentional product use issue | OT,2019-07-01/2019-07-07
258329931,25832993,,,,20250922,,RISANKIZUMAB,Incorrect dose administered,,RISANKIZUMAB | Incorrect dose administered,NaT
258330131,25833013,49,F,2021-05-26,20250922,,ABEMACICLIB,Motor dysfunction,OT,ABEMACICLIB | Motor dysfunction | OT,2021-05-24/2021-05-30
258331621,25833162,73,M,,20250922,,ATTRUBY,Hepatic enzyme increased,,ATTRUBY | Hepatic enzyme increased,NaT
258331631,25833163,9,M,2025-09-19,20250922,,BEYFORTUS,Expired product administered,,BEYFORTUS | Expired product administered,2025-09-15/2025-09-21
258333481,25833348,50,F,2022-08-01,20250922,,TAXOL,Meningitis,OT,TAXOL | Meningitis | OT,2022-08-01/2022-08-07
258333741,25833374,76,M,2025-07-25,20250922,,WELIREG,Dysphonia,,WELIREG | Dysphonia,2025-07-21/2025-07-27
258333801,25833380,,M,2025-01-01,20250922,,GILTERITINIB,Anaemia,OT,GILTERITINIB | Anaemia | OT,2024-12-30/2025-01-05
258335201,25833520,,,,20250922,,ULTOMIRIS,Lethargy,OT,ULTOMIRIS | Lethargy | OT,NaT
258335401,25833540,59,M,2025-07-17,20250922,,VANFLYTA,Intentional product use issue,,VANFLYTA | Intentional product use issue,2025-07-14/2025-07-20
258335541,25833554,76,M,2025-09-07,20250922,,LAGEVRIO,Wrong technique in product usage process,,LAGEVRIO | Wrong technique in product usage process,2025-09-01/2025-09-07
258335831,25833583,,M,,20250922,,BENRALIZUMAB,Throat irritation,OT,BENRALIZUMAB | Throat irritation | OT,NaT
258336371,25833637,78,F,2025-09-10,20250922,,SYNTHROID,Death,DE,SYNTHROID | Death | DE,2025-09-08/2025-09-14
258336851,25833685,,F,,20250922,,DAPAGLIFLOZIN,Haemorrhoids,OT,DAPAGLIFLOZIN | Haemorrhoids | OT,NaT
258337091,25833709,,,,20250922,,RITUXIMAB,Injection site bruising,OT,RITUXIMAB | Injection site bruising | OT,NaT
258337271,25833727,,M,2025-09-15,20250923,,FOSCARBIDOPA\FOSLEVODOPA,Altered state of consciousness,HO,FOSCARBIDOPA\FOSLEVODOPA | Altered state of consciousness | HO,2025-09-15/2025-09-21
258337711,25833771,,,,20250923,,LAMOTRIGINE,Toxicity to various agents,DE,LAMOTRIGINE | Toxicity to various agents | DE,NaT
258338271,25833827,72,F,2025-08-26,20250923,,ZEPBOUND,Nausea,,ZEPBOUND | Nausea,2025-08-25/2025-08-31
258338581,25833858,77,,,20250923,,TISLELIZUMAB,Liver injury,OT,TISLELIZUMAB | Liver injury | OT,NaT
258339891,25833989,,F,,20250923,,DAYBUE,Abnormal behaviour,,DAYBUE | Abnormal behaviour,NaT
258340031,25834003,,M,,20250923,,BREO ELLIPTA,Off label use,OT,BREO ELLIPTA | Off label use | OT,NaT
258340561,25834056,75,F,2025-06-06,20250923,,ATORVASTATIN,Drug interaction,OT,ATORVASTATIN | Drug interaction | OT,2025-06-02/2025-06-08
258341291,25834129,,F,,20250923,,TYVASO DPI,Insomnia,,TYVASO DPI | Insomnia,NaT
258341331,25834133,,F,,20250923,,MACITENTAN\TADALAFIL,Fluid retention,HO,MACITENTAN\TADALAFIL | Fluid retention | HO,NaT
258341921,25834192,80,F,2025-07-04,20250923,,LANREOTIDE ACETATE,Product use in unapproved indication,DE,LANREOTIDE ACETATE | Product use in unapproved indication | DE,2025-06-30/2025-07-06
258343181,25834318,79,F,,20250923,,TECENTRIQ,Disease progression,OT,TECENTRIQ | Disease progression | OT,NaT
258345011,25834501,71,M,,20250923,,LOVENOX,Off label use,,LOVENOX | Off label use,NaT
258346191,25834619,60,M,2025-04-29,20250923,,NUCALA,Lung disorder,,NUCALA | Lung disorder,2025-04-28/2025-05-04
258346402,25834640,,M,,20250923,,MATULANE,Rash,,MATULANE | Rash,NaT
258346651,25834665,,,,20250923,,TYLENOL,Foetal exposure during pregnancy,OT,TYLENOL | Foetal exposure during pregnancy | OT,NaT
258346671,25834667,,,,20250923,,TEDUGLUTIDE,Arrhythmia,OT,TEDUGLUTIDE | Arrhythmia | OT,NaT
258347621,25834762,,F,2025-09-19,20250923,,ALLOPURINOL,Skin exfoliation,HO,ALLOPURINOL | Skin exfoliation | HO,2025-09-15/2025-09-21
258347711,25834771,16,F,,20250923,,PREDNISONE,Therapy partial responder,OT,PREDNISONE | Therapy partial responder | OT,NaT
258347831,25834783,79,M,2025-09-15,20250923,,IDHIFA,Death,DE,IDHIFA | Death | DE,2025-09-15/2025-09-21
258348541,25834854,,F,,20250923,,PRIVIGEN,Neuropathy peripheral,OT,PRIVIGEN | Neuropathy peripheral | OT,NaT
258348871,25834887,,F,,20250923,,BENLYSTA,Dementia,OT,BENLYSTA | Dementia | OT,NaT
258349171,25834917,,,,20250923,,ZEPBOUND,Intercepted product dispensing error,,ZEPBOUND | Intercepted product dispensing error,NaT
258349281,25834928,,,,20250923,,IRINOTECAN,Thrombocytopenia,OT,IRINOTECAN | Thrombocytopenia | OT,NaT
258349571,25834957,40,F,,20250923,,ADBRY,Hypersensitivity,,ADBRY | Hypersensitivity,NaT
258349861,25834986,8,F,,20250923,,KEYTRUDA,Immune-mediated encephalopathy,DS,KEYTRUDA | Immune-mediated encephalopathy | DS,NaT
258349891,25834989,,,2024-03-08,20250923,,ADALIMUMAB-AATY,Drug ineffective,OT,ADALIMUMAB-AATY | Drug ineffective | OT,2024-03-04/2024-03-10
258350591,25835059,65,F,,20250923,,DUPIXENT,Rash,,DUPIXENT | Rash,NaT
258350881,25835088,,,,20250923,,TYLENOL,Foetal exposure during pregnancy,OT,TYLENOL | Foetal exposure during pregnancy | OT,NaT
258351441,25835144,,,2024-11-01,20250923,,KIMMTRAK,Therapeutic response decreased,OT,KIMMTRAK | Therapeutic response decreased | OT,2024-10-28/2024-11-03
258351501,25835150,67,M,,20250923,,IMATINIB,Disease progression,DE,IMATINIB | Disease progression | DE,NaT
258351811,25835181,68,M,2025-01-12,20250923,,OLANZAPINE,Disorientation,HO,OLANZAPINE | Disorientation | HO,2025-01-06/2025-01-12
258352091,25835209,36,F,2024-07-01,20250923,,DOXORUBICIN HYDROCHLORIDE,Malignant neoplasm progression,OT,DOXORUBICIN HYDROCHLORIDE | Malignant neoplasm progression | OT,2024-07-01/2024-07-07
258352391,25835239,,,2025-01-01,20250923,,NEMLUVIO,Product dose omission issue,,NEMLUVIO | Product dose omission issue,2024-12-30/2025-01-05
258352431,25835243,,M,,20250923,,RITUXIMAB,Diffuse large B-cell lymphoma refractory,OT,RITUXIMAB | Diffuse large B-cell lymphoma refractory | OT,NaT
258353941,25835394,,,,20250923,,QUETIAPINE FUMARATE,Drug level below therapeutic,HO,QUETIAPINE FUMARATE | Drug level below therapeutic | HO,NaT
258354221,25835422,53,M,2025-09-15,20250923,,GABAPENTIN,Pain,,GABAPENTIN | Pain,2025-09-15/2025-09-21
258354411,25835441,,F,,20250923,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
258356651,25835665,,F,,20250923,,ACOLTREMON,Eye irritation,,ACOLTREMON | Eye irritation,NaT
258358211,25835821,,,,20250923,,SKYRIZI,Pemphigoid,,SKYRIZI | Pemphigoid,NaT
258359431,25835943,10,F,,20250923,,DEXAMETHASONE,Reversible cerebral vasoconstriction syndrome,HO,DEXAMETHASONE | Reversible cerebral vasoconstriction syndrome | HO,NaT
258359511,25835951,40,F,2023-06-19,20250923,,KISQALI,Anaemia,HO,KISQALI | Anaemia | HO,2023-06-19/2023-06-25
258359861,25835986,91,F,,20250923,,AMIODARONE,Decompensated hypothyroidism,OT,AMIODARONE | Decompensated hypothyroidism | OT,NaT
258360971,25836097,61,M,,20250923,,CABOMETYX,Pain in extremity,,CABOMETYX | Pain in extremity,NaT
258361651,25836165,66,F,,20250923,,ZEPBOUND,Alopecia,,ZEPBOUND | Alopecia,NaT
258362131,25836213,43,M,,20250922,,DASATINIB,Hospitalisation,HO,DASATINIB | Hospitalisation | HO,NaT
258362171,25836217,,F,,20250923,,BENLYSTA,Drug hypersensitivity,OT,BENLYSTA | Drug hypersensitivity | OT,NaT
258362192,25836219,,F,,20250925,,NUPLAZID,Memory impairment,,NUPLAZID | Memory impairment,NaT
258363161,25836316,,F,,20250923,,ELAHERE,Visual impairment,,ELAHERE | Visual impairment,NaT
258363371,25836337,,M,,20250923,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,NaT
258363591,25836359,,,,20250923,,REPATHA,Anaphylactic reaction,OT,REPATHA | Anaphylactic reaction | OT,NaT
258363981,25836398,,M,,20250923,,BOTOX,Drug ineffective,,BOTOX | Drug ineffective,NaT
258364141,25836414,,F,,20250923,,NUPLAZID,Hallucination,OT,NUPLAZID | Hallucination | OT,NaT
258365211,25836521,74,M,,20250923,,PROPOFOL,Hypersexuality,OT,PROPOFOL | Hypersexuality | OT,NaT
258365381,25836538,58,F,,20250923,,RANIBIZUMAB,Visual acuity reduced,OT,RANIBIZUMAB | Visual acuity reduced | OT,NaT
258365531,25836553,34,F,2025-09-22,20250922,,TAVNEOS,Palliative care,OT,TAVNEOS | Palliative care | OT,2025-09-22/2025-09-28
258365791,25836579,21,F,2025-01-01,20250923,,VRAYLAR,Neck surgery,OT,VRAYLAR | Neck surgery | OT,2024-12-30/2025-01-05
258365871,25836587,,F,,20250923,,DUPIXENT,Sleep disorder,,DUPIXENT | Sleep disorder,NaT
258365881,25836588,73,M,2025-01-01,20250923,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2024-12-30/2025-01-05
258366551,25836655,66,M,2025-01-01,20250923,,LANTUS SOLOSTAR,Pneumonia,HO,LANTUS SOLOSTAR | Pneumonia | HO,2024-12-30/2025-01-05
258366641,25836664,,M,,20250923,,DAPAGLIFLOZIN,Death,DE,DAPAGLIFLOZIN | Death | DE,NaT
258367201,25836720,,M,,20250923,,MATULANE,Nausea,,MATULANE | Nausea,NaT
258367431,25836743,48,M,2025-01-01,20250923,,XELJANZ,Illness,,XELJANZ | Illness,2024-12-30/2025-01-05
258368551,25836855,64,M,,20250923,,INLYTA,Treatment noncompliance,OT,INLYTA | Treatment noncompliance | OT,NaT
258368791,25836879,64,M,2025-01-01,20250923,,IXIFI,Subdural haematoma,HO,IXIFI | Subdural haematoma | HO,2024-12-30/2025-01-05
258369391,25836939,22,F,2025-01-01,20250923,,DUPIXENT,Respiratory tract congestion,,DUPIXENT | Respiratory tract congestion,2024-12-30/2025-01-05
258369711,25836971,,,2025-08-28,20250923,,MOUNJARO,Liver function test increased,,MOUNJARO | Liver function test increased,2025-08-25/2025-08-31
258369871,25836987,68,F,,20250923,,PALBOCICLIB,Thrombocytopenia,LT,PALBOCICLIB | Thrombocytopenia | LT,NaT
258370781,25837078,76,M,2025-08-31,20250923,,DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE SULFATE,Death,DE,DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE SULFATE | Death | DE,2025-08-25/2025-08-31
258371241,25837124,61,F,2024-07-13,20250923,,RIBOCICLIB,Hypertension,OT,RIBOCICLIB | Hypertension | OT,2024-07-08/2024-07-14
258372091,25837209,,,2025-09-17,20250923,,THYMOGLOBULIN,Sudden death,DE,THYMOGLOBULIN | Sudden death | DE,2025-09-15/2025-09-21
258372831,25837283,,,,20250923,,AUSTEDO,Gastric bypass,OT,AUSTEDO | Gastric bypass | OT,NaT
258373711,25837371,,,,20250923,,OPZELURA,Therapeutic product effect incomplete,,OPZELURA | Therapeutic product effect incomplete,NaT
258374631,25837463,,,,20250923,,LITHIUM,Treatment failure,,LITHIUM | Treatment failure,NaT
258376211,25837621,0,,2023-11-10,20250923,,KERENDIA,Glomerular filtration rate decreased,,KERENDIA | Glomerular filtration rate decreased,2023-11-06/2023-11-12
258376251,25837625,,F,,20250923,,TECFIDERA,Pyrexia,,TECFIDERA | Pyrexia,NaT
258376461,25837646,,,,20250923,,BEVACIZUMAB,Cardiac dysfunction,OT,BEVACIZUMAB | Cardiac dysfunction | OT,NaT
258376761,25837676,,,2025-01-01,20250923,,YUTREPIA,Pneumonia,HO,YUTREPIA | Pneumonia | HO,2024-12-30/2025-01-05
258376901,25837690,39,M,2025-05-16,20250923,,HUMALOG,Diabetic ketoacidosis,HO,HUMALOG | Diabetic ketoacidosis | HO,2025-05-12/2025-05-18
258377011,25837701,52,M,2025-07-17,20250923,,HUMALOG,Oropharyngeal pain,HO,HUMALOG | Oropharyngeal pain | HO,2025-07-14/2025-07-20
258377121,25837712,52,M,2025-07-25,20250923,,HUMALOG,Hypoglycaemic unconsciousness,HO,HUMALOG | Hypoglycaemic unconsciousness | HO,2025-07-21/2025-07-27
258378412,25837841,7,F,,20250930,,GENOTROPIN,Device mechanical issue,,GENOTROPIN | Device mechanical issue,NaT
258378661,25837866,61,F,,20250923,,XANAX,Intentional overdose,HO,XANAX | Intentional overdose | HO,NaT
258379031,25837903,70,M,,20250923,,MYCOPHENOLATE MOFETIL,Disorientation,OT,MYCOPHENOLATE MOFETIL | Disorientation | OT,NaT
258379091,25837909,78,M,2025-01-01,20250923,,SKYRIZI,Wrist surgery,OT,SKYRIZI | Wrist surgery | OT,2024-12-30/2025-01-05
258379161,25837916,64,F,2025-06-13,20250923,,MUPIROCIN,Abdominal pain,,MUPIROCIN | Abdominal pain,2025-06-09/2025-06-15
258379591,25837959,,,2025-09-11,20250923,,FOSAPREPITANT,Flushing,OT,FOSAPREPITANT | Flushing | OT,2025-09-08/2025-09-14
258380801,25838080,,F,2025-01-01,20250923,,BIMZELX,Cough,OT,BIMZELX | Cough | OT,2024-12-30/2025-01-05
258381451,25838145,72,F,,20250923,,INGREZZA,Somnolence,,INGREZZA | Somnolence,NaT
258382211,25838221,45,M,2010-11-30,20250923,,REMICADE,Off label use,OT,REMICADE | Off label use | OT,2010-11-29/2010-12-05
258382231,25838223,,,,20250923,,TREMFYA,Cystitis,,TREMFYA | Cystitis,NaT
258382652,25838265,77,M,2025-07-29,20250930,,PEMBROLIZUMAB,Platelet count decreased,DS,PEMBROLIZUMAB | Platelet count decreased | DS,2025-07-28/2025-08-03
258383021,25838302,,M,,20250923,,CORTICOTROPIN,Fatigue,,CORTICOTROPIN | Fatigue,NaT
258383531,25838353,,,2025-09-08,20250923,,BENDAMUSTINE HYDROCHLORIDE,Agranulocytosis,OT,BENDAMUSTINE HYDROCHLORIDE | Agranulocytosis | OT,2025-09-08/2025-09-14
258384021,25838402,,M,2025-09-10,20250923,,DELFLEX,Death,DE,DELFLEX | Death | DE,2025-09-08/2025-09-14
258385451,25838545,78,F,2025-09-17,20250923,,CARBIDOPA\LEVODOPA,Death,DE,CARBIDOPA\LEVODOPA | Death | DE,2025-09-15/2025-09-21
258385751,25838575,52,F,2023-04-27,20250923,,OXALIPLATIN,Dyspnoea,LT,OXALIPLATIN | Dyspnoea | LT,2023-04-24/2023-04-30
258386341,25838634,,,2025-08-28,20250924,,NEMLUVIO,Inappropriate schedule of product administration,,NEMLUVIO | Inappropriate schedule of product administration,2025-08-25/2025-08-31
258386911,25838691,,,,20250924,,RITUXIMAB,Throat irritation,OT,RITUXIMAB | Throat irritation | OT,NaT
258387231,25838723,,M,,20250924,,PREDNISOLONE,Drug effective for unapproved indication,,PREDNISOLONE | Drug effective for unapproved indication,NaT
258387621,25838762,,F,,20250924,,BUPRENORPHINE,Diarrhoea,OT,BUPRENORPHINE | Diarrhoea | OT,NaT
258387851,25838785,53,M,2025-09-11,20250924,,BENLYSTA,Death,DE,BENLYSTA | Death | DE,2025-09-08/2025-09-14
258388141,25838814,,F,,20250924,,SKYRIZI,Neoplasm malignant,DE,SKYRIZI | Neoplasm malignant | DE,NaT
258389371,25838937,,F,,20250924,,XOLAIR PFS,Off label use,,XOLAIR PFS | Off label use,NaT
258389641,25838964,66,F,2025-08-06,20250924,,ATORVASTATIN,Ischaemic stroke,HO,ATORVASTATIN | Ischaemic stroke | HO,2025-08-04/2025-08-10
258389691,25838969,39,F,,20250924,,HYDROCORTISONE,Unmasking of previously unidentified disease,OT,HYDROCORTISONE | Unmasking of previously unidentified disease | OT,NaT
258389941,25838994,,,,20250924,,CATHFLO ACTIVASE,Intercepted product storage error,,CATHFLO ACTIVASE | Intercepted product storage error,NaT
258390071,25839007,,F,,20250924,,ACTEMRA,Infection,,ACTEMRA | Infection,NaT
258390191,25839019,,F,,20250924,,ELIGARD,No adverse event,,ELIGARD | No adverse event,NaT
258390961,25839096,46,M,2025-08-08,20250924,,KESIMPTA,Fatigue,OT,KESIMPTA | Fatigue | OT,2025-08-04/2025-08-10
258391101,25839110,37,F,,20250924,,RITUXIMAB,Throat irritation,OT,RITUXIMAB | Throat irritation | OT,NaT
258391261,25839126,67,F,2025-06-20,20250924,,XOLAIR,Cardiac flutter,OT,XOLAIR | Cardiac flutter | OT,2025-06-16/2025-06-22
258392272,25839227,,M,2025-01-01,20250924,,DUPIXENT,Hordeolum,OT,DUPIXENT | Hordeolum | OT,2024-12-30/2025-01-05
258393141,25839314,19,F,,20250924,,ZEPBOUND,Dizziness,,ZEPBOUND | Dizziness,NaT
258394941,25839494,83,F,2025-09-22,20250924,,ORENCIA,Accidental exposure to product,,ORENCIA | Accidental exposure to product,2025-09-22/2025-09-28
258395231,25839523,59,F,,20250924,,MOUNJARO,Injection site pain,,MOUNJARO | Injection site pain,NaT
258395241,25839524,76,F,2025-08-01,20250924,,TRULICITY,Bronchitis,,TRULICITY | Bronchitis,2025-07-28/2025-08-03
258396301,25839630,,,,20250924,,HUMIRA,Multiple sclerosis,OT,HUMIRA | Multiple sclerosis | OT,NaT
258396781,25839678,40,,,20250924,,BRUKINSA,Richter's syndrome,OT,BRUKINSA | Richter's syndrome | OT,NaT
258396851,25839685,65,M,,20250924,,HYDROCORTISONE,Drug ineffective,OT,HYDROCORTISONE | Drug ineffective | OT,NaT
258397801,25839780,74,M,,20250924,,ORGOVYX,Feeling hot,,ORGOVYX | Feeling hot,NaT
258397851,25839785,89,M,,20250924,,ORGOVYX,Product dose omission issue,,ORGOVYX | Product dose omission issue,NaT
258398871,25839887,56,F,2021-11-29,20250924,,TRASTUZUMAB,Hypersensitivity,HO,TRASTUZUMAB | Hypersensitivity | HO,2021-11-29/2021-12-05
258399631,25839963,,,,20250924,,URSODIOL,Drug ineffective for unapproved indication,OT,URSODIOL | Drug ineffective for unapproved indication | OT,NaT
258401481,25840148,80,M,,20250924,,REVLIMID,Disease recurrence,OT,REVLIMID | Disease recurrence | OT,NaT
258401631,25840163,,,,20250924,,BENLYSTA,Hospitalisation,HO,BENLYSTA | Hospitalisation | HO,NaT
258401911,25840191,28,F,,20250924,,PERAMPANEL,Acute kidney injury,OT,PERAMPANEL | Acute kidney injury | OT,NaT
258402351,25840235,35,M,,20250924,,CLONAZEPAM,Therapy interrupted,OT,CLONAZEPAM | Therapy interrupted | OT,NaT
258402921,25840292,,F,,20250924,,BUPRENORPHINE,Constipation,OT,BUPRENORPHINE | Constipation | OT,NaT
258403001,25840300,40,M,2024-09-15,20250924,,TILDRAKIZUMAB,Amaurosis fugax,HO,TILDRAKIZUMAB | Amaurosis fugax | HO,2024-09-09/2024-09-15
258403531,25840353,,,,20250924,,CARFILZOMIB,Dysgeusia,OT,CARFILZOMIB | Dysgeusia | OT,NaT
258403731,25840373,33,F,,20250924,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
258404781,25840478,67,,,20250924,,INGREZZA,Dyskinesia,,INGREZZA | Dyskinesia,NaT
258404881,25840488,63,F,2025-08-01,20250924,,ZEPBOUND,Wrong technique in product usage process,,ZEPBOUND | Wrong technique in product usage process,2025-07-28/2025-08-03
258405831,25840583,44,F,,20250923,,COSENTYX,Pustular psoriasis,OT,COSENTYX | Pustular psoriasis | OT,NaT
258406221,25840622,76,F,,20250924,,CAMZYOS,Arthropathy,OT,CAMZYOS | Arthropathy | OT,NaT
258406711,25840671,62,M,2025-08-21,20250924,,DOVATO,Mouth ulceration,HO,DOVATO | Mouth ulceration | HO,2025-08-18/2025-08-24
258407131,25840713,90,M,,20250923,,RINVOQ,Spinal fusion surgery,HO,RINVOQ | Spinal fusion surgery | HO,NaT
258408141,25840814,,,,20250924,,STEQEYMA,Accidental exposure to product,,STEQEYMA | Accidental exposure to product,NaT
258408691,25840869,64,M,,20250924,,SIMVASTATIN,Chronic lymphocytic leukaemia,OT,SIMVASTATIN | Chronic lymphocytic leukaemia | OT,NaT
258411201,25841120,,F,,20250924,,SKYRIZI,Limb mass,HO,SKYRIZI | Limb mass | HO,NaT
258411582,25841158,,,2024-12-17,20250929,,YUTIQ,Corneal oedema,OT,YUTIQ | Corneal oedema | OT,2024-12-16/2024-12-22
258412441,25841244,,,2024-01-01,20250924,,ATORVASTATIN,Pruritus,,ATORVASTATIN | Pruritus,2024-01-01/2024-01-07
258412591,25841259,28,M,,20250924,,IBUPROFEN,Drug abuse,OT,IBUPROFEN | Drug abuse | OT,NaT
258413061,25841306,8,M,2025-09-15,20250924,,METHYLPREDNISOLONE SODIUM SUCCINATE,Ocular hypertension,OT,METHYLPREDNISOLONE SODIUM SUCCINATE | Ocular hypertension | OT,2025-09-15/2025-09-21
258413631,25841363,,F,,20250924,,NUCALA,Asthma,HO,NUCALA | Asthma | HO,NaT
258413751,25841375,,,2025-01-01,20250924,,REZDIFFRA,Alanine aminotransferase increased,,REZDIFFRA | Alanine aminotransferase increased,2024-12-30/2025-01-05
258414421,25841442,,,2025-09-03,20250924,,TOLVAPTAN,Surgery,OT,TOLVAPTAN | Surgery | OT,2025-09-01/2025-09-07
258414541,25841454,,M,,20250924,,TYLENOL,Autism spectrum disorder,OT,TYLENOL | Autism spectrum disorder | OT,NaT
258414581,25841458,,M,,20250924,,OZEMPIC,Memory impairment,OT,OZEMPIC | Memory impairment | OT,NaT
258414761,25841476,,,,20250924,,TYLENOL,Autism spectrum disorder,OT,TYLENOL | Autism spectrum disorder | OT,NaT
258415961,25841596,64,F,2025-09-23,20250924,,TRAZODONE HYDROCHLORIDE,Sinus congestion,,TRAZODONE HYDROCHLORIDE | Sinus congestion,2025-09-22/2025-09-28
258416111,25841611,,,,20250924,,BEVACIZUMAB,Hepatocellular carcinoma,OT,BEVACIZUMAB | Hepatocellular carcinoma | OT,NaT
258416531,25841653,79,M,2025-09-11,20250924,,CLOPIDOGREL BISULFATE,Oedema,OT,CLOPIDOGREL BISULFATE | Oedema | OT,2025-09-08/2025-09-14
258416541,25841654,77,M,,20250924,,INQOVI,Cytopenia,HO,INQOVI | Cytopenia | HO,NaT
258416791,25841679,,F,,20250924,,ALDURAZYME,Weight increased,,ALDURAZYME | Weight increased,NaT
258417261,25841726,,F,,20250924,,ASPIRIN,Irritable bowel syndrome,HO,ASPIRIN | Irritable bowel syndrome | HO,NaT
258417451,25841745,,M,,20250924,,NUPLAZID,Lethargy,,NUPLAZID | Lethargy,NaT
258418151,25841815,91,F,,20250924,,ELIQUIS,Prescription drug used without a prescription,,ELIQUIS | Prescription drug used without a prescription,NaT
258418731,25841873,59,F,,20250924,,MOUNJARO,Injection site mass,,MOUNJARO | Injection site mass,NaT
258419831,25841983,,F,,20250924,,MOUNJARO,Renal cancer stage I,OT,MOUNJARO | Renal cancer stage I | OT,NaT
258419901,25841990,75,M,,20250924,,MOUNJARO,Rhabdomyolysis,HO,MOUNJARO | Rhabdomyolysis | HO,NaT
258420861,25842086,,F,,20250924,,MATULANE,Asthenia,,MATULANE | Asthenia,NaT
258420971,25842097,,F,,20250924,,INAVOLISIB,Fatigue,,INAVOLISIB | Fatigue,NaT
258421261,25842126,56,F,,20250924,,LONSURF,Extra dose administered,DE,LONSURF | Extra dose administered | DE,NaT
258421491,25842149,,F,,20250924,,TYLENOL,Autism spectrum disorder,OT,TYLENOL | Autism spectrum disorder | OT,NaT
258423141,25842314,50,M,2022-01-01,20250924,,AFATINIB,Off label use,OT,AFATINIB | Off label use | OT,2021-12-27/2022-01-02
258423781,25842378,82,F,2025-09-10,20250924,,COSENTYX,Urticaria,,COSENTYX | Urticaria,2025-09-08/2025-09-14
258424281,25842428,58,M,,20250924,,DURVALUMAB,Oesophagitis,OT,DURVALUMAB | Oesophagitis | OT,NaT
258424301,25842430,56,M,,20250924,,DUPIXENT,Surgery,OT,DUPIXENT | Surgery | OT,NaT
258424452,25842445,,F,,20250927,,DUPIXENT,Abortion spontaneous,OT,DUPIXENT | Abortion spontaneous | OT,NaT
258424591,25842459,,M,,20250924,,DUPIXENT,Tendon rupture,HO,DUPIXENT | Tendon rupture | HO,NaT
258425811,25842581,45,F,2025-09-13,20250924,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,2025-09-08/2025-09-14
258425981,25842598,57,,,20250924,,MYCOPHENOLATE MOFETIL,Dyspnoea exertional,OT,MYCOPHENOLATE MOFETIL | Dyspnoea exertional | OT,NaT
258426711,25842671,25,M,2025-09-15,20250924,,GAMUNEX-C,Throat irritation,OT,GAMUNEX-C | Throat irritation | OT,2025-09-15/2025-09-21
258427241,25842724,,F,,20250924,,UBRELVY,Off label use,,UBRELVY | Off label use,NaT
258427581,25842758,,F,2025-01-01,20250924,,WIXELA INHUB,COVID-19,,WIXELA INHUB | COVID-19,2024-12-30/2025-01-05
258427861,25842786,57,M,2025-09-01,20250924,,HUMIRA,Loss of consciousness,OT,HUMIRA | Loss of consciousness | OT,2025-09-01/2025-09-07
258427871,25842787,,,,20250924,,OFEV,Faeces soft,,OFEV | Faeces soft,NaT
258428111,25842811,,,,20250924,,VENLAFAXINE HYDROCHLORIDE,Tachycardia,OT,VENLAFAXINE HYDROCHLORIDE | Tachycardia | OT,NaT
258428641,25842864,55,,2022-08-01,20250924,,STIVARGA,Hypoaesthesia,OT,STIVARGA | Hypoaesthesia | OT,2022-08-01/2022-08-07
258428981,25842898,71,M,2024-05-01,20250924,,KEYTRUDA,Pruritus,HO,KEYTRUDA | Pruritus | HO,2024-04-29/2024-05-05
258429911,25842991,74,F,,20250924,,LANTUS SOLOSTAR,Skin burning sensation,OT,LANTUS SOLOSTAR | Skin burning sensation | OT,NaT
258430211,25843021,,F,,20250924,,DUPIXENT,Sleep disorder due to a general medical condition,,DUPIXENT | Sleep disorder due to a general medical condition,NaT
258430681,25843068,48,F,,20250924,,DUPIXENT,Drug ineffective,,DUPIXENT | Drug ineffective,NaT
258430932,25843093,64,M,2025-09-15,20250927,,DUPIXENT,Device operational issue,,DUPIXENT | Device operational issue,2025-09-15/2025-09-21
258431601,25843160,16,M,2024-12-01,20250924,,DUPIXENT,Headache,,DUPIXENT | Headache,2024-11-25/2024-12-01
258432751,25843275,43,F,2025-01-01,20250924,,DUPIXENT,Abdominal discomfort,,DUPIXENT | Abdominal discomfort,2024-12-30/2025-01-05
258432921,25843292,,M,,20250924,,DUPIXENT,Rash,,DUPIXENT | Rash,NaT
258433341,25843334,,F,2025-01-01,20250924,,DUPIXENT,Rash,,DUPIXENT | Rash,2024-12-30/2025-01-05
258433411,25843341,78,F,,20250924,,TOUJEO,Product storage error,,TOUJEO | Product storage error,NaT
258433751,25843375,69,F,2025-09-13,20250924,,DUPIXENT,Upper respiratory tract infection,,DUPIXENT | Upper respiratory tract infection,2025-09-08/2025-09-14
258434561,25843456,45,F,,20250924,,DUPIXENT,Extra dose administered,,DUPIXENT | Extra dose administered,NaT
258436631,25843663,,F,,20250924,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258436671,25843667,,F,,20250924,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258437261,25843726,51,F,2025-01-01,20250924,,SKYRIZI,Osteoarthritis,OT,SKYRIZI | Osteoarthritis | OT,2024-12-30/2025-01-05
258437481,25843748,72,F,2025-09-07,20250924,,CYCLOSPORINE,Eye irritation,,CYCLOSPORINE | Eye irritation,2025-09-01/2025-09-07
258437751,25843775,,F,,20250924,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258437981,25843798,,F,,20250924,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258438121,25843812,,F,,20250924,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258438341,25843834,,,,20250924,,OMALIZUMAB,Sinusitis,OT,OMALIZUMAB | Sinusitis | OT,NaT
258438551,25843855,75,M,2025-08-09,20250925,,TALETRECTINIB ADIPATE,Prescribed underdose,OT,TALETRECTINIB ADIPATE | Prescribed underdose | OT,2025-08-04/2025-08-10
258439971,25843997,62,M,2025-01-01,20250925,,DUPIXENT,Cataract,OT,DUPIXENT | Cataract | OT,2024-12-30/2025-01-05
258440131,25844013,,,,20250925,,TRAMADOL,Acute kidney injury,HO,TRAMADOL | Acute kidney injury | HO,NaT
258440191,25844019,74,M,,20250925,,SIMVASTATIN,Chronic lymphocytic leukaemia,OT,SIMVASTATIN | Chronic lymphocytic leukaemia | OT,NaT
258440601,25844060,48,F,,20250925,,METHOTREXATE,Drug ineffective,OT,METHOTREXATE | Drug ineffective | OT,NaT
258441031,25844103,11,F,2025-08-26,20250925,,CYCLOPHOSPHAMIDE,White blood cell disorder,HO,CYCLOPHOSPHAMIDE | White blood cell disorder | HO,2025-08-25/2025-08-31
258441131,25844113,,M,,20250925,,DUPIXENT,Asthma,HO,DUPIXENT | Asthma | HO,NaT
258441241,25844124,,,,20250925,,NEMOLIZUMAB,Death,OT,NEMOLIZUMAB | Death | OT,NaT
258442181,25844218,49,F,2025-08-18,20250925,,OPDIVO,Drug reaction with eosinophilia and systemic symptoms,HO,OPDIVO | Drug reaction with eosinophilia and systemic symptoms | HO,2025-08-18/2025-08-24
258442431,25844243,,,,20250925,,SPRAVATO,Hospitalisation,HO,SPRAVATO | Hospitalisation | HO,NaT
258442521,25844252,65,M,2025-08-01,20250925,,DUPIXENT,Condition aggravated,,DUPIXENT | Condition aggravated,2025-07-28/2025-08-03
258444611,25844461,1,M,,20250925,,CERTOLIZUMAB PEGOL,Maternal exposure during pregnancy,OT,CERTOLIZUMAB PEGOL | Maternal exposure during pregnancy | OT,NaT
258445101,25844510,63,M,,20250925,,PREDNISOLONE,Pulmonary alveolar haemorrhage,OT,PREDNISOLONE | Pulmonary alveolar haemorrhage | OT,NaT
258445491,25844549,,F,,20250925,,BENLYSTA,Back pain,OT,BENLYSTA | Back pain | OT,NaT
258445991,25844599,79,F,,20250925,,METHOTREXATE,Drug ineffective,OT,METHOTREXATE | Drug ineffective | OT,NaT
258446091,25844609,63,M,,20250925,,WINREVAIR,Pericardial effusion,OT,WINREVAIR | Pericardial effusion | OT,NaT
258446681,25844668,,F,2025-01-01,20250925,,VENTAVIS,Hospitalisation,HO,VENTAVIS | Hospitalisation | HO,2024-12-30/2025-01-05
258447781,25844778,76,M,2025-09-16,20250925,,REPATHA,Neoplasm malignant,OT,REPATHA | Neoplasm malignant | OT,2025-09-15/2025-09-21
258448421,25844842,43,M,2025-09-18,20250925,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,2025-09-15/2025-09-21
258449981,25844998,69,F,,20250925,,ZEPBOUND,Injection site hypersensitivity,,ZEPBOUND | Injection site hypersensitivity,NaT
258451104,25845110,,M,,20250925,,ABELCET,Drug ineffective,DE,ABELCET | Drug ineffective | DE,NaT
258451491,25845149,71,F,2025-09-18,20250925,,SKYRIZI,Cerebrovascular accident,OT,SKYRIZI | Cerebrovascular accident | OT,2025-09-15/2025-09-21
258451811,25845181,81,M,2025-01-01,20250925,,IMBRUVICA,Knee arthroplasty,OT,IMBRUVICA | Knee arthroplasty | OT,2024-12-30/2025-01-05
258452131,25845213,,F,,20250925,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258452301,25845230,,,,20250925,,TACROLIMUS,Bacterial infection,OT,TACROLIMUS | Bacterial infection | OT,NaT
258452642,25845264,31,M,2025-02-01,20250930,,CABOTEGRAVIR,Off label use,OT,CABOTEGRAVIR | Off label use | OT,2025-01-27/2025-02-02
258453361,25845336,63,F,,20250925,,CYCLOPHOSPHAMIDE,Neck pain,OT,CYCLOPHOSPHAMIDE | Neck pain | OT,NaT
258453391,25845339,,,,20250925,,FASENRA,Asthma,,FASENRA | Asthma,NaT
258453492,25845349,,,,20250925,,EYLEA HD,Blindness,OT,EYLEA HD | Blindness | OT,NaT
258453581,25845358,74,F,,20250925,,ATORVASTATIN CALCIUM,Drug reaction with eosinophilia and systemic symptoms,OT,ATORVASTATIN CALCIUM | Drug reaction with eosinophilia and systemic symptoms | OT,NaT
258454901,25845490,,,,20250925,,VYVANSE,Drug effect less than expected,,VYVANSE | Drug effect less than expected,NaT
258455131,25845513,43,F,2025-09-04,20250925,,LILETTA,Device expulsion,,LILETTA | Device expulsion,2025-09-01/2025-09-07
258455681,25845568,,,2014-09-14,20250925,,ESCITALOPRAM,Anhedonia,DS,ESCITALOPRAM | Anhedonia | DS,2014-09-08/2014-09-14
258455841,25845584,,F,,20250925,,REFRESH RELIEVA PF,Eye pain,,REFRESH RELIEVA PF | Eye pain,NaT
258457101,25845710,,F,,20250925,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258457841,25845784,84,F,2025-08-20,20250925,,SOTATERCEPT,Platelet count decreased,HO,SOTATERCEPT | Platelet count decreased | HO,2025-08-18/2025-08-24
258458572,25845857,25,F,,20250930,,LAMOTRIGINE,Therapeutic response decreased,OT,LAMOTRIGINE | Therapeutic response decreased | OT,NaT
258458961,25845896,26,M,,20250925,,CLONAZEPAM,Drug ineffective,OT,CLONAZEPAM | Drug ineffective | OT,NaT
258459471,25845947,41,F,2025-09-24,20250925,,BISOPROLOL,Diarrhoea haemorrhagic,OT,BISOPROLOL | Diarrhoea haemorrhagic | OT,2025-09-22/2025-09-28
258459501,25845950,64,F,2025-01-01,20250925,,DUPIXENT,Asthma,HO,DUPIXENT | Asthma | HO,2024-12-30/2025-01-05
258459591,25845959,,,,20250925,,DOXORUBICIN,Respiratory failure,HO,DOXORUBICIN | Respiratory failure | HO,NaT
258459641,25845964,,,2025-07-01,20250925,,TORSEMIDE,Drug ineffective,OT,TORSEMIDE | Drug ineffective | OT,2025-06-30/2025-07-06
258460181,25846018,41,F,,20250925,,ANIFROLUMAB,Oropharyngeal pain,OT,ANIFROLUMAB | Oropharyngeal pain | OT,NaT
258460481,25846048,,F,,20250924,,LENALIDOMIDE,Muscle spasms,,LENALIDOMIDE | Muscle spasms,NaT
258460951,25846095,72,M,,20250925,,ACECLOFENAC,Nephropathy toxic,OT,ACECLOFENAC | Nephropathy toxic | OT,NaT
258461041,25846104,82,M,,20250925,,QINLOCK,Drug ineffective,,QINLOCK | Drug ineffective,NaT
258461061,25846106,,F,,20250925,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258461131,25846113,69,F,2025-08-01,20250925,,ORENCIA,Arthralgia,,ORENCIA | Arthralgia,2025-07-28/2025-08-03
258461381,25846138,47,M,2025-04-09,20250925,,DEXAMETHASONE,Hypertension,OT,DEXAMETHASONE | Hypertension | OT,2025-04-07/2025-04-13
258462052,25846205,,,,20250928,,DUPIXENT,Injection site pain,,DUPIXENT | Injection site pain,NaT
258462261,25846226,23,M,2024-10-01,20250925,,DUPIXENT,Pruritus,,DUPIXENT | Pruritus,2024-09-30/2024-10-06
258462341,25846234,,M,,20250925,,DUPIXENT,Exposure via skin contact,,DUPIXENT | Exposure via skin contact,NaT
258462891,25846289,26,F,,20250925,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,NaT
258463271,25846327,20,F,,20250925,,DUPIXENT,Periorbital irritation,,DUPIXENT | Periorbital irritation,NaT
258463412,25846341,63,M,2025-01-01,20250930,,DUPIXENT,Hot flush,,DUPIXENT | Hot flush,2024-12-30/2025-01-05
258464221,25846422,63,M,2025-09-09,20250925,,PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Hepatic cytolysis,OT,PIPERACILLIN SODIUM\TAZOBACTAM SODIUM | Hepatic cytolysis | OT,2025-09-08/2025-09-14
258464261,25846426,6,F,2025-01-01,20250925,,TIVDAK,Conjunctivitis,OT,TIVDAK | Conjunctivitis | OT,2024-12-30/2025-01-05
258464371,25846437,48,,2025-08-20,20250925,,PACLITAXEL,Vomiting,DE,PACLITAXEL | Vomiting | DE,2025-08-18/2025-08-24
258466171,25846617,,M,,20250925,,TACROLIMUS,Transplant dysfunction,HO,TACROLIMUS | Transplant dysfunction | HO,NaT
258466401,25846640,50,M,2025-05-01,20250925,,ENTYVIO,Bone marrow oedema syndrome,DS,ENTYVIO | Bone marrow oedema syndrome | DS,2025-04-28/2025-05-04
258466511,25846651,77,F,2025-01-01,20250925,,DUPIXENT,Dehydration,HO,DUPIXENT | Dehydration | HO,2024-12-30/2025-01-05
258466661,25846666,23,F,2025-01-01,20250925,,DUPIXENT,Swelling,,DUPIXENT | Swelling,2024-12-30/2025-01-05
258467821,25846782,,,,20250925,,LEVETIRACETAM,Epilepsy,DE,LEVETIRACETAM | Epilepsy | DE,NaT
258468111,25846811,59,M,2025-08-28,20250925,,IBUPROFEN,Anaphylactic reaction,LT,IBUPROFEN | Anaphylactic reaction | LT,2025-08-25/2025-08-31
258468891,25846889,,,,20250925,,NITROGLYCERIN,Intercepted product storage error,,NITROGLYCERIN | Intercepted product storage error,NaT
258468911,25846891,12,M,,20250925,,NORDITROPIN,Tibia fracture,OT,NORDITROPIN | Tibia fracture | OT,NaT
258469441,25846944,93,F,2025-07-01,20250925,,NOVOLOG,Breast cancer,OT,NOVOLOG | Breast cancer | OT,2025-06-30/2025-07-06
258470031,25847003,,F,,20250925,,KOSELUGO,Tachycardia,,KOSELUGO | Tachycardia,NaT
258471292,25847129,,F,,20250927,,DUPIXENT,Eye infection,,DUPIXENT | Eye infection,NaT
258472391,25847239,,F,,20250923,,RETACRIT,Surgery,HO,RETACRIT | Surgery | HO,NaT
258473471,25847347,,F,2025-06-19,20250925,,PERSERIS,Intentional dose omission,,PERSERIS | Intentional dose omission,2025-06-16/2025-06-22
258473861,25847386,,F,,20250925,,DEPO-PROVERA,Meningioma benign,OT,DEPO-PROVERA | Meningioma benign | OT,NaT
258473951,25847395,38,F,2025-08-23,20250925,,SODIUM CHLORIDE,Hepatic function abnormal,DS,SODIUM CHLORIDE | Hepatic function abnormal | DS,2025-08-18/2025-08-24
258474071,25847407,,F,,20250925,,MOUNJARO,Depressed mood,OT,MOUNJARO | Depressed mood | OT,NaT
258474111,25847411,,F,,20250925,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,NaT
258476201,25847620,32,F,2025-01-01,20250925,,MIRENA,Bloody discharge,,MIRENA | Bloody discharge,2024-12-30/2025-01-05
258476291,25847629,,,,20250925,,GENOTROPIN,Device leakage,,GENOTROPIN | Device leakage,NaT
258477241,25847724,,F,,20250925,,PROLIA,Body height decreased,,PROLIA | Body height decreased,NaT
258478051,25847805,,F,,20250925,,SYNTHROID,Thyroid mass,,SYNTHROID | Thyroid mass,NaT
258479711,25847971,,F,,20250925,,DUPIXENT,Asthma,,DUPIXENT | Asthma,NaT
258479731,25847973,,,,20250925,,ELAHERE,Therapeutic product effect decreased,,ELAHERE | Therapeutic product effect decreased,NaT
258480731,25848073,65,F,2025-01-01,20250925,,DUPIXENT,Product dose omission issue,OT,DUPIXENT | Product dose omission issue | OT,2024-12-30/2025-01-05
258480811,25848081,16,M,2025-09-01,20250925,,SODIUM CHLORIDE,Poor venous access,,SODIUM CHLORIDE | Poor venous access,2025-09-01/2025-09-07
258480971,25848097,,F,2024-01-01,20250925,,MOUNJARO,Gallbladder enlargement,OT,MOUNJARO | Gallbladder enlargement | OT,2024-01-01/2024-01-07
258481511,25848151,,,,20250925,,TWIRLA,Product adhesion issue,,TWIRLA | Product adhesion issue,NaT
258481711,25848171,,,,20250925,,CARVYKTI,Cranial nerve paralysis,HO,CARVYKTI | Cranial nerve paralysis | HO,NaT
258481831,25848183,43,M,,20250925,,HYDROCODONE BITARTRATE,Drug diversion,,HYDROCODONE BITARTRATE | Drug diversion,NaT
258482471,25848247,,F,2025-01-01,20250925,,CIMZIA,Therapeutic response shortened,OT,CIMZIA | Therapeutic response shortened | OT,2024-12-30/2025-01-05
258483741,25848374,81,M,2025-09-13,20250924,,LENALIDOMIDE,Myocardial infarction,HO,LENALIDOMIDE | Myocardial infarction | HO,2025-09-08/2025-09-14
258485601,25848560,71,F,,20250925,,PAXLOVID,Cerebrovascular accident,OT,PAXLOVID | Cerebrovascular accident | OT,NaT
258486101,25848610,,F,,20250925,,VYEPTI,Peripheral coldness,,VYEPTI | Peripheral coldness,NaT
258486131,25848613,,F,,20250925,,TREMFYA,Product dose omission issue,,TREMFYA | Product dose omission issue,NaT
258486451,25848645,75,F,2025-08-01,20250925,,BIMZELX,Psoriatic arthropathy,OT,BIMZELX | Psoriatic arthropathy | OT,2025-07-28/2025-08-03
258486781,25848678,67,F,2025-08-21,20250925,,ACALABRUTINIB,Diplegia,HO,ACALABRUTINIB | Diplegia | HO,2025-08-18/2025-08-24
258487201,25848720,78,F,2025-09-12,20250925,,GAMMAGARD LIQUID,Nausea,HO,GAMMAGARD LIQUID | Nausea | HO,2025-09-08/2025-09-14
258487661,25848766,42,F,2022-01-01,20250925,,LYRICA,Somnolence,DE,LYRICA | Somnolence | DE,2021-12-27/2022-01-02
258488201,25848820,60,F,2025-01-01,20250925,,PREDNISONE,Insomnia,OT,PREDNISONE | Insomnia | OT,2024-12-30/2025-01-05
258488561,25848856,,,,20250925,,BICILLIN L-A,Recalled product administered,,BICILLIN L-A | Recalled product administered,NaT
258488661,25848866,,F,,20250925,,MAVENCLAD,Sepsis,OT,MAVENCLAD | Sepsis | OT,NaT
258488921,25848892,,,2024-07-18,20250925,,QSYMIA,Breast mass,,QSYMIA | Breast mass,2024-07-15/2024-07-21
258489181,25848918,,,,20250925,,QSYMIA,Sleep apnoea syndrome,,QSYMIA | Sleep apnoea syndrome,NaT
258489721,25848972,,,,20250925,,QSYMIA,Tremor,,QSYMIA | Tremor,NaT
258490811,25849081,,M,2016-01-01,20250925,,REFRESH CLASSIC,Corneal transplant,OT,REFRESH CLASSIC | Corneal transplant | OT,2015-12-28/2016-01-03
258491001,25849100,74,M,2025-09-16,20250925,,ATROVENT,Oxygen saturation decreased,OT,ATROVENT | Oxygen saturation decreased | OT,2025-09-15/2025-09-21
258491661,25849166,,,,20250925,,ZENPEP,Malaise,HO,ZENPEP | Malaise | HO,NaT
258492091,25849209,,F,,20250925,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Dementia,OT,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Dementia | OT,NaT
258492321,25849232,,,,20250925,,NEMLUVIO,Headache,,NEMLUVIO | Headache,NaT
258492751,25849275,24,F,2025-09-09,20250925,,EMGALITY,Food poisoning,,EMGALITY | Food poisoning,2025-09-08/2025-09-14
258493071,25849307,0,M,2024-11-11,20250925,,REBIF,Foetal exposure during pregnancy,OT,REBIF | Foetal exposure during pregnancy | OT,2024-11-11/2024-11-17
258493211,25849321,,,,20250925,,RYBREVANT,Blood pressure decreased,OT,RYBREVANT | Blood pressure decreased | OT,NaT
258493371,25849337,85,F,2025-01-01,20250925,,XARELTO,Arteriosclerosis coronary artery,HO,XARELTO | Arteriosclerosis coronary artery | HO,2024-12-30/2025-01-05
258494241,25849424,65,M,2025-08-01,20250925,,SKYRIZI,Cardiac operation,OT,SKYRIZI | Cardiac operation | OT,2025-07-28/2025-08-03
258494391,25849439,,,,20250925,,AVIBACTAM SODIUM\CEFTAZIDIME,Transaminases increased,OT,AVIBACTAM SODIUM\CEFTAZIDIME | Transaminases increased | OT,NaT
258494711,25849471,67,F,2025-05-21,20250926,,CETIRIZINE,Dry mouth,OT,CETIRIZINE | Dry mouth | OT,2025-05-19/2025-05-25
258494951,25849495,,F,,20250926,,SKYRIZI,Breast cancer,OT,SKYRIZI | Breast cancer | OT,NaT
258495931,25849593,26,F,,20250926,,BLINATUMOMAB,Leukaemic infiltration extramedullary,OT,BLINATUMOMAB | Leukaemic infiltration extramedullary | OT,NaT
258496291,25849629,,F,,20250926,,LEVOTHYROXINE,Blood thyroid stimulating hormone increased,OT,LEVOTHYROXINE | Blood thyroid stimulating hormone increased | OT,NaT
258497031,25849703,,F,,20250926,,OMNITROPE,Device breakage,,OMNITROPE | Device breakage,NaT
258497171,25849717,75,F,,20250926,,CABOMETYX,Diarrhoea,,CABOMETYX | Diarrhoea,NaT
258497281,25849728,75,F,2025-09-11,20250926,,ALENDRONIC ACID,Pain in extremity,OT,ALENDRONIC ACID | Pain in extremity | OT,2025-09-08/2025-09-14
258497401,25849740,19,M,2025-09-10,20250926,,COBENFY,Abdominal discomfort,,COBENFY | Abdominal discomfort,2025-09-08/2025-09-14
258497961,25849796,40,F,,20250926,,MOUNJARO,Product dose omission issue,,MOUNJARO | Product dose omission issue,NaT
258497981,25849798,,,,20250926,,KISUNLA,Amyloid related imaging abnormality-oedema/effusion,OT,KISUNLA | Amyloid related imaging abnormality-oedema/effusion | OT,NaT
258499041,25849904,,F,,20250926,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258500541,25850054,,F,,20250926,,XOLAIR PFS,Idiopathic urticaria,,XOLAIR PFS | Idiopathic urticaria,NaT
258501561,25850156,69,F,,20250926,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,NaT
258501621,25850162,41,M,,20250926,,EMGALITY,Injection site discomfort,,EMGALITY | Injection site discomfort,NaT
258502041,25850204,66,M,,20250926,,REVLIMID,Fatigue,,REVLIMID | Fatigue,NaT
258503011,25850301,,M,,20250926,,CARBIDOPA\LEVODOPA,Device use issue,OT,CARBIDOPA\LEVODOPA | Device use issue | OT,NaT
258503521,25850352,,,2025-06-03,20250926,,INFLIXIMAB,Product quality issue,OT,INFLIXIMAB | Product quality issue | OT,2025-06-02/2025-06-08
258505231,25850523,82,M,,20250926,,ORGOVYX,Hot flush,,ORGOVYX | Hot flush,NaT
258505461,25850546,,F,,20250926,,SKYRIZI,Oesophageal carcinoma,OT,SKYRIZI | Oesophageal carcinoma | OT,NaT
258505891,25850589,80,M,,20250926,,ORENCIA,Arthralgia,,ORENCIA | Arthralgia,NaT
258506201,25850620,67,F,,20250926,,METHOTREXATE,Fatigue,OT,METHOTREXATE | Fatigue | OT,NaT
258506301,25850630,66,M,2025-09-01,20250926,,NUPLAZID,Incorrect dose administered,,NUPLAZID | Incorrect dose administered,2025-09-01/2025-09-07
258506631,25850663,7,F,,20250926,,OLANZAPINE,Drug effective for unapproved indication,,OLANZAPINE | Drug effective for unapproved indication,NaT
258508091,25850809,,F,,20250926,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258508211,25850821,,,2025-08-01,20250926,,NEMLUVIO,Product dose omission issue,,NEMLUVIO | Product dose omission issue,2025-07-28/2025-08-03
258508842,25850884,73,M,,20250930,,FRUQUINTINIB,Colorectal cancer metastatic,DE,FRUQUINTINIB | Colorectal cancer metastatic | DE,NaT
258509121,25850912,,F,,20250926,,OFEV,Gastrointestinal haemorrhage,HO,OFEV | Gastrointestinal haemorrhage | HO,NaT
258510051,25851005,,F,1995-01-01,20250926,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,1994-12-26/1995-01-01
258510301,25851030,,F,,20250926,,BENLYSTA,Weight decreased,,BENLYSTA | Weight decreased,NaT
258510861,25851086,,F,,20250926,,RINVOQ,Ankle operation,OT,RINVOQ | Ankle operation | OT,NaT
258511171,25851117,,F,,20250926,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258511231,25851123,,F,,20250926,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258511311,25851131,,F,,20250926,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258511911,25851191,,F,,20250926,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258512051,25851205,,,,20250926,,RITUXIMAB,COVID-19,OT,RITUXIMAB | COVID-19 | OT,NaT
258512311,25851231,,F,,20250926,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258512931,25851293,,,,20250926,,BOSENTAN,Malaise,,BOSENTAN | Malaise,NaT
258513491,25851349,96,M,,20250926,,XTANDI,Glioblastoma,DE,XTANDI | Glioblastoma | DE,NaT
258513581,25851358,,F,,20250926,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258513661,25851366,48,F,2025-09-24,20250925,,HUMIRA,Injection site pain,OT,HUMIRA | Injection site pain | OT,2025-09-22/2025-09-28
258514561,25851456,,F,2025-09-20,20250926,,HUMAN RHO(D) IMMUNE GLOBULIN,Maternal exposure during pregnancy,HO,HUMAN RHO(D) IMMUNE GLOBULIN | Maternal exposure during pregnancy | HO,2025-09-15/2025-09-21
258515041,25851504,,,2025-02-10,20250926,,FLUOROURACIL,Hyperkalaemia,OT,FLUOROURACIL | Hyperkalaemia | OT,2025-02-10/2025-02-16
258515831,25851583,,M,,20250926,,ILUMYA,Death,DE,ILUMYA | Death | DE,NaT
258516651,25851665,87,F,,20250926,,INFLIXIMAB,Gallbladder cancer metastatic,DE,INFLIXIMAB | Gallbladder cancer metastatic | DE,NaT
258516671,25851667,80,M,2025-08-22,20250926,,MIRTAZAPINE,Medication error,DE,MIRTAZAPINE | Medication error | DE,2025-08-18/2025-08-24
258517221,25851722,64,M,,20250926,,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Oncologic complication,HO,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN | Oncologic complication | HO,NaT
258517251,25851725,,M,,20250926,,ALLEGRA,Adverse drug reaction,,ALLEGRA | Adverse drug reaction,NaT
258517341,25851734,,M,,20250926,,ALLEGRA,No adverse event,,ALLEGRA | No adverse event,NaT
258517391,25851739,,,,20250926,,OCREVUS,Respiratory tract infection,HO,OCREVUS | Respiratory tract infection | HO,NaT
258518671,25851867,,F,,20250926,,MATULANE,Nausea,,MATULANE | Nausea,NaT
258519221,25851922,,,,20250926,,VENTOLIN,Drug ineffective,HO,VENTOLIN | Drug ineffective | HO,NaT
258519901,25851990,,,,20250926,,OMALIZUMAB,Asthma,OT,OMALIZUMAB | Asthma | OT,NaT
258520031,25852003,,M,2025-06-01,20250926,,WEGOVY,Decreased appetite,OT,WEGOVY | Decreased appetite | OT,2025-05-26/2025-06-01
258520701,25852070,,F,,20250925,,LENALIDOMIDE,Blister infected,HO,LENALIDOMIDE | Blister infected | HO,NaT
258521301,25852130,,M,,20250926,,RESTASIS,Product storage error,,RESTASIS | Product storage error,NaT
258521911,25852191,,,,20250926,,NINTEDANIB,Death,DE,NINTEDANIB | Death | DE,NaT
258522141,25852214,75,F,,20250926,,ZEPBOUND,Incorrect dose administered,,ZEPBOUND | Incorrect dose administered,NaT
258522311,25852231,69,M,2025-09-15,20250926,,FLUOROURACIL,Abdominal pain,HO,FLUOROURACIL | Abdominal pain | HO,2025-09-15/2025-09-21
258522741,25852274,,,,20250926,,TRIAMCINOLONE ACETONIDE,Product use in unapproved indication,OT,TRIAMCINOLONE ACETONIDE | Product use in unapproved indication | OT,NaT
258523081,25852308,,F,,20250926,,ATOGEPANT,Therapeutic response unexpected,,ATOGEPANT | Therapeutic response unexpected,NaT
258523401,25852340,72,M,,20250926,,METHOTREXATE SODIUM,Drug hypersensitivity,,METHOTREXATE SODIUM | Drug hypersensitivity,NaT
258524351,25852435,,F,,20250926,,ESTRADIOL,Device adhesion issue,,ESTRADIOL | Device adhesion issue,NaT
258525111,25852511,33,M,,20250926,,IRINOTECAN HYDROCHLORIDE,Malignant neoplasm progression,OT,IRINOTECAN HYDROCHLORIDE | Malignant neoplasm progression | OT,NaT
258525251,25852525,66,M,,20250926,,DIGOXIN,Hyperkalaemia,HO,DIGOXIN | Hyperkalaemia | HO,NaT
258525271,25852527,61,F,2025-08-17,20250926,,OXALIPLATIN,Arthralgia,HO,OXALIPLATIN | Arthralgia | HO,2025-08-11/2025-08-17
258526411,25852641,63,M,2025-06-25,20250926,,TEMODAL,Taste disorder,HO,TEMODAL | Taste disorder | HO,2025-06-23/2025-06-29
258526851,25852685,,F,,20250926,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258527081,25852708,,F,,20250926,,ZOLPIDEM TARTRATE,Pharmaceutical nomadism,OT,ZOLPIDEM TARTRATE | Pharmaceutical nomadism | OT,NaT
258527241,25852724,,F,,20250926,,BREZTRI,Eye disorder,,BREZTRI | Eye disorder,NaT
258527461,25852746,44,M,,20250926,,SELEGILINE,Drug ineffective,,SELEGILINE | Drug ineffective,NaT
258527571,25852757,67,F,,20250926,,"CLONIDINE TRANSDERMAL SYSTEM USP, 0.2 MG/DAY",Blister,,"CLONIDINE TRANSDERMAL SYSTEM USP, 0.2 MG/DAY | Blister",NaT
258528621,25852862,52,F,2025-09-03,20250926,,XELJANZ,Knee arthroplasty,OT,XELJANZ | Knee arthroplasty | OT,2025-09-01/2025-09-07
258529001,25852900,51,F,2025-09-24,20250926,,IBRANCE,Blood creatine phosphokinase increased,OT,IBRANCE | Blood creatine phosphokinase increased | OT,2025-09-22/2025-09-28
258529341,25852934,,F,2023-08-08,20250926,,DEPO-PROVERA,Meningioma,OT,DEPO-PROVERA | Meningioma | OT,2023-08-07/2023-08-13
258529591,25852959,40,F,,20250926,,ZEPBOUND,Accidental underdose,,ZEPBOUND | Accidental underdose,NaT
258530621,25853062,44,F,2025-08-16,20250925,,PAZOPANIB,Death,DE,PAZOPANIB | Death | DE,2025-08-11/2025-08-17
258531231,25853123,,,,20250926,,PACLITAXEL,Dyspnoea,,PACLITAXEL | Dyspnoea,NaT
258531751,25853175,82,M,,20250926,,MORPHINE SULFATE,Amnesia,DE,MORPHINE SULFATE | Amnesia | DE,NaT
258532611,25853261,65,F,2025-04-24,20250926,,VERZENIO,Diarrhoea,OT,VERZENIO | Diarrhoea | OT,2025-04-21/2025-04-27
258532921,25853292,,,,20250926,,REVUFORJ,Cardiac disorder,OT,REVUFORJ | Cardiac disorder | OT,NaT
258532941,25853294,46,,,20250926,,LACOSAMIDE,Drug ineffective,,LACOSAMIDE | Drug ineffective,NaT
258533741,25853374,,,2025-09-25,20250926,,LUMIGAN,Therapeutic product effect incomplete,,LUMIGAN | Therapeutic product effect incomplete,2025-09-22/2025-09-28
258534601,25853460,88,F,2025-08-17,20250926,,VALACYCLOVIR HYDROCHLORIDE,Rash pruritic,HO,VALACYCLOVIR HYDROCHLORIDE | Rash pruritic | HO,2025-08-11/2025-08-17
258535662,25853566,,M,,20250930,,MEKINIST,Dyspnoea,HO,MEKINIST | Dyspnoea | HO,NaT
258536091,25853609,77,M,,20250926,,TECENTRIQ,Death,DE,TECENTRIQ | Death | DE,NaT
258536971,25853697,53,M,2025-09-01,20250926,,STIVARGA,Blood pressure increased,OT,STIVARGA | Blood pressure increased | OT,2025-09-01/2025-09-07
258537091,25853709,3,M,2023-02-01,20250926,,KITABIS PAK,Death,DE,KITABIS PAK | Death | DE,2023-01-30/2023-02-05
258537131,25853713,,F,,20250926,,COLCHICINE,Product use issue,,COLCHICINE | Product use issue,NaT
258538191,25853819,71,M,,20250926,,POMALYST,Rhinorrhoea,,POMALYST | Rhinorrhoea,NaT
258538791,25853879,,,,20250926,,INFED,Off label use,,INFED | Off label use,NaT
258538961,25853896,,F,,20250926,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258539241,25853924,,F,,20250926,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258539621,25853962,17,F,,20250926,,AMLODIPINE BESYLATE,Intentional overdose,HO,AMLODIPINE BESYLATE | Intentional overdose | HO,NaT
258540321,25854032,,,,20250926,,XCOPRI,Drug ineffective,OT,XCOPRI | Drug ineffective | OT,NaT
258541031,25854103,62,F,,20250926,,XELJANZ XR,Fatigue,,XELJANZ XR | Fatigue,NaT
258541671,25854167,49,F,2023-08-07,20250926,,PAXLOVID,Product communication issue,,PAXLOVID | Product communication issue,2023-08-07/2023-08-13
258541891,25854189,82,M,2023-10-01,20250926,,PAXLOVID,Product dose omission issue,,PAXLOVID | Product dose omission issue,2023-09-25/2023-10-01
258542251,25854225,11,M,,20250926,,EPIDIOLEX,Pain,OT,EPIDIOLEX | Pain | OT,NaT
258542441,25854244,,F,,20250926,,ZEPBOUND,Maternal exposure during pregnancy,,ZEPBOUND | Maternal exposure during pregnancy,NaT
258542711,25854271,,,,20250926,,MOUNJARO,Depressed mood,OT,MOUNJARO | Depressed mood | OT,NaT
258542941,25854294,79,F,2025-08-15,20250927,,SYNTHROID,Death,DE,SYNTHROID | Death | DE,2025-08-11/2025-08-17
258543411,25854341,28,M,2025-09-23,20250927,,SKYRIZI,Transfusion,OT,SKYRIZI | Transfusion | OT,2025-09-22/2025-09-28
258543852,25854385,,M,,20250927,,HYRIMOZ,Drug dose omission by device,,HYRIMOZ | Drug dose omission by device,NaT
258544761,25854476,9,F,,20250927,,AMOXICILLIN\CLAVULANIC ACID,Anaphylactic reaction,HO,AMOXICILLIN\CLAVULANIC ACID | Anaphylactic reaction | HO,NaT
258545421,25854542,79,F,2025-09-06,20250927,,TRELEGY ELLIPTA,Product complaint,,TRELEGY ELLIPTA | Product complaint,2025-09-01/2025-09-07
258545471,25854547,,F,,20250927,,DUPIXENT,Cough,,DUPIXENT | Cough,NaT
258546071,25854607,,M,,20250927,,DUPIXENT,Gait inability,,DUPIXENT | Gait inability,NaT
258547151,25854715,,M,,20250927,,IRBESARTAN,Neoplasm malignant,OT,IRBESARTAN | Neoplasm malignant | OT,NaT
258547931,25854793,,F,,20250927,,DUPIXENT,Abdominal pain upper,,DUPIXENT | Abdominal pain upper,NaT
258547941,25854794,9,F,2025-01-01,20250927,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2024-12-30/2025-01-05
258548511,25854851,83,M,2025-01-01,20250927,,DUPIXENT,Sensitive skin,OT,DUPIXENT | Sensitive skin | OT,2024-12-30/2025-01-05
258550291,25855029,37,F,2025-09-01,20250927,,DUPIXENT,Eczema,,DUPIXENT | Eczema,2025-09-01/2025-09-07
258550381,25855038,12,F,2025-01-01,20250927,,DUPIXENT,Vomiting,,DUPIXENT | Vomiting,2024-12-30/2025-01-05
258550891,25855089,,M,,20250927,,JEMPERLI,Off label use,,JEMPERLI | Off label use,NaT
258551371,25855137,,F,,20250927,,FASENRA,Cough,,FASENRA | Cough,NaT
258551471,25855147,,F,,20250927,,DUPIXENT,Accidental exposure to product,,DUPIXENT | Accidental exposure to product,NaT
258554161,25855416,2,F,2025-01-01,20250927,,DUPIXENT,Injection site swelling,,DUPIXENT | Injection site swelling,2024-12-30/2025-01-05
258554201,25855420,36,M,,20250927,,ELFABRIO,Gastric haemorrhage,OT,ELFABRIO | Gastric haemorrhage | OT,NaT
258554371,25855437,,F,,20250927,,SKYRIZI,Drug ineffective,,SKYRIZI | Drug ineffective,NaT
258554971,25855497,,F,,20250927,,NEXIUM,Colon cancer,OT,NEXIUM | Colon cancer | OT,NaT
258557131,25855713,67,F,2020-09-01,20250928,,NUCALA,Product use in unapproved indication,HO,NUCALA | Product use in unapproved indication | HO,2020-08-31/2020-09-06
258557491,25855749,79,,,20250928,,TISLELIZUMAB,Myelosuppression,OT,TISLELIZUMAB | Myelosuppression | OT,NaT
258557501,25855750,42,F,2025-09-03,20250928,,BENRALIZUMAB,COVID-19,HO,BENRALIZUMAB | COVID-19 | HO,2025-09-01/2025-09-07
258557961,25855796,,F,,20250928,,HUMALOG,Blood glucose increased,,HUMALOG | Blood glucose increased,NaT
258559721,25855972,60,M,,20250928,,TALTZ,Drug ineffective,,TALTZ | Drug ineffective,NaT
258561211,25856121,74,F,2025-01-01,20250928,,DUPIXENT,Weight decreased,OT,DUPIXENT | Weight decreased | OT,2024-12-30/2025-01-05
258562121,25856212,61,F,2025-08-28,20250928,,TALTZ,Abdominal discomfort,,TALTZ | Abdominal discomfort,2025-08-25/2025-08-31
258562701,25856270,,,2025-09-01,20250928,,VORASIDENIB,Nephrolithiasis,OT,VORASIDENIB | Nephrolithiasis | OT,2025-09-01/2025-09-07
258563291,25856329,58,,,20250928,,PEMBROLIZUMAB,Cardiac dysfunction,OT,PEMBROLIZUMAB | Cardiac dysfunction | OT,NaT
258563391,25856339,75,M,2024-06-16,20250928,,ZERBAXA,Pruritus,OT,ZERBAXA | Pruritus | OT,2024-06-10/2024-06-16
258563411,25856341,78,,,20250928,,BRUKINSA,Gastrointestinal tube insertion,LT,BRUKINSA | Gastrointestinal tube insertion | LT,NaT
258564491,25856449,,F,,20250929,,REPATHA,Nausea,,REPATHA | Nausea,NaT
258564501,25856450,48,M,2025-01-01,20250929,,SKYRIZI,Coronary arterial stent insertion,OT,SKYRIZI | Coronary arterial stent insertion | OT,2024-12-30/2025-01-05
258565521,25856552,,M,2025-01-01,20250929,,BIMZELX,Staphylococcal infection,HO,BIMZELX | Staphylococcal infection | HO,2024-12-30/2025-01-05
258567061,25856706,,F,,20250929,,NUCALA,Rhinorrhoea,,NUCALA | Rhinorrhoea,NaT
258567641,25856764,,,,20250929,,TRELEGY ELLIPTA,Cushingoid,,TRELEGY ELLIPTA | Cushingoid,NaT
258567951,25856795,,,,20250929,,ELAHERE,Cataract,,ELAHERE | Cataract,NaT
258569401,25856940,,,,20250929,,TRELEGY ELLIPTA,Condition aggravated,,TRELEGY ELLIPTA | Condition aggravated,NaT
258569541,25856954,2,F,,20250929,,TOBRAMYCIN,Therapy non-responder,HO,TOBRAMYCIN | Therapy non-responder | HO,NaT
258569571,25856957,15,,2025-09-12,20250929,,STERILE DILUENT (WATER),Overdose,,STERILE DILUENT (WATER) | Overdose,2025-09-08/2025-09-14
258569762,25856976,63,F,,20250930,,ORENCIA,Abdominal pain,,ORENCIA | Abdominal pain,NaT
258569891,25856989,69,F,,20250929,,AMLODIPINE,Therapy non-responder,HO,AMLODIPINE | Therapy non-responder | HO,NaT
258570231,25857023,,F,,20250929,,SKYRIZI,Device issue,,SKYRIZI | Device issue,NaT
258570241,25857024,60,M,,20250929,,DAPAGLIFLOZIN,Cerebral infarction,OT,DAPAGLIFLOZIN | Cerebral infarction | OT,NaT
258570351,25857035,,F,2025-09-24,20250929,,FASENRA,Asthma,,FASENRA | Asthma,2025-09-22/2025-09-28
258570771,25857077,,F,,20250929,,ACTEMRA,Oedema peripheral,OT,ACTEMRA | Oedema peripheral | OT,NaT
258571591,25857159,,M,,20250929,,FASENRA,Cough,,FASENRA | Cough,NaT
258571721,25857172,49,M,2024-03-01,20250929,,RINVOQ,Spinal fusion surgery,OT,RINVOQ | Spinal fusion surgery | OT,2024-02-26/2024-03-03
258574061,25857406,41,F,2025-09-23,20250929,,ZEPBOUND,Accidental underdose,,ZEPBOUND | Accidental underdose,2025-09-22/2025-09-28
258575351,25857535,72,M,,20250929,,VONJO,Intentional dose omission,,VONJO | Intentional dose omission,NaT
258575561,25857556,70,M,,20250929,,REVLIMID,Nasopharyngitis,,REVLIMID | Nasopharyngitis,NaT
258575921,25857592,,F,,20250929,,KEYTRUDA,Rash,,KEYTRUDA | Rash,NaT
258576081,25857608,59,F,2025-04-08,20250929,,BASAGLAR,Blood glucose increased,,BASAGLAR | Blood glucose increased,2025-04-07/2025-04-13
258576711,25857671,,,,20250929,,PREDNISOLONE,Treatment failure,OT,PREDNISOLONE | Treatment failure | OT,NaT
258576951,25857695,54,F,2025-09-08,20250929,,NITROFURANTOIN,Back pain,OT,NITROFURANTOIN | Back pain | OT,2025-09-08/2025-09-14
258577731,25857773,28,F,2024-01-01,20250929,,RISPERIDONE,Indifference,OT,RISPERIDONE | Indifference | OT,2024-01-01/2024-01-07
258577841,25857784,70,M,2024-09-26,20250929,,VEDOLIZUMAB,Remission not achieved,OT,VEDOLIZUMAB | Remission not achieved | OT,2024-09-23/2024-09-29
258578951,25857895,70,F,2025-06-01,20250929,,CLOPIDOGREL,Pneumonia,HO,CLOPIDOGREL | Pneumonia | HO,2025-05-26/2025-06-01
258579671,25857967,78,F,2025-09-01,20250929,,HUMIRA,Inflammation,,HUMIRA | Inflammation,2025-09-01/2025-09-07
258580741,25858074,81,M,,20250929,,ZOLEDRONIC ACID,Myocardial infarction,OT,ZOLEDRONIC ACID | Myocardial infarction | OT,NaT
258580911,25858091,80,M,2025-01-01,20250929,,POMALYST,Pathological fracture,OT,POMALYST | Pathological fracture | OT,2024-12-30/2025-01-05
258581491,25858149,33,F,,20250929,,HYDROXYCHLOROQUINE,Drug ineffective,OT,HYDROXYCHLOROQUINE | Drug ineffective | OT,NaT
258581721,25858172,,F,,20250929,,VEDOLIZUMAB,Product dose omission issue,OT,VEDOLIZUMAB | Product dose omission issue | OT,NaT
258581771,25858177,,,2025-09-03,20250929,,NEMLUVIO,Inappropriate schedule of product administration,,NEMLUVIO | Inappropriate schedule of product administration,2025-09-01/2025-09-07
258582221,25858222,68,M,,20250929,,TACROLIMUS,Oesophageal candidiasis,OT,TACROLIMUS | Oesophageal candidiasis | OT,NaT
258583171,25858317,41,F,2014-02-01,20250929,,GAMMAGARD LIQUID,Arthralgia,,GAMMAGARD LIQUID | Arthralgia,2014-01-27/2014-02-02
258583661,25858366,,F,,20250929,,ELIQUIS,Pollakiuria,,ELIQUIS | Pollakiuria,NaT
258584831,25858483,35,F,2016-06-01,20250929,,PARAGARD T 380A,Procedural haemorrhage,OT,PARAGARD T 380A | Procedural haemorrhage | OT,2016-05-30/2016-06-05
258585201,25858520,68,M,2024-06-01,20250929,,ATEZOLIZUMAB,Infection,OT,ATEZOLIZUMAB | Infection | OT,2024-05-27/2024-06-02
258585351,25858535,44,M,,20250929,,NEORAL,Post transplant lymphoproliferative disorder,DE,NEORAL | Post transplant lymphoproliferative disorder | DE,NaT
258586501,25858650,,M,,20250929,,CYCLOSPORINE,Graft versus host disease in liver,OT,CYCLOSPORINE | Graft versus host disease in liver | OT,NaT
258586841,25858684,,M,2025-09-23,20250929,,RISANKIZUMAB,Product storage error,,RISANKIZUMAB | Product storage error,2025-09-22/2025-09-28
258586901,25858690,76,F,,20250929,,ENHERTU,Urinary tract infection,HO,ENHERTU | Urinary tract infection | HO,NaT
258587281,25858728,75,F,2025-09-22,20250927,,DOXORUBICIN HYDROCHLORIDE,Cardiac failure chronic,HO,DOXORUBICIN HYDROCHLORIDE | Cardiac failure chronic | HO,2025-09-22/2025-09-28
258588001,25858800,,M,,20250928,,MYCOPHENOLIC ACID,Surgery,HO,MYCOPHENOLIC ACID | Surgery | HO,NaT
258588091,25858809,52,M,,20250928,,CAPECITABINE,Ileostomy,RI,CAPECITABINE | Ileostomy | RI,NaT
258589401,25858940,76,M,2021-01-01,20250929,,VELCADE,Plasmacytoma,OT,VELCADE | Plasmacytoma | OT,2020-12-28/2021-01-03
258589511,25858951,,M,,20250929,,BUDESONIDE,Sinusitis,,BUDESONIDE | Sinusitis,NaT
258589621,25858962,,M,2025-09-22,20250929,,CLOZARIL,Hospitalisation,HO,CLOZARIL | Hospitalisation | HO,2025-09-22/2025-09-28
258590211,25859021,,F,2025-09-12,20250929,,DEFITELIO,Haemorrhage,HO,DEFITELIO | Haemorrhage | HO,2025-09-08/2025-09-14
258590332,25859033,68,F,,20250930,,DOPTELET,Drug ineffective,,DOPTELET | Drug ineffective,NaT
258590861,25859086,,F,2021-01-01,20250929,,VEDOLIZUMAB,Arthritis enteropathic,HO,VEDOLIZUMAB | Arthritis enteropathic | HO,2020-12-28/2021-01-03
258590891,25859089,,F,,20250929,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258590931,25859093,,,,20250929,,MIRALAX,Product prescribing issue,,MIRALAX | Product prescribing issue,NaT
258591811,25859181,66,M,2025-09-16,20250929,,INCRUSE ELLIPTA,Drug ineffective,,INCRUSE ELLIPTA | Drug ineffective,2025-09-15/2025-09-21
258592031,25859203,,,,20250929,,INGREZZA,Drooling,,INGREZZA | Drooling,NaT
258593061,25859306,78,M,2025-09-16,20250929,,NUPLAZID,Death,DE,NUPLAZID | Death | DE,2025-09-15/2025-09-21
258593261,25859326,,,,20250929,,RITUXIMAB,Peripheral sensory neuropathy,OT,RITUXIMAB | Peripheral sensory neuropathy | OT,NaT
258594581,25859458,67,F,,20250929,,EMGALITY,Deafness,DS,EMGALITY | Deafness | DS,NaT
258595341,25859534,,M,,20250929,,TICE BCG,Incorrect dose administered,,TICE BCG | Incorrect dose administered,NaT
258595521,25859552,58,,2025-08-01,20250929,,OPDIVO,Toxicity to various agents,,OPDIVO | Toxicity to various agents,2025-07-28/2025-08-03
258595611,25859561,70,M,2025-03-01,20250929,,CREON,Pancreatic carcinoma recurrent,OT,CREON | Pancreatic carcinoma recurrent | OT,2025-02-24/2025-03-02
258596291,25859629,,,,20250929,,HEMLIBRA,Haemorrhage,,HEMLIBRA | Haemorrhage,NaT
258597031,25859703,19,M,2025-09-12,20250926,,DUPIXENT,Swelling,HO,DUPIXENT | Swelling | HO,2025-09-08/2025-09-14
258597161,25859716,,,,20250929,,NICOTINE POLACRILEX,Abdominal pain upper,,NICOTINE POLACRILEX | Abdominal pain upper,NaT
258597871,25859787,35,F,2025-09-01,20250929,,RENFLEXIS,Off label use,OT,RENFLEXIS | Off label use | OT,2025-09-01/2025-09-07
258598291,25859829,,F,,20250929,,ACTEMRA,Diverticulitis,OT,ACTEMRA | Diverticulitis | OT,NaT
258598731,25859873,,,2020-06-01,20250929,,BENZOYL PEROXIDE\CLINDAMYCIN,Product physical consistency issue,,BENZOYL PEROXIDE\CLINDAMYCIN | Product physical consistency issue,2020-06-01/2020-06-07
258599341,25859934,,F,,20250929,,MIRENA,Genital haemorrhage,,MIRENA | Genital haemorrhage,NaT
258600741,25860074,66,M,,20250929,,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM,Dyspnoea,HO,BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM | Dyspnoea | HO,NaT
258600781,25860078,17,F,,20250929,,PREDNISOLONE,Off label use,,PREDNISOLONE | Off label use,NaT
258601161,25860116,,,2025-08-17,20250929,,NICOTINE POLACRILEX,Oral discomfort,,NICOTINE POLACRILEX | Oral discomfort,2025-08-11/2025-08-17
258601571,25860157,,,,20250929,,PROLIA,Death,DE,PROLIA | Death | DE,NaT
258603981,25860398,,F,,20250929,,OPSUMIT,Exposure during pregnancy,,OPSUMIT | Exposure during pregnancy,NaT
258605521,25860552,12,F,,20250929,,PREDNISONE,Skin striae,,PREDNISONE | Skin striae,NaT
258606211,25860621,69,M,2025-09-29,20250929,,REPATHA,Pain in extremity,OT,REPATHA | Pain in extremity | OT,2025-09-29/2025-10-05
258608921,25860892,,M,,20250929,,DUPIXENT,Rash,,DUPIXENT | Rash,NaT
258608971,25860897,12,M,2025-01-01,20250929,,DUPIXENT,Blister,,DUPIXENT | Blister,2024-12-30/2025-01-05
258609021,25860902,29,M,2025-01-01,20250929,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2024-12-30/2025-01-05
258609041,25860904,66,M,2025-08-01,20250929,,DUPIXENT,Dyspnoea,,DUPIXENT | Dyspnoea,2025-07-28/2025-08-03
258609331,25860933,73,F,,20250929,,DUPIXENT,Accidental exposure to product,,DUPIXENT | Accidental exposure to product,NaT
258609911,25860991,11,F,2025-08-01,20250929,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,2025-07-28/2025-08-03
258609951,25860995,14,M,,20250929,,DUPIXENT,Dermatitis atopic,,DUPIXENT | Dermatitis atopic,NaT
258610041,25861004,8,F,2025-01-01,20250929,,DUPIXENT,Fear of injection,,DUPIXENT | Fear of injection,2024-12-30/2025-01-05
258610121,25861012,28,M,2025-09-01,20250929,,CABLIVI,Haemorrhoids,,CABLIVI | Haemorrhoids,2025-09-01/2025-09-07
258610191,25861019,39,M,2025-01-01,20250929,,DUPIXENT,Neurodermatitis,,DUPIXENT | Neurodermatitis,2024-12-30/2025-01-05
258612191,25861219,,,2025-01-01,20250929,,REZDIFFRA,Asthenia,,REZDIFFRA | Asthenia,2024-12-30/2025-01-05
258612282,25861228,,,,20250929,,RAVICTI,Colitis ulcerative,HO,RAVICTI | Colitis ulcerative | HO,NaT
258612891,25861289,33,M,2025-09-23,20250929,,OMVOH,Hyperhidrosis,,OMVOH | Hyperhidrosis,2025-09-22/2025-09-28
258613781,25861378,,F,,20250929,,TRUQAP,Diarrhoea,,TRUQAP | Diarrhoea,NaT
258614481,25861448,,F,,20250929,,GLATOPA,Device delivery system issue,,GLATOPA | Device delivery system issue,NaT
258615591,25861559,,,,20250930,,TRELEGY ELLIPTA,Wrong technique in device usage process,,TRELEGY ELLIPTA | Wrong technique in device usage process,NaT
258615781,25861578,,M,,20250930,,TALVEY,Anhidrosis,OT,TALVEY | Anhidrosis | OT,NaT
258616221,25861622,57,F,,20250930,,OLUMIANT,Overdose,,OLUMIANT | Overdose,NaT
258616781,25861678,67,F,2025-06-06,20250930,,TIROSINT,Drug abuse,HO,TIROSINT | Drug abuse | HO,2025-06-02/2025-06-08
258618531,25861853,,F,2025-01-01,20250930,,FERRIPROX,Maternal exposure during pregnancy,,FERRIPROX | Maternal exposure during pregnancy,2024-12-30/2025-01-05
258620141,25862014,,F,,20250930,,VEOZAH,Hepatotoxicity,OT,VEOZAH | Hepatotoxicity | OT,NaT
258621401,25862140,61,M,,20250930,,DUPIXENT,Dry eye,,DUPIXENT | Dry eye,NaT
258622821,25862282,55,F,,20250930,,CLOPIDOGREL,Treatment failure,LT,CLOPIDOGREL | Treatment failure | LT,NaT
258623621,25862362,,M,,20250930,,ULTOMIRIS,Dysphagia,OT,ULTOMIRIS | Dysphagia | OT,NaT
258624381,25862438,81,M,2023-03-01,20250930,,APIXABAN,Arthralgia,OT,APIXABAN | Arthralgia | OT,2023-02-27/2023-03-05
258624611,25862461,55,M,,20250930,,HADLIMA,Depression,HO,HADLIMA | Depression | HO,NaT
258624661,25862466,,M,,20250930,,EPIDIOLEX,Hospitalisation,HO,EPIDIOLEX | Hospitalisation | HO,NaT
258625021,25862502,,M,,20250930,,NUPLAZID,Swelling,,NUPLAZID | Swelling,NaT
258627041,25862704,,M,,20250930,,KRYSTEXXA,Chronic kidney disease,OT,KRYSTEXXA | Chronic kidney disease | OT,NaT
258627521,25862752,54,M,,20250930,,ADYNOVATE,Haemarthrosis,OT,ADYNOVATE | Haemarthrosis | OT,NaT
258627791,25862779,,F,,20250930,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258628921,25862892,,,2025-01-01,20250930,,VIGAFYDE,Drug intolerance,,VIGAFYDE | Drug intolerance,2024-12-30/2025-01-05
258629451,25862945,66,F,2025-09-01,20250930,,CRESTOR,Epilepsy,OT,CRESTOR | Epilepsy | OT,2025-09-01/2025-09-07
258629731,25862973,31,F,,20250930,,METHYLPHENIDATE HYDROCHLORIDE,Electrocardiogram QT prolonged,OT,METHYLPHENIDATE HYDROCHLORIDE | Electrocardiogram QT prolonged | OT,NaT
258629741,25862974,,M,,20250930,,TAFINLAR,Chills,,TAFINLAR | Chills,NaT
258630621,25863062,,F,,20250930,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258630791,25863079,82,F,2025-09-02,20250930,,EMPAGLIFLOZIN,Fournier's gangrene,HO,EMPAGLIFLOZIN | Fournier's gangrene | HO,2025-09-01/2025-09-07
258632591,25863259,40,M,2025-08-01,20250930,,RINVOQ,Femur fracture,OT,RINVOQ | Femur fracture | OT,2025-07-28/2025-08-03
258633451,25863345,,F,,20250930,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258634221,25863422,52,F,2025-08-02,20250930,,VYEPTI,Back pain,,VYEPTI | Back pain,2025-07-28/2025-08-03
258635061,25863506,,F,,20250930,,IBERDOMIDE,Intentional product use issue,DE,IBERDOMIDE | Intentional product use issue | DE,NaT
258635681,25863568,,M,,20250930,,NUCALA,Hypotension,HO,NUCALA | Hypotension | HO,NaT
258637331,25863733,7,M,,20250930,,ZOLEDRONIC ACID,Drug ineffective,OT,ZOLEDRONIC ACID | Drug ineffective | OT,NaT
258637841,25863784,,,2025-09-24,20250929,,CYMBALTA,Anxiety,RI,CYMBALTA | Anxiety | RI,2025-09-22/2025-09-28
258637911,25863791,,F,,20250930,,NUCALA,Dyspnoea,,NUCALA | Dyspnoea,NaT
258638201,25863820,,F,,20250930,,OPSUMIT,Hospitalisation,HO,OPSUMIT | Hospitalisation | HO,NaT
258638441,25863844,60,M,,20250930,,TACROLIMUS,Pancreatitis necrotising,HO,TACROLIMUS | Pancreatitis necrotising | HO,NaT
258640271,25864027,,F,,20250930,,TYLENOL,Exposure during pregnancy,,TYLENOL | Exposure during pregnancy,NaT
258640591,25864059,,,,20250930,,LINACLOTIDE,Product storage error,,LINACLOTIDE | Product storage error,NaT
258640741,25864074,,M,,20250929,,VYNDAMAX,Hospitalisation,HO,VYNDAMAX | Hospitalisation | HO,NaT
258640821,25864082,38,F,2025-06-23,20250929,,TEZSPIRE,Pregnancy,,TEZSPIRE | Pregnancy,2025-06-23/2025-06-29
258641271,25864127,84,M,,20250930,,PREDNISONE,Dysphonia,OT,PREDNISONE | Dysphonia | OT,NaT
258641291,25864129,,F,,20250930,,VENETOCLAX,Progressive multifocal leukoencephalopathy,DE,VENETOCLAX | Progressive multifocal leukoencephalopathy | DE,NaT
258641501,25864150,60,M,2025-08-11,20250930,,GABAPENTIN,Somnolence,OT,GABAPENTIN | Somnolence | OT,2025-08-11/2025-08-17
258641531,25864153,,,2020-08-11,20250930,,TADALAFIL,Drug ineffective,,TADALAFIL | Drug ineffective,2020-08-10/2020-08-16
258642161,25864216,58,,,20250930,,MOUNJARO,Incorrect dose administered,,MOUNJARO | Incorrect dose administered,NaT
258642261,25864226,71,M,2025-09-25,20250930,,REVLIMID,Product prescribing error,,REVLIMID | Product prescribing error,2025-09-22/2025-09-28
258642891,25864289,,F,,20250930,,CISPLATIN,Malnutrition,OT,CISPLATIN | Malnutrition | OT,NaT
258643471,25864347,6,F,,20250930,,SPRAVATO,Death,DE,SPRAVATO | Death | DE,NaT
258645521,25864552,69,F,2025-06-11,20250929,,VERZENIO,Haemorrhage,HO,VERZENIO | Haemorrhage | HO,2025-06-09/2025-06-15
258645561,25864556,,,,20250930,,HICON,Hypothyroidism,OT,HICON | Hypothyroidism | OT,NaT
258646761,25864676,,,,20250929,,ZEPBOUND,Therapeutic response changed,,ZEPBOUND | Therapeutic response changed,NaT
258647161,25864716,,M,2025-09-01,20250930,,CYPROHEPTADINE,Device information output issue,,CYPROHEPTADINE | Device information output issue,2025-09-01/2025-09-07
258647511,25864751,39,F,2025-05-23,20250930,,ATOMOXETINE,Asthenia,HO,ATOMOXETINE | Asthenia | HO,2025-05-19/2025-05-25
258647531,25864753,,M,,20250930,,ALLEGRA,No adverse event,,ALLEGRA | No adverse event,NaT
258648001,25864800,,F,,20250929,,TADALAFIL,Therapy interrupted,HO,TADALAFIL | Therapy interrupted | HO,NaT
258648081,25864808,31,F,2024-08-01,20250930,,HYDROCHLOROTHIAZIDE,Therapy cessation,LT,HYDROCHLOROTHIAZIDE | Therapy cessation | LT,2024-07-29/2024-08-04
258649051,25864905,88,M,,20250930,,HYDRALAZINE HYDROCHLORIDE,Glomerulonephritis,OT,HYDRALAZINE HYDROCHLORIDE | Glomerulonephritis | OT,NaT
258649211,25864921,94,F,2025-09-08,20250930,,ANORO ELLIPTA,Wrong technique in device usage process,,ANORO ELLIPTA | Wrong technique in device usage process,2025-09-08/2025-09-14
258649641,25864964,,M,,20250930,,VECTIBIX,Pruritus,,VECTIBIX | Pruritus,NaT
258649941,25864994,58,F,2025-09-24,20250930,,TRULICITY,Incorrect dose administered,,TRULICITY | Incorrect dose administered,2025-09-22/2025-09-28
258650371,25865037,15,F,2025-01-01,20250930,,SERTRALINE,Tubulointerstitial nephritis and uveitis syndrome,HO,SERTRALINE | Tubulointerstitial nephritis and uveitis syndrome | HO,2024-12-30/2025-01-05
258650731,25865073,60,M,,20250930,,PREDNISONE,Lung abscess,HO,PREDNISONE | Lung abscess | HO,NaT
258651071,25865107,,M,,20250929,,OTEZLA,Product use issue,HO,OTEZLA | Product use issue | HO,NaT
258651091,25865109,,,,20250930,,INVEGA HAFYERA,Substance abuse,OT,INVEGA HAFYERA | Substance abuse | OT,NaT
258651641,25865164,52,F,,20250930,,NAPROXEN SODIUM,Insulin autoimmune syndrome,OT,NAPROXEN SODIUM | Insulin autoimmune syndrome | OT,NaT
258652961,25865296,63,F,,20250930,,ABRAXANE,Hospitalisation,HO,ABRAXANE | Hospitalisation | HO,NaT
258653991,25865399,,F,,20250930,,BENLYSTA,Systemic lupus erythematosus,OT,BENLYSTA | Systemic lupus erythematosus | OT,NaT
258654331,25865433,66,F,2025-01-01,20250930,,DUPIXENT,Therapeutic response decreased,,DUPIXENT | Therapeutic response decreased,2024-12-30/2025-01-05
258654371,25865437,48,F,,20250930,,DUPIXENT,Therapeutic response decreased,,DUPIXENT | Therapeutic response decreased,NaT
258655381,25865538,77,F,,20250930,,DUPIXENT,Pollakiuria,,DUPIXENT | Pollakiuria,NaT
258655521,25865552,20,M,2025-09-01,20250930,,DUPIXENT,Dermatitis allergic,,DUPIXENT | Dermatitis allergic,2025-09-01/2025-09-07
258655691,25865569,40,M,2025-01-01,20250930,,DUPIXENT,Eye pruritus,,DUPIXENT | Eye pruritus,2024-12-30/2025-01-05
258656381,25865638,,M,2025-09-01,20250930,,DUPIXENT,Umbilical hernia,,DUPIXENT | Umbilical hernia,2025-09-01/2025-09-07
258658231,25865823,42,F,2025-09-10,20250930,,MOUNJARO,Malaise,HO,MOUNJARO | Malaise | HO,2025-09-08/2025-09-14
258658511,25865851,,M,2025-02-04,20250930,,DURVALUMAB,Polyneuropathy,OT,DURVALUMAB | Polyneuropathy | OT,2025-02-03/2025-02-09
258660791,25866079,,F,,20250930,,PLEGRIDY,Drug delivery system malfunction,,PLEGRIDY | Drug delivery system malfunction,NaT
258661801,25866180,57,F,2025-09-17,20250930,,BIVIGAM,Chest discomfort,OT,BIVIGAM | Chest discomfort | OT,2025-09-15/2025-09-21
258662861,25866286,40,F,,20250930,,ACTEMRA,Back pain,OT,ACTEMRA | Back pain | OT,NaT
258663541,25866354,44,F,2025-09-11,20250930,,ABEMACICLIB,Hepatocellular injury,HO,ABEMACICLIB | Hepatocellular injury | HO,2025-09-08/2025-09-14
258664311,25866431,72,M,2025-08-27,20250930,,TOUJEO,Product dose omission issue,HO,TOUJEO | Product dose omission issue | HO,2025-08-25/2025-08-31
258664931,25866493,62,F,,20250930,,PAXLOVID,Product prescribing error,,PAXLOVID | Product prescribing error,NaT
258665071,25866507,68,F,,20250930,,XELJANZ XR,Dyspnoea,,XELJANZ XR | Dyspnoea,NaT
258665111,25866511,,M,,20250930,,DUPIXENT,Cerebrovascular accident,OT,DUPIXENT | Cerebrovascular accident | OT,NaT
258665241,25866524,,F,2025-09-01,20250930,,RILPIVIRINE,Exposure during pregnancy,,RILPIVIRINE | Exposure during pregnancy,2025-09-01/2025-09-07
258665321,25866532,,F,,20250930,,MOUNJARO,Nausea,OT,MOUNJARO | Nausea | OT,NaT
258665621,25866562,67,M,,20250930,,BUDESONIDE\FORMOTEROL,Loss of consciousness,HO,BUDESONIDE\FORMOTEROL | Loss of consciousness | HO,NaT
258667211,25866721,43,F,,20250930,,ZEPOSIA,Colitis ulcerative,OT,ZEPOSIA | Colitis ulcerative | OT,NaT
258689811,25868981,70,M,2025-09-07,20250930,,POMALYST,Dehydration,,POMALYST | Dehydration,2025-09-01/2025-09-07
258697111,25869711,67,M,2025-09-30,20250930,,TAVNEOS,Atrial flutter,HO,TAVNEOS | Atrial flutter | HO,2025-09-29/2025-10-05
258698431,25869843,,M,,20250930,,RECOMBINATE,Pneumonia,HO,RECOMBINATE | Pneumonia | HO,NaT
69804953,6980495,7,M,,20250802,,PROPOFOL,Priapism,HO,PROPOFOL | Priapism | HO,NaT
71395843,7139584,22,F,2009-07-08,20250814,,CASPOFUNGIN ACETATE,Influenza,HO,CASPOFUNGIN ACETATE | Influenza | HO,2009-07-06/2009-07-12
72753233,7275323,80,F,2009-12-22,20250902,,TERIPARATIDE,Cardiac failure,DE,TERIPARATIDE | Cardiac failure | DE,2009-12-21/2009-12-27
